Psyllid ID: psy10194
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | 2.2.26 [Sep-21-2011] | |||||||
| Q9D411 | 328 | Testis-specific serine/th | yes | N/A | 0.831 | 0.905 | 0.469 | 2e-76 | |
| Q6SA08 | 328 | Testis-specific serine/th | yes | N/A | 0.798 | 0.868 | 0.454 | 2e-71 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.756 | 0.735 | 0.491 | 5e-70 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.745 | 0.728 | 0.487 | 7e-70 | |
| Q3SZW1 | 367 | Testis-specific serine/th | no | N/A | 0.745 | 0.724 | 0.487 | 8e-70 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.787 | 0.784 | 0.462 | 2e-68 | |
| Q96PF2 | 358 | Testis-specific serine/th | no | N/A | 0.759 | 0.756 | 0.460 | 4e-68 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.725 | 0.966 | 0.453 | 6e-64 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.725 | 0.966 | 0.438 | 4e-62 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.736 | 0.963 | 0.432 | 2e-60 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 286 bits (731), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 144/307 (46%), Positives = 194/307 (63%), Gaps = 10/307 (3%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
+V+E +GY +G IIG GSY TV A ++ VA+KIISK +A DYL KFLPRE++V+
Sbjct: 18 SVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
K L+H LI F QAIETT RVYII+E A+ G +L+ I++ G ET A KWF+Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIA 137
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---------NHMRYRSRQGYESLSET 208
Y H +G+VHRD+K ENLL+D N+K+SDFGFA+ + YR LS+T
Sbjct: 138 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSLSHLSQT 197
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF 268
+CGS+AYA PEIL G+PY P LSD WSMGV+L+ +V RLPFDDT +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKEVTF 257
Query: 269 PKDPNVSPECKALISKILAPVKTRLRIKNIKEDPW-FRNGPSRPEYPIMSGDSLEVETCC 327
P + +S ECK LI ++L R I ++ DPW + P +P I +++ T
Sbjct: 258 PANLTISQECKNLILQLLRQSTKRATILDVLRDPWMLKFQPEQPSNEIRLLEAMYQPTSS 317
Query: 328 ASEETSF 334
A S
Sbjct: 318 AKRHQSL 324
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 134/295 (45%), Positives = 187/295 (63%), Gaps = 10/295 (3%)
Query: 31 PDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFL 90
P ++++ +GY +G IG GSY +V A ++ VA+KIISK +A DYL KFL
Sbjct: 11 PTTTAYHSLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFL 70
Query: 91 PREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA 150
PRE++V+K L+H LI F +AIE+T RVYII+E A+ G +L+ I++ G E A KWF+
Sbjct: 71 PREIQVMKVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFS 130
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN---------HMRYRSRQG 201
QL I Y H + +VHRD+K ENLL+D N+K+SDFGFA+ YR
Sbjct: 131 QLTLGIAYLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNC 190
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ 261
+ LS+T+CGS+AYA PEIL+G+PY P LSD WSMGV+L+ +V LPFDDT +LL++
Sbjct: 191 FSHLSQTYCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRE 250
Query: 262 VQSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPW-FRNGPSRPEYPI 315
Q +V FP + +S ECK LI ++L R I +I +D W + P +P + I
Sbjct: 251 TQKEVTFPANHTISQECKNLILQMLRQATKRATILDIIKDSWVLKFQPEQPTHEI 305
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (676), Expect = 5e-70, Method: Compositional matrix adjust.
Identities = 137/279 (49%), Positives = 190/279 (68%), Gaps = 9/279 (3%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
VL+ GY LG +G GSYA VK A S R VAIKII + +AP+D+L+KFLPRE+E++
Sbjct: 5 AVLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEIL 64
Query: 98 KGLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
L H ++IK + ET+H +VYI+ME A +G LL++I+ G + E ARK F QL AI
Sbjct: 65 AMLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAI 124
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
YCH+ VVHRD+KC+NLL+D D+NIKLSDF F++ +R S G +LS+TFCGS AYA
Sbjct: 125 KYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKRCLRDDS--GRMALSKTFCGSPAYA 182
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVS 275
+PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWF----RNGPS 309
ECK LI +L P V RL I I W R PS
Sbjct: 243 GECKDLIYHMLQPDVNRRLHIDEILSHCWMQPKARGSPS 281
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 7e-70, Method: Compositional matrix adjust.
Identities = 132/271 (48%), Positives = 186/271 (68%), Gaps = 5/271 (1%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
VL+ GY +G +G GSYA VK A S R VA+KII + +APSD+L+KFLPRE+E++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEIL 64
Query: 98 KGLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
L H +++K + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 65 AMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G LS+TFCGS AYA
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLILSKTFCGSAAYA 182
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVS 275
+PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFR 305
ECK LI ++L P V RL I I W +
Sbjct: 243 GECKDLIYRMLQPDVNRRLHIDEILNHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 8e-70, Method: Compositional matrix adjust.
Identities = 132/271 (48%), Positives = 187/271 (69%), Gaps = 5/271 (1%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
VL+ GY +G +G GSYA VK A S R VA+KII + +AP+D+L+KFLPRE+E++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 98 KGLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
L H ++IK + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 65 AMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G +LS+TFCGS AYA
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLTLSKTFCGSAAYA 182
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVS 275
+PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLT 242
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFR 305
ECK LI ++L P V RL I I W +
Sbjct: 243 GECKDLIYRMLQPDVTRRLHIDEILSHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 134/290 (46%), Positives = 193/290 (66%), Gaps = 9/290 (3%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
VL GY +G +G GSYA VK A S R VA+KII + + P+D++++FLPRE++++
Sbjct: 5 AVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDIL 64
Query: 98 KGLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+ H ++IK + ET+ R+YI+ME +G LL+ I+ G + E ARK F QL A+
Sbjct: 65 ATVNHRSIIKTYEIFETSDGRIYIVMELGVQGDLLEFIKCRGALHEDVARKMFRQLSSAV 124
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G LS+TFCGS AYA
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGS--GRIVLSKTFCGSAAYA 182
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVS 275
+PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ N++
Sbjct: 183 APEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKNLT 242
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVE 324
ECK LI +IL P V RL I I W + P +P+ MS S + E
Sbjct: 243 GECKDLIYRILQPDVNRRLHIDEILSHSWLQ--PPKPK--AMSSASFKRE 288
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 4e-68, Method: Compositional matrix adjust.
Identities = 128/278 (46%), Positives = 188/278 (67%), Gaps = 7/278 (2%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
TVL GY +G +G GSYA VK A S R VA+KII + + P+D++++FLPRE++++
Sbjct: 5 TVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDIL 64
Query: 98 KGLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+ H ++IK + ET+ R+YIIME +G LL+ I+ +G + E ARK F QL A+
Sbjct: 65 ATVNHGSIIKTYEIFETSDGRIYIIMELGVQGDLLEFIKCQGALHEDVARKMFRQLSSAV 124
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
YCH+ +VHRD+KCENLL+D D+NIKLSDFGF++ + R G LS+TFCGS AYA
Sbjct: 125 KYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCL--RDSNGRIILSKTFCGSAAYA 182
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVS 275
+PE+L+ IPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ N++
Sbjct: 183 APEVLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRIQKEHRVDFPRSKNLT 242
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
ECK LI ++L P V RL I I W + P +P+
Sbjct: 243 CECKDLIYRMLQPDVSQRLHIDEILSHSWLQ--PPKPK 278
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 121/267 (45%), Positives = 176/267 (65%), Gaps = 8/267 (2%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
L S+GY LG IG G+Y+ VK A S +H +VAIKII KM P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKIIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 100 LKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
L H N+I+ + +E+ ++Y++ME AE G + D + G + E+RA+ F Q+V+AI Y
Sbjct: 65 LDHKNIIQVYEMLESADGKIYLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
CH GV HRD+KCEN L+ +N+KL+DFGFA+ + R LS+TFCGS AYA+P
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKSR-----RELSQTFCGSTAYAAP 178
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
E+L+GIP+ + DVWSMGVVL+ M+ LPFDDT ++L Q Q V FP +S EC
Sbjct: 179 EVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLGISTEC 238
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWF 304
+ L+ ++L P + R I+ + PW
Sbjct: 239 QDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 117/267 (43%), Positives = 176/267 (65%), Gaps = 8/267 (2%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
L S+GY LG IG G+Y+ VK A S +H +VAIK+I KM P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKVIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 100 LKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
L H N+I+ + +E+ ++ ++ME AE G + D + G + E+RA+ F Q+V+AI Y
Sbjct: 65 LDHKNIIQVYEMLESADGKICLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
CH GV HRD+KCEN L+ +N+KL+DFGFA+ + + LS+TFCGS AYA+P
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAK-----VLPKSHRELSQTFCGSTAYAAP 178
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
E+L+GIP+ + DVWSMGVVL+ M+ LPFDDT ++L Q Q V FP ++S +C
Sbjct: 179 EVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLSISADC 238
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWF 304
+ L+ ++L P + R I+ + PW
Sbjct: 239 QDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 119/275 (43%), Positives = 177/275 (64%), Gaps = 12/275 (4%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
+L GY LG IG GSY+ VK+ATS ++ VAIK++ + +AP D++ KFLPRE+ +++
Sbjct: 6 LLSELGYKLGRTIGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILR 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
G++HP+++ + IE + ++YI+ME A LL +++ G I +AR FAQ+ A+
Sbjct: 66 GVRHPHIVHVFEFIEVCNGKLYIVMEAAAT-DLLQAVQRNGRIPGVQARDLFAQIAGAVR 124
Query: 158 YCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
Y H+ +VHRD+KCEN+L+ D +KL+DFGF R GY LS T+CGS AYA
Sbjct: 125 YLHDHHLVHRDLKCENVLLSPDERRVKLTDFGFGRQ------AHGYPDLSTTYCGSAAYA 178
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276
SPE+L GIPY P+ DVWSMGVVL+ MV G +PFDD+ + L ++ + V++P+ +S
Sbjct: 179 SPEVLLGIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAGLPRRQKRGVLYPEGLELSE 238
Query: 277 ECKALISKIL--APVKTRLRIKNIKEDPWFRNGPS 309
CKALI+++L +P R + + W R G S
Sbjct: 239 RCKALIAELLQFSP-SARPSAGQVARNCWLRAGDS 272
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | ||||||
| 242016558 | 386 | cAMP-dependent protein kinase catalytic | 0.761 | 0.704 | 0.755 | 1e-124 | |
| 380027639 | 345 | PREDICTED: testis-specific serine/threon | 0.756 | 0.782 | 0.735 | 1e-121 | |
| 328776257 | 351 | PREDICTED: testis-specific serine/threon | 0.756 | 0.769 | 0.735 | 1e-121 | |
| 91087563 | 340 | PREDICTED: similar to CG9222 CG9222-PA [ | 0.773 | 0.811 | 0.737 | 1e-120 | |
| 350401037 | 363 | PREDICTED: testis-specific serine/threon | 0.775 | 0.763 | 0.720 | 1e-120 | |
| 383852844 | 364 | PREDICTED: testis-specific serine/threon | 0.826 | 0.810 | 0.668 | 1e-120 | |
| 270010686 | 327 | hypothetical protein TcasGA2_TC010125 [T | 0.773 | 0.844 | 0.737 | 1e-120 | |
| 357614817 | 329 | putative cAMP-dependent protein kinase c | 0.770 | 0.835 | 0.734 | 1e-120 | |
| 340709608 | 363 | PREDICTED: testis-specific serine/threon | 0.775 | 0.763 | 0.716 | 1e-119 | |
| 332019401 | 361 | Testis-specific serine/threonine-protein | 0.795 | 0.786 | 0.681 | 1e-114 |
| >gi|242016558|ref|XP_002428853.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513589|gb|EEB16115.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1155), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/274 (75%), Positives = 239/274 (87%), Gaps = 2/274 (0%)
Query: 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE 95
K+TVLE+HGYTLG IG GSYATVK+A S RH C VA+KI+SK QAP+DYLKKFLPRE+E
Sbjct: 44 KLTVLETHGYTLGKTIGTGSYATVKVARSERHDCLVAVKIVSKFQAPADYLKKFLPREIE 103
Query: 96 VVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDA 155
VVKGLKH NLI+FLQAIETTHRVYIIMEYAE GSLLD+IRK+ YIDE RARK+F QL+DA
Sbjct: 104 VVKGLKHINLIRFLQAIETTHRVYIIMEYAENGSLLDVIRKDQYIDEVRARKYFRQLIDA 163
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
++YCHERGVVHRDIKCENLL+D D N+KLSDFGFAR HMR ++ G LS+TFCGSYAY
Sbjct: 164 VDYCHERGVVHRDIKCENLLMDHDNNVKLSDFGFARGHMRIKN--GVAPLSDTFCGSYAY 221
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275
ASPEILKG+PY PQLSD+WS GVVL+A+V+GRLPFDDT Y+QLLKQVQSK+ FPK+P +S
Sbjct: 222 ASPEILKGVPYQPQLSDIWSTGVVLYAIVYGRLPFDDTNYNQLLKQVQSKISFPKEPKIS 281
Query: 276 PECKALISKILAPVKTRLRIKNIKEDPWFRNGPS 309
CK+LI+KILAPVK RL+I I+ DPWF GPS
Sbjct: 282 ANCKSLITKILAPVKFRLKIPAIRSDPWFVQGPS 315
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027639|ref|XP_003697528.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1133), Expect = e-121, Method: Compositional matrix adjust.
Identities = 200/272 (73%), Positives = 236/272 (86%), Gaps = 2/272 (0%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
++ K+T+LESHGYTLG IG GSYATVK+A S RH C+VA+KI+SK QAP DYLKKFLPR
Sbjct: 25 SEKKLTILESHGYTLGKTIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKFLPR 84
Query: 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
E+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYA+ GSLLDIIR++ +IDE R+R+WF QL
Sbjct: 85 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDEFRSRRWFRQL 144
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
++AI+YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M + + G LSETFCGS
Sbjct: 145 LEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQM--KPKNGTNPLSETFCGS 202
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
YAYASPEILKG+PY PQLSD+WSMGVVL+AMV+GRLPFDDT YSQLLKQVQ+KVVFPK+P
Sbjct: 203 YAYASPEILKGVPYLPQLSDIWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFPKEP 262
Query: 273 NVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
NVS C++LIS+IL P + R+ I NI+ D W
Sbjct: 263 NVSQACRSLISRILVPQRIRMNIDNIRNDTWL 294
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776257|ref|XP_395246.3| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1129), Expect = e-121, Method: Compositional matrix adjust.
Identities = 200/272 (73%), Positives = 236/272 (86%), Gaps = 2/272 (0%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
++ +T+LESHGYTLG IG GSYATVK+A S RH C+VA+KI+SK QAP DYLKKFLPR
Sbjct: 31 SEKXLTILESHGYTLGKPIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKFLPR 90
Query: 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
E+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYA+ GSLLDIIR++ +IDE R+R+WF QL
Sbjct: 91 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDELRSRRWFRQL 150
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
++AI+YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M +++ G LSETFCGS
Sbjct: 151 LEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQM--KAKNGINPLSETFCGS 208
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
YAYASPEILKG+PY PQLSDVWSMGVVL+AMV+GRLPFDDT YSQLLKQVQ+KVVFPK+P
Sbjct: 209 YAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFPKEP 268
Query: 273 NVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
NVS C++LIS+IL P + R+ I NI+ D W
Sbjct: 269 NVSQACRSLISRILVPQRIRMNIDNIRNDTWL 300
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91087563|ref|XP_971036.1| PREDICTED: similar to CG9222 CG9222-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 205/278 (73%), Positives = 235/278 (84%), Gaps = 2/278 (0%)
Query: 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL 86
G+ + K TVLESHGY LG IG GSYATV++A S RH+ VA+KI+SK AP+DYL
Sbjct: 19 GQPIIKEGKKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYL 78
Query: 87 KKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR 146
KKFLPRE+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYAE GSLL+IIRK+ YIDE R+R
Sbjct: 79 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSR 138
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
KWF QLVDA++YCHERGVVHRDIKCENLL++ +Y IKLSDFGFAR HM+ ++ G LS
Sbjct: 139 KWFRQLVDAVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKN--GQAPLS 196
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
ETFCGSYAYASPEILKGIPY PQ SD+WSMGVVLFAMV+GRLPFDDT Y L+KQV +KV
Sbjct: 197 ETFCGSYAYASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKV 256
Query: 267 VFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
VFPK+P VS CKALI+KILAP+K R+RI IK DPW+
Sbjct: 257 VFPKEPKVSLMCKALINKILAPLKARIRIPGIKTDPWY 294
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401037|ref|XP_003486034.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 201/279 (72%), Positives = 239/279 (85%), Gaps = 2/279 (0%)
Query: 26 KGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
+GK+ + K+T+LESHGYTLG IG GSYATVK+A S+RH C+VA+KI+SK QAP DY
Sbjct: 19 EGKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPGDY 78
Query: 86 LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRA 145
LKKFLPRE+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYA GSLLD+IR++ +IDE R+
Sbjct: 79 LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYARCGSLLDMIRRDTFIDEFRS 138
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205
R+WF QL++AI+YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M +S+ G L
Sbjct: 139 RRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQM--KSKNGIAPL 196
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
SETFCGSYAYASPEILKG+PY PQLSDVWSMGVVL+AMV+GRLPFDDT YSQLLKQVQ+K
Sbjct: 197 SETFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNK 256
Query: 266 VVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
V+FPK+PNVS C++LIS+IL + RL I +I+ D W
Sbjct: 257 VIFPKEPNVSQACRSLISRILVSQRIRLHIDHIRNDVWL 295
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852844|ref|XP_003701935.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1125), Expect = e-120, Method: Compositional matrix adjust.
Identities = 202/302 (66%), Positives = 245/302 (81%), Gaps = 7/302 (2%)
Query: 3 IGTNVVRQDRPRSNVWKGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLA 62
+ T + + P+ + + E+D+ D K+TVLESHGY LG IG GSYATVK+A
Sbjct: 1 MATAPIADNSPKPLLKSADNEHDE-----KTDKKLTVLESHGYNLGKTIGSGSYATVKIA 55
Query: 63 TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122
S RH C+VAIKI+SK QAP +YLKKFLPRE+EVVKGL+HPNLI+FLQAIETTHRVYIIM
Sbjct: 56 KSCRHDCQVAIKIVSKFQAPGEYLKKFLPREIEVVKGLRHPNLIRFLQAIETTHRVYIIM 115
Query: 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI 182
EYA+ GSLLDIIR++ +IDE R+R+WF QL++AI+YCH RGVVHRD+KCENLL+D+++N+
Sbjct: 116 EYAQNGSLLDIIRRDTFIDEVRSRRWFRQLLEAIDYCHGRGVVHRDVKCENLLMDSNFNV 175
Query: 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA 242
KLSDFGFAR M + + G LSETFCGSYAYASPEILKGIPY PQLSDVWSMGVVL+A
Sbjct: 176 KLSDFGFARGQM--KPKNGINPLSETFCGSYAYASPEILKGIPYLPQLSDVWSMGVVLYA 233
Query: 243 MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDP 302
MV+GRLPFDDT Y+QLLKQVQS++ FPKDP VS C++LIS+IL P +TRL I I+ D
Sbjct: 234 MVYGRLPFDDTNYNQLLKQVQSRITFPKDPKVSQSCRSLISRILVPQRTRLHIDRIRNDV 293
Query: 303 WF 304
W
Sbjct: 294 WL 295
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010686|gb|EFA07134.1| hypothetical protein TcasGA2_TC010125 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1124), Expect = e-120, Method: Compositional matrix adjust.
Identities = 205/278 (73%), Positives = 235/278 (84%), Gaps = 2/278 (0%)
Query: 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL 86
G+ + K TVLESHGY LG IG GSYATV++A S RH+ VA+KI+SK AP+DYL
Sbjct: 19 GQPIIKEGKKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYL 78
Query: 87 KKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR 146
KKFLPRE+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYAE GSLL+IIRK+ YIDE R+R
Sbjct: 79 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSR 138
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
KWF QLVDA++YCHERGVVHRDIKCENLL++ +Y IKLSDFGFAR HM+ ++ Q LS
Sbjct: 139 KWFRQLVDAVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGHMKIKNGQA--PLS 196
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
ETFCGSYAYASPEILKGIPY PQ SD+WSMGVVLFAMV+GRLPFDDT Y L+KQV +KV
Sbjct: 197 ETFCGSYAYASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKV 256
Query: 267 VFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
VFPK+P VS CKALI+KILAP+K R+RI IK DPW+
Sbjct: 257 VFPKEPKVSLMCKALINKILAPLKARIRIPGIKTDPWY 294
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357614817|gb|EHJ69292.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1121), Expect = e-120, Method: Compositional matrix adjust.
Identities = 205/279 (73%), Positives = 236/279 (84%), Gaps = 4/279 (1%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
D K+TVLE+HGY LG IG GSYATVK+ATS RH+C+VAIKIISK QAP DYLKKFLPR
Sbjct: 17 TDRKLTVLETHGYILGRTIGSGSYATVKVATSERHNCQVAIKIISKFQAPGDYLKKFLPR 76
Query: 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
E+EVVKGLKH NLI+FLQAIETTHRVYI+MEYAE GSLLDIIRK+ +IDE R R+WF QL
Sbjct: 77 EIEVVKGLKHENLIRFLQAIETTHRVYIVMEYAENGSLLDIIRKDQHIDEQRGRRWFKQL 136
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
V+A++YCHERGVVHRDIKCENLL+D NIKLSDFGFAR HM + + G +LSETFCGS
Sbjct: 137 VEAVDYCHERGVVHRDIKCENLLMDHGLNIKLSDFGFARGHM--KPKNGVYALSETFCGS 194
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
YAYASPEILKG+PY PQ SD+WSMGVVL+A+V+GRLPFDDT Y+QLLKQVQ+KV FP++P
Sbjct: 195 YAYASPEILKGVPYRPQDSDIWSMGVVLYAIVYGRLPFDDTNYTQLLKQVQNKVSFPREP 254
Query: 273 NVSPECKALISKILAPVKTRLRIKNIKEDPWFRNGPSRP 311
VS EC+ LI+KILAP+K R +I I DPW PS P
Sbjct: 255 KVSTECRKLITKILAPLKLRSKIPQILADPWL--SPSAP 291
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709608|ref|XP_003393396.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/279 (71%), Positives = 239/279 (85%), Gaps = 2/279 (0%)
Query: 26 KGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
+GK+ + K+T+LESHGYTLG IG GSYATVK+A S+RH C+VA+KI+SK QAP DY
Sbjct: 19 EGKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPGDY 78
Query: 86 LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRA 145
LKKFLPRE+EVVKGLKHPNLI+FLQAIETTHRVYIIMEYA+ GSLLD+IR++ +IDE R+
Sbjct: 79 LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDMIRRDTFIDEFRS 138
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205
R+WF QL++AI+YCH RGVVHRDIKCENLL+D ++NIKLSDFGFAR M +S+ G L
Sbjct: 139 RRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARGQM--KSKNGIAPL 196
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
SETFCGSYAYASPEIL G+PY PQLSDVWSMGVVL+AMV+GRLPFDDT YSQLLKQVQ+K
Sbjct: 197 SETFCGSYAYASPEILMGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNK 256
Query: 266 VVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
V+FPK+PNVS C++LIS+IL + RL I +I+ D W
Sbjct: 257 VIFPKEPNVSQACRSLISRILVSQRIRLDIDHIRNDVWL 295
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019401|gb|EGI59887.1| Testis-specific serine/threonine-protein kinase 4 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 195/286 (68%), Positives = 233/286 (81%), Gaps = 2/286 (0%)
Query: 19 KGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK 78
+ M+ K+ ++ K+TVLESHGYTLG IG GSYATVK+A S R+ +VA+KI+SK
Sbjct: 15 QAGMKLTDQKNGEKSEKKLTVLESHGYTLGKTIGAGSYATVKVAKSDRYGYQVAVKIVSK 74
Query: 79 MQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG 138
QAP +YL KFLPRE+EVVKGLKHPNLI FLQAIETTHRVYIIMEYA+ GSLLDIIR++
Sbjct: 75 FQAPGEYLTKFLPREIEVVKGLKHPNLIHFLQAIETTHRVYIIMEYAQNGSLLDIIRRDT 134
Query: 139 YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198
YIDE R+R+WF QL++AI YCHE G+VHRD+KCENLL+D +NIKLSDFGFAR M+ ++
Sbjct: 135 YIDELRSRRWFRQLLEAIEYCHEHGIVHRDVKCENLLMDFRFNIKLSDFGFARGQMKLKN 194
Query: 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL 258
G LS T+CGSYAYASPEIL+GIPY PQLSD+WSMGVVL+AMV GRLPFDDT Y+QL
Sbjct: 195 --GEWPLSTTYCGSYAYASPEILRGIPYQPQLSDIWSMGVVLYAMVHGRLPFDDTNYAQL 252
Query: 259 LKQVQSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
LKQVQ++VVFPK P VS C++LIS+IL P RLRI +IK D W
Sbjct: 253 LKQVQNRVVFPKHPKVSQPCRSLISRILVPQFARLRINSIKNDAWL 298
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 357 | ||||||
| FB|FBgn0031784 | 337 | CG9222 [Drosophila melanogaste | 0.753 | 0.798 | 0.575 | 3.9e-83 | |
| UNIPROTKB|F6RLA2 | 326 | TSSK4 "Uncharacterized protein | 0.868 | 0.950 | 0.467 | 1.6e-70 | |
| MGI|MGI:1918349 | 328 | Tssk4 "testis-specific serine | 0.829 | 0.902 | 0.473 | 3.8e-69 | |
| UNIPROTKB|E2R1G2 | 358 | TSSK2 "Uncharacterized protein | 0.784 | 0.782 | 0.470 | 5.8e-66 | |
| UNIPROTKB|Q9BXA7 | 367 | TSSK1B "Testis-specific serine | 0.742 | 0.722 | 0.496 | 2e-65 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.736 | 0.716 | 0.492 | 5.2e-65 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.736 | 0.716 | 0.492 | 5.2e-65 | |
| MGI|MGI:1347557 | 365 | Tssk1 "testis-specific serine | 0.736 | 0.720 | 0.492 | 5.2e-65 | |
| RGD|1307352 | 365 | Tssk1b "testis-specific serine | 0.736 | 0.720 | 0.488 | 5.2e-65 | |
| UNIPROTKB|Q6SA08 | 328 | TSSK4 "Testis-specific serine/ | 0.798 | 0.868 | 0.457 | 6.7e-65 |
| FB|FBgn0031784 CG9222 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
Identities = 157/273 (57%), Positives = 201/273 (73%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
T+LE HG LG +IG G+YA VK+ S + VA+KIISK++APS+Y +KFLPRE+E V
Sbjct: 69 TILEEHGIILGKVIGTGNYAKVKIGFSEEYGKRVAVKIISKVKAPSEYTQKFLPREIEAV 128
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
KGL H NLI F Q+IET+HRVY+IM+ AE G+LLD +R+ ++DE ++R F QLV A+
Sbjct: 129 KGLHHENLITFYQSIETSHRVYLIMQLAENGTLLDYVRERKFLDEPQSRTLFKQLVSAVE 188
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y H +GVVHRDIKCENLL+D ++N+KL DFGFAR R Q LS+TFCGSYAYAS
Sbjct: 189 YIHSKGVVHRDIKCENLLLDENWNLKLIDFGFARKDTRTSDNQVI--LSKTFCGSYAYAS 246
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
PEILKG+ Y P +SD+W+ GVV +AMVFGRLP+D + LLK++ +VFPK P+ S E
Sbjct: 247 PEILKGVAYDPFMSDIWACGVVCYAMVFGRLPYDGSNVHILLKRINQSLVFPKSPSASSE 306
Query: 278 CKALISKILAPVKTRLRIKNIKEDPWFRNGPSR 310
CK +I ILAPVK R I +KEDPW+ PS+
Sbjct: 307 CKHMIMHILAPVKIRYNIPQVKEDPWY--SPSK 337
|
|
| UNIPROTKB|F6RLA2 TSSK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 1.6e-70, P = 1.6e-70
Identities = 153/327 (46%), Positives = 203/327 (62%)
Query: 26 KGK-DLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD 84
KG + P +V+E +GY +G +IG GSY TV A ++ VA+KIISK +A D
Sbjct: 3 KGDMEAPPTSAYRSVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASED 62
Query: 85 YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETR 144
YL KFLPRE++V+K L+H LI F QAIETT RVYII+E A+ G +L+ I++ G E
Sbjct: 63 YLNKFLPREIQVMKVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPL 122
Query: 145 ARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA---------RNHMR 195
A KWF+QL I Y H +G+VHRD+K ENLL+D N+K+SDFGFA RN
Sbjct: 123 AGKWFSQLTLGIAYLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSNQSVRNSPS 182
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255
YR + LS+T+CGS+AYA PEIL G+PY P LSD WSMGV+L+ +V RLPFDDT
Sbjct: 183 YRQMNCFSHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNL 242
Query: 256 SQLLKQVQSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPW-FRNGPSRPEYP 314
+LLK+ Q +V FP + +S ECK LI + L R I +I +DPW + P +P +
Sbjct: 243 KKLLKETQKEVTFPPNYAISQECKNLILQTLRQAPKRATILDIIKDPWVLKFQPEQPTHE 302
Query: 315 IMSGDSLEVETCCASEETSFSTAQSVE 341
I +E C T+ + QS+E
Sbjct: 303 IRL-----LEAMCQPPSTT-NRHQSLE 323
|
|
| MGI|MGI:1918349 Tssk4 "testis-specific serine kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
Identities = 145/306 (47%), Positives = 194/306 (63%)
Query: 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
+V+E +GY +G IIG GSY TV A ++ VA+KIISK +A DYL KFLPRE++V+
Sbjct: 18 SVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 77
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
K L+H LI F QAIETT RVYII+E A+ G +L+ I++ G ET A KWF+Q+ I
Sbjct: 78 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETLAGKWFSQMALGIA 137
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-------HMR--YRSRQGYESLSET 208
Y H +G+VHRD+K ENLL+D N+K+SDFGFA+ H YR LS+T
Sbjct: 138 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPSYRQMNSLSHLSQT 197
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF 268
+CGS+AYA PEIL G+PY P LSD WSMGV+L+ +V RLPFDDT +LL++ Q +V F
Sbjct: 198 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLRETQKEVTF 257
Query: 269 PKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF-RNGPSRPEYPIMSGDSLEVETCC 327
P + +S ECK LI ++L R I ++ DPW + P +P I +++ T
Sbjct: 258 PANLTISQECKNLILQLLRQSTKRATILDVLRDPWMLKFQPEQPSNEIRLLEAMYQPTSS 317
Query: 328 ASEETS 333
A S
Sbjct: 318 AKRHQS 323
|
|
| UNIPROTKB|E2R1G2 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 5.8e-66, P = 5.8e-66
Identities = 136/289 (47%), Positives = 195/289 (67%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY +G +G GSYA VK A S R VA+KII + +AP D+L+KFLPRE+E++
Sbjct: 6 VLKQRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPKDFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H +++K + ET+ +VYI+ME +G LL+ I+ G + E AR+ F QL AI
Sbjct: 66 MLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALHEDDARRKFHQLSSAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ +VHRD+KCENLL+D D+NIKLSDFGF++ +R S G +LS+TFCGS AYA+
Sbjct: 126 YCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLTLSKTFCGSAAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ N++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKNLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVE 324
ECK LI ++L P V RL I I W + P +P+ MS S + E
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHSWLQ--PPKPK--AMSSASFKRE 288
|
|
| UNIPROTKB|Q9BXA7 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 134/270 (49%), Positives = 188/270 (69%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY LG +G GSYA VK A S R VAIKII + +AP+D+L+KFLPRE+E++
Sbjct: 6 VLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H ++IK + ET+H +VYI+ME A +G LL++I+ G + E ARK F QL AI
Sbjct: 66 MLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ VVHRD+KC+NLL+D D+NIKLSDF F++ +R S G +LS+TFCGS AYA+
Sbjct: 126 YCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKRCLRDDS--GRMALSKTFCGSPAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPWFR 305
ECK LI +L P V RL I I W +
Sbjct: 244 ECKDLIYHMLQPDVNRRLHIDEILSHCWMQ 273
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 132/268 (49%), Positives = 186/268 (69%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY +G +G GSYA VK A S R VA+KII + +AP+D+L+KFLPRE+E++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H ++IK + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 66 MLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G +LS+TFCGS AYA+
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLTLSKTFCGSAAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPW 303
ECK LI ++L P V RL I I W
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCW 271
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 132/268 (49%), Positives = 186/268 (69%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY +G +G GSYA VK A S R VA+KII + +AP+D+L+KFLPRE+E++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H ++IK + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 66 MLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G +LS+TFCGS AYA+
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLTLSKTFCGSAAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPW 303
ECK LI ++L P V RL I I W
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCW 271
|
|
| MGI|MGI:1347557 Tssk1 "testis-specific serine kinase 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 132/268 (49%), Positives = 185/268 (69%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY +G +G GSYA VK A S R VA+KII + +APSD+L+KFLPRE+E++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H +++K + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 66 MLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G LS+TFCGS AYA+
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLILSKTFCGSAAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPW 303
ECK LI ++L P V RL I I W
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILNHCW 271
|
|
| RGD|1307352 Tssk1b "testis-specific serine kinase 1B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
Identities = 131/268 (48%), Positives = 186/268 (69%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
VL+ GY +G +G GSYA VK A S R VA+KII + +AP+D+L+KFLPRE+E++
Sbjct: 6 VLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEILA 65
Query: 99 GLKHPNLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
L H +++K + ET+ +VYI+ME +G LL+ I+ G + E ARK F QL AI
Sbjct: 66 MLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAIK 125
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
YCH+ VVHRD+KCENLL+D D+NIKLSDFGF++ +R S G +LS+TFCGS AYA+
Sbjct: 126 YCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDDS--GRLTLSKTFCGSAAYAA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK-QVQSKVVFPKDPNVSP 276
PE+L+GIPY P++ D+WS+GV+L+ MV G +P+DD+ ++L+ Q + +V FP+ +++
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPW 303
ECK LI ++L P V RL I I W
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHCW 271
|
|
| UNIPROTKB|Q6SA08 TSSK4 "Testis-specific serine/threonine-protein kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 6.7e-65, P = 6.7e-65
Identities = 135/295 (45%), Positives = 188/295 (63%)
Query: 31 PDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFL 90
P ++++ +GY +G IG GSY +V A ++ VA+KIISK +A DYL KFL
Sbjct: 11 PTTTAYHSLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFL 70
Query: 91 PREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA 150
PRE++V+K L+H LI F +AIE+T RVYII+E A+ G +L+ I++ G E A KWF+
Sbjct: 71 PREIQVMKVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFS 130
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHM-----RYRSRQG 201
QL I Y H + +VHRD+K ENLL+D N+K+SDFGFA+ N YR
Sbjct: 131 QLTLGIAYLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNC 190
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ 261
+ LS+T+CGS+AYA PEIL+G+PY P LSD WSMGV+L+ +V LPFDDT +LL++
Sbjct: 191 FSHLSQTYCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRE 250
Query: 262 VQSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPW-FRNGPSRPEYPI 315
Q +V FP + +S ECK LI ++L R I +I +D W + P +P + I
Sbjct: 251 TQKEVTFPANHTISQECKNLILQMLRQATKRATILDIIKDSWVLKFQPEQPTHEI 305
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6SA08 | TSSK4_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4542 | 0.7983 | 0.8689 | yes | N/A |
| Q9D411 | TSSK4_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4690 | 0.8319 | 0.9054 | yes | N/A |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.3837 | 0.7366 | 0.6004 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 357 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-79 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-57 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-54 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-45 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-44 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-38 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-37 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-35 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-34 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-33 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-32 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-32 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-32 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-32 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-32 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-32 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-31 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-30 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-30 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-30 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-29 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-29 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-28 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-26 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-25 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-24 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 4e-87
Identities = 92/264 (34%), Positives = 151/264 (57%), Gaps = 14/264 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G GS+ V LA + VAIK+I K + D ++ + RE++++K LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ E ++Y++MEY E G L D+++K G + E AR + Q++ A+ Y H +G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRD+K EN+L+D D ++KL+DFG AR + TF G+ Y +PE+L G
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR-------QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSK--VVFPKDPNVSPECKAL 281
Y D+WS+GV+L+ ++ G+ PF D + +L K++ P + ++SPE K L
Sbjct: 172 GYGKA-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 282 ISKILAP-VKTRLRIKNIKEDPWF 304
I K+L + RL + + P+F
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 5e-79
Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 14/267 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L +G GS+ TV A VA+KI+ K S + RE+ +++ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ + A E +Y++MEY E G L D + + G + E A+K Q++ + Y H G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K EN+L+D + +K++DFG A+ ++ SL+ TF G+ Y +PE+L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK-----SSSSLT-TFVGTPWYMAPEVLLGG 173
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---SQLLKQVQS---KVVFPKDPNVSPEC 278
DVWS+GV+L+ ++ G+ PF QL++++ + PK + S E
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWF 304
K LI K L R + I + PWF
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 5e-63
Identities = 74/195 (37%), Positives = 117/195 (60%), Gaps = 10/195 (5%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G + TV LA + +VAIKII K S L + L RE+E++K L HPN++K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 111 AIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
E + +Y++MEY E GSL D++ EG + E + Q+++ + Y H G++HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 170 KCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
K EN+L+D+D +KL+DFG ++ +SL +T G+ AY +PE+L G Y
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL------TSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 229 QLSDVWSMGVVLFAM 243
+ SD+WS+GV+L+ +
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 6e-57
Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 20/262 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G GS+ V L A+K++ K + + E ++ + HP ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
A +T ++Y+++EYA G L + KEG E RAR + A++V A+ Y H G+++RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE--TFCGSYAYASPEILKGIPYCP 228
EN+L+DAD +IKL+DFG A ++ S TFCG+ Y +PE+L G Y
Sbjct: 121 PENILLDADGHIKLTDFGLA--------KELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKILA 287
D WS+GV+L+ M+ G+ PF ++ +++ + + FP +SPE + LIS +L
Sbjct: 173 A-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP--EFLSPEARDLISGLLQ 229
Query: 288 PVKTRLRIKN-----IKEDPWF 304
T+ R+ + IK P+F
Sbjct: 230 KDPTK-RLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-57
Identities = 75/248 (30%), Positives = 122/248 (49%), Gaps = 16/248 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII--SKMQAPSDYLKKFLPREVEVVKGLKH 102
Y + IG GS+ V L +K I S M ++ EV+++K L H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE---REDALNEVKILKKLNH 58
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINY 158
PN+IK+ ++ E ++ I+MEYA+ G L I+K+ E + WF QL A+ Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H R ++HRDIK +N+ + ++ +KL DFG + + L++T G+ Y SP
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS------KVLSSTVDLAKTVVGTPYYLSP 172
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
E+ + PY SD+WS+G VL+ + + PF+ +L ++ P S E
Sbjct: 173 ELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSEL 231
Query: 279 KALISKIL 286
+ L+S +L
Sbjct: 232 RNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 1e-56
Identities = 92/281 (32%), Positives = 148/281 (52%), Gaps = 24/281 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP 103
+ G IIG GS++TV LA + E AIKI+ K Q + K++ E EV+ L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
+IK + +Y ++EYA G LL IRK G +DE R + A+++ A+ Y H +G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSE----------TF 209
++HRD+K EN+L+D D +IK++DFG A+ N ++ ++ +F
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVF 268
G+ Y SPE+L P SD+W++G +++ M+ G+ PF + +++ + F
Sbjct: 183 VGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 269 PKDPNVSPECKALISKIL-APVKTRLRIK----NIKEDPWF 304
P PN P+ K LI K+L + RL + +K P+F
Sbjct: 242 P--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-54
Identities = 69/253 (27%), Positives = 128/253 (50%), Gaps = 20/253 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK--KFLPREVEVVKGLKH 102
+T G ++G GS+ +V LA +A+K ++ D + + L RE+ ++ L+H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVK---SVELSGDSEEELEALEREIRILSSLQH 58
Query: 103 PNLIKFL--QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
PN++++ + E + + I +EY GSL +++K G + E RK+ Q+++ + Y H
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
G+VHRDIK N+L+D+D +KL+DFG A+ + + G+ + +PE+
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL----GDIETGEGTGSVRGTPYWMAPEV 174
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-----NVS 275
++G Y +D+WS+G + M G+ P+ + K+ +P ++S
Sbjct: 175 IRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEHLS 230
Query: 276 PECKALISKILAP 288
E K + K L
Sbjct: 231 EEAKDFLRKCLRR 243
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 79/263 (30%), Positives = 134/263 (50%), Gaps = 8/263 (3%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
I G+Y V LA AIK+I K + E +++ + P ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ + +Y++MEY G L ++ G +DE AR + A++V A+ Y H G++HRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 171 CENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+N+LID++ ++KL+DFG ++ + R + E + G+ Y +PE++ G +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 229 QLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA 287
D WS+G +L+ + G PF +T + K+ +P+D VS E LISK+L
Sbjct: 181 T-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 288 P-VKTRL---RIKNIKEDPWFRN 306
P + RL I+ IK P+F+
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-46
Identities = 80/236 (33%), Positives = 127/236 (53%), Gaps = 10/236 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y LG +IG G++ V + VAIK IS + + LK + +E++++K LKHPN
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPN 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K++ +IET+ +YII+EYAE GSL II+K G E+ + Q++ + Y HE+GV
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK N+L D +KL+DFG A + G+ + +PE+++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATK------LNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
SD+WS+G + ++ G P +D + L + VQ P +SPE K
Sbjct: 175 GAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP-PLPEGISPELK 228
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 6e-46
Identities = 83/282 (29%), Positives = 137/282 (48%), Gaps = 23/282 (8%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
Y + +G GS+ V LA + VA+K+++K + RE++++ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 104 -NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY---IDETRARKWFAQLVDAINYC 159
N++K + +Y++MEY + GSL D+++K G + E+ A AQ++ A+ Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 160 HERGVVHRDIKCENLLIDADYN-IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H +G++HRDIK EN+L+D D +KL DFG A+ S +L T G+ Y +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 219 EILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNV-- 274
E+L G+ Y SD+WS+G+ L+ ++ G PF+ K S Q ++ P++
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 275 ----------SPECKALISKILAP-VKTRLRIKNIKEDPWFR 305
S L+ K+LA K RL +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 87/297 (29%), Positives = 147/297 (49%), Gaps = 44/297 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKK----FLPREVEVVKGL 100
+ + +IG G++ V L A+K++ K SD +K+ + E +++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK----SDMIKRNQIAHVRAERDILADA 58
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
P ++K + + +Y++MEY G L++++ ++ E AR + A+LV A++ H
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFG----FARNHMRY-------------------R 197
+ G +HRDIK +N+LIDAD +IKL+DFG + R R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ 257
+ + + G+ Y +PE+L+G PY D WS+GV+L+ M++G PF YS
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPF----YSD 233
Query: 258 LLKQVQSKV-------VFPKDPNVSPECKALISKILAPVKTRL-RIKNIKEDPWFRN 306
L++ +K+ FP DP VSPE LI ++L + RL + IK P+F+
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 23/268 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G+G + V+L + A+K + K ++ + E E+++ HP ++K +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ +Y++MEY G L I+R G DE AR + A +V A Y H RG+++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
ENLL+D++ +KL DFGFA+ ++ + TFCG+ Y +PEI+ Y
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKK--LKSGQKTW-----TFCGTPEYVAPEIILNKGY-DFS 172
Query: 231 SDVWSMGVVLFAMVFGRLPF--DDTK----YSQLLKQVQSKVVFPKDPNVSPECKALISK 284
D WS+G++L+ ++ GR PF DD Y+ +LK K+ FP + K LI +
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-GKLEFPN--YIDKAAKDLIKQ 229
Query: 285 ILAPVKT-RL-----RIKNIKEDPWFRN 306
+L RL IK+IK+ WF
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 26/268 (9%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIIS--KMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
IG GS+ TV+ + K I M ++ K+ L EV +++ LKHPN+++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVR 63
Query: 108 FLQAI--ETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHE 161
+ I + +YI+MEY E G L +I+K YI+E + QL+ A+ CH
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 162 RG-----VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
R V+HRD+K N+ +DA+ N+KL DFG A+ + + S S ++T+ G+ Y
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDS-----SFAKTYVGTPYYM 177
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276
SPE L + Y + SD+WS+G +++ + PF QL +++ S
Sbjct: 178 SPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 277 ECKALISKILAPVKTRLR--IKNIKEDP 302
E +I +L V R + + + P
Sbjct: 237 ELNEVIKSMLN-VDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 87/275 (31%), Positives = 143/275 (52%), Gaps = 33/275 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-------VV 97
+ +G GS+ V L A+KI+SK + +K ++VE ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKL---KQVEHVLNEKRIL 55
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
+ ++HP L+ + + +Y++MEY G L +RK G E AR + AQ+V A+
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y H +V+RD+K ENLL+D+D IK++DFGFA+ R + R + T CG+ Y +
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGR------TYTLCGTPEYLA 166
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSP 276
PEI+ Y + D W++G++++ M+ G PF D Q+ ++ ++ KV FP SP
Sbjct: 167 PEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSP 223
Query: 277 ECKALISKILAPVKTR----LR--IKNIKEDPWFR 305
+ K LI +L T+ L+ + +IK PWF
Sbjct: 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-43
Identities = 68/246 (27%), Positives = 123/246 (50%), Gaps = 16/246 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + IG G + V A R EVAIK+I S K+ + E++++K KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHPN 58
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
++K+ + ++I+ME+ GSL D+++ + E++ +L+ + Y H G
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRDIK N+L+ +D +KL DFG + ++R T G+ + +PE++ G
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------TMVGTPYWMAPEVING 171
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN---VSPECKA 280
PY + +D+WS+G+ + G+ P+ + + L ++ + P N S E K
Sbjct: 172 KPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLRNPEKWSDEFKD 229
Query: 281 LISKIL 286
+ K L
Sbjct: 230 FLKKCL 235
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-42
Identities = 80/265 (30%), Positives = 138/265 (52%), Gaps = 21/265 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
I G++ +V LA AIK++ K M A + R + +++G P + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES-PYVAKL 62
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ ++ +Y++MEY G +I+ G + E A+++ A++V + H+RG++HRD
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
IK ENLLID ++KL+DFG +RN G E ++ F G+ Y +PE + G+
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRN--------GLE--NKKFVGTPDYLAPETILGVGD-D 171
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FPKDPN--VSPECKALISKI 285
++SD WS+G V+F +FG PF + + S+ + +P++ SPE LI+++
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 286 LAP-VKTRLR---IKNIKEDPWFRN 306
L RL + IK P+F++
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-41
Identities = 83/271 (30%), Positives = 133/271 (49%), Gaps = 25/271 (9%)
Query: 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
G IG G++ V A + +A+K I ++Q K + E++V++ LKHPNL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 107 KFLQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
K+ +E HR VYI MEY G+L +++ +DE R + QL++ + Y H G+
Sbjct: 63 KYY-GVEV-HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFA----RNHMRYRSRQGYESLSETFCGSYAYASPEI 220
VHRDIK N+ +D + IKL DFG A N ++ G+ AY +PE+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV------QSLAGTPAYMAPEV 174
Query: 221 LKGIPYCPQL--SDVWSMGVVLFAMVFGRLPFD--DTKYSQLLKQV--QSKVVFPKDPNV 274
+ G +D+WS+G V+ M G+ P+ D ++ Q++ V K P +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQL 233
Query: 275 SPECKALISKILA--PVKTRLRIKNIKEDPW 303
SPE K + + L P K R + + P+
Sbjct: 234 SPEGKDFLDRCLESDPKK-RPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 72/249 (28%), Positives = 117/249 (46%), Gaps = 21/249 (8%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
TLG +G G++ V T EVA+K + K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFA-QLVDAINYC 159
HPN++K L + I+MEY G LLD +RK FA Q+ + Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGYESLSETFCGSYAYA 216
+ +HRD+ N L+ + +K+SDFG +R+ Y+ + G +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK--------LPIRWM 171
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275
+PE LK + + SDVWS GV+L+ + G P+ +++L+ ++ PK PN
Sbjct: 172 APESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230
Query: 276 PECKALISK 284
PE L+ +
Sbjct: 231 PELYKLMLQ 239
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 24/270 (8%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+++G G + V++ A+K++ K + F E +++ P + +
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
A + +Y++MEY G LL ++ R E DE A+ + A+LV AI+ H+ G VHR
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 168 DIKCENLLIDADYNIKLSDFGFA----RNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
DIK EN+LID +IKL+DFG A N M S+ G+ Y +PE+L
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKM---------VNSKLPVGTPDYIAPEVLTT 177
Query: 224 IPYCPQLS-----DVWSMGVVLFAMVFGRLPF-DDT---KYSQLLKQVQSKVVFPKDPNV 274
+ + + D WS+GV+ + M++GR PF + T Y+ ++ Q + FP+DP V
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-NFQRFLKFPEDPKV 236
Query: 275 SPECKALISKILAPVKTRLRIKNIKEDPWF 304
S + LI +L K RL + + P+F
Sbjct: 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 70/245 (28%), Positives = 115/245 (46%), Gaps = 14/245 (5%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
TLG +G G++ V + EVA+K + K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCH 160
HPN++K L +YI+MEY E G LL +RK FA Q+ + Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ +HRD+ N L+ + +K+SDFG +R+ Y + +PE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKL--PIRWMAPES 174
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
LK + + SDVWS GV+L+ + G P+ ++L+ +++ P+ PN PE
Sbjct: 175 LKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELY 233
Query: 280 ALISK 284
L+ +
Sbjct: 234 DLMLQ 238
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 5e-39
Identities = 84/264 (31%), Positives = 139/264 (52%), Gaps = 18/264 (6%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G G++ V L A+KI+ K + D + L E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTAL 60
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +T R+ +MEYA G L + +E E RAR + A++V A+ Y H VV+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K ENL++D D +IK++DFG + + + +TFCG+ Y +PE+L+ Y
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGAT------MKTFCGTPEYLAPEVLEDNDY-G 173
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKILA 287
+ D W +GVV++ M+ GRLPF + + +L + + ++ FP+ +SPE K+L++ +L
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLK 231
Query: 288 P-VKTRL-----RIKNIKEDPWFR 305
K RL K I E +F
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-39
Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 16/244 (6%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK-KFLPREVEVVKGLKHPNLIK 107
++G GS V A+K I D K L RE++ ++ + P ++K
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH-ERGVVH 166
A + I++EY + GSL D+++K G I E Q++ ++Y H +R ++H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RDIK NLLI++ +K++DFG ++ + + TF G+ Y SPE ++G Y
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKV---LENTLDQCN---TFVGTVTYMSPERIQGESY 177
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTK---YSQLLKQVQSK-VVFPKDPNVSPECKALI 282
+D+WS+G+ L G+ PF + +L++ + SPE + I
Sbjct: 178 -SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 283 SKIL 286
S L
Sbjct: 237 SACL 240
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-38
Identities = 69/257 (26%), Positives = 111/257 (43%), Gaps = 37/257 (14%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
LG +G G++ V T +VA+K + K A + ++FL E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFL-EEASIMKKLS 59
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCH 160
HPN+++ L +YI+ EY G LLD +RK G + A Q+ + Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM---RYRSRQGY---------ESLSET 208
+ VHRD+ N L+ + +K+SDFG +R+ YR R G ESL +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD- 178
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVV 267
G + SDVWS GV+L+ + G P+ ++L+ ++
Sbjct: 179 --GKFTSK--------------SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222
Query: 268 FPKDPNVSPECKALISK 284
P+ N E L+ +
Sbjct: 223 LPRPENCPDELYELMLQ 239
|
Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 84/267 (31%), Positives = 143/267 (53%), Gaps = 21/267 (7%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
++G GS+ V LA A+K++ K + D + V + G KHP L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T R++ +MEY G L+ I++ G DE RAR + A++V + + HERG+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K +N+L+D++ +IK++DFG + + + TFCG+ Y +PEIL PY
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVT------TSTFCGTPDYIAPEILSYQPYG 174
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECKALISKIL 286
P + D W++GV+L+ M+ G+ PF+ +L + + V +P+ +S E K+++ L
Sbjct: 175 PAV-DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFL 231
Query: 287 A--PVKTRLRI-----KNIKEDPWFRN 306
P K RL ++IK P+FR
Sbjct: 232 TKNPEK-RLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 5e-37
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 20/241 (8%)
Query: 50 IIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+G G++ V + EVA+K + K A + K FL +E V+K L HPN++
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRK---------EGYIDETRARKWFAQLVDAIN 157
+ L +Y+++EY E G LLD +RK + + + Q+ +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y + VHRD+ N L+ D +K+SDFG +R+ Y + + +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKL-PIRWMA 175
Query: 218 PEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276
PE LK + + SDVWS GV+L+ G P+ ++L+ ++ PK
Sbjct: 176 PESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234
Query: 277 E 277
E
Sbjct: 235 E 235
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 78/238 (32%), Positives = 129/238 (54%), Gaps = 10/238 (4%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
++G G++ V L A+KI+ K + E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
A +T R+ +MEYA G L + +E E RAR + A++V A+ Y H R VV+RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ 229
K ENL++D D +IK++DFG + + + +TFCG+ Y +PE+L+ Y +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGIS------DGATMKTFCGTPEYLAPEVLEDNDY-GR 174
Query: 230 LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKIL 286
D W +GVV++ M+ GRLPF + + +L + + ++ FP+ +SPE K+L++ +L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 69/244 (28%), Positives = 125/244 (51%), Gaps = 14/244 (5%)
Query: 48 GTIIGMGSYATVKLATSSRHSCEVAIK---IISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
G ++G GS+ +V + A+K + Q + +K+ L +E+ ++ L+HPN
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ-LEQEIALLSKLQHPN 63
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++++L +YI +E GSL +++K G E R + Q++ + Y H+R
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRDIK N+L+D + +KL+DFG A+ + + S +++F GS + +PE++
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEF-------SFAKSFKGSPYWMAPEVIAQQ 176
Query: 225 -PYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKDPNVSPECKALI 282
Y +D+WS+G + M G+ P+ + + K +SK + P ++S E K I
Sbjct: 177 GGYGLA-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 283 SKIL 286
K L
Sbjct: 236 LKCL 239
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 89/300 (29%), Positives = 139/300 (46%), Gaps = 58/300 (19%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGL 100
Y +G G+Y V A + VA+K I ++ D ++ +P RE+ ++K L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RL----DNEEEGIPSTALREISLLKEL 55
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
KHPN++K L I T ++Y++ EY + LD ++ G + + QL+ + Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH---MRYRSRQGYESLSETFCGSYAY 215
CH ++HRD+K +N+LI+ D +KL+DFG AR +R Y T Y
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-----YTHEVVTLW----Y 164
Query: 216 ASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLK--QV--------- 262
+PEIL G Y + D+WS+G + M+ G+ F D++ QL K Q+
Sbjct: 165 RAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223
Query: 263 -------QSKVVFPK---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWF 304
K FPK P + PE L+SK+L P K R+ K + P+F
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 76/263 (28%), Positives = 136/263 (51%), Gaps = 14/263 (5%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV-VKGLKHPNLIK 107
+IG GS+ V LA A+K++ K +K + E V +K +KHP L+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+ +T ++Y +++Y G L +++E E RAR + A++ A+ Y H +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K EN+L+D+ ++ L+DFG + + + + TFCG+ Y +PE+L+ PY
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIE------HSKTTSTFCGTPEYLAPEVLRKQPY- 173
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA 287
+ D W +G VL+ M++G PF +++ + +K + K PN+S + L+ +L
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK-PNISVSARHLLEGLLQ 232
Query: 288 PVKT-RLRIKN----IKEDPWFR 305
+T RL K+ IK +F
Sbjct: 233 KDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 81/265 (30%), Positives = 139/265 (52%), Gaps = 14/265 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + IG GS+ + LA + S IK I + P K+ +EV ++ +KHPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHPN 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYI-DETRARKWFAQLVDAINYCHER 162
++ F + + R++I+MEY + G L+ I R+ G + E + WF Q+ + + H+R
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 163 GVVHRDIKCENLLIDADYNI-KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
++HRDIK +N+ + + + KL DFG A R L+ T G+ Y SPEI
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIA------RQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
+ PY + +D+WS+G VL+ + + PF+ QL+ ++ P PN S + ++L
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233
Query: 282 ISKI--LAPVKTRLRIKNIKEDPWF 304
IS++ ++P + R I +I + P+
Sbjct: 234 ISQLFKVSP-RDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 69/204 (33%), Positives = 117/204 (57%), Gaps = 8/204 (3%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK-GLKHPNLIK 107
+IG GSYA V L + A+K+I K D ++ E V + HP L+
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T R++ ++E+ G L+ ++++ + E AR + A++ A+N+ HERG+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K +N+L+DA+ +IKL+D+G + + R G + TFCG+ Y +PEIL+G Y
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGI----RPG--DTTSTFCGTPNYIAPEILRGEDYG 174
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFD 251
+ D W++GV++F M+ GR PFD
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKM-QAPSD-YLKKFLPREVEVVKGLKHP 103
LG + G G+Y V + VAIK K ++ D +KK REV+V++ L+H
Sbjct: 5 VLGVV-GEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
N++ +A R+Y++ EY E+ L + G + R + QL+ AI YCH
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRDIK EN+L+ +KL DFGFAR +R R T Y +PE+L G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLTDYVAT----RWYRAPELLVG 175
Query: 224 -IPYCPQLSDVWSMGVVLFAMVFGR 247
Y + DVW++G ++ ++ G
Sbjct: 176 DTNYGKPV-DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
+ + T +G G Y V LA + + E VA+K + K + + E +++ K
Sbjct: 3 FQILTQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
L+K L A + +Y+ MEY G ++ G + E AR + A++ +A++ HE G
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
+HRD+K EN LIDA +IKL+DFG ++ + + + + GS Y +PE+L+G
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIV---------TYANSVVGSPDYMAPEVLRG 172
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFD----DTKYSQLL---KQVQSKVVFPKDPNVSP 276
Y + D WS+G +L+ + G PF + + L + +Q V N+S
Sbjct: 173 KGYDFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 277 ECKALISKILAPVKTRLR-IKNIKEDPWFRN 306
E LI+K++ R +++IK P+F+
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 79/240 (32%), Positives = 135/240 (56%), Gaps = 13/240 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G G++ V L A+KI+ K + D + L E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTAL 60
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH-ERGVVHR 167
+ +T R+ +MEYA G L + +E E RAR + A++V A++Y H E+ VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K ENL++D D +IK++DFG + ++ + +TFCG+ Y +PE+L+ Y
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATM------KTFCGTPEYLAPEVLEDNDY- 173
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKIL 286
+ D W +GVV++ M+ GRLPF + + +L + + ++ FP+ +SPE K+L+S +L
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 75/258 (29%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
++G G++ V L V IK I Q D + E +V+K L HPN+I++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYY 65
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHR 167
+ + I+MEYA G+L + I+K +DE +F Q++ A+++ H + ++HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 168 DIKCENLLIDADYNI-KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
D+K +N+L+D + K+ DFG ++ +S + T G+ Y SPE+ +G PY
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISK-------ILSSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286
Q SD+W++G VL+ + + F+ L+ ++ S P SP+ + LI +L
Sbjct: 179 -NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML 237
Query: 287 A--PVKTRLRIKNIKEDP 302
P K R ++ I P
Sbjct: 238 NLDPSK-RPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKK----FLPREVEVVKGLKHPNLI 106
IG+G++ V L + A+K + K +D L + + E +++ + ++
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRK----ADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
K + + +Y +M+Y G ++ ++ + G +E AR + A+L AI H+ G +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH 124
Query: 167 RDIKCENLLIDADYNIKLSDFGFAR--------------NHMRYRS-------------- 198
RDIK +N+LID D +IKL+DFG +H R S
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 199 ---------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
RQ L+ + G+ Y +PE+L Y QL D WS+GV+L+ M+ G+ P
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPP 243
Query: 250 F-DDTKYSQLLKQV--QSKVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPW 303
F DT LK + ++ + P +S E LI ++ + RL IK P+
Sbjct: 244 FLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPF 303
Query: 304 FR 305
F+
Sbjct: 304 FK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 73/263 (27%), Positives = 135/263 (51%), Gaps = 21/263 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G++ V L A+K+++ + ++ + E V+K + HP +I+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+Y++MEY G L +R G + + +++V A+ Y H + +V+RD+K
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
EN+L+D + +IKL+DFGFA+ + R R + T CG+ Y +PE+++ + +
Sbjct: 129 PENILLDKEGHIKLTDFGFAK---KLRDR------TWTLCGTPEYLAPEVIQSKGHNKAV 179
Query: 231 SDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAPV 289
D W++G++++ M+ G PF DD + K + K+ FP+ ++ K LI K+L
Sbjct: 180 -DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVD 236
Query: 290 KTRLRIKN-------IKEDPWFR 305
+TR R+ N +K WF+
Sbjct: 237 RTR-RLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 66/229 (28%), Positives = 120/229 (52%), Gaps = 11/229 (4%)
Query: 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+ +G +G GS+ V++A AIK + K + + + +E ++ L H
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P ++ + + + +RVY ++E+ G L +RK G A+ + A+LV A Y H +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+++RD+K ENLL+D ++K++DFGFA+ + R + T CG+ Y +PE+++
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDR------TFTLCGTPEYLAPEVIQ 188
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPK 270
+ + D W+MGV+L+ + G PF DDT + K + ++ FP
Sbjct: 189 SKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236
|
Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 69/203 (33%), Positives = 119/203 (58%), Gaps = 8/203 (3%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKF 108
+IG GSYA V L ++ A+K++ K D ++ E V + +P L+
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+TT R+++++EY G L+ ++++ + E AR + A++ A+N+ HERG+++RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+L+DAD +IKL+D+G + + G + TFCG+ Y +PEIL+G Y
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGL------GPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 229 QLSDVWSMGVVLFAMVFGRLPFD 251
+ D W++GV++F M+ GR PFD
Sbjct: 176 SV-DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 74/252 (29%), Positives = 131/252 (51%), Gaps = 17/252 (6%)
Query: 48 GTIIGMGSYATVKLATSSRHSCEVAIK--IISKMQAPSDYLKK----FLPREVEVVKGLK 101
G +IG GS+ +V L ++ +A+K + + A S K+ L RE+ ++K L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
H N++++L + + I +EY GS+ ++ G +ET R + Q++ +NY H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYAS 217
RG++HRDIK N+L+D IK+SDFG ++ N + ++ SL GS + +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ----GSVFWMA 180
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSP 276
PE++K Y + +D+WS+G ++ M+ G+ PF D Q + ++ P+ P N+S
Sbjct: 181 PEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-PEIPSNISS 238
Query: 277 ECKALISKILAP 288
E + K
Sbjct: 239 EAIDFLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 71/244 (29%), Positives = 129/244 (52%), Gaps = 9/244 (3%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKF 108
+IG GS+ V LA A+K++ K +K + E V+ K +KHP L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +T ++Y +++Y G L +++E E RAR + A++ A+ Y H +V+RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K EN+L+D+ +I L+DFG + ++ + + TFCG+ Y +PE+L PY
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIE------HNGTTSTFCGTPEYLAPEVLHKQPY-D 174
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP 288
+ D W +G VL+ M++G PF +++ + +K + K PN++ + L+ +L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK-PNITNSARHLLEGLLQK 233
Query: 289 VKTR 292
+T+
Sbjct: 234 DRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 31/263 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G+ V +A+K I + ++K + RE++++ P ++ F
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA--IQKQILRELDILHKCNSPYIVGFYG 66
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHE-RGVVHR 167
A + I MEY + GSL D I KE I E K ++ + Y HE ++HR
Sbjct: 67 AFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K N+L+++ IKL DFG S Q SL++TF G+ +Y +PE ++G Y
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGV--------SGQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 228 PQLSDVWSMGVVLFAMVFGRLPF---DDTKYS--QLLKQV--QSKVVFPKDPNVSPECKA 280
+ SD+WS+G+ L + GR P+ +D +LL+ + + P SP+ +
Sbjct: 178 VK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK-FSPDFQD 235
Query: 281 LISKILAPVKTRLRIKNIKEDPW 303
++ L IK+ +E P
Sbjct: 236 FVNLCL--------IKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 82/261 (31%), Positives = 137/261 (52%), Gaps = 15/261 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
++G GS+ V LA + AIK + K + D + R V + +HP L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLTH 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T ++ +MEY G L+ I+ G DE RAR + A+++ + + H++G+++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K +N+L+D D +IK++DFG + +M E + TFCG+ Y +PEILKG Y
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENM-NG-----EGKASTFCGTPDYIAPEILKGQKY- 173
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPKDPNVSPECKALISKIL 286
+ D WS GV+L+ M+ G+ PF +L + + FP+ +S E K +SK+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLF 231
Query: 287 A-PVKTRLRIK-NIKEDPWFR 305
RL + +I++ P+FR
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 67/222 (30%), Positives = 121/222 (54%), Gaps = 9/222 (4%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G GS+ V LA A+K++ K + D ++ + + + HP L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+T R++ +ME+ G L+ I+K DE RAR + A++ A+ + H++G+++RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+L+D + + KL+DFG + + G + TFCG+ Y +PEIL+ + Y P
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGI----FNG--KTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFP 269
+ D W+MGV+L+ M+ G PF+ L + + +VV+P
Sbjct: 176 SV-DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 8/217 (3%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKF 108
+IG GS+ V LA A+K++ K + + E V+ K LKHP L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +T ++Y +++Y G L +++E E RAR + A++ AI Y H +++RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K EN+L+D+ ++ L+DFG + + E + TFCG+ Y +PE+L+ PY
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVE------PEETTSTFCGTPEYLAPEVLRKEPY-D 174
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
+ D W +G VL+ M++G PF SQ+ + K
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 84/274 (30%), Positives = 141/274 (51%), Gaps = 25/274 (9%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKF 108
+IG GSYA V L + A+K++ K D ++ E V + HP L+
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+T R++ ++EY G L+ ++++ + E AR + A++ A+NY HERG+++RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+L+D++ +IKL+D+G + +R + TFCG+ Y +PEIL+G Y
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLR------PGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 229 QLSDVWSMGVVLFAMVFGRLPFD--------DTKYSQLLKQV--QSKVVFPKDPNVSPEC 278
+ D W++GV++F M+ GR PFD D L QV + ++ P+ +V
Sbjct: 176 SV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA-A 233
Query: 279 KALISKILAPVKTRL------RIKNIKEDPWFRN 306
L S + K RL +I+ P+FRN
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 72/245 (29%), Positives = 131/245 (53%), Gaps = 14/245 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+ V AT EVAIK + +++ + K+ + E+ ++K KHPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQN---KELIINEILIMKDCKHPN 76
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
++ + + ++++MEY + GSL DII ++E + +++ + Y H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
V+HRDIK +N+L+ D ++KL+DFGFA + +S++ + G+ + +PE++K
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR------NSVVGTPYWMAPEVIKR 190
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP-KDPN-VSPECKAL 281
Y P++ D+WS+G++ M G P+ + L + +K + P K+P SPE K
Sbjct: 191 KDYGPKV-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249
Query: 282 ISKIL 286
++K L
Sbjct: 250 LNKCL 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 66/269 (24%), Positives = 133/269 (49%), Gaps = 19/269 (7%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+ L +IG G++ V + R + ++ A+K ++K + + + E +++ L H
Sbjct: 1 HFELLRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L+ + + +Y++++ G L + ++ E + + W ++V A+ Y H +
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G++HRDIK +N+L+D ++ ++DF A + ++L+ + G+ Y +PE+L
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIAT-KVT------PDTLTTSTSGTPGYMAPEVLC 172
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPF---DDTKYSQLL-KQVQSKVVFPKDPNVSPEC 278
Y D WS+GV + + G+ P+ T Q+ KQ + V++P S E
Sbjct: 173 RQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--ATWSTEA 229
Query: 279 KALISKILAP-VKTRL--RIKNIKEDPWF 304
I+K+L + RL +K++K P+F
Sbjct: 230 IDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 4e-31
Identities = 73/240 (30%), Positives = 120/240 (50%), Gaps = 14/240 (5%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKII--SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
IG GS+ L S + IK I SKM ++ +EV V+ +KHPN++++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE---REESRKEVAVLSNMKHPNIVQY 64
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYI--DETRARKWFAQLVDAINYCHERGVVH 166
++ E +YI+M+Y E G L I + + E + WF Q+ A+ + H+R ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RDIK +N+ + D IKL DFG A R L+ T G+ Y SPEI + PY
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIA------RVLNSTVELARTCIGTPYYLSPEICENRPY 178
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286
+ SD+W++G VL+ M + F+ L+ ++ P + S + + L+S++
Sbjct: 179 NNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 69/223 (30%), Positives = 120/223 (53%), Gaps = 11/223 (4%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVK-GLKHPNLIK 107
++G GS+ V LA + + EV AIK++ K D E ++ KHP L
Sbjct: 2 VLGKGSFGKVMLA-ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T R++ +MEY G L+ I++ DE R+R + A++ A+ + H GV++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K +N+L+DA+ + KL+DFG + + + TFCG+ Y +PEIL+ + Y
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGI------LNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFP 269
P + D W++GV+++ M+ G+ PF+ L + + V++P
Sbjct: 175 PSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 38/267 (14%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A VAIK I K++ S+ + K RE++++K L HPN+IK L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERGVVHRDI 169
+Y++ E+ + L +I+ + E+ + + QL+ + +CH G++HRD+
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ 229
K ENLLI+ + +KL+DFG AR+ + S + + Y +PE+L G
Sbjct: 125 KPENLLINTEGVLKLADFGLARS---FGSPVRP--YTHYVVTRW-YRAPELLLGDKGYST 178
Query: 230 LSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQ-------------------SKVVFP 269
D+WS+G + ++ R F QL K + K FP
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238
Query: 270 KD---------PNVSPECKALISKILA 287
K PN SP+ L+S++L
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLH 265
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 38/290 (13%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G G V L A+K++ K + +K+ L E E++ L HP L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPTLY 67
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+ +T + ++M+Y G L ++++ + E AR + A+++ A+ Y H G+V+R
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127
Query: 168 DIKCENLLIDADYNIKLSDFGFARNH------MRYRSRQG------YESLSET------- 208
D+K EN+L+ +I LSDF ++ + R+G SET
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 209 ----FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS 264
F G+ Y +PE++ G + + D W++G++L+ M++G PF + + +
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNILK 246
Query: 265 K-VVFPKDPNVSPECKALISKILAPVK---TRLRIK----NIKEDPWFRN 306
K V FP P VS + LI K+L VK RL K IK+ P+FR
Sbjct: 247 KEVTFPGSPPVSSSARDLIRKLL--VKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 77/271 (28%), Positives = 133/271 (49%), Gaps = 28/271 (10%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIK------IISKMQAPSDYLKKFLPREVEVVKGLKHP 103
++G G + V LA + AIK II++ + S +K R E +HP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK---RIFETANSERHP 62
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
L+ +T V +MEYA G L+ I + + E RA + A +V + Y HE
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-SEPRAVFYAACVVLGLQYLHENK 121
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
+V+RD+K +NLL+D + +K++DFG + M + R TFCG+ + +PE+L
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPEVLTE 175
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282
Y + D W +GV+++ M+ G PF D + V +V +P+ +S E +++
Sbjct: 176 TSYTRAV-DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIM 232
Query: 283 SKILAPVKTRLRI-------KNIKEDPWFRN 306
++L R R+ +++K+ P+FR+
Sbjct: 233 RRLLRRNPER-RLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 74/239 (30%), Positives = 128/239 (53%), Gaps = 12/239 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G G++ V L A+KI+ K + D + L E V+K +HP L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSL 60
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +T R+ +MEY G L + +E E R R + A++V A++Y H +V+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K ENL++D D +IK++DFG + + + +TFCG+ Y +PE+L+ Y
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATM------KTFCGTPEYLAPEVLEDNDY-G 173
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKIL 286
+ D W +GVV++ M+ GRLPF + + +L + + + FP+ +S + K+L+S +L
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 71/270 (26%), Positives = 140/270 (51%), Gaps = 15/270 (5%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS V +AT +VA+K KM ++ L EV +++ +HPN+++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ ++++ME+ E G+L DI+ ++E + ++ A+++ H +GV+HRDIK
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
+++L+ +D +KLSDFGF + R+ ++ G+ + +PE++ +PY ++
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPEVISRLPYGTEV 196
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVFPKDP-NVSPECKALISKILA- 287
D+WS+G+++ MV G P+ + Q +K+++ + K+ VSP ++ + ++L
Sbjct: 197 -DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255
Query: 288 PVKTRLRIKNIKEDPWFRN-GPSRPEYPIM 316
R + P+ GP P+M
Sbjct: 256 DPAQRATAAELLNHPFLAKAGPPSSIVPLM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 82/270 (30%), Positives = 143/270 (52%), Gaps = 27/270 (10%)
Query: 49 TIIGMGSYATVKLATSSRHSCEV-AIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNL 105
++G GS+ V LA + + E+ AIKI+ K + D + + V + G K P L
Sbjct: 6 MVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFL 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ +T R+Y +MEY G L+ I++ G E A + A++ + + H +G++
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP 225
+RD+K +N+++DA+ +IK++DFG + ++ + TFCG+ Y +PEI+ P
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGMCKENIF------GGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FPKDPNVSPE----CKA 280
Y + D W+ GV+L+ M+ G+ PFD +L + + V +PK ++S E CK
Sbjct: 178 YGKSV-DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKG 234
Query: 281 LISKILAPVKTRLRI-----KNIKEDPWFR 305
L++K P K RL ++I+E +FR
Sbjct: 235 LLTK--HPAK-RLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYLKKFLP-REVEVVKGLK- 101
Y + +G G++ +V LA + + + E VAIK KM+ ++ + REV+ ++ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARN-KETGELVAIK---KMKKKFYSWEECMNLREVKSLRKLNE 56
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYC 159
HPN++K + +Y + EY E G+L ++ RK E+ R Q++ + +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H+ G HRD+K ENLL+ +K++DFG AR + RSR Y + + Y +PE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EI--RSRPPY----TDYVSTRWYRAPE 168
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
IL D+W++G ++ + R
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 73/261 (27%), Positives = 134/261 (51%), Gaps = 14/261 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKF 108
+IG GS+ V LA A+K++ K + +K + E V+ K +KHP L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +TT ++Y ++++ G L +++E E RAR + A++ A+ Y H +V+RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K EN+L+D+ ++ L+DFG + + + TFCG+ Y +PE+++ PY
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGI------AQSDTTTTFCGTPEYLAPEVIRKQPY-D 174
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP 288
D W +G VL+ M++G PF +++ + K + + P S +++ ++L
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR-PGASLTAWSILEELLEK 233
Query: 289 VKT-RLRIKN----IKEDPWF 304
+ RL K I+E P+F
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 9e-30
Identities = 79/277 (28%), Positives = 142/277 (51%), Gaps = 17/277 (6%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
+++ Y + +IG G++ V+L A+K++SK + F E +++
Sbjct: 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
P +++ A + +Y++MEY G L++++ + E A+ + A++V A++
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAI 158
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H G++HRD+K +N+L+D ++KL+DFG + + +T G+ Y SPE
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-----MKMDETGMVRCDTAVGTPDYISPE 213
Query: 220 ILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDT---KYSQLLKQVQSKVVFPKDP 272
+LK G Y + D WS+GV LF M+ G PF D+ YS+++ S + FP+D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS-LNFPEDV 272
Query: 273 NVSPECKALISKILAPVKTRL---RIKNIKEDPWFRN 306
+S K LI L + RL ++ IK+ P+F+N
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 64/213 (30%), Positives = 118/213 (55%), Gaps = 17/213 (7%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L+ A +T ++++I++Y G L + + + E+ R + A++V A+++ H+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+++RDIK EN+L+D++ ++ L+DFG ++ + + Y +FCG+ Y +PE+++
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY-----SFCGTIEYMAPEVIR 179
Query: 223 -GIPYCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQ--LLKQVQ-SKVVFPKDPNVSP 276
G + D WS+GV+ F ++ G PF D + SQ + +++ SK FPK +S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--MSA 237
Query: 277 ECKALISKILAP-VKTRL---RIKNIKEDPWFR 305
E + I K+L K RL IK P+F+
Sbjct: 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 73/260 (28%), Positives = 130/260 (50%), Gaps = 16/260 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V A+K I K S E V+ + P ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ ++ ++Y+++ + G L +++EG D +RAR + A+L+ A+ H+ V++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
EN+L+D +I L DFG + +M+ + + TFCG+ Y +PE+L G Y +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDK------TNTFCGTPEYLAPELLLGHGYT-KA 173
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALISKIL--A 287
D W++GV+L+ M+ G PF D +++ +++ Q + FP + K L+ +L
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRD 231
Query: 288 PVKTRLRI---KNIKEDPWF 304
P + RL + IK P+F
Sbjct: 232 PTR-RLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 63/243 (25%), Positives = 122/243 (50%), Gaps = 7/243 (2%)
Query: 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK--KFLPREVEVVKGLKHPN 104
G ++G G++ V L E+A+K + + K L E++++K L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++++ + + I MEY GS+ D ++ G + ET RK+ Q+++ + Y H +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRDIK N+L D+ N+KL DFG ++ S + G+ + SPE++ G
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVISGE 182
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSPECKALIS 283
Y + +DVWS+G + M+ + P+ + + + ++ ++ P+ P +VSP+ + +
Sbjct: 183 GYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241
Query: 284 KIL 286
+
Sbjct: 242 RTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 83/269 (30%), Positives = 141/269 (52%), Gaps = 25/269 (9%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIK 107
++G GS+ V LA AIKI+ K D + E V+ K P L +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T R+Y +MEY G L+ I++ G E +A + A++ + + H RG+++R
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL-SETFCGSYAYASPEILKGIPY 226
D+K +N+++D++ +IK++DFG + HM + + + TFCG+ Y +PEI+ PY
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHM-------VDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPE----CKAL 281
+ D W+ GV+L+ M+ G+ PFD +L + + + V +PK ++S E CK L
Sbjct: 179 GKSV-DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGL 235
Query: 282 ISKILAPVKTRLRI-----KNIKEDPWFR 305
++K P K RL ++I+E +FR
Sbjct: 236 MTKH--PSK-RLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 7/209 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L +IG+G+ A V A ++ +VAIK I + + L +EV+ + HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNHPN 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR---KEGYIDETRARKWFAQLVDAINYCHE 161
++K+ + ++++M Y GSLLDI++ G +DE +++ + Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
G +HRDIK N+L+ D ++K++DFG + + R + +TF G+ + +PE++
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT--RKVRKTFVGTPCWMAPEVM 178
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
+ + +D+WS G+ + G P+
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 84/283 (29%), Positives = 140/283 (49%), Gaps = 29/283 (10%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVV 97
+++ + + +IG G++ V+L A+K++SK M SD F E +++
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD--SAFFWEERDIM 97
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAI 156
+++ A + +Y++MEY G L++++ Y I E AR + A++V A+
Sbjct: 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLAL 155
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+ H G +HRD+K +N+L+D ++KL+DFG M+ G +T G+ Y
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKM-DANGM-VRCDTAVGTPDYI 210
Query: 217 SPEILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------ 267
SPE+LK G Y + D WS+GV L+ M+ G PF Y+ L SK++
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----YADSLVGTYSKIMDHKNSL 266
Query: 268 -FPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPWFRN 306
FP D +S + K LI L + RL + IK P+F+N
Sbjct: 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-29
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAIK ++ Q P K+ + E+ V++ KHPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPN 77
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ +L + ++++MEY GSL D++ E +DE + + + A+ + H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRK 190
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y P++ D+WS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 64/226 (28%), Positives = 123/226 (54%), Gaps = 28/226 (12%)
Query: 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
E +++ +KHP ++ + A +T ++Y+I+EY G L + +EG E A + +++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
A+ + H++G+++RD+K EN+L+DA ++KL+DFG + + +++ TFCG+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH------EGTVTHTFCGT 163
Query: 213 YAYASPEIL------KGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSK 265
Y +PEIL K + D WS+G +++ M+ G PF + + + K ++ K
Sbjct: 164 IEYMAPEILMRSGHGKAV-------DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216
Query: 266 VVFPKDPNVSPECKALISKILA-PVKTRL-----RIKNIKEDPWFR 305
+ P P ++PE + L+ K+L +RL ++ P+FR
Sbjct: 217 LNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-29
Identities = 68/270 (25%), Positives = 133/270 (49%), Gaps = 12/270 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF---LPREVEVVKGLK 101
+ G +G G++++ A + +A+K ++ ++ S ++ L +E+ ++ L
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HP++I+ L A + +E+ GS+ ++ K G E + QL+ ++Y HE
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 162 RGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
++HRD+K NLLID+ ++++DFG A + G G+ A+ +PE+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG--EFQGQLLGTIAFMAPEV 179
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---QLLKQVQSKVVFPKDP-NVSP 276
L+G Y + DVWS+G V+ M + P++ K+S L+ ++ S P P ++SP
Sbjct: 180 LRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 277 ECKALISKIL-APVKTRLRIKNIKEDPWFR 305
+ + + L + R + + + P FR
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 69/216 (31%), Positives = 115/216 (53%), Gaps = 17/216 (7%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
IG G+Y V A + + VA+K I +M+ + RE+++++ L+HPN+++ L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVR-L 63
Query: 110 QAIETTHR---VYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+ I T+ +Y++ EY + LLD E E++ + + QL++ + Y H G+
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLD--SPEVKFTESQIKCYMKQLLEGLQYLHSNGI 121
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG- 223
+HRDIK N+LI+ D +KL+DFG AR R+ Y + T Y PE+L G
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVITLW----YRPPELLLGA 176
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQL 258
Y P++ D+WS+G +L + G+ F T+ QL
Sbjct: 177 TRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 17/247 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + ++G GS+ L + A+K I ++ S +E ++ +KHPN
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS--RKEAVLLAKMKHPN 59
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHER 162
++ F ++ E +YI+MEY + G L+ I+ + E +WF Q+ + + HE+
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSETFCGSYAYASPE 219
V+HRDIK +N+ + + +KL DFG AR + Y T+ G+ Y PE
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC---------TYVGTPYYVPPE 170
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
I + +PY + SD+WS+G +L+ + + PF + L+ +V P + S E +
Sbjct: 171 IWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 280 ALISKIL 286
+LI ++
Sbjct: 230 SLIKQMF 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 79/277 (28%), Positives = 143/277 (51%), Gaps = 17/277 (6%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
+++ Y + +IG G++ V+L A+K++SK + F E +++
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
P +++ A + +Y++MEY G L++++ + E AR + A++V A++
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 158
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H G +HRD+K +N+L+D ++KL+DFG +++G +T G+ Y SPE
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK----MNKEGMVR-CDTAVGTPDYISPE 213
Query: 220 ILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDT---KYSQLLKQVQSKVVFPKDP 272
+LK G Y + D WS+GV L+ M+ G PF D+ YS+++ ++ + FP D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-KNSLTFPDDN 272
Query: 273 NVSPECKALISKILAPVKTRL---RIKNIKEDPWFRN 306
++S E K LI L + RL ++ IK +F+N
Sbjct: 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 81/269 (30%), Positives = 144/269 (53%), Gaps = 27/269 (10%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
++G GS+ V LA AIKI+ K + D + + V + G K P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQ 65
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+T R+Y +MEY G L+ I++ G E A + A++ + + H +G+++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL-SETFCGSYAYASPEILKGIPY 226
D+K +N+++D++ +IK++DFG + +M ++ + ++TFCG+ Y +PEI+ PY
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENM-------WDGVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPE----CKAL 281
+ D W+ GV+L+ M+ G+ PF+ +L + + + V +PK ++S E CK L
Sbjct: 179 GKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGL 235
Query: 282 ISKILAPVKTRLRI-----KNIKEDPWFR 305
++K P K RL ++IKE +FR
Sbjct: 236 MTK--HPGK-RLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 27/252 (10%)
Query: 48 GTIIGMGSYATVKLATSSRHSCEVAIKII-----------SKMQAPSDYLKKFLPREVEV 96
G +IG G+Y V LA + +A+K + S+ + L+ E+E
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS----EIET 61
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+K L H N++++L T + I +EY GS+ +R G +E R + Q+++ +
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE-TFCGSYAY 215
Y H +G++HRD+K +NLL+DAD K+SDFG ++ +S Y++ + GS +
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQGSVFW 176
Query: 216 ASPEI--LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
+PE+ Y ++ D+WS+G V+ M GR P+ D + + ++ +K P
Sbjct: 177 MAPEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK---RSAPP 232
Query: 274 VSPECKALISKI 285
+ P+ +S +
Sbjct: 233 IPPDVSMNLSPV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 67/186 (36%), Positives = 98/186 (52%), Gaps = 19/186 (10%)
Query: 72 AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI--ETTHRVYIIMEYAEKGS 129
A+K I+ P L+K + RE+E+ K K P ++K+ A E++ + I MEY E GS
Sbjct: 30 ALKTITTDPNPD--LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87
Query: 130 LLDIIRKE-----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKL 184
L D I K+ G I E K ++ ++Y H R ++HRDIK N+L+ +KL
Sbjct: 88 L-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL 146
Query: 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
DFG S + SL+ TF G+ Y +PE ++G PY SDVWS+G+ L +
Sbjct: 147 CDFGV--------SGELVNSLAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVA 197
Query: 245 FGRLPF 250
R PF
Sbjct: 198 QNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 14/249 (5%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
+ + +G GSY +V + A+K + + + S ++ E+ ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY----IDETRARKWFAQLVDAINYC 159
N+I + +A +++ I+MEYA G L I K I E + F QL+ +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
HE+ ++HRD+K N+L+ A+ +K+ D G S+ +++++T G+ Y +PE
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGI--------SKVLKKNMAKTQIGTPHYMAPE 171
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
+ KG PY SD+WS+G +L+ M PF+ L +VQ P P S + +
Sbjct: 172 VWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 280 ALISKILAP 288
I +L
Sbjct: 231 NFIRSMLQV 239
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 65/238 (27%), Positives = 114/238 (47%), Gaps = 10/238 (4%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V A+K I + + ++ E V+ L +I++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQID-LSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ ++ I+MEYAE G L +++ + + E + ++F Q++ + + H + ++HRD
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
IK NL +DA N+K+ D G A + + + T G+ Y SPE+ + PY
Sbjct: 127 IKSLNLFLDAYDNVKIGDLGVA------KLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286
+ SDVW++GVVL+ G+ PFD L+ ++ V P S + LI + L
Sbjct: 181 K-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 69/246 (28%), Positives = 122/246 (49%), Gaps = 12/246 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y ++G G++ L + V K ++ + S+ ++ E+ ++ L+HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN-LTRLSEKERRDALNEIVILSLLQHPN 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCHER 162
+I + + + I MEYA G+L D I +K +E + Q+V A++Y H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE-SLSETFCGSYAYASPEIL 221
G++HRDIK N+ + IKL DFG ++ G E S++ET G+ Y SPE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISK-------ILGSEYSMAETVVGTPYYMSPELC 173
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
+G+ Y + SD+W++G VL+ ++ + FD T L+ ++ P S E +L
Sbjct: 174 QGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232
Query: 282 ISKILA 287
+ +L
Sbjct: 233 VHSLLQ 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAIK I+ + P K+ + E+ V+K LK+PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPN 77
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ FL + ++++MEY GSL D++ E +DE + + + A+ + H V
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRK 190
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y P++ D+WS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 53/302 (17%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK------- 101
+IG G++ V+L A+K + K S+ L+K +V V+ +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRK----SEMLEK---EQVAHVRAERDILAEAD 59
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
+P ++K + + + +Y+IMEY G ++ ++ K+ E R + A+ + AI+ H+
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFG----FARNHMR--YRSRQGYES----------- 204
G +HRDIK +NLL+DA +IKLSDFG ++H YR
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 205 ----LSETF-----------CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
+ET+ G+ Y +PE+ Y + D WS+GV+++ M+ G P
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPP 238
Query: 250 F-DDTKYSQLLKQVQSK--VVFPKDPNVSPECKALISKILAPVKTRLR---IKNIKEDPW 303
F D K + K + FP + +SPE K LI ++ + RL + IK P+
Sbjct: 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298
Query: 304 FR 305
F+
Sbjct: 299 FK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 81/280 (28%), Positives = 135/280 (48%), Gaps = 46/280 (16%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI---- 106
IG G++ V A+K++SK K + + EV + N++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK---------KEIVAKKEVAHTIGERNILVRTL 51
Query: 107 ----------KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
KF + +T +Y++ +Y G L ++KEG E RA+ + A+LV A+
Sbjct: 52 LDESPFIVGLKF--SFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+ H+ +V+RD+K EN+L+DA +I L DFG ++ ++ + TFCG+ Y
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------DNKTTNTFCGTTEYL 163
Query: 217 SPEIL---KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVFPKDP 272
+PE+L KG Y + D WS+GV++F M G PF Q+ + + KV FPK+
Sbjct: 164 APEVLLDEKG--YTKHV-DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN- 219
Query: 273 NVSPECKALISKIL--APVKTRL----RIKNIKEDPWFRN 306
+S E + + +L P + RL +KE P+F +
Sbjct: 220 VLSDEGRQFVKGLLNRNP-QHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 26/258 (10%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKII-----SKMQAPSDYLKKFLPREVEVVK 98
+ + IG G ++ V A VA+K + +A D LK E++++K
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-----EIDLLK 57
Query: 99 GLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVD 154
L HPN+IK+L + + + I++E A+ G L +I+ + I E K+F QL
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
A+ + H + ++HRDIK N+ I A +KL D G R+ S + + S G+
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLV--GTPY 171
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--QLLKQVQSKVVFPKDP 272
Y SPE + Y + SD+WS+G +L+ M + PF K + L K++ K +P P
Sbjct: 172 YMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EKCDYPPLP 229
Query: 273 N--VSPECKALISKILAP 288
S E + L+S+ + P
Sbjct: 230 ADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 12/211 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-- 102
Y +IG G+Y V VA+KII+ + P D + + REV ++ L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSD-IQREVALLSQLRQSQ 60
Query: 103 -PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
PN+ K+ + R++IIMEYAE GS+ +++ G I E +++ A+ Y H+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK 119
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
GV+HRDIK N+L+ N+KL DFG A + S++ TF G+ + +PE++
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR------STFVGTPYWMAPEVI 173
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
Y +D+WS+G+ ++ M G P+ D
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 77/261 (29%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK-GLKHPNLIKF 108
++G GS+ V LA + AIK + K D + E V+ +HP L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+T ++ +MEY G L+ I+ D RA + A+++ + + H +G+V+RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+L+D D +IK++DFG + +M ++ + TFCG+ Y +PEIL G Y
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAK------TCTFCGTPDYIAPEILLGQKYNT 175
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALISKILA 287
+ D WS GV+L+ M+ G+ PF +L + ++ +P+ ++ E K ++ K+
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFV 232
Query: 288 --PVKTRLRIK-NIKEDPWFR 305
P + RL +K +I++ P+FR
Sbjct: 233 REPER-RLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-27
Identities = 65/192 (33%), Positives = 107/192 (55%), Gaps = 9/192 (4%)
Query: 50 IIGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G G+Y V L + + E VAIK K ++ +K+ RE+++++ LK N+++
Sbjct: 8 VVGEGAYGVV-LKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+A ++Y++ EY EK L + + + R + QL+ AI++CH+ +VHRD
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRD 125
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
IK ENLLI + +KL DFGFARN +G + + + Y SPE+L G PY
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARN-----LSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 229 QLSDVWSMGVVL 240
+ D+WS+G +L
Sbjct: 181 AV-DMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 30/287 (10%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-YLKKFLPREVEVVKGLKHPN 104
LG ++G GSY V VAIK +++ D +KK RE+ ++K L+H N
Sbjct: 5 NLG-LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
L+ ++ R+Y++ E+ + L D+ + +DE+R RK+ Q++ I +CH +
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---YASPEIL 221
+HRDIK EN+L+ +KL DFGFAR + E + A Y +PE+L
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFART---------LAAPGEVYTDYVATRWYRAPELL 172
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280
G + D+W++G ++ M+ G F D+ QL ++ N+ P +
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK------CLGNLIPRHQE 226
Query: 281 LISKILAPVKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVETCC 327
+ K P+ +R+ +KE P +P +SG L++ C
Sbjct: 227 IFQK--NPLFAGMRLPEVKEIE-----PLEKRFPKLSGLVLDLAKQC 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 41/286 (14%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A + VA+K I ++ ++ + RE+ ++K L HPN++K L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 111 AIETTHRVYIIMEYAEKG--SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
I T +++Y++ E+ + +D G I + + QL+ + +CH V+HRD
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +NLLI+ + IKL+DFG AR +E + + Y +PEIL G Y
Sbjct: 126 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------TLWYRAPEILLGCKYYS 179
Query: 229 QLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQS------------------KVVFP 269
D+WS+G + MV R F D++ QL + ++ K FP
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239
Query: 270 K---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWF 304
K P + + + L+S++L P K R+ K P+F
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNK-RISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 71/260 (27%), Positives = 137/260 (52%), Gaps = 13/260 (5%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G GS+ V LA A+K + K + D ++ + + + ++P L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+T ++ +ME+ G L+ I+ +G D RA + A++V + + H +G+++RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+++D D +IK++DFG + ++ +R + TFCG+ Y +PEIL+G+ Y
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNR------ASTFCGTPDYIAPEILQGLKYTF 175
Query: 229 QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN-VSPECKALISKILA 287
+ D WS GV+L+ M+ G+ PF +L + + +V P P ++ E K ++ K+
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLFE 232
Query: 288 --PVKTRLRIKNIKEDPWFR 305
P + + NI+ P+F+
Sbjct: 233 RDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAIK ++ Q P K+ + E+ V++ K+PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPN 77
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ +L + ++++MEY GSL D++ E +DE + + + A+++ H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRK 190
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y P++ D+WS+G++ MV G P+
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 84/292 (28%), Positives = 133/292 (45%), Gaps = 53/292 (18%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A VA+K I +++ + + RE+ ++K L HPN+++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIR-----KEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ + +++Y++ E+ + LD+ + +D + + QL+ I YCH V+
Sbjct: 66 VVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNH---MRYRSRQGYESLSETFCGSYAYASPEILK 222
HRD+K +NLLID + +KL+DFG AR +R Y T Y +PEIL
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVR-----TYTHEVVTLW----YRAPEILL 172
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLK--------------QVQS--- 264
G D+WS+G + MV R F D++ QL + V S
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 265 -KVVFPK---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWF 304
K FPK PN+ + L+SK+L P K R+ K + P+F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK-RISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V + + VA+K I ++++ + + RE+ ++K L+HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 111 AIETTHRVYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ R+Y+I E+ + LD + K Y+D + + Q++ I +CH R V+HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY-- 226
+K +NLLID IKL+DFG AR +E + + Y +PE+L G P
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------TLWYRAPEVLLGSPRYS 180
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK--------------QVQS----KVV 267
P D+WS+G + M + F D++ QL + V S K
Sbjct: 181 TP--VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 268 FPK---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWF 304
FPK N+ + L+ K+L P K R+ K P+F
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK-RISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 51/301 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L IG G+Y V A R +VAIK IS + K+ L RE+++++ L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60
Query: 105 LIKFL-----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
+I L + E + VYI+ E E L +I+ + + + + Q++ + Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----Y 215
H V+HRD+K N+L++++ ++K+ DFG AR + + F Y Y
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARG-------VDPDEDEKGFLTEYVVTRWY 172
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQL--------------LK 260
+PE+L + D+WS+G + ++ + F Y QL LK
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 261 QVQSKVV------FPKD---------PNVSPECKALISKILA--PVKTRLRIKNIKEDPW 303
+ S+ PK P SPE L+ K+L P K R+ P+
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP-KKRITADEALAHPY 291
Query: 304 F 304
Sbjct: 292 L 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 46/295 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGL 100
Y + IG G++ V A VA+K + L+ +P RE++ ++
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQAC 56
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYC 159
+HP ++K L ++MEY L +++R E + E + + + L+ + Y
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H G++HRD+K NLLI AD +K++DFG AR R + Y +PE
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-----VATRWYRAPE 170
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQ--------------- 263
+L G D+W++G + ++ G F + QL +
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230
Query: 264 ----SKVVFPKD---------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304
+K+ FP+ P+ SPE L+ +L RL P+F
Sbjct: 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 7/210 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
+T G ++G G+Y TV +++ +V + + + A +Y K L EV+++K L
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEK--LQEEVDLLKSL 59
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
KH N++++L + + I ME+ GS+ I+ + G + E K+ Q++D + Y H
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
VVHRDIK N+++ + IKL DFG AR + ++ ++ G+ + +PE+
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
+ Y + SD+WS+G +F M G+ P
Sbjct: 180 INESGYGRK-SDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 71/264 (26%), Positives = 131/264 (49%), Gaps = 12/264 (4%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
Y ++G GSY V L + IK ++ ++ S +K +E +++ LKHP
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 104 NLIKFLQAIETTH-RVYIIMEYAEKGSLLDIIR--KEGYIDETRARKWFAQLVDAINYCH 160
N++ + ++ E +YI+M + E G L ++ K + E + +WF Q+ A+ Y H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
E+ ++HRD+K +N+ + IK+ D G A R + ++ T G+ Y SPE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIA------RVLENQCDMASTLIGTPYYMSPEL 173
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280
PY + SDVW++G ++ M + F+ + L+ ++ + P + SPE
Sbjct: 174 FSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232
Query: 281 LISKILAP-VKTRLRIKNIKEDPW 303
LI+ +L+ + R +K+I P+
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-26
Identities = 67/262 (25%), Positives = 118/262 (45%), Gaps = 35/262 (13%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G GSY +V A VAIK++ ++ + K E+ ++K P ++K+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIK----EISILKQCDSPYIVKYY 64
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ ++I+MEY GS+ DI++ + E Q + + Y H +HRD
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 169 IKCENLLIDADYNIKLSDFGFA---RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP 225
IK N+L++ + KL+DFG + + M R T G+ + +PE+++ I
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKR---------NTVIGTPFWMAPEVIQEIG 175
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP----KDP-NVSPECKA 280
Y +D+WS+G+ M G+ P+ D + + + +K P DP SPE
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PPPTLSDPEKWSPEFND 231
Query: 281 LISKILAPVKTRLRIKNIKEDP 302
+ K L +K+ +E P
Sbjct: 232 FVKKCL--------VKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 21/222 (9%)
Query: 51 IGMGSYATVKLA---TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G GS+ V+ TS VA+K + + SD + FL +E ++ L H NLI+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFL-KEAAIMHSLDHENLIR 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVV 165
L + TH + ++ E A GSLLD +RK+ G+ + + Q+ + + Y + +
Sbjct: 61 -LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 166 HRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYASPEIL 221
HRD+ N+L+ +D +K+ DFG R N Y E L F A+ +PE L
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME---EHLKVPF----AWCAPESL 172
Query: 222 KGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLLKQV 262
+ + SDVW GV L+ M +G P+ SQ+LK++
Sbjct: 173 RTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 77/272 (28%), Positives = 139/272 (51%), Gaps = 19/272 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS V +AT VA+K KM ++ L EV +++ +H N+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ ++++ME+ E G+L DI+ +E A A L A++ H +GV+HRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-KALSVLHAQGVIHRDIK 143
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
+++L+ D +KLSDFGF + R+ ++ G+ + +PE++ +PY P++
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPELISRLPYGPEV 197
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN---VSPECKALISKILA 287
D+WS+G+++ MV G P+ + + +K ++ + PK N VSP K + ++L
Sbjct: 198 -DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDRLLV 255
Query: 288 --PVKTRLRIKNIKEDPWF-RNGPSRPEYPIM 316
P + R + + P+ + GP P+M
Sbjct: 256 RDPAQ-RATAAELLKHPFLAKAGPPSCIVPLM 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 50/301 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII--SKMQAPSDYLKKFLPREVEVVKGLKH 102
Y G +G G+YA V A VAIK I + + D + RE+++++ LKH
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRA--RKWFAQLVDAINYCH 160
PN+I L + ++ E+ E + L+ + K+ I T A + + + + Y H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNH---MR----------YRSRQGYESLSE 207
++HRD+K NLLI +D +KL+DFG AR+ R YR+ E
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRA-------PE 172
Query: 208 TFCGSYAYAS-----------PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT--K 254
G+ Y E+L +P+ P SD+ +G + A G P ++
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA--LGT-PTEENWPG 229
Query: 255 YSQLLKQVQSKVVFPKD-----PNVSPECKALISKILA--PVKTRLRIKNIKEDPWFRNG 307
+ L V+ K P P S + L+ ++L P K R+ + E P+F N
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK-RITARQALEHPYFSND 288
Query: 308 P 308
P
Sbjct: 289 P 289
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 55/191 (28%), Positives = 111/191 (58%), Gaps = 10/191 (5%)
Query: 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
E +++ + HP ++K A +T ++Y+I+++ G L + KE E + + A+L
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 107
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
A+++ H G+++RD+K EN+L+D + +IKL+DFG ++ + + + + +FCG+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK------AYSFCGT 161
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKD 271
Y +PE++ + Q +D WS GV++F M+ G LPF + + + ++K+ P+
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ- 219
Query: 272 PNVSPECKALI 282
+SPE ++L+
Sbjct: 220 -FLSPEAQSLL 229
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 27/204 (13%)
Query: 118 VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176
+Y++M+Y G LL ++ K E + E AR + A++V AI+ H+ G VHRDIK +N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP-----YCPQLS 231
D + +I+L+DFG R S G+ Y SPEIL+ + Y P+
Sbjct: 136 DKNGHIRLADFGSC-----LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPE-C 189
Query: 232 DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------FPKD-PNVSPECKALIS 283
D WS+GV ++ M++G PF Y++ L + K++ FP D +VS E K LI
Sbjct: 190 DWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIR 245
Query: 284 KILAPVKTRL---RIKNIKEDPWF 304
+++ +TRL +++ K+ P+F
Sbjct: 246 RLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD--YLKKFLPREVEVVKGLKHPNLIKF 108
IG GSY V R+ I I K D +KK RE+ ++K LKHPNL+
Sbjct: 9 IGEGSYGVV---FKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
++ +++++ EY + L ++ + + E +K Q + A+N+CH+ +HRD
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG-IPYC 227
+K EN+LI IKL DFGFA R G + + Y +PE+L G Y
Sbjct: 126 VKPENILITKQGQIKLCDFGFA------RILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 228 PQLSDVWSMGVVLFAMVFG 246
P + DVW++G V ++ G
Sbjct: 180 PPV-DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAI+ ++ Q P K+ + E+ V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ +L + ++++MEY GSL D++ E +DE + + + A+ + H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRK 191
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y P++ D+WS+G++ M+ G P+
Sbjct: 192 AYGPKV-DIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 67/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
LG IG G + V L +VA+K + + FL E V+ L+HPNL
Sbjct: 9 KLGATIGKGEFGDVMLGDYRGQ--KVAVKCLKDDSTAAQ---AFLA-EASVMTTLRHPNL 62
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFA-QLVDAINYCHERG 163
++ L + + +YI+ EY KGSL+D +R G + + FA + + + Y E+
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY--AYASPEIL 221
VHRD+ N+L+ D K+SDFG A+ + QG +S G + +PE L
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDS------GKLPVKWTAPEAL 171
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
+ + + SDVWS G++L+ + FGR+P+ ++ V+
Sbjct: 172 REKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 93 EVEVVK-GLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARK 147
EV ++K L+HPN++++ + R+YI+M+ E L + K+ E R
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 148 WFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
F Q+V A+ Y H E+ +VHRD+ N+++ D + ++DFG A+ ++ ES
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-------QKQPESKL 170
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
+ G+ Y+ PEI+K PY + +DVW+ G +L+ M + PF T L ++ V
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 267 VFP-KDPNVSPECKALISKILAP 288
P + S + +I+ L P
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 73/244 (29%), Positives = 119/244 (48%), Gaps = 29/244 (11%)
Query: 51 IGMGSYATVKLATSSRHSCE-VAIKII---SKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+G G+YATV +R + E VA+K I ++ PS + RE+ ++K LKH N++
Sbjct: 8 LGEGTYATV-YKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIV 61
Query: 107 KFLQAIETTHRVYIIMEYAEKG--SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+ I T +++ ++ EY +K +D G +D + + QL+ I +CHE V
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---YASPEIL 221
+HRD+K +NLLI+ +KL+DFG AR + TF Y +P++L
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR---------AFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---PNVS--P 276
G D+WS+G ++ M+ GR F T L ++ + P + P +S P
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 277 ECKA 280
E K
Sbjct: 233 EYKP 236
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A VAIK+I K++ D+ + + +E+ ++K +HPN++ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHPNIVAYFG 67
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
+ +++I+MEY GSL DI + G + E + + + + Y HE G +HRDI
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE--TFCGSYAYASPEIL---KGI 224
K N+L+ D ++KL+DFG S Q ++++ +F G+ + +PE+ +
Sbjct: 128 KGANILLTEDGDVKLADFGV--------SAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 225 PYCPQLSDVWSMGVVLFAM 243
Y D+W++G+ +
Sbjct: 180 GY-DGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 60/216 (27%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS V +AT +VA+K KM ++ L EV +++ H N++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ ++++ME+ E G+L DI+ +E A + L A++Y H +GV+HRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVL-RALSYLHNQGVIHRDIK 145
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
+++L+ +D IKLSDFGF + ++ ++ G+ + +PE++ +PY ++
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPYGTEV 199
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
D+WS+G+++ M+ G P+ + Q +++++ +
Sbjct: 200 -DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 78/301 (25%), Positives = 139/301 (46%), Gaps = 32/301 (10%)
Query: 21 NMEYDKGKDLPDAD--GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCE-VAIKIIS 77
N++ K KD + ++ + +G GS+ V LAT VAIK
Sbjct: 6 NLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 78 KMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE 137
K + + E +++ + HP + + + +Y+++E+ G +R+
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN 125
Query: 138 GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197
+ AQ+V Y +V+RD+K ENLL+D D IK++DFGFA+
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----- 180
Query: 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--- 254
++ + T CG+ Y +PEIL + + + +D W++G+ ++ ++ G PF +
Sbjct: 181 ----VDTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLL 235
Query: 255 -YSQLLKQVQSKVVFPK--DPNVSPECKALISKILAPVKTRLR------IKNIKEDPWFR 305
Y ++L+ + + FPK D N CK L+ K+L+ T+ +N+KE PWF
Sbjct: 236 IYQKILEGI---IYFPKFLDNN----CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288
Query: 306 N 306
N
Sbjct: 289 N 289
|
Length = 340 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 62/258 (24%), Positives = 126/258 (48%), Gaps = 36/258 (13%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G++ V A A KII ++++ + L+ F+ E++++ KHPN++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-QIES-EEELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
A ++++I++E+ + G+L I+ + E + E + R Q+++A+N+ H V+HRD+
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL-----KGI 224
K N+L+ D ++KL+DFG + + ++ +TF G+ + +PE++ K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKR------DTFIGTPYWMAPEVVACETFKDN 183
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-------------------- 264
PY +D+WS+G+ L + P + ++L ++
Sbjct: 184 PY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 265 KVVFPKDPNVSPECKALI 282
K KDP+ P L+
Sbjct: 243 KSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 74/254 (29%), Positives = 129/254 (50%), Gaps = 24/254 (9%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+I G+Y V L A+K I+K + + + F+ R++ + ++P ++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+ ET + ++MEY E G +++ G + AR +FA+ V A+ Y H G+VHR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES---------LSETFCGSYAYASP 218
D+K +NLLI + +IKL+DFG ++ + + YE L + CG+ Y +P
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 219 E-ILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPK-DP 272
E IL+ G P D W+MG++L+ + G +PF +L QV S + +P+ D
Sbjct: 186 EVILRQGYGKPV-----DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 273 NVSPECKALISKIL 286
+ + + LIS++L
Sbjct: 241 ALPADAQDLISRLL 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-24
Identities = 62/233 (26%), Positives = 115/233 (49%), Gaps = 30/233 (12%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L+ A +T ++++I++Y G + + + E R + +++ A+ + H+
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+V+RDIK EN+L+D++ ++ L+DFG ++ + + Y +FCG+ Y +PEI++
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-----SFCGTIEYMAPEIIR 179
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-----FPKDPNVSPE 277
G + D WS+G+++F ++ G PF +V +++ FP + PE
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPE 237
Query: 278 CKALISKILAP-VKTRL-----RIKNIKEDPWFR------------NGPSRPE 312
+ L+ K+L K RL IKE P+F+ N P RP
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 48/303 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G+G++ V LA A+K + K + E +++ + +++
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ + +Y +M+Y G ++ ++ + G E AR + A+L A+ H+ G +HRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128
Query: 171 CENLLIDADYNIKLSDFGF--------------ARNHMRYRS------------------ 198
+N+LID D +IKL+DFG + +H+R S
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188
Query: 199 ---------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
RQ L+ + G+ Y +PE+L Y QL D WS+GV+L+ M+ G+ P
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPP 247
Query: 250 FDDTKYSQLLKQV---QSKVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPW 303
F + +V Q+ + P +SPE LI K+ + RL IK P+
Sbjct: 248 FLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPF 307
Query: 304 FRN 306
F+
Sbjct: 308 FKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-24
Identities = 66/254 (25%), Positives = 130/254 (51%), Gaps = 11/254 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF--LPREVEVVKGLKH 102
+ LG ++G G++ V L + E+A+K + + K+ L E++++K L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 103 PNLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
++++ + + I ME+ GS+ D ++ G + E RK+ Q+++ ++Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQGYESLSETFCGSYAYASPE 219
+VHRDIK N+L D+ N+KL DFG ++ S G +S++ G+ + SPE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMSPE 179
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK-DPNVSPEC 278
++ G Y + +D+WS+G + M+ + P+ + + + ++ ++ P P+VS C
Sbjct: 180 VISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238
Query: 279 KALISKILAPVKTR 292
+ + +I K R
Sbjct: 239 RDFLKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 79/301 (26%), Positives = 133/301 (44%), Gaps = 48/301 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G+G++ V LA A+K + K + + E +++ + ++K
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ + +Y +M+Y G ++ ++ + E AR + A+L AI H+ G +HRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128
Query: 171 CENLLIDADYNIKLSDFGFAR--------------NHMRYRS------------------ 198
+N+LID D +IKL+DFG +H+R S
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 199 ---------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
+Q L+ + G+ Y +PE+L Y QL D WS+GV+LF M+ G+ P
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPP 247
Query: 250 F-DDTKYSQLLKQV--QSKVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPW 303
F T LK + ++ + P +SPE LI+K+ + RL +IK P+
Sbjct: 248 FLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 304 F 304
F
Sbjct: 308 F 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 78/272 (28%), Positives = 136/272 (50%), Gaps = 27/272 (9%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+IG G++ V + A+KI++K + E +V+ + +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
A + + +Y++M+Y G LL ++ K E + E AR + A++V AI+ H+ VHRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP--- 225
IK +N+L+D + +I+L+DFG M + Q S G+ Y SPEIL+ +
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-----SSVAVGTPDYISPEILQAMEDGK 182
Query: 226 --YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------FPKD-PNVS 275
Y P+ D WS+GV ++ M++G PF Y++ L + K++ FP +VS
Sbjct: 183 GKYGPE-CDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 276 PECKALISKILAPVKTRL---RIKNIKEDPWF 304
+ K LI +++ + RL I++ K+ P+F
Sbjct: 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 34/253 (13%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G ++ V AT VA+K + + ++ +E++++K L HPN+IK+L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
+ + + I++E A+ G L +I +++ I E K+F QL A+ + H R V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RDIK N+ I A +KL D G R + S+ + + + G+ Y SPE + Y
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR---FFSSKT---TAAHSLVGTPYYMSPERIHENGY 183
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTK----------------------YSQLLKQVQS 264
+ SD+WS+G +L+ M + PF K YS+ L+++ S
Sbjct: 184 NFK-SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 265 KVVFPKDPNVSPE 277
++P DP+ P+
Sbjct: 243 MCIYP-DPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 29/268 (10%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP--REVEVVKGLKHPNLIK 107
++G G+Y V A +AIK I P + P E+ + LKH N+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWF--AQLVDAINYCHERGV 164
+L + I ME GSL ++R K G + + F Q+++ + Y H+ +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 165 VHRDIKCENLLIDADYN--IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL- 221
VHRDIK +N+L++ Y+ +K+SDFG ++ G +ETF G+ Y +PE++
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFGTSKR------LAGINPCTETFTGTLQYMAPEVID 182
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD-PNV----SP 276
KG +D+WS+G + M G+ PF + Q KV K P + S
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKIHPEIPESLSA 239
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPW 303
E K I + P R ++ +DP+
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-23
Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 32/277 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+TL IG GS+ V A R + VAIK+I +A + + + +E++ + + P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRSPY 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+ K+ + +++IIMEY GS LD++ K G +DET +++ + Y HE G
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK N+L+ + ++KL+DFG + S++ TF G+ + +PE++K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR------NTFVGTPFWMAPEVIKQS 173
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF--------------------DDTKYSQLLKQVQS 264
Y + +D+WS+G+ + G P + K+S+ K S
Sbjct: 174 GYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS 232
Query: 265 KVVFPKDPNVSPECKALIS-KILAPVKTRLRIKNIKE 300
KDP P K L+ K + K + + E
Sbjct: 233 L-CLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 7e-23
Identities = 69/290 (23%), Positives = 140/290 (48%), Gaps = 46/290 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG----- 99
+ L ++G G+Y V L ++ +S + Y K L + V K
Sbjct: 2 FELLKVLGTGAYGKVFL-----------VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEH 50
Query: 100 -------LKH----PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKW 148
L+H P L+ A +T ++++I++Y G L + + E + +
Sbjct: 51 TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 149 FAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208
++V A+ + H+ G+++RDIK EN+L+D++ ++ L+DFG ++ + Y +
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY-----S 165
Query: 209 FCGSYAYASPEILKGIPYC-PQLSDVWSMGVVLFAMVFGRLPF----DDTKYSQLLKQV- 262
FCG+ Y +P+I++G + D WSMGV+++ ++ G PF + +++ +++
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
Query: 263 QSKVVFPKDPNVSPECKALISKILAP-VKTRL-----RIKNIKEDPWFRN 306
+S+ +P++ +S K +I ++L K RL IK+ P+F+
Sbjct: 226 KSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-23
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA----PSDYLKKFLPREVEVVKGL 100
Y L +G GS+ TV L + E +K++ ++ P++ ++ E +++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKL 59
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAI 156
HP ++KF + II EY E L + + + E + +WF QL+ +
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+Y H+R ++HRD+K +N+ + + +K+ DFG +R M G L+ TF G+ Y
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM------GSCDLATTFTGTPYYM 172
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAM 243
SPE LK Y + SD+WS+G +L+ M
Sbjct: 173 SPEALKHQGYDSK-SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-23
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 51 IGMGSYATVKLAT----SSRHSCEVAIKIISKMQAP---SDYLKKFLPREVEVVKGLKHP 103
+G G + V+L +VA+K ++ SD RE+E+++ L H
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHE 66
Query: 104 NLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
N++K+ E + +IMEY GSL D +++ I+ R + +Q+ ++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYA 216
+ +HRD+ N+L++++ +K+SDFG A+ + Y ++ ES + YA
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PIFWYA 180
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAM 243
PE L+ + SDVWS GV L+ +
Sbjct: 181 -PECLRTSKFSSA-SDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 62/239 (25%), Positives = 126/239 (52%), Gaps = 15/239 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS V +A +VA+K+ M ++ L EV +++ +H N+++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKM---MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ ++++ME+ + G+L DI+ + ++E + ++ A+ Y H +GV+HRDIK
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
+++L+ D +KLSDFGF + ++ ++ G+ + +PE++ PY ++
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPYGTEV 198
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN---VSPECKALISKIL 286
D+WS+G+++ MV G P+ Q +K+++ PK N +SP + + ++L
Sbjct: 199 -DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFLERML 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 76/243 (31%), Positives = 118/243 (48%), Gaps = 32/243 (13%)
Query: 74 KIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLD 132
KII K F E V + +K +PN IK ++ T +IM+Y + G L D
Sbjct: 47 KIIKA--------KNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98
Query: 133 IIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKLSDFGFAR 191
+++KEG + E +K QLV+A+N H+ ++H DIK EN+L D A I L D+G +
Sbjct: 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
Query: 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLS-DVWSMGVVLFAMVFGRLPF 250
G S + G+ Y SPE +KG Y +S D W++GV+ + ++ G+ PF
Sbjct: 159 -------IIGTPSCYD---GTLDYFSPEKIKGHNY--DVSFDWWAVGVLTYELLTGKHPF 206
Query: 251 DDTK-----YSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRL-RIKNIKEDPW 303
+ + LLK+ Q K+ F K NVS + +L + RL I + P+
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIK--NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
Query: 304 FRN 306
+
Sbjct: 265 LKI 267
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 77/294 (26%), Positives = 140/294 (47%), Gaps = 44/294 (14%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKK----FLPREVEVVKGLKHPNL 105
+IG G++ V+L A+KI+ K +D L+K + E +++ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRK----ADMLEKEQVAHIRAERDILVEADGAWV 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+K + + +Y+IME+ G ++ ++ K+ + E + + A+ V AI+ H+ G +
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 166 HRDIKCENLLIDADYNIKLSDFG------------FARN----------HMRYRSRQGYE 203
HRDIK +NLL+DA ++KLSDFG F RN S++ E
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 204 S-------LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS 256
+ L+ + G+ Y +PE+ Y +L D WS+GV+++ M+ G PF
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 257 QLLKQV---QSKVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPWF 304
+ ++V + +VFP + +S + K LI + + R+ ++ IK P+F
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 80/275 (29%), Positives = 137/275 (49%), Gaps = 33/275 (12%)
Query: 50 IIGMGSY---ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+IG G++ A VK+ + R A+KI++K + E V+ +
Sbjct: 8 VIGRGAFGEVAVVKMKHTER---IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVV 165
A + + +Y++M+Y G LL ++ K E + E AR + A++V AI+ H+ V
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI- 224
HRDIK +N+L+D + +I+L+DFG + + Q S G+ Y SPEIL+ +
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-----SSVAVGTPDYISPEILQAME 179
Query: 225 ----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------FPKD-P 272
Y P+ D WS+GV ++ M++G PF Y++ L + K++ FP
Sbjct: 180 DGMGKYGPE-CDWWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHEERFQFPSHIT 234
Query: 273 NVSPECKALISKILAPVKTRL---RIKNIKEDPWF 304
+VS E K LI +++ + RL I++ K+ +F
Sbjct: 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G++ V + + EVA+K + P D +KFL +E E++K HPN++K +
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKT-CRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIG 59
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN---YCHERGVVHR 167
+YI+ME GSLL +RK+ + +K +DA Y + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+ N L+ + +K+SDFG +R Y + +PE L Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 228 PQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ SDVWS G++L+ G P+ Q ++++S P P + PE
Sbjct: 174 SE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPE 222
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 36/253 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSC-----EVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
TL +G GS+ V + VAIK +++ + + ++ FL E V+K
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FL-NEASVMKEF 66
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE----------GYIDETRARKWFA 150
++++ L + T ++ME KG L +R G + + A
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYR-SRQGYESLS 206
++ D + Y + VHRD+ N ++ D +K+ DFG R YR +G +
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSK 265
+ +PE LK + + SDVWS GVVL+ M P+ ++LK V
Sbjct: 187 --------WMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237
Query: 266 VVFPKDPNVSPEC 278
PE
Sbjct: 238 GHLDL-----PEN 245
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 30/212 (14%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
IG G+ TV A+K+I D +++ + RE+E+++ + HPN++K
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 110 QAIETTHRVYIIMEYAEKGSLLDI-IRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ + +++E+ + GSL I E ++ + AR Q++ I Y H R +VHRD
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-AR----QILSGIAYLHRRHIVHRD 193
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF--C----GSYAYASPEI-- 220
IK NLLI++ N+K++DFG +R L++T C G+ AY SPE
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSR------------ILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 221 --LKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
L Y D+WS+GV + GR PF
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 25/245 (10%)
Query: 51 IGMGSYATVKLA---TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G G++ +V S EVA+K + + + KK RE V+ L HP +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
L + + ++ME A G LL ++K I + ++ Q+ + Y + VHR
Sbjct: 61 -LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 168 DIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYA---YASPEI 220
D+ N+L+ + K+SDFG +R YR+ G + YA I
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---------GRWPLKWYAPECI 170
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
G SDVWS GV L+ +G P+ + K ++++ ++S P+ E
Sbjct: 171 NYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY 228
Query: 280 ALISK 284
+++
Sbjct: 229 SIMLS 233
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-22
Identities = 66/254 (25%), Positives = 129/254 (50%), Gaps = 11/254 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF--LPREVEVVKGLKH 102
+ LG ++G G++ V L + E+A+K + + K+ L E++++K L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 103 PNLIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
++++ + ++ I +EY GS+ D ++ G + E R++ Q++ ++Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFA-RNHMRYRSRQGYESLSETFCGSYAYASPE 219
+VHRDIK N+L D+ N+KL DFG + R S G +S++ G+ + SPE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMSPE 179
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSPEC 278
++ G Y + +DVWS+ + M+ + P+ + + + ++ ++ P P VS C
Sbjct: 180 VISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238
Query: 279 KALISKILAPVKTR 292
+ + +I K R
Sbjct: 239 RDFLKQIFVEEKRR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 67/232 (28%), Positives = 122/232 (52%), Gaps = 19/232 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G + V +AT ++H+ +VA+K M+ S ++ FL E V+K L+H L+K L
Sbjct: 14 LGAGQFGEVWMATYNKHT-KVAVK---TMKPGSMSVEAFL-AEANVMKTLQHDKLVK-LH 67
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRD 168
A+ T +YII E+ KGSLLD ++ + + + AQ+ + + + +R +HRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 169 IKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
++ N+L+ A K++DFG AR Y +R+G + + +PE + +
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-------PIKWTAPEAINFGSF 180
Query: 227 CPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ SDVWS G++L +V +GR+P+ ++++ ++ P+ N E
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-22
Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 16/246 (6%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G ++ V AT VA+K + + +E++++K L HPN+IK+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCHERGVVH 166
+ + + I++E A+ G L +I+ ++ I E K+F QL A+ + H R V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RDIK N+ I A +KL D G R + S+ + + + G+ Y SPE + Y
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGR---FFSSKT---TAAHSLVGTPYYMSPERIHENGY 183
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLKQVQSKVVFPKDPN--VSPECKALI 282
+ SD+WS+G +L+ M + PF D L K+++ + +P P+ S E + L+
Sbjct: 184 NFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSEELRQLV 241
Query: 283 SKILAP 288
+ + P
Sbjct: 242 NMCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-22
Identities = 71/245 (28%), Positives = 121/245 (49%), Gaps = 36/245 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPN 104
T +G G + V L R +VAIK+I + + D+++ E +V+ L HPN
Sbjct: 7 TFLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-----EAKVMMKLSHPN 60
Query: 105 LIKFLQAIETTHR-VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVD-------AI 156
L++ L + T R ++I+ EY G LL+ Y+ E + + L+D A+
Sbjct: 61 LVQ-LYGVCTKQRPIFIVTEYMANGCLLN------YLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYA 214
Y G +HRD+ N L+ D +K+SDFG AR + +Y S QG + F
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK-----F--PVK 166
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVF--GRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+A PE+ + + SDVWS GV+++ VF G++P++ S++++ V + + P
Sbjct: 167 WAPPEVFDYSRFSSK-SDVWSFGVLMWE-VFSEGKMPYERFSNSEVVESVSAGYRLYR-P 223
Query: 273 NVSPE 277
++P
Sbjct: 224 KLAPT 228
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 67/237 (28%), Positives = 117/237 (49%), Gaps = 28/237 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKII--SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G + V + T + + +VA+K + M +P +L+ E +++K L+H L++
Sbjct: 14 LGAGQFGEVWMGTWNGTT-KVAVKTLKPGTM-SPEAFLQ-----EAQIMKKLRHDKLVQL 66
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRK-EG-YIDETRARKWFAQLVDAINYCHERGVVH 166
+YI+ EY KGSLLD ++ EG + + AQ+ + + Y R +H
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126
Query: 167 RDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYASPE-IL 221
RD+ N+L+ + K++DFG AR + Y +R+G + F + +PE
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAK-----F--PIKWTAPEAAN 177
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
G SDVWS G++L +V +GR+P+ ++L+QV+ P+ PN E
Sbjct: 178 YGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 72/253 (28%), Positives = 111/253 (43%), Gaps = 34/253 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF--LPREVEVVKGLKH 102
+TL +G G + V VAIKI+ SD L K +EV+ +K L+H
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRV-RVAIKILK-----SDDLLKQQDFQKEVQALKRLRH 61
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFA-QLVDAINYCH 160
+LI VYII E EKGSLL +R EG + + A Q+ + + Y
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS------YA 214
E+ +HRD+ N+L+ D K++DFG AR + E S Y
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLAR------------LIKEDVYLSSDKKIPYK 169
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
+ +PE + SDVWS G++L+ M +G++P+ ++ Q+ + P
Sbjct: 170 WTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC--- 225
Query: 274 VSPECKALISKIL 286
+C I KI+
Sbjct: 226 -PAKCPQEIYKIM 237
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 55/159 (34%), Positives = 87/159 (54%), Gaps = 10/159 (6%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQ 151
RE++V+ P ++ F A + + I ME+ + GSL +++K G I E K
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 152 LVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
++ + Y E+ ++HRD+K N+L+++ IKL DFG S Q +S++ +F
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 163
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
G+ +Y SPE L+G Y Q SD+WSMG+ L M GR P
Sbjct: 164 GTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 16/224 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+Y V A +R +VAIK I K+ L RE+++++ KH N
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDN 65
Query: 105 LIKFLQAIETTHR----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
+I + VY++M+ E L II + + E R + QL+ + Y H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----YA 216
V+HRD+K NLL++ D +++ DFG AR + Y F Y Y
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY------FMTEYVATRWYR 178
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK 260
+PE+L +P D+WS+G + M+ R F Y LK
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G GS V A S VA+K I S +K L RE+++++ L H N++K +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS--VKHAL-REIKIIRRLDHDNIVKVYE 69
Query: 111 AIETTHR--------------VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+ + VYI+ EY E L + ++G + E AR + QL+ +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 157 NYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
Y H V+HRD+K N+ I+ D +K+ DFG AR + S +GY LSE + Y
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY--LSEGLVTKW-Y 184
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
SP +L + D+W+ G + M+ G+ F
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIK-IISKMQAPSDYLKKFLPREVEVVKGLK-H 102
Y + +G G+Y V A R VA+K I + +D + F RE+ ++ L H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 103 PNLIKFLQAI--ETTHRVYIIMEYAE--------KGSLLDIIRKEGYIDETRARKWFAQL 152
PN++K L I E +Y++ EY E L D+ ++ YI QL
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR--YI--------MYQL 116
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+ A+ Y H V+HRD+K N+L+++D +KL+DFG AR+ L++
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD----- 171
Query: 213 YA----YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
Y Y +PEIL G + D+WS+G +L M+ G+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-21
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 51 IGMGSYATVKLATSSRHSCE-VAIKIISKMQA----PSDYLKKFLPREVEVVKGLKHPNL 105
IG G+Y TV A +R + E VA+K + PS L RE+ ++K LKH N+
Sbjct: 8 IGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKELKHKNI 61
Query: 106 IKFLQAIETTHRVYIIMEYAEKG--SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
++ + + ++ ++ EY ++ D G ID + + QL+ + +CH
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNH-MRYRSRQGYESLSETFCGSYAYASPEILK 222
V+HRD+K +NLLI+ + +KL+DFG AR + R Y + T Y P++L
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLW----YRPPDVLF 172
Query: 223 GIPYCPQLSDVWSMGVVLFAM 243
G D+WS G + +
Sbjct: 173 GAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-21
Identities = 65/251 (25%), Positives = 126/251 (50%), Gaps = 11/251 (4%)
Query: 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF--LPREVEVVKGLKHPNL 105
G ++G G++ V L E+A K + + K+ L E++++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 106 IKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
+++ + + I MEY GS+ D ++ G + E+ RK+ Q+++ ++Y H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFA-RNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+VHRDIK N+L D+ N+KL DFG + R S G S++ G+ + SPE++
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMSPEVIS 182
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN-VSPECKAL 281
G Y + +DVWS+G + M+ + P+ + + + ++ ++ P+ P+ +S +
Sbjct: 183 GEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 282 ISKILAPVKTR 292
+ I + R
Sbjct: 242 LGCIFVEARHR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 54/159 (33%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQ 151
RE++V+ P ++ F A + + I ME+ + GSL +++K G I E K
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 152 LVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
++ + Y E ++HRD+K N+L+++ IKL DFG S Q +S++ +F
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 159
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
G+ +Y SPE L+G Y Q SD+WS+G+ L M GR P
Sbjct: 160 GTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 69/287 (24%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKK----FLPREVEVVKGLKHPNL 105
+IG G++ V+L A+KI+ K +D L+K + E +++ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRK----ADMLEKEQVGHIRAERDILVEADSLWV 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+K + + +Y+IME+ G ++ ++ K+ + E + + A+ V AI+ H+ G +
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF---------------- 209
HRDIK +NLL+D+ ++KLSDFG + + Y +L+ +
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 210 -------------CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS 256
G+ Y +PE+ Y +L D WS+GV+++ M+ G PF
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 257 QLLKQV---QSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKE 300
+ K+V + ++FP + +S + K LI + + R+ ++E
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFL 109
IG G+++ V A S + AIK + K + + RE++ ++ L HPN+++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPNILRLI 64
Query: 110 QAI--ETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVH 166
+ + T R+ ++ E + +L ++I+ ++ + E R + + QL+ ++++ H G+ H
Sbjct: 65 EVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY-ESLSETFCGSYAYASPE-ILKGI 224
RDIK EN+LI D +KL+DFG R S+ Y E +S + Y +PE +L
Sbjct: 124 RDIKPENILIK-DDILKLADFGSCRG---IYSKPPYTEYISTRW-----YRAPECLLTDG 174
Query: 225 PYCPQLSDVWSMGVVLFAMV 244
Y P++ D+W++G V F ++
Sbjct: 175 YYGPKM-DIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 75/242 (30%), Positives = 113/242 (46%), Gaps = 28/242 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGLKHPNLI 106
+G GSYATV S + VA+K+IS M+ ++ +P RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKT-----EEGVPFTAIREASLLKGLKHANIV 66
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
I T + + EY +I+ G + R + QL+ + Y H + ++H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG-IP 225
RD+K +NLLI +KL+DFG AR + Q Y S T Y P++L G
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLW----YRPPDVLLGATD 180
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLK-----QVQSKVVFP---KDPNVS 275
Y L D+W G + M+ G+ F + QL K V ++ +P K PN
Sbjct: 181 YSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239
Query: 276 PE 277
PE
Sbjct: 240 PE 241
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V +R VAIKII +A + + + +E+ V+ P + K+
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ +++IIMEY GS LD++R G DE + +++ ++Y H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
N+L+ ++KL+DFG A + ++ TF G+ + +PE+++ Y +
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFVGTPFWMAPEVIQQSAYDSK- 181
Query: 231 SDVWSMGVVLFAMVFGRLPFDD 252
+D+WS+G+ + G P D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 60/309 (19%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKK----FLPREVEVVKGLKHPNL 105
+IG G++ V+L A+K + K S+ KK + E +V+ P +
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLK----SEMFKKDQLAHVKAERDVLAESDSPWV 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ + + +Y+IME+ G L+ ++ K E R + A+ V AI H+ G +
Sbjct: 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 166 HRDIKCENLLIDADYNIKLSDFGF---------------------ARNHMRYRSRQGYES 204
HRDIK +N+LID +IKLSDFG +N + R+ +S
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 205 LSETF--------------------CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
++ T G+ Y +PEI Y Q D WS+G ++F +
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECL 242
Query: 245 FGRLPF-----DDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAPVKTRL---RIK 296
G PF +T Y +++ ++ + FP D ++S E + LI +++ + RL
Sbjct: 243 IGWPPFCSENSHET-YRKIINWRET-LYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300
Query: 297 NIKEDPWFR 305
IK P+FR
Sbjct: 301 EIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 56/199 (28%), Positives = 107/199 (53%), Gaps = 16/199 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G++ V A + A K+I + L+ ++ E++++ HPN++K L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMV-EIDILASCDHPNIVKLLD 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
A + ++I++E+ G++ ++ + E + E + R Q ++A+NY HE ++HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL-----KGI 224
K N+L D +IKL+DFG + + R R+ ++F G+ + +PE++ K
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRR------DSFIGTPYWMAPEVVMCETSKDR 183
Query: 225 PYCPQLSDVWSMGVVLFAM 243
PY + +DVWS+G+ L M
Sbjct: 184 PYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 51/168 (30%), Positives = 90/168 (53%), Gaps = 10/168 (5%)
Query: 86 LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRA 145
++K + RE++++ + P ++ F A + + + ME+ + GSL I +K G I
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEIL 105
Query: 146 RKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204
K +V+ + Y + ++HRDIK N+L+++ IKL DFG S + S
Sbjct: 106 GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINS 157
Query: 205 LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
+++TF G+ Y SPE ++G Y + SDVWS+G+ + + G+ PF
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 27/231 (11%)
Query: 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
Y + IG G+Y V AT +VAIK IS + + + ++ L RE+++++ K
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTL-REIKILRRFK 61
Query: 102 HPNLIKFL-----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
H N+I L + E+ + VYI+ E E L +I+ + ++ + + Q++ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSND-HIQYFLYQILRGL 119
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
Y H V+HRD+K NLL++ + ++K+ DFG AR G+ L+E + + Y
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF--LTE-YVATRWYR 176
Query: 217 SPEIL-------KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLL 259
+PEI+ K I D+WS+G +L M+ R F Y QL
Sbjct: 177 APEIMLNSKGYTKAI-------DIWSVGCILAEMLSNRPLFPGKDYLHQLN 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 29/278 (10%)
Query: 24 YDKGKDLPDADGKMTVLES-----HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK 78
Y K DLP+ + V ES H Y L T++G +AT E K+++K
Sbjct: 46 YKKCVDLPEGE---EVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKE---KVVAK 99
Query: 79 MQAPSDYLKKFLPR-EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-- 135
+D + R E+ + H ++K ++ ++ +IMEY G L I+
Sbjct: 100 FVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159
Query: 136 -KEGY-IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193
KE E F Q+V A++ H R ++HRD+K N+ + IKL DFGF
Sbjct: 160 LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGF---- 215
Query: 194 MRYRSRQGYESLS----ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
S+Q +S+S +FCG+ Y +PE+ + Y + +D+WS+GV+L+ ++ P
Sbjct: 216 ----SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRP 270
Query: 250 FDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA 287
F ++++QV P VS KAL+ +L+
Sbjct: 271 FKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308
|
Length = 478 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 10/202 (4%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V +R VAIKII +A + + + +E+ V+ P + ++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYITRYYG 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ +++IIMEY GS LD++ K G ++ET +++ ++Y H +HRDIK
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
N+L+ ++KL+DFG A + ++ TF G+ + +PE++K Y +
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKR------NTFVGTPFWMAPEVIKQSAYDFK- 181
Query: 231 SDVWSMGVVLFAMVFGRLPFDD 252
+D+WS+G+ + G P D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--- 101
Y IG G+Y TV A VA+K + ++ + + RE+ ++K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 102 HPNLIKFLQ--AIETTHR---VYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVD 154
HPN+++ L T R + ++ E+ ++ + L K G + + QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+++ H +VHRD+K +N+L+ +D +K++DFG AR + +E + +
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-------SFEMALTSVVVTLW 171
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
Y +PE+L Y + D+WS+G + FA +F R P
Sbjct: 172 YRAPEVLLQSSYATPV-DMWSVGCI-FAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 64/254 (25%), Positives = 128/254 (50%), Gaps = 18/254 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + ++G G+ TV A A+K++ M+ S+ K EV + +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 105 LIKFLQAI--------ETTHRVYIIMEYAEKGSLLDIIRKEGYID----ETRARKWFAQL 152
++K + E + ++++YA G L I+ + E A F Q+
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 153 VDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+ A+++ H + ++HRDIK N+L+ ++ +KL DFGF++ + S + + TFCG+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS----DDVGRTFCGT 208
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
Y +PEI + PY + +D++S+GV+L+ ++ + PFD +++ + + P P
Sbjct: 209 PYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 273 NVSPECKALISKIL 286
++SPE + +++ +L
Sbjct: 268 SISPEMQEIVTALL 281
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 9e-20
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQ---APSDYLKKFLPREVEVVKGLKHPNLIK 107
+G GSYATV S VA+K I AP + RE ++K LKH N++
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIVT 67
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
I T + ++ EY + + G + R + QL+ + YCH+R V+HR
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL-SETFCGSYA---YASPEILKG 223
D+K +NLLI +KL+DFG AR +S+ S+T+ Y P++L G
Sbjct: 128 DLKPQNLLISERGELKLADFGLARA----------KSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 224 -IPYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y L D+W +G + + M GR F
Sbjct: 178 STEYSTSL-DMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 69/205 (33%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIIS---KMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G G+YATV S VA+K I + AP + REV ++K LKH N++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIVT 68
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHERGVVH 166
I T + ++ EY +K L + G K F QL+ +NYCH R V+H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG-IP 225
RD+K +NLLI+ +KL+DFG AR + + Y + T Y P+IL G
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLW----YRPPDILLGSTD 181
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPF 250
Y Q+ D+W +G + + M GR F
Sbjct: 182 YSTQI-DMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G+Y TV A R +VAIK K+ P S+ K RE+ ++K +KH N+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 109 L------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
L +++ H Y++M + G+ L + K + E R + Q++ + Y H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G++HRD+K NL ++ D +K+ DFG AR +S + + Y +PE++
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQ---------TDSEMTGYVVTRWYRAPEVIL 188
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262
+ Q D+WS+G ++ M+ G+ F + L ++
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 73/262 (27%), Positives = 125/262 (47%), Gaps = 38/262 (14%)
Query: 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP--- 91
GK V + + + IG G+Y V A VA+K + D K+ P
Sbjct: 2 GKRCVDK---FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-----LDNEKEGFPITA 53
Query: 92 -REVEVVKGLKHPNLIKFLQAI----------ETTHRVYIIMEYAEKGSLLDIIRKEGYI 140
RE+++++ L H N++ + + + Y++ EY + L+ ++ + G +
Sbjct: 54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL-ESGLV 111
Query: 141 D--ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198
E + + QL++ +NYCH++ +HRDIKC N+L++ IKL+DFG AR + S
Sbjct: 112 HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 199 RQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF--DDTKY 255
R Y + T Y PE+L G Y P + DVWS G +L +F + P + +
Sbjct: 172 RP-YTNKVITLW----YRPPELLLGEERYGPAI-DVWSCGCIL-GELFTKKPIFQANQEL 224
Query: 256 SQLLKQVQSKVVFPKDPNVSPE 277
+QL ++ S++ P V P+
Sbjct: 225 AQL--ELISRLCGSPCPAVWPD 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 69/251 (27%), Positives = 120/251 (47%), Gaps = 30/251 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V +R VAIKII +A + + + +E+ V+ P + K+
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ +++IIMEY GS LD++ + G +DET+ +++ ++Y H +HRDIK
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
N+L+ +KL+DFG A + ++ TF G+ + +PE++K Y +
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKR------NTFVGTPFWMAPEVIKQSAYDSK- 181
Query: 231 SDVWSMGV-------------------VLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD 271
+D+WS+G+ VLF + P + YS+ LK+ + K+
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF-VEACLNKE 240
Query: 272 PNVSPECKALI 282
P+ P K L+
Sbjct: 241 PSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 36 KMTVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLP 91
K T LE ++G G++ TV + VAIK++ + +P K+ L
Sbjct: 5 KETELE-----KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEIL- 57
Query: 92 REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFA 150
E V+ + HP++++ L I + +V +I + G LLD +R + I W
Sbjct: 58 DEAYVMASVDHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLS 206
Q+ ++Y E+ +VHRD+ N+L+ ++K++DFG A+ + Y + G +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA-MVFGRLPFDD 252
+ + E + Y + SDVWS GV ++ M FG P++
Sbjct: 177 --------WMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 60/232 (25%), Positives = 116/232 (50%), Gaps = 18/232 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G + V + + +S +VA+K ++ + ++ FL E ++K L+H L++
Sbjct: 14 LGAGQFGEVWMGYYN-NSTKVAVK---TLKPGTMSVQAFL-EEANLMKTLQHDKLVRLYA 68
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ +YII EY KGSLLD ++ + G + + + AQ+ + + Y + +HRD
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 169 IKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
++ N+L+ K++DFG AR Y +R+G + + +PE + +
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-------PIKWTAPEAINFGSF 181
Query: 227 CPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ SDVWS G++L+ +V +G++P+ S ++ +Q P+ N E
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 69 CEVAIKIISKMQAPSDYLKKFLPR---------EVEVVKGLKHPNLIKFLQAIETTHRVY 119
C +K KM A KK L + E ++++ + ++ A ET +
Sbjct: 10 CACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLC 69
Query: 120 IIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID 177
++M G L I G E RA + AQ++ + + H+R +V+RD+K EN+L+D
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 178 ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMG 237
N+++SD G A + +G G+ Y +PE+L+G Y + D +++G
Sbjct: 130 DHGNVRISDLGLAVELKGGKKIKGR-------AGTPGYMAPEVLQGEVYDFSV-DWFALG 181
Query: 238 VVLFAMVFGRLPFDDTKYS---QLLKQ--VQSKVVFPKDPNVSPECKALISKILAP-VKT 291
L+ M+ GR PF K + LK+ ++ V +P SPE K L +L +
Sbjct: 182 CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPEK 239
Query: 292 RL-----RIKNIKEDPWFRN 306
RL ++E P F++
Sbjct: 240 RLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 52/159 (32%), Positives = 86/159 (54%), Gaps = 10/159 (6%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQ 151
RE++V+ P ++ F A + + I ME+ + GSL ++++ I E K
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 152 LVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
++ + Y E+ ++HRD+K N+L+++ IKL DFG S Q +S++ +F
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMANSFV 163
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
G+ +Y SPE L+G Y Q SD+WSMG+ L + GR P
Sbjct: 164 GTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 30 LPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF 89
LPD G + L +IG G+Y V A + VAIKI M D ++
Sbjct: 1 LPDPTGI--------FELVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIED-EEEE 48
Query: 90 LPREVEVVKGL-KHPNLIKF----LQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDE 142
+ E +++ HPN+ F ++ + ++++ME GS+ D+++ +
Sbjct: 49 IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108
Query: 143 TRARKWFA----QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198
+W A + + + Y HE V+HRDIK +N+L+ + +KL DFG +
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG 168
Query: 199 RQGYESLSETFCGSYAYASPEIL----KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
R+ TF G+ + +PE++ + SDVWS+G+ + G+ P D
Sbjct: 169 RRN------TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 21/264 (7%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCE---VAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
TLG IG G + V E VA+K +PS +KFL +E +++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFL-QEAYIMRQFDH 66
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHE 161
P+++K L + T + V+I+ME A G L ++ Y + + ++ QL A+ Y
Sbjct: 67 PHIVK-LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+ VHRDI N+L+ + +KL DFG + RY + Y S+ + +PE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS----RYLEDESYYKASKGKL-PIKWMAPE-- 178
Query: 222 KGIPY--CPQLSDVWSMGVVLFA-MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
I + SDVW GV ++ ++ G PF K + ++ ++++ P PN P
Sbjct: 179 -SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237
Query: 279 KALISKILA--PVKTRLRIKNIKE 300
+L++K A P K R R +K
Sbjct: 238 YSLMTKCWAYDPSK-RPRFTELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 83/329 (25%), Positives = 141/329 (42%), Gaps = 60/329 (18%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKH 102
YT +G G+Y +V A R +VAIK K+ P S+ K RE+ ++K ++H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 103 PNLIKFLQAIETT------HRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDA 155
N+I L + Y++M Y + D+ + G+ + E + + Q++
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
+ Y H G++HRD+K NL ++ D +K+ DFG AR+ ++ + + Y
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA---------DAEMTGYVVTRWY 180
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLK----------- 260
+PE++ + Q D+WS+G ++ M+ G+ F Y +Q+LK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 261 ---------QVQSKVVFPKD------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304
++S +P+ P SP+ L+ K+L V RL E P+F
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
Query: 305 ---RNGPSRPEYPIMSGDSLEVETCCASE 330
R+ E DSLE E E
Sbjct: 301 DSFRDADEETEQQPYD-DSLENEKLSVDE 328
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 8/204 (3%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G GSYATV S + VA+K+I + RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
I T + ++ EY + + G + + + QL+ ++Y H+R ++HRD+K
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
+NLLI +KL+DFG AR +S + +E + Y P++L G
Sbjct: 131 PQNLLISDTGELKLADFGLARA----KSVPSHTYSNEVV--TLWYRPPDVLLGSTEYSTC 184
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTK 254
D+W +G + M+ G F K
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
H Y L +G G+Y V A + A+KII K++ D+ + +E+ +VK KH
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDF--SLIQQEIFMVKECKH 65
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
N++ + + + +++I MEY GSL DI G + E + + + + Y H +
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL- 221
G +HRDIK N+L+ + ++KL+DFG A +++ ++F G+ + +PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR------KSFIGTPYWMAPEVAA 179
Query: 222 --KGIPYCPQLSDVWSMGV 238
K Y QL D+W++G+
Sbjct: 180 VEKNGGY-NQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G G + V + + H+ +VAIK + + +P +L E ++K L+HP L++ L
Sbjct: 14 LGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMSPEAFLA-----EANLMKQLQHPRLVR-L 66
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERGVVHR 167
A+ T +YII EY E GSL+D ++ I T + AQ+ + + + + +HR
Sbjct: 67 YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 168 DIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEILKGIP 225
D++ N+L+ K++DFG AR Y +R+G + + +PE +
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-------PIKWTAPEAINYGT 179
Query: 226 YCPQLSDVWSMGVVLFAMV-FGRLPF 250
+ + SDVWS G++L +V +GR+P+
Sbjct: 180 FTIK-SDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 70 EVAIKII-SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR-VYIIMEYAEK 127
VA+K + P D+L E +++K L+HP LI+ L A+ T +YI+ E +
Sbjct: 32 PVAVKTLKPGTMDPKDFL-----AEAQIMKKLRHPKLIQ-LYAVCTLEEPIYIVTELMKY 85
Query: 128 GSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI-KL 184
GSLL+ ++ + + AQ+ + Y + +HRD+ N+L+ + NI K+
Sbjct: 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV-GENNICKV 144
Query: 185 SDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA 242
+DFG AR Y +R+G + + +PE + + SDVWS G++L
Sbjct: 145 ADFGLARVIKEDIYEAREGAKF-------PIKWTAPEAALYNRFSIK-SDVWSFGILLTE 196
Query: 243 MV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+V +GR+P+ +++L+QV P P E
Sbjct: 197 IVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY---LKKFLPREVEVVKGLKHPNLI 106
I+G G+ TV A +A+K+I P D L+K + E+E++ P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVI-----PLDITVELQKQIMSELEILYKCDSPYII 62
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
F A +R+ I E+ + GSL D+ RK I E + +V + Y ++H
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RD+K N+L++ +KL DFG S Q S+++T+ G+ AY +PE + G Y
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGV--------STQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPF 250
SDVWS+G+ + GR P+
Sbjct: 171 -GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIIS---KMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G G+YATV S VA+K I + AP + REV ++K LKH N++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKNLKHANIVT 67
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHERGVVH 166
I T + ++ EY + L + G + K F QL+ ++YCH+R ++H
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RD+K +NLLI+ +KL+DFG AR + + Y + T Y P++L G
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLW----YRPPDVLLGSTE 180
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPF 250
D+W +G +L+ M GR F
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 26/251 (10%)
Query: 69 CEVAIKIISKMQAPSDYLKKFLPR---------EVEVVKGLKHPNLIKFLQAIETTHRVY 119
C V +K KM A KK L + E E+++ + P ++ A E+ +
Sbjct: 10 CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLC 69
Query: 120 IIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID 177
++M G L I G ++ R + AQ+ I + H +V+RD+K EN+L+D
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD 129
Query: 178 ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMG 237
N +LSD G A + +++++ G+ Y +PEILK PY + D ++MG
Sbjct: 130 DQGNCRLSDLGLA------VELKDGKTITQR-AGTNGYMAPEILKEEPYSYPV-DWFAMG 181
Query: 238 VVLFAMVFGRLPFDD-----TKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKT 291
++ MV GR PF D K + ++ +V F N + E K + LA +
Sbjct: 182 CSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ-NFTEESKDICRLFLAKKPED 240
Query: 292 RLRIKNIKEDP 302
RL + +DP
Sbjct: 241 RLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 28/265 (10%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
D TVL+ Y IG G+ V A + VAIK +S+ + K+ R
Sbjct: 16 GDSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-R 72
Query: 93 EVEVVKGLKHPNLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR 146
E+ ++K + H N+I L +++E VYI+ME + +L +I+ E +D R
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME--LDHERMS 129
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
Q++ I + H G++HRD+K N+++ +D +K+ DFG AR G +
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMM 182
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
+ + Y +PE++ G+ Y + D+WS+G ++ M+ G + F T + +V ++
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 267 VFPKDPNVSPECKALISKILAPVKT 291
P C + K+ V+T
Sbjct: 242 GTP--------CPEFMKKLQPTVRT 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 70/303 (23%)
Query: 51 IGMGSYATVKLATSSRHSCE-VAIKIISKMQ----APSDYLKKFLPREVEVVKGLKHPNL 105
IG G+Y V A R + E +A+K I Q PS + RE+ ++K ++H N+
Sbjct: 10 IGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAI-----REISLLKEMQHGNI 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDET-------RARKWFA-QLVDAIN 157
++ + + R+Y++ EY LD+ K+ ++D + R K + Q++ I
Sbjct: 64 VRLQDVVHSEKRLYLVFEY------LDLDLKK-HMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 158 YCHERGVVHRDIKCENLLIDADYN-IKLSDFGFARNHMRYRSRQGYESLSETFCGSYA-- 214
YCH V+HRD+K +NLLID N +KL+DFG AR + TF
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR---------AFGIPVRTFTHEVVTL 167
Query: 215 -YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQ--------- 263
Y +PEIL G + D+WS+G + MV + F D++ +L K +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227
Query: 264 ---------SKVVFPK---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPW 303
K FPK P + P L+SK+L P K R+ + E +
Sbjct: 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSK-RITARAALEHEY 286
Query: 304 FRN 306
F++
Sbjct: 287 FKD 289
|
Length = 294 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-18
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
TLG IIG G + V + +VA+K I D + E V+ L H NL
Sbjct: 9 TLGEIIGEGEFGAVLQGEYTGQ--KVAVKNIK-----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 106 IKFLQAIETTHR-VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV-------DAIN 157
++ L I H +YI+ME KG+L++ +R G RA QL+ + +
Sbjct: 62 VRLLGVI--LHNGLYIVMELMSKGNLVNFLRTRG-----RALVSVIQLLQFSLDVAEGME 114
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y + +VHRD+ N+L+ D K+SDFG AR G ++ + +
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR-----VGSMGVDNSKLPV----KWTA 165
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQ 263
PE LK + + SDVWS GV+L+ + +GR P+ ++ + V+
Sbjct: 166 PEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 25/242 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G G + V + T + + VAIK + +P +L+ E +V+K L+H L++ L
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQ-----EAQVMKKLRHEKLVQ-L 66
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHR 167
A+ + +YI+ EY KGSLLD ++ E Y+ + AQ+ + Y VHR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 168 DIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEILKGIP 225
D++ N+L+ + K++DFG AR Y +RQG + + +PE
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-------PIKWTAPEAALYGR 179
Query: 226 YCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
+ + SDVWS G++L + GR+P+ ++L QV+ P PEC +
Sbjct: 180 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP----CPPECPESLHD 234
Query: 285 IL 286
++
Sbjct: 235 LM 236
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L IG G + V L +VA+K I +D + E V+ L+H NL
Sbjct: 9 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNL 61
Query: 106 IKFLQAI-ETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHER 162
++ L I E +YI+ EY KGSL+D +R G + K+ + +A+ Y
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
VHRD+ N+L+ D K+SDFG + S +T + +PE L+
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKE---------ASSTQDTGKLPVKWTAPEALR 172
Query: 223 GIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQ 263
+ + SDVWS G++L+ + FGR+P+ ++ +V+
Sbjct: 173 EKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIIS---KMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G G+YATV S VA+K I + AP + REV ++K LKH N++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIVT 68
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHERGVVH 166
+ T + ++ EY +K L + G I K F Q++ + YCH R V+H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP- 225
RD+K +NLLI+ +KL+DFG AR + + Y + T Y P++L G
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLW----YRPPDVLLGSSE 181
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPF 250
Y Q+ D+W +G + F M GR F
Sbjct: 182 YSTQI-DMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK-----MQAPSDYLK 87
D TVL+ Y IG G+ V A + VAIK +S+ A Y
Sbjct: 8 GDSTFTVLKR--YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-- 63
Query: 88 KFLPREVEVVKGLKHPNLIKFLQA------IETTHRVYIIMEYAEKGSLLDIIRKEGYID 141
RE+ ++K + H N+I L +E VY++ME + +L +I+ + +D
Sbjct: 64 ----RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LD 116
Query: 142 ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201
R Q++ I + H G++HRD+K N+++ +D +K+ DFG AR G
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AG 169
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255
+ + + Y +PE++ G+ Y + D+WS+G ++ M+ G + F T +
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDH 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 68/233 (29%), Positives = 116/233 (49%), Gaps = 22/233 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G + V + T + + +VAIK + P + + +E +++K L+H L+ L
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVP-LY 67
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHR 167
A+ + +YI+ E+ KGSLLD + KEG Y+ + AQ+ D + Y +HR
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 168 DIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEILKGIP 225
D++ N+L+ + K++DFG AR Y +RQG + + +PE
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-------PIKWTAPEAALYGR 179
Query: 226 YCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + SDVWS G++L +V GR+P+ ++L+QV+ P P PE
Sbjct: 180 FTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-PQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 70 EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-THRVYIIMEYAEKG 128
EVAIK++ ++ + RE + L HPN++ L + E ++ + EY
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 129 SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLS 185
+L +++ +G + + Q++DA+ H +G+VHRD+K +N+++ + K+
Sbjct: 65 TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 186 DFGF------ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVV 239
DFG R+ + E L G+ Y +PE L+G P P SD+++ G++
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVL-----GTPTYCAPEQLRGEPVTPN-SDLYAWGLI 178
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G Y V ++S VA+K + + +++FL +E V+K +KHPNL++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL-KEAAVMKEIKHPNLVQLLG 69
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
YII E+ G+LLD +R+ ++ Q+ A+ Y ++ +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGYESLSETFCGSYAYASPEILKGIP 225
+ N L+ ++ +K++DFG +R M Y + G + + +PE L
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKF-------PIKWTAPESLAYNK 181
Query: 226 YCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQL 258
+ + SDVW+ GV+L+ + +G P+ SQ+
Sbjct: 182 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQV 214
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
T+ +IG G + V +L + +VAIK + K + FL E ++ H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFL-TEASIMGQFDH 64
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
PN+I+ + + V II EY E GSL +R+ +G + + + Y E
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR-----YRSRQGYESLSETFCGSYAYA 216
VHRD+ N+L++++ K+SDFG +R + Y ++ G + +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIR--------WT 175
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
+PE + + SDVWS G+V++ M +G P+ D ++K V+
Sbjct: 176 APEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A +S + +VAIK I+ K+ L RE+++++ L H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAIKD 71
Query: 111 AIETTHR-----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ HR VYI+ E + L IIR + + + + QL+ + Y H V+
Sbjct: 72 IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVL 130
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----YASPEIL 221
HRD+K NLL++A+ ++K+ DFG AR S F Y Y +PE+L
Sbjct: 131 HRDLKPSNLLLNANCDLKICDFGLART----------TSEKGDFMTEYVVTRWYRAPELL 180
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLK 260
DVWS+G + FA + GR P F Y LK
Sbjct: 181 LNCSEYTTAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 33/246 (13%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISK-----MQAPSDYLKKFLPREVEVVKGLKHP 103
T +G G+Y +V A +R +VA+K +S+ + A Y RE+ ++K +KH
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY------RELRLLKHMKHE 74
Query: 104 NLIKFLQ------AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
N+I L +IE + VY++ G+ L+ I K + + + QL+ +
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y H G++HRD+K N+ ++ D +++ DFG A RQ + ++ + + Y +
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--------RQADDEMT-GYVATRWYRA 183
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
PEI+ + Q D+WS+G ++ ++ G+ F Y LK++ V P SPE
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP-----SPE 238
Query: 278 CKALIS 283
IS
Sbjct: 239 VLKKIS 244
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 26/256 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G+Y +V +A+K I +++ + + E++++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQII-MELDILHKAVSPYIVDFYG 66
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGY----IDETRARKWFAQLVDAINYCHER-GVV 165
A VY+ MEY + GSL D + G I E R+ +V + + E ++
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG-- 223
HRD+K N+L++ + +KL DFG + N + SL++T G +Y +PE +K
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--------SLAKTNIGCQSYMAPERIKSGG 177
Query: 224 ----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK---DPNVSP 276
Y Q SDVWS+G+ + M GR P+ Y+ + Q+ + V S
Sbjct: 178 PNQNPTYTVQ-SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 277 ECKALISKILAPVKTR 292
+ + ++K L + R
Sbjct: 237 DAQDFVAKCLNKIPNR 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
IG G+Y V A + VA+K + +M D + RE+ ++ L+HPN+++
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 110 QAIETTH--RVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ + H ++++MEY E+ SLLD + E++ + QL+ + Y HE ++
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA-------YASP 218
HRD+K NLL+ +K++DFG AR + Y +P
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTY-------------GLPAKPMTPKVVTLWYRAP 177
Query: 219 EILKGIPYCPQLSDVWSMGVVL 240
E+L G D+W++G +L
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G + VK R +VAIK+I + D +F+ E +V+ L H L++
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMKLSHEKLVQLYG 66
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV-------DAINYCHERG 163
+YI+ EY G LL+ +R E R +QL+ + + Y +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLR------EHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEIL 221
+HRD+ N L+D +K+SDFG +R + Y S S+ F ++ PE+L
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-----SVGSKF--PVRWSPPEVL 173
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
+ + SDVW+ GV+++ + G++P++ S+ +++V
Sbjct: 174 LYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G+Y V A + AIK+I K++ D+ + +E+ ++K KH N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDF--AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170
+ +++I ME+ GSL DI G + E++ + + + Y H +G +HRDIK
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL----KGIPY 226
N+L+ + ++KL+DFG + +++ ++F G+ + +PE+ KG
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKR------KSFIGTPYWMAPEVAAVERKG--G 185
Query: 227 CPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLKQVQSKVVFPK 270
QL D+W++G+ + + P FD L +S PK
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 42/149 (28%), Positives = 83/149 (55%), Gaps = 8/149 (5%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL----KHPNLI 106
I G++ V L +S A+K++ K +D + K + +V+ + K P ++
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKK----ADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
++++ + VY++MEY G + ++ GY DE A K+ +++ A++Y H G++H
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMR 195
RD+K +N+LI + +IKL+DFG ++ +
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 31/230 (13%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G G + V + T + ++ +VA+K + +P +L+ E +++K L+H L++ L
Sbjct: 14 LGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSPESFLE-----EAQIMKKLRHDKLVQ-L 66
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVD-------AINYCHER 162
A+ + +YI+ EY KGSLLD + K+G E RA K LVD + Y
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFL-KDG---EGRALK-LPNLVDMAAQVAAGMAYIERM 121
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEI 220
+HRD++ N+L+ K++DFG AR Y +RQG + + +PE
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-------PIKWTAPEA 174
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFP 269
+ + SDVWS G++L +V GR+P+ ++L+QV+ P
Sbjct: 175 ALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 24/230 (10%)
Query: 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+ +G G+Y +V A ++ VA+K +S+ + K+ RE+ ++K +KH N+I
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 81
Query: 109 L------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
L +++E + VY++ G+ L+ I K + + + Q++ + Y H
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---YASPE 219
++HRD+K NL ++ D +K+ DFG AR+ + G A Y +PE
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARH------------TDDEMTGYVATRWYRAPE 187
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269
I+ + Q D+WS+G ++ ++ GR F T + LK + V P
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 8/160 (5%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQ 151
RE++++K + H +I + A V ++M K L + + G + +A +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA-RNHMRYRSRQGYESLSETFC 210
L++A+ Y H RG++HRD+K EN+ +D N L DFG A + + Q Y +
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY-----GWS 248
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
G+ SPE+L PYC + +D+WS G+VLF M +
Sbjct: 249 GTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 56/299 (18%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIK-IISKMQ---APSDYLKKFLPREVEVVKGLKHPNL 105
IG G+Y V A VA+K +M P L RE+ +++ L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQMLSESIY 62
Query: 106 IKFLQAIETTHR------VYIIMEYAEKG--SLLDIIRKEGY--IDETRARKWFAQLVDA 155
I L +E +Y++ EY + +D + + + + QL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 156 INYCHERGVVHRDIKCENLLIDADYN-IKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+ +CH+ GV+HRD+K +NLL+D +K++D G R +E + +
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV------TLW 176
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLK----------QVQ 263
Y +PE+L G + D+WS+G + M + F D++ QLL QV
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236
Query: 264 SKV-------VFPK---------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWF 304
V FP+ P++SPE L+ K+L P K R+ K P+F
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK-RISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 63/229 (27%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
D TVL+ Y IG G+ V A + VAIK +S+ + K+ R
Sbjct: 9 GDSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-R 65
Query: 93 EVEVVKGLKHPNLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR 146
E+ ++K + H N+I L +++E VY++ME + +L +I+ E +D R
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME--LDHERMS 122
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
Q++ I + H G++HRD+K N+++ +D +K+ DFG AR G +
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMM 175
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255
+ + Y +PE++ G+ Y + D+WS+G ++ MV ++ F Y
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 46 TLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
TLG +G G++ V A + + VA+K++ K A L + E+E++K +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLV-SEMEMMKMI 72
Query: 101 -KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-------KEGYIDETRARK----- 147
KH N+I L +Y+++EYA G+L D +R D +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 148 ---WFA-QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQG 201
FA Q+ + + + +HRD+ N+L+ D+ +K++DFG AR +H+ Y +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA-MVFGRLPFDDTKYSQLLK 260
L + +PE L Y Q SDVWS GV+L+ G P+ +L K
Sbjct: 193 NGRL------PVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
Query: 261 QVQSKVVFPKDPNVSPECKALI 282
++ K N + E L+
Sbjct: 246 LLKEGYRMEKPQNCTQELYHLM 267
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 20/154 (12%)
Query: 92 REVEVVKGLKHPNLIKFLQAI---ETTHRVYIIMEYAE---KGSLLDIIRKEGYIDETRA 145
RE+ ++ L+HPN++ ++ + ++Y++MEY E K SL++ +++ E +
Sbjct: 53 REINILLKLQHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLK-SLMETMKQPFLQSEVKC 110
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS-RQGYES 204
QL+ + + H+ ++HRD+K NLL++ +K+ DFG AR Y S + Y
Sbjct: 111 --LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQ 165
Query: 205 LSETFCGSYAYASPEILKGIP-YCPQLSDVWSMG 237
L T Y +PE+L G Y + D+WS+G
Sbjct: 166 LVVTLW----YRAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 62/229 (27%), Positives = 111/229 (48%), Gaps = 20/229 (8%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR 92
AD TVL+ Y IG G+ V A + VA+K +S+ + K+ R
Sbjct: 13 ADSTFTVLKR--YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-R 69
Query: 93 EVEVVKGLKHPNLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR 146
E+ ++K + H N+I L +++E VY++ME + +L +I E +D R
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME--LDHERMS 126
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
Q++ I + H G++HRD+K N+++ +D +K+ DFG AR +
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------ACTNFMM 179
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255
+ + Y +PE++ G+ Y + D+WS+G ++ +V G + F T +
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDH 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 52/202 (25%), Positives = 107/202 (52%), Gaps = 22/202 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G++ V A + A K+I + L+ ++ E+E++ HP ++K L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMV-EIEILATCNHPYIVKLLG 76
Query: 111 AIETTHRVYIIMEYAEKGS----LLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
A +++I++E+ G+ +L++ R + E + + Q+++A+ Y H ++H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI-----L 221
RD+K N+L+ D +IKL+DFG + +++ R+ ++F G+ + +PE+ +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR------DSFIGTPYWMAPEVVMCETM 187
Query: 222 KGIPYCPQLSDVWSMGVVLFAM 243
K PY + +D+WS+G+ L M
Sbjct: 188 KDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P ++ A T ++ I++ G L + + G E R + A+++ + + H R
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL- 221
VV+RD+K N+L+D ++++SD G A + + ++ + S+ G++ Y +PE+L
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASV-----GTHGYMAPEVLQ 168
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFD--DTKYSQLLKQVQSKVVFPKDPNVSPECK 279
KG+ Y +D +S+G +LF ++ G PF TK + ++ + + SPE +
Sbjct: 169 KGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227
Query: 280 ALISKILA-PVKTRL-----RIKNIKEDPWFRN 306
+L+ +L V RL + +KE P+FR+
Sbjct: 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 18/233 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G++ V + VA+K + P D KFL +E ++K HPN+++ +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFL-QEARILKQYSHPNIVRLIG 60
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDA---INYCHERGVVHR 167
+YI+ME + G L +R EG + ++ + +A + Y + +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILKGIP 225
D+ N L+ +K+SDFG +R Y S G + + + +PE L
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI------PVKWTAPEALNYGR 172
Query: 226 YCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
Y + SDVWS G++L+ A G +P+ + Q + ++ V P P + P+
Sbjct: 173 YSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCPD 223
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 60/236 (25%), Positives = 112/236 (47%), Gaps = 24/236 (10%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKH 102
Y + +G G+Y V A ++ +VAIK K+ P S K RE+ ++K + H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 103 PNLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
N+I L ++E VY++ L +I++ + D+ + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDD-HIQFLVYQILRGL 131
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
Y H G++HRD+K N+ ++ D +K+ DFG AR+ + + + Y
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---------DDEMTGYVATRWYR 182
Query: 217 SPEI-LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD 271
+PEI L + Y Q D+WS+G ++ ++ G+ F + + LK++ + V P +
Sbjct: 183 APEIMLNWMHY-NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 70/316 (22%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII----SKMQAPSDYLKKFLPREVEVVKGL 100
Y + +G G++ V A + VA+K I K P L RE++++K L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-----REIKILKKL 64
Query: 101 KHPNLIKFLQAI-----ETTHR---VYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFA 150
KHPN++ + ++ + VY++ Y + LL+ + + E++ + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML 122
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---------NHMRYRSRQG 201
QL++ INY HE ++HRDIK N+LID +K++DFG AR +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 202 YESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQL 258
Y +L T Y PE+L G Y + D+W +G V FA +F R P + QL
Sbjct: 183 YTNLVVT----RWYRPPELLLGERRYTTAV-DIWGIGCV-FAEMFTRRPILQGKSDIDQL 236
Query: 259 --------------------LKQVQSKVVFPKDPN--------VSPECKALISKILA--P 288
L + F P + PE L+SK+L+ P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 289 VKTRLRIKNIKEDPWF 304
K RL + E P+F
Sbjct: 297 YK-RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 73/242 (30%), Positives = 118/242 (48%), Gaps = 41/242 (16%)
Query: 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+ Y LG IIG GS+ V A S +VAIK + +Q P ++ RE+ ++K L
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV--LQDP-----QYKNRELLIMKNLN 117
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDET--RARKWFA--------- 150
H N+I FL+ T + EK L+++ + +I +T + K +A
Sbjct: 118 HINII-FLKDYYYTECF----KKNEKNIFLNVVME--FIPQTVHKYMKHYARNNHALPLF 170
Query: 151 -------QLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGY 202
QL A+ Y H + + HRD+K +NLLID + + +KL DFG A+N + G
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL-----AGQ 225
Query: 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQ 261
S+S + S Y +PE++ G D+WS+G ++ M+ G F + QL++
Sbjct: 226 RSVS--YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
Query: 262 VQ 263
+Q
Sbjct: 284 IQ 285
|
Length = 440 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 15/218 (6%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
++G G++ V T + VA+K K P + KFL E ++K HPN++K +
Sbjct: 2 LLGKGNFGEVFKGTLKDKT-PVAVKT-CKEDLPQELKIKFL-SEARILKQYDHPNIVKLI 58
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDA---INYCHERGVVH 166
+YI+ME G L +RK+ DE + ++ +DA + Y + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RD+ N L+ + +K+SDFG +R + G S S + +PE L Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 227 CPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQ 263
+ SDVWS G++L+ G P+ Q +QV+
Sbjct: 172 SSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 46 TLGTIIGMGSY--ATVKLATSSRHSCE---VAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
L T+IG V LA +H VA+K I+ + LK L +E+ + L
Sbjct: 1 ELLTLIGKCFEDLMIVHLA---KHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQL 56
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR---KEGYIDETRARKWFAQLVDAIN 157
+HPN++ ++ + +Y++ GS D+++ EG E +++A++
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALD 115
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY-A 216
Y H +G +HR +K ++L+ D + LS ++ + +++ RQ
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 217 SPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ 261
SPE+L+ G Y + SD++S+G+ + G +PF D +Q+L +
Sbjct: 176 SPEVLQQNLQG--YNEK-SDIYSVGITACELANGHVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 47/289 (16%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFL 109
IG G++ TV +A+K I + +K L +++VV + P ++KF
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 110 QAIETTHRVYIIMEYAEKGSLLDI----------IRKEGYIDETRARKWFAQLVDAINYC 159
A+ +I ME L+DI + I E K V A+NY
Sbjct: 70 GALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 160 HER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF-CGSYAYAS 217
E ++HRD+K N+L+D + NIKL DFG S Q +S+++T G Y +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGI--------SGQLVDSIAKTRDAGCRPYMA 175
Query: 218 PEILKGIPYCPQ----LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF---PK 270
PE + P SDVWS+G+ L+ + G+ P+ K++ + Q+ +VV P
Sbjct: 176 PERID--PSARDGYDVRSDVWSLGITLYEVATGKFPYP--KWNSVFDQLT-QVVKGDPPI 230
Query: 271 DPN-----VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPEY 313
N SP I+ L R + K + E P+ ++ R
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 47 LGTIIGMGSYATVKLATSSRHS-----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
LG +G G + V AT+ R VA+K++ + + S+ L E ++K +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLKQVN 61
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE-----GYIDETRARKW-------- 148
HP++IK A + +I+EYA+ GSL +R+ Y+ R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 149 ----------FA-QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197
FA Q+ + Y E +VHRD+ N+L+ +K+SDFG +R+
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD---VY 178
Query: 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
Y S+ + + E L Y Q SDVWS GV+L+ +V
Sbjct: 179 EEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 46/278 (16%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFL 109
IG G+ V + +A+K + + + K+ L +++VV K P ++K
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRIL-MDLDVVLKSHDCPYIVKCY 80
Query: 110 QAIETTHRVYIIMEY----AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GV 164
T V+I ME +K LL R +G I E K +V A++Y E+ GV
Sbjct: 81 GYFITDSDVFICMELMSTCLDK--LL--KRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEILK 222
+HRD+K N+L+DA N+KL DFG + + + ++R G AY +PE +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---------GCAAYMAPERID 187
Query: 223 GIPYCPQL---SDVWSMGVVLFAMVFGRLPFD--DTKYSQLLKQVQSKV-VFPKDPNVSP 276
P+ +DVWS+G+ L + G+ P+ T++ L K +Q + P + SP
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247
Query: 277 ECKALISKILAPVKTRLRIKNIKEDPWFRNGPSRPEYP 314
+ + + L K+ ++ RP+Y
Sbjct: 248 DFCSFVDLCL--------TKDHRK---------RPKYR 268
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKM-QAPSDYLKKFLPREVEVVKGLKHP 103
Y + +IG GSY V A + +VAIK I+ + + SD + + RE+++++ L+HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHP 59
Query: 104 NLIKFLQAIETTHR-----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
++++ + R +Y++ E E L +I+ + + + QL+ A+ Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---- 214
H V HRD+K +N+L +AD +K+ DFG AR ++ + F Y
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN-------DTPTAIFWTDYVATRW 171
Query: 215 YASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y +PE+ Y P + D+WS+G + ++ G+ F
Sbjct: 172 YRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLIK 107
IG+G+Y TV A VA+K + ++Q D L REV ++K L+ HPN+++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 108 FLQAIETTH-----RVYIIMEYAEKG--SLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
+ T+ +V ++ E+ ++ + LD + G ET + Q + +++ H
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-IKDLMRQFLRGLDFLH 125
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+VHRD+K EN+L+ + +KL+DFG AR Y + + T Y +PE+
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLW----YRAPEV 178
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLK 260
L Y + D+WS+G + FA +F R P +++ QL K
Sbjct: 179 LLQSTYATPV-DMWSVGCI-FAEMFRRKPLFCGNSEADQLGK 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK--- 107
+GMG++ V A VAIK I K + + L K RE++++K L+H N+I
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 108 -FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVH 166
F+ +E +Y + E G+ L + +++ + + Q++ + Y H GVVH
Sbjct: 77 IFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131
Query: 167 RDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
RD+K N+LI+ + ++K+ DFG AR M GY S + Y +PEI+
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVS-------TRYYRAPEIMLT 179
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPF 250
D+WS G + M+ G+ F
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 74 KIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDI 133
++I+K L E+ + L H N++K + + + Y+I + + L
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSF 252
Query: 134 IRKEGYIDETR-----ARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFG 188
+ E + + R R QL+ A+ Y H++ ++HRDIK EN+ ++ D I L DFG
Sbjct: 253 MYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRL 248
A + R Y + G+ A SPEIL G YC +++D+WS G++L M+
Sbjct: 313 TAMPFEKEREAFDY-----GWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDF 366
Query: 249 -PFDD---TKYSQLLKQVQSKVV----FPKDP 272
P D QLLK + S V FP P
Sbjct: 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V A R + VAIK +S S+ + + +EV ++ L+HPN I++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 111 AIETTHRVYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
H +++MEY +L++ +K E A + + Y H +HRD
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAIC--HGALQGLAYLHSHERIHRD 140
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI---P 225
IK N+L+ +KL+DFG A S + +F G+ + +PE++ +
Sbjct: 141 IKAGNILLTEPGTVKLADFGSA----------SLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 226 YCPQLSDVWSMGV 238
Y ++ DVWS+G+
Sbjct: 191 YDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 19/219 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G + V L +VAIK I + + + E +V+ L HP L++
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYG 66
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
+ ++ E+ E G L D +R + G + + + + Y V+HRD+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 170 KCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
N L+ + +K+SDFG R + +Y S G + ++SPE+ Y
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-------PVKWSSPEVFSFSKYS 179
Query: 228 PQLSDVWSMGVVLFAMVF--GRLPFDDTKYSQLLKQVQS 264
+ SDVWS GV+++ VF G+ P+++ S++++ + +
Sbjct: 180 SK-SDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETINA 216
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCE--VAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
Y L +G G+Y V A ++ S E VAIK I+ + + K+ L RE+++++ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFR 59
Query: 102 -HPNL-------IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV 153
H N+ I F + +Y+ E E L IIR + + + + Q++
Sbjct: 60 GHKNITCLYDMDIVFPGNF---NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQGYESLSETFCGS 212
+ Y H V+HRD+K NLL++AD +K+ DFG AR G+ ++E + +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--MTE-YVAT 172
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y +PEI+ + DVWS+G +L A + GR P
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 43/269 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G + V L R K IS + + K L EV V++ LKH N+++++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 111 AI--ETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCH---- 160
+ ++YI+ME+ + G L I+K G I+E QL+ A+ YCH
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 161 ----ERGVVHRDIKCENLL----------IDADYN-------IKLSDFGFARNHMRYRSR 199
ER V+HRD+K +N+ I A N K+ DFG ++N
Sbjct: 140 GPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN------- 191
Query: 200 QGYESLSETFCGSYAYASPEIL-KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQ 257
G ES++ + G+ Y SPE+L SD+W++G +++ + G+ PF +SQ
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
Query: 258 LLKQVQSKVVFPKDPNVSPECKALISKIL 286
L+ +++ P S E LI +L
Sbjct: 252 LISELKRGPDLPIKGK-SKELNILIKNLL 279
|
Length = 1021 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-15
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
+G G + V L R +VAIK I++ + D+++ E +V+ L HP L++
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEEDFIE-----EAKVMMKLSHPKLVQLY 65
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+YI+ E+ E G LL+ +R ++G + + + + + Y +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 169 IKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
+ N L+ + +K+SDFG R + Y S G + ++ PE+ Y
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-------PVKWSPPEVFNFSKY 178
Query: 227 CPQLSDVWSMGVVLFAMVF--GRLPFDDTKYSQL 258
+ SDVWS GV+++ VF G++PF+ K S
Sbjct: 179 SSK-SDVWSFGVLMWE-VFTEGKMPFE--KKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V AT+S + VA+K +S ++ + + +EV+ ++ LKHPN I++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 111 AIETTHRVYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
H +++MEY LL++ +K + E + + Y H ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI---P 225
IK N+L+ +KL+DFG A S + +F G+ + +PE++ +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSA----------SKSSPANSFVGTPYWMAPEVILAMDEGQ 196
Query: 226 YCPQLSDVWSMGV 238
Y ++ DVWS+G+
Sbjct: 197 YDGKV-DVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 21/240 (8%)
Query: 40 LESHGYTLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV 96
+++ + +IG G + V +L + VAIK + K + FL E +
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASI 58
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDA 155
+ HPN+I + + V I+ EY E GSL +RK +G + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR-----NHMRYRSRQGYESLSETFC 210
+ Y + G VHRD+ N+L++++ K+SDFG +R Y +R G + T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT-- 176
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFP 269
+PE + + SDVWS G+V++ M +G P+ + ++K ++ P
Sbjct: 177 ------APEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKM-QAPSDYLK-KFLPREVEVVKGLKHPNLIKF 108
IG G++ V T R VA+K KM + + K + RE++++ KH N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK---KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 109 LQAIETTH-----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
L ++ H +Y++ E + L II + + + Q++ + Y H G
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRDIK NLL++++ +K+ DFG AR S+ +++ Y Y +PEIL G
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH----MTQEVVTQY-YRAPEILMG 178
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPF 250
+ D+WS+G + ++ R+ F
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 28/283 (9%)
Query: 50 IIGMGSYATVK----LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
++G G++ TV + + VAIK + + +P K + E V+ + +P++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHV 71
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
+ L I T V +I + G LLD +R+ + I W Q+ +NY ER +
Sbjct: 72 CRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYASPEI 220
VHRD+ N+L+ ++K++DFG A+ + Y + G + + + E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK--------WMALES 182
Query: 221 LKGIPYCPQLSDVWSMGVVLFA-MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
+ Y Q SDVWS GV ++ M FG P+D S++ ++ P+ P + +
Sbjct: 183 ILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241
Query: 280 ALISK---ILAPVKTRLRIKNIKEDPWFRNGPSRPEYPIMSGD 319
++ K I A + + R + I E P R Y ++ GD
Sbjct: 242 MIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQR--YLVIQGD 281
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 44 GYTLGTIIGMGSYATVKLATS--SRHSCEVAIKIISKMQAPSDYLKKFLP---REVEVVK 98
Y + IG G+Y V A + E AIK K + + RE+ +++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLR 57
Query: 99 GLKHPNLIKFLQAI--ETTHRVYIIMEYAEKGSLLDIIR-----KEGYIDETRARKWFAQ 151
LKH N++ ++ VY++ +YAE L II+ K I + + Q
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYN----IKLSDFGFAR 191
+++ ++Y H V+HRD+K N+L+ + +K+ D G AR
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 71 VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130
VA+K + K + K+FL +E ++ HPN++K L YIIME E G L
Sbjct: 29 VAVKTLRKGATDQEK-KEFL-KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 131 LDIIRKEGYIDETRARKWFAQL----------VDAINYCH---ERGVVHRDIKCENLLI- 176
L +R R ++ L +D C + +HRD+ N L+
Sbjct: 87 LSYLRD------ARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS 140
Query: 177 ----DADYNIKLSDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL 230
DAD +K+ DFG AR+ + Y ++G L + +PE L + Q
Sbjct: 141 EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL------PVRWMAPESLLDGKFTTQ- 193
Query: 231 SDVWSMGVVLFA-MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
SDVWS GV+++ + G+ P+ ++L+ V + K N
Sbjct: 194 SDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 48/138 (34%), Positives = 74/138 (53%), Gaps = 25/138 (18%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFG---FARNHMRYRSRQGYESLSE 207
QL+ AI+Y H G++HRDIK EN+L++ +I L DFG FAR S + ++
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS---WSTPFHYGIA- 323
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF------AMVFG------RLPFDDTKY 255
G+ +PE+L G PY P + D+WS G+V+F A +F R P+ D +
Sbjct: 324 ---GTVDTNAPEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQI 378
Query: 256 SQLLKQVQSKV-VFPKDP 272
++++Q Q V FP+
Sbjct: 379 LRIIRQAQVHVDEFPQHA 396
|
Length = 461 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 54/179 (30%), Positives = 95/179 (53%), Gaps = 20/179 (11%)
Query: 71 VAIKIISKMQAPS-DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR--VYIIMEYAEK 127
VA+K K+Q + ++L+ F RE+E++K L+H N++K+ + R + ++MEY
Sbjct: 36 VAVK---KLQHSTAEHLRDF-EREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 128 GSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSD 186
GSL D + + +D + + +Q+ + Y + VHRD+ N+L++++ +K+ D
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151
Query: 187 FGFAR----NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF 241
FG + + Y+ R+ ES + YA PE L + SDVWS GVVL+
Sbjct: 152 FGLTKVLPQDKEYYKVREPGES------PIFWYA-PESLTESKFSVA-SDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V A R + VAIK +S S+ + + +EV+ ++ +KHPN I++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 111 AIETTHRVYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
H +++MEY LL++ +K + E + + Y H ++HRD
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI---P 225
IK N+L+ +KL+DFG A S + +F G+ + +PE++ +
Sbjct: 151 IKAGNILLTEPGQVKLADFGSA----------SIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 226 YCPQLSDVWSMGVVLFAMVFGRLPF 250
Y ++ DVWS+G+ + + P
Sbjct: 201 YDGKV-DVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 32/234 (13%)
Query: 50 IIGMGSYATVKLATSSRHSCEV--AIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLI 106
+IG G++ V A + + AIK + + + D+ + E+EV+ L HPN+I
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRK-------------EGYIDETRARKWFAQLV 153
L A E +Y+ +EYA G+LLD +RK +++
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 154 DAIN---YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY-RSRQGYESLSETF 209
D Y ++ +HRD+ N+L+ +Y K++DFG +R Y + G +
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQV 262
S Y+ Y SDVWS GV+L+ +V G P+ ++L +++
Sbjct: 180 IESLNYSV--------YTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 32/260 (12%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEV--AIKIISKMQAPSDYLKKFLPREVEVVKGL-KH 102
+IG G++ V A + ++ AIK++ + + +D+ + E+EV+ L H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHH 62
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-------------EGYIDETRARKWF 149
PN+I L A E +YI +EYA G+LLD +RK G +++
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 150 AQLVDAIN---YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY-RSRQGYESL 205
D Y E+ +HRD+ N+L+ + K++DFG +R Y + G +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
S Y+ Y + SDVWS GV+L+ +V G P+ ++L +++
Sbjct: 183 RWMAIESLNYSV--------YTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 265 KVVFPKDPNVSPECKALISK 284
K N E L+ +
Sbjct: 234 GYRMEKPRNCDDEVYELMRQ 253
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 9/237 (3%)
Query: 51 IGMGSYATVKLATSSRHSCE--VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G++ TVK E VA+KI+ K LK L RE V++ L +P +++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ E + ++ME AE G L ++K ++ E + Q+ + Y E VHRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+ N+L+ + K+SDFG ++ + + Y + +PE + +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSK---ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 229 QLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
+ SDVWS GV+++ A +G+ P+ K +++ + ++S PE L+
Sbjct: 178 K-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL 233
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 14/234 (5%)
Query: 52 GMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111
G + +V LA + V ++I + ++ ++ K L EV + +HPN++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRI-TDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 112 IETTHRVYII---MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
T +++I M Y SLL EG + E + +NY H+ G +HR+
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYIHRN 126
Query: 169 IKCENLLIDADYNIKLSD----FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
IK ++LI D + LS + RN + + + S + + SPE+L+
Sbjct: 127 IKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQD 183
Query: 225 PYCPQL-SDVWSMGVVLFAMVFGRLPFDDTKYSQ-LLKQVQSKVVFPKDPNVSP 276
Y + SD++S+G+ + GR+PF D +Q LL++++ P D P
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 48/175 (27%), Positives = 93/175 (53%), Gaps = 18/175 (10%)
Query: 141 DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200
E RA + AQ++ + + H+R +++RD+K EN+L+D D N+++SD G A +S+
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF----DDTKYS 256
++ + G+ + +PE+L+G Y + D +++GV L+ M+ R PF + +
Sbjct: 154 -----TKGYAGTPGFMAPELLQGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENK 207
Query: 257 QLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKN-----IKEDPWFR 305
+L +++ + V D SP K+ +LA + RL ++ ++ P FR
Sbjct: 208 ELKQRILNDSVTYPD-KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 30/272 (11%)
Query: 50 IIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+IG G + V +L + VAIK + K + FL E ++ HPN+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNII 68
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ + V II E+ E G+L +R +G + + + Y E V
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA--YASPEILKG 223
HRD+ N+L++++ K+SDFG +R S Y S + G + +PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS---SLGGKIPIRWTAPEAIAY 185
Query: 224 IPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282
+ SDVWS G+V++ M +G P+ D ++ ++ P +C +
Sbjct: 186 RKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP----PMDCPTAL 240
Query: 283 SKILAPVKTRLRIKNIKEDPWFRNGPSRPEYP 314
+++ D W ++ +RP++
Sbjct: 241 HQLML-------------DCWQKDRNARPKFG 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETT--HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWF 149
+E+ ++K L H N++K+ + +IMEY GSL D + K ++ + +
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFA 113
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESL 205
Q+ + + Y H + +HRD+ N+L+D D +K+ DFG A+ H YR R+ +S
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS- 172
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
+ YA E LK + SDVWS GV L+ ++
Sbjct: 173 -----PVFWYA-VECLKENKFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-14
Identities = 40/148 (27%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
PN++ + I + V++++++AE G L I K I E ++W A++V A++ H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG---SYAYASPE 219
G+V RD+ N+L+D +I+L+ F + + ++ G Y +PE
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFS------------RWSEVEDSCDGEAVENMYCAPE 152
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
+ GI + D WS+G +LF ++ G+
Sbjct: 153 V-GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG GS+ V A R+S VAIK +S S+ + + +EV ++ L+HPN I++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 111 AIETTHRVYIIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
H +++MEY LL++ +K + E + + Y H ++HRD
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI---P 225
+K N+L+ +KL DFG A + + F G+ + +PE++ +
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSA----------SIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 226 YCPQLSDVWSMGV 238
Y ++ DVWS+G+
Sbjct: 191 YDGKV-DVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51 IGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLI 106
IG G+Y V A ++ VA+K + ++Q + + REV V++ L+ HPN++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 107 KFLQAIETTH-----RVYIIMEYAEKG--SLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
+ + ++ ++ E+ ++ + LD + + G ET + QL+ +++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQLLRGLDFL 126
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H VVHRD+K +N+L+ + IKL+DFG AR + ++ + + Y +PE
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQMALTSVVVTLWYRAPE 179
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
+L Y + D+WS+G + FA +F R P
Sbjct: 180 VLLQSSYATPV-DLWSVGCI-FAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 36/259 (13%)
Query: 46 TLGTIIGMGSYATVKLATS-------SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
TLG +G G + V +A + + + VA+K++ D L E+E++K
Sbjct: 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 75
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRA---RKW 148
+ KH N+I L A +Y+I+EYA KG+L + +R E D R +
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 149 FAQLVD-------AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSR 199
F LV + Y + +HRD+ N+L+ + +K++DFG AR N++ Y +
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQL 258
L + +PE L Y Q SDVWS GV+++ + G P+ +L
Sbjct: 196 TTNGRL------PVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 259 LKQVQSKVVFPKDPNVSPE 277
K ++ K N + E
Sbjct: 249 FKLLKEGHRMDKPANCTNE 267
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 17/244 (6%)
Query: 40 LESHGYTLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV 96
L++ + I+G G + + L S+ VAI + SD ++ E
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR--AGCSDKQRRGFLAEALT 59
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDA 155
+ H N+++ I + + I+ EY G+L +RK EG + + L
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA- 214
+ Y E G VH+ + +L+++D K+S F R E++ T G
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF-------RRLQEDKSEAIYTTMSGKSPV 172
Query: 215 -YASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+A+PE ++ + SDVWS G+V++ M +G P+ D ++K V+ P
Sbjct: 173 LWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231
Query: 273 NVSP 276
N
Sbjct: 232 NCPN 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 51/217 (23%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 90 LPREVEVVKGLKHPNLIKF--LQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRAR 146
L +E+E+++ L H N++K+ + + + + +IME+ GSL + + R + I+ +
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
K+ Q+ ++Y R VHRD+ N+L+++++ +K+ DFG + + + Y ++
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEYYTVK 169
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---------- 256
+ + +PE L + SDVWS GV L+ + L + D++ S
Sbjct: 170 DDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYEL----LTYCDSESSPMTLFLKMIG 224
Query: 257 ---------QLLKQVQSKVVFPKDPNVSPECKALISK 284
+L++ ++ P+ PN E L+ K
Sbjct: 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 67/259 (25%), Positives = 111/259 (42%), Gaps = 36/259 (13%)
Query: 46 TLGTIIGMGSYATVKLATS-------SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
LG +G G + V A + + VA+K++ D L E+E++K
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD--LISEMELMK 72
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARK---W 148
+ KH N+I L +Y+I+EYA KG+L + +R + D T+ +
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 149 FAQLVD-------AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSR 199
F LV + Y R +HRD+ N+L+ D +K++DFG AR + + Y +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQL 258
L + +PE L Y Q SDVWS G++++ + G P+ +L
Sbjct: 193 TSNGRL------PVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEEL 245
Query: 259 LKQVQSKVVFPKDPNVSPE 277
K ++ K N + E
Sbjct: 246 FKLLREGHRMDKPSNCTHE 264
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 47/215 (21%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF-----------LPREVE 95
G +G G+Y V+ A + VAIK + ++ +D K RE++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 96 VVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDA 155
++ +KH N++ + + ++M+ L ++ ++ + E++ + Q+++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH-----MRYRSRQGYESLSETFC 210
+N H+ +HRD+ N+ I++ K++DFG AR + S+ E
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 211 GSYA---YASPEILKGIPYCPQLSDVWSMGVVLFA 242
Y +PE+L G D+WS+G + FA
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI-FA 225
|
Length = 335 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-13
Identities = 62/277 (22%), Positives = 126/277 (45%), Gaps = 42/277 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-P 103
+ L ++G G+Y V + AIK++ + +K+ E+ ++K H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 63
Query: 104 NLIKFLQAIETTH------RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA----QLV 153
N+ + A + +++++ME+ GS+ D+I+ T +W A +++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREIL 121
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
+++ H+ V+HRDIK +N+L+ + +KL DFG + R R+ TF G+
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR------NTFIGTP 175
Query: 214 AYASPEILKGIPYCPQ--------LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
+ +PE++ C + SD+WS+G+ M G P D + +++
Sbjct: 176 YWMAPEVIA----CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD------MHPMRAL 225
Query: 266 VVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDP 302
+ P++P + K K + +++ L +KN + P
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQSFIESCL-VKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 33/223 (14%)
Query: 51 IGMGSYATVKLAT----SSRHSCE-VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+G G++ V L + E VA+K + + + +K RE E++ +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIR--------------KEGYIDETRARKWFAQ 151
+KF ++ EY E G L +R G + ++ + Q
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN--HMRYRSRQGYESLSETF 209
+ + Y + VHRD+ N L+ D +K+ DFG +R+ Y G+ L
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML---- 186
Query: 210 CGSYAYASPE-ILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPF 250
+ PE I+ SDVWS GVVL+ + +G+ P+
Sbjct: 187 --PIRWMPPESIMYRKFTTE--SDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 70/231 (30%), Positives = 103/231 (44%), Gaps = 53/231 (22%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-----IDETRARKWFAQLVDAIN 157
P + F A+ V+I ME + + LD K+ Y I E K +V A+
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 158 YCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF-CGSYAY 215
Y H + V+HRD+K N+LI+ + +KL DFG S +S+++T G Y
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI--------SGYLVDSVAKTIDAGCKPY 169
Query: 216 ASPEILKGIPYCPQL--------SDVWSMGVVLFAMVFGRLPFDD--TKYSQLLKQV--Q 263
+PE + P+L SDVWS+G+ + + GR P+D T + Q LKQV +
Sbjct: 170 MAPERIN-----PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQVVEE 223
Query: 264 SKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWFRNGPSRPEYP 314
P + SPE + ++K L KN KE RP YP
Sbjct: 224 PSPQLPAEK-FSPEFQDFVNKCL--------KKNYKE---------RPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 49/187 (26%), Positives = 94/187 (50%), Gaps = 12/187 (6%)
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P ++ A T ++ I++ G L + + G E R + +++ + + H R
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL- 221
VV+RD+K N+L+D ++++SD G A + + ++ + S+ G++ Y +PE+L
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASV-----GTHGYMAPEVLQ 168
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
KG Y +D +S+G +LF ++ G PF TK + ++ V + SPE K
Sbjct: 169 KGTAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227
Query: 280 ALISKIL 286
+L+ +L
Sbjct: 228 SLLEGLL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 37/277 (13%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR---------EVEVVKGL 100
++G G + V C ++ KM A KK + + E ++++ +
Sbjct: 7 VLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINY 158
++ A ET + +++ G L I G +E RA + A+++ +
Sbjct: 58 NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H V+RD+K EN+L+D +I++SD G A S +G G+ Y +P
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-------VGTVGYMAP 170
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---PNVS 275
E+L Y D W +G +++ M+ G+ PF K ++V +V+ ++ S
Sbjct: 171 EVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229
Query: 276 PECKALISKILAP-VKTRLRIK-----NIKEDPWFRN 306
E K++ +L K RL + +K P+FRN
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 55/233 (23%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 50 IIGMGSYATVK----LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
++G G++ TV + VAIKI+++ P ++ E ++ + HP+L
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHL 71
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
++ L + + + ++ + G LLD + + + I W Q+ + Y ER +
Sbjct: 72 VRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYASPEI 220
VHRD+ N+L+ + ++K++DFG AR + Y + G + + + E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK--------WMALEC 182
Query: 221 LKGIPYCPQLSDVWSMGVVLFA-MVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+ + Q SDVWS GV ++ M FG P+D ++ ++ P+ P
Sbjct: 183 IHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 61/268 (22%), Positives = 116/268 (43%), Gaps = 32/268 (11%)
Query: 20 GNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKM 79
+ + D +P V+ S GYT+ + GS V +AT V +KI
Sbjct: 43 ESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---G 99
Query: 80 QAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY 139
Q + ++ L + V HP++I+ + + +++ + + ++
Sbjct: 100 QKGTTLIEAMLLQNV------NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP 153
Query: 140 IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199
+ +A Q+++ + Y H + ++HRD+K EN+ I+ + + D G A+ + +
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDD------ 252
G ET +PE+L Y + +D+WS G+VLF M+ + F+D
Sbjct: 214 LGLAGTVET-------NAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
Query: 253 ----TKYSQLLKQVQSKVV----FPKDP 272
+ +S LLK + + V FP+DP
Sbjct: 266 EYVKSCHSHLLKIISTLKVHPEEFPRDP 293
|
Length = 357 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 43/280 (15%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPR---------EVEVVKGL 100
++G G + V C ++ KM A KK + + E ++++ +
Sbjct: 7 VLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINY 158
++ A ET + +++ G L I G +E RA + A++ +
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H+ +V+RD+K EN+L+D +I++SD G A + ++ +G G+ Y +P
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-------VGTVGYMAP 170
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-------YSQLLKQVQSKVVFPKD 271
E++K Y D W++G +L+ M+ G+ PF K +L+K+VQ +
Sbjct: 171 EVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229
Query: 272 PNVSPECKALISKILAPVKTRL-----RIKNIKEDPWFRN 306
P+ CK L+ K K RL + +KE P F+
Sbjct: 230 PDARSLCKMLLCK---DPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 47 LGTIIGMGSYATVKLATS-------SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
LG +G G + V +A + +VA+K++ D L E+E++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKM 79
Query: 100 L-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR------------KEGYIDETRAR 146
+ KH N+I L A +Y+I+EYA KG+L + +R +E +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 147 KWFA----QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN--HMRYRSRQ 200
K Q+ + Y + +HRD+ N+L+ D +K++DFG AR+ H+ Y +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLL 259
L + +PE L Y Q SDVWS GV+L+ + G P+ +L
Sbjct: 200 TNGRL------PVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 260 K 260
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 16/225 (7%)
Query: 47 LGTIIGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYL--KKFLPREVEVVKGL-KH 102
G +G G++ V AT+ S +K+ KM P+ + ++ L E++++ L H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCH 160
N++ L A + +I EY G LL+ +R+ E ++ + Q+ + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ +HRD+ N+L+ +K+ DFG AR+ M + Y A I
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM---NDSNYVVKGNARLPVKWMAPESI 215
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFD----DTKYSQLLK 260
+ Y + SDVWS G++L+ + G P+ D+K+ +L+K
Sbjct: 216 FNCV-YTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 22/245 (8%)
Query: 50 IIGMGSYATVK----LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
++G G++ TV + VAIK++ + +P K + E V+ G+ P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYV 71
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
+ L I T V ++ + G LLD +R+ + I W Q+ ++Y E +
Sbjct: 72 CRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSYAYASPEI 220
VHRD+ N+L+ + ++K++DFG AR + Y + G + + + E
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK--------WMALES 182
Query: 221 LKGIPYCPQLSDVWSMGVVLFA-MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
+ + Q SDVWS GV ++ M FG P+D ++ ++ P+ P + +
Sbjct: 183 ILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241
Query: 280 ALISK 284
++ K
Sbjct: 242 MIMVK 246
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 61/277 (22%), Positives = 120/277 (43%), Gaps = 42/277 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L ++G G+Y V + AIK++ + + +K E+ ++K H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHR 73
Query: 105 LIK-----FLQAIETTH--RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA----QLV 153
I F++ H +++++ME+ GS+ D+++ W A +++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREIL 131
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
+ + H V+HRDIK +N+L+ + +KL DFG + R R+ TF G+
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR------NTFIGTP 185
Query: 214 AYASPEILKGIPYCPQ--------LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
+ +PE++ C + SD+WS+G+ M G P D + +++
Sbjct: 186 YWMAPEVIA----CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD------MHPMRAL 235
Query: 266 VVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDP 302
+ P++P + K K + ++ L +KN P
Sbjct: 236 FLIPRNPPPKLKSKKWSKKFIDFIEGCL-VKNYLSRP 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTH---RVYIIMEYAEKGSLLDIIR---------KEGY 139
RE+ +++ LKHPN+I LQ + +H +V+++ +YAE L II+ K
Sbjct: 47 REIALLRELKHPNVIA-LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQ 104
Query: 140 IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD----YNIKLSDFGFARNHMR 195
+ + + Q++D I+Y H V+HRD+K N+L+ + +K++D GFAR
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---L 161
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF----- 250
+ S + + ++ Y +PE+L G + + D+W++G + FA + P
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTSEPIFHCRQ 220
Query: 251 DDTKYSQ-----LLKQVQSKVVFPKDPN 273
+D K S L ++ S + FP D +
Sbjct: 221 EDIKTSNPFHHDQLDRIFSVMGFPADKD 248
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 24/237 (10%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +IG G V LA S VA+K I + + + LKK RE ++ L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR---------KEGYIDETRAR--KWFAQLV 153
++ VY M Y E +L +++ KE + F ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET----- 208
I Y H +GV+HRD+K +N+L+ + + D+G A + E
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 209 -------FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL 258
G+ Y +PE L G+P +D++++GV+L+ M+ P+ K ++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKI 239
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 46/263 (17%)
Query: 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK 87
+ L D ++E+ IG G+Y V T+ + A+KI+ P +
Sbjct: 15 ESLGDPTDTWEIIET--------IGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVD 62
Query: 88 KFLPREVEVVKGL-KHPNLIKFLQAIETTHR-----VYIIMEYAEKGSLLDII----RKE 137
+ + E +++ L HPN++KF + +++++E GS+ +++
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 138 GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197
+DE + + + H ++HRD+K N+L+ + +KL DFG + R
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQL--------SDVWSMGVVLFAMVFGRLP 249
R+ T G+ + +PE++ C Q DVWS+G+ + G P
Sbjct: 183 LRR------NTSVGTPFWMAPEVIA----CEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
Query: 250 FDDTKYSQLLKQVQSKVVFPKDP 272
D + V++ P++P
Sbjct: 233 LFD------MHPVKTLFKIPRNP 249
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 32/256 (12%)
Query: 50 IIGMGSYATVKLATSSRHSC--EVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLI 106
+IG G++ V A + + AIK + + + D+ + E+EV+ L HPN+I
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 71
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRA----------------RKWFA 150
L A E +Y+ +EYA G+LLD +RK ++ A + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY-RSRQGYESLSETF 209
+ ++Y ++ +HRD+ N+L+ +Y K++DFG +R Y + G +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 191
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVF 268
S Y+ Y SDVWS GV+L+ +V G P+ ++L +++
Sbjct: 192 IESLNYSV--------YTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242
Query: 269 PKDPNVSPECKALISK 284
K N E L+ +
Sbjct: 243 EKPLNCDDEVYDLMRQ 258
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 46/261 (17%)
Query: 67 HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126
H+ VAIK + + P + + +E ++ L HPN++ L + V ++ EY
Sbjct: 33 HAQLVAIKTLKDINNPQQWGE--FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 127 KGSLLD--IIR-----------KEGYIDETRARKWF----AQLVDAINYCHERGVVHRDI 169
+G L + I+R ++G + + F Q+ + Y VH+D+
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP- 228
N+LI ++K+SD G +R E + Y P+ L I + P
Sbjct: 151 AARNILIGEQLHVKISDLGLSR---------------EIYSADYYRVQPKSLLPIRWMPP 195
Query: 229 ---------QLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
SD+WS GVVL+ + FG P+ ++++ V+ + + P + P
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRM 255
Query: 279 KALISKILAPVKTRL-RIKNI 298
+L+++ +R R K+I
Sbjct: 256 YSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 52/291 (17%)
Query: 51 IGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
IG G++ V A VA+K++ K +A +D F RE ++ HPN+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEFDHPNI 70
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-------EGYIDETRARKWF--------- 149
+K L + ++ EY G L + +R + ARK
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 150 ------AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203
Q+ + Y ER VHRD+ N L+ + +K++DFG +RN Y
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY----SADYY 186
Query: 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQV 262
SE + PE + Y + SDVW+ GVVL+ + +G P+ + +++ V
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245
Query: 263 QSKVVFPKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWFRNGPSRPEY 313
+D NV + P L + N+ W + RP +
Sbjct: 246 -------RDGNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
AI Y HE ++HRDIK EN+ I+ ++ L DFG A + + + Y + G+ A
Sbjct: 194 AIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY-----GWAGTIA 248
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
+PE+L PY P + D+WS G+VLF M
Sbjct: 249 TNAPELLARDPYGPAV-DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 55/240 (22%), Positives = 109/240 (45%), Gaps = 38/240 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFL 109
IG G+Y V + ++ + A+KI+ P + + + E ++K L HPN++KF
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 110 -----QAIETTHRVYIIMEYAEKGSLLDIIR---KEG-YIDETRARKWFAQLVDAINYCH 160
+ ++ ++++++E GS+ D+++ K G ++E + + + + H
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+HRD+K N+L+ + +KL DFG + R R+ T G+ + +PE+
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR------NTSVGTPFWMAPEV 195
Query: 221 LKGIPYCPQL--------SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+ C Q DVWS+G+ + G P D L +++ P++P
Sbjct: 196 IA----CEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD------LHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 21/165 (12%)
Query: 92 REVEVVKGLKHPNLIKFLQAIETTH---RVYIIMEYAEKGSLLDIIR---------KEGY 139
RE+ +++ LKHPN+I LQ + +H +V+++ +YAE L II+ K
Sbjct: 47 REIALLRELKHPNVIS-LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ 104
Query: 140 IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD----YNIKLSDFGFARNHMR 195
+ + Q++D I+Y H V+HRD+K N+L+ + +K++D GFAR
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---L 161
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVL 240
+ S + + ++ Y +PE+L G + + D+W++G +
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 46 TLGTIIGMGSYATVKLATS-------SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
TLG +G G + V +A + VA+K++ D L E+E++K
Sbjct: 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD--LVSEMEMMK 72
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE------------GYIDETRA 145
+ KH N+I L A +Y+++EYA KG+L + +R +E
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 146 RKWFA----QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN--HMRYRSR 199
K Q+ + Y + +HRD+ N+L+ D +K++DFG AR+ ++ Y +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQL 258
L + +PE L Y Q SDVWS GV+L+ + G P+ +L
Sbjct: 193 TTNGRL------PVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
Query: 259 LKQVQSKVVFPKDPNVSPECKALISKILAPVKT-RLRIKNIKED 301
K ++ K N + E ++ + V + R K + ED
Sbjct: 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 99 GLKHPNLIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKW-------FA 150
GL H N++ L IE +++ Y G+L +++ + + A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 151 -QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF 209
Q+ ++Y H+RGV+H+DI N +ID + +K++D +R+ Y L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLF----PMDYHCLGDNE 179
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDD 252
+ + E L Y SDVWS GV+L+ ++ G+ P+ +
Sbjct: 180 NRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINY 158
L H +++ L I + ++ + + GSLLD +R+ +D R W Q+ + Y
Sbjct: 66 LDHAYIVRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
E +VHR++ N+L+ +D ++++DFG A + Y + Y SE A
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVA--DLLYPDDKKY-FYSEHKTPIKWMALE 181
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPF 250
IL G Y Q SDVWS GV ++ M+ +G P+
Sbjct: 182 SILFG-RYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 58/257 (22%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKI---ISKMQAPSDYLKKFLPREVEV 96
++ H L +G G++ V LA + C KI + ++ SD +K RE E+
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-------------YIDET 143
+ L+H +++KF + ++ EY + G L +R G + ++
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 144 RARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN--HMRYRSRQG 201
+ Q+ + Y + VHRD+ N L+ + +K+ DFG +R+ Y G
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLLK 260
+ L + PE + + + SDVWS+GVVL+ + +G+ P+ +++++
Sbjct: 181 HTML------PIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
Query: 261 QVQSKVVFPKDPNVSPE 277
+ V + P P+
Sbjct: 234 CITQGRVLQR-PRTCPK 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 29/190 (15%)
Query: 71 VAIKII---SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127
VA+K++ A +D+LK E++++ LK+PN+I+ L + + +I EY E
Sbjct: 47 VAVKMLRADVTKTARNDFLK-----EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 128 GSLLDII-RKEGYIDETRARK-----------WFAQLVDAINYCHERGVVHRDIKCENLL 175
G L + ++E T A Q+ + Y VHRD+ N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 176 IDADYNIKLSDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDV 233
+ Y IK++DFG +RN Y QG L + A IL G SDV
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW-----MAWESILLG--KFTTASDV 214
Query: 234 WSMGVVLFAM 243
W+ GV L+ M
Sbjct: 215 WAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 38/263 (14%)
Query: 69 CEVAIKIISKMQAPSDYLKKFLPR---------EVEVVKGLKHPNLIKFLQAIETTHRVY 119
C ++ KM A KK + + E ++++ + ++ A ET +
Sbjct: 17 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 76
Query: 120 IIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID 177
+++ G L I G DE RA + A++ + H +V+RD+K EN+L+D
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136
Query: 178 ADYNIKLSDFGFA---RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVW 234
+I++SD G A R R G+ Y +PE++K Y D W
Sbjct: 137 DYGHIRISDLGLAVEIPEGETIRGR----------VGTVGYMAPEVVKNERYTFS-PDWW 185
Query: 235 SMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNV-----SPECKALISKILAP- 288
+G +++ M+ G+ PF K ++V+ +V +D S +++ ++L
Sbjct: 186 GLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--EDQEEYSEKFSEAARSICRQLLTKD 243
Query: 289 VKTRLRIK-----NIKEDPWFRN 306
RL + +K P+FR
Sbjct: 244 PGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 48/215 (22%)
Query: 64 SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123
++ VA+K++ + A + + FL +EV+++ L PN+ + L + +IME
Sbjct: 42 NADAPVLVAVKVL-RPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCMIME 99
Query: 124 YAEKGSLLDIIRKEGYIDETRARKWF-------------AQLVDAINYCHERGVVHRDIK 170
Y E G L ++K ++ ET Q+ + Y VHRD+
Sbjct: 100 YMENGDLNQFLQK--HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157
Query: 171 CENLLIDADYNIKLSDFGFARN-----HMRYRSRQ-------GYESLSETFCGSYAYASP 218
N L+ +Y IK++DFG +RN + R + R +ES+ G +
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV---LLGKFTTK-- 212
Query: 219 EILKGIPYCPQLSDVWSMGVVLFA-MVFGRL-PFD 251
SDVW+ GV L+ + R P++
Sbjct: 213 ------------SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 47 LGTIIGMG--SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L T+IG G TV LA V ++ I+ ++A ++ + FL E+ V K HPN
Sbjct: 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII---RKEGYIDETRARKWFAQLVDAINYCHE 161
++ + + ++++ + GS D+I +G + E ++ A++Y H
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MSELAIAYILQGVLKALDYIHH 119
Query: 162 RGVVHRDIKCENLLIDADYNIKL----SDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
G VHR +K ++LI D + L S+ + R R + S + S
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV---LPWLS 176
Query: 218 PEIL-KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259
PE+L + + SD++S+G+ + G +PF D +Q+L
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 29/234 (12%)
Query: 50 IIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+IG G + V L R VAIK + K + FL E ++ H N+I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFL-SEASIMGQFSHHNII 69
Query: 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVV 165
+ + II EY E G+L +R +G + + + Y + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---------YA 216
HRD+ N+L++++ K+SDFG +R L + G+Y +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSR------------VLEDDPEGTYTTSGGKIPIRWT 177
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFP 269
+PE + + SDVWS G+V++ M FG P+ D +++K + P
Sbjct: 178 APEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 42/194 (21%)
Query: 71 VAIKII---SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127
VA+K++ + A +D+LK E++++ LK PN+I+ L T+ + +I EY E
Sbjct: 49 VAVKMLREDANKNARNDFLK-----EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 128 GSLLDII-RKEGYIDETRARKWF----------AQLVDAINYCHERGVVHRDIKCENLLI 176
G L + R E +A Q+ + Y VHRD+ N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 177 DADYNIKLSDFGFARNHMR--YRSRQG-------YESLSETFCGSYAYASPEILKGIPYC 227
+Y IK++DFG +RN Y QG + S G + A
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA----------- 212
Query: 228 PQLSDVWSMGVVLF 241
SDVW+ GV L+
Sbjct: 213 ---SDVWAFGVTLW 223
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 50 IIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
+IG G + V L S A+K ++++ + +++FL +E ++K HPN++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFL-KEGIIMKDFSHPNVL 59
Query: 107 KFLQ-AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHERGV 164
L + + +++ Y + G L + IR E + + F Q+ + Y +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY--AYASPEILK 222
VHRD+ N ++D + +K++DFG AR+ + Y S+ + + E L+
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIY----DKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 223 GIPYCPQLSDVWSMGVVLFA-MVFGRLPFDD 252
+ + SDVWS GV+L+ M G P+ D
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGL 100
Y IG G++ V A + VA+K + K+ P RE+++++ L
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-----KEGFPITALREIKILQLL 68
Query: 101 KHPNLIKFLQAIETTHR--------VYIIMEYAE---KGSLLDIIRKEGYIDETRARKWF 149
KH N++ ++ T Y++ E+ E G L + K + +K
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVM 125
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR--SRQGYESLSE 207
L++ + Y H ++HRD+K N+LI D +KL+DFG AR + Y +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 208 TFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAM 243
T Y PE+L G Y P + D+W G ++ M
Sbjct: 186 TLW----YRPPELLLGERDYGPPI-DMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 51 IGMGSYATVKLATSSR--HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
IG G + V L + R V +K + P + L FL +EV+ + L HPN+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FL-QEVQPYRELNHPNVLQC 60
Query: 109 L-QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQ-----LVDAINYCHER 162
L Q IE+ + +++E+ G L + +R + A+K Q + + + H+
Sbjct: 61 LGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+H D+ N + AD ++K+ D+G A +Y + Y + + +PE+++
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQY--PEDYYITKDCHAVPLRWLAPELVE 175
Query: 223 GIPY------CPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQV 262
+ S++WS+GV ++ + P+ D Q+LKQV
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 25/245 (10%)
Query: 46 TLGTIIGMGSYATV-----KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
T+ +G GS+ V K VAIK +++ + + ++ FL E V+K
Sbjct: 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FL-NEASVMKEF 66
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSL---LDIIRKEGYIDETRARKWFAQLV---- 153
++++ L + +IME +G L L +R E + +A +++
Sbjct: 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 154 ---DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQGYESLSETF 209
D + Y + VHRD+ N ++ D+ +K+ DFG R+ + R+G + L
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 185
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLLKQVQSKVVF 268
+ SPE LK + SDVWS GVVL+ + P+ Q+L+ V +
Sbjct: 186 ----RWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240
Query: 269 PKDPN 273
K N
Sbjct: 241 DKPDN 245
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 71 VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130
VAIK + + P +++ +E E++ L+HPN++ L ++ EY G L
Sbjct: 38 VAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 131 LD-IIRK--------EGYIDETRARKWF-------AQLVDAINYCHERGVVHRDIKCENL 174
+ ++R E + ++ Q+ + Y VHRD+ N
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155
Query: 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE-ILKGIPYCPQLSDV 233
L+ +K+SDFG +R+ S Y S++ + PE IL G + + SD+
Sbjct: 156 LVGEGLTVKISDFGLSRD---IYSADYYRVQSKSLL-PVRWMPPEAILYG-KFTTE-SDI 209
Query: 234 WSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFP 269
WS GVVL+ + +G P+ ++++ ++S+ + P
Sbjct: 210 WSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 44/243 (18%)
Query: 67 HSCEVAIKII---SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123
VA+KI+ + A +D+LK EV+++ LK PN+I+ L + +I E
Sbjct: 45 RPLLVAVKILRPDANKNARNDFLK-----EVKILSRLKDPNIIRLLGVCVDEDPLCMITE 99
Query: 124 YAEKGSL--------LDIIRKEGYIDETRARKWF-----------AQLVDAINYCHERGV 164
Y E G L LD + G A Q+ + Y
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILK 222
VHRD+ N L+ + IK++DFG +RN Y QG L + A IL
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRW-----MAWECILM 214
Query: 223 GIPYCPQLSDVWSMGVVLFA--MVFGRLPFDDTKYSQLLKQV------QSKVVFPKDPNV 274
G SDVW+ GV L+ M+ P+ + Q+++ Q + V+ P
Sbjct: 215 G--KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP 272
Query: 275 SPE 277
P+
Sbjct: 273 CPQ 275
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/251 (22%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 51 IGMGSYATVKLA-----TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+G G++ V LA + ++ VA+K ++ P+ +K RE E++ L+H ++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIR----------------KEGYIDETRARKWF 149
+KF + ++ EY + G L +R +G + ++
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN--HMRYRSRQGYESLSE 207
+Q+ + Y + VHRD+ N L+ A+ +K+ DFG +R+ Y G+ L
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-- 187
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLLKQVQSKV 266
+ PE + + + SDVWS GV+L+ + +G+ P+ +++++ +
Sbjct: 188 ----PIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
Query: 267 VFPKDPNVSPE 277
V + P V P+
Sbjct: 243 VLER-PRVCPK 252
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 25/229 (10%)
Query: 51 IGMGSYATV-----KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+G GS+ V + VA+K +++ + + ++ FL E V+KG ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FL-NEASVMKGFTCHHV 71
Query: 106 IKFLQAIETTHRVYIIMEYAEKG---SLLDIIRKEGYIDETRAR-------KWFAQLVDA 155
++ L + ++ME G S L +R E + R + A++ D
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQGYESLSETFCGSYA 214
+ Y + + VHRD+ N ++ D+ +K+ DFG R+ + R+G + L
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-----R 186
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQV 262
+ +PE LK + SD+WS GVVL+ + P+ Q+LK V
Sbjct: 187 WMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 40/276 (14%)
Query: 49 TIIGMGSYATVKLATSSRHSCE-----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
T +G G + V LA + E V +K + K + L+ RE+++ + L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHK 68
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA--QLVDAINYCHE 161
N+++ L Y+I+EY + G L +R DE + Q V A+
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIA 127
Query: 162 RGV--------VHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSETFC 210
G+ VHRD+ N L+ + +K+S ++ N Y+ R L
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---- 183
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF--GRLPFDDTKYSQLLKQVQSKVVF 268
+ +PE ++ + + SDVWS GV+++ VF G LPF ++L ++Q+ +
Sbjct: 184 ----WLAPEAVQEDDFSTK-SDVWSFGVLMWE-VFTQGELPFYGLSDEEVLNRLQAGKLE 237
Query: 269 PKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWF 304
P P + K++ TR N K+ P F
Sbjct: 238 LPVPEGCPSR---LYKLM----TRCWAVNPKDRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 141 DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200
DE RA + A+L + +V+RD+K EN+L+D +I++SD G A + +
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK 260
G G+ Y +PE++ Y D W +G +++ M+ G+ PF K +
Sbjct: 160 GR-------VGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211
Query: 261 QVQSKVVFPKDP---NVSPECKALISKILAP-VKTRLRIK-----NIKEDPWFRN 306
+V +V ++ S + K++ +L K RL + +K+ P F+N
Sbjct: 212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 54/243 (22%), Positives = 109/243 (44%), Gaps = 23/243 (9%)
Query: 51 IGMGSYATVK--LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G++ VK + + +VAIK++ S + + RE E++ L +P +++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV--RDEMMREAEIMHQLDNPYIVRM 60
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+ E + ++ME A G L + K+ I + + Q+ + Y + VHR
Sbjct: 61 IGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 168 DIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGYESLSETFCGSY--AYASPEIL 221
D+ N+L+ + K+SDFG ++ + Y++R G + + +PE +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA---------GKWPLKWYAPECI 170
Query: 222 KGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280
+ + SDVWS G+ ++ A +G+ P+ K +++ ++ PE A
Sbjct: 171 NFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229
Query: 281 LIS 283
L+
Sbjct: 230 LMK 232
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 28/224 (12%)
Query: 46 TLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
LG I+G G + +V S+ +VA+K + +++FL E +K H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDH 60
Query: 103 PNLIKFL---------QAIETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFA 150
PN++K + Q I + M++ + S L R G + K+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSE 207
+ + Y R +HRD+ N ++ D + ++DFG ++ + YR QG +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR--QGRIAKMP 178
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA-MVFGRLPF 250
+ + E L Y SDVW+ GV ++ G+ P+
Sbjct: 179 V-----KWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 38/203 (18%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 70 EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK----FLQAIETTHRVYIIMEYA 125
EV I+ K L E++ ++ + N++K + ++ R+ +I+EY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 126 EKGSLLDIIRKEGYID-ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKL 184
+G L +++ KE + +T+ N ++++ + L+ +Y +K+
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164
Query: 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFA 242
H + + F Y S ++L I Y + D++S+GVVL+
Sbjct: 165 I------CHGLEKILSSPPFKNVNF---MVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWE 214
Query: 243 MVFGRLPFDDTKYSQLLKQVQSK 265
+ G++PF++ ++ + +K
Sbjct: 215 IFTGKIPFENLTTKEIYDLIINK 237
|
Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 49/234 (20%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCE-----VAIKII---SKMQAPSDYLKKFLPREVEVV 97
TL +G G++ V + VA+K + Q SD+L E ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-----EALIM 63
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK---WFAQLVD 154
H N+++ + +I++E G L +R E R R + D
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR------ENRPRPERPSSLTMKD 117
Query: 155 AIN----------YCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMRYRS--- 198
+ Y E +HRDI N L+ K++DFG AR+ YR+
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD--IYRASYY 175
Query: 199 RQGYESLSETFCGSYAYASPE-ILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPF 250
R+G ++ + PE L GI +DVWS GV+L+ G +P+
Sbjct: 176 RKGGRAMLPI-----KWMPPEAFLDGIFTSK--TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 55/245 (22%), Positives = 107/245 (43%), Gaps = 38/245 (15%)
Query: 51 IGMGSYATVKLA--TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
IG G + V L S +V +K + + + +K FL E + + L+H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FL-EEAQPYRSLQHSNLLQC 60
Query: 109 L-QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-----------QLVDAI 156
L Q E T + ++ME+ G L +GY+ R + ++ +
Sbjct: 61 LGQCTEVTPYL-LVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRMACEIALGL 113
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+ H+ +H D+ N L+ AD +K+ D+G + H +Y ++ Y + +
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS--HNKY--KEDYYVTPDQLWVPLRWI 169
Query: 217 SPEILKGIPYC------PQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLL----KQVQSK 265
+PE++ + + S+VWS+GV ++ + G P+ Q+L ++ Q K
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK 229
Query: 266 VVFPK 270
+ P+
Sbjct: 230 LPKPR 234
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 51 IGMGSYATVKLATSSRHSCE-----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+G G++ V LA E VA+K + + S+ ++ RE E++ L+H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHI 69
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG----YIDETRAR-----------KWFA 150
++F + ++ EY G L +R G + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
Q+ + Y VHRD+ N L+ +K+ DFG +R+ S Y T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---IYSTDYYRVGGRTML 186
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM-VFGRLPF 250
+ PE + + + SD+WS GVVL+ + +G+ P+
Sbjct: 187 -PIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 71 VAIKIIS-KMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGS 129
VAIK + K + P L++ E + L+HPN++ L + + +I Y
Sbjct: 38 VAIKTLKDKAEGP---LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94
Query: 130 LLD--IIRKE----GYIDETRARK----------WFAQLVDAINYCHERGVVHRDIKCEN 173
L + ++R G D+ + K Q+ + + VVH+D+ N
Sbjct: 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154
Query: 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE-ILKGIPYCPQLSD 232
+L+ N+K+SD G R + Y+ + + + SPE I+ G SD
Sbjct: 155 VLVFDKLNVKISDLGLFR---EVYAADYYKLMGNSLL-PIRWMSPEAIMYG--KFSIDSD 208
Query: 233 VWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFP 269
+WS GVVL+ + +G P+ +++ ++++ V P
Sbjct: 209 IWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 53/227 (23%), Positives = 102/227 (44%), Gaps = 32/227 (14%)
Query: 45 YTLGTIIGMGSYATVK---LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+TLG ++G G + +V+ L + +VA+K++ S +++FL RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL-REAACMKEFD 59
Query: 102 HPNLIKFLQAIETTHRV-------YIIMEYAEKGSL-----LDIIRKEGY-IDETRARKW 148
HPN+IK L + R +I+ + + G L + I +E + + ++
Sbjct: 60 HPNVIK-LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 149 FAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQGYESLSE 207
+ + Y + +HRD+ N +++ + + ++DFG ++ + RQG
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG------ 172
Query: 208 TFCGS---YAYASPEILKGIPYCPQLSDVWSMGVVLFA-MVFGRLPF 250
C S + + E L Y SDVW+ GV ++ M G+ P+
Sbjct: 173 --CASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
Q+ + + + + VHRD+ N+LI +K+ DFG AR+ MR Y S TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR---DSNYISKGSTFL 303
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV------FGRLPFDDTKYSQL 258
+ +PE + Y LSDVWS G++L+ + + LP ++ Y+ +
Sbjct: 304 -PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 48/236 (20%), Positives = 98/236 (41%), Gaps = 27/236 (11%)
Query: 46 TLGTIIGMGSYATVK--LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
LG +G G + +V +VA+K + ++ FL E +K HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 104 NLIKFLQA-IETTHR-----VYIIMEYAEKGSLLDII------RKEGYIDETRARKWFAQ 151
N+++ + ++T +I+ + + G L + Y+ K+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSET 208
+ + Y + +HRD+ N +++ + N+ ++DFG ++ N Y RQG +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--RQGRIAKMPV 178
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQ 263
+ + E L Y + SDVWS GV ++ + G+ P+ + S++ ++
Sbjct: 179 -----KWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 34/155 (21%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 100 LKHPNLIKFL-QAIETTHRVYIIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVD 154
L+HPN+++ L Q +E ++ EY E G L + +E ++ ++
Sbjct: 52 LQHPNILQCLGQCVEAI-PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+ + H+ +H D+ N + +D +K+ D+G R ++ Y + C
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG----PSRYKEDYIETEDDKCVPLR 166
Query: 215 YASPEILK----GIPYCPQL--SDVWSMGVVLFAM 243
+ +PE++ G+ Q S+VW++GV L+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 42/195 (21%), Positives = 70/195 (35%), Gaps = 32/195 (16%)
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWF----AQLVDA 155
L H +L+K L + ++ EY + G L + +E W QL A
Sbjct: 58 LSHKHLVK-LYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSL---HWKLDVAKQLASA 113
Query: 156 INYCHERGVVHRDIKCEN-LLIDADYN------IKLSDFGFARNHMRYRSRQGYESLSET 208
++Y ++ +VH ++ +N L+ N IKLSD G + R
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV-------- 165
Query: 209 FCGSYAYASPEILKGIPYCP-QLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKV 266
+ +PE ++ +D WS G L + G P S+ + Q +
Sbjct: 166 --ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 267 VFPKDPNVSPECKAL 281
P P+C L
Sbjct: 224 RLP-----MPDCAEL 233
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
Q+ + + + VHRD+ N+L+ +K+ DFG AR+ M Y S TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH---DSNYVSKGSTFL 301
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPF-----DDTKYSQL 258
+ +PE + Y LSDVWS G++L+ + G P+ D T Y+++
Sbjct: 302 -PVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 19/40 (47%), Positives = 26/40 (65%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190
Q++ + H G+VHRDIK ENLL+ D +K+ DFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS----RQGYESLS 206
Q+ + + R +HRD+ N+L+ + +K+ DFG AR+ Y+ R+G L
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGSARL- 238
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF 241
+ +PE + Y Q SDVWS GV+L+
Sbjct: 239 -----PLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS----RQGYESLS 206
Q+ + + R +HRD+ N+L+ + +K+ DFG AR+ Y+ R+G L
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGDARL- 243
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF 241
+ +PE + Y Q SDVWS GV+L+
Sbjct: 244 -----PLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 30/117 (25%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR--QGYESLSET 208
Q+ +++ + +HRD+ N+L+ K+ DFG AR+ M + +G L
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL--- 276
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFD----DTKYSQLLK 260
+ +PE + Y Q SDVWS G++L+ + G+ P+ ++K+ +++K
Sbjct: 277 ---PVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 27/129 (20%)
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKLSDFGFARNHMRYRSRQGYES 204
+ Q++ A++ H G+VHRD+K +N++ + K+ D G A + R G
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAAD-----LRVGINY 312
Query: 205 LSETFCGSYAYASPE--ILKG-IPYCP-------------QLS-----DVWSMGVVLFAM 243
+ + F YA+PE I+ P P QL+ D++S G++ M
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
Query: 244 VFGRLPFDD 252
F L D
Sbjct: 373 AFPNLRSDS 381
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 34/163 (20%)
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
L+HPN++K + + Y+I EY E +L +++R + R RK + A+ +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW---ERRRKIAIGIAKALRFL 796
Query: 160 HER---GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC------ 210
H R VV ++ E ++ID H+R SL C
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKD----------EPHLRL-------SLPGLLCTDTKCF 839
Query: 211 GSYAYASPEI--LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD 251
S AY +PE K I + SD++ G++L ++ G+ P D
Sbjct: 840 ISSAYVAPETRETKDI---TEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 34/251 (13%)
Query: 67 HSCEVAIKIISKMQAPS--DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124
+S E IK+I K+ PS D F +++ + H +++ L + I++E
Sbjct: 27 YSYEKEIKVILKVLDPSHRDISLAFF-ETASMMRQVSHKHIV-LLYGVCVRDVENIMVEE 84
Query: 125 AEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL-----ID 177
+ LD+ RK + K QL A++Y ++ +VH ++ +N+L ID
Sbjct: 85 FVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGID 144
Query: 178 ADYN--IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWS 235
+ IKLSD G + SRQ E + + +PE ++ +D WS
Sbjct: 145 GECGPFIKLSDPGIP---ITVLSRQ--ECVERI-----PWIAPECVEDSKNLSIAADKWS 194
Query: 236 MGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAPVKTRLR 294
G L+ + + G +P D ++ + + + + V+P CK LA + T
Sbjct: 195 FGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML-----VTPSCKE-----LADLMTHCM 244
Query: 295 IKNIKEDPWFR 305
+ + P+FR
Sbjct: 245 NYDPNQRPFFR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS----RQGYESLS 206
Q+ + + R +HRD+ N+L+ + +K+ DFG AR+ Y+ R+G L
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYVRKGDARL- 237
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF 241
+ +PE + Y Q SDVWS GV+L+
Sbjct: 238 -----PLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576|consensus | 829 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1345|consensus | 378 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG2052|consensus | 513 | 99.98 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024|consensus | 563 | 99.97 | ||
| KOG0590|consensus | 601 | 99.97 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1163|consensus | 341 | 99.95 | ||
| KOG0603|consensus | 612 | 99.94 | ||
| KOG1165|consensus | 449 | 99.94 | ||
| KOG0606|consensus | 1205 | 99.93 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG4158|consensus | 598 | 99.91 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240|consensus | 1431 | 99.91 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195|consensus | 448 | 99.9 | ||
| KOG1166|consensus | 974 | 99.89 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0590|consensus | 601 | 99.84 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1033|consensus | 516 | 99.8 | ||
| KOG1023|consensus | 484 | 99.79 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606|consensus | 1205 | 99.7 | ||
| KOG0601|consensus | 524 | 99.64 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1243|consensus | 690 | 99.55 | ||
| KOG1266|consensus | 458 | 99.51 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| KOG0601|consensus | 524 | 99.47 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG3741|consensus | 655 | 99.32 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3087|consensus | 229 | 99.29 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.17 | |
| KOG2137|consensus | 700 | 99.15 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| KOG1035|consensus | 1351 | 98.69 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.6 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.49 | |
| KOG0576|consensus | 829 | 98.46 | ||
| KOG1235|consensus | 538 | 98.45 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.13 | |
| KOG2270|consensus | 520 | 98.12 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 98.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.99 | |
| KOG2268|consensus | 465 | 97.98 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| KOG1826|consensus | 2724 | 97.76 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.37 | |
| KOG1093|consensus | 725 | 97.2 | ||
| PLN02236 | 344 | choline kinase | 97.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.65 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.5 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.46 | |
| KOG1236|consensus | 565 | 96.35 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.23 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.87 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.64 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.11 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.61 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.2 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-61 Score=448.34 Aligned_cols=260 Identities=29% Similarity=0.595 Sum_probs=239.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|..++.||+|+|+.||.+++..+|+.||+|++.+........++.+.+||+|.+.|+|||||+++++|++.+++|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 35799999999999999999999999999999999998887888888999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
.|+|..++|..++++.+.++|.+++.+++||+.||.|||+.+|+|||||..|+|++.+.++||+|||+|..+...
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~----- 171 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD----- 171 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKA 280 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 280 (357)
.....+.||||.|+|||++...++.-. +||||+||+||.||+|++||+..+..+...+|.. .+.+|. .+|.++++
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~d 247 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKD 247 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHH
Confidence 245568999999999999998888666 9999999999999999999999998888888764 455665 79999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
||..|| .+|.+|||++++|.|+||..+-.+
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999 599999999999999999655433
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-62 Score=438.29 Aligned_cols=265 Identities=32% Similarity=0.570 Sum_probs=229.7
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH----HHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY----LKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
+......|.+.+.||+|+||.|.+|..+.+++.||||++++....... -...+.+|+++|+.|+|||||+++++|+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 334556799999999999999999999999999999999875433211 2334679999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC---CCeEEeecccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD---YNIKLSDFGFA 190 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~---~~~kl~Dfg~~ 190 (357)
..+..||||||+.||+|.+.+-.++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999766 67999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhcc-c
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ-LLKQVQSK-V 266 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~-~~~~~~~~-~ 266 (357)
+... ......++||||.|.|||++.+. .+++.++|+|||||+||-+|+|.+||.+..... +.++|..+ +
T Consensus 327 K~~g-------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 327 KVSG-------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred hccc-------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 8653 23456789999999999999754 455667999999999999999999998766554 66666544 2
Q ss_pred C--CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 267 V--FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 267 ~--~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
. .+.+..++.++++||++|| .||++|||++|+|+||||+..+.
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 2 3456789999999999999 59999999999999999997653
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-58 Score=408.65 Aligned_cols=266 Identities=28% Similarity=0.544 Sum_probs=240.9
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.....++|++.++||+|+||+||+++.+++++.||+|++++.........+.+..|..+|..++||.||+++..|++.+.
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 35667899999999999999999999999999999999998776666667788899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|+|+||+.||.|+..|++.+.++|..++.++..|+.||.|||+.||+||||||+|||+|.+|+++|+|||+++.....
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999864322
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.....++|||+.|+|||++.+.+|+.. +|+||||+++|+|++|.+||.+.+...+.+++...-....+..++.+
T Consensus 179 -----~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ 252 (357)
T KOG0598|consen 179 -----GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEE 252 (357)
T ss_pred -----CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHH
Confidence 234557899999999999999988554 99999999999999999999999988888888766544444469999
Q ss_pred HHHHHHHcc-cCCCCCC----CHHhHhcCCccccCCCC
Q psy10194 278 CKALISKIL-APVKTRL----RIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~----s~~e~l~hp~f~~~~~~ 310 (357)
+++++++|| ++|.+|. ++.++.+||||....|.
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 999999999 5999996 68999999999987654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-58 Score=424.63 Aligned_cols=269 Identities=34% Similarity=0.615 Sum_probs=238.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~ 117 (357)
.....+|.+++.||+|+|++|++|+...++..||||++.+.....+...+.+.+|-.+|.+| +||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55678999999999999999999999999999999999887766666667788999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||+|.+|+++|+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999776543
Q ss_pred cc-----ccccccc--ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCC
Q psy10194 198 SR-----QGYESLS--ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFP 269 (357)
Q Consensus 198 ~~-----~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~ 269 (357)
.. ....... ..++||..|.+||++........ +|+|+||||+|+|+.|.+||.+.+..-+.++|.. .+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 32 1111112 45899999999999998877555 9999999999999999999999988877777763 34444
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+.+++.+++||+++| .||.+|+|+++|.+||||.+..|.
T Consensus 308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 308 --EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred --CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 579999999999999 599999999999999999887654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-57 Score=398.42 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=230.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-eE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-RV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-~~ 118 (357)
+...+.+..+.||+|+.|+||+|+++.++..+|+|++.. ..++..++++.+|+++++.++|||||++++.|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 344578889999999999999999999999999999943 234566788889999999999999999999999998 59
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
.|+||||+||+|.+++...++++|..+..++.++++||.|||+ ++|+||||||+|||++..|.+||||||.+..+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-- 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-- 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh--
Confidence 9999999999999999998999999999999999999999995 9999999999999999999999999999986542
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcccCCCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-----KYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-----~~~~~~~~~~~~~~~~~~~ 272 (357)
....+++||..|||||.+.+..|.-. +||||||++++||.+|+.||... ++.+++..|........+.
T Consensus 232 ------S~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 232 ------SIANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred ------hhcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 35568899999999999999988554 99999999999999999999764 6778888887765554444
Q ss_pred C-CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 273 N-VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 273 ~-~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
. +|+++++||..|| +||.+|+++.|+++|||++...
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 4 9999999999999 6999999999999999998643
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=423.70 Aligned_cols=261 Identities=38% Similarity=0.666 Sum_probs=241.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+-|++++.||.|+.|.|.+|++..+|+.+|||++.+.....+.....+.+||-+|+.+.|||+++++++++...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45899999999999999999999999999999998875555566677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++||.|++++.+.|+|++.++.++++||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|.... .
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-------~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-------P 164 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-------C
Confidence 999999999999999999999999999999999999999999999999999999999999999999997532 2
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCCCCCCCCHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPKDPNVSPECKAL 281 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 281 (357)
..+..+-||+|.|.|||++.+.+|...++||||+|||||.||+|+.||++.+...++.+++.+. .+| ..+++++++|
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--s~Is~eaQdL 242 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--SNISSEAQDL 242 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--CcCCHHHHHH
Confidence 4567789999999999999999999999999999999999999999999999999999987653 344 6899999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
|++|| .||.+|+|.+||++|||+......+.
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 99999 59999999999999999988766543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-57 Score=385.77 Aligned_cols=260 Identities=31% Similarity=0.568 Sum_probs=237.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
...++|++.+.||.|+||.|.+++++.+|..+|+|++++.....-...+...+|..+|+.+.||.++++++.|.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999998877666666777889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998763
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 278 (357)
....+.||||.|+|||++...+|. .++|.||||+++|||+.|.+||.+.+...+.++|. ..+.+|. .+++++
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~ 268 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDA 268 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHH
Confidence 335689999999999999999985 55999999999999999999999999888887775 4566665 699999
Q ss_pred HHHHHHcc-cCCCCCC-----CHHhHhcCCccccCCCCC
Q psy10194 279 KALISKIL-APVKTRL-----RIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~~~ 311 (357)
++||+.|| .|-.+|. ..+++..||||+...|..
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 99999999 5888884 578999999999877653
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=397.85 Aligned_cols=260 Identities=33% Similarity=0.610 Sum_probs=230.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.+++++++.+.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999987665 34556777899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC------CCeEEeecccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD------YNIKLSDFGFARNHM 194 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~------~~~kl~Dfg~~~~~~ 194 (357)
|||||+||+|.+++++.+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999754 469999999999875
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC--CCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP--KDP 272 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~--~~~ 272 (357)
. ..+..+.||+|.|||||++....| +.|+|+||+|+|+|+|++|+.||...+..++...+..+-... ...
T Consensus 167 ~-------~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 167 P-------GSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred c-------hhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 2 345678999999999999998888 455999999999999999999999999999888776543322 223
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.++..+.+|+-.+| .++..|.+..+-+.|++....+.
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 57777889999988 59999999999999999987663
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-56 Score=407.92 Aligned_cols=273 Identities=29% Similarity=0.501 Sum_probs=241.6
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..+..++|.+.+.||+|+||.||+|+-+.+|..+|+|++++.........+.++.|-.+|...++|+||+++..|.+.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 35577899999999999999999999999999999999998877666667788899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||||++||++..+|.+.+.|++..++.++.+++.|+..||+.|++||||||+|+|||..|++||+|||++..+....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985332100
Q ss_pred ------------------cccc-----------------------cccccccCCCCCCccchhhhcCCCCCCCcccHHHH
Q psy10194 198 ------------------SRQG-----------------------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSM 236 (357)
Q Consensus 198 ------------------~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 236 (357)
.... ...+....+|||.|+|||++.+.+|.- .+|+|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~-~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK-ECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc-cccHHHH
Confidence 0000 011123467999999999999999854 4999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCCC---HHhHhcCCccccCCCC
Q psy10194 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKTRLR---IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 237 G~il~~ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~s---~~e~l~hp~f~~~~~~ 310 (357)
||||||||.|-+||.+.++.+...+|.. .+.+|....++++++|||.+||.||.+|+. ++||.+||||++..|.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999988887753 467888888999999999999999999986 8999999999998875
Q ss_pred C
Q psy10194 311 P 311 (357)
Q Consensus 311 ~ 311 (357)
.
T Consensus 455 ~ 455 (550)
T KOG0605|consen 455 H 455 (550)
T ss_pred h
Confidence 4
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=410.90 Aligned_cols=261 Identities=43% Similarity=0.813 Sum_probs=233.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-c-hHHHhhHHHHHHHHHcCC-CCCccceEEEEEe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-S-DYLKKFLPREVEVVKGLK-HPNLIKFLQAIET 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~ 114 (357)
.....++|.+++.||+|+||.|++|.+..++..||+|++.+.... . ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 345677999999999999999999999999999999987664221 1 234567779999999999 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg~~~~~ 193 (357)
...+++|||||.||+|++++.+.+++.|.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999 99999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKD 271 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~ 271 (357)
. .......+.|||+.|+|||++.+.. |...++||||+|++||.|++|..||.+.+...+...+... +.+|.
T Consensus 172 ~------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~- 244 (370)
T KOG0583|consen 172 P------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS- 244 (370)
T ss_pred C------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC-
Confidence 3 1235667899999999999999988 9889999999999999999999999998888888776544 44554
Q ss_pred CCC-CHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 272 PNV-SPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 272 ~~~-~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.+ |+++++|+++|| .+|.+|+++.+++.||||+.
T Consensus 245 -~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 -YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 45 999999999999 59999999999999999997
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-55 Score=377.48 Aligned_cols=256 Identities=27% Similarity=0.465 Sum_probs=218.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|+...++|+|+||.||+|+++++|+.||||.+.. ...+..+++...|||++|++|+|+|+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E-sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE-SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeecc-CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 368889999999999999999999999999999954 4445677788889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+. ++.+.+.+. ..+++..++.++.|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+.+..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~------ 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA------ 153 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC------
Confidence 99988 555555543 4589999999999999999999999999999999999999999999999999997652
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-----------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS----------------- 264 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~----------------- 264 (357)
.....+..+.|.||+|||++.+...+..++||||+||++.||++|.+.|.+.+.-+.+-.|..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 123456778899999999999865556669999999999999999999998776554443331
Q ss_pred ---ccCCCCC----------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 265 ---KVVFPKD----------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 265 ---~~~~~~~----------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
++.+|.. +.++.-+.||++.||+ ||.+|++.+|+|.|+||++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1222221 4678899999999995 9999999999999999954
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-55 Score=395.32 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=222.6
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCC-eE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTH-RV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~-~~ 118 (357)
...+|.+.++||.|+||.||+|+...++..||||.+++.....++.. . .||+..|++|+ ||||+++.+++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-n-LREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-N-LREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-H-HHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 34689999999999999999999999999999999987655433222 2 38999999999 999999999998887 99
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||||+. +|.++++. +..|++..++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+....
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--
Confidence 999999987 99999975 56799999999999999999999999999999999999999999999999999986532
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---------
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--------- 268 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--------- 268 (357)
....+..+-|.||+|||++....+++.+.|||++|||++|+.+-++.|.+.+.-+.+-+|..-+..
T Consensus 163 -----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 -----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred -----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 223345677999999999999888899999999999999999999999998776666555432221
Q ss_pred -----------CCC---------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 269 -----------PKD---------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 269 -----------~~~---------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
|.- +..++++.+||.+||+ ||.+||||.|+|+||||+...
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 111 4579999999999998 999999999999999998754
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=359.21 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=224.0
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|...++||+|.||.||+|++..+|+.||||.|+.....+ .+.....|||+.|+.++|+||+.++++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47888999999999999999999999999999998765443 34445569999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||++. +|...++. .-.++..+++.++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--- 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--- 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---
Confidence 99987 99999975 45799999999999999999999999999999999999999999999999999997653322
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC----------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---------- 271 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~---------- 271 (357)
.....+-|.||+|||++.+...+...+||||.|||+.||+.|.+-|.+.+.-+.+..+...+..|..
T Consensus 157 ---~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 ---IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ---ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 1222366999999999999887788899999999999999999999988877777766543332211
Q ss_pred -----------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 272 -----------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 272 -----------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+..+.++.||+..|+. ||.+|+++.|+|+|+||...|.+
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 3467889999999996 99999999999999999975543
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=388.35 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=224.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--C
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--H 116 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~ 116 (357)
....+.|+..++||+|+||.||+|++..+|..||+|.+.......+. ...+.|||.||++|+||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-PITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-hHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 34456789999999999999999999999999999999876655444 44556999999999999999999998665 6
Q ss_pred eEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+|||+|||+. +|.-++... -.|++.+++.+++||+.||.|||++||+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999987 999888663 3799999999999999999999999999999999999999999999999999997653
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------- 267 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-------- 267 (357)
... ...+..+.|+||+|||++.+...++.++|+||+||||.||++|++.|.+.+..+.++.|..-..
T Consensus 271 ~~~-----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 271 SGS-----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCC-----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 322 2245567799999999999988778889999999999999999999999888877777643111
Q ss_pred ---CCC-----------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 ---FPK-----------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 ---~~~-----------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+|. ...++..+.+|+..||. ||.+|.||.++|+|+||...+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 110 03578999999999995 999999999999999995443
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=384.20 Aligned_cols=306 Identities=28% Similarity=0.520 Sum_probs=244.7
Q ss_pred ccCcccccCCCCCccccCcccccCCCCCCCC-----CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEee
Q psy10194 3 IGTNVVRQDRPRSNVWKGNMEYDKGKDLPDA-----DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIIS 77 (357)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~ 77 (357)
|+-+...|.+|.+.....+...-+.+.-+.. +...-....+.|++.+.||+|.||.|.+|++..++..||||++.
T Consensus 52 L~~s~~~q~~~~~~~~~~~~~~~~~~vket~k~~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~ 131 (576)
T KOG0585|consen 52 LSHSERQQKPPYSTSLQNNSPRSWRRVKETNKIVRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILP 131 (576)
T ss_pred ccccccccCCcccccccccccccccccceeeeeeeecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeec
Confidence 3444555567777666555554333222211 11111234578999999999999999999999999999999997
Q ss_pred cCCCCch-------H----HHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEEEEEeecCCCCHHHHHHHcCC-CCHH
Q psy10194 78 KMQAPSD-------Y----LKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVYIIMEYAEKGSLLDIIRKEGY-IDET 143 (357)
Q Consensus 78 ~~~~~~~-------~----~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~ 143 (357)
+...... . -.+.+.+||.+|++|+|||||+|+++..+ .+.+|||+|||..|.+..-- ..++ +++.
T Consensus 132 K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~ 210 (576)
T KOG0585|consen 132 KKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQ 210 (576)
T ss_pred hhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHH
Confidence 6432211 0 12467899999999999999999999965 46899999999988876433 3344 9999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcC
Q psy10194 144 RARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223 (357)
Q Consensus 144 ~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 223 (357)
+++.++++++.||+|||.+||+||||||+|+|++.+|++||+|||.+...... ...+.........|||.|+|||.+.+
T Consensus 211 ~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~-~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 211 QARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQG-SDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred HHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccC-CccccHHHHhhcCCCccccchHhhcC
Confidence 99999999999999999999999999999999999999999999999765332 11222233344789999999999977
Q ss_pred ---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhH
Q psy10194 224 ---IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALISKIL-APVKTRLRIKNI 298 (357)
Q Consensus 224 ---~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~ 298 (357)
..+...+.||||+||+||.|+.|+.||.+....++.++|.. .+.+|..+.+...+++||.+|| +||.+|+++.++
T Consensus 290 ~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 290 GNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred CCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 56778889999999999999999999999998888888765 5678888889999999999999 799999999999
Q ss_pred hcCCccccCCCC
Q psy10194 299 KEDPWFRNGPSR 310 (357)
Q Consensus 299 l~hp~f~~~~~~ 310 (357)
..|||....-..
T Consensus 370 k~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 370 KLHPWVTRDGDS 381 (576)
T ss_pred eecceeccCCCC
Confidence 999999776433
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-54 Score=394.53 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=232.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+. ..+.+.+|++|++.++||||+.++++|++...+++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 478899999999999999999999999999999988765543 3567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||.| +|+.++..++.++|+.++.++.+++.||.|||+++|.|||+||+|||++.+|.+|+||||+|+.....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~------ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN------ 153 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC------
Confidence 99987 99999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
..+...+.|||.|||||++.+.+|+.. +|+||||||+|||+.|++||......++.+.|......+. ...+..+..|+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p-~~~S~~f~nfl 231 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP-STASSSFVNFL 231 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-ccccHHHHHHH
Confidence 345567789999999999999988665 8999999999999999999999999998888876544433 37999999999
Q ss_pred HHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 283 SKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+.+| +||.+|+++.+++.|||++..-
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhh
Confidence 9999 7999999999999999997643
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=396.76 Aligned_cols=262 Identities=28% Similarity=0.526 Sum_probs=233.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCC
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTH 116 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~ 116 (357)
..+...+|.+.++||+|+||.|+++..+.+++.||||++++.........+....|.+|+...+ ||.++.++..|.+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4677889999999999999999999999999999999999877666555667778999988885 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++|+||||+.||++..+ ...+.|++..++.++..++.||.|||++||+|||||.+|||+|.+|++||+|||+++....
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 99999999999995444 4456799999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 275 (357)
....+.++||||.|+|||++.+..| +.++|.|||||+||+||.|..||.+.+.+++.+.|.. ...+|. .+|
T Consensus 521 -----~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls 592 (694)
T KOG0694|consen 521 -----QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLS 592 (694)
T ss_pred -----CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--ccc
Confidence 2346779999999999999999998 5559999999999999999999999999999888764 455665 599
Q ss_pred HHHHHHHHHcc-cCCCCCCCH-----HhHhcCCccccCCC
Q psy10194 276 PECKALISKIL-APVKTRLRI-----KNIKEDPWFRNGPS 309 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~-----~e~l~hp~f~~~~~ 309 (357)
.++.+++++|| ++|++|+.. ++|..||||+...|
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 99999999999 699999975 78999999998765
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=373.29 Aligned_cols=274 Identities=30% Similarity=0.473 Sum_probs=238.2
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+-..+..+.|++.+.||.|.-|+||+|....++..+|+|++.+...........+..|..||+.++||.++.||..|+..
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34456677899999999999999999999999999999999987776655566677899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
++.|+|||||+||+|..+++++ +.|++..++.++..++.||+|||-+|||+|||||+||||..+|++.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999764 57999999999999999999999999999999999999999999999999987533
Q ss_pred cccc-------------------------------c-c------------------cccccccccCCCCCCccchhhhcC
Q psy10194 194 MRYR-------------------------------S-R------------------QGYESLSETFCGSYAYASPEILKG 223 (357)
Q Consensus 194 ~~~~-------------------------------~-~------------------~~~~~~~~~~~gt~~y~aPE~~~~ 223 (357)
.... . . ......+..++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 2100 0 0 000123445789999999999999
Q ss_pred CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-HhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCC----HHh
Q psy10194 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKALISKIL-APVKTRLR----IKN 297 (357)
Q Consensus 224 ~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s----~~e 297 (357)
.++. .++|+|+||+++||||.|..||.+.+..+.+.. +.+...+|..+.++..++|||++|| +||.+|+. |.|
T Consensus 310 ~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9984 559999999999999999999999877665555 5667788888899999999999999 79999999 999
Q ss_pred HhcCCccccCCCC
Q psy10194 298 IKEDPWFRNGPSR 310 (357)
Q Consensus 298 ~l~hp~f~~~~~~ 310 (357)
|.+||||++..|.
T Consensus 389 IK~HpFF~gVnWa 401 (459)
T KOG0610|consen 389 IKRHPFFEGVNWA 401 (459)
T ss_pred hhcCccccCCChh
Confidence 9999999998764
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=368.37 Aligned_cols=264 Identities=28% Similarity=0.446 Sum_probs=223.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-----
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET----- 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~----- 114 (357)
-....|...+.||+|+||.|+.+.++.+|..||||.+.......-. .+...||+++|+.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~-akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID-AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH-HHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3445566689999999999999999999999999998754443333 3445599999999999999999999854
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
-+.+|+|+|+|+. +|.+.++.+..|++..+..++.||+.||.|+|+.+|+||||||.|+|++.+..+||||||+|+...
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 4679999999955 999999988889999999999999999999999999999999999999999999999999999765
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC----
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK---- 270 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~---- 270 (357)
.. ......+..+.|.||+|||++.....++.+.||||+|||+.||++|++.|.+.+....++.+..-...|.
T Consensus 177 ~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 177 KF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred cc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 33 1233445677899999999998877778889999999999999999999998876666555543222221
Q ss_pred --------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 271 --------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 271 --------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
-+..++.+.+|+.+||. ||.+|+|++|+|+|||+..--.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 15789999999999996 9999999999999999976433
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-53 Score=375.32 Aligned_cols=259 Identities=37% Similarity=0.671 Sum_probs=240.2
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
-..++|++.+.||+|.||.|.+|.....|..||||.|++....++...-.+++||+||..|+||||+.++++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 35678999999999999999999999999999999999988888777778899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||||..+|.|.+++.+.+.|++.+++.+|+||+.|+.|+|.++++|||||.+|||+|.++++||+|||++..+..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
..+..++||+|-|.+||++.+.+|....+|.||||++||-|..|..||++.+...++.+|..+-++.. .-+..+.
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--~~PSdA~ 280 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--ETPSDAS 280 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--CCCchHH
Confidence 34667899999999999999999999899999999999999999999999999999999988766543 4667788
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
-||+.|| .+|.+|.|++++..|=|....
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 9999999 699999999999999777543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=373.46 Aligned_cols=262 Identities=27% Similarity=0.508 Sum_probs=217.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC--eEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH--RVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~--~~~ 119 (357)
..+|..++.||+|+||+||++.+.++|...|||.+....... .+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 567889999999999999999999999999999987653222 556789999999999999999999754444 799
Q ss_pred EEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||+++|+|.+++.+.+ .|++..++.+.+||++||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999876 7999999999999999999999999999999999999999 7999999999998654311
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CcHHH-HHHHHhcccCCCCCCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQ-LLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~-~~~~~-~~~~~~~~~~~~~~~~~~ 275 (357)
. .........||+.|||||++........++|||||||++.||+||+.||.. ..... +............+..+|
T Consensus 173 ~---~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 173 T---KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred c---cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 1 112233567999999999999643333469999999999999999999987 33333 333333332234445799
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+++++||.+|+ .+|++||||+++|.|||.+....
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999 59999999999999999987544
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-54 Score=358.22 Aligned_cols=263 Identities=30% Similarity=0.545 Sum_probs=229.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+-.+.|++.++||+|.|+.||++.+..+|+.+|+|++........ ..+.+.+|++|-+.|+||||+++.+.+....+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3456789999999999999999999999999999999865433322 345678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec---CCCCeEEeeccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~ 195 (357)
|+|+|++.|++|..-|.....++|..+-.+++||+++|.|+|.+||||||+||.|+|+- ....+||+|||+|.....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999999987776667789999999999999999999999999999999999993 445699999999987651
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cC--CCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VV--FPKDP 272 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~--~~~~~ 272 (357)
......+.|||.|+|||++...+|..+ +|||+.|+|||-||.|.+||.+.+...+.++|..+ +. -+.++
T Consensus 166 -------g~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~ 237 (355)
T KOG0033|consen 166 -------GEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD 237 (355)
T ss_pred -------ccccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC
Confidence 233456789999999999999988555 99999999999999999999999999999888754 33 34568
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+++++++||++|| .||.+|+|+.|+|+|||+++-..-
T Consensus 238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~ 276 (355)
T KOG0033|consen 238 TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERV 276 (355)
T ss_pred cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHH
Confidence 99999999999999 599999999999999999875543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-51 Score=381.65 Aligned_cols=266 Identities=25% Similarity=0.456 Sum_probs=224.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.+++.++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644333344566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc--
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ-- 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 200 (357)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543210000
Q ss_pred ---------------------------ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy10194 201 ---------------------------GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT 253 (357)
Q Consensus 201 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~ 253 (357)
.........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000112346899999999999887775 5599999999999999999999988
Q ss_pred cHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCC---CCCCCHHhHhcCCccccCCC
Q psy10194 254 KYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPV---KTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 254 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p---~~R~s~~e~l~hp~f~~~~~ 309 (357)
+..+....+.. ...++....++++++++|.+|+.+| ..||+++|+++||||++..+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 87777776653 3445555568999999999988543 45789999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-53 Score=360.91 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=217.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEE-EE-EeCCe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ-AI-ETTHR 117 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~-~~-~~~~~ 117 (357)
....+|+|.++||+|+||+||++++..+|..+|.|.+.- ..-+...++.+..|+.+|++|+|||||++++ -| ++..-
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345679999999999999999999999999999999973 3334555777889999999999999999998 34 44455
Q ss_pred EEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--CeecCCCCCceEecCCCCeEEeeccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHE--RG--VVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~--~g--ivH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
++||||+|.+|+|.++++. ...++|..+|.++.|++.||..+|+ .. |+||||||.||+++.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 8999999999999999964 4579999999999999999999998 44 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
++.+... .......+|||.||+||.+...+|. .+|||||+||++|||+.-++||.+.+..++.++|...-..|
T Consensus 175 ~r~l~s~------~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 175 GRFLSSK------TTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred HhHhcch------hHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 9977533 2345678999999999999999995 55999999999999999999999999999999998886555
Q ss_pred CC-CCCCHHHHHHHHHcc-cCCCCCCCH
Q psy10194 270 KD-PNVSPECKALISKIL-APVKTRLRI 295 (357)
Q Consensus 270 ~~-~~~~~~~~~li~~~L-~~p~~R~s~ 295 (357)
.+ ..+|.++.++|..|+ .||..||+.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 55 578999999999999 599999985
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=376.90 Aligned_cols=260 Identities=26% Similarity=0.486 Sum_probs=225.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.....+|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34457899999999999999999999999999999999764333333345677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.....+.+.... .+.+..++..+
T Consensus 171 ------~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~ 242 (329)
T PTZ00263 171 ------RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRA 242 (329)
T ss_pred ------CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHH
Confidence 1124578999999999988777 456999999999999999999999888777776665442 22334589999
Q ss_pred HHHHHHcc-cCCCCCCC-----HHhHhcCCccccCCC
Q psy10194 279 KALISKIL-APVKTRLR-----IKNIKEDPWFRNGPS 309 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~~ 309 (357)
++||++|| .||.+|++ +++++.||||.+..+
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 99999999 59999997 799999999987543
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=374.97 Aligned_cols=266 Identities=32% Similarity=0.505 Sum_probs=233.1
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETT 115 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~ 115 (357)
...-....|.+++.||+|.||.||+++.+.+|..+|+|++.+...........+.+|+.+|+.+. ||||+.++++|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 33445667999999999999999999999999999999998876655444567889999999998 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC----CCCeEEeeccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA----DYNIKLSDFGFAR 191 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~----~~~~kl~Dfg~~~ 191 (357)
..+++|||+|.||.|++.+.+. .+++..+..++.|++.++.|||+.||+||||||+|+|+.. ++.+|++|||++.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999999776 4999999999999999999999999999999999999943 3589999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVF 268 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~ 268 (357)
.... .......+||+.|+|||++...+|... +||||+|+++|.|++|.+||.+.+.......+... +..
T Consensus 188 ~~~~-------~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 188 FIKP-------GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred EccC-------CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 7643 234567899999999999998888655 99999999999999999999998877666666543 334
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCC
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~ 311 (357)
+.++.++..++++|+.|| .||.+|+|+.++|+|||++.....+
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 556789999999999999 5999999999999999998764444
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=347.80 Aligned_cols=262 Identities=30% Similarity=0.592 Sum_probs=236.8
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
..+......++|.+++.||+|.||.||+|+.+.++..||+|++-+.........+++++|++|...|+||||++++++|.
T Consensus 13 ~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 13 SRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred cccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 33445567789999999999999999999999999999999999888777777888999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIR--KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+....|+++||...|+|...+. ....+++..++.++.|++.||.|+|..+++||||||+|+|++..|.+||+|||.+.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999999999999998 56789999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPK 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~ 270 (357)
... ...-.+.|||..|.+||...+..++.. +|+|++|++.|+++.|.+||......+..+++.. .+.+|
T Consensus 173 ~~p--------~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p- 242 (281)
T KOG0580|consen 173 HAP--------SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP- 242 (281)
T ss_pred ecC--------CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-
Confidence 542 122347899999999999999998655 9999999999999999999999888888877754 44444
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
..++.++.|+|.+|| .+|.+|.+..|++.|||+..
T Consensus 243 -~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 -STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 689999999999999 59999999999999999864
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=357.49 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=220.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVYI 120 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~l 120 (357)
+.|+..+.|++|+||.||+|+++.+++.||+|.++........ --...|||.+|..++|||||.+-++... -+.+||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF-PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF-PITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC-cchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4588999999999999999999999999999999765533322 2233499999999999999999998744 467999
Q ss_pred EEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||||+. +|..++...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--- 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--- 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC---
Confidence 9999987 9999998765 8999999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC--------
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD-------- 271 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~-------- 271 (357)
....+..+-|.||+|||++.+...++.+.|+||+|||+.+|+++++.|.+....+.+++|...+..|..
T Consensus 231 ---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 ---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred ---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 122345567999999999999887778899999999999999999999998887777776543222211
Q ss_pred -----------------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 272 -----------------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 272 -----------------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
..++....+|+..||. ||.+|+||.|+|+|.||...|.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 1256899999999996 9999999999999999998553
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=380.95 Aligned_cols=266 Identities=27% Similarity=0.487 Sum_probs=224.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..++..||||++.+...........+.+|+.+++.++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997643333334556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc-
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG- 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~- 201 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432110000
Q ss_pred -------------------------------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy10194 202 -------------------------------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250 (357)
Q Consensus 202 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf 250 (357)
........+||+.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 00011235799999999999887774 5599999999999999999999
Q ss_pred CCCcHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCCC---HHhHhcCCccccCCC
Q psy10194 251 DDTKYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKTRLR---IKNIKEDPWFRNGPS 309 (357)
Q Consensus 251 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~s---~~e~l~hp~f~~~~~ 309 (357)
...+..+....+.. ...++....+++++.+||.+||.+|.+|++ +++++.||||+...+
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 98887766665543 233444456899999999999998999997 999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=369.07 Aligned_cols=256 Identities=25% Similarity=0.464 Sum_probs=221.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997543333334456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.....+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....+.+.... ......+++.+++||
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 229 (291)
T cd05612 154 --RTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLI 229 (291)
T ss_pred --CcccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHH
Confidence 1124578999999999988776 456999999999999999999999888777766665432 122345799999999
Q ss_pred HHcc-cCCCCCCC-----HHhHhcCCccccCCC
Q psy10194 283 SKIL-APVKTRLR-----IKNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~s-----~~e~l~hp~f~~~~~ 309 (357)
++|| .||.+|++ ++++++||||+...+
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999 59999995 999999999986443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=362.51 Aligned_cols=271 Identities=28% Similarity=0.478 Sum_probs=230.2
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
....+...+|++..+||.|..++||+|+....+..||||++.......+ .+.+.+|+..|+.++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3344677899999999999999999999999999999999987766554 57788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+.+|+||.||.+|++.++++.. ..++|..+..|++++++||.|||.+|.+|||||+.||||+.+|.+||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999763 35999999999999999999999999999999999999999999999999988765
Q ss_pred cccccccccccccccCCCCCCccchhhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHhcccCC---
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILK-GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL-KQVQSKVVF--- 268 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~-~~~~~~~~~--- 268 (357)
-....... ... .++.||++|+|||++. ...-++.|+||||||++..||.+|..||....+..++ ..+.+....
T Consensus 177 ~~~G~R~~-~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQV-TRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred cccCceee-Eee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 54332221 122 6789999999999954 3333467799999999999999999999988776644 445544432
Q ss_pred -----CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 269 -----PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 269 -----~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.....++..++++|..|| +||.+|||+.++|+|+||+....+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 222457889999999999 699999999999999999876543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=374.96 Aligned_cols=265 Identities=25% Similarity=0.459 Sum_probs=226.3
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCC-cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHS-CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
..+...+...+|.+.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 33445567788999999999999999999876554 68999998764433333345567899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.+.+.+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.....+.+...... .+.
T Consensus 181 ~~~---------~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~ 249 (340)
T PTZ00426 181 VDT---------RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-FPK 249 (340)
T ss_pred cCC---------CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCC
Confidence 421 1234578999999999988766 45699999999999999999999988877777776654322 234
Q ss_pred CCCHHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 273 NVSPECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
.+++.+.++|++|| .+|.+|+ +++++++||||++..+
T Consensus 250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 68999999999999 5899995 8999999999987653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=372.89 Aligned_cols=253 Identities=32% Similarity=0.519 Sum_probs=216.8
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997643333333345568999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccccc
Q psy10194 129 SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 129 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------GATMKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------CCcccc
Confidence 99999988888999999999999999999999999999999999999999999999999998743211 112234
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-c
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-A 287 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~ 287 (357)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... ...+..+++++.+||.+|| .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred eecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 6799999999999887774 55999999999999999999999888777666654332 2223468999999999999 5
Q ss_pred CCCCCC-----CHHhHhcCCccccCCC
Q psy10194 288 PVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 288 ~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
||.+|| ++.++++||||....+
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=378.82 Aligned_cols=265 Identities=27% Similarity=0.475 Sum_probs=221.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986543222233455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc---
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR--- 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 199 (357)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999997532100000
Q ss_pred ----------------------------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh
Q psy10194 200 ----------------------------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF 245 (357)
Q Consensus 200 ----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~ 245 (357)
..........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0000112245799999999999887774 55999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCC---CHHhHhcCCccccCC
Q psy10194 246 GRLPFDDTKYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPWFRNGP 308 (357)
Q Consensus 246 G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~---s~~e~l~hp~f~~~~ 308 (357)
|+.||.+.+..+....+.. ....+....+++++.++|.+|+.+|.+|+ ++.++++||||+...
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 9999998877665555433 23344445789999999999888999999 999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=376.47 Aligned_cols=265 Identities=26% Similarity=0.454 Sum_probs=220.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||.||++.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987543323333456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc--
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ-- 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 200 (357)
||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986332110000
Q ss_pred --------c-------------------------------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHH
Q psy10194 201 --------G-------------------------------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF 241 (357)
Q Consensus 201 --------~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 241 (357)
. ........+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0 0000113579999999999988777 45699999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCC---CCCHHhHhcCCccccCC
Q psy10194 242 AMVFGRLPFDDTKYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKT---RLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 242 ~ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~---R~s~~e~l~hp~f~~~~ 308 (357)
+|++|..||...+..+....+.. ...++....+++++.+||++||.+|.+ |+++.+++.||||++..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999988777666655543 344455456899999999999976555 56999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=379.35 Aligned_cols=265 Identities=27% Similarity=0.468 Sum_probs=223.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|++.++||+|+||+||+|++..++..||+|++.+...........+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999976443333445667799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc----
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR---- 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~---- 199 (357)
||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999997532110000
Q ss_pred -------------------------------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHH
Q psy10194 200 -------------------------------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA 242 (357)
Q Consensus 200 -------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ 242 (357)
..........+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHH
Confidence 0000112345799999999999888775 55999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCCC---HHhHhcCCccccCCC
Q psy10194 243 MVFGRLPFDDTKYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKTRLR---IKNIKEDPWFRNGPS 309 (357)
Q Consensus 243 ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~s---~~e~l~hp~f~~~~~ 309 (357)
|++|+.||...+..+....+.. ....+....+++++.++|.+|+.+|.+|++ ++++++||||+...+
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999999998776655555432 334455567899999999999889999987 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=376.91 Aligned_cols=253 Identities=30% Similarity=0.560 Sum_probs=224.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
..|....+||+|+.|.||.|....+++.||||.+....... ++.+.+|+.+|+..+|+|||++++.|...+.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45888899999999999999999999999999998765554 456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++||+|.+.+... .++|.++..++++++.||.|||.+||+|||||.+|||++.+|.+||+|||++..+.....+
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--- 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--- 425 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc---
Confidence 999999999998654 4899999999999999999999999999999999999999999999999999877654432
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc--cCCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--VVFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 280 (357)
-.+.+|||.|||||++....|.+. .||||||++++||+-|++||-..++..-+..+... ........+|+.+++
T Consensus 426 ---R~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 426 ---RSTMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ---cccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 236789999999999999988555 99999999999999999999887777666665433 334445689999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
|+.+|| .|+.+|++|.|||+||||+.
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999999 59999999999999999954
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=373.87 Aligned_cols=265 Identities=28% Similarity=0.454 Sum_probs=220.9
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|.+.+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999976544444445667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc----
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR---- 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~---- 199 (357)
|++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999997543110000
Q ss_pred -------------------------------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHH
Q psy10194 200 -------------------------------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFA 242 (357)
Q Consensus 200 -------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ 242 (357)
..........+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0000112345799999999999887774 55999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHh---cccCCCCCCCCCHHHHHHHHHcc-c--CCCCCCCHHhHhcCCccccCCC
Q psy10194 243 MVFGRLPFDDTKYSQLLKQVQ---SKVVFPKDPNVSPECKALISKIL-A--PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 243 ll~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L-~--~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
|++|..||...+..+....+. .....+....+++++.+||.+|| . ++..|+++++++.||||+...+
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 999999998877655544443 23344555578999999999977 3 4556999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=349.28 Aligned_cols=257 Identities=28% Similarity=0.502 Sum_probs=224.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCC-----CCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ-----APSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTH 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~ 116 (357)
..|.-.+.||.|..+.|.++.++.++..+|+|++.... .......+...+|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777899999999999999999999999999996432 22344566677899999998 4999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+++|+|.|+.|.|++++.+.-.++++..+.+++||++|+.|||.++||||||||+|||++++.+++|+|||++..+...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccCCCCCCccchhhhc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---CC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILK-----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---VF 268 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---~~ 268 (357)
. -....||||+|+|||.+. +.+-++..+|+|++|+|||-|+.|.+||......-++..|.++- .-
T Consensus 177 e-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 177 E-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred h-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 2 234679999999999984 33333555999999999999999999999888877888776543 34
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
|.+.+++...+|||++|| .||.+|+|++|+|.||||..
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 667789999999999999 59999999999999999954
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=369.55 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=221.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997653333233455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCC----CCCC
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKD----PNVS 275 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~----~~~~ 275 (357)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+... ...+.. ..++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred --ccCCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 2235678999999999988766 45599999999999999999999988877766555432 222222 2568
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.++|.+||. +|.+|++++++++||||....
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 999999999995 799999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=373.64 Aligned_cols=266 Identities=29% Similarity=0.556 Sum_probs=226.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997644333233456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc----
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS---- 198 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 198 (357)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999976543220
Q ss_pred -------------------ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy10194 199 -------------------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259 (357)
Q Consensus 199 -------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~ 259 (357)
............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0000112334578999999999988866 45599999999999999999999988777666
Q ss_pred HHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCCC-HHhHhcCCccccCCC
Q psy10194 260 KQVQS---KVVFPKDPNVSPECKALISKILAPVKTRLR-IKNIKEDPWFRNGPS 309 (357)
Q Consensus 260 ~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~s-~~e~l~hp~f~~~~~ 309 (357)
..+.. ....+....+++++.+||.+||.+|.+|++ ++++++||||++..+
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 66554 344555556899999999999999999999 999999999987644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=374.09 Aligned_cols=266 Identities=26% Similarity=0.481 Sum_probs=224.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.++..++|++|+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643333334556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc--
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ-- 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 200 (357)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987442211000
Q ss_pred ---------------------------ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy10194 201 ---------------------------GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT 253 (357)
Q Consensus 201 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~ 253 (357)
.........+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 001112345799999999999888775 4599999999999999999999988
Q ss_pred cHHHHHHHHhc---ccCCCCCCCCCHHHHHHHHHcccCCCCCC---CHHhHhcCCccccCCC
Q psy10194 254 KYSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVKTRL---RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 254 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~p~~R~---s~~e~l~hp~f~~~~~ 309 (357)
+.......+.. ...++....+++++++||.+|+.+|.+|+ +++++++||||++..+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 87776666653 23344444689999999999888898888 4899999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=368.89 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=223.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||+||+|.+..++..||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654433344566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++|+|.+++.+. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999976432111
Q ss_pred cccccccCCCCCCccchhhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCCCC
Q psy10194 202 YESLSETFCGSYAYASPEILKG-----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKDPN 273 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 273 (357)
.......||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+.......+... ..++..+.
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 158 --VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred --eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 12223568999999999863 223356699999999999999999999887776666665432 34455567
Q ss_pred CCHHHHHHHHHcccCCCCCCCHHhHhcCCccccCCC
Q psy10194 274 VSPECKALISKILAPVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 274 ~~~~~~~li~~~L~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+++++.+||..||.+|.+||++++++.||||+...+
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCH
Confidence 899999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=350.89 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=218.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC-ccceEEEEEeCC-----
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN-LIKFLQAIETTH----- 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~l~~~~~~~~----- 116 (357)
..|...++||+|+||+||+|+...+|+.||+|.+...... +..-....+|+.+++.|+|+| |+++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4577788899999999999999999999999999765443 223344569999999999999 999999998877
Q ss_pred -eEEEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 117 -RVYIIMEYAEKGSLLDIIRKEG----YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 117 -~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.+++|+||+.- +|.+++...+ .++...++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999976 9999997654 57888999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK- 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~- 270 (357)
..... ....+..++|.+|+|||++.+..+++...||||+|||++||++++..|.+....+.+..|-..+..|.
T Consensus 169 a~~ip------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 169 AFSIP------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HhcCC------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 54321 12244567899999999999986666669999999999999999999999887776666653322221
Q ss_pred ------------------C----------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 271 ------------------D----------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 271 ------------------~----------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+ +..+++..+++..||. +|.+|+|++.+|.||||+..+..
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 1 2345789999999996 99999999999999999976544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=356.30 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=210.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
-++|.+.++||.|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 357999999999999999999999999999999986543221 123456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+.+ +|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--- 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--- 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---
Confidence 999986 9999886543 57999999999999999999999999999999999999999999999999986532111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-------------- 266 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-------------- 266 (357)
.......|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred ---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 112344679999999998765544667999999999999999999998877655444332111
Q ss_pred ------CCCC---------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 267 ------VFPK---------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 ------~~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.++. .+.+++++.+||++||. ||.+|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111 13568899999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=354.31 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=211.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--C---eE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--H---RV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~---~~ 118 (357)
.|.-.+++|.|+||.||.|...++++.||||.+-.... .-.+|+.+|+.++|||||++..+|... . +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48889999999999999999999999999998754332 223899999999999999999988442 2 45
Q ss_pred EEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeeccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNH 193 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg~~~~~ 193 (357)
.+||||++. +|.+.++. +..++.-.++-+..||++||+|||+.||+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999986 99999874 5678999999999999999999999999999999999999976 89999999999987
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC---
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK--- 270 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~--- 270 (357)
.....+ .....|..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+.+..+..-+..|.
T Consensus 177 ~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 177 VKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred ccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 644332 2445699999999999988888889999999999999999999999877666655543222211
Q ss_pred -------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 271 -------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 271 -------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
....++++.+|+.++|+ +|.+|.++.|++.||||+.-
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 13578999999999997 99999999999999999754
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=364.48 Aligned_cols=259 Identities=37% Similarity=0.638 Sum_probs=230.0
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.-|.+.+.||+|.|+.|.+|++.-+|..||||++.+....+-. ...+.+|++.|+.++|||||++|++..++..+|+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3589999999999999999999999999999999987765443 344558999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe-cCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI-DADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+-.+|+|+++|-+ ...+.|..++++|.||+.|+.|+|+..+|||||||+|+.+ .+-|-+||.|||++..+.+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 99999999999854 4569999999999999999999999999999999999875 77899999999999776532
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 279 (357)
....+.||+..|.|||++.+..|+.+++||||||+|||.|.+|++||...+..+.+-.|.. ++..| ..++.+|+
T Consensus 173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--shvS~eCr 247 (864)
T KOG4717|consen 173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--SHVSKECR 247 (864)
T ss_pred ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--hhhhHHHH
Confidence 3345789999999999999999999999999999999999999999998877776666653 44444 47999999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~ 311 (357)
+||..|| .||++|.++++|..|+|++.....+
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 9999999 6999999999999999999876544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=369.47 Aligned_cols=264 Identities=27% Similarity=0.470 Sum_probs=223.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999999999999999997543333333455678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-- 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-- 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC--
Confidence 999999999999998654 58999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccCCCCCCccchhhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIP---YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 273 (357)
.......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+.......+... ..++....
T Consensus 197 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred ---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 11223467999999999987542 3456799999999999999999999988877766666532 34455557
Q ss_pred CCHHHHHHHHHccc-CCCC--CCCHHhHhcCCccccCCC
Q psy10194 274 VSPECKALISKILA-PVKT--RLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~--R~s~~e~l~hp~f~~~~~ 309 (357)
++.++.+||++||. +|.+ |++++++++||||++..+
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 89999999999995 6876 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=360.32 Aligned_cols=252 Identities=30% Similarity=0.512 Sum_probs=215.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
+.||+|+||.||++.+..++..||+|++.+...........+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997654333333455668999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccccc
Q psy10194 129 SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 129 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------AATMKT 154 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc------cccccc
Confidence 99999988888999999999999999999999999999999999999999999999999998743211 112234
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-c
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-A 287 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~ 287 (357)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....+.+.... ...+..+++++.+||.+|| .
T Consensus 155 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred ccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCC
Confidence 679999999999987776 455999999999999999999998887776666554322 2233468999999999999 5
Q ss_pred CCCCCC-----CHHhHhcCCccccCC
Q psy10194 288 PVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 288 ~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
||.+|+ ++.++++||||....
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999997 899999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=368.48 Aligned_cols=263 Identities=28% Similarity=0.489 Sum_probs=221.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
....+|++.+.||+|+||.||++.+..++..+|+|++.+...........+.+|+.+++.++||||+++++++.++..++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999997543333333455678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-- 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-- 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC--
Confidence 999999999999999654 58999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccccCCCCCCccchhhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIP---YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 273 (357)
.......+||+.|+|||++.+.. +.+.++|+|||||++|+|++|..||...+.......+... ..++....
T Consensus 197 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred ---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 11223567999999999997543 3456799999999999999999999988776666666532 34455456
Q ss_pred CCHHHHHHHHHcccC-CC--CCCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKILAP-VK--TRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L~~-p~--~R~s~~e~l~hp~f~~~~ 308 (357)
+++.+++++..||.+ +. .|+++.++++||||+...
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 899999999999963 43 389999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=357.38 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=208.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||+||+|.+..++..||+|++........ ...+.+|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999865432221 23456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+.+ +|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 156 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP---- 156 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC----
Confidence 999964 88877755 356899999999999999999999999999999999999999999999999998643211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcccCC-----------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKVVF----------- 268 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~~~----------- 268 (357)
........|++.|+|||++.+....+.++|||||||++|+|++|..||.+... ...++.+......
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 11223456899999999987765556679999999999999999999986432 2222222110000
Q ss_pred -------------C-------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 269 -------------P-------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 -------------~-------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+ .....++.+.+|+++||. ||.+|||++|+++||||++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0 001245789999999995 9999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=360.58 Aligned_cols=250 Identities=28% Similarity=0.493 Sum_probs=214.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999754333333345566899999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCC
Q psy10194 131 LDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210 (357)
Q Consensus 131 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 210 (357)
.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .......+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------DDKTNTFC 154 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------CCcccccc
Confidence 999988888999999999999999999999999999999999999999999999999998753211 11223567
Q ss_pred CCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCC
Q psy10194 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APV 289 (357)
Q Consensus 211 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p 289 (357)
||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.... ...+..+++++.+||.+|| .||
T Consensus 155 gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 155 GTPEYLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred CCcccCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCH
Confidence 9999999999988777 455999999999999999999999888777766655432 2233468999999999999 599
Q ss_pred CCCC---CHHhHhcCCccccCC
Q psy10194 290 KTRL---RIKNIKEDPWFRNGP 308 (357)
Q Consensus 290 ~~R~---s~~e~l~hp~f~~~~ 308 (357)
.+|| ++.+++.||||....
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCCC
Confidence 9997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=361.58 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=215.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
+.||+|+||.||++.+..++..||+|++.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999997643322333445568999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccccc
Q psy10194 129 SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 129 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------GATMKT 154 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC------CCcccc
Confidence 99999988888999999999999999999999999999999999999999999999999998643211 111234
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L- 286 (357)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.. ...++ ..+++++.++|.+||
T Consensus 155 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence 578999999999988777 4559999999999999999999988877776666543 23333 468999999999999
Q ss_pred cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 287 APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
.||.+|+ ++.++++||||....
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 5999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=353.53 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=213.2
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|++.+.||+|+||+||+|.+..++..||+|.+.+...........+.+|+.+++.++|++|+++++.+.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999876443333333456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 99999999887543 36899999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh---cccCCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ---SKVVFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 278 (357)
.......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+. ..........+++++
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 232 (285)
T cd05631 156 --ETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232 (285)
T ss_pred --CeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence 112345689999999999887774 55999999999999999999998754322222221 122223335689999
Q ss_pred HHHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 279 KALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
.+|+++|| .||.+|++ ++++++||||....
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999 59999997 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=358.01 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=219.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCCeEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+..|+.++..+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976433223334456688999998876 56888999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~------ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG------ 154 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+.... ...+..+++++.+++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 232 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSIC 232 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Confidence 1122345789999999999887774 55999999999999999999999888877777765432 223346899999999
Q ss_pred HHcc-cCCCCCCCH-----HhHhcCCccccCCC
Q psy10194 283 SKIL-APVKTRLRI-----KNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~s~-----~e~l~hp~f~~~~~ 309 (357)
++|| .+|.+|++. +++++||||+...+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999 599999986 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=351.49 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=210.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|++..++..||+|++...... +...+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999998764332 233455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 154 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS----- 154 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-----
Confidence 999987776665555679999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-----------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK----------------- 265 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~----------------- 265 (357)
........|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 112234568999999999988776 45699999999999999999999876544332222110
Q ss_pred ---cCCCC-----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 266 ---VVFPK-----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 266 ---~~~~~-----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
...+. ...+|+++.+||++||. ||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00110 12368889999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=359.07 Aligned_cols=252 Identities=28% Similarity=0.501 Sum_probs=214.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..||+|++.+.....+...+.+.+|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764322222234455788888766 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------GKTTS 154 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998653211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+..+..+.+..... .....+++++.++|++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred ccccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcc
Confidence 46789999999999877764 459999999999999999999999888887777765432 223468999999999999
Q ss_pred cCCCCCCCH------HhHhcCCccccCC
Q psy10194 287 APVKTRLRI------KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~------~e~l~hp~f~~~~ 308 (357)
.||.+|+++ ++++.||||....
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 599999998 9999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=364.65 Aligned_cols=265 Identities=28% Similarity=0.479 Sum_probs=223.0
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+..++..+|+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34558999999999999999999999999999999998754333333345567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 9999999999999998654 58999999999999999999999999999999999999999999999999997543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIP---YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKDP 272 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~~ 272 (357)
.......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...+.......+... ..++...
T Consensus 197 ----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 197 ----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred ----cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 11223567999999999987543 3456799999999999999999999988877777666542 3455556
Q ss_pred CCCHHHHHHHHHcccCCC---CCCCHHhHhcCCccccCCC
Q psy10194 273 NVSPECKALISKILAPVK---TRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 273 ~~~~~~~~li~~~L~~p~---~R~s~~e~l~hp~f~~~~~ 309 (357)
.++..++++|..||.+|. .|++++++++|+||++..+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 799999999999996433 3889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=357.38 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=214.4
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHH---HcCCCCCccceEEEEEeCCeEEEE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV---KGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l---~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999764322222234555666655 456799999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+++++|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~----- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF----- 154 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence 999999999988854 46999999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+...... .+..+++.+.++
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~l 231 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSREAISI 231 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCHHHHHH
Confidence 112235679999999999988776 45599999999999999999999988877777666543222 234689999999
Q ss_pred HHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 282 ISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 282 i~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
|.+|| .||.+|| ++.++++||||++..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 99999 5999999 699999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=357.71 Aligned_cols=259 Identities=26% Similarity=0.485 Sum_probs=213.6
Q ss_pred CEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~ 118 (357)
+|++.+.||+|+||.||++... .++..||+|++.+.... .....+.+.+|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47889999998753221 222344566899999999 489999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcccCCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT----KYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~----~~~~~~~~~~~~~~~~~~~~~ 274 (357)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ....+...+.. ...+....+
T Consensus 160 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (332)
T cd05614 160 ----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFI 234 (332)
T ss_pred ----CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCC
Confidence 112234579999999999987654566799999999999999999999643 22333333322 222334568
Q ss_pred CHHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 275 SPECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
++.+.++|.+|| .||.+|+ +++++++||||++..
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999 5999999 888999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=358.65 Aligned_cols=252 Identities=32% Similarity=0.563 Sum_probs=210.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
++||+|+||.||+|.+..++..||+|++++.........+.+.+|+.+++.+ +||||+++++++.+.+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865444444455677899999888 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------GDTTS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998642211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc--------H-HHHHHHHhcccCCCCCCCCCHHH
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--------Y-SQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
..+||+.|+|||++.+..+. .++|+|||||++|+|++|+.||.... . ....+.+... ....+..++.++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCCCCCHHH
Confidence 56799999999999887774 55999999999999999999996311 1 1222223222 222334689999
Q ss_pred HHHHHHcc-cCCCCCCC------HHhHhcCCccccCC
Q psy10194 279 KALISKIL-APVKTRLR------IKNIKEDPWFRNGP 308 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s------~~e~l~hp~f~~~~ 308 (357)
.++|.+|| .||.+|++ ++++++||||....
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99999999 59999997 78999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=358.27 Aligned_cols=261 Identities=25% Similarity=0.456 Sum_probs=208.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----CeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-----HRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-----~~~ 118 (357)
+|++.++||+|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch-hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864332222 233466899999999999999999988543 358
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 59999998888899999999999999999999999999999999999999999999999999975422111
Q ss_pred ccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-------------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS------------- 264 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~------------- 264 (357)
.........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 159 ---TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ---ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 01122345789999999998652 2335669999999999999999999987654332221111
Q ss_pred --------------ccCCC---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 265 --------------KVVFP---KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 265 --------------~~~~~---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
....+ ..+.+++.+.++|.+|| .+|.+|||++++++||||.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000 11357889999999999 59999999999999999986544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=360.25 Aligned_cols=252 Identities=32% Similarity=0.536 Sum_probs=214.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
+.||+|+||.||++.+..++..||+|++.+...........+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997644333333345568999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 129 SLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 129 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~------~~~~~ 154 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD------GATMK 154 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC------Ccccc
Confidence 999999888889999999999999999999997 79999999999999999999999999998643211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... ...+..+++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cccCCcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhh
Confidence 4578999999999988777 455999999999999999999998887777666654322 2223468999999999999
Q ss_pred cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 287 APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
.||.+|+ ++.++++||||.+..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 5999997 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=359.95 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=210.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
||+|+||+||+|.+..++..||+|++.+..............|..++..+ +||||+++++++.+...+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998754322222222233566666554 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~------~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD------NKTTN 154 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC------CCCcc
Confidence 999999988888999999999999999999999999999999999999999999999999998653211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+..+.+...........+++++.+||++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 5679999999999976654466799999999999999999999988887777766544332223468999999999999
Q ss_pred cCCCCCC----CHHhHhcCCccccCC
Q psy10194 287 APVKTRL----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~----s~~e~l~hp~f~~~~ 308 (357)
.+|.+|| ++.++++||||....
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCCC
Confidence 5999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=357.32 Aligned_cols=252 Identities=29% Similarity=0.541 Sum_probs=211.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHH-HHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-VVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..||+|++.+...........+.+|.. +++.++||||+++++.+.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997543222222223334444 56889999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------SKTTS 154 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 12233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+..+.+..... ...+.+++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhh
Confidence 56789999999999887764 559999999999999999999998888777776654432 233468999999999999
Q ss_pred cCCCCCCCH----HhHhcCCccccCC
Q psy10194 287 APVKTRLRI----KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~----~e~l~hp~f~~~~ 308 (357)
.||.+|+++ .++++||||....
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 599999997 6999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=355.43 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=219.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+|.+.+.||+|+||.||+|.+..++..||+|++.+.........+....|..++..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999765433333334455677887776 5899999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~------ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD------ 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..... ..+..+++++.+++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 232 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAIC 232 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHH
Confidence 1122356789999999999887774 559999999999999999999999888777777654332 22346899999999
Q ss_pred HHcc-cCCCCCCCH-----HhHhcCCccccCCC
Q psy10194 283 SKIL-APVKTRLRI-----KNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~s~-----~e~l~hp~f~~~~~ 309 (357)
.+|| .+|.+|+++ .++++||||+...+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999 599999984 89999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=357.06 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=214.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
++||+|+||.||+|.+..++..||+|++.+.........+.+..|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999764332333344455788888765 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~------~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN------GVTTT 154 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC------Ccccc
Confidence 999999988888999999999999999999999999999999999999999999999999998743211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+.....+.+...... .+..+++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMT 232 (321)
T ss_pred ccccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHHhc
Confidence 46789999999999887774 4599999999999999999999998888877776654322 22358999999999999
Q ss_pred cCCCCCC-------CHHhHhcCCccccCC
Q psy10194 287 APVKTRL-------RIKNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~-------s~~e~l~hp~f~~~~ 308 (357)
.||.+|+ +++++++||||....
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 5999999 899999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=354.43 Aligned_cols=252 Identities=32% Similarity=0.547 Sum_probs=211.3
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc-CCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG-LKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||.||+|.+..++..||+|++++.........+....|..++.. .+||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976432222223334456666654 4799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~------~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG------EGKAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998753211 12233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+..... ..+..++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-HFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred cccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHcc
Confidence 56799999999999887764 559999999999999999999998888777776654322 233468999999999999
Q ss_pred cCCCCCCCH-HhHhcCCccccCC
Q psy10194 287 APVKTRLRI-KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~-~e~l~hp~f~~~~ 308 (357)
.+|.+|+++ .++++||||....
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCCC
Confidence 599999986 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=353.25 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=216.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||++++..++..+|+|++.... .......+.+|+.+++.++||||+++++++...+.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34679999999999999999999999999999999986532 2334566789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 9999999999999998888899999999999999999999986 699999999999999999999999999875432
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-------------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK------------- 265 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~------------- 265 (357)
.......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+...
T Consensus 157 -----~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 -----SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred -----cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 11234568999999999988776 45699999999999999999999765554443222110
Q ss_pred ---------------------------------cC-CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 266 ---------------------------------VV-FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 266 ---------------------------------~~-~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.. ......+++++++||.+|| .||++|||++++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 0011247889999999999 599999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=361.89 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=228.1
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
....|+..+.||+|+||.||+|.+..+++.||+|++......++ .+.+.+|+.+|.+++++||.++|+.|..+..+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 34568888999999999999999999999999999987655443 4567799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
+||||.||++.++++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++........
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987653322
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
...+++|||.|||||++....|+. ++||||||++.++|++|.+||...++..++-.|...........+++.+++
T Consensus 167 ----rr~tfvGTPfwMAPEVI~~~~Y~~-KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 167 ----RRKTFVGTPFWMAPEVIKQSGYDT-KADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred ----ccccccccccccchhhhccccccc-hhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHH
Confidence 225789999999999999778855 589999999999999999999998886555555444444444579999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
||..|| ++|+.||+|.++|+|+|++...
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999 5999999999999999998744
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=354.83 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=216.6
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
....+...+..+.+.||+|+||+||++.+..+. .||+|++......... .+.+.+|+.+|..++|||||++++++...
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344555666777888999999999999987542 3999999765554444 67888999999999999999999999888
Q ss_pred C-eEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC-CeecCCCCCceEecCCC-CeEEeecccc
Q psy10194 116 H-RVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERG-VVHRDIKCENLLIDADY-NIKLSDFGFA 190 (357)
Q Consensus 116 ~-~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~g-ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 190 (357)
. .++|||||+++|+|.+++.. ...++...+..++.+|++||.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 79999999999999999977 678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVF 268 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~ 268 (357)
+...... ...+...||+.|||||++.+. ..++.|+||||||+++|||+||+.||.+.........+. .....
T Consensus 192 r~~~~~~------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 192 REKVISK------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred eeecccc------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 7643211 122235799999999999952 334777999999999999999999999988866666664 44444
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+..+++.+..+|.+|+ .||.+||++.+++.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 445569999999999999 59999999988765
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=353.76 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=215.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||++.+..++..||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997533333333455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--- 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999865432111
Q ss_pred cccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCC-CCCC
Q psy10194 202 YESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFP-KDPN 273 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~-~~~~ 273 (357)
......+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+....+... ..++ ....
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 158 --VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred --ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence 11123468999999999863 233456799999999999999999999887776666555432 2222 2235
Q ss_pred CCHHHHHHHHHccc-C--CCCCCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKILA-P--VKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~--p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.++++|++||. + +..|++++++++||||.+..
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 89999999999994 3 33488999999999997754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=344.13 Aligned_cols=264 Identities=32% Similarity=0.561 Sum_probs=234.4
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..+.-++|.+.++||+|.||.|-+++.+.++..||+|++++..............|-++|+..+||.+..+...|...+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 34566789999999999999999999999999999999988655444434445589999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|+||||.+||.|+-.+.+...+++..++.+...|+.||.|||+++||+||||.+|+|+|++|++||+|||+++....+.
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998654332
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH-hcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 276 (357)
....++||||.|+|||++....|. .++|.|.+|++||+|++|+.||...+.+.+.+.| ...+.+|. .+++
T Consensus 323 ------~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~ls~ 393 (516)
T KOG0690|consen 323 ------DTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TLSP 393 (516)
T ss_pred ------ceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cCCH
Confidence 345689999999999999998885 5599999999999999999999998888777765 45677775 5999
Q ss_pred HHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCCCC
Q psy10194 277 ECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~~~ 310 (357)
+++.|+..+| +||.+|+. +.|+.+|+||....|.
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 9999999999 69999986 8899999999887653
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=353.84 Aligned_cols=252 Identities=28% Similarity=0.508 Sum_probs=211.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc-CCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG-LKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
++||+|+||.||+|.+..++..||+|++++.....+........|..++.. ++||||+++++++.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976432111223344567777765 4899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------DNRAS 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC------CCcee
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.....+.+..... .....++++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-HYPRWITKESKDILEKLFE 232 (316)
T ss_pred ccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHcc
Confidence 56789999999999887774 559999999999999999999998887777776654332 122358999999999999
Q ss_pred cCCCCCCCH-HhHhcCCccccCC
Q psy10194 287 APVKTRLRI-KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~-~e~l~hp~f~~~~ 308 (357)
.||.+|+++ +++++||||+...
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCC
Confidence 599999998 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=354.52 Aligned_cols=252 Identities=27% Similarity=0.529 Sum_probs=213.6
Q ss_pred eEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 49 TIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
+.||+|+||.||++... .++..||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999863 46789999998753221 122234566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (357)
+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~ 155 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------GT 155 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC------CC
Confidence 999999999988888999999999999999999999999999999999999999999999999998643211 11
Q ss_pred ccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 205 LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 205 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...++.+++++.++|.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence 2234578999999999987766 456999999999999999999999888777666665432 23345689999999999
Q ss_pred cc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 285 IL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 285 ~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
|| .+|.+|+ +++++++||||....
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99 5999999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=354.37 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=209.3
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875444444455567888888766 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~------~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------GDTTS 154 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---------KYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|+.||... ......+.+... ....+..++..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-CCCCCCCCCHHH
Confidence 46789999999999887774 4599999999999999999999521 112222333222 222334689999
Q ss_pred HHHHHHcc-cCCCCCCC------HHhHhcCCccccCCC
Q psy10194 279 KALISKIL-APVKTRLR------IKNIKEDPWFRNGPS 309 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s------~~e~l~hp~f~~~~~ 309 (357)
.++|++|| .||.+|++ +.++++||||+...+
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999 59999998 579999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.28 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=210.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-C-----CCccceEEEEEeCC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-H-----PNLIKFLQAIETTH 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~Iv~l~~~~~~~~ 116 (357)
.+|.+.+.||+|+||+|-+|.+..+++.||||++++.. ....+...|+.+|..|+ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 48999999999999999999999999999999997632 22344458999999997 3 48999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC--CCeEEeecccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD--YNIKLSDFGFARN 192 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~--~~~kl~Dfg~~~~ 192 (357)
++|||+|.+.. +|.++++.+. .|+...++.++.||+.||.+||+.||||+||||+||||..- ..+||+|||++..
T Consensus 262 HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999999965 9999998764 58899999999999999999999999999999999999543 3799999999986
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC-
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD- 271 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~- 271 (357)
... ...+.+.+..|+|||++.+.+|+.. .||||||||++||++|.+.|.+.+..+.+..|.+-+..|..
T Consensus 341 ~~q---------~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 341 ESQ---------RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cCC---------cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 532 2226677999999999999999665 99999999999999999999988877766665432211110
Q ss_pred -------------------------------------------------C------------CCCHHHHHHHHHccc-CC
Q psy10194 272 -------------------------------------------------P------------NVSPECKALISKILA-PV 289 (357)
Q Consensus 272 -------------------------------------------------~------------~~~~~~~~li~~~L~-~p 289 (357)
+ .....+.|||++||. ||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0 124668999999996 99
Q ss_pred CCCCCHHhHhcCCccccC
Q psy10194 290 KTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 290 ~~R~s~~e~l~hp~f~~~ 307 (357)
.+|+|+.++|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999843
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.13 Aligned_cols=253 Identities=32% Similarity=0.541 Sum_probs=215.4
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764332223344456788888877 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG------GVTTS 154 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998642211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+|++.|+|||++.+..+. .++|+|||||++|+|++|+.||...+.......+..... ..+..+++++.+||++||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred ceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHcc
Confidence 45789999999999887774 559999999999999999999998887777766654332 223468999999999999
Q ss_pred cCCCCCCCH-----HhHhcCCccccCCC
Q psy10194 287 APVKTRLRI-----KNIKEDPWFRNGPS 309 (357)
Q Consensus 287 ~~p~~R~s~-----~e~l~hp~f~~~~~ 309 (357)
.||.+||++ .+++.||||....+
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 599999999 99999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=360.56 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=208.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4566789999999999999999999999999999996532 2355899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++|+|++. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 99999996 5999999887889999999999999999999999999999999999999999999999999986432211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHhc-------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-------YSQLLKQVQS------- 264 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-------~~~~~~~~~~------- 264 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....+..+..
T Consensus 237 ----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 237 ----ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred ----ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 112234679999999999988776 456999999999999999998874321 1111111100
Q ss_pred --------------------ccCCCC-------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 265 --------------------KVVFPK-------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 265 --------------------~~~~~~-------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
....+. ...++.++.+||.+||. ||.+|||++|+|+||||+..+..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000000 01356789999999995 99999999999999999875443
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=389.20 Aligned_cols=266 Identities=28% Similarity=0.458 Sum_probs=234.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|.|.++||+|+||.|.+++++.++..||+|++.+-..........|..|-.+|..-+.+-|+.++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 55689999999999999999999999999999999998732222223466778999999989999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|..++.+.++++++.++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.+..+...+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-- 229 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-- 229 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccCCCCCCccchhhhc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---ccCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS---KVVFPKDP 272 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~~ 272 (357)
...+...+|||.|++||++. +.+.+...+|+||+||++|+|+.|..||...+..+...+|.. .+.||...
T Consensus 230 ---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 230 ---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred ---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 34456778999999999995 213445559999999999999999999999888777777754 57788667
Q ss_pred CCCHHHHHHHHHcccCCCCCCC---HHhHhcCCccccCCCC
Q psy10194 273 NVSPECKALISKILAPVKTRLR---IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 273 ~~~~~~~~li~~~L~~p~~R~s---~~e~l~hp~f~~~~~~ 310 (357)
.+|.++++||.++|.+|+.|.+ ++++..||||.+..|.
T Consensus 307 ~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred ccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 8999999999999999999998 9999999999998873
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=350.26 Aligned_cols=252 Identities=30% Similarity=0.502 Sum_probs=211.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc-CCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG-LKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||.||+|.+..++..||+|++++.....+........|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432111112334467777765 5899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG------DAKTC 154 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC------CCcee
Confidence 999999988788999999999999999999999999999999999999999999999999998643211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+..+.+..... ..+..++.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-CYPRWLTREAKDILVKLFV 232 (316)
T ss_pred eecCCccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHhc
Confidence 4578999999999988777 4559999999999999999999998887777776654322 122358999999999999
Q ss_pred cCCCCCCCHH-hHhcCCccccCC
Q psy10194 287 APVKTRLRIK-NIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~~-e~l~hp~f~~~~ 308 (357)
.+|.+|+++. ++++||||+...
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCC
Confidence 5999999996 999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=364.22 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=204.1
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
...+|+++++||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4467999999999999999999999999999999885432 2234799999999999999999887432
Q ss_pred ---CeEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeec
Q psy10194 116 ---HRVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDF 187 (357)
Q Consensus 116 ---~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Df 187 (357)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 357799999976 7777664 346799999999999999999999999999999999999998665 7999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV- 266 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~- 266 (357)
|+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 216 Gla~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAG-------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCC-------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999754321 112245689999999998776555677999999999999999999998876544433332111
Q ss_pred -----------------CCCC----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 267 -----------------VFPK----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 267 -----------------~~~~----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.++. +...++++.+||.+||. ||.+|||+.|+++||||+...
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 1111 12467899999999994 999999999999999997643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=353.15 Aligned_cols=252 Identities=28% Similarity=0.531 Sum_probs=211.5
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHH-HHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-VVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..+|+|++.+...........+.+|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997643222222333344544 57789999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------~~~~~ 154 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------SDTTT 154 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC------CCCcc
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+....+..... ...+..+..+.++|++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLE 232 (325)
T ss_pred cccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhc
Confidence 56789999999999887774 569999999999999999999998887777766654322 233468999999999999
Q ss_pred cCCCCCCCH----HhHhcCCccccCC
Q psy10194 287 APVKTRLRI----KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~----~e~l~hp~f~~~~ 308 (357)
.+|.+||++ .+++.||||....
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 599999976 5899999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=349.43 Aligned_cols=257 Identities=29% Similarity=0.499 Sum_probs=216.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+|.+.+.||+|+||+||+|.+..++..||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999997643322222344557888888875 577888999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~------ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD------ 154 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+.....+.+..... ..+..++.++.+++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li 232 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSIC 232 (323)
T ss_pred CccccCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHH
Confidence 112234568999999999988776 4569999999999999999999998887777766654322 22346899999999
Q ss_pred HHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 283 SKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 283 ~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
.+|| .+|.+|++ .+++++||||+...
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999 59999997 57899999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=356.51 Aligned_cols=256 Identities=29% Similarity=0.527 Sum_probs=232.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe-EEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR-VYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~-~~lv 121 (357)
..|.+++.+|+|+||.+++++++.++..+++|.|......+. .++...+|+.+++++.|||||.+.+.|..++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 579999999999999999999999999999999976655443 34567799999999999999999999988877 9999
Q ss_pred EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|+||+||+|.+.|.+. ..++++.+..|+.||+.||.|||++.|+|||||+.|||+++++.++|+|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 9999999999999654 479999999999999999999999999999999999999999999999999999765322
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
....+.+|||.|+.||++.+.+| ..|+|||||||++|+|++-+++|...+...++.++......|.+..++.+++
T Consensus 161 ----~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 161 ----SLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR 235 (426)
T ss_pred ----hhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence 24557889999999999999999 5569999999999999999999999999999999998888888889999999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.+|+.|| ++|..||++.++|.+|..+.
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999 58999999999999998863
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=351.93 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=216.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.++||+|+||.||++.+..++..+|+|++.+...........+.+|+.++..++|++|+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986533223333455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence 99999999999976 4679999999999999999999999999999999999999999999999999986542111
Q ss_pred cccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---CCCC-CCC
Q psy10194 202 YESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---VFPK-DPN 273 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---~~~~-~~~ 273 (357)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+....+.... .++. ...
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 -TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred -cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 112234579999999999862 2334566999999999999999999999888777776665432 2222 236
Q ss_pred CCHHHHHHHHHccc-CC--CCCCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKILA-PV--KTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p--~~R~s~~e~l~hp~f~~~~ 308 (357)
+++++++||++||. ++ ..|++++++++||||.+..
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 89999999999994 33 3478999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=348.24 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=210.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHH-HHHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREV-EVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~-~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
++||+|+||.||+|.+..++..||+|++.+...........+.+|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754332222233333444 467889999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
++|...+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------EETTS 154 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC------CCccc
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... ...++..+.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcc
Confidence 56789999999999877764 55999999999999999999999888777766665432 2333468899999999999
Q ss_pred cCCCCCCCH----HhHhcCCccccCC
Q psy10194 287 APVKTRLRI----KNIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~----~e~l~hp~f~~~~ 308 (357)
.+|.+|+++ .++++|+||....
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 599999875 5999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=350.65 Aligned_cols=252 Identities=31% Similarity=0.536 Sum_probs=210.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875444444455677899998887 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------GDTTS 154 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC------CCcee
Confidence 999999988888999999999999999999999999999999999999999999999999998643211 11223
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC------cH-HHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT------KY-SQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... +. ....+.+.. .....+..++..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHH
Confidence 5679999999999988777 45699999999999999999999532 12 222333322 222333468999999
Q ss_pred HHHHcc-cCCCCCCC------HHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLR------IKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s------~~e~l~hp~f~~~~ 308 (357)
+|.+|| .||.+|++ +++++.||||+...
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999999 59999998 56999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.28 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=211.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|.+.+.||+|+||.||+|.+..++..||+|.+........ ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 579999999999999999999999999999999875432221 234558999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---- 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc----
Confidence 99976 888887654 458999999999999999999999999999999999999999999999999986532111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--------------- 266 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--------------- 266 (357)
.......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 112234578999999998765555667999999999999999999998776655443332111
Q ss_pred -----CCC---------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 267 -----VFP---------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 267 -----~~~---------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.++ ..+.+++++.+||.+||. ||.+|||++|+++||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 011 113578999999999995 9999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=350.82 Aligned_cols=252 Identities=29% Similarity=0.543 Sum_probs=210.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHH-HHHHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPRE-VEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E-~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||+||+|.+..++..||+|++.+...........+.+| ..+++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999975432222222223334 4457889999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------~~~~~ 154 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------NGTTS 154 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC------CCCcc
Confidence 999999988888999999999999999999999999999999999999999999999999998753211 11233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+..+.+.... ....+.+++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcc
Confidence 56799999999999887764 55999999999999999999999888777776665432 2233578999999999999
Q ss_pred cCCCCCCCHH----hHhcCCccccCC
Q psy10194 287 APVKTRLRIK----NIKEDPWFRNGP 308 (357)
Q Consensus 287 ~~p~~R~s~~----e~l~hp~f~~~~ 308 (357)
.+|.+|+++. ++++|+||....
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 5999999876 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.75 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=215.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||+||++.+..++..||+|++.+...........+.+|+.++..++|++|+++++.+.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987533222333455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||++||+|.+++.+ .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--- 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---CCCC-CCC
Q psy10194 202 YESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---VFPK-DPN 273 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---~~~~-~~~ 273 (357)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||...+..+....+.... .++. ...
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 158 --VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred --eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence 112235789999999998752 223556999999999999999999999887766666654322 2222 235
Q ss_pred CCHHHHHHHHHccc-CCCC--CCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKILA-PVKT--RLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~--R~s~~e~l~hp~f~~~~ 308 (357)
++.+++++|.+||. ++.+ |++++++++||||+...
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 78999999999995 3333 57999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=355.91 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=213.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----eE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-----RV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-----~~ 118 (357)
+|++.+.||+|+||.||++.+..++..||+|.+........ ..+.+.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV-SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH-HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47889999999999999999999999999999865432222 2345668999999999999999999998776 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999997 4899988888889999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-----------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV----------- 267 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~----------- 267 (357)
........+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 158 ----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 11222346789999999998766556779999999999999999999988766554443322110
Q ss_pred -------------C-------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 -------------F-------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 -------------~-------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
. ......++++.+||.+||. ||.+|||+.|+++||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 1123468899999999995 999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=341.51 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=202.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECC-CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEE-----
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIE----- 113 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~----- 113 (357)
++|++.+.||+|+||.||+|.+.. ++..||+|.+......... .....+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 5678999998754332221 22334677776655 6999999999985
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 4999998653 458999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK- 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~- 270 (357)
..... .......|++.|+|||++.+..+. .++|||||||++|+|++|++||.+....+.+..+......+.
T Consensus 159 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 159 IYSFQ-------MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eccCC-------cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 54311 122345689999999999877764 459999999999999999999998776665555432211110
Q ss_pred -------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 271 -------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 271 -------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.+.+++.+.+|+.+||. ||++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 13578889999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=363.98 Aligned_cols=266 Identities=24% Similarity=0.418 Sum_probs=224.6
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.........+|.+.+.||+|+||+||+|.+..++..||+|++........ ....+.+|+.++..++|+||+++.+.+..
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH-HHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 33444456799999999999999999999999999999999976544333 34456789999999999999999887743
Q ss_pred CC--------eEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCe
Q psy10194 115 TH--------RVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI 182 (357)
Q Consensus 115 ~~--------~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~ 182 (357)
.+ .+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 32 47899999999999999864 3468999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~ 262 (357)
||+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 183 kL~DFGls~~~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 183 KLGDFGFSKMYAATVS----DDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EEEecccCeecccccc----ccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999876432211 122345679999999999988776 45699999999999999999999998888877777
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
......+.++.+++++.+++.+|| .+|.+||++.+++.|||++.
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 666555556689999999999999 59999999999999999865
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.26 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=214.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|++.++||+|+||+||++.+..++..||+|++.............+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999876443333334455689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888653 468999999999999999999999999999999999999999999999999987542111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---ccCCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS---KVVFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 278 (357)
.....+|++.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+.....+.+.. .........+++.+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence 11234689999999999877764 458999999999999999999987655433322222 11222234689999
Q ss_pred HHHHHHcc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 279 KALISKIL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
.+||.+|| .||.+|| +++++++||||....+
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 99999999 5999999 8999999999986443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.12 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=214.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||.||++.+..++..+|+|++.... .......+.+|+++++.++|+||++++++|.+.+.++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45678999999999999999999999999999999886542 2333456779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 9999999999999998888899999999999999999999975 799999999999999999999999999865421
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh---------------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ--------------- 263 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~--------------- 263 (357)
.......|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...........+.
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 157 -----SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred -----hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 11224568999999999987666 455999999999999999999997654433322111
Q ss_pred -----------------------------cccCC-CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 264 -----------------------------SKVVF-PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 264 -----------------------------~~~~~-~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..... .....++.++++||.+|| .||.+|||+.|++.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000 001136789999999999 5999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=341.86 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=206.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||+|+||+||++.+..++..||+|.+.+.........+.+..|+.+++.++|+||+++.+++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998764433333334556899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccc
Q psy10194 131 LDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206 (357)
Q Consensus 131 ~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 206 (357)
.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------~~~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ------SKT 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC------ccc
Confidence 987742 4568999999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS----QLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 207 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
....||+.|+|||++.+..+. .++|+|||||++|+|++|+.||...... .....+... .......+++.+.+++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHH
Confidence 345689999999999887774 5599999999999999999999764322 222222211 1222346899999999
Q ss_pred HHcc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 283 SKIL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
.+|| .||.+|+ +++++++||||+...+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 9999 5999999 8899999999987443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=360.63 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=219.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCC-CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRH-SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998777 778899876432 23334566789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
||||++||+|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 456899999999999999999999999999999999999999999999999999765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+......+....+++
T Consensus 223 ~~----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~ 297 (478)
T PTZ00267 223 VS----LDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSS 297 (478)
T ss_pred cc----cccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCH
Confidence 11 122345679999999999988766 4569999999999999999999998888777777665544444457899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
++.++|.+|| .+|.+||++.+++.|+|++.
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999 59999999999999999853
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=349.74 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=209.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4467899999999999999999999999999999986433 33445667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--- 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence 9999999998653 335788889999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhcccCCCCCCC
Q psy10194 201 GYESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---SQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~---~~~~~~~~~~~~~~~~~~ 273 (357)
.......||..|+|||++.. ..+...++|||||||++|+|++|+.||..... ......+...........
T Consensus 223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 11224568999999998743 23445579999999999999999999974332 223333332333333457
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
++.++.+||.+|| .+|.+||++.|+++||||...
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 8999999999999 599999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=349.06 Aligned_cols=251 Identities=27% Similarity=0.511 Sum_probs=212.6
Q ss_pred eEeeecCceEEEEEEE---CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec
Q psy10194 49 TIIGMGSYATVKLATS---SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
+.||+|+||.||++.+ ..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999986 35788999999976432221 2334568999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 126 EKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 126 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
++|+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------EKK 154 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------CCc
Confidence 99999999988888999999999999999999999999999999999999999999999999998754321 112
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHc
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKI 285 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 285 (357)
....+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+.... ...+..+++.+.+||++|
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred eecccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence 234678999999999987766 456999999999999999999999888777666654332 223346899999999999
Q ss_pred c-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 286 L-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 286 L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
| .||.+||+ +++++.||||+...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9 59999999 77899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=332.07 Aligned_cols=268 Identities=28% Similarity=0.501 Sum_probs=223.0
Q ss_pred EEE-EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEE
Q psy10194 45 YTL-GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 45 y~~-~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
|++ .+.||+|+++.|-.+....++..||||+|.+... ..+..+.+|++++.+++ |+||+.++++|+++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 444 5789999999999999999999999999987633 23556679999999885 999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~ 199 (357)
|.+.||+|...|++...|++.++..+.+.|+.||.+||.+||+||||||+|||..... -+|||||.+..-.....+.
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999999999999999999999999999999999999999999999985443 5999999988654322211
Q ss_pred -cccccccccCCCCCCccchhhhc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---------------HHHHH
Q psy10194 200 -QGYESLSETFCGSYAYASPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---------------YSQLL 259 (357)
Q Consensus 200 -~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---------------~~~~~ 259 (357)
........+.+|+..|||||+.. ...+++.++|.||||+|+|-||.|.+||.+.. ...+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 22233455789999999999863 34566778999999999999999999996532 34566
Q ss_pred HHHhcc-cCCCC--CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCCCCC
Q psy10194 260 KQVQSK-VVFPK--DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPEYPI 315 (357)
Q Consensus 260 ~~~~~~-~~~~~--~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~~~~ 315 (357)
+.|.++ +.||. +..+|.+++++|+.|| .|+.+|.++.++++|||++......-+|.
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 666654 45554 3479999999999999 69999999999999999988765544443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=336.99 Aligned_cols=253 Identities=31% Similarity=0.589 Sum_probs=210.1
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|++++.||+|+||+||++.+..++..+|+|++......... .....+|+.+++.++||||+++++++.+....++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999775433322 22334699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (357)
+.+++|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+..... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------NNE 153 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS------TTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccc
Confidence 99999999999788899999999999999999999999999999999999999999999999999875311 112
Q ss_pred ccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhc-ccCC--CCCCCCCHHH
Q psy10194 205 LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---QLLKQVQS-KVVF--PKDPNVSPEC 278 (357)
Q Consensus 205 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---~~~~~~~~-~~~~--~~~~~~~~~~ 278 (357)
......+++.|+|||++......+.++|+||||+++|+|++|..||...... ........ .... ......++.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 3335668999999999984444467799999999999999999999987322 22222221 1111 1111234899
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.++|.+|| .+|++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 599999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=353.40 Aligned_cols=257 Identities=41% Similarity=0.691 Sum_probs=233.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
...|.+.+.||+|.|+.|.++++..++..||||++++.........+ +.+|+++|+.++|||||+++.+.+.+..+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 35699999999999999999999999999999999998877666555 66999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+.+|.+++++.+++...+..++.+|.|++.|++|||+.+|+|||||++|||++.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~------ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY------ 207 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987652
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH-hcccCCCCCCCCCHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 280 (357)
..+..+.||++.|.|||++.+..|..+.+|+||+|+++|.|+.|..||++.+...+...+ ...+..+. .++.+|.+
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~ 284 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCED 284 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHH
Confidence 345668999999999999999999999999999999999999999999998877666554 34455554 48899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+|+++| .+|.+|++.++++.|+|....-
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchhh
Confidence 999999 5999999999999999996543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=330.74 Aligned_cols=260 Identities=26% Similarity=0.493 Sum_probs=217.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc------hHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS------DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
+|.++..||+|++|.||+|.+..++..+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788999999999999999998889999999886543322 2234567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.............|+..|+|||.+.+..+. .++|+|||||++|+|++|+.||...+.......+........+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 111111112234588999999999877664 4599999999999999999999876655555554444333344568999
Q ss_pred HHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 278 CKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 278 ~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+.++|++||. +|.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999995 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.30 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=222.0
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||++.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987654333334566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
....+|++.|+|||.+.+... +.++|+||||+++|+|++|+.||...+.....+.+... ..+....+++.+.++|
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 229 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLI 229 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHH
Confidence 234568999999999987765 45599999999999999999999887766655555432 2233346799999999
Q ss_pred HHcc-cCCCCCC-----CHHhHhcCCccccCCCC
Q psy10194 283 SKIL-APVKTRL-----RIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 283 ~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~~ 310 (357)
.+|| .+|.+|+ +++++++||||+...+.
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 9999 5899999 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.42 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=204.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC---
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH--- 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~--- 116 (357)
....+|++.+.||+|+||.||++.+..++..||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34578999999999999999999999999999999986543322 22345568999999999999999999986443
Q ss_pred ---eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 117 ---RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 117 ---~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 67766643 4889999999999999999999999999999999999999999999999998753
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-------
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV------- 266 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~------- 266 (357)
.. ........||+.|+|||++.+..+.. ++|||||||++|+|++|+.||.+.+.......+....
T Consensus 174 ~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 174 CT-------NFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cc-------CccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 21 11223456899999999998877754 5999999999999999999998765433222111100
Q ss_pred ----------------CC--------------C----CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 267 ----------------VF--------------P----KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 267 ----------------~~--------------~----~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.. + .....++++++||.+||. ||++|||+.|+++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0 011246789999999995 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=348.12 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=219.3
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
...+....+.+.+.||+|-||.||+|.+..+ ..||+|.++...... +.+.+|+.+|+.|+|++||+++++|..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 3456667788899999999999999998654 379999997654432 34559999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
.++|||||++.|+|.++|+. ...+...+...++.||++|++||+++++|||||...||||+.++.+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999986 5679999999999999999999999999999999999999999999999999999432
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
... .......--...|.|||.+....++. ||||||||++||||+| |+.||.++...++++.+..++++|.++.
T Consensus 355 d~~-----Y~~~~~~kfPIkWtAPEa~~~~~FS~-kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 355 DDE-----YTASEGGKFPIKWTAPEALNYGKFSS-KSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG 428 (468)
T ss_pred CCc-----eeecCCCCCCceecCHHHHhhCCccc-ccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC
Confidence 111 11111122256799999999888854 5999999999999996 9999999999999999999999999999
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+|+++-+++..|+ .+|++|||++.+..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999999999 59999999986653
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=329.78 Aligned_cols=257 Identities=29% Similarity=0.499 Sum_probs=213.9
Q ss_pred cCEEEE-eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE----eCC
Q psy10194 43 HGYTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE----TTH 116 (357)
Q Consensus 43 ~~y~~~-~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~----~~~ 116 (357)
++|++. ++||-|-.|.|..+.++.+++.+|+|++.-. ...++|+++.-.. .|||||.++++|+ ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 456664 6899999999999999999999999987432 2345888875555 5999999999984 356
Q ss_pred eEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeeccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFAR 191 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~ 191 (357)
.+.+|||+++||.|++.++.++ .++|+++..|++||..|+.|||+.+|+||||||+|+|.+. +..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 7889999999999999998766 4999999999999999999999999999999999999964 4579999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcc-c
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQSK-V 266 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~~~-~ 266 (357)
.... .....+.|-||.|.|||++....|+ ..+|+||+||++|-||+|.+||..+.- ..+..+|..+ +
T Consensus 213 ~t~~-------~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 213 ETQE-------PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccCC-------CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 6432 2334577889999999999888875 449999999999999999999986543 2344455443 3
Q ss_pred CCC--CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCCCCCCC
Q psy10194 267 VFP--KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSRPEYPI 315 (357)
Q Consensus 267 ~~~--~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~~~~~~ 315 (357)
.|| .+..+|..++++|+.||+ +|.+|+|+.+++.|||+......|..|.
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 444 456899999999999995 9999999999999999998877666554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=334.38 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=211.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|++.+.||+|+||+||++.+..++..||+|.+.+...........+.+|+.+++.++|++|+.+++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999876544433334456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988643 358999999999999999999999999999999999999999999999999986532111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhcccCCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---QLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
......|++.|+|||++.+..+. .++|+|||||++|+|++|+.||...... .....+...........+++++
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence 11234689999999999887764 4599999999999999999999864321 1122221222222234689999
Q ss_pred HHHHHHccc-CCCCCCC-----HHhHhcCCcccc
Q psy10194 279 KALISKILA-PVKTRLR-----IKNIKEDPWFRN 306 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s-----~~e~l~hp~f~~ 306 (357)
.+|+.+||. ||.+||| ++|+++||||+.
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999995 9999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=347.15 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=207.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------ 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------ 115 (357)
.++|.+.+.||+|+||+||+|.+..++..||+|.+....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 468999999999999999999999999999999986543222 2234456899999999999999999987533
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..++++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4578999998 6799888754 5699999999999999999999999999999999999999999999999999975431
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------- 267 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-------- 267 (357)
......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 171 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 171 ---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ---------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 123456899999999998755556779999999999999999999987665444433321110
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 ----------------FPK------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 ----------------~~~------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+. ....++.+.+||.+||. ||.+|||+.|+++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 12457788999999995 999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.11 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=203.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||+|+||+||++.+..++..||+|.+.............+..|+.+++.++||||+++++.+.+...+++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998654333222234455799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccccc
Q psy10194 131 LDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 131 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-------~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-------TITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------eeec
Confidence 98886533 58899999999999999999999999999999999999999999999999987543211 1123
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
..|++.|+|||++.+..+ +.++|+|||||++|+|++|..||..... ..................+++++.+||++
T Consensus 154 ~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 154 RAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred cCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence 468999999999988776 5569999999999999999999976432 22222222211111224689999999999
Q ss_pred cc-cCCCCCCCH----HhHhcCCccccC
Q psy10194 285 IL-APVKTRLRI----KNIKEDPWFRNG 307 (357)
Q Consensus 285 ~L-~~p~~R~s~----~e~l~hp~f~~~ 307 (357)
|| .||.+||++ ++++.||||+..
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99 599999999 678899999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=336.43 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=211.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
-++|.+.+.||.|+||.||+|.+..++..||+|.+........ ...+.+|+.+++.++||||+++++++.....+++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999865432221 23455899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--- 158 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC---
Confidence 999975 89888865 4568999999999999999999999999999999999999999999999999986532111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------------- 267 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~------------- 267 (357)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+.....
T Consensus 159 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 ---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred ---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1112345688999999987765556679999999999999999999987766554433321110
Q ss_pred -------CC---------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 -------FP---------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 -------~~---------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+ ....+++.+.+||.+||. ||.+|||++|+++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11 013578899999999995 999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=334.08 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=201.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEEe-----C
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIET-----T 115 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~~-----~ 115 (357)
+|++.+.||+|+||+||+|.+..++..||+|.+........ ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999865432221 122234666666655 79999999998854 3
Q ss_pred CeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..+++|||++.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 898888663 34899999999999999999999999999999999999999999999999998754
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-----
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF----- 268 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~----- 268 (357)
... .......|++.|+|||++.+..+ +.++|||||||++|+|++|.+||...........+......
T Consensus 159 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 159 SCQ-------MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cCc-------ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 311 11223467899999999987776 45599999999999999999999877655544443221100
Q ss_pred -C--------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 269 -P--------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 -~--------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+ ..+.++..+.++|.+||. ||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 013578889999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.72 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=206.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
...+|++.+.||+|+||.||++.+..++..||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch-hHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45789999999999999999999999999999999875433322 234456899999999999999999987543
Q ss_pred -CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 -HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
..+++||||+.+ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 457999999976 78777754 47899999999999999999999999999999999999999999999999997542
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-----
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP----- 269 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~----- 269 (357)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 178 ~-------~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 178 T-------SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred C-------CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1 1122345689999999999887774 45999999999999999999998776554443332211100
Q ss_pred --------------------------------C----CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 270 --------------------------------K----DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 270 --------------------------------~----~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
. ....+..+++||.+||. ||.+|||+.++|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 01235678999999995 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=327.62 Aligned_cols=258 Identities=24% Similarity=0.435 Sum_probs=216.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch--HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD--YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
+.|.+.+.||+|++|.||.|.+..++..+|+|.+........ ...+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468999999999999999999999999999999875433222 223457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~- 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS- 160 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754322111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 279 (357)
........|+..|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+.. .........++..+.
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 161 --GTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred --cccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence 111123457889999999988765 5569999999999999999999987665544444332 223333456899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
++|++|| .+|.+||++.++++|+||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999 589999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=356.51 Aligned_cols=252 Identities=20% Similarity=0.351 Sum_probs=200.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC------CCCccceEEEEEe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK------HPNLIKFLQAIET 114 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~l~~~~~~ 114 (357)
..++|++.++||+|+||+||+|.+..++..||||+++.... ..+....|+.+++.+. |.+++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 45789999999999999999999999999999999864321 2233446777776664 4568889888865
Q ss_pred C-CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCC------------
Q psy10194 115 T-HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADY------------ 180 (357)
Q Consensus 115 ~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~------------ 180 (357)
. ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 67999999888889999999999999999999998 6999999999999998765
Q ss_pred ----CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH
Q psy10194 181 ----NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS 256 (357)
Q Consensus 181 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~ 256 (357)
.+||+|||.+.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~---------~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER---------HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred CCCceEEECCCCccccCc---------cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999875321 122356799999999999888774 5599999999999999999999876654
Q ss_pred HHHHHHhcccCC-------------------------CC----------------CCCCCHHHHHHHHHccc-CCCCCCC
Q psy10194 257 QLLKQVQSKVVF-------------------------PK----------------DPNVSPECKALISKILA-PVKTRLR 294 (357)
Q Consensus 257 ~~~~~~~~~~~~-------------------------~~----------------~~~~~~~~~~li~~~L~-~p~~R~s 294 (357)
+.+..+...... +. ....++.+.+||.+||. ||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 433332211000 00 00124667899999995 9999999
Q ss_pred HHhHhcCCccccC
Q psy10194 295 IKNIKEDPWFRNG 307 (357)
Q Consensus 295 ~~e~l~hp~f~~~ 307 (357)
++|+|+||||+..
T Consensus 432 a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 432 ARQMTTHPYVLKY 444 (467)
T ss_pred HHHHhcCcccccc
Confidence 9999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=335.72 Aligned_cols=266 Identities=27% Similarity=0.461 Sum_probs=222.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||+|++|.||+|.+..++..+|+|.+.+.........+.+.+|+.+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765444344556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 568999999999999999999999999999999999999999999999999987543211100
Q ss_pred c-----------------------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy10194 201 G-----------------------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ 257 (357)
Q Consensus 201 ~-----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~ 257 (357)
. .........|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0 0011223468899999999987766 556999999999999999999998877665
Q ss_pred HHHHHh-cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCC----HHhHhcCCccccCCC
Q psy10194 258 LLKQVQ-SKVVFPKDPNVSPECKALISKIL-APVKTRLR----IKNIKEDPWFRNGPS 309 (357)
Q Consensus 258 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s----~~e~l~hp~f~~~~~ 309 (357)
....+. ....++....+++.+.++|.+|| .+|.+||+ +++++.||||++..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 555443 34444444458999999999999 59999999 999999999987643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=344.20 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=205.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC----
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT---- 115 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~---- 115 (357)
...++|++.+.||+|+||.||++.+..++..+|+|.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH-HHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 345789999999999999999999999999999999875433322 234556899999999999999999998543
Q ss_pred --CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 --HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...++||||+++ +|.+.+.. .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 77777654 4889999999999999999999999999999999999999999999999999754
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC------
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------ 267 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~------ 267 (357)
... .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 170 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 170 GTS-------FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred CCc-------cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 211 122345789999999999887774 459999999999999999999987664433222111000
Q ss_pred -------------------------------CC----CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 268 -------------------------------FP----KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 268 -------------------------------~~----~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
++ .....+.++.+||.+||. ||.+|||+.|+++||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 011245788999999995 99999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=332.62 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=212.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999886432 2334455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------ 152 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc------
Confidence 999999999999888889999999999999999999997 6999999999999999999999999999864321
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------------- 267 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-------------- 267 (357)
......+|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 --SMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --cccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 12234578999999999877665 4569999999999999999999976554433322211100
Q ss_pred ---------------------CC--CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 268 ---------------------FP--KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 268 ---------------------~~--~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.+ ....++.++.+++.+|| .+|++||++.++++||||.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00 01136788999999999 599999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=321.68 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=218.3
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||+|++|.||+|.+..++..|++|.+....... .....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999987544333 334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 99999999999764 578999999999999999999999999999999999999999999999999987553221
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...+.......+......+....+++.+.++
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQL 232 (256)
T ss_pred --chhhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 11234568899999999988776 455999999999999999999998888777666666554444444788999999
Q ss_pred HHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 282 ISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 282 i~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+.+||. +|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999995 89999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=337.42 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=191.8
Q ss_pred EeEeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEEEEEe
Q psy10194 48 GTIIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVYIIME 123 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~lv~e 123 (357)
+++||+|+||+||+|.+. .++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999965 4678899999865432 2235689999999999999999999854 567899999
Q ss_pred ecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe----cCCCCeEEeecccc
Q psy10194 124 YAEKGSLLDIIRKE---------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI----DADYNIKLSDFGFA 190 (357)
Q Consensus 124 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll----~~~~~~kl~Dfg~~ 190 (357)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 888887532 258999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH---------HHHHHH
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---------SQLLKQ 261 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~---------~~~~~~ 261 (357)
........ .........||+.|+|||++.+....+.++||||+||++|+|++|++||..... ...+..
T Consensus 160 ~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 160 RLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred eccCCCCc---cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 76432111 111223457899999999998766557779999999999999999999964321 011111
Q ss_pred HhcccCCC-------------------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 262 VQSKVVFP-------------------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 262 ~~~~~~~~-------------------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
+......+ .....+.++.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11100000 001235678999999995 9999999999999999
Q ss_pred c
Q psy10194 304 F 304 (357)
Q Consensus 304 f 304 (357)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=322.19 Aligned_cols=253 Identities=28% Similarity=0.518 Sum_probs=214.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-CCeEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-THRVYIIM 122 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-~~~~~lv~ 122 (357)
+|++.+.||.|++|.||++.+..++..+|+|.+....... ...+.+.+|+.+++.++|+|++++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999986543322 234556789999999999999999998864 45689999
Q ss_pred eecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||+++++|.+++.. ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999875 3468999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......|++.|+|||++.+..+. .++|+|||||++|+|++|+.||...+.......+......+....+++++.+
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08223 157 ---DMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232 (257)
T ss_pred ---CccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH
Confidence 122345689999999999887764 4599999999999999999999887776666665554443444578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
++.+|| .+|.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.00 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=213.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|+..+.||+|+||+||++.+..++..+|+|.+.............+.+|+.+++.++|+||+.+.+.+.+++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544333334456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 99999999888543 36999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---CCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---VFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 278 (357)
.......|++.|+|||++.+..+. .++|+|||||++|+|++|..||...........+.... .......+++++
T Consensus 156 --~~~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 156 --ESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred --CcccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 111244689999999999877764 45999999999999999999998766544333332211 122234688999
Q ss_pred HHHHHHcc-cCCCCCCC-----HHhHhcCCccccC
Q psy10194 279 KALISKIL-APVKTRLR-----IKNIKEDPWFRNG 307 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~ 307 (357)
.+|+..|| .+|.+||+ +.+++.|+||+..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 99999999 59999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.54 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=212.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC---chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP---SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
+|++++.||.|+||+||+|.. .++..+|+|.+...... .......+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 46789999998654321 12233557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+||+++++|.+++.+.+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543211111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc--cCCCCCCCCCHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--VVFPKDPNVSPEC 278 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 278 (357)
..........|+..|+|||.+.+..+. .++|+|||||++|+|++|..||...+.......+... ........++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 112222345689999999999877664 5599999999999999999999876544433333222 2223345689999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.++|.+|| .+|.+||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999 599999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=339.98 Aligned_cols=254 Identities=21% Similarity=0.380 Sum_probs=203.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|++.++||+|+||.||+|.+ ..++..||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4457899999999999999999975 23456799999864322 22245567899999999 8999999999886
Q ss_pred eC-CeEEEEEeecCCCCHHHHHHHc-------------------------------------------------------
Q psy10194 114 TT-HRVYIIMEYAEKGSLLDIIRKE------------------------------------------------------- 137 (357)
Q Consensus 114 ~~-~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 137 (357)
.. ..+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999998642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCC
Q psy10194 138 -------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210 (357)
Q Consensus 138 -------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 210 (357)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~ 237 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGSAR 237 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc----hhcccCCC
Confidence 2477888999999999999999999999999999999999999999999999975432111 01112334
Q ss_pred CCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-c
Q psy10194 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY-SQLLKQVQSKVVFPKDPNVSPECKALISKIL-A 287 (357)
Q Consensus 211 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~ 287 (357)
+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+... ......+...........+++++.+++.+|| .
T Consensus 238 ~~~~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 238 LPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCccccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 5678999999987776 456999999999999996 9999987553 3344444444444444578999999999999 5
Q ss_pred CCCCCCCHHhHhc
Q psy10194 288 PVKTRLRIKNIKE 300 (357)
Q Consensus 288 ~p~~R~s~~e~l~ 300 (357)
||.+|||+.++++
T Consensus 317 dp~~RPs~~el~~ 329 (338)
T cd05102 317 DPKERPTFSALVE 329 (338)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=328.35 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=206.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|++|.||+|.+..++..||+|.+...... +.....+.+|+.+++.++||||+++++++.++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 2223456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE---GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 997 5888887542 568999999999999999999999999999999999999999999999999987542111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-------------- 266 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-------------- 266 (357)
.......+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.........+....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 112234568899999998765544667999999999999999999998765433222111000
Q ss_pred --------------CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 267 --------------VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 --------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.......+++++.++|.+||. ||.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000123578999999999994 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.27 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=214.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC--chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
+|.+.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999989999999999765433 123345566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+ +++|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 889999998765 79999999999999999999999999999999999999999999999999997653211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-----------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP----------- 269 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~----------- 269 (357)
.......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+....+....+......+
T Consensus 157 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 ---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred ---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 111223457889999998765555677999999999999999988887766544444432211110
Q ss_pred ----------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCCC
Q psy10194 270 ----------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 270 ----------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~~ 311 (357)
.....+..+.++|.+||. +|.+|||+.+++.|+||++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 012457889999999995 999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=326.80 Aligned_cols=255 Identities=28% Similarity=0.462 Sum_probs=210.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++|+||+++++.+.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4799999999999999999999999999999998654322 223345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|..++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999988888877767799999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-----------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK----------------- 265 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~----------------- 265 (357)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+....+....+...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1123457889999999876554566799999999999999999999876654433222110
Q ss_pred ---cCCCC----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 266 ---VVFPK----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 266 ---~~~~~----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
...+. .+.++..+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00111 13568899999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=299.02 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=217.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|.-.++||+|.||+||++++.++++.||+|.+......+ .+-....+||.+++.++|.|||+++++...+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666789999999999999999999999999997655433 333445599999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||.. +|..+..+ ++.++...++.++.|+++||.++|+.++.|||+||+|+|++.+|.+||+|||+++.+...-.+
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc--- 157 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--- 157 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe---
Confidence 9965 99988865 678999999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcccCCCCC----------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKD---------- 271 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~~~~~~~~~---------- 271 (357)
....+.|.+|++|.++.+...++...|+||-|||+.|+. .|++.|.+.+..+.++++...+..|..
T Consensus 158 ---ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 158 ---YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred ---eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 122345899999999998877777799999999999999 688999999988888877543322211
Q ss_pred ------------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 272 ------------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ------------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+.++..-++|+..+|. +|.+|++++++++||||.+.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 3456678899999995 89999999999999999763
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.78 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=212.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++.....+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999999999999987654322 334557799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999864 45789999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--------------- 267 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--------------- 267 (357)
.......|+..|+|||.+.+....+.++|||||||++|+|++|.+||...........+.....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 1223456899999999987666556779999999999999999988877665444433322111
Q ss_pred -----CCC---------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 268 -----FPK---------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 -----~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
++. .+..+..+.++|.+||. +|.+||++++++.||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 110 13467999999999995 999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=328.77 Aligned_cols=266 Identities=27% Similarity=0.457 Sum_probs=220.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||.||++.+..++..|++|.+.+...........+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654333333456678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc---
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR--- 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 199 (357)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988632110000
Q ss_pred ------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCC-
Q psy10194 200 ------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKD- 271 (357)
Q Consensus 200 ------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~- 271 (357)
...........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+....+....+... ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 000011123457889999999887766 45599999999999999999999988777766665543 223322
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCC---HHhHhcCCccccCCC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLR---IKNIKEDPWFRNGPS 309 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s---~~e~l~hp~f~~~~~ 309 (357)
..+++++.++|.+|| .+|.+||+ +.++++||||....+
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 357899999999999 59999998 799999999976443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.55 Aligned_cols=257 Identities=23% Similarity=0.426 Sum_probs=220.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
-|.|+..||.|+||.||+|.++.++...|.|+|.... +...+.+.-||.||..++||+||+|++.|...+.++|+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3678899999999999999999999889999985432 2234555579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||.||-+..++.. ...|++.++..+++|++.||.|||+++|+|||||..|||++.+|.++|+|||.+.........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk--- 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK--- 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh---
Confidence 9999999988755 557999999999999999999999999999999999999999999999999999765543322
Q ss_pred ccccccCCCCCCccchhhhc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCC
Q psy10194 203 ESLSETFCGSYAYASPEILK-----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVS 275 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 275 (357)
-..++|||+|||||+.. ..+| +.++||||||++|.+|..+.+|....++..++-++...-. ...+..++
T Consensus 187 ---RDsFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 187 ---RDSFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred ---hccccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 23678999999999974 4455 5569999999999999999999999888877766654322 22335789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
..+.|++++|| ++|..||++.++++||||++.+..
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 99999999999 699999999999999999987654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=330.14 Aligned_cols=253 Identities=24% Similarity=0.424 Sum_probs=205.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|+||.||+|.+..+|..+|+|.+...... ......+.+|+.+++.++||||+++++++.+...+++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 589999999999999999999999999999998654322 2223456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|+.+ +|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----- 153 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----- 153 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence 9975 88887754 5679999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhcccC--------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVV-------------- 267 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf-~~~~~~~~~~~~~~~~~-------------- 267 (357)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..|| .+.+..+..+.+.....
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 11123456889999999877665566799999999999999998885 44443333333221100
Q ss_pred ----C----------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 268 ----F----------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 ----~----------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
. ...+.+++++.++|.+||. ||.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0113578999999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=320.18 Aligned_cols=259 Identities=24% Similarity=0.435 Sum_probs=213.0
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~ 118 (357)
++|++.+.||+|+||.||++.+..++..||+|.+..... ......+.+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 222334567789999999999999999998866 3578
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998878899999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 277 (357)
. ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||................. ...+..++..
T Consensus 162 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 162 S---GTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred c---ccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 0 011223458889999999987666 4559999999999999999999987654444443332222 2223467889
Q ss_pred HHHHHHHcccCCCCCCCHHhHhcCCccc
Q psy10194 278 CKALISKILAPVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 278 ~~~li~~~L~~p~~R~s~~e~l~hp~f~ 305 (357)
+.++|++|+.+|++||+++++++|||+.
T Consensus 238 ~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999998999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.46 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=205.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
...+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999754 35678999987542 2245899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999996 58999997778899999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHHhcc-----cCCC-
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---QLLKQVQSK-----VVFP- 269 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---~~~~~~~~~-----~~~~- 269 (357)
........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.... ..+..+... ..++
T Consensus 241 ----~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 241 ----TPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ----cccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 1122345789999999999887774 4599999999999999999999764321 111111100 0000
Q ss_pred ----------------------C-----CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 270 ----------------------K-----DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 270 ----------------------~-----~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
. ...++.++.++|++||. ||.+|||+.++|.||||...++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0 02356789999999995 99999999999999999875543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.70 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=205.1
Q ss_pred EEeEeeec--CceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 47 LGTIIGMG--SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 47 ~~~~Lg~G--~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
+.++||+| +|++||++.+..++..||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 7899999999999999999998654433 33456777899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc-c
Q psy10194 125 AEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ-G 201 (357)
Q Consensus 125 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~ 201 (357)
+++|+|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++||+.+.......... .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 3458999999999999999999999999999999999999999999999998765432111100 0
Q ss_pred cccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccC------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVV------------ 267 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~------------ 267 (357)
.........++..|+|||++.+. ...+.++|||||||++|+|++|..||.............. ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 01111223567789999998753 2235569999999999999999999986544332222111 000
Q ss_pred --------------------------------CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 268 --------------------------------FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 268 --------------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.+....+++.+.+||.+||. ||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112357889999999995 99999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=326.07 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=201.6
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHH---cCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK---GLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~---~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
.||+|+||.||++.+..++..+|+|.+.+.............+|..+++ ..+||||+.+++.+...+.+++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987654332222223334444443 3479999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccc
Q psy10194 127 KGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206 (357)
Q Consensus 127 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 206 (357)
+++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--------~~ 152 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KP 152 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------Cc
Confidence 9999999988888999999999999999999999999999999999999999999999999998644211 11
Q ss_pred ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--QLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 207 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
....|++.|+|||.+.+....+.++|+||+||++|+|++|..||...... ..............++.+++++.++|++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 23468999999999875443456699999999999999999999754321 1222222222233345689999999999
Q ss_pred cc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 285 IL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 285 ~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
|| .+|.+|+ +++++++||||+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99 5999999 699999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=335.98 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=224.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..+.|+.-++||+|+||.||-++...+|..||.|.+.+.............+|-.+|..++.+.||.+-..|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45667899999999999999999999999999999998876665555556667999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
|+|+..|+||+|.-.|-+.+ .|++..++.++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|..+...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998886655 7999999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcc-cCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQSK-VVFPKD 271 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~~~-~~~~~~ 271 (357)
. .....+||.+|||||++.+..|+.. .|.|||||++|+|+.|..||..... +++-+.+... ..++
T Consensus 341 ~-------~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~-- 410 (591)
T KOG0986|consen 341 K-------PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS-- 410 (591)
T ss_pred C-------ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--
Confidence 2 2334589999999999999887554 8999999999999999999975332 2333333322 2233
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCCCC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~~~ 310 (357)
+.+|++++++.+.+| +||++|+. ++++.+||||++..++
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 579999999999999 69999886 6799999999987765
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.30 Aligned_cols=252 Identities=24% Similarity=0.443 Sum_probs=216.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||.|+||.||+|.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999986554443445677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999887789999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---YSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||.... ...+...... .....+..++..+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAID 231 (258)
T ss_pred -cccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHH
Confidence 1223457889999999987775 556999999999999999999998766 3444433332 223333568899999
Q ss_pred HHHHcc-cCCCCCCCH--HhHhcCCcc
Q psy10194 281 LISKIL-APVKTRLRI--KNIKEDPWF 304 (357)
Q Consensus 281 li~~~L-~~p~~R~s~--~e~l~hp~f 304 (357)
+|.+|| .+|.+|+++ +|++.||||
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999 599999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=332.08 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=219.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
-|.+..+||+|+||.||+|.++++|+.+|||.+.... ..+.+..||.++++++.|++|++|+.|.....++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4777999999999999999999999999999875432 24556689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||..|++.++++ ++++|++.++..+++..++||+|||...-+|||||..|||++.+|..||+|||.+-.+.....+
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--- 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--- 185 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh---
Confidence 999999999986 5678999999999999999999999999999999999999999999999999999766533222
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (357)
-.+.+|||.|+|||++..-+|.+. +||||||++..+|..|++||.+..+..-+-.+.... .|..+...|.++.|
T Consensus 186 ---RNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 186 ---RNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFND 261 (502)
T ss_pred ---hCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHH
Confidence 236789999999999998888665 899999999999999999999877654433332221 12233468999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+|+.|| +.|++|.|+.++++|||+++.+..
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 999999 799999999999999999887643
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=320.87 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=214.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||.|+||+||+|....++..+++|++....... ..+.+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999986544332 3456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE---GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|++++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCC---CCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPK---DPNV 274 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~---~~~~ 274 (357)
. ........|+..|+|||.+......+.++|+|||||++|+|++|..||...+............. .+. ...+
T Consensus 159 ~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 159 T--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred c--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence 1 01223446889999999988764446679999999999999999999987665544444332211 111 1257
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
++.+.+++.+|| .+|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 899999999999 599999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=361.76 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=211.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~ 118 (357)
..++|.+.+.||+|+||+||+|.+..++..+|+|++........ ....+.+|+.+++.|+||||++++++|.+ ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~-~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34689999999999999999999999999999999876544333 34556789999999999999999998854 4679
Q ss_pred EEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CCeecCCCCCceEecC---------
Q psy10194 119 YIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHER-------GVVHRDIKCENLLIDA--------- 178 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-------givH~dlkp~NIll~~--------- 178 (357)
||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999865 35799999999999999999999985 4999999999999954
Q ss_pred --------CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCC
Q psy10194 179 --------DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLP 249 (357)
Q Consensus 179 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~p 249 (357)
.+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~-------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE-------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc-------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 235899999999754211 122345789999999998643 2335669999999999999999999
Q ss_pred CCCCc-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 250 FDDTK-YSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 250 f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
|...+ ...++..+......+. ...++++.+||..|| .+|.+||++.|+|.|+|+...
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 97644 3444444544433332 357899999999999 599999999999999999754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=323.40 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
....+|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+.....++
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 4456899999999999999999999999999999998644322 1345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 999999999999999888889999999999999999999999999999999999999999999999999997543211
Q ss_pred cccccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCC---CCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFP---KDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~---~~~~ 273 (357)
.......|++.|+|||.+.. ....+.++|+|||||++|+|++|..||...........+.. ....+ ....
T Consensus 161 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 161 ----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred ----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 11123467889999999852 22234569999999999999999999976554332222211 11111 1235
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPW 303 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~ 303 (357)
++..+.++|++|| .+|.+||+++++++|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7899999999999 59999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.90 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=218.2
Q ss_pred CCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceE
Q psy10194 31 PDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFL 109 (357)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~ 109 (357)
-+..|....++.++++|.+.|.+|||+.||+|++...+..||+|++-.. ++...+.+.+||.+|+.|+ |+|||.++
T Consensus 25 ~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 25 NYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred cCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 3467788899999999999999999999999999988889999986432 5556788899999999997 99999999
Q ss_pred E-EEE---e---CCeEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecC
Q psy10194 110 Q-AIE---T---THRVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDA 178 (357)
Q Consensus 110 ~-~~~---~---~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~ 178 (357)
+ ... . .-.++|+||||.||.|-++++. ...|++.+++.||.++++||++||... |+|||||-+||||+.
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 9 321 1 2357899999999999999974 446999999999999999999999998 999999999999999
Q ss_pred CCCeEEeeccccccccccc-cccccccc--cccCCCCCCccchhhhc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy10194 179 DYNIKLSDFGFARNHMRYR-SRQGYESL--SETFCGSYAYASPEILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252 (357)
Q Consensus 179 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~ll~G~~pf~~ 252 (357)
+|+.||||||.+....... +......+ .-....|+.|+|||.+. +.+. +.|+|||+|||+||.|+..+.||+.
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCc
Confidence 9999999999997543322 11111111 11123599999999974 4455 6679999999999999999999987
Q ss_pred CcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 253 TKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.... ..+...+.+|..+.++..+.+||+.||+ +|.+||++-|++.+
T Consensus 261 sg~l---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 261 SGKL---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred Ccce---eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 6433 3345678888888999999999999995 99999999998875
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=323.53 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=206.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.++||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368899999999999999999999999999999865432 223455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------- 147 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------- 147 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-------
Confidence 99999999754 3478999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHHhccc-CCCCCCCC
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-------SQLLKQVQSKV-VFPKDPNV 274 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-------~~~~~~~~~~~-~~~~~~~~ 274 (357)
......+|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..... ......+.... ........
T Consensus 148 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 148 -SIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred -ccccCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence 12234578999999999987776 4559999999999999999999964321 12222222111 11122357
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
++++.++|.+|| .+|.+||+++++++||||+..
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 899999999999 599999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=325.32 Aligned_cols=250 Identities=17% Similarity=0.251 Sum_probs=208.9
Q ss_pred EeecCEEEE--eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe---
Q psy10194 40 LESHGYTLG--TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--- 114 (357)
Q Consensus 40 ~~~~~y~~~--~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--- 114 (357)
+...++... ..||+|+++.||+|.. ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 334444444 6799999999999997 577999999977655555555677899999999999999999999876
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 115 -THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 115 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
...+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 457899999999999999998888899999999999999999999984 999999999999999999999999999875
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPK 270 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~ 270 (357)
.... .....|++.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+..+....+.. ....+.
T Consensus 173 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 173 LSSP---------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hccc---------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 4321 1234578999999999762 2336679999999999999999999998887777666543 333344
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+...++++.+++.+|| .||.+|||++++++
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 4468999999999999 59999999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=323.80 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=217.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||.|++|.||+|.+..++..+|+|.+...... .....+.+|+.+++.++|+||+++++.+.+...+++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 4789999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++... ++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999999765 78999999999999999999999999999999999999999999999999997654321
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCC-CCHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN-VSPECKAL 281 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 281 (357)
.......|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+........... +++++.++
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred -cccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 11224467889999999988775 5669999999999999999999987766655555544433222223 78999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+.+|| .+|.+||+++++++||||+....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 99999 59999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.54 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=218.9
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||.|+||.||.+.+..++..+++|.+........ ....+.+|+.+++.++|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875543333 34456699999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
......|++.|.|||.+.+..+ +.++|+||||+++|+|++|..||......+....+......+....++.++.++
T Consensus 157 ---~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd08221 157 ---MAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232 (256)
T ss_pred ---cccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHH
Confidence 2234568999999999987765 455999999999999999999999888777776666554444456789999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+.+|| .+|.+||++.++++|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 99999 589999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=327.29 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=211.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~~ 119 (357)
.++|++.+.||+|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++|+||+++++++... +.++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4679999999999999999999999999999999875433221 122345799999999999999999998655 5789
Q ss_pred EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 99999975 88888865 3678999999999999999999999999999999999999999999999999987653211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC----------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF---------- 268 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~---------- 268 (357)
.......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+.+..+......
T Consensus 163 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 -----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred -----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 11122345788999999876555566799999999999999999999887776665554432110
Q ss_pred ----------CCC---------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 269 ----------PKD---------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 ----------~~~---------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+.. ...++.+.++|.+||. ||++|||+++++.||||+..+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 000 1358899999999995 9999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=319.82 Aligned_cols=259 Identities=23% Similarity=0.430 Sum_probs=211.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC--chHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~ 118 (357)
.+|++.+.||+|+||.||+|.+..++..|++|.+...... .......+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999999999999999998654322 22334567789999999999999999998865 4678
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++++||+++++|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-CCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP-KDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 277 (357)
. ........++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..................+ .+..+++.
T Consensus 162 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 162 S---GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred c---CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 0 111123457889999999987766 455999999999999999999998766554444333222222 22357889
Q ss_pred HHHHHHHcccCCCCCCCHHhHhcCCccc
Q psy10194 278 CKALISKILAPVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 278 ~~~li~~~L~~p~~R~s~~e~l~hp~f~ 305 (357)
+.++++.|+.+|.+||+++|+++||||+
T Consensus 238 ~~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 9999954447999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=321.13 Aligned_cols=259 Identities=25% Similarity=0.468 Sum_probs=212.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc---hHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS---DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
.|+.++.||+|++|.||++.+..++..+|+|++....... ....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999987543221 2235667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 199 (357)
|+||+++++|.+++.+.+++++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5999999998765432111
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHhc-ccCCCCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ---LLKQVQS-KVVFPKDPNVS 275 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~---~~~~~~~-~~~~~~~~~~~ 275 (357)
. ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||....... ....+.. ......++.++
T Consensus 161 ~--~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 161 A--GEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred C--CccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 112233467899999999987666 456999999999999999999997544322 2222211 22222334688
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
+++.+++.+|| .+|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999 5899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=317.61 Aligned_cols=253 Identities=29% Similarity=0.507 Sum_probs=217.2
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|+||.||++.+..++..||+|.+........ ....+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433322 34466799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 999999999987543 579999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+......+....++.++.++
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08218 157 ---LARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNL 232 (256)
T ss_pred ---hhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 1123457889999999987765 456999999999999999999998887777776665555444455789999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
|.+|| .+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999 589999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=337.49 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=199.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.....+|++.+.||+|+||.||+|.+..++..||+|+..+. ....|+.+++.++|+||+++++++......
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 34556899999999999999999999999999999975432 123689999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||++.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 133 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 133 CMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 999999965 88888754 46799999999999999999999999999999999999999999999999999864321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCcH----------HHHHHHHhc-c
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKY----------SQLLKQVQS-K 265 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf-~~~~~----------~~~~~~~~~-~ 265 (357)
........||+.|+|||++.+..+. .++|||||||++|+|+++..++ ..... ..+.+.+.. .
T Consensus 210 -----~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 210 -----APAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred -----CcccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 1122345689999999999887774 5599999999999999855544 32111 111111110 0
Q ss_pred ---cCCC----------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 266 ---VVFP----------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 266 ---~~~~----------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
..++ ....++.++.+||.+||. ||.+|||+.|+|+||||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0011 012457788899999995 9999999999999999985
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=325.27 Aligned_cols=256 Identities=22% Similarity=0.373 Sum_probs=214.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||.|+||.||++.+..++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+..+..+++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5699999999999999999999888999999998643 2223455668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++++|.+++.+ ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---- 157 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---- 157 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc----
Confidence 99999999999876 4579999999999999999999999999999999999999999999999999886543211
Q ss_pred cccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCC
Q psy10194 202 YESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVS 275 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 275 (357)
.......|++.|+|||.+... ...+.++|+|||||++|+|++|+.||...+.......+..... ......++
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence 112234678999999998532 2224569999999999999999999988776665555544322 22334688
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.++.++|.+|| .+|.+||++.++++||||.+.
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999 589999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.87 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=208.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|.+.+.||+|+||.||+|.+..++..||+|.++..... ....+.+|+.+++.++||||+++++.+...+.+++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45789999999999999999999999999999998654321 234466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+++++|.+++...+.+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---- 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---- 160 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccCCCCCCccchhhhc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH-hcccCCCC---CCCC
Q psy10194 202 YESLSETFCGSYAYASPEILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPK---DPNV 274 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~-~~~~~~~~---~~~~ 274 (357)
.......|++.|+|||++. ...+ +.++|+|||||++|+|++|..||............ ......+. ...+
T Consensus 161 --~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 161 --AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred --cccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 1122446899999999974 2334 55699999999999999999999765543333222 22222111 1247
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCc
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPW 303 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~ 303 (357)
+..+.++|.+|| .+|++||+++++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 889999999999 58999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.92 Aligned_cols=273 Identities=28% Similarity=0.484 Sum_probs=236.2
Q ss_pred CCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccc
Q psy10194 29 DLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIK 107 (357)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~ 107 (357)
..+...++...+...+|.+..+||+|+||.|.++..+.+.+.||||++++.-...+...+--..|-++|.... .|.+++
T Consensus 335 ~~~~~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 335 SKFHNSSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred ccCCCCCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHH
Confidence 3334455556889999999999999999999999999999999999998765443333333446777777664 688999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 108 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
+...|.+-+.+|+||||++||+|-..++.-+.+.|+.+..++..|+-||-+||++||++||||.+|||+|.+|++||+||
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-c
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-V 266 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~ 266 (357)
|+++.... ......++||||.|+|||++..++|... +|.||+|++||||+.|++||++.+..++.+.|.+. .
T Consensus 495 GmcKEni~------~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv 567 (683)
T KOG0696|consen 495 GMCKENIF------DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV 567 (683)
T ss_pred cccccccc------CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC
Confidence 99975332 1334568999999999999999999554 89999999999999999999999999999888754 4
Q ss_pred CCCCCCCCCHHHHHHHHHcc-cCCCCCCCH-----HhHhcCCccccCCCC
Q psy10194 267 VFPKDPNVSPECKALISKIL-APVKTRLRI-----KNIKEDPWFRNGPSR 310 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L-~~p~~R~s~-----~e~l~hp~f~~~~~~ 310 (357)
.+| ..+|.++.++.+.+| +.|.+|+.. +++..||||+...|.
T Consensus 568 syP--KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 568 SYP--KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred cCc--ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 455 469999999999999 689999874 689999999987764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=320.37 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=212.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
++..+|++.+.||+|+||.||+|.+. ..+..||+|.++... .....+.+.+|+..++.++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45678999999999999999999764 455689999986542 2233456778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.|++||||||+|||++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 5789999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
... .......++..|+|||.+.+..+ +.++|||||||++|+++ +|..||......+..+.+......+....+
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd05064 160 EAI-----YTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNC 233 (266)
T ss_pred cch-----hcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence 110 01112234678999999987776 45699999999999977 599999998888888888777666666788
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+..+.+++.+|+. +|.+||+++++++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999995 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.37 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=214.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ......+.+.+|+.+++.++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999988899999999865432 2233445677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
+||+++++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKA 280 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 280 (357)
......|++.|+|||.+......+.++|+|||||++|+|++|+.||...........+.. .........+++.+.+
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 123456789999999987665235669999999999999999999987665444444433 2222233468899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
++.+|| .+|.+||++.+++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999 599999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=342.25 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=202.1
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|.+.+.||+|+||.||+|.+..++..||+|.... ..+.+|+++++.++|+||+++++++......++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45689999999999999999999999999999995321 234589999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||++. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 999996 5888887653 5699999999999999999999999999999999999999999999999999975432111
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHhccc----C
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT--------KYSQLLKQVQSKV----V 267 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~--------~~~~~~~~~~~~~----~ 267 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..|+... ....+.+.+.... .
T Consensus 316 ---~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 ---TPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred ---cccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 112234679999999999988776 45699999999999999987655321 1122222222110 0
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 268 FP-----------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 268 ~~-----------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
++ ....+++++.+||.+||. ||.+|||+.|+|+||||++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 001356789999999995 9999999999999999974
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.80 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=213.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++|+||+++++.+..+..+++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998643 233345567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+++++|..++.+ ...+++..++.++.||+.+|.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--- 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--- 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc---
Confidence 999999999988754 4578999999999999999999999999999999999999999999999999886532211
Q ss_pred ccccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCC
Q psy10194 201 GYESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNV 274 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 274 (357)
.......+++.|+|||++.+. ...+.++|+|||||++|+|++|..||...+......++..... ......+
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 165 ---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred ---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence 111234578899999998532 2224569999999999999999999987766554444433221 2233468
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+.++.++|.+|| .+|.+||+++++++||||.....
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 899999999999 59999999999999999986443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=324.12 Aligned_cols=254 Identities=26% Similarity=0.459 Sum_probs=212.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||+|+||.||++.+..++..+++|.+....... .+.+.+|+.+++.++|+||+++++.+......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999999999999999987544332 345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----- 170 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-----
Confidence 99999999999865 458999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (357)
.......|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||...........+.... ..+....+++.+.+
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 11123468899999999987666 456999999999999999999998776544332222111 12223468899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+|.+|| .+|.+||++.++++||||...
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999 599999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=322.96 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=215.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||.|++|.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++||||+++++.+...+.+++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4699999999999999999999999999999998654322 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 170 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---- 170 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence 999999999988654 589999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (357)
......|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.... .......+++.+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 1223467889999999987766 445999999999999999999998877655444443221 12233468999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+|.+|| .+|.+||++.+++.||||+....
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 999999 59999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.54 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=212.7
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|++.+.||+|+||.||++.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 678899999999999999999999999999885432 22345567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+++++|..++.+ ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------ 157 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------ 157 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------
Confidence 999999988754 5679999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHH
Q psy10194 204 SLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPE 277 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 277 (357)
.......|++.|+|||++.. ....+.++|+|||||++|+|++|+.||...+..+....+.... ....+..++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 11223468899999999842 1222456999999999999999999998876655544443322 22233468899
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+.++|.+|| .+|.+||++.++++||||......
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 999999999 599999999999999999875443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=324.86 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=211.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.++||+|+||.||+|.+..++..||+|.+.+..... ...+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46999999999999999999999899999999986544332 33456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999998998887766679999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc------------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS------------------ 264 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~------------------ 264 (357)
.......++..|+|||++.+....+.++||||||+++|+|++|+.||......+....+..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 1122345788999999987655556679999999999999999999976554333222211
Q ss_pred --ccCCC----------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 265 --KVVFP----------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 265 --~~~~~----------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
....+ ..+.++..+.+|+.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00111 123578899999999995 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.24 Aligned_cols=249 Identities=31% Similarity=0.564 Sum_probs=212.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||.|++|.||+|.+..++..+|+|++.+.........+.+.+|+.+++.++||||+++++.+.+...+++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876544444556788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCC
Q psy10194 131 LDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210 (357)
Q Consensus 131 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 210 (357)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------~~~~~~ 153 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------KTWTFC 153 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------cccccc
Confidence 9999888889999999999999999999999999999999999999999999999999987653211 122346
Q ss_pred CCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQS-KVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 211 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L- 286 (357)
|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.... .......+.. ......+...++++.++|.+||
T Consensus 154 ~~~~~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 154 GTPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred CCcCccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence 7899999999887666 455999999999999999999998766 5555555442 2222223346899999999999
Q ss_pred cCCCCCCC-----HHhHhcCCccccC
Q psy10194 287 APVKTRLR-----IKNIKEDPWFRNG 307 (357)
Q Consensus 287 ~~p~~R~s-----~~e~l~hp~f~~~ 307 (357)
.+|.+|++ ++|+++||||.+-
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhCC
Confidence 59999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.53 Aligned_cols=264 Identities=27% Similarity=0.459 Sum_probs=208.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-----H 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-----~ 116 (357)
.++|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 3689999999999999999999999999999999864322 22334456899999999999999999987544 3
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
..++|+||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88887754 56999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--------- 267 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--------- 267 (357)
... .......+|++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...+.
T Consensus 160 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDH---TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccc---cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 111 11223457899999999876654446679999999999999999999977654332222111000
Q ss_pred --------------C----C---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 268 --------------F----P---KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 268 --------------~----~---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
. + ..+.+++++.++|.+|| .+|++|||+.++++||||........
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 0 0 01346888999999999 49999999999999999987655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.37 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=202.8
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHH---HHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREV---EVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
+||+|+||.||+|.+..+++.||+|.+.+..............|. .+++...||+|+++++.+...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765433222122222333 34455679999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccc
Q psy10194 127 KGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206 (357)
Q Consensus 127 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 206 (357)
|++|.+++...+.+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--------~~ 152 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KP 152 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------CC
Confidence 9999999988888999999999999999999999999999999999999999999999999998654211 11
Q ss_pred ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---KYSQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 207 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
...+|+..|+|||.+.+....+.++|+||+||++|+|++|+.||... .......... ......+..+++++.+++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLLE 231 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-ccCCCCCCcCCHHHHHHHH
Confidence 23468999999999976543456699999999999999999999765 3233222222 2223333457999999999
Q ss_pred Hcc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 284 KIL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 284 ~~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
+|| .+|.+|+ ++.++++||||+...+
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 999 5899999 9999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=314.16 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=216.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|+||.||++.+..++..+|+|.+........ ....+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976544333 34567799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+++++|.+++... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999999763 3589999999999999999999999999999999999998554 58999999997653211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......+....+++++.+
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 231 (256)
T cd08220 157 ----KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ 231 (256)
T ss_pred ----cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHH
Confidence 1223467889999999987665 45699999999999999999999888777766666655444445578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
++.+|| .+|.+|||+.++++||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=342.25 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=215.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
=+||+|.||+||.|++..+....|||.|.... ....+-+..||.+.+.|+|.|||++++.+..+.++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 46999999999999999999999999986433 223456779999999999999999999999999999999999999
Q ss_pred CHHHHHHH-cCCC--CHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-CCCCeEEeecccccccccccccccccc
Q psy10194 129 SLLDIIRK-EGYI--DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKLSDFGFARNHMRYRSRQGYES 204 (357)
Q Consensus 129 sL~~~l~~-~~~l--~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (357)
+|.+++.. .|++ .|..+-.+.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||.++.+-.. +.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi------nP 731 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI------NP 731 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC------Cc
Confidence 99999975 5788 8889999999999999999999999999999999996 5689999999999876543 34
Q ss_pred ccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 205 LSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY--SQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 205 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
...++.||..|||||++..+ .-+..++|||||||++.||.||++||..... ..+.+-=.-+...+.+..++.+++.+
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 56688899999999999654 3345669999999999999999999975332 22322222233445556799999999
Q ss_pred HHHccc-CCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 282 ISKILA-PVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 282 i~~~L~-~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
|.+|.. ||..||+|.++|.+||++..+.++.
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r 843 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPR 843 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccCCCCCC
Confidence 999995 8999999999999999998865544
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.56 Aligned_cols=257 Identities=27% Similarity=0.461 Sum_probs=213.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|.+.+.||+|+||.||++.+..++..||+|.+....... .+.+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999986543322 345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~----- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 169 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-----
Confidence 99999999999865 458999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 280 (357)
.......|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.... .......+++.+.+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 170 -SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred -cCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 11223467899999999988766 456999999999999999999997765433322222111 11123457899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
++.+|| .+|.+||+++++++||||+.....
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 999999 599999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=318.32 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=210.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-------chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-------SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+|.+.+.||+|+||.||+|.+..++..+|+|.+...... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999889999999988542211 1112345678999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
..++||||+++++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cC--CC--C
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VV--FP--K 270 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~--~~--~ 270 (357)
.. ........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...........+... .. ++ .
T Consensus 162 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 162 YD----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred cc----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 11 11123345788999999987654 2356699999999999999999999766554433332211 11 11 1
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
...++.++.++|.+|| .+|.+||+++++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2356899999999999 599999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=323.99 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=212.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||++.+..++..||+|.+.... .+.....+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46889999999999999999999999999999886432 2223355678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE---GYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 123 e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||+++++|..++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999998763 378999999999999999999996 5999999999999999999999999999865421
Q ss_pred ccccccccccCCCCCCccchhhhcCCCC-----CCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---HhcccCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPY-----CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ---VQSKVVFPK 270 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~---~~~~~~~~~ 270 (357)
.......|++.|+|||.+.+... .+.++|+|||||++|+|++|+.||........... +........
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 156 -----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred -----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 12223457889999999854332 25569999999999999999999976554443333 233333333
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+.++.++.++|.+|| .+|.+||++++++.||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 4468999999999999 5999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=323.03 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=215.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCC-----cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHS-----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
...+|++.+.||+|+||.||+|.....+ ..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3457999999999999999999876554 679999886432 334456678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD 179 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~ 179 (357)
...+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457889999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQL 258 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~ 258 (357)
+.++|+|||++........ ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY----YRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CcEEECCCcceeecccccc----ccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999875422111 112234456889999999887776 456999999999999997 9999999888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
...+......+....+++++.+|+.+|| .+|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888776666666689999999999999 589999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.40 Aligned_cols=254 Identities=28% Similarity=0.542 Sum_probs=214.6
Q ss_pred CEEE--EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 44 GYTL--GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~--~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
-|.| .++||+|-||+||-|.++.+|+.||||+|.+.+..... ...+++|+.||+.++||.||.+.-.|++.+.+|+|
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 3554 58999999999999999999999999999988776543 46788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC---CCeEEeecccccccccc
Q psy10194 122 MEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD---YNIKLSDFGFARNHMRY 196 (357)
Q Consensus 122 ~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~ 196 (357)
||.+.| +..+.| .+.++|++...+.++.||+.||.|||-.+|+|+||||+|||+... .++||||||+|+.....
T Consensus 642 MEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999976 666655 346789999999999999999999999999999999999999543 47999999999876422
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
..-...+|||.|+|||++.+.+|... .|+||.|+|+|.-|.|..||... +..+.++...--+....+..++
T Consensus 721 -------sFRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 721 -------SFRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred -------hhhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcC
Confidence 22335689999999999999999655 89999999999999999999643 3333333322222333456899
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++.|||..+|+ .-.+|.|+++.|.|||+++.
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999995 89999999999999999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.14 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=212.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||.|+||.||+|.+..++..+++|++...... ..+.+.+|+.+++.++||||+++++.+.+...++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 36899999999999999999999988999999998754322 345677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999998775 7899999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccCCCCCCccchhhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCC---CCCCC
Q psy10194 201 GYESLSETFCGSYAYASPEILKGI---PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVF---PKDPN 273 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~---~~~~~ 273 (357)
......++..|+|||.+.+. .+ +.++|+|||||++|+|++|..||...+.......+... +.. .....
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 157 ----KRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred ----ccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 11234678899999998765 45 45699999999999999999999877655444433322 111 11234
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPW 303 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~ 303 (357)
++.++.+++.+|| .+|.+|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999 58999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.49 Aligned_cols=253 Identities=22% Similarity=0.380 Sum_probs=206.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET------ 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~------ 114 (357)
.+.|++.+.||+|+||.||+|.+..++..+|+|.+...... ...+.+|+.+++.+ +|+||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35688899999999999999999999999999998654322 23456899999988 69999999999865
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
...+++||||+.+++|.+++... ..+++..++.++.|++.||+|||++||+|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999998763 4689999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VV 267 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~ 267 (357)
..... .......|++.|+|||++... ...+.++|+|||||++|+|++|..||...........+... ..
T Consensus 161 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 161 LDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred ccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 43211 112345689999999998632 22345699999999999999999999776544433333222 22
Q ss_pred CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 268 FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
......++.++.+|+.+|| .+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2223467899999999999 599999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.94 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=207.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||.|++|.||+|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999988654322 2223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+. ++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 996 589888865 3568999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF------------- 268 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~------------- 268 (357)
.......+++.|+|||.+.+....+.++|+|||||++|+|+||+.||...+......++......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 11123356889999999877665566799999999999999999999876654433322211100
Q ss_pred ------C---------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 269 ------P---------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 ------~---------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+ ..+.++++++++|.+||. ||.+||++++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 013578899999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.63 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=212.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC---CCCccceEEEEEeCCeEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~l~~~~~~~~~~~l 120 (357)
.|++.+.||+|+||.||+|.+..++..+|+|.+...... .....+.+|+.+++.+. |||++++++++.....+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 478899999999999999999999999999998654322 22345668999999886 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||+++++|.+++.. +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 9999999999999865 478999999999999999999999999999999999999999999999999987654221
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC-CCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD-PNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 279 (357)
.......|+..|+|||.+.+....+.++|+|||||++|+|++|..||...........+......... ..++.++.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 156 ---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred ---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHH
Confidence 11223468889999999876554466799999999999999999999887665544433322111111 23788999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.+|| .+|.+||++.+++.|+||+...
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999 5899999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=319.09 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=212.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|++|.||++.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+.....+++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4688899999999999999999999999999998765432 33456678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcccCCCCCC-CC
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-----KYSQLLKQVQSKVVFPKDP-NV 274 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-----~~~~~~~~~~~~~~~~~~~-~~ 274 (357)
.....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+..+.+.......... .+
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 156 -----AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred -----hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 112567889999999988766 45599999999999999999999754 2333344333332222222 27
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+.++.++|.+|| .+|.+|||+.+++.||||+..
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 899999999999 599999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.28 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=190.4
Q ss_pred EeEeeecCceEEEEEEECC--CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE--eCCeEEEEEe
Q psy10194 48 GTIIGMGSYATVKLATSSR--HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE--TTHRVYIIME 123 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~--~~~~~~lv~e 123 (357)
+.+||+|+||+||+|.... ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999654 567899998865332 223568999999999999999999884 4567899999
Q ss_pred ecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe----cCCCCeEEeecccc
Q psy10194 124 YAEKGSLLDIIRKE---------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI----DADYNIKLSDFGFA 190 (357)
Q Consensus 124 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll----~~~~~~kl~Dfg~~ 190 (357)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9975 888877421 248899999999999999999999999999999999999 46678999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---------HHHHH
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---------QLLKQ 261 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---------~~~~~ 261 (357)
+........ ........||+.|+|||++.+....+.++|||||||++|+|++|++||...... .....
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 764321110 112234568999999999987665567799999999999999999999643211 00111
Q ss_pred HhcccCC-------------------------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 262 VQSKVVF-------------------------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 262 ~~~~~~~-------------------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
+...... ......+..+.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 0000000 0011345678899999995 9999999999999999
Q ss_pred c
Q psy10194 304 F 304 (357)
Q Consensus 304 f 304 (357)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=318.64 Aligned_cols=254 Identities=21% Similarity=0.381 Sum_probs=208.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeC-----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETT----- 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~----- 115 (357)
.++|.+.+.||+|+||.||++....++..+|+|++..... ....+.+|+.+++.+ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 5779999999999999999999999999999999865332 234456889999988 799999999998653
Q ss_pred CeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999999999998853 4578999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIP----YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
....... ......|+..|+|||.+.... ..+.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 177 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 177 QLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred hcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 5432111 112346788999999986433 135669999999999999999999988766554444443322
Q ss_pred C--CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 268 F--PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 ~--~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
. .....++..+.++|.+|| .+|.+||++.++++||||+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1 223357789999999999 5999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=313.18 Aligned_cols=249 Identities=27% Similarity=0.494 Sum_probs=213.9
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||.|+||.||++.+..++..+|+|.+..... ....+.+.+|+.+++.++|+||+++++.+.+.+.+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2234566789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 9999999998864 3458999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......+....++..+.++
T Consensus 155 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (255)
T cd08219 155 --AYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSL 231 (255)
T ss_pred --cccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence 11223567899999999987766 456999999999999999999999888777777766555555556789999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcC
Q psy10194 282 ISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~h 301 (357)
|.+|| .+|.+||++.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 99999 599999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=319.43 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=203.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|++|.||+|.+..++..||+|.+....... ....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999986543221 123345899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--- 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--- 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---
Confidence 999985 999988654 468999999999999999999999999999999999999999999999999986432110
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcccC------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQSKVV------------ 267 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~~~~~------------ 267 (357)
.......++..|+|||++.+....+.++||||+|+++|+|++|+.||.... ..+....+.....
T Consensus 158 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred ---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 111223467889999998765544667999999999999999999997654 2222222211000
Q ss_pred --------CC---------CCCCCC--HHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 268 --------FP---------KDPNVS--PECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 --------~~---------~~~~~~--~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.. ..+.++ .++.+++.+||. +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 001234 888999999995 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=318.80 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=202.7
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeC--CeEEEE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETT--HRVYII 121 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~--~~~~lv 121 (357)
|++.+.||+|+||.||+|.+..++..+|+|.+++....... .. ..+|+.+++.+. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~-~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VN-NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hh-HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 68899999999999999999999999999998754332222 22 237888888885 99999999999887 899999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+++ +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 999975 88888765 457899999999999999999999999999999999999999 999999999997543211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-------------- 266 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-------------- 266 (357)
......+++.|+|||.+......+.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 154 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 ----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred ----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 11234578899999987665555667999999999999999999998776555443332111
Q ss_pred -----CCCC---------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 267 -----VFPK---------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 -----~~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.++. ...++.++.++|.+||. +|.+||+++++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0110 12568999999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.55 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=212.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE----eCCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE----TTHRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~----~~~~~ 118 (357)
++|++.+.||+|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc-chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 789999999999999999999999999999999875433222 2345568999999999999999999875 34578
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 59999998778899999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-----------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV----------- 267 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~----------- 267 (357)
. .........|+..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 163 ~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 163 E--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred C--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 112223457899999999987654456779999999999999999999987654433222111000
Q ss_pred ----------CC---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 268 ----------FP---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 268 ----------~~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
++ ..+.+++++.++|.+|| .+|.+||++.+++.||||+.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 00 01357899999999999 599999999999999999865544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=313.61 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=218.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|++|.||+|.+..++..|++|++...... .....+.+|+..++.++|+||+++++.+.....+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998664432 33566779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++++|.+++.....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 999999999999887889999999999999999999999 9999999999999999999999999999876532111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcccCCCCCCC-CCHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---KYSQLLKQVQSKVVFPKDPN-VSPE 277 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---~~~~~~~~~~~~~~~~~~~~-~~~~ 277 (357)
......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+........... ++..
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 156 ---QCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred ---cccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 1123457889999999887755 55699999999999999999999776 45555555554444444445 8899
Q ss_pred HHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 278 CKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 278 ~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
+.++|.+||. +|.+||++.++++||||+.
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 9999999995 8999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=319.95 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCe----
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHR---- 117 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~---- 117 (357)
++|++.+.||+|+||.||+|.+..++..||+|.+....... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986543222 12345668999999995 6999999999977665
Q ss_pred -EEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeecccc
Q psy10194 118 -VYIIMEYAEKGSLLDIIRKE-----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFA 190 (357)
Q Consensus 118 -~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~ 190 (357)
.++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887542 35799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--- 267 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--- 267 (357)
....... .......+++.|+|||++.+....+.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 159 ~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 159 RAFSIPV------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecCCCc------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 7543211 1112234688999999987655556679999999999999999999987654443332221110
Q ss_pred ---------------CC---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 268 ---------------FP---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 ---------------~~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
.+ ..+.+++++.++|.+|| .+|.+||++.+++.||||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 01357899999999999 4999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=313.16 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=216.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE--eCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE--TTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~--~~~~~~lv 121 (357)
+|++.+.||.|+||.||++.+..++..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765443 333456778999999999999999999775 35678999
Q ss_pred EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 122 MEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCH-----ERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
|||+++++|.+++.+ ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 467899999999999999999999 89999999999999999999999999999886
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
...... ......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+...+.+.+..........
T Consensus 160 ~~~~~~------~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd08217 160 LGHDSS------FAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY 232 (265)
T ss_pred ccCCcc------cccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcc
Confidence 542211 1223468999999999987665 456999999999999999999999888777777776655444455
Q ss_pred CCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 273 NVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 273 ~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.++..+.+++.+||. +|.+||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 788999999999994 99999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=322.40 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=203.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC----------------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR----------------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (357)
..++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998532 34479999986532 2333556779999999999999
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCCe
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-------------------YIDETRARKWFAQLVDAINYCHERGVV 165 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~LH~~giv 165 (357)
|+++++++.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 367788999999999999999999999
Q ss_pred ecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh
Q psy10194 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF 245 (357)
Q Consensus 166 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~ 245 (357)
||||||+|||++.++.+||+|||++........ ........++..|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----YRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILM 235 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce----eEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999875432111 112223456788999999887766 456999999999999986
Q ss_pred --CCCCCCCCcHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 246 --GRLPFDDTKYSQLLKQVQSK-------VVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 246 --G~~pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+..||...+..+....+... ......+.+++.+.+++.+|| .+|.+|||+.++.+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 67889877666655443221 112223468899999999999 59999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.01 Aligned_cols=260 Identities=35% Similarity=0.627 Sum_probs=219.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv 121 (357)
++|.+.+.||+|+||.||++.+..++..||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997654444444566778999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||++++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999876543221000
Q ss_pred --------------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 202 --------------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 202 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
.........|+..|+|||.+....+ +.++|+||||++++++++|+.||.........+.+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cC
Confidence 0112234567899999999887665 5569999999999999999999988776555555442 22
Q ss_pred CCCCCCCCHHHHHHHHHcc-cCCCCCCCH----HhHhcCCcc
Q psy10194 268 FPKDPNVSPECKALISKIL-APVKTRLRI----KNIKEDPWF 304 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L-~~p~~R~s~----~e~l~hp~f 304 (357)
......+++.+.++|.+|| .+|.+||++ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2333468999999999999 589999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.83 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=205.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET 114 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~ 114 (357)
..++|++++.||+|+||.||+|.+ ..++..||+|+++..... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 355799999999999999999974 345668999998643322 2245567899999999 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC--------------------------------------------------------
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-------------------------------------------------------- 138 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 138 (357)
.+..++|||||++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999986421
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 139 -------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 139 -------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 467888999999999999999999999999999999999999999999999975432111
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcccCCCCCCCCCHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY-SQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
........++..|+|||++.+..+ +.++|||||||++|+|++ |..||..... ....+.+........+...+.+
T Consensus 270 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 270 ---YVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred ---ccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 011122334677999999988776 456999999999999997 8999977543 3444455555444444567899
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+.+|+.+|| .||++||++.++++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999 599999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.37 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=214.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||+|+||.||++.+..++..|++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999989999999998765443 3345667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--~ 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--G 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc--c
Confidence 99999999999888789999999999999999999999999999999999999999999999999987654322111 1
Q ss_pred cccccCCCCCCccchhhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcc--cCCCCCCCCCHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQSK--VVFPKDPNVSPEC 278 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~ 278 (357)
.......+++.|+|||++.+.. ..+.++||||||+++|++++|+.||.... .......+... ...+....+++.+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1122356788999999987654 23566999999999999999999997653 22222222222 2233334568999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.++|.+|| .+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999 589999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=324.40 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=204.0
Q ss_pred CEEEEeEeeecCceEEEEEEECC--CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSR--HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRVY 119 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~~ 119 (357)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8899999999764422233345566899999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC----CCCeEEeecccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE-----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA----DYNIKLSDFGFA 190 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~----~~~~kl~Dfg~~ 190 (357)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777776432 36899999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHH
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ---------LLKQ 261 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~---------~~~~ 261 (357)
......... .......++++.|+|||++.+....+.++|||||||++|+|++|+.||....... .+..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 160 RLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 765322110 1122345678999999998776544667999999999999999999997543221 0000
Q ss_pred Hhc---------------------------ccCCC---------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 262 VQS---------------------------KVVFP---------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 262 ~~~---------------------------~~~~~---------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+.. ...++ .....+..+.+++.+||. ||++|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 00011 001567889999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.50 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=213.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||+||++.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999886543 23345667799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||||+++++|.+++...+.+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888889999999999999999999997 69999999999999999999999999998643211
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-----------HHHHHHhcccCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-----------QLLKQVQSKVVF 268 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-----------~~~~~~~~~~~~ 268 (357)
......|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...... +....+......
T Consensus 158 -----~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 158 -----IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred -----ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 1124568999999999887766 44599999999999999999999865431 222222211111
Q ss_pred C-CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 269 P-KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 269 ~-~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
. ....++.++.+|+.+||. ||.+|||+.|+++|+||...
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1 112478899999999994 99999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.32 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=216.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
..|+..+.||.|+||.||+|.+..++..+|+|++..... ......+.+|+.+++.++|+||+++++.+.+...+++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 458888999999999999999999999999999875432 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++|++|.+++.. +++++.++..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
......++..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+...........++..+.+++
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233 (277)
T ss_pred --ccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHH
Confidence 1123457889999999987766 4559999999999999999999988776665555443333333345788999999
Q ss_pred HHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 283 SKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+|| .+|.+||++.+++.|+||.....+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 9999 589999999999999999865443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=315.28 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=208.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCC----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTH---- 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~---- 116 (357)
.++|++.+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|+.+++.+ +|+||+++++.+....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999998899999999875432 234577899999998 6999999999996544
Q ss_pred --eEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 117 --RVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 117 --~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
.+++||||+++++|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999999864 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
........ ......|++.|+|||++... ...+.++|||||||++|+|++|..||...........+....
T Consensus 161 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 161 AQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred eecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 75432111 12234688999999998542 223456999999999999999999998765554444444332
Q ss_pred C--CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 267 V--FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 ~--~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
. ......++.++.++|.+|| .||.+|||+.++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2 1122347889999999999 599999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=318.62 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=201.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|.+.+.||+|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999986543222 123455899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+. ++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--- 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence 99996 577776654 4568899999999999999999999999999999999999999999999999987532211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccC------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVV------------ 267 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~------------ 267 (357)
.......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...... +.+..+.....
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 ---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred ---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 11123456889999999876544455699999999999999999999765421 22211111000
Q ss_pred --------C----C-------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 268 --------F----P-------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 --------~----~-------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
. + ..-..++++.+++.+||. ||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 001236789999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=314.24 Aligned_cols=250 Identities=30% Similarity=0.529 Sum_probs=206.7
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHH-HHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV-VKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
+.||+|+||.||+|.+..++..||+|.+.+...........+..|..+ ....+|+||+++++.+...+.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999999875433222222223344443 4455899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----------~~ 151 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----------NK 151 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------cc
Confidence 99999998888899999999999999999999999999999999999999999999999999865321 22
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCC--CCCCCCHHHHHHHHH
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFP--KDPNVSPECKALISK 284 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~ 284 (357)
...|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... .++ ....+++.+.++|.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 152 KFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred cCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 3457889999999987764 566999999999999999999998887777666554322 222 223578999999999
Q ss_pred cc-cCCCCCCC---HHhHhcCCccccCCC
Q psy10194 285 IL-APVKTRLR---IKNIKEDPWFRNGPS 309 (357)
Q Consensus 285 ~L-~~p~~R~s---~~e~l~hp~f~~~~~ 309 (357)
|| .+|.+||+ ++|++.||||.+..+
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 99 59999995 579999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=328.28 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=209.4
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIE 113 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~ 113 (357)
.....+..+.|++.++||+||.+.||++...+.+ .||+|.+..... +.....-+.+||.+|.+|+ |.+|++|+++-.
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 4566788899999999999999999999976555 555565543333 3445566779999999995 899999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.++++||||||-+. +|..+|+.... ++.-.++.+.+|++.|+.++|..||||.||||.|+|+ -.|.+||+|||.|..
T Consensus 431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 431 TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 99999999999865 99999987553 3435899999999999999999999999999999998 678999999999987
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCC----------CCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHH
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPY----------CPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQ 261 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~ 261 (357)
...... .......+||+.||+||.+..... ..+++||||||||||+|+.|+.||.... ....+..
T Consensus 509 I~~DTT----sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a 584 (677)
T KOG0596|consen 509 IQPDTT----SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA 584 (677)
T ss_pred cCcccc----ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence 654333 234456789999999999853222 2456999999999999999999997643 2233333
Q ss_pred Hhcc---cCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 262 VQSK---VVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 262 ~~~~---~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
|... +.||..+.- .++.++++.|| .||++||++.++|+|||.+..+
T Consensus 585 I~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred hcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 3322 234432222 23999999999 5999999999999999998643
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=318.02 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=205.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||+|+||+||+|.+..++..||+|.+.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998764433333344456899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccccc
Q psy10194 131 LDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 131 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
.+++.+.+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-------KKIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-------Ccccc
Confidence 99997755 7999999999999999999999999999999999999999999999999998754321 11123
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
..++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..... ..+...+. .......+.+++.+.++|.+
T Consensus 154 ~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred ccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHH
Confidence 457889999999987775 4559999999999999999999976543 22222211 12223334689999999999
Q ss_pred cc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 285 IL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 285 ~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
|| .+|.+|| ++.+++.||||....+
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 99 5999999 8888999999976443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=326.94 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=208.8
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
+.+........+|++.+.||+|+||.||+|.+..++..||+|.+.+...... ....+.+|+.+++.++|+||+++++++
T Consensus 6 ~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 6 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT-HAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred cccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh-HHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 3344444556889999999999999999999999999999999865433222 234456899999999999999999988
Q ss_pred EeC------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEee
Q psy10194 113 ETT------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 113 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~D 186 (357)
... ...++||||+.+ +|.+.+... +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred ccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 543 357999999965 888888654 89999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
||++...... .......|++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+.......+...+
T Consensus 162 fg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 162 FGLARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred CccceeCCCC-------CCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999754321 112234678899999999887774 55999999999999999999998765433332221110
Q ss_pred CC-------------------------------------CC-----CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 267 VF-------------------------------------PK-----DPNVSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 267 ~~-------------------------------------~~-----~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
.. +. ....+..++++|.+||. ||.+|||+.|+|.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00 00 11346678999999995 9999999999999999
Q ss_pred ccc
Q psy10194 304 FRN 306 (357)
Q Consensus 304 f~~ 306 (357)
|+.
T Consensus 314 ~~~ 316 (353)
T cd07850 314 INV 316 (353)
T ss_pred Hhh
Confidence 974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=337.80 Aligned_cols=267 Identities=24% Similarity=0.439 Sum_probs=239.5
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+..+.-.+..+...||-|+||.|-++........+|+|++++....+....+.+..|-++|..++.|.||++|..|.++
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 45566778889999999999999999998776667999999998888888888888999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.++|++||-|-||.|+..+...+.|++..++.++..+++|++|||++||++|||||+|+|++.+|.+||.|||+|+....
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987653
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-CCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF-PKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 274 (357)
. .-+.++||||.|.|||++.+.+++.. +|.||||+++|||++|.+||.+.++......|..++.. ..+..+
T Consensus 573 g-------~KTwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 573 G-------RKTWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred C-------CceeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccccc
Confidence 2 34458999999999999999998555 99999999999999999999999988888888766542 222479
Q ss_pred CHHHHHHHHHccc-CCCCCCC-----HHhHhcCCccccCCCC
Q psy10194 275 SPECKALISKILA-PVKTRLR-----IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s-----~~e~l~hp~f~~~~~~ 310 (357)
+..+.+||+++.+ .|.+|+. +.++.+|.||.+-.|.
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 9999999999995 7999987 8999999999876553
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=317.25 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=206.9
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||.|++|.||+|.+..++..||+|.+....... ....+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 5899999999999999999999999999999987543221 12345589999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE---GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 9986 888888653 368999999999999999999999999999999999999999999999999987542211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC------------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF------------ 268 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~------------ 268 (357)
.......+++.|++||.+.+....+.++|+|||||++|+|++|+.||.+.+..+....+......
T Consensus 155 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 155 ---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 11123456889999999877655566799999999999999999999877655544433211100
Q ss_pred -------C---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 269 -------P---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 -------~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+ ..+.+++.+.++|.+|| .+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 01246788999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=316.09 Aligned_cols=255 Identities=25% Similarity=0.471 Sum_probs=214.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|.-.+.||+|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45556899999999999999988999999998854322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+.+++|.+++.. +.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~------ 169 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------ 169 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC------
Confidence 9999999999877 678999999999999999999999999999999999999999999999999876432211
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC--CCCCCCCHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--PKDPNVSPECKAL 281 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 281 (357)
.......|++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+...... .....++..+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSF 248 (285)
T ss_pred cccccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHH
Confidence 11123468899999999987766 45699999999999999999999887776666665544221 1223478999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+.+|| .+|.+||++.++++||||+....
T Consensus 249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 249 LDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999 58999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=317.42 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=211.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
...+|++.+.||+|+||.||+|..+. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999997542 3457999987644322 2233466899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE----------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
...++||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999999652 234667889999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~ 264 (357)
|||+++....... ........++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+....+..+.+..
T Consensus 162 Dfg~~~~~~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 162 DFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred cCCcccccccccc----ccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999875432111 111122345678999999987766 455999999999999998 8999998887777776655
Q ss_pred ccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc------CCccccC
Q psy10194 265 KVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE------DPWFRNG 307 (357)
Q Consensus 265 ~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~------hp~f~~~ 307 (357)
....+.....++.+.+++.+|| .+|.+|||+.++++ ||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 4444444567899999999999 59999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.98 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=204.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++...... .....+.+|+.+++.+ +|+||+++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 556689999999999999999998643 3357999998654322 2245577899999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc--------------------------------------------------------
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE-------------------------------------------------------- 137 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 137 (357)
....+++||||+++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 138 --------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 138 --------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----~ 268 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----Y 268 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----e
Confidence 2478889999999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQ-LLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||....... ....+...........+++++.++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 11122335678999999987776 456999999999999997 999998765433 333344444444445679999999
Q ss_pred HHHccc-CCCCCCCHHhHhc
Q psy10194 282 ISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 282 i~~~L~-~p~~R~s~~e~l~ 300 (357)
+.+||. ||.+|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999995 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=313.25 Aligned_cols=251 Identities=24% Similarity=0.437 Sum_probs=212.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..+++|.+..... .+.+.+|+.+++.++|+||+++++.+.+...++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 4689999999999999999999998889999999864321 45677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999965 45789999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCCHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVSPEC 278 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 278 (357)
......|+..|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.... .......++..+
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 155 ----KRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred ----ccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 1123447889999999987766 556999999999999999999998766554433332221 122234578899
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.++|.+|| .+|.+|||+.+++.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999 599999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=315.93 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHH-HHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-VVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
++|++.+.||+|+||.||++.+..++..||+|.+........ ..+ +..|+. .++.++||||+++++.+......++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876443322 223 334555 46777899999999999999999999
Q ss_pred EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
|||++ |+|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 488887754 34689999999999999999999997 9999999999999999999999999998754321
Q ss_pred ccccccccccccCCCCCCccchhhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcccCC-CCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGI---PYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQSKVVF-PKD 271 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~~~~~~-~~~ 271 (357)
.......|+..|+|||.+.+. ...+.++|+|||||++|+|++|+.||.... ..+....+...... ...
T Consensus 158 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd06617 158 -------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230 (283)
T ss_pred -------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc
Confidence 111234578899999988642 223456999999999999999999997532 22222232222211 122
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..++.++.++|.+|| .+|.+||+++++++||||+...
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 358899999999999 5999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=320.09 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=204.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH----- 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~----- 116 (357)
.++|++.+.||+|+||.||+|.+..++..||+|.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3579999999999999999999999999999999865432221 2233457999999999999999999986543
Q ss_pred ---eEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 117 ---RVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 117 ---~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
..++||||+.+ +|.+.+... ..+++.+++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999975 888887654 3689999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---cc---
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS---KV--- 266 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~---~~--- 266 (357)
........ ........++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+.. ..
T Consensus 169 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 169 FSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 53222111 11223446788999999987655445679999999999999999999987665443322221 10
Q ss_pred --------------CCCC-----------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 267 --------------VFPK-----------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 --------------~~~~-----------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
..+. ....++.+.++|.+|| .+|.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0010 0123577889999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=317.15 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=212.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
++.++|.+.+.||+|+||.||++.. ..++..+|+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4667899999999999999999985 2345668999875432 3334567799999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN 181 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~ 181 (357)
.+.+++||||+++++|.+++...+ .+++..++.++.||+.||+|||+.|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997543 4899999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy10194 182 IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLK 260 (357)
Q Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~ 260 (357)
++|+|||++........ ........+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||......+...
T Consensus 159 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred EEeccCCccccccCCce----eecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999875432111 111223345778999999987666 456999999999999998 999999888877777
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 261 QVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+......+....+++++.+++.+||. +|.+|||+.+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 777665555555789999999999995 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=317.41 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=210.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 4799999999999999999999999999999988654332 233456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||++++.+..+..+...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999877777666667799999999999999999999999999999999999999999999999999876542211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-----------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK----------------- 265 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~----------------- 265 (357)
.......++..|+|||++.+....+.++|+||||+++|+|++|+.||......+.+..+...
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 12234567889999999988745567799999999999999999999876544333222110
Q ss_pred ---cCCC-----------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 266 ---VVFP-----------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 266 ---~~~~-----------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
..++ ....+++++.+||++|| .+|.+||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 01234889999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=320.93 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=209.3
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcE--EEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCE--VAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~ 114 (357)
+.++-++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++..+ +|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 346667999999999999999999998777754 466665432 2233455677899999999 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA 178 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~ 178 (357)
.+.+++||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 999999999999999999996532 5789999999999999999999999999999999999999
Q ss_pred CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHH
Q psy10194 179 DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQ 257 (357)
Q Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~ 257 (357)
++.++|+|||++....... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred CCcEEeCccccCcccchhh-------hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 9999999999986322110 0111223567999999877665 456999999999999998 999998887777
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 258 LLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+.+...........+++++.+|+.+||+ +|.+||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777666554444445688999999999995 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.00 Aligned_cols=256 Identities=24% Similarity=0.450 Sum_probs=213.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555688999999999999999899999999885432 2234557799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------ 172 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV------ 172 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc------
Confidence 9999999998854 468999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC--CCCCCCCHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--PKDPNVSPECKAL 281 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 281 (357)
.......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.......+...... +....++..+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 112234688999999999877664 4699999999999999999999887766655555433222 2223578999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+.+|| .+|.+|||++++++||||+.....
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999 599999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=317.80 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=207.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|++|+||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 4799999999999999999999999999999998654322 223345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||+++ +|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 99964 8888876544 3578889999999999999999999999999999999985 4579999999997542211
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC------------
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------------ 267 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~------------ 267 (357)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||......+....+.....
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 ----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred ----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1112345688999999987755556679999999999999999999987655443333211100
Q ss_pred -------CC---------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 -------FP---------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 -------~~---------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+ ..+.+++++.++|.+||+ +|++||++.++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 113578999999999995 899999999999999998643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.76 Aligned_cols=258 Identities=23% Similarity=0.435 Sum_probs=213.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~ 118 (357)
.+|++.+.||+|+||.||++.+..++..+|+|.+..... ........+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998754321 1223345677899999999999999999998664 568
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++|+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998878899999999999999999999999999999999999999999999999999976532111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 277 (357)
. ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||..........++... .....+..+++.
T Consensus 162 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 162 S---GTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred c---CccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 0 111123468899999999987766 45599999999999999999999876655544444322 222234578999
Q ss_pred HHHHHHHcccCCCCCCCHHhHhcCCcc
Q psy10194 278 CKALISKILAPVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 278 ~~~li~~~L~~p~~R~s~~e~l~hp~f 304 (357)
+.++|.+||.++.+||++.+++.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999888999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=336.78 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=214.5
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|.-.+.||.|+||-||-|++..+.+.||||.+.-.......--..+..|+++|+.+.|||++.+-++|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678899999999999999999999999998765544444445567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|-| +-.|++. ..+++-+.++..|+.+.+.||+|||+.+.+|||||..|||++..|.+||+|||.|....+
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 965 8888885 356799999999999999999999999999999999999999999999999999976533
Q ss_pred cccccCCCCCCccchhhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILK--GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
...++|||.|||||++. ..+.++-++||||||+++.+|.-.++|+..++.. .+.....+....-....+|..+.+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~ 256 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 256 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHH
Confidence 34688999999999984 3333445599999999999999999997776644 444444444444445689999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
||..|| +.|.+|||.+++|.|+|...
T Consensus 257 Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 257 FVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 999999 58999999999999999865
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=311.02 Aligned_cols=253 Identities=31% Similarity=0.564 Sum_probs=214.6
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||+|+||.||++.+..++..+|+|.+........ ..+.+.+|+.+++.++|+||+++++.+.+...+++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876433222 24456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC-eEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN-IKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+++++|.+++.+.. .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999987643 5799999999999999999999999999999999999988864 6999999987543211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+....+......+..+.++.++.+
T Consensus 157 ---~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd08225 157 ---ELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS 232 (257)
T ss_pred ---ccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHH
Confidence 11223457899999999887665 45699999999999999999999887776666655554444445578899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+|.+|| .+|.+|||+.+++.||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=322.64 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=212.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcE----EEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCE----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+...+|++.+.||+|+||.||+|.+..++.. ||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 46678999999999999999999997665554 8999886432 23334567789999999999999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
. ..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4 567999999999999999764 46889999999999999999999999999999999999999999999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
...... .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....++...+......+..+
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd05108 160 GADEKE----YHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234 (316)
T ss_pred cCCCcc----eeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 422110 11112234678999999988777 455999999999999997 999999888777766666666666666
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.++.++.+++.+|| .+|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78999999999999 599999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.91 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=213.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|.+.+.||+|+||.||+|.+..++..+|+|.+..... ....+.+|+.+++.++|+||+++++++.....++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 345679999999999999999999999999999999864321 1345668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998753 358999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+....+...........+++
T Consensus 159 ~-----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd05052 159 Y-----TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP 232 (263)
T ss_pred e-----eccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 1 011112235679999999877764 45999999999999998 9999998888887777777666666667899
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+++.+||. +|.+||++.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999995 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=303.34 Aligned_cols=263 Identities=22% Similarity=0.380 Sum_probs=210.0
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE--
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-- 112 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-- 112 (357)
+....+...+|+|.+.||+|||+-||+++...++..||+|.+.-.. ....+...+|++..+.++|||+++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 5667789999999999999999999999999999999999986443 22245566999999999999999998875
Q ss_pred ---EeCCeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecCCCCeE
Q psy10194 113 ---ETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 113 ---~~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~~~~~k 183 (357)
......||+++|...|+|.+.+.+ +..++|.++..|+.+|++||.+||+.. ++||||||.|||++..+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 234569999999999999999864 347999999999999999999999998 99999999999999999999
Q ss_pred Eeecccccccccccccc----ccccccccCCCCCCccchhhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-
Q psy10194 184 LSDFGFARNHMRYRSRQ----GYESLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS- 256 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~- 256 (357)
|.|||.+......-... ....... -..|..|+|||++.-.. ..+.++|||||||+||.|+.|..||+.....
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~-e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAE-ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHH-HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 99999987543211100 0011111 22588999999986432 3356799999999999999999999642110
Q ss_pred --HHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 257 --QLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
-.+......+.+|....+|..+.++|+.|| .||.+||++.+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 001111235667877889999999999999 599999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=324.52 Aligned_cols=268 Identities=21% Similarity=0.338 Sum_probs=213.5
Q ss_pred eecCEE-EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-----------HHhhHHHHHHHHHcCCCCCccce
Q psy10194 41 ESHGYT-LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-----------LKKFLPREVEVVKGLKHPNLIKF 108 (357)
Q Consensus 41 ~~~~y~-~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~Iv~l 108 (357)
...+|. +.+.||+|+||+||+|.+..++..||+|.+......... ....+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 355676 467899999999999999999999999998654332210 01235689999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecc
Q psy10194 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFG 188 (357)
Q Consensus 109 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg 188 (357)
++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc--------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Q psy10194 189 FARNHMRYRSR--------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLK 260 (357)
Q Consensus 189 ~~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~ 260 (357)
.+......... ...........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98754310000 0001112233568899999998776555677999999999999999999998877665544
Q ss_pred HHhcccCCC---------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 261 QVQSKVVFP---------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 261 ~~~~~~~~~---------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+......+ .....+..+.++|.+||. +|.+||++++++.||||+..+.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 432211100 012457889999999995 9999999999999999987544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=317.67 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=212.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
...+|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34678999999999999999998743 357899999865432 22346677999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG--------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN 181 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~ 181 (357)
...++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997543 4788999999999999999999999999999999999999999
Q ss_pred eEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q psy10194 182 IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLK 260 (357)
Q Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~ 260 (357)
++|+|||++........ ........+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+..+...
T Consensus 161 ~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY----YRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred EEECCcccceecccCcc----eecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999875321111 1112233457889999999887764 45999999999999998 999998888888777
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 261 QVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+...........++..+.+++.+|| .+|.+||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 77765554445678999999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.84 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=215.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
-|++.+.||+|+||.||+|.+..++..+|+|++..... ......+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999988999999998864332 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 9999999999864 4689999999999999999999999999999999999999999999999999865432111
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
......|+..|+|||.+.+.... .++|+|||||++|+|++|..||...........+...........++.++.+++.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred -hhccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 11234578899999999876664 4599999999999999999999877766655555444333333468899999999
Q ss_pred Hcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 284 KIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 284 ~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+|| .+|.+||++.++++||||....
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhhh
Confidence 999 5999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=306.71 Aligned_cols=253 Identities=32% Similarity=0.526 Sum_probs=217.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|++|.||++.+..++..|++|.+....... .....+.+|+++++.++|+|++++++++.+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5899999999999999999999899999999997665432 334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 999999999998888899999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
......++..|+|||.+.+... +.++|+||||+++|+|++|..||.......................++..+.+++.
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLM 232 (254)
T ss_pred -cccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 1223457889999999877664 56699999999999999999999876654444444333333444578999999999
Q ss_pred Hcc-cCCCCCCCHHhHhcCCcc
Q psy10194 284 KIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 284 ~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+|| .+|++||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 999 599999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=325.47 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=210.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-----H 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-----~ 116 (357)
.++|.+.+.||+|+||+||++.+..++..||+|.+......... ...+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45799999999999999999999999999999998754322222 33455899999999999999999988544 3
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
..++|+||+. ++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999996 599999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-----------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK----------- 265 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~----------- 265 (357)
. .......++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 162 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 162 G------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred c------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 1 12233457889999999876443466799999999999999999999776543322211100
Q ss_pred ------------cC-C------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 266 ------------VV-F------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 266 ------------~~-~------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.. . ...+.+++++.++|.+||. +|.+|||++++++||||......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00 0 0124688999999999995 99999999999999999875443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=334.31 Aligned_cols=269 Identities=27% Similarity=0.464 Sum_probs=228.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
.+.-|..++.||-|+||+|.++.-.++...||.|.+.+...........++.|-.||...+.+-||+||..|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 44558889999999999999999999999999999987665555556677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc--
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS-- 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 198 (357)
||+|++||++-.+|-+.+.|+|..++.++..|..|+++.|.+|++||||||+|||||.+|++||.|||++.-+.....
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999863321000
Q ss_pred ----------------------------------ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH
Q psy10194 199 ----------------------------------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244 (357)
Q Consensus 199 ----------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll 244 (357)
...........+||+.|+|||++...+| +..+|.||.|||||+|+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHh
Confidence 0001112334679999999999998888 45599999999999999
Q ss_pred hCCCCCCCCcHHHHHHH---HhcccCCCCCCCCCHHHHHHHHHcccCCCCCCC---HHhHhcCCccccCCCC
Q psy10194 245 FGRLPFDDTKYSQLLKQ---VQSKVVFPKDPNVSPECKALISKILAPVKTRLR---IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 245 ~G~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~p~~R~s---~~e~l~hp~f~~~~~~ 310 (357)
.|++||-...+.+...+ +...+.++....+|+++.+||.+|..+++.|+. ++|+..||||+...+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchH
Confidence 99999987665544333 344566677778999999999999988888875 7889999999987654
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=313.06 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=209.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-CC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-TH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-~~ 116 (357)
...|++.+.||+|+||.||+|...++.. .+|||.++..... ..+....-||+.+++.++|||++.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3569999999999999999996554433 6899998765432 2344455699999999999999999999966 88
Q ss_pred eEEEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC----CCeEEeec
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD----YNIKLSDF 187 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~----~~~kl~Df 187 (357)
.+++++||.+. +|.++|+- ...++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999987 99999853 2468999999999999999999999999999999999999877 89999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---------HHHH
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---------YSQL 258 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---------~~~~ 258 (357)
|+++.+...-.. -......+.|.+|+|||++.+...++.+.|||++|||+.||+|-++.|.+.. ..+.
T Consensus 181 GlaR~~~~plkp---l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 181 GLARLFNNPLKP---LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cHHHHhhccccc---cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999875421110 1112234569999999999999999999999999999999999998886532 1123
Q ss_pred HHHHhcccCCCCC------------------------------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 259 LKQVQSKVVFPKD------------------------------------PNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 259 ~~~~~~~~~~~~~------------------------------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+++|..-+..|.. ..-++...+|+.+||. ||.+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 3333322222211 1236668999999996 99999999999999
Q ss_pred CccccCCCC
Q psy10194 302 PWFRNGPSR 310 (357)
Q Consensus 302 p~f~~~~~~ 310 (357)
+||...+-.
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 999876443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=312.33 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=214.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||.|+||.||++.+..++..+++|++...........+.+.+|+.+++.++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999998765443334456677899999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc--ccccccccc
Q psy10194 131 LDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR--QGYESLSET 208 (357)
Q Consensus 131 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~ 208 (357)
.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999988778999999999999999999999999999999999999999999999999998754321110 000011223
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHcc-
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALISKIL- 286 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L- 286 (357)
..++..|+|||.+..... +.++|+||||+++|+|++|..||...........+.. ...++....++..+.+++.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 457889999999887665 5569999999999999999999998887777766654 2333333335899999999999
Q ss_pred cCCCCCCCH---HhHhcCCccccC
Q psy10194 287 APVKTRLRI---KNIKEDPWFRNG 307 (357)
Q Consensus 287 ~~p~~R~s~---~e~l~hp~f~~~ 307 (357)
.+|.+|||+ .++++||||.+.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 589999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.51 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=205.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE------e
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE------T 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~------~ 114 (357)
.+.|++.+.||.|+||+||+|.+..++..+|+|++.... .....+..|+.+++.+ +|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 367999999999999999999999999999999986532 1234466888888888 6999999999984 3
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.+.++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999998653 4588999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV- 267 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~- 267 (357)
..... .......|++.|+|||.+.. ....+.++|+|||||++|+|++|..||...........+.....
T Consensus 171 ~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 171 LDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhccc------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 43211 11224568999999999863 12234569999999999999999999977654443333322211
Q ss_pred CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 268 FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
......++.++.+||.+||. +|.+||++.++++||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 12223588999999999995 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.21 Aligned_cols=253 Identities=30% Similarity=0.513 Sum_probs=219.2
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||.|+||.||++.+..++..+++|.+...... ......+.+|+++++.++|+|++++.+.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999998765433 2334557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
++++++|.+++.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......|++.|+|||.+.+..+ +.++|+||+|+++++|++|..||...+..............+....++..+.
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd08215 158 ----DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELR 232 (258)
T ss_pred ----ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 12234568899999999887776 4559999999999999999999988877777776665544444457889999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 280 ALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+++.+||. +|.+||++.++++||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999995 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=319.99 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=207.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRVYI 120 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~~l 120 (357)
++|++.+.||+|+||.||+|.+..++..+++|.+...... +.....+.+|+.+++.++||||+++++++... ..+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4799999999999999999999999999999998754433 22233456899999999999999999998877 89999
Q ss_pred EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+|||++.++.++|+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 9999975 999988764 458999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-----------
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF----------- 268 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~----------- 268 (357)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+......
T Consensus 161 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 ----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred ----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 11123456889999999877655566799999999999999999999876655444433211100
Q ss_pred ------------------CCCCC--CCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 269 ------------------PKDPN--VSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 ------------------~~~~~--~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
...+. +++.+.++|.+||. +|++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011 58889999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.90 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=211.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEE----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATS----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
-.+|++.+.||+|+||.||+|.. ..++..+++|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 36799999999999999999985 34567899999864332 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE-----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~ 180 (357)
.++||||+++++|.+++... ..+++.++..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2478889999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy10194 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLL 259 (357)
Q Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~ 259 (357)
.++|+|||++........ ........++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADY----YRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred cEEeccccccccccCCcc----eecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999976432111 111223345678999999987766 456999999999999998 99999888777777
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 260 KQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+.+......+....+++.+.+++.+||+ +|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7777666666666789999999999995 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.27 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=213.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 346799999999999999999998644 4579999886543 23334556789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998663 47899999999999999999999999999999999999999999999999999865411
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+......+....++
T Consensus 160 ~~----~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 160 EA----TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred cc----ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 11 011112234678999999987766 455999999999999997 999998888777777777665656666789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+.+.+++.+||. +|.+||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999995 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.96 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=211.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|.+.+.||+|+||+||+|.+..++..||+|.+...........+.+.+|+.+++.++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45999999999999999999999899999999987654444444556779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+.| +|.+++.. .+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------ 167 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ 167 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC------
Confidence 99975 77777653 55799999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 278 (357)
.....|++.|+|||++.+ ....+.++||||||+++|+|++|+.||...+.......+..... ......++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 123457889999998742 23335569999999999999999999988776555444432211 11123578899
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.++|.+|| .+|.+||++.+++.||||...
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999 599999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.49 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=208.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45679999999999999999998642 356799998854322 22344567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG----------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
...++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999986532 35778899999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~ 264 (357)
|||++........ ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.....+.+..
T Consensus 162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 162 DFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCccccCCcce----eecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999875432111 011112345778999999987776 455999999999999998 7999998888777776665
Q ss_pred ccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 265 KVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 265 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
....+....++..+.+++.+||. +|.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54444455788999999999995 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.35 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=213.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999999998999999999864432 2234567799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence 9999999998864 4689999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
......|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+...........++.++.++|.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 1123457889999999987766 45599999999999999999999876655555444433322233457889999999
Q ss_pred Hcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 284 KIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 284 ~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+|| .+|.+||++.++++||||....
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHHh
Confidence 999 5999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.93 Aligned_cols=254 Identities=21% Similarity=0.371 Sum_probs=205.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE-----e
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE-----T 114 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~-----~ 114 (357)
..++|++.+.||+|+||.||+|.+..++..+|+|++...... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 456899999999999999999999999999999987543221 24466899999998 6999999999873 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 5679999999999999998753 356899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
....... .......|++.|+|||++... ...+.++|||||||++|+|++|+.||...........+....
T Consensus 172 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 172 AQLTSTR------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred eecccCC------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 7543211 112234589999999998532 223556999999999999999999998776544433332221
Q ss_pred C--CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 267 V--FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 ~--~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
. ......++..+.++|.+|| .+|.+|||+.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1 1122346789999999999 599999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.94 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=209.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++||||+++++.+.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887654445555566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 123 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 34589999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhcccCCCC-CCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPK-DPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~--~~~~~~~~~~~~~~~~-~~~~~ 275 (357)
......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.... .......+......+. ...++
T Consensus 162 ------~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 162 ------AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred ------HHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 11234678899999999877664 55999999999999999999996543 3344444443322222 23578
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+.++|.+|| .+|.+||++.++++
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 89999999999 49999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.12 Aligned_cols=252 Identities=29% Similarity=0.446 Sum_probs=205.8
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|++.+.||.|++|.||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987543222 2234456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 125 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
++ ++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 95 59999987765 78999999999999999999999999999999999999999999999999987542111
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--------------- 267 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--------------- 267 (357)
.......+++.|+|||++.+....+.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1112235688999999887655446669999999999999999999987654332222211000
Q ss_pred ----C---------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 268 ----F---------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 ----~---------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+ ...+.++..+.++|.+||+ +|.+|||+++++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 0124578999999999995 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=309.24 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=203.9
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++.....+++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999899999999875432 2334456779999999999999999999999999999999999999
Q ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 129 SLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 129 sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
+|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++........ .....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~ 154 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----ASTGG 154 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc----cccCC
Confidence 999999764 4689999999999999999999999999999999999999999999999999875331100 00011
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 286 (357)
...++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+......+....++..+.+++.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 1123457999999987776 445999999999999997 99999887776666666655555555678999999999999
Q ss_pred c-CCCCCCCHHhHhc
Q psy10194 287 A-PVKTRLRIKNIKE 300 (357)
Q Consensus 287 ~-~p~~R~s~~e~l~ 300 (357)
. +|.+|||+.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 5 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=322.88 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=211.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe--
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR-- 117 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~-- 117 (357)
...++|.+.+.||+|++|.||+|.+..++..||+|++....... .....+.+|+.+++.++|+||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 34678999999999999999999999999999999886533222 223445689999999999999999988866554
Q ss_pred ----EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 118 ----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 118 ----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 5699998865 46999999999999999999999999999999999999999999999999999754
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC----
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP---- 269 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~---- 269 (357)
... .....++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 169 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 169 DDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 311 2234578899999998765455667999999999999999999998776555444433211110
Q ss_pred --------------------------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 270 --------------------------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 270 --------------------------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
....+++.+.++|.+|| .+|.+|||+.++++||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 01246899999999999 599999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=308.11 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=212.7
Q ss_pred eEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec
Q psy10194 49 TIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
+.||+|+||.||+|.+... +..+++|.+....... ..+.+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998866 8899999987654332 3566779999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 126 EKGSLLDIIRKE---------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 126 ~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. ........+++.|+|||.+....+ +.++|||||||++|+|++ |..||......+..+.+...........++
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd00192 159 DY----YRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233 (262)
T ss_pred cc----cccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 21 112234456889999999987765 556999999999999998 699999988888888887766666666789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+++.+++.+||. +|.+|||+.+++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999995 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.77 Aligned_cols=243 Identities=28% Similarity=0.473 Sum_probs=198.5
Q ss_pred cCEEEEeEe--eecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEE
Q psy10194 43 HGYTLGTII--GMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 43 ~~y~~~~~L--g~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~ 119 (357)
++|.+.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+.++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 356666665 99999999999999999999999986543221 122222222 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+++++|.+++.+...+++.+++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---
Confidence 9999999999999998887899999999999999999999999999999999999999988 999999999875421
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHHhcccCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ-----LLKQVQSKVVFPKDPN 273 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~-----~~~~~~~~~~~~~~~~ 273 (357)
.....|+..|+|||++.+..+. .++|+||||+++|+|++|..||....... +.... ....+..+.
T Consensus 163 -------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T PHA03390 163 -------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKN 232 (267)
T ss_pred -------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccc
Confidence 1134578999999999887764 55999999999999999999997544322 22222 112233346
Q ss_pred CCHHHHHHHHHccc-CCCCCCC-HHhHhcCCcccc
Q psy10194 274 VSPECKALISKILA-PVKTRLR-IKNIKEDPWFRN 306 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s-~~e~l~hp~f~~ 306 (357)
+++.+.++|.+||. +|.+|++ ++++++||||.+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 89999999999995 8999996 699999999963
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=323.55 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=216.3
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----eE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-----RV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-----~~ 118 (357)
+|.+.+.||.|++|.||+|.+..++..||+|.+...... ....+.+.+|+.+++.++|+||+++.+++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 589999999999999999999988999999998764321 223455678999999999999999999987765 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+.+ +|.+++.+...+++..++.++.||+.||.+||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999975 8999998877899999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC--------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK-------- 270 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~-------- 270 (357)
. ........+++.|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+..+....+......+.
T Consensus 159 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 159 E---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred c---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 0 01123345788999999998774446669999999999999999999988776655554443221111
Q ss_pred ----------------------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 271 ----------------------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 271 ----------------------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+.+++.+.++|.+|| .+|.+||++++++.||||+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1346889999999999 599999999999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=318.62 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------ 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------ 115 (357)
.++|++.+.||+|+||.||+|.+..++..+|+|.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 4789999999999999999999999999999999865432221 123455899999999999999999887433
Q ss_pred --CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 116 --HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 116 --~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
..+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 77777654 45799999999999999999999999999999999999999999999999999975
Q ss_pred ccccccccc-----cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 193 HMRYRSRQG-----YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 193 ~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
......... .........|++.|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 442221111 011122345788999999987655456679999999999999999999987766554443322110
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 268 FP-----------------------------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 268 ~~-----------------------------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.+ ....+++.+.++|.+|| .+|.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 00235578999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.77 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=205.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------ 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------ 115 (357)
..+|.+.+.||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3689999999999999999999999999999999865443 2234566899999999999999999876543
Q ss_pred --------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEee
Q psy10194 116 --------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSD 186 (357)
Q Consensus 116 --------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~D 186 (357)
..+++||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357999999975 89888854 46899999999999999999999999999999999999974 55789999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
||.+.......... .......|+..|+|||.+......+.++|||||||++|+|++|+.||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 159 FGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred cccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99987543211111 111223578899999987665445667999999999999999999998766544433322111
Q ss_pred CC-----------------------C------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 267 VF-----------------------P------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 267 ~~-----------------------~------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.. + ..+.++.++.+||.+||. ||.+|||+.+++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0 013578899999999995 99999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.56 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=214.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|.+.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 3689999999999999999999988889999999854322 2235567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 9999999999998654 488999999999999999999999999999999999999999999999998865432211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--ccCCCCCCCCCHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS--KVVFPKDPNVSPECK 279 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 279 (357)
......|++.|+|||.+....+ +.++|+|||||++|++++|..||...+.......+.. ...+.....++..+.
T Consensus 171 ---~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 171 ---KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred ---ccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 1123457889999999987666 4569999999999999999999987665443332221 112223345788999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
++|.+|| .+|.+||++.+++.|+||+......+
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~ 280 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence 9999999 48999999999999999987654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=344.65 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=206.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.++||+|+||.||+|.+..++..||+|++.......+...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999997654444555667789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 123 EYAEKGSLLDIIRKE-----------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
||++||+|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 234567788999999999999999999999999999999999999999999997
Q ss_pred cccccccc------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q psy10194 192 NHMRYRSR------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259 (357)
Q Consensus 192 ~~~~~~~~------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~ 259 (357)
........ ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 65211100 000111224579999999999988776 55699999999999999999999875544332
Q ss_pred HHH--hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 260 KQV--QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 260 ~~~--~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
... ...........+++.+.+++.+|| .||.+|++..+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 221 111112222468899999999999 59999987655443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=307.38 Aligned_cols=247 Identities=21% Similarity=0.389 Sum_probs=207.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||+|+||.||++.... +..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 568999999999999999998754 457999987643322 244668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++|+|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 99999999999865 35689999999999999999999999999999999999999999999999999875422111
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+..+....+........+...+.++.+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 156 --TSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred --eccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 01112234567999999987766 456999999999999999 99999988888777777765554444567899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhc
Q psy10194 281 LISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~ 300 (357)
++.+|+ .+|.+||+++++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=312.40 Aligned_cols=254 Identities=18% Similarity=0.275 Sum_probs=209.1
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
..+.|.+.+.||+|+||.||+|.+.. ++..|++|.+..... ......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999877 677899998754332 22234566899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEe
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG-------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLS 185 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~ 185 (357)
...++||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997643 489999999999999999999999999999999999998655 59999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~ 264 (357)
|||++........ .........+..|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..
T Consensus 162 dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 162 DFGMARDIYRASY----YRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred cCccccccCCccc----eecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999976521111 001112233567999999987776 556999999999999996 9999998887777776665
Q ss_pred ccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 265 KVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 265 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.........++..+.+++.+||+ +|.+||++.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54444456789999999999995 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=308.71 Aligned_cols=250 Identities=23% Similarity=0.427 Sum_probs=211.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.+.+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34578999999999999999999965 456799998764322 2355678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++.+ ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999865 3568899999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||.+....+ +.++|+|||||++|+|++ |..||...........+......+....++.
T Consensus 158 ~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (261)
T cd05072 158 Y-----TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD 231 (261)
T ss_pred e-----eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 1 11112335678999999887666 445999999999999998 9999998887777777777666666667899
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+++.+||. +|++||+++++.+
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999995 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.19 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=207.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVYI 120 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~l 120 (357)
++|+..+.||.|++|.||+|.+..++..+|+|.+...... .....+.+|+++++.++||||++++++|.. ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4789999999999999999999999999999998754332 334557789999999999999999998854 447899
Q ss_pred EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhcccC--CC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-----KYSQLLKQVQSKVV--FP 269 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-----~~~~~~~~~~~~~~--~~ 269 (357)
......++..|+|||.+.+..+. .++|+|||||++|+|++|..||... ...+....+..... .+
T Consensus 159 --------~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 159 --------LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred --------ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 11234568899999999877764 4599999999999999999999765 22333333332111 11
Q ss_pred C----CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 270 K----DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 ~----~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
. ....++.+.++|.+||. +|.+|||+.|++.||||.+..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 1 12356789999999995 999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=313.04 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=208.5
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeEEEEE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRVYIIM 122 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~~lv~ 122 (357)
|++.+.||+|++|.||+|.+..++..+|+|.+.... ........+.+|+.+++.++|+|++++++++... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998654 2223344566899999999999999999999888 8999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--- 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--- 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence 99975 899888665 5799999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC------C-----
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------K----- 270 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~------~----- 270 (357)
.......++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+......+ .
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 --ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred --ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 112234567889999987765444667999999999999999999998877655554443211100 0
Q ss_pred ------------------CCC-CCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 271 ------------------DPN-VSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 271 ------------------~~~-~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
... +++.+.+++.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 38899999999994 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=315.35 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=210.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQ 110 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~ 110 (357)
.+..++|.+++.||+|+||.||++.+.. +...+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4556789999999999999999998643 234699999875422 22234566899999999 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 111 AIETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 111 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
++...+..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997542 478899999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.++.++|+|||.+........ ........+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred EEcCCCcEEECCCcccccccccch----hhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999875432111 011112234568999999987766 456999999999999998 89999988
Q ss_pred cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
...++...+......+....++.++.+++.+||. +|.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8888777777665555556789999999999995 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=317.96 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=206.4
Q ss_pred CEEEEeEeeecCceEEEEEEECCC--CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe----CC
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRH--SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET----TH 116 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~----~~ 116 (357)
+|++.+.||+|+||.||++.+..+ +..||+|.+....... ...+.+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8899999986533222 2234456899999998 59999999987532 25
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.++++++++. ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6789999986 599999988888999999999999999999999999999999999999999999999999999765422
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--------- 267 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--------- 267 (357)
... .........|++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+.....
T Consensus 159 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 159 PGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 211 111223457899999999886644345669999999999999999999987654433332221110
Q ss_pred --------------------C-CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 268 --------------------F-PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 268 --------------------~-~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+ ...+.++..+.+|+.+||. +|.+|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 0113468899999999995 99999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=310.54 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=210.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
..+..++|++.++||+|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 2 RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 35677899999999999999999999876665 47999886432 2333456778999999999999999999986
Q ss_pred eCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
. ...++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 5 457799999999999999976 45689999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKD 271 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (357)
....... .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+......+..
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05109 159 LDIDETE----YHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 233 (279)
T ss_pred cccccce----eecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 5322110 01112234678999999987776 456999999999999998 99999887777766666665555556
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
...+.++.+++.+|| .||.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.23 Aligned_cols=255 Identities=27% Similarity=0.495 Sum_probs=214.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--CeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT--HRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~--~~~~lv 121 (357)
+|++.+.||+|++|.||+|.+..++..+++|++...... ....+.+.+|+.+++.++|+||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998765432 33456677999999999999999999999988 899999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
+|++++++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988878999999999999999999999999999999999999999999999999998765432210
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhc-ccCCCCCCCCCHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQS-KVVFPKDPNVSPECK 279 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ 279 (357)
.......++..|+|||.+.+... +.++|+||||+++|+|++|..||.... .......+.. .........++..+.
T Consensus 158 --~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 158 --EGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred --ccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 01234567889999999887665 556999999999999999999998765 2222222221 222233346789999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 280 ALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999995 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=308.37 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=201.2
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3468999999999999999899999999886533 2234567799999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeecccccccccccccccc
Q psy10194 127 KGSLLDIIRKE-GYI--DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 127 ~gsL~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
+++|.+++... ..+ ++..+..++.||+.||+|||+.||+||||||+||+++. ++.++|+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----- 163 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----- 163 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-----
Confidence 99999999764 455 88899999999999999999999999999999999976 6799999999987543211
Q ss_pred ccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHhcccCCCCCCCCCHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ--LLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......|++.|+|||++.+.. ..+.++|+||||+++|+|++|..||....... .............+..+++++.
T Consensus 164 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 164 -PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred -CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHH
Confidence 1122345788999999986543 23566999999999999999999997543221 1111111122223346889999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 280 ALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+++.+||. +|.+|||+.+++.||||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999995 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=313.16 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=207.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCc--EEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSC--EVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~ 119 (357)
++|++.+.||+|+||.||+|....++. .+++|.++... .....+.+.+|+.++.++ +||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877664 46888775322 223345567899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 120 IIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
+||||+++++|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478899999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~ 262 (357)
|+|||++....... .......+..|+|||.+....+ +.++|||||||++|+|++ |..||......+....+
T Consensus 160 l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 160 IADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred ECCcCCCcccccee-------ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999986422110 0111123457999999987776 455999999999999997 99999998888877777
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
......+....++..+.+|+.+|| .+|.+||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 766655555678999999999999 589999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=306.41 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=209.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|++|.||+|.+.. +..||+|.+...... .+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 345679999999999999999999654 467999998654322 344668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 68999999999999999999999999999999999999999999999999997654111
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||.+.........+......+....++.
T Consensus 158 ~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (261)
T cd05068 158 Y-----EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231 (261)
T ss_pred c-----cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 0 00111123457999999887766 455999999999999998 9999998888777777766655555567899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+++.+|| .+|.+||++.++++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.68 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=209.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|.++..........+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999987544444444567789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 123 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999999864 3458999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhcccCCCCCC-CCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPKDP-NVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~--~~~~~~~~~~~~~~~~~~-~~~ 275 (357)
.......|++.|.|||.+.+..+ +.++|+|||||++|+|++|+.||.... ..+..+.+......+... .++
T Consensus 161 -----~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 161 -----TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred -----cccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 11123457889999999987776 445999999999999999999996543 334444444433333322 678
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
..+.++|.+||. +|.+||++.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999995 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=310.22 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=211.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCC-----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRH-----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
+..++|.+.+.||+|+||.||++.+... +..||+|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999987643 37899999854332 2234456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEE
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE----------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKL 184 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl 184 (357)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998643 23678899999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy10194 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQ 263 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~ 263 (357)
+|||+++....... ........++..|+|||.+.+..+ +.++|||||||++|++++ |..||...+.....+.+.
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 161 GDFGMTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCcccchhhccCcc----cccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999875432111 111223456788999999987666 455999999999999998 999999888888777777
Q ss_pred cccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 264 SKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 264 ~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.......+..++.++.+++.+||. +|++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 555555556789999999999995 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=313.51 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=209.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999853 345568888875432 22345677999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD 179 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~ 179 (357)
+..++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37899999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQL 258 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~ 258 (357)
+.++|+|||++........ ........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred CcEEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999875432111 111223456788999999987766 445999999999999998 9999988887777
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+............+..+.+++.+|| .+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 7777665555445568899999999999 59999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=306.79 Aligned_cols=249 Identities=21% Similarity=0.385 Sum_probs=208.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.+++.++||||+++++++.....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 446999988654322 23466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||.+........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999999999764 4689999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+......+.....+..+.
T Consensus 156 ---~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 156 ---TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred ---eecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 01112234667999999987666 455999999999999998 9999988877777777766655555556789999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcC
Q psy10194 280 ALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+++.+||. +|.+||++.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999995 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=314.59 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=212.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCC-----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRH-----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~ 112 (357)
.+..++|++.+.||+|+||.||++..... ...+|+|.+..... ......+.+|+.+++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35567899999999999999999987643 36799999865432 22234567899999999 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHH----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRK----------------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll 176 (357)
...+.++++|||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 999999999999999999999864 2468899999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY 255 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~ 255 (357)
+.++.++|+|||++........ ........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY----YRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred cCCCeEEeCccccccccccccc----eeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999976432211 011112234678999999877766 455999999999999997 9999999888
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 256 SQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.+..+.+........+...+..+.+|+.+||. +|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 88887777666555556788999999999995 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=319.17 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=208.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH---- 116 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~---- 116 (357)
..++|.+.+.||+|+||.||++.+..++..||+|.+.+... .......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 46789999999999999999999999999999999865332 2333455678999999999999999999986543
Q ss_pred --eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 117 --RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 117 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 6799888764 569999999999999999999999999999999999999999999999999987542
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--------
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-------- 266 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-------- 266 (357)
. ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+....
T Consensus 170 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 170 S---------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred c---------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 1 11234568899999998765445667999999999999999999998765433322221100
Q ss_pred ---------------C-C------CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 267 ---------------V-F------PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 267 ---------------~-~------~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
. . ...+.+++.+.++|.+|| .||.+|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 0 011357889999999999 5999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=315.50 Aligned_cols=253 Identities=24% Similarity=0.472 Sum_probs=211.3
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|.....||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 44566899999999999999889999999998653322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (357)
+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------~ 172 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------P 172 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc------c
Confidence 999999988754 568999999999999999999999999999999999999999999999999986432211 1
Q ss_pred ccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHHHHHH
Q psy10194 205 LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKALI 282 (357)
Q Consensus 205 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 282 (357)
......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...........+..... ......+++.+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence 1123568899999999987766 4569999999999999999999987776665555543221 122346789999999
Q ss_pred HHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 283 SKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+|| .+|.+||++.++++||||.+..
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999 5999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.57 Aligned_cols=249 Identities=27% Similarity=0.498 Sum_probs=210.9
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999866443 234567799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999999775 5799999999999999999999999999999999999999999999999999876542211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 280 (357)
.....|+..|+|||.+.+... +.++|+||||+++|+|++|..||...+............. .+....++..+.+
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 234567889999999987664 5569999999999999999999987754444433332211 2222234899999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCc
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPW 303 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~ 303 (357)
+|.+|| .||.+|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999 59999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=328.80 Aligned_cols=235 Identities=26% Similarity=0.486 Sum_probs=205.3
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
.+-||+|+.|-||+|+.. ++.||||.++. .-..+|+-|+.|+||||+.+.++|.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 456999999999999975 45899997742 122688999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
|-|...|+....++......|.++|+.|+.|||.+.|+|||||.-||||+.+..+||+|||.++...... ...
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM 269 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM 269 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence 9999999999999999999999999999999999999999999999999999999999999998654332 233
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHcc
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVFPKDPNVSPECKALISKIL 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L 286 (357)
.++||..|||||++.+.+. ..|+|||||||+|||||||..||.+.+...++--+- +.+..|.+..++..++=||++|+
T Consensus 270 SFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence 6789999999999999887 567999999999999999999998877655443332 33456666789999999999999
Q ss_pred c-CCCCCCCHHhHhcCC
Q psy10194 287 A-PVKTRLRIKNIKEDP 302 (357)
Q Consensus 287 ~-~p~~R~s~~e~l~hp 302 (357)
+ .|.+||++.++|.|=
T Consensus 349 ~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILLHL 365 (904)
T ss_pred hcCCCCCccHHHHHHHH
Confidence 5 899999999999994
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=326.53 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=219.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCc---E-EEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSC---E-VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+..++-.+.++||+|+||.||+|.....+. . ||+|..+............+.+|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 4556677778999999999999998765422 3 89998875343334445556699999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...+++|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++..
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999999876 4999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH-hcccCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQV-QSKVVFPKD 271 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~-~~~~~~~~~ 271 (357)
..+..... ...-...|+|||.+....+ +.++||||+||++||+++ |..||.+....+...++ ..++..+.+
T Consensus 313 ~~~~~~~~------~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 313 SQYVMKKF------LKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cceeeccc------cccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 42222111 1113568999999998866 566999999999999997 89999999999999988 778888888
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
..-+.++..++.+|+ .+|+.|+++.++.+ +++.
T Consensus 386 ~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~ 419 (474)
T KOG0194|consen 386 SKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEA 419 (474)
T ss_pred CCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHH
Confidence 888999999999999 59999999999887 5543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=311.18 Aligned_cols=258 Identities=27% Similarity=0.460 Sum_probs=217.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
...|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+.+++.++|+||+++++.+......++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3458899999999999999999998899999999875433 244566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
+||+++++|.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 99999999999998776 899999999999999999999999999999999999999999999999998865432111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC--CCCCCCCHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--PKDPNVSPEC 278 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 278 (357)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .....++..+
T Consensus 172 ----~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (286)
T cd06614 172 ----KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246 (286)
T ss_pred ----hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHH
Confidence 1123457889999999987776 45699999999999999999999887766555444332222 2223488999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 279 KALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.++|.+||. +|.+||++.++++|+||....+.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 999999995 89999999999999999874443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=304.02 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=216.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+|++.+.||+|+||.||++.+..++..+|+|.+........ ....+.+|+.+++.++|+||+++.+++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999876544332 34455689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999865 356899999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
......|++.|+|||.+.+..+. .++|+||||+++|+|++|+.||...+..+....+......+.....+.++.
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHH
Confidence 12234578899999999877664 459999999999999999999998887777666665554444457889999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+++.+|| .+|.+||++.++++||+.
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999 589999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.93 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=208.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.+.||+|+||.||++.+. ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346899999999999999999876 4568999998654332 23456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 999999999999875 34689999999999999999999999999999999999999999999999999875431110
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......++..|+|||.+.+..+. .++|+||||+++|+|++ |..||......+....+......+....++..+.
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 001111234579999999877764 45999999999999998 8999988877777777776666666667899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+++.+|| .+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999 489999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=319.22 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=206.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------ 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------ 115 (357)
..+|.+.+.||+|+||.||+|.+..++..||+|.+.+.... +.....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 46899999999999999999999989999999998654322 22334566899999999999999999998654
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..+++|+||+.. +|.+++ ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 356999999965 777665 34589999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-------- 267 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-------- 267 (357)
......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.......+.....
T Consensus 170 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 170 ---------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred ---------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 112345788999999987754456679999999999999999999988765443333222110
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 268 ----------------FPK------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 268 ----------------~~~------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+. .+..++.+.+||.+|| .||.+||++.+++.||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 1356788999999999 59999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=361.00 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=219.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
-++..+..||.|.||.||-|.+.++|+..|+|.+..-... ......+.+|..++..++|||+|+++++--+.+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3577789999999999999999999999999998643332 444566789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||++|+|.+++...+..++-..+.+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|.+....... .
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~--~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT--M 1391 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc--C
Confidence 99999999999998888889999999999999999999999999999999999999999999999999877644211 1
Q ss_pred ccccccCCCCCCccchhhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
..-.....||+.|||||++.+.. -...+.|||||||++.||+||+.||...+. ..++-.+..+-..+.+..+|++.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 22334678999999999997542 224458999999999999999999976443 333334443333333445999999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+||.+|| +||++|.++.|+++|.|-+..
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999 699999999999999887643
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.97 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=209.3
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|...+.||+|+||.||+|.+..++..+++|.+.............+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998765444444445567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+.+ +|.+++.. ...+++.+++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------- 172 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------- 172 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---------
Confidence 965 78777754 4578999999999999999999999999999999999999999999999999885421
Q ss_pred cccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKA 280 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 280 (357)
......|+..|+|||++.. ....+.++|+|||||++|+|++|..||...+.......+.. .........++..+.+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1124567889999999842 23335569999999999999999999987765554444332 2222223457888999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
|+.+|| .+|.+||++.+++.||||+..+
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999 4899999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.04 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=206.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
..++|.+.+.||+|+||.||++.+..++..||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 347899999999999999999999999999999998653322 22234566899999999999999999988543
Q ss_pred -CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 -HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 67998887654 58999999999999999999999999999999999999999999999999987532
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-------
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------- 267 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~------- 267 (357)
. ......|++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 172 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 172 D---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred c---------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1 112346788999999987644446679999999999999999999976654443332211100
Q ss_pred -----------------CCC------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 268 -----------------FPK------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 268 -----------------~~~------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+. ....++++.++|.+|| .||.+|+++.+++.||||+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 000 1135788999999999 599999999999999999875543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=303.88 Aligned_cols=246 Identities=34% Similarity=0.577 Sum_probs=211.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||.|+||.||++.+..++..+|+|++.+...........+.+|+.+++.++|+||+++++.++....+++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999998765544443455677899999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCC
Q psy10194 131 LDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210 (357)
Q Consensus 131 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 210 (357)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------SRTNTFC 154 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------CcccCCc
Confidence 9999888789999999999999999999999999999999999999999999999999987543211 1223456
Q ss_pred CCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCC
Q psy10194 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APV 289 (357)
Q Consensus 211 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p 289 (357)
++..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+.. ...+.+...+..+.+++++|| .||
T Consensus 155 ~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 155 GTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred CCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 7889999999987665 4559999999999999999999987776665555544 333444567999999999999 599
Q ss_pred CCCCCH---HhHhcCCcc
Q psy10194 290 KTRLRI---KNIKEDPWF 304 (357)
Q Consensus 290 ~~R~s~---~e~l~hp~f 304 (357)
.+||++ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.34 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=193.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCC-cEEEEE--------------EeecCCCCchHHHhhHHHHHHHHHcCCCCCccc
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHS-CEVAIK--------------IISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~-~~vaiK--------------~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 107 (357)
.+|++.+.||+|+||+||+|...... ...++| .+.+...........+.+|+.+++.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 67999999999999999998764322 222222 111111122233455779999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCe
Q psy10194 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKE-----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI 182 (357)
Q Consensus 108 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~ 182 (357)
+++++.+.+..++|++++.+ +|.+++... .......++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999965 787776432 224467788999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCc---HHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP-FDDTK---YSQL 258 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~p-f~~~~---~~~~ 258 (357)
||+|||++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..+ |.... ...+
T Consensus 307 kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 307 VLGDFGTAMPFEKER-----EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred EEEeCCCceecCccc-----ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999997653211 112234678999999999988777 4559999999999999998754 43221 1222
Q ss_pred HHHHhcc----cCCC--------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 259 LKQVQSK----VVFP--------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 259 ~~~~~~~----~~~~--------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.+.+... ..++ ....++.++.++|.+||. ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 2211100 0000 012356788899999995 99999999999999999875
Q ss_pred CC
Q psy10194 308 PS 309 (357)
Q Consensus 308 ~~ 309 (357)
..
T Consensus 461 ~~ 462 (501)
T PHA03210 461 EE 462 (501)
T ss_pred Cc
Confidence 43
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=306.07 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=206.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|++.++||+|+||.||+|.+..++ .||+|++...... .+.+.+|+.+++.++||||+++++.+. ....++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 4567999999999999999999986654 6999998753322 234678999999999999999999874 456799
Q ss_pred EEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999999753 3578999999999999999999999999999999999999999999999999975432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......++..|+|||...+..+ +.++|+|||||++|+|++ |..||.+.........+......+....++..
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd05071 158 -----TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 231 (262)
T ss_pred -----ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence 11112345678999999877766 455999999999999999 89999888777777777666555555678999
Q ss_pred HHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 278 CKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 278 ~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.+++.+||+ +|.+||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999995 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=312.30 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=211.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
..+|++.+.||+|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4568889999999999999998754 35689999986433 2334566778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~ 180 (357)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998532 3478889999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy10194 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLL 259 (357)
Q Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~ 259 (357)
.+||+|||+++....... ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADY----YKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ceEecccccccccccchh----eeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999875432211 111223345788999999987766 455999999999999997 89999988888888
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 260 KQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+.+......+....++..+.+++.+|| .+|.+||++++++..
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 887776665556679999999999999 589999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.50 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=203.6
Q ss_pred EeeecCceEEEEEEE--CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 50 IIGMGSYATVKLATS--SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4567889999986443 23344566778999999999999999999885 4567899999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
++|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.++|+|||++......... .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe---eeecC
Confidence 999999988788999999999999999999999999999999999999999999999999999764322110 01111
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 286 (357)
...++..|+|||.+....+ +.++|+|||||++|+|++ |..||.........+.+......+.+..+++++.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~ 235 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235 (257)
T ss_pred CCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHh
Confidence 2234678999999876665 445999999999999997 99999988877777777766555555679999999999999
Q ss_pred c-CCCCCCCHHhHhc
Q psy10194 287 A-PVKTRLRIKNIKE 300 (357)
Q Consensus 287 ~-~p~~R~s~~e~l~ 300 (357)
. +|.+||++++|..
T Consensus 236 ~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 236 TYGVDERPGFAVVEL 250 (257)
T ss_pred ccCchhCcCHHHHHH
Confidence 5 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=314.12 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=206.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH---- 116 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~---- 116 (357)
..++|++.+.||+|+||+||+|.+..++..||+|.++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4568999999999999999999999999999999987543222 22344568999999999999999999986654
Q ss_pred ------eEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 117 ------RVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 117 ------~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
.+++|+||+++ +|.+.+... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 89999999986 777777653 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF- 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~- 268 (357)
+........ .......++..|+|||.+.+....+.++|||||||++|+|++|++||...+....+..+......
T Consensus 163 ~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 163 ARLYNSEES-----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccCCcc-----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 875532211 11122345778999999876544466799999999999999999999876655444333321100
Q ss_pred ----------------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 269 ----------------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 ----------------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
.....++..+.++|.+||. +|.+||++++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468999999999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=323.67 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=206.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCC-----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRH-----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~ 112 (357)
.+..++|.++++||+|+||.||+|.+... +..||+|++..... ....+.+.+|+.+++.+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34567899999999999999999986432 34699999865332 233456779999999996 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHc-------------------------------------------------------
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKE------------------------------------------------------- 137 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 137 (357)
.....+++|||||++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999988542
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe
Q psy10194 138 -----------------------------------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176 (357)
Q Consensus 138 -----------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll 176 (357)
..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 236788889999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY 255 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~ 255 (357)
+.++.+||+|||++........ ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred eCCCEEEEEeCCcceecccccc----ccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999875432111 111223346788999999987766 456999999999999996 9999987543
Q ss_pred -HHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 256 -SQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
......+......+....+++.+.+++.+|| .+|++||++.++.+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3344555555555555678999999999999 59999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=307.76 Aligned_cols=251 Identities=28% Similarity=0.439 Sum_probs=207.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|+||+++++.+...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47889999999999999999999899999999887654444444566779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 123 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 3568999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHHhcccCCC-CCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY--SQLLKQVQSKVVFP-KDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~--~~~~~~~~~~~~~~-~~~~~~ 275 (357)
.......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||..... ....+.+......+ ....++
T Consensus 161 -----~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 161 -----TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred -----cccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 11223468899999999987766 4559999999999999999999976543 33334443322222 123578
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+.+++.+|| .+|.+|||+.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999 49999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=306.87 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=211.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3468999999999999999999876444 3689998865332 2335567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.++||||+++++|.+++... +.+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999999765322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.... .......++..|+|||.+.+..+ +.++|+|||||++|++++ |..||......+....+......+....++
T Consensus 160 ~~~~---~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd05066 160 PEAA---YTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235 (267)
T ss_pred ccee---eecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence 1100 01112223567999999987766 455999999999999886 999998887777777777666666666789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+.+++.+|| .+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999999 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=309.09 Aligned_cols=248 Identities=25% Similarity=0.447 Sum_probs=204.4
Q ss_pred EEEeEeeecCceEEEEEEEC----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 46 TLGTIIGMGSYATVKLATSS----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|++.++.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46889999999999999987 45667999999442 2333356677899999999999999999999988889999
Q ss_pred EeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||+++|+|.+++... ..+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999876 6799999999999999999999999999999999999999999999999999976521111
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
........+...|+|||.+....+ +.++||||||+++|++++ |+.||...+..++...+......+....++..+
T Consensus 159 ---~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T PF07714_consen 159 ---YKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDI 234 (259)
T ss_dssp ---EEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHH
T ss_pred ---cccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHH
Confidence 011122335678999999987665 667999999999999999 789999998888888887777666666799999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.++|..|| .+|.+||++.++++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999 59999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.63 Aligned_cols=266 Identities=31% Similarity=0.541 Sum_probs=228.4
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET 114 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~ 114 (357)
....+..++|.+..+||+|+|+.|.+++++.+.+.||+|++++.-..+++..+.++.|-.+..+. +||.+|.+...|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 33456778999999999999999999999999999999999987766666667777888777665 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+..+++|.||++||+|--.++++..|+++.++.+...|..||.|||++||++||||.+|+|+|.+|++||.|+|.++...
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999999888888899999999999999999999999999999999999999999999999999998643
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC-------CCcHHHHHHHH--hcc
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-------DTKYSQLLKQV--QSK 265 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~-------~~~~~~~~~~~--~~~ 265 (357)
.. .....++||||.|+|||++.+..|.-. +|.|+||+++++|+.|+.||. +.+.++.+-++ ...
T Consensus 403 ~~------gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 403 GP------GDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred CC------CcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 22 345678999999999999999988554 999999999999999999995 23344444333 234
Q ss_pred cCCCCCCCCCHHHHHHHHHcc-cCCCCCCC------HHhHhcCCccccCCCC
Q psy10194 266 VVFPKDPNVSPECKALISKIL-APVKTRLR------IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 266 ~~~~~~~~~~~~~~~li~~~L-~~p~~R~s------~~e~l~hp~f~~~~~~ 310 (357)
+..|. .+|-.+..+++..| +||.+|.. +.++..|+||+...|.
T Consensus 476 iripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 476 IRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 44444 57888889999999 69999875 6899999999987653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.23 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=212.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47889999999999999999999999999999876544444445567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 124 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|+.| +|.+++.. ..++++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-------
Confidence 9975 77777643 56789999999999999999999999999999999999999999999999998864321
Q ss_pred ccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECK 279 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 279 (357)
.....|++.|+|||.+.. ....+.++|+|||||++|+|++|..||...........+... ........+++.+.
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence 123457889999999742 233356699999999999999999999877665555444333 22333346889999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+++.+|| .+|.+||++.++++|+|+.....+
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999 589999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=306.85 Aligned_cols=251 Identities=18% Similarity=0.313 Sum_probs=205.7
Q ss_pred EEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe----
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR---- 117 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~---- 117 (357)
|.+++.||+|+||.||.|....+ +..||+|.+....... .....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987543 4789999987543332 234456789999999999999999998865443
Q ss_pred --EEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 118 --VYIIMEYAEKGSLLDIIRKE------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 118 --~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
.++||||+++|+|..++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988432 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
++........ .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+..+.+......
T Consensus 160 ~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 160 SKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234 (273)
T ss_pred eeeccccccc----cccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 8754322110 11112234678999999877666 456999999999999998 99999888877777777766555
Q ss_pred CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 269 PKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.....+++++.+++.+||. +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5556789999999999995 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=326.33 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=214.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+......++..||+|+||+||+|.+.. .||||++..... .+...+.+++|+..+++-+|.||+-+.++|.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3555667889999999999999999865 599999976554 44467889999999999999999999999987776
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
.||+.+|+|-+|..++.- ...|.....+.|++||++|+.|||.++|+|||||..|||+.+++++||+|||++..-....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999999853 3468999999999999999999999999999999999999999999999999998655543
Q ss_pred cccccccccccCCCCCCccchhhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC---
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGI---PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--- 271 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~--- 271 (357)
. ........|...|+|||++..+ +| +..+||||||+++|||++|..||...+.++++-.+-.++..+..
T Consensus 543 g----~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 543 G----EQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred c----ccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 2 2233455678899999999643 44 45599999999999999999999977777777777777666543
Q ss_pred -CCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 272 -PNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 272 -~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
...++++++|+..|++ ++++||.+.+||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 3567899999999995 9999999999887
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=307.84 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=211.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.++||.|+||.||+|.+.. +..+++|++..... .....+.+|+.+++.++|+||+++++++.+.+.+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3469999999999999999999887 78999999865432 1234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+++++|.+++.+ ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999999975 34689999999999999999999999999999999999999999999999999975432110
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+..+....+......+....+++.+
T Consensus 160 -----~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 160 -----LSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI 233 (261)
T ss_pred -----cccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHH
Confidence 1112335678999999987766 455999999999999998 899999888877777777666666667889999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 279 KALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+++.+|| .+|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.87 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=211.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
..+|++.+.||+|+||.||+|.+..++. .||+|.+.... .+.....+.+|+.+++.++||||+++++++.+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999876654 59999986532 233456678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++.. .+.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 4568999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
...... .......+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+......+....++.
T Consensus 161 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 238 (269)
T cd05065 161 SDPTYT-SSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238 (269)
T ss_pred cccccc-cccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence 111100 0001112457999999987777 445999999999999886 9999998888777777776666666677899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+++.+|| .+|.+||++++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=303.08 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=204.0
Q ss_pred eEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec
Q psy10194 49 TIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
++||+|+||.||+|.....+ ..+|+|.+...... ...+.+.+|+.+++.++|+||+++++++. .+.+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999875544 78999998755433 23456778999999999999999999876 45679999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 126 EKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 126 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
++++|.+++...+.+++..++.++.|++.||.|||..|++|+||||+|||++.++.++|+|||.+......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---~~~ 154 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---YRA 154 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc---ccc
Confidence 99999999988888999999999999999999999999999999999999999999999999998765322111 001
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
.....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+......+....+++.+.++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred ccCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111223567999999987776 455999999999999997 999999888777777776665556666789999999999
Q ss_pred ccc-CCCCCCCHHhHhc
Q psy10194 285 ILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 285 ~L~-~p~~R~s~~e~l~ 300 (357)
||. +|++||++.++++
T Consensus 234 cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 234 CWKYRPEDRPTFSELES 250 (257)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 995 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.61 Aligned_cols=253 Identities=21% Similarity=0.378 Sum_probs=209.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
++..+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 35678999999999999999999742 34567889987543 23345567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG---------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD 179 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~ 179 (357)
....++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997643 47899999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQL 258 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~ 258 (357)
+.++|+|||++........ ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY----YRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCEEECCCCceeEcCCCce----eecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999875421110 011122335678999999987776 455999999999999998 9999988777777
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
...+...........+++.+.++|.+|| .||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7666655555555678999999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=319.78 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=201.6
Q ss_pred eEeeec--CceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 49 TIIGMG--SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 49 ~~Lg~G--~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
..||.| +||+||++.+..++..||+|++....... ...+.+.+|+.+++.++||||++++++|...+..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987544333 334677899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc-cc
Q psy10194 127 KGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG-YE 203 (357)
Q Consensus 127 ~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 203 (357)
+++|.+++.+. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++||+.+........... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 3589999999999999999999999999999999999999999999999986543221111000 00
Q ss_pred cccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-c---------------
Q psy10194 204 SLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-V--------------- 266 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~--------------- 266 (357)
.......++..|+|||++.+.. ..+.++|||||||++|+|++|+.||............... .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0111223466799999987642 2356699999999999999999999876543332222111 0
Q ss_pred ------------------------------CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 267 ------------------------------VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 267 ------------------------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..+....+++.+.+|+++||. ||.+|||+.++++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 011112457789999999995 999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.75 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=204.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~l 120 (357)
.++|...+.||+|+||.||++.+..++..+|+|.+...... .....+.+|+.++..+. |+||+++++++......++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35677788999999999999999999999999998754332 23445678999998886 9999999999999999999
Q ss_pred EEeecCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 121 IMEYAEKGSLLDIIR-----KEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 121 v~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+|||+.. +|.++.. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999865 6655432 246799999999999999999999975 99999999999999999999999999987543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhccc--CCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKV--VFP 269 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~--~~~ 269 (357)
.. .......|++.|+|||++.+. ...+.++|||||||++|+|++|+.||..... ......+.... ..+
T Consensus 160 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 160 DS-------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred cC-------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 21 111233578899999999766 2345669999999999999999999976542 12222221111 111
Q ss_pred --CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 270 --KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 --~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
....++.++.+||.+|| .+|.+|||+++++.||||+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 11248899999999999 5999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=328.94 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=215.0
Q ss_pred ecCE-EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCC-CCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC--e
Q psy10194 42 SHGY-TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ-APSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH--R 117 (357)
Q Consensus 42 ~~~y-~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~--~ 117 (357)
..+| ++..+||+|+|-+||+|.+..+|..||.--++... ...+...+.+..|+.+|+.|+||||+++++.+.+.. .
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3444 45778999999999999999999999876554322 122333567789999999999999999999886654 4
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEec-CCCCeEEeecccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLID-ADYNIKLSDFGFARNHM 194 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 194 (357)
+.+|+|.+..|+|..++++.+..+.+.++.|++||++||.|||++. |+|||||-+||||+ ..|.+||+|+|+|....
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999999999999999999999999999999885 99999999999996 56899999999998643
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHHhcccCCCCC-C
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKVVFPKD-P 272 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~-~~~~~~~~~~~~~~~~~~~~-~ 272 (357)
. ......+|||.|||||.+. ..| ...+||||||++|.||.|+..||. +.+..++.+++..+...... .
T Consensus 198 ~--------s~aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 K--------SHAKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred c--------cccceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 2 2223468999999999997 344 666999999999999999999996 46778888888877654322 2
Q ss_pred CCCHHHHHHHHHcccCCCCCCCHHhHhcCCccccC
Q psy10194 273 NVSPECKALISKILAPVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 273 ~~~~~~~~li~~~L~~p~~R~s~~e~l~hp~f~~~ 307 (357)
--+|++++||.+||...+.|+|+.|+|.||||+..
T Consensus 268 V~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLATKSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcCchhccCHHHHhhChhhccc
Confidence 23799999999999779999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=318.55 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=209.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeC--CeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETT--HRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~--~~~ 118 (357)
.++|.+.+.||+|+||.||+|.+..++..+|+|.+......... ...+.+|+.+++.+ +||||+++++++... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 46799999999999999999999988999999988653322222 33455899999999 999999999998643 468
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+.+ +|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999975 999988765 789999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-----------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV----------- 267 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~----------- 267 (357)
.. .........|++.|+|||.+.+....+.++|+||||+++|+|++|+.||.+....+....+.....
T Consensus 163 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 163 NP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred cc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 11 011223456899999999887655556679999999999999999999976554433332211110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 -------------------FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 -------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
....+.++.++.++|.+||. +|.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00113478999999999995 999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.33 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=208.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS-------RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~ 111 (357)
+...+|.+.+.||+|+||.||+|.+. .....+|+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 34468999999999999999999863 2345689998864332 22244567899999999 59999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
+.+...+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999653 34788999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.+||+|||+++........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EcCCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999754321110 11112234567999999987666 456999999999999998 899999888
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
..+....+...........++.++.+++.+||. +|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 888777777665444455788999999999995 8999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.89 Aligned_cols=259 Identities=25% Similarity=0.468 Sum_probs=210.5
Q ss_pred CEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~ 118 (357)
.|++.+.||.|+||.||+|... .+|..||+|++...... .....+.+.+|+.+++.+ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47889999998653221 122345567899999999 589999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcccCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTK----YSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 273 (357)
.......|+..|+|||.+.... ..+.++||||||+++|+|++|..||.... ...+.+.+... ..+....
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (290)
T cd05613 161 -----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQE 234 (290)
T ss_pred -----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCcc
Confidence 1122456889999999987532 33556999999999999999999996432 23333333222 2233456
Q ss_pred CCHHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
+++.+.+++.+|| .+|.+|+ ++++++.||||+...
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8999999999999 5899997 899999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=319.12 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=202.3
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe-
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~- 114 (357)
.++|++.+.||+|+||.||+|.... ++..||+|++..... .. ..+.+.+|+.+++.+ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~-~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-AS-EYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HH-HHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4579999999999999999997533 457899998864322 22 234456899999999 79999999998854
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc---------------------------------------------------------
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE--------------------------------------------------------- 137 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------- 137 (357)
...++++|||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46788999999999999998542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCC
Q psy10194 138 ----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213 (357)
Q Consensus 138 ----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~ 213 (357)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ........++.
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----~~~~~~~~~~~ 239 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVRKGDARLPL 239 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc----hhhccCCCCCc
Confidence 2578999999999999999999999999999999999999999999999999976532211 11122344577
Q ss_pred CccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCC
Q psy10194 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYS-QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVK 290 (357)
Q Consensus 214 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~ 290 (357)
.|+|||++.+..+.. ++|||||||++|+|++ |..||.+.... .+...+............++++.+++.+||+ +|.
T Consensus 240 ~y~aPE~~~~~~~~~-~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 240 KWMAPESIFDKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cccCcHHhcCCCCCc-cccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 899999998887754 5999999999999997 99999775433 3334444444444445688999999999994 999
Q ss_pred CCCCHHhHhcC
Q psy10194 291 TRLRIKNIKED 301 (357)
Q Consensus 291 ~R~s~~e~l~h 301 (357)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.38 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=206.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcE----EEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCE----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+...+|++.+.||+|+||+||+|.+..++.. +++|.+.... .......+..|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 35567899999999999999999998777664 6667664321 12223456678888999999999999998754
Q ss_pred CCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...++++||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 557889999999999999975 457899999999999999999999999999999999999999999999999999754
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
..... ........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......+.+......+...
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05111 160 YPDDK----KYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ 234 (279)
T ss_pred cCCCc----ccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence 32111 111223456778999999987766 456999999999999998 999999887777666666555555455
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+.++.+++.+|+ .+|.+|||+.++++
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 235 ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67889999999999 59999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=311.62 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=212.3
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-------RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQ 110 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~ 110 (357)
.+...+|.+.+.||+|+||.||+|++. .++..+|+|.+..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 366788999999999999999999752 2345799998864322 22345577999999999 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 111 AIETTHRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 111 ~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
.+......++||||+++|+|.+++.+. ..++...+..++.||+.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999753 2467888999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.++.++|+|||++........ ........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY----YKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccc----cccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999976532211 111122345678999999987766 455999999999999998 88999988
Q ss_pred cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
...++.+.+...........++..+.+++.+||. +|.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8888888887666555556789999999999995 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.59 Aligned_cols=251 Identities=18% Similarity=0.349 Sum_probs=204.2
Q ss_pred EEEEeEeeecCceEEEEEEECCCCc--EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------C
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSC--EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------H 116 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------~ 116 (357)
|.++++||+|+||.||+|.+..++. .+|+|.++..... ....+.+.+|+.+++.++|+||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578899999999999999877765 5899988654332 33345667899999999999999999987432 3
Q ss_pred eEEEEEeecCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
..++||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999998742 234789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
........ ........+++.|+|||.+.+..+ +.++|||||||++|+|++ |+.||......+..+.+......+
T Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 160 KKIYNGDY----YRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred cccCcccc----eecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 76432111 011122345778999999987766 455999999999999998 899998887777777777665555
Q ss_pred CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 270 KDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+.++..+.++|.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 556789999999999995 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=339.18 Aligned_cols=150 Identities=27% Similarity=0.513 Sum_probs=139.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
-.+|.+.++||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999765555555566788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
|||+.|++|.+++...+.+++..++.++.||+.||.|||..||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.96 Aligned_cols=250 Identities=24% Similarity=0.423 Sum_probs=211.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45678999999999999999999975 4567999998754332 245678999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999999764 368999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||.+.+... +.++|+||||+++|+|++ |+.||.+.........+......+.....+.
T Consensus 158 ~-----~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (261)
T cd05034 158 Y-----TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE 231 (261)
T ss_pred h-----hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 0 00111223568999999987666 455999999999999998 9999998888888888877766666667899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
++.+++.+|| .+|.+||+++++.+
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999 58999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.78 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=207.7
Q ss_pred CEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
+|++.+.||+|+||.||+|.... ....+++|.+..... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998643 234688888764332 22235577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 119 YIIMEYAEKGSLLDIIRKE------------------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
++|+||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478899999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.++.++|+|||++......... .......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999998754321110 01122345678999999877666 456999999999999998 99999988
Q ss_pred cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
....+.+.+......+....++.++.+++..||+ +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8888887777666666666789999999999994 8999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=303.93 Aligned_cols=255 Identities=21% Similarity=0.343 Sum_probs=211.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+..++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++|+||+++.+++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876554 689998865432 223455778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999975 35789999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
..... ........++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+......+....+
T Consensus 160 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 160 DPEGT---YTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235 (268)
T ss_pred ccccc---eeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 11100 00111223457999999987666 556999999999999997 99999888877777777766666666678
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.++.+++.+|+. +|.+||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999995 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.88 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=212.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+...+|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4567889999999999999999999876654 588998765432 3334567789999999999999999999987
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++|++|+||||+|||++.++.++|+|||.+...
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999999764 46899999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
....... ......++..|+|||.+....+. .++|+|||||++|++++ |+.||......++.+.+......+.+.
T Consensus 160 ~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05057 160 DVDEKEY----HAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234 (279)
T ss_pred cCcccce----ecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 4221110 11112235679999998776664 55999999999999998 999999988888877777666666666
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+..+.+++.+|| .+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 78899999999999 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=303.26 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=206.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.++||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++. ....++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4568999999999999999999865 4557999998754432 234678999999999999999999885 456789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998753 3589999999999999999999999999999999999999999999999999975432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+..+....+......+.....+..
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05070 158 -----TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231 (260)
T ss_pred -----ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 11112234567999999877666 455999999999999999 99999988887777777766666666678999
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+++.+|| .+|.+|||++++.+
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=309.79 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=207.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|.+.+.||+|+||.||++.+ ..++..+|+|.++.... ....+.+.+|+.+++.+ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 6667899999999999999999975 23455799998865432 23345677999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
..+..++||||+.+|+|.+++.... .+++.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999999997543 38999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHH-HHHHHhcccCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQ-LLKQVQSKVVFP 269 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~-~~~~~~~~~~~~ 269 (357)
........ .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||....... ....+.......
T Consensus 190 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T cd05055 190 DIMNDSNY----VVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264 (302)
T ss_pred cccCCCce----eecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence 54322110 11122345788999999987776 456999999999999998 999998766544 333444444444
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.....++++.+++.+|| .+|.+||++.++++
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44568899999999999 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.27 Aligned_cols=244 Identities=27% Similarity=0.489 Sum_probs=209.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|++.+.||.|+||.||+|... +..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4568999999999999999999865 67899999865432 24556789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999999997765 689999999999999999999999999999999999999999999999999976521111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
...++..|+|||.+....+ +.++|+||||+++|+|++ |..||......+....+...........+++.
T Consensus 158 ---------~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05039 158 ---------SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227 (256)
T ss_pred ---------cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHH
Confidence 1223567999999877666 456999999999999997 99999988888877777665554445578999
Q ss_pred HHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 278 CKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 278 ~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.++|.+||. +|.+||++.++++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999995 9999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=301.63 Aligned_cols=249 Identities=22% Similarity=0.413 Sum_probs=208.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||.||+|... ++..||+|.+...... ...+.+|+.+++.++|+||+++++++. .+.++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 5678999998654432 235668999999999999999999874 46789
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||+.+++|.+++... ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||++....+ +.++||||||+++|+|++ |+.||.+.+..+....+......+.....+.
T Consensus 157 ~-----~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05067 157 Y-----TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE 230 (260)
T ss_pred c-----ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCH
Confidence 1 11112345678999999987766 455999999999999998 9999998888777777776666666667889
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
++.+++.+|| .+|.+||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999 59999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=305.33 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=204.1
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEEeCCe----
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIETTHR---- 117 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~~~~~---- 117 (357)
|++.+.||+|+||.||+|.+..++..+|+|.+...... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 68899999999999999999888999999999754432 22334455777777655 59999999999988776
Q ss_pred -EEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 118 -VYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 118 -~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
++++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8998887643 58999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC----
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK---- 270 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~---- 270 (357)
... ......++..|+|||++.+..+ +.++|+|||||++|+|++|.+||......+....+......+.
T Consensus 159 ~~~-------~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 159 FEM-------ALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred CCc-------ccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 211 1122346889999999988776 4559999999999999999999988776665555533211100
Q ss_pred ----------------------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 271 ----------------------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 271 ----------------------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.+.+++.+.++|.+|| .||.+||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0235688899999999 599999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.74 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=209.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
..|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++.++|+|++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34778899999999999999999999999999987543333333445668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+.+ +|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 99974 88777643 55689999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 278 (357)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+.... .......++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence 123457889999999752 2233556999999999999999999998766554444433322 222334688999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.++|++|| .+|.+||++.+++.|||+...
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999 589999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.87 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=207.9
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|++.+.||+|++|.||+|....+++.+|+|++..... .+...+.+.+|+.+++.++|+||+++++++.+.+.+++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6778999999999999999999999999999976542 223344566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+++ +|.+++.+. ..+++..++.++.|++.||.+||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 985 999999876 5799999999999999999999999999999999999999999999999999876432111
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-----------------
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV----------------- 266 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~----------------- 266 (357)
......++..|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223457789999998776444666999999999999999999998876554444332211
Q ss_pred --CCC---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 267 --VFP---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 --~~~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
.++ ..+.++..+.++|.+|| .+|++||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001 01245789999999999 599999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.42 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=210.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~ 111 (357)
+...+|.+++.||+|+||.||+|.+.. ....+|+|.+.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 444679999999999999999998643 22368999876432 223345677899999999 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
+......++++||+++|+|.+++.+.. .++...+..++.|++.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999997532 3677889999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.++|+|||+++....... ........++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDY----YKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EcCCCcEEECCcccceecccccc----cccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999875432111 0111223345679999999887774 45999999999999998 899999988
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+....+......+.....+.++.+++.+||. +|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888888777666655556788999999999995 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=301.59 Aligned_cols=269 Identities=22% Similarity=0.347 Sum_probs=217.1
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-- 114 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-- 114 (357)
-...+.+.|+-..+||+|.||.||+|+.+.+++.||+|++--.......-.. ..+|+++|+.|.|+|++.++++|..
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpit-alreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHH-HHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 3456677899999999999999999999999999999876433322222233 3489999999999999999988732
Q ss_pred ------CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 115 ------THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 115 ------~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
...+|+||.+|+. +|.-++... -+++..++..++++++.||.|+|.+.|+|||+|+.|+|++.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3458999999987 999888654 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS--- 264 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~--- 264 (357)
|+++.+....... ....+..+.|.+|++||.+.+...++.+.|||..|||+.+|.+|.+.|.++.....+..|..
T Consensus 169 Glar~fs~~~n~~--kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 169 GLARAFSTSKNVV--KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccceecccccC--CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9998765433222 22245566799999999999887777779999999999999999999998877665554431
Q ss_pred ccC---CCC---------------C-------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 265 KVV---FPK---------------D-------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 265 ~~~---~~~---------------~-------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
... +|. . -.-++++.+|+..||+ ||.+|+++++++.|.||...+.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 110 110 0 0125688999999996 9999999999999999987554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=303.49 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=208.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC--chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
+|.+.+.||+|+||.||++.+...+..+++|+++..... .......+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999998877777777776543221 111223455789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999988853 456899999999999999999999999999999999999974 67999999998754321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
........|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...........+...........++.+
T Consensus 159 -----~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 159 -----CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred -----cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence 1122345578899999998776664 4599999999999999999999877766665555544333334568899
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+.++|.+|| .+|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999 589999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.65 Aligned_cols=265 Identities=22% Similarity=0.401 Sum_probs=227.1
Q ss_pred CCCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC
Q psy10194 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102 (357)
Q Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (357)
+...+.+.+...+...+-.+.+.||+|+||.||+|... +....||||.++... +...++.|+||+.++..|+|
T Consensus 471 ~~~~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H 548 (774)
T KOG1026|consen 471 EPQLNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQH 548 (774)
T ss_pred CCCCCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccC
Confidence 44555677777888999999999999999999999743 244579999986543 34457889999999999999
Q ss_pred CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Q psy10194 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG--------------YIDETRARKWFAQLVDAINYCHERGVVHRD 168 (357)
Q Consensus 103 ~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~givH~d 168 (357)
||||+|+++|..++.+++|+|||..|+|.++|.... +|+..+.+.|+.||+.|+.||-++.+||||
T Consensus 549 ~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 549 PNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred CCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 999999999999999999999999999999996421 288999999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCC
Q psy10194 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGR 247 (357)
Q Consensus 169 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~ 247 (357)
|-.+|+||+.+..+||+|||+++..-.. ++......-.-...|||||.+....+.+. |||||+||+|||++ .|+
T Consensus 629 LATRNCLVge~l~VKIsDfGLsRdiYss----DYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~ 703 (774)
T KOG1026|consen 629 LATRNCLVGENLVVKISDFGLSRDIYSS----DYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGK 703 (774)
T ss_pred hhhhhceeccceEEEecccccchhhhhh----hhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhcccc
Confidence 9999999999999999999999853211 01111111112568999999999999666 99999999999999 599
Q ss_pred CCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHh
Q psy10194 248 LPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIK 299 (357)
Q Consensus 248 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l 299 (357)
.||.+...+++++.+..+-..+.+.+++.++.+|+..|+ ..|.+||++.||-
T Consensus 704 QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 704 QPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999999998889988999999999999999 5899999999874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=306.66 Aligned_cols=253 Identities=25% Similarity=0.452 Sum_probs=211.0
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
....+||+|+||.||++....++..||+|.+.... ......+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33468999999999999999999999999875322 223455778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 126 EKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 126 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
++++|.+++.. +.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~~ 172 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PR 172 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc------cc
Confidence 99999998754 468999999999999999999999999999999999999999999999999886543211 11
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKALIS 283 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~ 283 (357)
.....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..... ......+++.+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 123467899999999877666 4569999999999999999999988776665555543322 2233468899999999
Q ss_pred Hcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 284 KIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 284 ~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+|| .+|.+||++.+++.||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999 59999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=300.61 Aligned_cols=243 Identities=26% Similarity=0.453 Sum_probs=204.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE-EeCCeEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-ETTHRVY 119 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-~~~~~~~ 119 (357)
...+|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++ ......+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4468999999999999999999765 6689999875422 134567899999999999999999875 4556789
Q ss_pred EEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999999997643 4789999999999999999999999999999999999999999999999998754221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
.....++..|+|||++.+..+. .++|||||||++|+|++ |+.||...+..+....+.........+.+++
T Consensus 156 --------~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05082 156 --------QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226 (256)
T ss_pred --------CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 1122345679999999877664 55999999999999997 9999998888777777766655555567899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+++.+|| .+|.+|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999 59999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=300.93 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=205.5
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|++...||+|++|.||+|.+..+. .+|+|.+...... .+.+.+|+.+++.++|+|++++++++. .+..++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 3467999999999999999999876554 6899987653322 345668999999999999999999885 456789
Q ss_pred EEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999753 3478999999999999999999999999999999999999999999999999975432111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......++..|+|||.+.+... +.++|+||||+++|+|++ |..||.+....+....+......+.....+..
T Consensus 158 -----~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05069 158 -----TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPES 231 (260)
T ss_pred -----cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 11112235678999999877665 456999999999999999 99999988877777777666555555678999
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+++++|| .+|.+||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999 59999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.61 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=209.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998743 56789999886433 233345677899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG----------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCEN 173 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~N 173 (357)
...++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999996432 36788899999999999999999999999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDD 252 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~ 252 (357)
||++.++.++|+|||++........ ........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY----YKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCcc----ccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999875432111 011112234667999999887776 456999999999999997 8899988
Q ss_pred CcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 253 TKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
....+....+......+....++.++.+|+.+||. +|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88777777776555555455789999999999995 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.95 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=206.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCC----------------cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHS----------------CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (357)
...+|++.+.||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999999999876533 4579998865432 233556778999999999999
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCc
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-----------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCEN 173 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~N 173 (357)
|+++++++......++|||++.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 68999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh--CCCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF--GRLPFD 251 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~--G~~pf~ 251 (357)
|+++.++.++|+|||++....... .........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD----YYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCc----ceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999987542211 1112224456788999999887665 456999999999999997 788998
Q ss_pred CCcHHHHHHHHhcc-------cCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 252 DTKYSQLLKQVQSK-------VVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 252 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.....+.+..+... ...+....++.++.+++.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 77666655554322 1223334578999999999994 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=323.03 Aligned_cols=243 Identities=33% Similarity=0.542 Sum_probs=205.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~ 119 (357)
....|.+...+|.|+|+.|..+.+..+++.+++|++.+.... ..+|+.++... +||||+++.+++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 356789999999999999999999999999999999775221 22566554444 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe-cCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI-DADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+|||.+.|+.|.+.+...+.+. .++..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999998887766555 8888999999999999999999999999999999 68999999999999865422
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 277 (357)
..+.|-|..|.|||++....| +.++|+||||++||+||+|..||...... ++..++... . ....+|..
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~-~--~s~~vS~~ 538 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP-K--FSECVSDE 538 (612)
T ss_pred -------hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC-c--cccccCHH
Confidence 234566899999999997777 56699999999999999999999865554 444443322 1 12579999
Q ss_pred HHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 278 CKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 278 ~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
+++||.+||+ ||.+|+++.+++.||||
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccCcch
Confidence 9999999995 99999999999999999
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=303.14 Aligned_cols=254 Identities=20% Similarity=0.339 Sum_probs=210.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET- 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~- 114 (357)
+..++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 566789999999999999999999876 35788999875332 23335567789999999999999999998765
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEee
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE--------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~D 186 (357)
....+++++|+.+++|.+++... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57789999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcc
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSK 265 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~ 265 (357)
||+++........ .......++..|+|||.+.+..+ +.++|||||||++|++++ |+.||...+..+....+...
T Consensus 161 ~g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 161 NALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCcccccCCceE----EeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999754321110 01112335678999999987766 556999999999999998 99999988877777777766
Q ss_pred cCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 266 VVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 266 ~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
...+....+++++.+++.+|| .+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 655555567899999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=308.17 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=203.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCC--------------CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCcc
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRH--------------SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~--------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 106 (357)
..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 457899999999999999999987543 2358999986532 233345677999999999999999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 107 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
++++++......++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986432 368889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh--CCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF--GRLPFDD 252 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~--G~~pf~~ 252 (357)
+++.++.+||+|||++........ ........++..|+|||++.+..+ +.++|+|||||++|+|++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc----eeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999875432111 111223345778999999887776 556999999999999987 7789987
Q ss_pred CcHHHHHHHHhc-------ccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 253 TKYSQLLKQVQS-------KVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 253 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+..+....+.. .......+.+++.+.+|+.+||. +|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 766665544321 11122344678999999999995 9999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=306.30 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=208.3
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|.+.+.||+|++|.||+|.+..++..+++|.+....... .....+.+|+.+++.++|+||+++++++.++..+++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677899999999999999999899999999986544332 2345566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 976 88888765 4678999999999999999999999999999999999999999999999999987553221
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC--------------
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP-------------- 269 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 269 (357)
.......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 111234578899999999876445677999999999999999999998877655444432211110
Q ss_pred ---------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 270 ---------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 270 ---------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
..+.++.++.++|.+||. ||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112478899999999995 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=298.89 Aligned_cols=244 Identities=21% Similarity=0.365 Sum_probs=201.0
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 50 IIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++. ...+++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999764 445679999986543 2344566789999999999999999999885 4578999999999
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccc
Q psy10194 128 GSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206 (357)
Q Consensus 128 gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 206 (357)
++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---KAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce---ecc
Confidence 999999875 4578999999999999999999999999999999999999999999999999987543211100 011
Q ss_pred ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHc
Q psy10194 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKI 285 (357)
Q Consensus 207 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 285 (357)
....+++.|+|||.+.+..+ +.++|||||||++|++++ |..||......+....+......+.+...++++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11223578999999887666 456999999999999996 9999998888777777776666566667899999999999
Q ss_pred cc-CCCCCCCHHhHhc
Q psy10194 286 LA-PVKTRLRIKNIKE 300 (357)
Q Consensus 286 L~-~p~~R~s~~e~l~ 300 (357)
|. +|++||++.++.+
T Consensus 235 ~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 235 WIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCChhhCcCHHHHHH
Confidence 95 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=309.39 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=208.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-CCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-THRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-~~~~ 118 (357)
...++|.+.+.||.|+||.||+|.+..++..||+|.+.+.... ....+.+.+|+.+++.++||||+++.+++.. ...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3567899999999999999999999999999999988653322 2234556689999999999999999999865 5678
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||.+.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 9999999 4589888764 4588999999999999999999999999999999999999999999999999864321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc--------------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-------------- 264 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-------------- 264 (357)
......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||...........+..
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 ------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 112345688999999987644446679999999999999999999976554222111110
Q ss_pred -------------ccCCC---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 265 -------------KVVFP---KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 265 -------------~~~~~---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
....+ ..+.+++.+.++|.+|| .+|++||++++++.||||.....++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~ 299 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence 00001 11357899999999999 49999999999999999976555443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=304.99 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=203.5
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEEe
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
|++.+.||+|++|+||+|....++..|++|.+.......+ .....+|+..++.++ |+||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6789999999999999999998899999999865433222 122347899999999 9999999999999999999999
Q ss_pred ecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 779999887654 78999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF------------- 268 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~------------- 268 (357)
......|+..|+|||++......+.++|+||||+++++|++|+.||......+....+......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred ---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1123457889999998865554566799999999999999999999776554433322211000
Q ss_pred -------C---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 269 -------P---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 269 -------~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+ ..+..+..+.++|.+|| .+|.+||+++|++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 01134688999999999 499999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=301.33 Aligned_cols=242 Identities=27% Similarity=0.430 Sum_probs=199.9
Q ss_pred eEeeecCceEEEEEEECCCCc--EEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEEEEeec
Q psy10194 49 TIIGMGSYATVKLATSSRHSC--EVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
+.||+|+||.||+|.+.+++. .+++|.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999887775 46788775322 223345667899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 126 EKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 126 ~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
++|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997542 478999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
+....... .......+..|+|||++....+ +.++|+|||||++|+|++ |..||.+.+.....+.+......
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC
Confidence 85322110 0111233567999999877666 456999999999999996 99999888877777777665555
Q ss_pred CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 269 PKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+....++.++.+++.+|+. +|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 5555688999999999995 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=304.35 Aligned_cols=260 Identities=26% Similarity=0.484 Sum_probs=209.4
Q ss_pred CEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~ 118 (357)
+|++.+.||+|++|.||++.+. .++..||+|.+.+.... .....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999854 46778999998753221 122344566899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+.+++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcccCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTK----YSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 273 (357)
.......|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .....+.+... ..+....
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (288)
T cd05583 161 -----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKT 234 (288)
T ss_pred -----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcc
Confidence 1122346889999999987643 23556999999999999999999996432 22333333222 2334456
Q ss_pred CCHHHHHHHHHcc-cCCCCCCC---HHhHhcCCccccCCC
Q psy10194 274 VSPECKALISKIL-APVKTRLR---IKNIKEDPWFRNGPS 309 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s---~~e~l~hp~f~~~~~ 309 (357)
+++.+.++|.+|| .+|++||| +.++++||||+...+
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 8899999999999 59999998 567899999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.59 Aligned_cols=253 Identities=21% Similarity=0.403 Sum_probs=206.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC--CC----CccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--HP----NLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~Iv~l~~~~~ 113 (357)
....+|.+.+++|+|+||.|-.+.+..++..||+|+++.. +..+++..-|+++|+.+. .| -++.+.++|+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3467899999999999999999999999999999999653 344566668999999994 23 3678889999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-------------
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA------------- 178 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~------------- 178 (357)
..++.|||+|.+ |-|+++++.++. +++...++.++.||+.++++||+.+++|.||||+|||+..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999999 569999998765 6889999999999999999999999999999999999821
Q ss_pred -------CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy10194 179 -------DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD 251 (357)
Q Consensus 179 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~ 251 (357)
+..++|+|||.|...... ....+.|..|+|||++.+-+|+.+ +||||+||||+|+.+|...|.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~---------hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH---------HSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC---------cceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecc
Confidence 235899999999865322 245677999999999999999655 999999999999999999998
Q ss_pred CCcHHH---HHHHHhcccC-------------------CCC-----------------------CCCCCHHHHHHHHHcc
Q psy10194 252 DTKYSQ---LLKQVQSKVV-------------------FPK-----------------------DPNVSPECKALISKIL 286 (357)
Q Consensus 252 ~~~~~~---~~~~~~~~~~-------------------~~~-----------------------~~~~~~~~~~li~~~L 286 (357)
..+..+ +++.+...+. ++. .+....++.|||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 655333 4444432110 000 0112345789999999
Q ss_pred c-CCCCCCCHHhHhcCCccccC
Q psy10194 287 A-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 287 ~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
. ||.+|+|+.|+|.||||...
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 6 99999999999999999853
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.03 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=207.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|++.+.||+|+||.||++... .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+.. ..++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999865 44579999876432 123456789999999999999999999877 7789
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||+++++|.+++.+. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 457888999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+......+.....+.
T Consensus 157 ~-----~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05073 157 Y-----TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230 (260)
T ss_pred c-----ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCH
Confidence 1 11112235677999999987665 445999999999999998 9999998888777777777766666678899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
++.+++.+|| .+|.+||++.++++
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999 59999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.24 Aligned_cols=261 Identities=24% Similarity=0.393 Sum_probs=206.9
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETT 115 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~ 115 (357)
...+..++|++.+.||+|+||.||+|.+..++..||+|.+.+..... . ...+.+|+.++... .|+||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-E-NKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-H-HHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 34556788999999999999999999999889999999997543322 2 33344567666555 599999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...++||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999864 78877755 4578999999999999999999997 59999999999999999999999999998654
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhccc--C
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIP---YCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKV--V 267 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~--~ 267 (357)
.... ......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|+.||..... .+.+..+.... .
T Consensus 166 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 166 VDSK-------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238 (296)
T ss_pred cCCC-------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC
Confidence 3211 112234688999999987543 234569999999999999999999976432 23333333222 2
Q ss_pred CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 268 FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.+....++.++.+|+.+|| .+|.+||++++++.||||+..
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 2222357899999999999 599999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=297.42 Aligned_cols=245 Identities=24% Similarity=0.419 Sum_probs=202.3
Q ss_pred eEeeecCceEEEEEEECC-CC--cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec
Q psy10194 49 TIIGMGSYATVKLATSSR-HS--CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
+.||+|++|.||+|.+.. ++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999755 33 35899998765443 445667799999999999999999999988 8999999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 126 EKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 126 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999999997654 6899999999999999999999999999999999999999999999999999865432111 1
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKAL 281 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 281 (357)
.......++..|+|||.+.+..+. .++|||||||++|+|++ |..||...+..+..+.+.. ....+....++..+.++
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 111234567889999998877764 45999999999999998 9999988777776666553 22333344678999999
Q ss_pred HHHcc-cCCCCCCCHHhHhc
Q psy10194 282 ISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+|| .+|.+||++.++++
T Consensus 234 i~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHCCCCcccCCCHHHHHH
Confidence 99999 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.50 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=209.5
Q ss_pred EEEeEeeecCceEEEEEEECCCC----cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHS----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+.+.||.|+||.||++.+...+ ..+|+|.+...... ...+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 56789999999999999998766 88999998654322 1345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999976544 899999999999999999999999999999999999999999999999999765422110
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
. .....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.....+.+......+.....+.++
T Consensus 160 ~-----~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T smart00219 160 K-----KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI 233 (258)
T ss_pred c-----cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence 0 001226789999999866555 556999999999999998 899999888888877777666555556789999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhc
Q psy10194 279 KALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+++.+||. +|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 999999995 9999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.13 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=202.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC----------------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR----------------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 105 (357)
.++|++.+.||+|+||.||++.+.. ++..+|+|++.... .......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986432 34468999886432 23334567799999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-----------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987542 366788999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh--CCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF--GRLPFDD 252 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~--G~~pf~~ 252 (357)
|++.++.++|+|||++........ ........+++.|+|||...+..+ +.++|+|||||++|+|++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY----YRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc----eeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999875432111 111122334678999998877766 456999999999999998 7899987
Q ss_pred CcHHHHHHHHhc-------ccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 253 TKYSQLLKQVQS-------KVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 253 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+..+....... ....+....+++.+.+|+.+|| .||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666555443321 2223444568899999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.02 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=204.5
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
++||+|+||.||++.+.. +..||+|.+...... .....+.+|+++++.++|+||+++++++.+....++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 889999988654332 33456778999999999999999999999999999999999999
Q ss_pred CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 129 SLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 129 sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
+|.+++.. ...+++..+..++.+++.+|.|||++|++||||+|+|||++.++.++|+|||++........ .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~ 153 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY----TVSDG 153 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc----eeccc
Confidence 99999865 45689999999999999999999999999999999999999999999999999875431110 00111
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 286 (357)
...++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+......+.....+.++.+++.+||
T Consensus 154 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred cCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence 2233567999999887766 456999999999999998 89999888777777777665555555678999999999999
Q ss_pred -cCCCCCCCHHhHhc
Q psy10194 287 -APVKTRLRIKNIKE 300 (357)
Q Consensus 287 -~~p~~R~s~~e~l~ 300 (357)
.+|.+||++.++++
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 58999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=296.23 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=208.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++||||+++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999875 3568999988654332 23466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+++++|.+++... +.+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 9999999999998764 5689999999999999999999999999999999999999999999999999875421110
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.........+.+............+..+.
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 01112234568999999987666 456999999999999998 9999998887777777766544444456789999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcC
Q psy10194 280 ALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+|+.+||. +|.+||++.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999995 89999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.11 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=207.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+...+|.+.+.||+|+||.||+|.+... ...+++|....... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4556799999999999999999987543 34689998754332 3345567799999999999999999999876 4
Q ss_pred eEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5679999999999999997643 589999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
... .......+++.|+|||.+....+ +.++||||||+++|+|++ |..||......+....+......+....+
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05056 160 ESY-----YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC 233 (270)
T ss_pred ccc-----eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 211 01112234568999999877666 456999999999999985 99999888777777677666555566678
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+..+.++|.+|+. +|.+|||+.+++.
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999995 8999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.64 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=196.3
Q ss_pred CEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCe
Q psy10194 44 GYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THR 117 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~ 117 (357)
.|.+.+.||+|+||+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 34899999999999998865 345677899999865422 2234556789999999999999999998765 346
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+++||||+++++|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999999999999764 49999999999999999999999999999999999999999999999999987553211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---------------HHHHHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---------------QLLKQV 262 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---------------~~~~~~ 262 (357)
.. ........++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... ...+.+
T Consensus 162 ~~---~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 162 EY---YRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred hh---hccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 10 011122345667999999887666 45699999999999999999998643211 111111
Q ss_pred hcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 263 QSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
......+....++.++.+++.+||. +|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222233345678999999999995 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=294.03 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=202.4
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
++||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 47999999999999864 67789999886543 2233445778999999999999999999999999999999999999
Q ss_pred CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccc
Q psy10194 129 SLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207 (357)
Q Consensus 129 sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 207 (357)
+|.+++.. ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~ 152 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-----YSSSG 152 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-----cccCC
Confidence 99999865 3468999999999999999999999999999999999999999999999999986432111 01111
Q ss_pred cCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc
Q psy10194 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286 (357)
Q Consensus 208 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 286 (357)
...+++.|+|||++.+..+ +.++||||||+++|++++ |..||...........+...........++..+.+++.+||
T Consensus 153 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred CCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 2234567999999977665 456999999999999998 99999988877777777666555555678999999999999
Q ss_pred -cCCCCCCCHHhHhc
Q psy10194 287 -APVKTRLRIKNIKE 300 (357)
Q Consensus 287 -~~p~~R~s~~e~l~ 300 (357)
.+|.+||++.++++
T Consensus 232 ~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 232 DYKPENRPKFSELQK 246 (250)
T ss_pred ccCcccCCCHHHHHH
Confidence 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=312.50 Aligned_cols=255 Identities=20% Similarity=0.351 Sum_probs=201.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|++.+.||+|+||.||+|.+ ..++..||||++...... .....+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456899999999999999999984 345778999998653322 2234566899999999 6899999999875
Q ss_pred e-CCeEEEEEeecCCCCHHHHHHHc-------------------------------------------------------
Q psy10194 114 T-THRVYIIMEYAEKGSLLDIIRKE------------------------------------------------------- 137 (357)
Q Consensus 114 ~-~~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 137 (357)
. ...+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45688999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 138 ------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 138 ------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~ 237 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----YVR 237 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc----hhh
Confidence 2367788899999999999999999999999999999999999999999999875422111 011
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY-SQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||..... ......+......+.....++++.+++.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316 (343)
T ss_pred cCCCCCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 112335678999999987766 455999999999999996 9999976543 2344444444444444457889999999
Q ss_pred Hcc-cCCCCCCCHHhHhcC
Q psy10194 284 KIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 284 ~~L-~~p~~R~s~~e~l~h 301 (357)
+|| .+|.+||++.++++|
T Consensus 317 ~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 999 589999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.54 Aligned_cols=246 Identities=20% Similarity=0.339 Sum_probs=191.6
Q ss_pred eEeeecCceEEEEEEECC--CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 49 TIIGMGSYATVKLATSSR--HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++|+||+++++.+.+...+++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999996432 34568888765432 23334556789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 127 KGSLLDIIRKEG-----YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 127 ~gsL~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 999999997642 246788899999999999999999999999999999999999999999999864321110
Q ss_pred cccccccCCCCCCccchhhhcC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccC--CC---
Q psy10194 202 YESLSETFCGSYAYASPEILKG------IPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVV--FP--- 269 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~--~~--- 269 (357)
........+++.|+|||++.. ....+.++|||||||++|+|++ |..||......+....+..... .+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 156 -YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred -eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 011123345678999999753 2233567999999999999998 8899987766655544332221 11
Q ss_pred CCCCCCHHHHHHHHHcccCCCCCCCHHhHhc
Q psy10194 270 KDPNVSPECKALISKILAPVKTRLRIKNIKE 300 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~~p~~R~s~~e~l~ 300 (357)
....+++.+.+++..|+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 1236788999999999899999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=300.33 Aligned_cols=253 Identities=20% Similarity=0.350 Sum_probs=208.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
...+|++.+.||+|+||.||+|+... +...+++|.+.... .....+.+.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34689999999999999999999653 34578999875432 223455677999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEee
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG---------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~D 186 (357)
+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999997655 689999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcc
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSK 265 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~ 265 (357)
||++....... ........++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+...
T Consensus 161 ~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 161 LSLSKDVYNSE-----YYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred cccccccCccc-----ccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 99986432111 0111233457789999998877664 55999999999999998 88999877766666666533
Q ss_pred -cCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 266 -VVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 266 -~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
..++....++..+.+++.+|| .+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 334444578999999999999 599999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.95 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=202.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEE----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATS----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-- 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-- 115 (357)
..-|++.+.||+|+||.||++.. ..++..||+|.+..... ......+.+|+.+++.++||||+++.+++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 44578999999999999999974 45678899999865432 33345678999999999999999999998775
Q ss_pred CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
...++||||++|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 6789999999999999999764 358999999999999999999999999999999999999999999999999987653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---------------cHHHHH
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---------------KYSQLL 259 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---------------~~~~~~ 259 (357)
..... ........++..|+|||.+.+..+. .++|||||||++|+|+++..|+... ......
T Consensus 161 ~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEY---YTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccc---eeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 22111 1112234567789999998877664 4599999999999999987665321 112222
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 260 KQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+......+....++..+.+|+.+||+ +|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3333344444556789999999999995 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.20 Aligned_cols=255 Identities=21% Similarity=0.375 Sum_probs=209.3
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+...+|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 4667889999999999999999999877765 468887754332 2223456789999999999999999999865
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
. ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 4679999999999999987643 6899999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
...... .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......+.+......+..+
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd05110 160 EGDEKE----YNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234 (303)
T ss_pred cCcccc----cccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 322111 11122345778999999987766 455999999999999997 999998877776666666665555556
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
..+..+.+++..|+ .+|.+||+++++++.
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78899999999999 599999999998884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.47 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=206.7
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQA 111 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~ 111 (357)
..+...+|.+++.||+|+||.||+|.+. .++..||+|++...... ...+.+.+|+.++..+. ||||+++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3456678999999999999999999864 34568999999654322 22345678999999997 9999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcC-----------------------------------------------------
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEG----------------------------------------------------- 138 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------- 138 (357)
+......++||||+.+|+|.+++.+.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCc
Q psy10194 139 ---------------------------------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCEN 173 (357)
Q Consensus 139 ---------------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~N 173 (357)
.+++..++.++.||+.||.|||+.|++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35667788999999999999999999999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDD 252 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~ 252 (357)
||++.++.++|+|||++......... .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||..
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999754321110 11123356788999999987776 455999999999999998 8999977
Q ss_pred CcHHHH-HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 253 TKYSQL-LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 253 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
....+. ...+......+.+..++.++.+++.+|+ .+|.+||+++++++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 345 LPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 554443 3334444444445568999999999999 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.92 Aligned_cols=268 Identities=28% Similarity=0.447 Sum_probs=223.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHH----HhhHHHHHHHHHcCCCCCccceEEEE-E
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL----KKFLPREVEVVKGLKHPNLIKFLQAI-E 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~----~~~~~~E~~~l~~l~h~~Iv~l~~~~-~ 113 (357)
.....+|.+..+||+|+|+.||+|.+......||+|+-.....+.++. .+...+|.+|.+.|+||.||++|++| .
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 355678999999999999999999999999999999986655444332 23445899999999999999999998 5
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCCceEec---CCCCeEEeecc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER--GVVHRDIKCENLLID---ADYNIKLSDFG 188 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--givH~dlkp~NIll~---~~~~~kl~Dfg 188 (357)
+.+.+|-|+|||+|.+|.-+|+.++.+++.+++.|+.||+.||.||... .|+|-||||.|||+- .-|.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6778999999999999999999999999999999999999999999976 599999999999993 44789999999
Q ss_pred ccccccccccc-cccccccccCCCCCCccchhhhcC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHH--
Q psy10194 189 FARNHMRYRSR-QGYESLSETFCGSYAYASPEILKG---IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQ-- 261 (357)
Q Consensus 189 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~-- 261 (357)
+++........ ...-.+.....||.||++||.+.- .+..+.++||||+|||+|.++.|+.||...... ++++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99976543322 222345667889999999998753 345567899999999999999999999765432 33322
Q ss_pred H--hcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 262 V--QSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 262 ~--~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
| ...+.||..+.++.++++||++||+ .-+.|+.+.++..||+|..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1 2346688888999999999999997 6889999999999999975
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.64 Aligned_cols=246 Identities=19% Similarity=0.313 Sum_probs=191.7
Q ss_pred eEeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 49 TIIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.+...+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999854 34567899987654322 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 127 KGSLLDIIRKE-----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 127 ~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
+|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 99999998643 2456778889999999999999999999999999999999999999999999864321110
Q ss_pred cccccccCCCCCCccchhhhcCCC------CCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcc--cCCCC--
Q psy10194 202 YESLSETFCGSYAYASPEILKGIP------YCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSK--VVFPK-- 270 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~--~~~~~-- 270 (357)
........|++.|+|||++.+.. ..+.++|+||||+++|+|++ |+.||......+........ ...+.
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 -YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred -eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11122345788899999986432 12556999999999999996 99999876655543332211 11111
Q ss_pred -CCCCCHHHHHHHHHcccCCCCCCCHHhHhc
Q psy10194 271 -DPNVSPECKALISKILAPVKTRLRIKNIKE 300 (357)
Q Consensus 271 -~~~~~~~~~~li~~~L~~p~~R~s~~e~l~ 300 (357)
....++.+.+++..|+.+|.+|||+++|+.
T Consensus 235 ~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 124678899999999988999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.04 Aligned_cols=258 Identities=21% Similarity=0.390 Sum_probs=198.0
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
+++.+| +++.||.++...++..||+|++........ ..+.+.+|+.+++.++|+||+++++++...+.++++|||++
T Consensus 6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhc--CCceEEEEEecCCCCEEEEEEEeccccchh-HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344444 445566666677899999999976533333 34567899999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc-cccc
Q psy10194 127 KGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR-QGYE 203 (357)
Q Consensus 127 ~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 203 (357)
+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......... ....
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999999753 46899999999999999999999999999999999999999999999999988754321110 1111
Q ss_pred cccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHHhcccCC-------------
Q psy10194 204 SLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL-LKQVQSKVVF------------- 268 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~-~~~~~~~~~~------------- 268 (357)
.......++..|+|||++... ...+.++|+||+||++|+|++|..||........ .+.+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 122334567889999998753 2234569999999999999999999987553332 2222211100
Q ss_pred -------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 269 -------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 269 -------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.....++.++.+|+.+||. +|.+|||++++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0011245788999999994 99999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=299.70 Aligned_cols=237 Identities=21% Similarity=0.284 Sum_probs=190.0
Q ss_pred EeeecCceEEEEEEECC------------------------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc
Q psy10194 50 IIGMGSYATVKLATSSR------------------------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~------------------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 105 (357)
.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999987432 12358888875432 2233456688999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---- 180 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---- 180 (357)
+++++++......++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 56789999999999999999999999999999999999997643
Q ss_pred ---CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHH
Q psy10194 181 ---NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYS 256 (357)
Q Consensus 181 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~ 256 (357)
.++++|||++...... ....++..|+|||.+.+....+.++|||||||++|+|+ +|..||......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3899999987543211 12346788999999876554466799999999999985 799999877665
Q ss_pred HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 257 QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+...........+ ...++.+.++|.+||. +|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 EKERFYEKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5444433333333 2456889999999994 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.40 Aligned_cols=238 Identities=16% Similarity=0.277 Sum_probs=190.2
Q ss_pred eEeeecCceEEEEEEECCC------------CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 49 TIIGMGSYATVKLATSSRH------------SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+.||+|+||.||+|..... ...+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985322 2358888765432 233455678899999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC-------eEEeecc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN-------IKLSDFG 188 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~-------~kl~Dfg 188 (357)
..++||||+++++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988865 456899999999999999999999999999999999999986664 8999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcccC
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
++...... ....|+..|+|||.+......+.++|||||||++|+|+ +|..||......+..........
T Consensus 158 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05077 158 IPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM 227 (262)
T ss_pred CCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCcc
Confidence 98654211 12356888999999875554566799999999999998 68999987665544332222222
Q ss_pred CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 268 FPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.....++++.+||.+||. ||.+||++.+++++
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 223456889999999994 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.05 Aligned_cols=228 Identities=25% Similarity=0.367 Sum_probs=188.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHH
Q psy10194 54 GSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDI 133 (357)
Q Consensus 54 G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 133 (357)
|.+|.||++.+..+++.||+|.+.+... ..+|...+....||||+++++++.+.+..++||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999865421 22444555556799999999999999999999999999999999
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCC
Q psy10194 134 IRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213 (357)
Q Consensus 134 l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~ 213 (357)
+.+...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------~~~~~~~~ 146 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------CDGEAVEN 146 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------cccCCcCc
Confidence 988778999999999999999999999999999999999999999999999999987654321 11234577
Q ss_pred CccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCC
Q psy10194 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTR 292 (357)
Q Consensus 214 ~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R 292 (357)
.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...... +........++.+++.+.++|.+|| .||.+|
T Consensus 147 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 147 MYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 8999999877666 45599999999999999999988643211 1111122233468999999999999 599999
Q ss_pred CCH-----HhHhcCCcc
Q psy10194 293 LRI-----KNIKEDPWF 304 (357)
Q Consensus 293 ~s~-----~e~l~hp~f 304 (357)
+++ ++++.||||
T Consensus 221 ~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 221 LGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCCccchHHHHcCCCC
Confidence 985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.54 Aligned_cols=241 Identities=27% Similarity=0.436 Sum_probs=203.3
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|.+.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++... ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 46799999999999999999864 56789999885422 134567899999999999999999998654 57999
Q ss_pred EeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999999997643 5799999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||......+....+......+....++..+
T Consensus 154 ------~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd05083 154 ------VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADV 226 (254)
T ss_pred ------CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHH
Confidence 011223567999999887766 455999999999999997 999999888887777777666555556789999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhc
Q psy10194 279 KALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+++.+||. +|.+||++++++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999994 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.82 Aligned_cols=238 Identities=20% Similarity=0.312 Sum_probs=191.9
Q ss_pred eEeeecCceEEEEEEECCCCc-------EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 49 TIIGMGSYATVKLATSSRHSC-------EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
+.||+|+||.||+|.+...+. .+++|.+.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865443 37788764322 23345566899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC--------eEEeecccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN--------IKLSDFGFARN 192 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~--------~kl~Dfg~~~~ 192 (357)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999987664 69999998864
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcccCCCCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQVQSKVVFPKD 271 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (357)
... .....+++.|+|||++.+....+.++|||||||++|+|++| ..||..................+
T Consensus 158 ~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (258)
T cd05078 158 VLP----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP-- 225 (258)
T ss_pred cCC----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCC--
Confidence 321 12345788999999998755446679999999999999998 57776665554443333333333
Q ss_pred CCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 272 PNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 272 ~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
...+.++.+++.+||+ +|.+|||++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3467899999999995 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=297.26 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=199.5
Q ss_pred eecCEEEEeEeeecCceEEEEEEE----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATS----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-- 114 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-- 114 (357)
+..+|++.+.||+|+||.||++.. ..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 356899999999999999999973 4578899999986432 2334567799999999999999999998743
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...+++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 45689999999999999999754 46899999999999999999999999999999999999999999999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH----------------H
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS----------------Q 257 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~----------------~ 257 (357)
...... ........++..|+|||.+.+..+ +.++|+|||||++|+|++|..++...... .
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEY---YKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcc---eeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 321110 001111223456999999987666 45699999999999999988776432211 1
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 258 LLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.+.+......+....++.++.+|+.+||. +|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122233334445556789999999999995 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=297.43 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=200.5
Q ss_pred eEeeecCceEEEEEEECCCC------cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 49 TIIGMGSYATVKLATSSRHS------CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+.||+|+||.||+|...... ..+|+|.+.+... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876543 6799998754321 122345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-----CeEEeecccc
Q psy10194 123 EYAEKGSLLDIIRKE-------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-----NIKLSDFGFA 190 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-----~~kl~Dfg~~ 190 (357)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999998877 8999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
........ ........++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 159 RDIYKSDY----YRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred cccccccc----cccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 75432111 011122345678999999987776 556999999999999998 999998877777766666555555
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
....++..+.+++.+|| .+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 55678999999999999 58999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=293.73 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=196.6
Q ss_pred eEeeecCceEEEEEEECC---CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE-eCCeEEEEEee
Q psy10194 49 TIIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE-TTHRVYIIMEY 124 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~-~~~~~~lv~e~ 124 (357)
+.||+|+||.||+|.+.. ....+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998643 34579999875422 2223455668999999999999999999775 45668899999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+.+++|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~--~ 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS--V 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee--e
Confidence 9999999999764 456788889999999999999999999999999999999999999999999987543211000 0
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+......+....+++.+.+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred cccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 01112345678999999887766 456999999999999999 5677887777776666665544444456789999999
Q ss_pred HHccc-CCCCCCCHHhHhcC
Q psy10194 283 SKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 283 ~~~L~-~p~~R~s~~e~l~h 301 (357)
.+||. +|++||++.+++..
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHcCCChhhCCCHHHHHHH
Confidence 99995 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.36 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=206.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~l 120 (357)
.++.++...||.|+.|+|++++...+|...|||.+.+....+ + .+.+...+.++... ++|+||+.+++|-.+..+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-E-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-H-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 344556788999999999999999999999999997655432 2 33444566665554 48999999999999999999
Q ss_pred EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
.||.|.. -+..++++ .++++|..+-.+...++.||.||-. +||+|||+||+|||+|..|++||||||.+-.+...
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 9999854 67777655 5679999999999999999999985 58999999999999999999999999999765432
Q ss_pred ccccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHhcccC--CCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQSKVV--FPKDPN 273 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~~~~~--~~~~~~ 273 (357)
...+.-.|.+.|||||-+.-. +.+.-.+||||||++++||.||+.||.+.+ ..+++.++.+... .+....
T Consensus 246 -----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 246 -----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred -----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence 233455689999999998532 333444899999999999999999998844 3455555554333 222345
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+|+.+.+|+..|| +|+.+||...++|+|||+...+
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 8999999999999 6999999999999999997643
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=293.09 Aligned_cols=235 Identities=20% Similarity=0.277 Sum_probs=190.4
Q ss_pred eEeeecCceEEEEEEECCCC----------cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 49 TIIGMGSYATVKLATSSRHS----------CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999987766 34777776543211 4556689999999999999999999988 778
Q ss_pred EEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-------CeEEeecccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-------NIKLSDFGFA 190 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-------~~kl~Dfg~~ 190 (357)
++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999998887 7999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||..................
T Consensus 156 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 225 (259)
T cd05037 156 ITVLS----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL 225 (259)
T ss_pred ccccc----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC
Confidence 76432 1123457789999998776 344666999999999999998 68888776544443333322222
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+. .....+.++|.+|| .+|.+||++.++++
T Consensus 226 ~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PM--PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC--CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23488999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.37 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=204.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--T 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~ 115 (357)
..+|++.+.||+|+||.||++.... ++..+|+|++...... ...+.+.+|+.+++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 4678889999999999999998643 4788999998755432 345667899999999999999999999877 6
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997654 68999999999999999999999999999999999999999999999999998654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---------------HHHHH
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---------------YSQLL 259 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---------------~~~~~ 259 (357)
..... ........++..|+|||.+.+..+ +.++|+|||||++|+|++|..||.... .....
T Consensus 161 ~~~~~---~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 161 EDKDY---YYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cCCcc---eeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 21110 011112234567999999987766 445999999999999999999986532 12233
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 260 KQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
..+......+....++.++.+++.+||. +|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3344444455555678999999999995 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=304.34 Aligned_cols=247 Identities=29% Similarity=0.428 Sum_probs=190.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-eEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-RVYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-~~~lv 121 (357)
++|.-..+||+|+||.||+|...++ ..||||.+....... .+.+.+|+.++..++|||+|+|+++|.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 5788889999999999999997654 799999776544321 233779999999999999999999999888 59999
Q ss_pred EeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERG---VVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~g---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
+||+++|+|.+.+.... +++|..+..|+.+++.||+|||... |+|||||++|||+|.+..+||+|||+|+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999997654 8999999999999999999999854 999999999999999999999999999543210
Q ss_pred ccccccccccccC-CCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc------HHHHHH-HHhcc-cC
Q psy10194 197 RSRQGYESLSETF-CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK------YSQLLK-QVQSK-VV 267 (357)
Q Consensus 197 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~------~~~~~~-~~~~~-~~ 267 (357)
. ....+. .||.+|+|||++..+.. +.++||||||++|.|+++|+.+.+... ..++.. .+... +.
T Consensus 231 ~------~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 231 D------TSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred c------cceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence 0 111111 78999999999987444 667999999999999999998887432 112111 12211 11
Q ss_pred ---CCC-C-CCCC--HH---HHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 268 ---FPK-D-PNVS--PE---CKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 268 ---~~~-~-~~~~--~~---~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+. . ...+ .+ +..+..+|+. +|.+||++.|+++
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 0 1233 23 3345557884 7999999999754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=290.04 Aligned_cols=246 Identities=17% Similarity=0.316 Sum_probs=189.7
Q ss_pred eEeeecCceEEEEEEECCC--CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecC
Q psy10194 49 TIIGMGSYATVKLATSSRH--SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
+.||+|+||.||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23456676654322 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 127 KGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 127 ~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
+|+|.+++.+. ..+++..++.++.||+.||.|||+.+++||||||+|||++.++.++|+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----~ 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----Y 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch----h
Confidence 99999999753 346677888999999999999999999999999999999999999999999875321110 0
Q ss_pred ccccccCCCCCCccchhhhcCCC------CCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhccc--CC--C-C
Q psy10194 203 ESLSETFCGSYAYASPEILKGIP------YCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKV--VF--P-K 270 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~--~~--~-~ 270 (357)
.......+|+..|+|||++.... ..+.++|||||||++|+|++ |..||......+....+.... .. + .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 11122456788999999985321 12456999999999999996 678998766655554432221 11 1 1
Q ss_pred CCCCCHHHHHHHHHcccCCCCCCCHHhHhc
Q psy10194 271 DPNVSPECKALISKILAPVKTRLRIKNIKE 300 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L~~p~~R~s~~e~l~ 300 (357)
...+++.+.+++..|+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 235789999999999988999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=290.72 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=205.9
Q ss_pred CEEEEeEeeecCceEEEEEEECC-CCcEEEEEEeecCCC-------CchHHHhhHHHHHHHHHc-CCCCCccceEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQA-------PSDYLKKFLPREVEVVKG-LKHPNLIKFLQAIET 114 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~~~~ 114 (357)
+|++.+.||+|+||.||++.+.. ++..+|+|.+..... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 678899998854321 122223445578887764 799999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......+
T Consensus 161 ~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 161 AKQKQPES-------KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred eeeccccc-------ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 97543211 2234567889999999987666 556999999999999999999998887777666665554433
Q ss_pred CC-CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 270 KD-PNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 270 ~~-~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.. ..+++.+.++|.+|| .||.+||++.|+..+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 32 367899999999999 599999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=331.22 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=201.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE-E--------
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-E-------- 113 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-~-------- 113 (357)
.+|+....||+||||.||+|+++-+|..||||.|.... .+.....+.+|+..+.+|+|||||+++..+ +
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 45778899999999999999999999999999997655 444556677999999999999999987321 0
Q ss_pred ---------------------------------------------------------------------eC---------
Q psy10194 114 ---------------------------------------------------------------------TT--------- 115 (357)
Q Consensus 114 ---------------------------------------------------------------------~~--------- 115 (357)
+.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------CeEEEEEeecCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHhc
Q psy10194 116 --------------------------------HRVYIIMEYAEKGSLLDIIRKEGYI-DETRARKWFAQLVDAINYCHER 162 (357)
Q Consensus 116 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~qi~~~l~~LH~~ 162 (357)
..+||-||||+.-+|.+++.++... ....+|.+|++|+.||+|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1368999999986777777666544 4788999999999999999999
Q ss_pred CCeecCCCCCceEecCCCCeEEeecccccccc-----------ccccccc-cccccccCCCCCCccchhhhcCCC--CCC
Q psy10194 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHM-----------RYRSRQG-YESLSETFCGSYAYASPEILKGIP--YCP 228 (357)
Q Consensus 163 givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~-----------~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~ 228 (357)
|||||||||.||+++.++.+||+|||+|.... ......+ .....+..+||..|+|||++.+.. .++
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998622 0111111 122456778999999999998776 568
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcccCCCCC----CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCC
Q psy10194 229 QLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKD----PNVSPECKALISKILA-PVKTRLRIKNIKEDP 302 (357)
Q Consensus 229 ~~~DiwSlG~il~~ll~G~~pf~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp 302 (357)
.|+||||||+|++||+ .||.. +.-...+..++ ....|.+ ..--+.-..+|+.||. ||.+||||.|+|++.
T Consensus 797 ~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML---YPFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 8899999999999999 56753 23333444554 2223322 2233566789999995 999999999999999
Q ss_pred ccc
Q psy10194 303 WFR 305 (357)
Q Consensus 303 ~f~ 305 (357)
||-
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 996
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=291.47 Aligned_cols=251 Identities=18% Similarity=0.352 Sum_probs=201.2
Q ss_pred EEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----
Q psy10194 45 YTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH----- 116 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~----- 116 (357)
|.+.+.||+|+||.||+|... .++..+|+|++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578899999865443333 3455678999999999999999999885432
Q ss_pred -eEEEEEeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 117 -RVYIIMEYAEKGSLLDIIRKE------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 117 -~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
..+++++|+.+|+|.+++... ..++...++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999999887432 2478899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
+........ ........+++.|++||.+.+..+. .++|||||||++|+|++ |..||...+..+....+......
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 160 SKKIYSGDY----YRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccCCcc----eecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 875432111 0011123346789999999877664 55999999999999998 89999888777666666554444
Q ss_pred CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 269 PKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
...+..++.+.+++.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4445688999999999995 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=292.48 Aligned_cols=257 Identities=16% Similarity=0.246 Sum_probs=190.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCc--hHH------HhhHHHHHHHHHcCCCCCccce
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPS--DYL------KKFLPREVEVVKGLKHPNLIKF 108 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~Iv~l 108 (357)
+...+|++.++||+|+||.||+|.+..+ +..+|+|+........ +.. ......+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4557899999999999999999998877 6667777643322111 000 0011123344566789999999
Q ss_pred EEEEEeCC----eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEE
Q psy10194 109 LQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKL 184 (357)
Q Consensus 109 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl 184 (357)
++.+.... ..+++++++.. ++.+.+......++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 45788888754 78777776666789999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHH----
Q psy10194 185 SDFGFARNHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQL---- 258 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~---- 258 (357)
+|||+++.......... .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976532111110 0112233569999999999988777 566999999999999999999998763 2222
Q ss_pred ----HHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 259 ----LKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 259 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
...+..... ..+..++.+.++++.|+. +|++||+++++++
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222222111 123578999999999994 9999999999875
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.88 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=214.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCc-----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSC-----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
+.+......+...||+|+||.||.|....... .||+|.+++.. +......+.+|..+|+.++|||||++++++
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 33557788999999999999999998654322 38888876543 344456677999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKE-------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
.+....+|++|||+||+|..+|++. ..|+..+...++.+|++|+.||+++++|||||..+|+|++....+||+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999999765 358999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~ 264 (357)
|||+|+......- ........-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+++..+..
T Consensus 845 DFGlArDiy~~~y----yr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 845 DFGLARDIYDKDY----YRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE 919 (1025)
T ss_pred ccchhHhhhhchh----eeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence 9999994321111 000001011357999999998777 556999999999999995 9999999999998887766
Q ss_pred ccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 265 KVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 265 ~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+-+.+.+..++..+.++|..|++ +|++||++..|++
T Consensus 920 ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 66888888999999999999995 9999999999886
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=279.25 Aligned_cols=250 Identities=28% Similarity=0.510 Sum_probs=204.5
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEe--CCe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIET--THR 117 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~--~~~ 117 (357)
..++|++.+++|+|.+++||.|.+..+.+.++||+++... .+.+.+|+.||+.|. ||||++++++..+ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4578999999999999999999999999999999986533 466789999999997 9999999999865 456
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 196 (357)
+.+|+||+++.+...+... |+...++.++.+|+.||.|+|++||+|||+||.|+++|... .++|+|+|+|.+....
T Consensus 110 paLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 8899999999777766643 88899999999999999999999999999999999998654 6999999999876432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHHh-----------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD--TKYSQLLKQVQ----------- 263 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~--~~~~~~~~~~~----------- 263 (357)
.-....+.+..|--||++-.-..+....|+|||||++..|++.+.||.. .+.+++.+...
T Consensus 187 -------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 187 -------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred -------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 1223456688899999998777667779999999999999999999853 33333322111
Q ss_pred cccCCC------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 264 SKVVFP------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 264 ~~~~~~------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.++... ....+++++.||+.++|. |..+|+||+|++.||||..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 001000 012357999999999997 9999999999999999975
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.02 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=222.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+......|.++||.|.||+|+.|+.+..+ ..||||.++... .++.+..|..|+.||-+++||||++|.++.....
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 55667889999999999999999987665 459999986433 4556777889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+.||.|||++|+|..+|+. .+.|+..++..+++.|+.|+.||-++|+|||||...|||++.+..+|++|||+++.+..
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999999965 46799999999999999999999999999999999999999999999999999996643
Q ss_pred cccccccccccccCCC--CCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 196 YRSRQGYESLSETFCG--SYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
.. +...++..| ...|.|||.+....+ +.+|||||+|++|||.+ .|..||.++...++++.|..+++.|.+.
T Consensus 784 d~-----~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 784 DP-----EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred CC-----CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 22 112222222 468999999998887 55699999999999977 7999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+++..+.+|+..|+ +|-.+||.+.||+.+
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999 589999999998863
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=310.93 Aligned_cols=201 Identities=30% Similarity=0.478 Sum_probs=172.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC------C
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT------H 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~------~ 116 (357)
.-|...+.||+|+||.||+++++.+|..||||.+.+...... .+...+|+++|++|+|+|||+++++=++. +
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 456778899999999999999999999999999987653333 45556999999999999999999986543 4
Q ss_pred eEEEEEeecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe--cCCC--CeEEeeccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK---EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADY--NIKLSDFGF 189 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll--~~~~--~~kl~Dfg~ 189 (357)
...+|||||.||+|...+++ ...|++.+++.++..+..||.|||++||+||||||.||++ +.+| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 57899999999999999964 3469999999999999999999999999999999999998 3334 489999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~ 252 (357)
|+.... ........||+.|.+||++....+++..+|.|||||++|++.||..||..
T Consensus 171 Arel~d-------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDD-------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCC-------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 987653 23556788999999999998655556669999999999999999999954
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.44 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=179.2
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCC----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE---
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRH----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA--- 111 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~--- 111 (357)
.+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+......+. ..++ .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHHH--HHHhhchhhHHHHHHhhhc
Confidence 34567899999999999999999999888 89999998754321111 1111 1111122222222221
Q ss_pred ---EEeCCeEEEEEeecCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCeecC
Q psy10194 112 ---IETTHRVYIIMEYAEKGSLLDIIRKEGY--------------------IDETRARKWFAQLVDAINYCHERGVVHRD 168 (357)
Q Consensus 112 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~LH~~givH~d 168 (357)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||+.||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456789999999999999999865321 12345678999999999999999999999
Q ss_pred CCCCceEecC-CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCC---------------------
Q psy10194 169 IKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY--------------------- 226 (357)
Q Consensus 169 lkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------- 226 (357)
|||+|||++. ++.+||+|||+++...... .......+|++.|+|||.+.....
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc-----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 9999999985 5799999999997543211 122345678999999997643221
Q ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-c---------C----------CCCCCCCCHHHHHHHHHcc
Q psy10194 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-V---------V----------FPKDPNVSPECKALISKIL 286 (357)
Q Consensus 227 ~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~---------~----------~~~~~~~~~~~~~li~~~L 286 (357)
.+.++|||||||++|+|+++..++... ...+...+... . . +...+..+....+||.+||
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 123469999999999999987775432 11111111100 0 0 0001123345669999999
Q ss_pred -cCCCCCCCHHhHhcCCccccCCC
Q psy10194 287 -APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 287 -~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.||.+|||+.++|+||||+....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 59999999999999999987544
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.94 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=214.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE-----eCC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE-----TTH 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~-----~~~ 116 (357)
.-|+|..+||.|.+|.||++++..+++..|+|+.......++ .+..|+++++.+ +|||++.++++|. .++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de----EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE----EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH----HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 346789999999999999999999999999999876655443 345788899887 5999999999984 357
Q ss_pred eEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
.++||||||.||+..++++. +..+.|..+..|++.++.||.+||.+.++|||||=.|||++.+|.+||+|||++..+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999999999999865 4578999999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccccCCCCCCccchhhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKG-----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF- 268 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~- 268 (357)
.... .-.+.+|||.|||||++.- ..|+ ..+|+||||++..||.-|.+|+.++.+...+-.|......
T Consensus 175 sT~g------rRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 175 STVG------RRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred cccc------cccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 4322 2346789999999999853 2343 3489999999999999999999998877655444432221
Q ss_pred -CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 269 -PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 269 -~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..+...+.++.++|..|| +|..+||+..++|+|||+...+
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 123568999999999999 7999999999999999998543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.40 Aligned_cols=240 Identities=36% Similarity=0.669 Sum_probs=204.6
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHH
Q psy10194 55 SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII 134 (357)
Q Consensus 55 ~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 134 (357)
+||.||+|.+..++..+++|++........ .+.+.+|+..++.++|+||+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999876443322 456779999999999999999999999999999999999999999999
Q ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCC
Q psy10194 135 RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214 (357)
Q Consensus 135 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~ 214 (357)
.....++...++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFVGTPE 151 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-------ccccccCCcC
Confidence 877668999999999999999999999999999999999999999999999999997654221 2234557889
Q ss_pred ccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcccCCCCCCC--CCHHHHHHHHHcc-cCCC
Q psy10194 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKDPN--VSPECKALISKIL-APVK 290 (357)
Q Consensus 215 y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L-~~p~ 290 (357)
|++||.+.+..+.. ++|+||||++++++++|..||.. .+.....+.+........... ++.++.+++.+|| .+|.
T Consensus 152 ~~~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 152 YMAPEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CCCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 99999998766644 69999999999999999999987 555666655554443332222 8899999999999 5999
Q ss_pred CCCCHHhHhcCCcc
Q psy10194 291 TRLRIKNIKEDPWF 304 (357)
Q Consensus 291 ~R~s~~e~l~hp~f 304 (357)
+||++.++++||||
T Consensus 231 ~Rp~~~~~~~~~~~ 244 (244)
T smart00220 231 KRLTAEEALQHPFF 244 (244)
T ss_pred hccCHHHHhhCCCC
Confidence 99999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.39 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=187.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC----------------CCCcEEEEEEeecCCCCch-H----------HHhhHH
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS----------------RHSCEVAIKIISKMQAPSD-Y----------LKKFLP 91 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----------------~~~~~vaiK~i~~~~~~~~-~----------~~~~~~ 91 (357)
....++|++.++||+|+||.||+|... ..+..||||.+........ . ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 346789999999999999999999642 2346799999854321100 0 011122
Q ss_pred HHHHHHHcCCCCCc-----cceEEEEEe--------CCeEEEEEeecCCCCHHHHHHHc---------------------
Q psy10194 92 REVEVVKGLKHPNL-----IKFLQAIET--------THRVYIIMEYAEKGSLLDIIRKE--------------------- 137 (357)
Q Consensus 92 ~E~~~l~~l~h~~I-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~--------------------- 137 (357)
.|+.++..++|.++ ++++++|.. ....++|+||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666666765543 666666642 35689999999999999988532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCC
Q psy10194 138 ---GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214 (357)
Q Consensus 138 ---~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~ 214 (357)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++....... ........+++.
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-----~~~~~~g~~tp~ 375 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-----NFNPLYGMLDPR 375 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----ccCccccCCCcc
Confidence 123567788999999999999999999999999999999999999999999986542211 011112234789
Q ss_pred ccchhhhcCCCC---------------------CCCcccHHHHHHHHHHHHhCCC-CCCCCcHH------------HHHH
Q psy10194 215 YASPEILKGIPY---------------------CPQLSDVWSMGVVLFAMVFGRL-PFDDTKYS------------QLLK 260 (357)
Q Consensus 215 y~aPE~~~~~~~---------------------~~~~~DiwSlG~il~~ll~G~~-pf~~~~~~------------~~~~ 260 (357)
|+|||.+..... .+.+.|+||+||++|+|++|.. ||...... .+..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 999999854221 1123699999999999999886 77532111 0111
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHcc-cCC---CCCCCHHhHhcCCcccc
Q psy10194 261 QVQSKVVFPKDPNVSPECKALISKIL-APV---KTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~L-~~p---~~R~s~~e~l~hp~f~~ 306 (357)
.......++..+..++.+++|+.+|| .+| .+|+|++|+|+||||..
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11123445555678999999999999 444 68999999999999964
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=296.27 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=208.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC------CCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK------HPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~l~~~~ 112 (357)
.+...+|.+....|+|-||+|..|.+...+..||||+|... +.+.+.=..|+.+|+.|+ --|+++++..|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 46778999999999999999999999999999999999763 233444458999999995 35899999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeecc
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFG 188 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg 188 (357)
.+.+++|||+|-+.- +|.+.+++.| .|....++.++.||+.||..|-.+||+|.||||+|||++.. ..+||||||
T Consensus 504 ~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 999999999999855 9999998754 58889999999999999999999999999999999999865 469999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---c
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS---K 265 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~---~ 265 (357)
.|...... -.+.+..+..|.|||++.+.+|+.. .|+||+||+||||.||+..|.+.....++..... .
T Consensus 583 SA~~~~en--------eitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 583 SASFASEN--------EITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred cccccccc--------cccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99764321 1223344678999999999999665 8999999999999999999998877776654431 0
Q ss_pred c-------------CCCCC-------------------------------------------CCCCHHHHHHHHHccc-C
Q psy10194 266 V-------------VFPKD-------------------------------------------PNVSPECKALISKILA-P 288 (357)
Q Consensus 266 ~-------------~~~~~-------------------------------------------~~~~~~~~~li~~~L~-~ 288 (357)
+ .|..+ +.+-..+++|+..||. |
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 00000 0123568899999995 9
Q ss_pred CCCCCCHHhHhcCCcccc
Q psy10194 289 VKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 289 p~~R~s~~e~l~hp~f~~ 306 (357)
|.+|+|+.++|.||||+.
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999974
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=284.67 Aligned_cols=132 Identities=20% Similarity=0.406 Sum_probs=114.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-----C---CCccceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-----H---PNLIKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~Iv~l~~~ 111 (357)
+...+|.+.++||.|.|++||+|.+..+...||+|+++.. ....+....||++|+++. | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 4458999999999999999999999999999999998642 234556679999999883 2 479999999
Q ss_pred EEe----CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEe
Q psy10194 112 IET----THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLI 176 (357)
Q Consensus 112 ~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll 176 (357)
|.. +.++|||+|++ |.+|..+|... ..++...++.|++|++.||.|||. +||+|.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 954 56899999999 66999998763 469999999999999999999995 699999999999998
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.49 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=212.9
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
....+-.....++++||+|-||.|.+|... .+..||+|.++...... .+..+.+||++|.+|+||||++++++|..+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 344566778899999999999999999954 46899999997655433 367788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+.+++|+||+++|+|.+++.++. .+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++.+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999999998773 3355667779999999999999999999999999999999999999999999854
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHHhccc-----
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV--FGRLPFDDTKYSQLLKQVQSKV----- 266 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll--~G~~pf~~~~~~~~~~~~~~~~----- 266 (357)
-... +.......+-...|+|+|.+..+.+. .++|+|+||+++||++ +...||.....++..+....-+
T Consensus 688 ysg~----yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 688 YSGD----YYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccCC----ceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 2111 11122223346789999999888884 4599999999999976 7899999988888777665322
Q ss_pred --CCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 267 --VFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 267 --~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
....++.++..+.++|-+|+ .+-++||+++++..
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 23445678999999999999 59999999999876
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=295.64 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=225.0
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~ 109 (357)
..+....|-..+.++.++||+|+||.|++|.++..+ ..||||.+....... ....|.+|+.+|..|+|+|+++||
T Consensus 100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEe
Confidence 445556677778888999999999999999986532 358999987655433 356677999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 110 QAIETTHRVYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 110 ~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
++..+ ....+|||++++|+|.+.|.+ .+.|.......++.||+.|+.||.++++|||||-..|+|+-....+||+||
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecc
Confidence 99988 677899999999999999976 456888899999999999999999999999999999999988899999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhccc
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~ 266 (357)
|+.+.+...... ..+.....-...|+|||.+....+ +.++|+|++||++|||++ |+.||.+....++++.+..+.
T Consensus 257 GLmRaLg~ned~---Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 257 GLMRALGENEDM---YVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE 332 (1039)
T ss_pred cceeccCCCCcc---eEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc
Confidence 999987644332 233334444678999999998888 455999999999999995 899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 267 VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+..+.++.++.+++..|++ .|.+||++..|.+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 999999999999999999995 89999999988654
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.98 Aligned_cols=264 Identities=26% Similarity=0.367 Sum_probs=207.3
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHH-HHcCCCCCccceEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV-VKGLKHPNLIKFLQAI 112 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~l~~~~ 112 (357)
+.....++.+..+-...||.|+||+|++..++.+|+..|||.|+......+ .+.+..|... ++.-+.||||++++.+
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 334445666667778899999999999999999999999999976655322 3445556654 4555789999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEee
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIR-----KEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~D 186 (357)
..+..++|.||.|.- ||..+.+ .+..++|..+-.|....+.||.||-. ..|+|||+||+|||++..|.+||||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 999999999999964 8877654 24579999999999999999999985 5899999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHHh
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQVQ 263 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~~ 263 (357)
||.+-.+... ...+.-.|...|+|||-+... +| .-+||+||||++|||+.||+.||...+ ..+.+.++.
T Consensus 212 FGIcGqLv~S-------iAkT~daGCrpYmAPERi~p~~~gy-DiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 212 FGICGQLVDS-------IAKTVDAGCRPYMAPERIDPSDKGY-DIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred ccchHhHHHH-------HHhhhccCCccccChhccCCccCCc-chhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 9998754321 122344678899999998643 45 445999999999999999999997643 223333332
Q ss_pred cc-cC---CCC-CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 264 SK-VV---FPK-DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 264 ~~-~~---~~~-~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+ .. ++. .-.++..+..+|..|| +|-+.||...+++.+||++...
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 22 11 111 1358999999999999 7999999999999999998654
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.99 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=209.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCC----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRH----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.....+.++||.|-||.||.|....- .-.||||.++.....+. .+.+..|..+|+.++||||++++++|.+ ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 33444568899999999999986432 34589999876444333 6667799999999999999999999965 46
Q ss_pred EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+||||.++-|.|..+++.+ ..|+......++.||+.||+|||+..+|||||-..|||+.....+||+|||+++.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 79999999999999999765 46899999999999999999999999999999999999999999999999999876532
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. +...+ ...-...|||||.+.-..+ +.++|||-||+++||++ .|..||.+....+++-.+.++-+.|.++.++
T Consensus 545 ~----yYkaS-~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 545 A----YYKAS-RGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCP 618 (974)
T ss_pred c----hhhcc-ccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCC
Confidence 1 11111 1122567999999988777 45599999999999987 7999999988888888889999999999999
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHh
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIK 299 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l 299 (357)
+.+..|+.+|++ +|.+||.+.++.
T Consensus 619 p~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999997 999999977643
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=274.02 Aligned_cols=256 Identities=24% Similarity=0.419 Sum_probs=206.4
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT- 115 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~- 115 (357)
.......+|.-.+.+|.|+- .|..+.+.-.++.||+|............ +...+|..++..++|+||++++.+|.-.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~a-kra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHA-KRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccc-hhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 55667788999999999999 88888888899999999886654433333 3345899999999999999999998443
Q ss_pred -----CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 116 -----HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 116 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
...|+|||++.. +|.+.+.. .++-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||++
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 357999999976 99988873 3677889999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--- 267 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--- 267 (357)
+.... ....+..+.|..|.|||++.+..+.. .+||||+||++.+|++|+..|.+.+.-+...++.+...
T Consensus 166 r~e~~-------~~~mtpyVvtRyyrapevil~~~~ke-~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDT-------DFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCc-------ccccCchhheeeccCchheeccCCcc-cchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 86431 23455677899999999999988644 49999999999999999999987653332222221110
Q ss_pred -----------------------------CCC---------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 268 -----------------------------FPK---------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 -----------------------------~~~---------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
+|. .+.-+..+++++.+||. +|++|+|++++|+||||+
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 110 01235678999999994 999999999999999996
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.09 Aligned_cols=256 Identities=21% Similarity=0.387 Sum_probs=206.4
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----eEE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-----RVY 119 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-----~~~ 119 (357)
.+-.+-||-|+||.||.+.+..+|+.||+|.+......-.. .+.+-+|+++|..++|.|++..+++..-.. .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s-~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLAS-CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHH-HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34467899999999999999999999999988654332222 234458999999999999999999875432 467
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+|+|.+.. +|..+|.+-..++.+.++-++.||++||.|||+.||.||||||.|+|++.+..+||||||+++.......
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 88999976 9999998888899999999999999999999999999999999999999999999999999986543222
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC---------
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK--------- 270 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~--------- 270 (357)
...+..+.|..|+|||++.+...++.+.||||.|||+.||+..+..|...++-+.++.|.+-+..|.
T Consensus 212 ----~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 212 ----LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred ----hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 1122334588999999999998889999999999999999999999987776665555443221111
Q ss_pred ------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 271 ------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 271 ------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
...-..+..+++..||. ||.+|++..+++.|++....
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 01234567778888885 89999999999999998653
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=300.09 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=198.3
Q ss_pred ecCEEEEeEeeecCce-EEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEE
Q psy10194 42 SHGYTLGTIIGMGSYA-TVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g-~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~ 119 (357)
.--|.-.+++|.|+.| .||+|.. .++.||||.+-... ...+.+|+..|+..+ |||||++++.-.+....|
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 3445666889999997 4788875 45699999874322 345679999999885 999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---C--CCeEEeecccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEG----YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---D--YNIKLSDFGFA 190 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~--~~~kl~Dfg~~ 190 (357)
|..|.|.. +|.+++...+ .......+.++.|++.||++||+.+||||||||+||||+. + ..++|+|||++
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999987 9999997631 1122456888999999999999999999999999999965 3 46899999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcccCC-
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQVQSKVVF- 268 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~~~~~~~- 268 (357)
+++....+.- ....+..||-+|+|||++..... ..++||+||||++|+.++| .+||.+.-.. ....+......
T Consensus 659 Kkl~~~~sS~---~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl~~~~~L~ 733 (903)
T KOG1027|consen 659 KKLAGGKSSF---SRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANILTGNYTLV 733 (903)
T ss_pred cccCCCcchh---hcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh-hhhhhcCcccee
Confidence 9876544322 22456779999999999987766 4469999999999998875 9999764322 22222222211
Q ss_pred CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCCCCC
Q psy10194 269 PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSRPEY 313 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~~~~ 313 (357)
...+....++.+||.+||. +|..||+|.++|.||+|.+.+.+-.+
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~F 779 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSF 779 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHH
Confidence 1111122289999999995 89999999999999999876655443
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=283.15 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=218.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++..+.....+||-|.||.||.+.++.-...||||.++..... .+.+..|+.+|+.++|||+|+|+++|..+..+
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 46677778889999999999999999999999999998654332 45566899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
|||+|||..|+|.++|.+- ..++.-.+..++.||..|+.||..++++||||-..|+|+..+..+|++|||+++.+...
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999999999763 34677778889999999999999999999999999999999999999999999876421
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. ........-...|.|||-+....+.. |+|||+||++|||+.| |-.||.+.+..++...+..++++..+..++
T Consensus 419 T-----YTAHAGAKFPIKWTAPEsLAyNtFSi-KSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 419 T-----YTAHAGAKFPIKWTAPESLAYNTFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred c-----eecccCccCcccccCccccccccccc-chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 1 01111112256799999998877754 5999999999999995 899999999999999999999999999999
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+...+|++.|++ .|..||++.|+-+
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHH
Confidence 999999999997 9999999988754
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.59 Aligned_cols=204 Identities=33% Similarity=0.559 Sum_probs=181.5
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHH-----HhhHHHHHHHHHcCC---CCCccceEEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL-----KKFLPREVEVVKGLK---HPNLIKFLQAI 112 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~-----~~~~~~E~~~l~~l~---h~~Iv~l~~~~ 112 (357)
...+|...+.||.|+||.|++|.++.+...|+||.|.+.+.-.+.+ .-.+..||.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3356999999999999999999999999999999998765432222 223457999999997 99999999999
Q ss_pred EeCCeEEEEEeec-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 113 ETTHRVYIIMEYA-EKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 113 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
++++++||+||-- +|.+|+++|...+.++|.++..|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.+.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999964 567999999999999999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~ 252 (357)
... ......+.||..|.|||++.+..|....-|||+||++||-++....||..
T Consensus 719 ~~k--------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK--------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc--------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 653 23345788999999999999999999989999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.27 Aligned_cols=236 Identities=20% Similarity=0.304 Sum_probs=183.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|...++||+|+||.||+|.+..++..||+|.+...... ...|+..++.++||||+++++++.+.+..++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456678999999999999999889999999988643321 1256888999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH---ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH---~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999964 789999999999999999999 6799999999999999988887775 55543221
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHhccc-----CCCC
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-----YSQLLKQVQSKV-----VFPK 270 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-----~~~~~~~~~~~~-----~~~~ 270 (357)
......|++.|+|||++.+..+ +.++|||||||++|||++|+.||.... ..+......... ..+.
T Consensus 834 ----~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 834 ----TDTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ----cCCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 0112357899999999987776 456999999999999999999985321 111111111000 0000
Q ss_pred -------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 271 -------DPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 271 -------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
......++.+++.+|+ .+|.+||++.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011235678889999 599999999999884
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.39 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=217.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|.+.+.+|+|++|.||+++++.+++..|+|+++.....+ ..-+++|+-+++.++||||+.+++-|...+.+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 467999999999999999999999999999999997655433 34456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||||.||+|.+...-.+++++.++...++..++||+|||+.|-+|||||=.|||++..|.+|++|||.+..+.-.-.
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--- 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--- 167 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh---
Confidence 99999999999998889999999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccccCCCCCCccchhhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCC---CCCCCC
Q psy10194 202 YESLSETFCGSYAYASPEILK--GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFP---KDPNVS 275 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~ 275 (357)
-...+.||+.|+|||+.. ...-+...+|+|++|+...++---++|..+..+...+..... .+..| .....+
T Consensus 168 ---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 168 ---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred ---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 123578999999999963 223336679999999999999988888777766665544332 33222 224689
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+.+.+|++.+| ++|++||+++.+|.|||....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999 799999999999999999654
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.70 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=213.2
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC----C---CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS----R---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQ 110 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~ 110 (357)
.+...+..+.+.||+|+||.|++|... . ....||||..+..... ...+.+..|+.+|+.+. |+||+.+++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 444444578889999999999998632 1 1456999998665443 34667789999999985 999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 111 AIETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 111 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
.+.....+++|+||+..|+|.+++.+.+ .++..+...++.||+.|++||++..++||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999997654 489999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.+..+||+|||+++.......- ........-...|||||.+....+ +.++||||+|++|||+++ |..||.+.
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y---~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYY---RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred EecCCCEEEEccccceeccCCCCce---EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999853321110 000000001345999999998655 666999999999999995 89999986
Q ss_pred c-HHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 254 K-YSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
. ..++.+.+..+.....+..+++++.++++.|+. +|.+||++.++.+ +|..
T Consensus 526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 5 667778889998888888899999999999994 8999999999887 5654
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=263.50 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=201.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC---CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCe
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHR 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~ 117 (357)
...|.+.++||+|+|++||++.+.. ....||+|.+....... .+.+|+++|..+. +.||+++.+.+..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-----ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-----RILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-----HHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4568999999999999999998776 77899999987655442 3668999999985 8999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 196 (357)
..+|+||++..+..+++.. ++..+++.+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|......
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999888888865 678999999999999999999999999999999999974 467899999999721111
Q ss_pred c------c--------------------------------ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHH
Q psy10194 197 R------S--------------------------------RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGV 238 (357)
Q Consensus 197 ~------~--------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~ 238 (357)
. . +...........||++|+|||++..-+--+.++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0001111223469999999999988777777899999999
Q ss_pred HHHHHHhCCCCCCCCc--HHHHHHHH--------------hcc---------------------c--------------C
Q psy10194 239 VLFAMVFGRLPFDDTK--YSQLLKQV--------------QSK---------------------V--------------V 267 (357)
Q Consensus 239 il~~ll~G~~pf~~~~--~~~~~~~~--------------~~~---------------------~--------------~ 267 (357)
|+..+++++.||.... ...+.+.. ... + .
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 9999999999994211 00000000 000 0 0
Q ss_pred CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 268 FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
....+..+..+.+|+++||. ||.+|+|++++|+||||..
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00012346689999999995 9999999999999999984
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.06 Aligned_cols=257 Identities=22% Similarity=0.381 Sum_probs=215.6
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
.+.+.+....+..++||+|+||+||+|.+--.++ +||||++......+. ...+.+|+-+|..++|||+++|+++
T Consensus 689 ~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgv 766 (1177)
T KOG1025|consen 689 LLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGV 766 (1177)
T ss_pred heeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhh
Confidence 3455666777889999999999999998755454 578888765444332 4556799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
+.... +.||++|+++|.|.++++. .+.+.....+.|..||++|+.|||.+++|||||-.+|||+..-..+||.|||++
T Consensus 767 c~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 767 CMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred cccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 97766 8899999999999999975 457899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+.+...... -......-.+.|+|=|.+....| +.++||||+||++||++| |..|+.+....++-+.+..+.+.+
T Consensus 846 ~ll~~d~~e----y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 846 KLLAPDEKE----YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS 920 (1177)
T ss_pred hccCccccc----ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC
Confidence 876532221 11111222567899999888877 455999999999999985 999999999999999998888888
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.++..+.++.-++.+|+ .|+..||+++++..
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 88999999999999999 69999999887643
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=254.27 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=195.1
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC--CCCCccceEE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL--KHPNLIKFLQ 110 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~l~~ 110 (357)
.+...+.++...-.+.++||+|.||.||+|+... +.||||++.. ..++.+.+|-+|.+.. .|+||+++++
T Consensus 200 ~~~sspl~~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~ 271 (534)
T KOG3653|consen 200 PAPSSPLLELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIG 271 (534)
T ss_pred CCCCcccccCCchhhHHHhhcCccceeehhhccC--ceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhc
Confidence 4445555667778889999999999999999764 6999999854 2245566787777754 7999999998
Q ss_pred EEEeCC----eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---------cCCeecCCCCCceEec
Q psy10194 111 AIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE---------RGVVHRDIKCENLLID 177 (357)
Q Consensus 111 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~---------~givH~dlkp~NIll~ 177 (357)
.-+... .++||++|.+.|+|.++|+.+- +++.....++..+++||+|||+ .+|+|||||..||||.
T Consensus 272 ~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK 350 (534)
T KOG3653|consen 272 AEKRGTADRMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK 350 (534)
T ss_pred hhccCCccccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence 765544 8999999999999999997764 8999999999999999999995 3599999999999999
Q ss_pred CCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCC-----CcccHHHHHHHHHHHHhCCC----
Q psy10194 178 ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP-----QLSDVWSMGVVLFAMVFGRL---- 248 (357)
Q Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlG~il~~ll~G~~---- 248 (357)
.+++..|+|||+|..+..... .......+||..|||||++.+..... ...||||+|.+||||++.-.
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKP----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred cCCcEEeeccceeEEecCCCC----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 999999999999998763322 22233478999999999997653322 34799999999999996422
Q ss_pred --------CCC-----CCcHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 249 --------PFD-----DTKYSQLLKQVQSKVVFPKDP------NVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 249 --------pf~-----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
||. .-..+++...+..+-..|..+ ..-..+.+.+..|+ .|++.|+|+..+.+
T Consensus 427 ~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 427 GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 332 122344444433322222221 23466889999999 59999999876544
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=232.01 Aligned_cols=214 Identities=28% Similarity=0.411 Sum_probs=171.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc-CCCCCccceEEEEEeCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG-LKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~~~~~~~~ 118 (357)
+..++...+..||+|++|.|-+.++..+|...|+|.+...-. +.. .+.+.+|+.+... ..+|.+|.+++.+......
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHH-HHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344455557889999999999999999999999999965433 333 3445577876554 4699999999999999999
Q ss_pred EEEEeecCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 119 YIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+|.||.|.. ||..+. +.++..+|..+=.|+..++.||.|||++ .++|||+||+|||++.+|++|+||||.+-.+
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999965 888765 4577899999999999999999999975 8999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhc
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQS 264 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~-~~~~~~~~~~~~ 264 (357)
...- ..+.-.|...|+|||.+.. ..| +-++||||||++++||.+++.||.. ..+.+.++++..
T Consensus 200 ~dSi-------Akt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSI-------AKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhh-------HHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 4211 1112346778999999853 245 5569999999999999999999975 345555555543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=240.95 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=191.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEE-EEeCCeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQA-IETTHRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~-~~~~~~~~ 119 (357)
.+.|.|.+.||+|.||.+-+|.++.+...+++|.+.+.... .+.+.+|...--.|. |.||+.-|++ |++.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 35799999999999999999999999999999999765432 345567877655554 8999998876 67888999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe-cCC-CCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI-DAD-YNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll-~~~-~~~kl~Dfg~~~~~~~~~ 197 (357)
++|||++.|+|.+.+...| +.|...+.++.|++.|+.|||+.++||||||.+|||+ +.+ -.+||||||........-
T Consensus 99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999999999886654 8999999999999999999999999999999999998 333 379999999987543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCC----CCCCcccHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHHhccc-C
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIP----YCPQLSDVWSMGVVLFAMVFGRLPFDDT-----KYSQLLKQVQSKV-V 267 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~ll~G~~pf~~~-----~~~~~~~~~~~~~-~ 267 (357)
. ..--+..|.+||+..... ...+.+|+|.||+++|.++||..||... ...+..+...... .
T Consensus 178 ~---------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 178 K---------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred h---------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 1 111255799999875321 2234489999999999999999999732 2223333222221 2
Q ss_pred CCC-CCCCCHHHHHHHHHccc-CCCCC---CCHHhHhcCCcccc
Q psy10194 268 FPK-DPNVSPECKALISKILA-PVKTR---LRIKNIKEDPWFRN 306 (357)
Q Consensus 268 ~~~-~~~~~~~~~~li~~~L~-~p~~R---~s~~e~l~hp~f~~ 306 (357)
.|. -..+++.+..+.++-|. ++++| -++......-|...
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 222 13588999999999994 78888 55666666667654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=229.67 Aligned_cols=212 Identities=39% Similarity=0.697 Sum_probs=183.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCH
Q psy10194 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 51 Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL 130 (357)
||+|++|.||++....++..+++|++....... ..+.+.+|+..++.+.|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654321 235677999999999999999999999999999999999998999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeecccccccccccccccccccccc
Q psy10194 131 LDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGYESLSET 208 (357)
Q Consensus 131 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 208 (357)
.+++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~~~~ 152 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------LLKT 152 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------hhhc
Confidence 9999765 46899999999999999999999999999999999999998 89999999999975532210 1223
Q ss_pred CCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-
Q psy10194 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA- 287 (357)
Q Consensus 209 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~- 287 (357)
..+...|.+||.+......+.++|+|++|++++++ ..+.+++..|+.
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhC
Confidence 44688899999987763445669999999999999 679999999994
Q ss_pred CCCCCCCHHhHhcCC
Q psy10194 288 PVKTRLRIKNIKEDP 302 (357)
Q Consensus 288 ~p~~R~s~~e~l~hp 302 (357)
+|.+||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 899999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-31 Score=231.73 Aligned_cols=214 Identities=37% Similarity=0.634 Sum_probs=180.1
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
|++.+.||+|++|+||++.+..++..+++|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988899999998754432 2356677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
+++++|.+++..... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~----- 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA----- 153 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----
Confidence 999999999987766 89999999999999999999999999999999999999999999999999876542210
Q ss_pred cccccCCCCCCccchhhh-cCCCCCCCcccHHHHHHHHHHHHhCCCCCCC--CcHHHHHHHHhccc
Q psy10194 204 SLSETFCGSYAYASPEIL-KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD--TKYSQLLKQVQSKV 266 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~--~~~~~~~~~~~~~~ 266 (357)
.......++..|++||.+ ....+.. ++|+|+||+++++|++|+.||.. .+...+.+.+..+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 012234578889999998 4445544 69999999999999999999977 34445666665444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=241.94 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=183.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHH--cCCCCCccceEEEEEeC----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK--GLKHPNLIKFLQAIETT---- 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~--~l~h~~Iv~l~~~~~~~---- 115 (357)
.++-.+.+.||+|.||+||+|.+. |+.||||++...... ...+|.+|.+ .|+|+||+.++..=..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 466889999999999999999986 568999999654321 2236666665 56999999998653221
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCeecCCCCCceEecCCCCeEEeec
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER--------GVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------givH~dlkp~NIll~~~~~~kl~Df 187 (357)
..++||.+|.+.|||+|+|.+ ..++......++..++.||++||.. .|+|||||..|||+.++|..-|+|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 368999999999999999988 4589999999999999999999942 4999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCC----CC-CCcccHHHHHHHHHHHHh-----C-----CCCCCC
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP----YC-PQLSDVWSMGVVLFAMVF-----G-----RLPFDD 252 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~-~~~~DiwSlG~il~~ll~-----G-----~~pf~~ 252 (357)
|+|........ ..+......+||-.|||||++...- +. ...+||||||.++||+.. | ++||.+
T Consensus 361 GLAv~h~~~t~--~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 361 GLAVRHDSDTD--TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eeeEEecccCC--cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99987654322 2234456789999999999996431 11 123799999999999984 2 467754
Q ss_pred -----CcHHHHHHHHhcccCCCCCCC---CC---HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 253 -----TKYSQLLKQVQSKVVFPKDPN---VS---PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 253 -----~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+++.+-+-..-..|..++ -. ..+..+++.|+ .+|..|.|+--+.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 234444444332222222211 12 23445677788 58888888766554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=275.80 Aligned_cols=204 Identities=18% Similarity=0.240 Sum_probs=145.3
Q ss_pred CCC-CCccceEEEE-------EeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCC
Q psy10194 100 LKH-PNLIKFLQAI-------ETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170 (357)
Q Consensus 100 l~h-~~Iv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlk 170 (357)
++| +||+++++.| ...+.+++++|++ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777776 2334677889988 5599999965 3469999999999999999999999999999999
Q ss_pred CCceEecCCCC-------------------eEEeeccccccccccccc----------cccccccccCCCCCCccchhhh
Q psy10194 171 CENLLIDADYN-------------------IKLSDFGFARNHMRYRSR----------QGYESLSETFCGSYAYASPEIL 221 (357)
Q Consensus 171 p~NIll~~~~~-------------------~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~ 221 (357)
|+||||+..|. +|++|||+++........ ..........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965444 455555555432110000 0000011224689999999999
Q ss_pred cCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 222 ~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+..+ +.++|||||||+||||++|..|+.... .....+......+......+...+++.+|| .+|.+||++.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88777 566999999999999999998876432 122222222211211123566788999999 48999999999999
Q ss_pred CCccccC
Q psy10194 301 DPWFRNG 307 (357)
Q Consensus 301 hp~f~~~ 307 (357)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999764
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=232.65 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=210.3
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCC-----cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHS-----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
...+...+++...++-+|.||.||.|.+.+.. +.|-+|.++... ++-....+..|..++..+.|||+..+.++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 33466677999999999999999999765432 335566654322 22334556688888999999999999998
Q ss_pred E-EeCCeEEEEEeecCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCe
Q psy10194 112 I-ETTHRVYIIMEYAEKGSLLDIIRK--------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI 182 (357)
Q Consensus 112 ~-~~~~~~~lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~ 182 (357)
+ ++....++++.+..-|+|..++.. -..++..+...++.|++.|++|||+.|++|.||-.+|.++|+..++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 7 667788999999988999999862 1246778889999999999999999999999999999999999999
Q ss_pred EEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQ 261 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~ 261 (357)
||+|=.+++.+-+.. +..+....-....||+||.+.+..|+ .++|+||||++||||+| |+.||...++.++...
T Consensus 436 kltDsaLSRDLFP~D----YhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGD----YHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred EeccchhccccCccc----ccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 999999998643211 11121222235689999999998885 55999999999999995 9999999999999999
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 262 VQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+++...+-++++++-.++..|++ .|++||+.+|+..
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99999988888999999999999995 9999999998764
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=265.28 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=207.3
Q ss_pred ecCE-EEEeEeeecCceEEEEEEECCCCcEEEEEEeec---CCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 42 SHGY-TLGTIIGMGSYATVKLATSSRHSCEVAIKIISK---MQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 42 ~~~y-~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~---~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
...| ....++|.|++|.|+.+........++.|.... ...........+..|..+-..|+|+|++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3445 457889999999999888777666666665442 111122222225678888888999999888888777776
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
..-+||||++ +|+.++.+.+.++..++..+++||+.||.|||+.||.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6667999999 999999988889999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHHh--ccc-----CCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL-KQVQ--SKV-----VFP 269 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~-~~~~--~~~-----~~~ 269 (357)
.. ........+|+..|+|||++.+..|++...||||.|++++.|.+|+.||......+.. .... ... ...
T Consensus 475 e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 475 EK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred ch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 11 1245567889999999999999999999999999999999999999999754333221 1110 011 011
Q ss_pred CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 270 KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
....++...+.+|.+||+ +|.+|+|+++|++.+||+..
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 123578999999999995 99999999999999999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=206.94 Aligned_cols=158 Identities=19% Similarity=0.217 Sum_probs=125.7
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccccc
Q psy10194 128 GSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206 (357)
Q Consensus 128 gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 206 (357)
|+|.+++.. ...+++.+++.++.|++.||.|||+.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999976 456999999999999999999999999 999999999999999 9998754321
Q ss_pred ccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcccCCC------CCCCCCH--H
Q psy10194 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKVVFP------KDPNVSP--E 277 (357)
Q Consensus 207 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~~~~------~~~~~~~--~ 277 (357)
...||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......+....... ....++. +
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred -cCCCcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 12579999999999888774 569999999999999999999976432 22233332221111 1112333 6
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
+.++|.+|| .+|.+||++.++++|+|+.
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999 5999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=210.40 Aligned_cols=260 Identities=32% Similarity=0.530 Sum_probs=207.3
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC-CccceEEEEEeCCeEEEEEe
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP-NLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~l~~~~~~~~~~~lv~e 123 (357)
|.+.+.||.|+|+.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 68899999776555443456677999999999988 79999999988888899999
Q ss_pred ecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeeccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 199 (357)
++.++++.+++.... .+++.....++.|++.++.|+|..|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 799999999999999999999999999999999999999988 7999999999754322211
Q ss_pred cccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHhcccCC--C--
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQSKVVF--P-- 269 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~~~~~~--~-- 269 (357)
..........+|+..|+|||.+.+. .......|+||+|++++++++|..||..... ......+...... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1000134567899999999999874 3445669999999999999999999877653 4444444333221 1
Q ss_pred CCCCC----CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 270 KDPNV----SPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 270 ~~~~~----~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..... ...+.+++..++ .+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 11111 257899999999 589999999999988766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=220.06 Aligned_cols=178 Identities=17% Similarity=0.194 Sum_probs=134.9
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECC-CCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
+.......++|.+.+.||+|+||+||+|.+.. ++..+|||++..... ......+.+.+|+++|+.++|+|++..+..
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 33445567789999999999999999999876 677789998753211 123345668899999999999999853322
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCC-CCCceEecCCCCeEEeecccc
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDI-KCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dl-kp~NIll~~~~~~kl~Dfg~~ 190 (357)
....++||||++|++|... .. .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.++|+|||++
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 2457999999999999732 11 11 2468899999999999999999999 999999999999999999999
Q ss_pred cccccccccccc--ccccccCCCCCCccchhhhc
Q psy10194 191 RNHMRYRSRQGY--ESLSETFCGSYAYASPEILK 222 (357)
Q Consensus 191 ~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 222 (357)
+........... ........+++.|.|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 876543221110 01123567888999999985
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=212.52 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=189.5
Q ss_pred CEEEEeEeeecCceEEEEEEECCCC-cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC----CCCccceEEEE-EeCCe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHS-CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK----HPNLIKFLQAI-ETTHR 117 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----h~~Iv~l~~~~-~~~~~ 117 (357)
+|.+.++||+|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+. ..++..+++.. ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987774 5788888765432221 14567888888886 26899999999 58889
Q ss_pred EEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-----CCeEEeecccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-----YNIKLSDFGFA 190 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-----~~~kl~Dfg~~ 190 (357)
.++||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||+|++++.. ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 67999988654 579999999999999999999999999999999999999755 36999999999
Q ss_pred ccccccccc----cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHHh
Q psy10194 191 RNHMRYRSR----QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ---LLKQVQ 263 (357)
Q Consensus 191 ~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~---~~~~~~ 263 (357)
+........ ...........||..|.++..+.+..... +.|+||++.++.+++.|..||....... ......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r-~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR-RDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC-chhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 833211111 11111123456999999999999888854 4999999999999999999997655322 222222
Q ss_pred cccCCC-CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 264 SKVVFP-KDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 264 ~~~~~~-~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
...... .....+.++.++...+-. +...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222222 122344566666655554 78888887766553
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=195.87 Aligned_cols=241 Identities=25% Similarity=0.294 Sum_probs=185.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~~ 117 (357)
.+..+.|+++++||+|+||.+|+|....+|+.||||+-+..... -.+..|.++.+.|.+ ..|..+..+.....+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 56778999999999999999999999999999999987543322 235578999999874 788888888888899
Q ss_pred EEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC---CCeEEeeccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD---YNIKLSDFGFARNH 193 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~---~~~kl~Dfg~~~~~ 193 (357)
-.+||+.. |.+|.+++.- ...++...+..++.|++.-++|+|.++++||||||+|+|.+-+ ..+.|+|||+++.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 6799998753 3458999999999999999999999999999999999998643 46999999999987
Q ss_pred ccccccccccc-ccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHHhc-ccCC
Q psy10194 194 MRYRSRQGYES-LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL---KQVQS-KVVF 268 (357)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~---~~~~~-~~~~ 268 (357)
....+...... ......||..|.+--.+.+...+.. .|+-|+|.+|.++.-|..||.+....... ++|.+ +...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 65554332221 2234568999999887776666444 89999999999999999999886544322 22221 1212
Q ss_pred CC---CCCCCHHHHHHHHHcc
Q psy10194 269 PK---DPNVSPECKALISKIL 286 (357)
Q Consensus 269 ~~---~~~~~~~~~~li~~~L 286 (357)
+. -..+|.++--.+.-|-
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHh
Confidence 11 1355666666665543
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=226.89 Aligned_cols=241 Identities=28% Similarity=0.513 Sum_probs=200.7
Q ss_pred EeeecCceEEEEEE---ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEEeec
Q psy10194 50 IIGMGSYATVKLAT---SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~---~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
.+|+|+||.|++++ ..+.+..+|+|+..+......... ....|-.++..++ ||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999875 345677799999876554433222 3346777888887 999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 126 EKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 126 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
.||.|...+.....+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||.++......
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999888889999999999999999999999999999999999999999999999999998653221
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 284 (357)
..|||..|||||++. ++ ..++|.||+|+++++|++|..||.. +....|.. ...+| ...+..+++++..
T Consensus 152 --~~cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p--~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP--RELSAEARSLFRQ 220 (612)
T ss_pred --hcccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc--hhhhHHHHHHHHH
Confidence 128999999999998 33 3448999999999999999999988 44444433 45454 4699999999999
Q ss_pred cc-cCCCCCCC-----HHhHhcCCccccCCCC
Q psy10194 285 IL-APVKTRLR-----IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 285 ~L-~~p~~R~s-----~~e~l~hp~f~~~~~~ 310 (357)
|+ .+|.+|.. +.++++|+||+...+.
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99 58999986 4799999999887654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=197.47 Aligned_cols=208 Identities=23% Similarity=0.304 Sum_probs=174.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~ 118 (357)
+-.-.|+++++||+|+||.+++|.+.-++++||||.-..... .-.++.|.+..+.|. .++|..++.+...+.+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 445579999999999999999999999999999998654322 234668888888885 69999999988888889
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-----CeEEeecccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-----NIKLSDFGFARN 192 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-----~~kl~Dfg~~~~ 192 (357)
.||+|++ |.+|.|++.- +..|+.+.+..++.|++.-++++|++.+|+|||||+|+||+.-+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 6799998864 34699999999999999999999999999999999999996433 489999999998
Q ss_pred ccccccccccc-cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Q psy10194 193 HMRYRSRQGYE-SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK 254 (357)
Q Consensus 193 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~ 254 (357)
+....++.... .-.....||..||+--...+...+.+ .|+-|||-+++++|-|..||.+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCcccccc
Confidence 76655543322 22345679999999988888888655 899999999999999999997643
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=222.54 Aligned_cols=231 Identities=27% Similarity=0.476 Sum_probs=178.0
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.-...+|..+++|..|++|-||+++++.+.+.+|+|+- +.. .+.+. ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~--------lilRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN--------LILRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhccc-ccc--------hhhhc--cccccCCccee------------
Confidence 34567899999999999999999999999999999542 211 11111 33333344333
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|+=..+++..++++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+.+.......
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 45556666666666544 8899999999999999999999999999999999999875432111
Q ss_pred c---------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCC
Q psy10194 199 R---------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVF 268 (357)
Q Consensus 199 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~ 268 (357)
. ..........||||.|+|||++...+|.- .+|+|+||+|+|+++-|..||.+..+++++.++... +.+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygk-pvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCC-CccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0 11122234569999999999999988854 499999999999999999999999999998886543 344
Q ss_pred C-CCCCCCHHHHHHHHHcc-cCCCCCC---CHHhHhcCCccccCCCC
Q psy10194 269 P-KDPNVSPECKALISKIL-APVKTRL---RIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 269 ~-~~~~~~~~~~~li~~~L-~~p~~R~---s~~e~l~hp~f~~~~~~ 310 (357)
+ .+..+++++++++.+|| ++|..|. .+-++.+|+||+...+.
T Consensus 278 pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 278 PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 4 34578999999999999 5888885 47789999999988776
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=186.47 Aligned_cols=141 Identities=21% Similarity=0.232 Sum_probs=111.5
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-----------------------HHhhHHHHHHHHHcCCCCC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-----------------------LKKFLPREVEVVKGLKHPN 104 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~ 104 (357)
...||+|+||+||+|.+. +|..||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999754221100 1123346999999998877
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCCeecCCCCCceEecCCCCeE
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC-HERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~givH~dlkp~NIll~~~~~~k 183 (357)
+.....+.. .. .+|||||++|+++.......+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644333322 22 389999999987776654567799999999999999999999 799999999999999998 57899
Q ss_pred Eeecccccc
Q psy10194 184 LSDFGFARN 192 (357)
Q Consensus 184 l~Dfg~~~~ 192 (357)
|+|||++..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=187.86 Aligned_cols=175 Identities=16% Similarity=0.170 Sum_probs=134.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhh------HHHHHHHHHcCCCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF------LPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
+...+|++.++||.|+||.||++.. ++..+|+|++.......+..... +.+|+..+..+.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4568999999999999999999755 35589999997654444333222 578999999999999999998865
Q ss_pred eC--------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 114 TT--------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 114 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
.. ...++||||++|.+|.++.. +++ ....+++.+|..||+.|++|||++|+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 43 35789999999999988742 333 2466999999999999999999999999999988 9999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHH
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll 244 (357)
|||......... ....++....+. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~------------------a~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRK------------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchh------------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence 999886432100 011134444555 5699999999887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=190.93 Aligned_cols=234 Identities=22% Similarity=0.285 Sum_probs=150.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC----------CCCccceEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK----------HPNLIKFLQAIE 113 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------h~~Iv~l~~~~~ 113 (357)
....+..||.|+++.||.+++.++++.+|+|+............+.+++|.-....+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677899999999999999999999999999986555444444556666665544432 222333333321
Q ss_pred ---------e---CCe-----EEEEEeecCCCCHHHHHHH---cCC----CCHHHHHHHHHHHHHHHHHHHhcCCeecCC
Q psy10194 114 ---------T---THR-----VYIIMEYAEKGSLLDIIRK---EGY----IDETRARKWFAQLVDAINYCHERGVVHRDI 169 (357)
Q Consensus 114 ---------~---~~~-----~~lv~e~~~~gsL~~~l~~---~~~----l~~~~~~~i~~qi~~~l~~LH~~givH~dl 169 (357)
. ... .+++|+-+.+ +|.+++.. ... +.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 122 3778888865 88887642 221 222333445589999999999999999999
Q ss_pred CCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCC-------CCCCCcccHHHHHHHHHH
Q psy10194 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-------PYCPQLSDVWSMGVVLFA 242 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~ 242 (357)
+|+|+|++.+|.++|+||+........... ...+..|.+||..... ...+.+.|.|+||+++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999988765432221 1125679999987432 223566899999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCC
Q psy10194 243 MVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTR 292 (357)
Q Consensus 243 ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R 292 (357)
|.||+.||........... .+..-.+++..+++||..||. +|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986543221111 222223789999999999995 88887
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-25 Score=195.09 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=184.3
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCC-----------------------------------cEEEEEEeecCC--
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHS-----------------------------------CEVAIKIISKMQ-- 80 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-----------------------------------~~vaiK~i~~~~-- 80 (357)
+.+..++|+|++-||+|+.+.||.+....++ -+.|||.+=...
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 3466788999999999999999988644311 123455442211
Q ss_pred CCchHHHhhHHHHHH-------H-------HHc--------CCCCCccceEEEEE-------------------------
Q psy10194 81 APSDYLKKFLPREVE-------V-------VKG--------LKHPNLIKFLQAIE------------------------- 113 (357)
Q Consensus 81 ~~~~~~~~~~~~E~~-------~-------l~~--------l~h~~Iv~l~~~~~------------------------- 113 (357)
..+..+.+.+-+|.- . .+. -.|||||+++..|-
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 122223333333321 0 011 24999999987662
Q ss_pred --eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe--cCCC--CeEEeec
Q psy10194 114 --TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADY--NIKLSDF 187 (357)
Q Consensus 114 --~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll--~~~~--~~kl~Df 187 (357)
....+|+||..++. +|..++-.+. .+....+-++.|+++|+.|||.+||.|||+|.+|||+ |+++ .+.|+||
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 23468999999976 9999997654 6778888999999999999999999999999999998 4444 5889999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH-HH
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP-----YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL-KQ 261 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~-~~ 261 (357)
|++.......-...+........|...-+|||+....+ ....++|.|+.|.+.||+++...||.......+- ..
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 99876554333333344445567888999999986432 2235689999999999999999999763211111 11
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCH---HhHhcCCc
Q psy10194 262 VQSKVVFPKDPNVSPECKALISKILA-PVKTRLRI---KNIKEDPW 303 (357)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~---~e~l~hp~ 303 (357)
..+....+.+..+++.+++++..+|+ ||++|+++ ..+++--.
T Consensus 470 Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 470 YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSL 515 (598)
T ss_pred hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHH
Confidence 22333344556899999999999995 99999994 45555433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=180.17 Aligned_cols=142 Identities=20% Similarity=0.197 Sum_probs=113.1
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc-----------------------hHHHhhHHHHHHHHHcCCCCC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS-----------------------DYLKKFLPREVEVVKGLKHPN 104 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~~ 104 (357)
.+.||+|+||+||+|.+. +|..||||++....... ........+|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999997642210 001223457899999999988
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeE
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~k 183 (357)
+.....+.... .++||||++|+++.........+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75544443332 48999999988665443344568899999999999999999999 9999999999999998 89999
Q ss_pred Eeeccccccc
Q psy10194 184 LSDFGFARNH 193 (357)
Q Consensus 184 l~Dfg~~~~~ 193 (357)
|+|||++...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=219.74 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=184.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCC--CCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ--APSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.|...+.||++.|=.|.+|++.+. .|+||++-+.. ..-....+.+ .|++ ...+++||.+.+..+...+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 578899999999999999997654 48999875432 2222233333 4555 5556899999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc-cccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~-~~~~~~~~ 200 (357)
-+|... +|.|.+..++.+..-+.+.|+.||+.||..+|..||+|+|||.+|||++.-.-+.|+||...+. +.+..+..
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999977 9999999888899999999999999999999999999999999999999999999999987753 22222222
Q ss_pred ccccccccCCCCCCccchhhhcCC----------CCCCCcccHHHHHHHHHHHHh-CCCCCCCC-----------cHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGI----------PYCPQLSDVWSMGVVLFAMVF-GRLPFDDT-----------KYSQL 258 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~ll~-G~~pf~~~-----------~~~~~ 258 (357)
.+.....+-..-.+|+|||-+-.. +..+++.||||+||+++||++ |++||.-. +.+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 222223333334589999987431 213556899999999999985 79999521 12222
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
++++ -+..+++||..|+ .||++|.+|++.|+.
T Consensus 259 Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2221 2346899999999 599999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=175.17 Aligned_cols=195 Identities=14% Similarity=0.097 Sum_probs=140.5
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHH-HhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEEe
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL-KKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~-~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
-+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|+.|. ++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3578899999999997765 56678877765544432221 224679999999995 5889999886 44699999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCC-CCCceEecCCCCeEEeeccccccccccccc---
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDI-KCENLLIDADYNIKLSDFGFARNHMRYRSR--- 199 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dl-kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 199 (357)
|+.|.+|.+.+... ...++.|++.+|.++|+.||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 99999987554221 2357889999999999999999999 799999999999999999999754321110
Q ss_pred ---ccccc-ccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q psy10194 200 ---QGYES-LSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDT 253 (357)
Q Consensus 200 ---~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~ 253 (357)
.+... ...-...++.|++|+.-.-. ..+-...+.++.|+.+|.++|+..++...
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 00000 01112257788888764322 22223368999999999999999887543
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=180.85 Aligned_cols=248 Identities=19% Similarity=0.308 Sum_probs=197.1
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+...+.-.+..+..+|.+...|+.|++++..+ .+++|++.. ......+.+.+..|.-.|+.+.||||+.+++.|...
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cccCcchhhhhhhhhhccCCCcccccccccCc--chhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 33444555566778899999999999998755 577787754 334555667788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecCCCCeEEe--eccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYNIKLS--DFGF 189 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~~~~~kl~--Dfg~ 189 (357)
..+.++..|++.|+|...+.+.. ..+..++..++.++++|++|||+.. |----|....+++|.+.+.+|+ |--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 99999999999999999997654 4677899999999999999999875 4455688899999999877764 3222
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCC--CCcccHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHHhccc
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC--PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL-LKQVQSKV 266 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~-~~~~~~~~ 266 (357)
+.. .....-.|.|++||.+...+.+ ..++|+|||++++|||.|...||.+..+.+. ++...+++
T Consensus 340 sfq-------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl 406 (448)
T KOG0195|consen 340 SFQ-------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL 406 (448)
T ss_pred eee-------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence 211 1122237899999999866543 3468999999999999999999988766543 44456777
Q ss_pred CCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHh
Q psy10194 267 VFPKDPNVSPECKALISKIL-APVKTRLRIKNIK 299 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l 299 (357)
....++.+++.+..|++-|+ .||-+||.++.++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 77788899999999999999 5999999987654
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=204.84 Aligned_cols=207 Identities=22% Similarity=0.329 Sum_probs=169.7
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
..+....+....|.|.+.||+|+||+||.|...+ |+.||+|+-+....++-++-..+...++ .+. -+.|+.+...+
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~--~~~~~~~~~a~ 763 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM--LPSIMHISSAH 763 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh--hcchHHHHHHH
Confidence 3444556778899999999999999999999877 9999999988877776666555544333 111 34566667667
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-------CCCeEEe
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-------DYNIKLS 185 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-------~~~~kl~ 185 (357)
...+..++|+||.+.|+|.++++..+.+++..+..+..|++..|..||.++|||+||||+|+||.. .--++|+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 778888999999999999999998889999999999999999999999999999999999999942 2359999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRL 248 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~ 248 (357)
|||.+-.+...... ......++|-.+-.+|...|.+|... +|.|.|+.+++.||.|+.
T Consensus 844 DfG~siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 99999765433321 23345678889999999999999555 999999999999999963
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=170.27 Aligned_cols=134 Identities=18% Similarity=0.217 Sum_probs=106.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-----CCCCccceEEEEEeCC---eEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-----KHPNLIKFLQAIETTH---RVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~l~~~~~~~~---~~~ 119 (357)
.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 6666655 79988653322 245678999999999 5799999999998874 334
Q ss_pred -EEEee--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHhcCCeecCCCCCceEecCC----CCeEEeecccc
Q psy10194 120 -IIMEY--AEKGSLLDIIRKEGYIDETRARKWFAQLVDAI-NYCHERGVVHRDIKCENLLIDAD----YNIKLSDFGFA 190 (357)
Q Consensus 120 -lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~givH~dlkp~NIll~~~----~~~kl~Dfg~~ 190 (357)
+|+|| +.+++|.+++++. .+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999764 46666 35678888777 99999999999999999999743 37999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=172.63 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=114.9
Q ss_pred CEEEEeEeeecCceEEEEEE-ECCCCcEEEEEEeecCCCCc---------------------hHHHhhHHHHHHHHHcCC
Q psy10194 44 GYTLGTIIGMGSYATVKLAT-SSRHSCEVAIKIISKMQAPS---------------------DYLKKFLPREVEVVKGLK 101 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~-~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 101 (357)
.|.+.+.||+|+||.||+|. +..+|..||+|++....... ......+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 77789999999987543110 012234568999999997
Q ss_pred CCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-CeecCCCCCceEecCCC
Q psy10194 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG-VVHRDIKCENLLIDADY 180 (357)
Q Consensus 102 h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g-ivH~dlkp~NIll~~~~ 180 (357)
+. ++.+..++... ..++||||++|++|.........+....+..++.||+.+|.+||+.| ++||||||+||+++ ++
T Consensus 109 ~~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~ 185 (237)
T smart00090 109 EA-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG 185 (237)
T ss_pred hc-CCCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC
Confidence 53 22222333222 34899999999888776544556777778899999999999999999 99999999999999 88
Q ss_pred CeEEeecccccc
Q psy10194 181 NIKLSDFGFARN 192 (357)
Q Consensus 181 ~~kl~Dfg~~~~ 192 (357)
.++|+|||.+..
T Consensus 186 ~i~LiDFg~a~~ 197 (237)
T smart00090 186 KVVIIDVSQSVE 197 (237)
T ss_pred CEEEEEChhhhc
Confidence 999999999864
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-22 Score=199.80 Aligned_cols=261 Identities=31% Similarity=0.495 Sum_probs=209.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC-CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~ 119 (357)
...|.+.+.||+|+|+.|-++.... ....+|.|.+.... ........+..|..+-+.+. |.|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4467788889999999999988744 34457777765543 22223344556888888887 999999999999999999
Q ss_pred EEEeecCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCeecCCCCCceEecCCC-CeEEeeccccccccc
Q psy10194 120 IIMEYAEKGSLLDII-RKEG-YIDETRARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMR 195 (357)
Q Consensus 120 lv~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 195 (357)
+++++..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5443 5778888999999999999999 99999999999999999999 999999999987654
Q ss_pred cccccccccccccCCC-CCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHHhc--ccCCCC
Q psy10194 196 YRSRQGYESLSETFCG-SYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ--LLKQVQS--KVVFPK 270 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~--~~~~~~~--~~~~~~ 270 (357)
. .+........+| ++.|.|||.+.+..+.....|+||+|+++..+++|..||....... ....... ......
T Consensus 178 ~---~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 178 K---NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred c---CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 2 222345556788 9999999999987777777999999999999999999997543222 1111111 112344
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
+..++....+++.++| .+|..|.+.+++..++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 5678999999999999 58999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-20 Score=158.38 Aligned_cols=137 Identities=20% Similarity=0.272 Sum_probs=114.1
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-----HHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-----LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
+.||+|++|.||+|.. .+..+++|+.......... ....+.+|+.++..+.|++|.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 5667899976543222111 12346689999999999998887777777788899999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
|++|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 7889999999999999999999999999999998 88999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=153.90 Aligned_cols=133 Identities=20% Similarity=0.274 Sum_probs=106.7
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEeecCCCCch-----HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-----YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
.||+|+||.||++.. ++..+++|.......... .....+.+|+.+++.+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 456899998654322111 1124566899999999888766555555566777899999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7899999999999999999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=154.75 Aligned_cols=138 Identities=22% Similarity=0.288 Sum_probs=108.0
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch-------------------HHHhhHHHHHHHHHcCCCCC-
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-------------------YLKKFLPREVEVVKGLKHPN- 104 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~- 104 (357)
|.+.+.||+|+||.||++... ++..+|||++........ .......+|+.++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999874 788999999765321100 01123557888888887764
Q ss_pred -ccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 105 -LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 105 -Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
++..++ ....++||||++|++|..+... .....++.+++.++.++|+.||+|+||+|+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2445899999999998765431 34567889999999999999999999999999999999999
Q ss_pred Eeeccccccc
Q psy10194 184 LSDFGFARNH 193 (357)
Q Consensus 184 l~Dfg~~~~~ 193 (357)
|+|||.+...
T Consensus 166 liDfg~~~~~ 175 (198)
T cd05144 166 IIDWPQMVST 175 (198)
T ss_pred EEECCccccC
Confidence 9999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.6e-19 Score=172.94 Aligned_cols=138 Identities=19% Similarity=0.245 Sum_probs=111.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEee-cCCCC----chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIIS-KMQAP----SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~-~~~~~----~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.|...+.||+|+||+||++...... +++|+.. +.... .....+.+.+|+.+++.++|++++....++.+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3466899999999999999876543 3444322 21111 112234567899999999999998887777777778
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 356789999999999999999999999999999 678999999999864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-20 Score=172.84 Aligned_cols=260 Identities=19% Similarity=0.270 Sum_probs=170.1
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFL 109 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~ 109 (357)
.+.........+.+.+..+..+++.+...+...+ ...++.+..+.... .. -....+++-.+.... |+..+ +.
T Consensus 235 ~~~~~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~--~~-~~~~~r~~~~l~~~~~~~~s~-~~ 310 (516)
T KOG1033|consen 235 KESSRHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL--CA-CKYTFRQLGVLVDSSHSNRSI-LE 310 (516)
T ss_pred cCcccccccccccccccccccccCCchhhhhcccchhhhhccchhhhccch--hh-hhhhhhhhhheeccccCCccc-cc
Confidence 3444445556677777777788877776654333 22333333222110 01 111123444333333 33322 22
Q ss_pred E-------EE-----EeCCeEEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 110 Q-------AI-----ETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 110 ~-------~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
+ .. ....+++|.|++|.-.+|.+++.+.. ..+......++.|++.|+.| +|.+|+|+||.||
T Consensus 311 d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~ni 387 (516)
T KOG1033|consen 311 DLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNI 387 (516)
T ss_pred CCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccc
Confidence 2 11 12346899999999999999997433 46778899999999999999 9999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
++..+..+||.|||+........+........+...||.+|++||.+.+..| ..++||||||+||++++. =...|...
T Consensus 388 f~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er~ 466 (516)
T KOG1033|consen 388 FFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFERI 466 (516)
T ss_pred ccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHHH
Confidence 9999999999999998765443322222234456689999999999999888 556999999999999996 33333322
Q ss_pred cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
. ....+..+...|....-.+.-..|+.+|| ..|.+||++.+.--|+|.
T Consensus 467 ~---t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 467 A---TLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred H---hhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1 12223333222222222355568999999 589999988888777775
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=166.17 Aligned_cols=200 Identities=25% Similarity=0.436 Sum_probs=155.9
Q ss_pred HHcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCC-eecCCCCCce
Q psy10194 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV-VHRDIKCENL 174 (357)
Q Consensus 97 l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~gi-vH~dlkp~NI 174 (357)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. .-.++.-....+++.|+.||.|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999976 4467888888899999999999998876 9999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCC------CCCCcccHHHHHHHHHHHHhCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP------YCPQLSDVWSMGVVLFAMVFGRL 248 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~ll~G~~ 248 (357)
++|....+||+|||+......... ........-..-|.|||.+.... ..+.+.|+||+|++++++++...
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred eeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999876542000 01111111245799999997641 13566899999999999999999
Q ss_pred CCCCC----cHHHHHHHHhc-ccC--CCC---CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 249 PFDDT----KYSQLLKQVQS-KVV--FPK---DPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 249 pf~~~----~~~~~~~~~~~-~~~--~~~---~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
||... ...+++..+.. ... .|. .....+++..++.+|+ .+|..||+++++-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99752 23455656555 221 111 1145668999999999 58999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=146.14 Aligned_cols=138 Identities=22% Similarity=0.302 Sum_probs=98.5
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhh---------------------HHHHHHHHHcCCCC--C
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF---------------------LPREVEVVKGLKHP--N 104 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~ 104 (357)
.+.||+|+||+||+|.+. ++..||||++............. ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 78899999987543221111111 13455555555433 2
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCe
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNI 182 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~ 182 (357)
+.+.+.. ...++||||++++.+.. .+.... . ...++.++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444433 23589999999854332 122111 1 16688999999999999999 9999999999999999 8999
Q ss_pred EEeeccccccc
Q psy10194 183 KLSDFGFARNH 193 (357)
Q Consensus 183 kl~Dfg~~~~~ 193 (357)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-17 Score=144.90 Aligned_cols=137 Identities=18% Similarity=0.255 Sum_probs=103.4
Q ss_pred eEee-ecCceEEEEEEECCCCcEEEEEEeecCCC----------CchHHHhhHHHHHHHHHcCCCCCc--cceEEEEEeC
Q psy10194 49 TIIG-MGSYATVKLATSSRHSCEVAIKIISKMQA----------PSDYLKKFLPREVEVVKGLKHPNL--IKFLQAIETT 115 (357)
Q Consensus 49 ~~Lg-~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~I--v~l~~~~~~~ 115 (357)
..|| .|+.|+||.+... +..+++|.+..... ........+.+|+.++..|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888764 56889998754211 111223456789999999988775 6666664332
Q ss_pred C-e---EEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 116 H-R---VYIIMEYAEK-GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 116 ~-~---~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
. . .++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 2599999997 689988865 3456543 678999999999999999999999999999999999999988
Q ss_pred cc
Q psy10194 191 RN 192 (357)
Q Consensus 191 ~~ 192 (357)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=130.38 Aligned_cols=132 Identities=21% Similarity=0.255 Sum_probs=111.3
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC--CCccceEEEEEeCCeEEEEEee
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH--PNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+.+ .++++++..+...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999754 5799998865432 3456689999999976 5899999988888899999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER---GVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
+.|+.+..+ +......++.+++.+|+.||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777654 5566677899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-18 Score=167.48 Aligned_cols=271 Identities=21% Similarity=0.315 Sum_probs=203.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
..-.++.+.+-+.+|+++.++.+.-..++...++|+..+.........+.+.++-.++-...+|-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567788889999999999999888888777777654432211110111112222222223455555444455667889
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc---
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY--- 196 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 196 (357)
+|++|..+++|...+.+.+..+..-++..+..+..++++||...+.|+|++|.|+|...+|+.++.|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999998888888899999999999999999999999999999999999999999999844322111
Q ss_pred ------------------cccccc----ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Q psy10194 197 ------------------RSRQGY----ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK 254 (357)
Q Consensus 197 ------------------~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~ 254 (357)
...... ........||+.|.+||.+.+...... +|+|++|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcc
Confidence 000000 112345678999999999998887555 899999999999999999999998
Q ss_pred HHHHHHHHhcc-cCCCCC-CCCCHHHHHHHHHcc-cCCCCCCCHH---hHhcCCccccCCCCC
Q psy10194 255 YSQLLKQVQSK-VVFPKD-PNVSPECKALISKIL-APVKTRLRIK---NIKEDPWFRNGPSRP 311 (357)
Q Consensus 255 ~~~~~~~~~~~-~~~~~~-~~~~~~~~~li~~~L-~~p~~R~s~~---e~l~hp~f~~~~~~~ 311 (357)
.+...+.+... ..++.. ...+.++++++..+| .++.+|..+. ++..|+||+...+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 88887776543 333322 357899999999999 5899999988 999999999987754
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=150.65 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=192.4
Q ss_pred EeecCEEEEeEeee--cCceEEEEEEE--CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGM--GSYATVKLATS--SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~--G~~g~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~ 114 (357)
.....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+...... .....-.+|+...+.++ |+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCccccc
Confidence 44566778999999 99999999998 8889999999743322211 11111225666666664 8999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHH----HHHHHHhcCCeecCCCCCceEecCC-CCeEEeecc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVD----AINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFG 188 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~----~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg 188 (357)
.+..++-+|+|. .+|.++..... .+++..++..+.+... ||.++|..+++|-|+||.||+...+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999995 58888886644 4899999999999999 9999999999999999999999988 789999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-C
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-V 267 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~ 267 (357)
+........-... ........|..-|++||+..+.. +.+.|+++||.++.+..+|..++.......+ .++...+ .
T Consensus 269 ~v~~i~~~~~~~~-~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip 344 (524)
T KOG0601|consen 269 LVSKISDGNFSSV-FKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIP 344 (524)
T ss_pred eeEEccCCccccc-eeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCc
Confidence 9886654332111 11112335677899999987643 4558999999999999888776644311111 0111111 1
Q ss_pred CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 268 FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.......+.++...+..|++ ++..|++++.++.|+++..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11112456666778888995 8999999999999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=7e-16 Score=149.29 Aligned_cols=143 Identities=20% Similarity=0.318 Sum_probs=96.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC----------------------------c---hHHHhhHHH
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP----------------------------S---DYLKKFLPR 92 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~----------------------------~---~~~~~~~~~ 92 (357)
.|.. +.||+|++|+||+|+..++|+.||||++++.-.. . ++..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 7899999999999999888999999999753100 0 011222333
Q ss_pred HHHH------HHcC----CCCCccceEEEEEe-CCeEEEEEeecCCCCHHHH--HHHcC----CCCHHHHHHHHHHHHHH
Q psy10194 93 EVEV------VKGL----KHPNLIKFLQAIET-THRVYIIMEYAEKGSLLDI--IRKEG----YIDETRARKWFAQLVDA 155 (357)
Q Consensus 93 E~~~------l~~l----~h~~Iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~----~l~~~~~~~i~~qi~~~ 155 (357)
|+.+ +.++ .+.+.+.+-.++.+ ....+|||||+.|+.+.++ +...+ .+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 3333 3333 23333443344422 4556899999999999875 33333 244444555555554
Q ss_pred HHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 156 INYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 156 l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
..|++|+|+||.||+++.+| .++++|||+...+.
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.5e-14 Score=120.13 Aligned_cols=141 Identities=16% Similarity=0.234 Sum_probs=102.5
Q ss_pred EeEeeecCceEEEEEEECC------CCcEEEEEEeecCCC-----------------------CchHHHhhHHHHHHHHH
Q psy10194 48 GTIIGMGSYATVKLATSSR------HSCEVAIKIISKMQA-----------------------PSDYLKKFLPREVEVVK 98 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~------~~~~vaiK~i~~~~~-----------------------~~~~~~~~~~~E~~~l~ 98 (357)
...||.|.-+.||.|.... .+..+|||+.+.... +.........+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357899999853110 00111222348999999
Q ss_pred cCCC--CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCCeecCCCCCceE
Q psy10194 99 GLKH--PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC-HERGVVHRDIKCENLL 175 (357)
Q Consensus 99 ~l~h--~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~givH~dlkp~NIl 175 (357)
++.. -++.+++++ ..-+|||||+.+..+..-..+...+++.++..++.+++.+|..| |..|++|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 456666654 45589999997654432222333466677888899999999998 8999999999999999
Q ss_pred ecCCCCeEEeeccccccc
Q psy10194 176 IDADYNIKLSDFGFARNH 193 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~ 193 (357)
++ ++.+.|+|||.+...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 96 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=136.32 Aligned_cols=142 Identities=22% Similarity=0.226 Sum_probs=96.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc-------------------------------hHHHh------hHH
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS-------------------------------DYLKK------FLP 91 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~-------------------------------~~~~~------~~~ 91 (357)
+.||+|++|+||+|+.. +|+.||||+.+...... +.... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999965 68899999985431000 00001 123
Q ss_pred HHHHHHHcC----CCCCccceEEEE-EeCCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q psy10194 92 REVEVVKGL----KHPNLIKFLQAI-ETTHRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVD-AINYCHERGV 164 (357)
Q Consensus 92 ~E~~~l~~l----~h~~Iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~-~l~~LH~~gi 164 (357)
+|+..+..+ .+.+-+.+-.++ ......++||||++|++|.++.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 455544444 222223332333 2234568999999999998876432 112 23446666665 4788999999
Q ss_pred eecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 165 VHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 165 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+|+|++|.||+++.++.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-13 Score=132.15 Aligned_cols=169 Identities=15% Similarity=0.344 Sum_probs=131.8
Q ss_pred EEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCC
Q psy10194 61 LATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYI 140 (357)
Q Consensus 61 ~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l 140 (357)
.|..+.++.+|.|...+.... .....+.+-++.|+.++||||+++++.++.....|||+|.+. .|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 466677888999888866544 234456678899999999999999999999999999999985 688788764
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchh
Q psy10194 141 DETRARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219 (357)
Q Consensus 141 ~~~~~~~i~~qi~~~l~~LH-~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 219 (357)
+...+..-+.||+.||.||| ..+++|++|.-+.|+++..|..||++|.++........ ......-.-.|..|+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChh
Confidence 47777888999999999997 67899999999999999999999999998865432221 000111122467777
Q ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhC
Q psy10194 220 ILKGIPYCPQLSDVWSMGVVLFAMVFG 246 (357)
Q Consensus 220 ~~~~~~~~~~~~DiwSlG~il~~ll~G 246 (357)
.+....+ ..|.|-|||++++++.|
T Consensus 176 ~~~~s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcccc---chhhhhHHHHHHHHhCc
Confidence 6544333 26999999999999998
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=3e-15 Score=131.72 Aligned_cols=204 Identities=19% Similarity=0.307 Sum_probs=140.6
Q ss_pred HHcCCCCCccceEEEEEe-----CCeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--Ce
Q psy10194 97 VKGLKHPNLIKFLQAIET-----THRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERG--VV 165 (357)
Q Consensus 97 l~~l~h~~Iv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~g--iv 165 (357)
+-++.|.||+++..++.+ .....++.||+..|+|.++|++ +..+.....++|+-||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 334569999999888744 4458899999999999999975 346888999999999999999999885 99
Q ss_pred ecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh
Q psy10194 166 HRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF 245 (357)
Q Consensus 166 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~ 245 (357)
|+++..+.|++..+|-+|+.--............. ..-.....+.++|.+||.=..... +-++|||++|....+|..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~--~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTR--EAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAI 277 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhh--HhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHH
Confidence 99999999999999988875322221111111111 111122345788999997544444 334899999999999987
Q ss_pred CCCC-CCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 246 GRLP-FDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 246 G~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
|..- -...........+.....- .-...-++++..||. .|..||++++++.||-.-..
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~----len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIG----LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred heeccCCCcceeehhhhhhhheee----ccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 7653 2222221222222221111 112234578899996 79999999999999977443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=115.37 Aligned_cols=127 Identities=17% Similarity=0.123 Sum_probs=95.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEEEEeecC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~lv~e~~~ 126 (357)
.+.|+.|.++.||++... +..+++|+....... .....+|+.+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 668999987543211 1234578889888865444 44554432 33479999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----eecCCCCCceEecCCCCeEEeeccccc
Q psy10194 127 KGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV-----VHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 127 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~gi-----vH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
|.++... . .....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 0 1123467899999999999985 9999999999998 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.4e-14 Score=133.36 Aligned_cols=252 Identities=22% Similarity=0.207 Sum_probs=182.4
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEEC-CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeC
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSS-RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETT 115 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~ 115 (357)
......+|..+..||.|.|+.|+.+.-. .++..|++|...+...........+ .|+-+...+. |.++++....+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccc
Confidence 3445567889999999999999987754 6788899998866544433333333 5666666664 88888888777777
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 194 (357)
+..++-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||++..+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 7778999999999888776544557888999999999999999999999999999999999775 788999999986432
Q ss_pred ccccccccccccccCCCCCCcc-chhhh-cCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhcccCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYA-SPEIL-KGIPYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLKQVQSKVVFPKD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~-aPE~~-~~~~~~~~~~DiwSlG~il~~ll~G~~p-f~~~~~~~~~~~~~~~~~~~~~ 271 (357)
... ....+.-.+. ..|++ ....+ ..+.|++|||..+.+.++|... +....... +.. -..+..
T Consensus 419 ~~~---------~~~~~~~r~~p~~~~~~e~~~~-~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----i~~-~~~p~~ 483 (524)
T KOG0601|consen 419 FSS---------GVFHHIDRLYPIAEILLEDYPH-LSKADIFSLGLSVDEAITGSPLSESGVQSLT----IRS-GDTPNL 483 (524)
T ss_pred eec---------ccccccccccccchhhcccccc-ccccccccccccccccccCcccCccccccee----eec-ccccCC
Confidence 111 1112233344 24444 44455 4559999999999999988643 32222111 111 123333
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
+....++..+.+.++ .|+..|+.+.++..|.-|.
T Consensus 484 ~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 484 PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 455578888888888 5899999999999887664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.2e-12 Score=104.91 Aligned_cols=134 Identities=18% Similarity=0.232 Sum_probs=98.8
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-----HHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-----LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
..+++|+-+.+|.+... |..+++|.-.+...-.+. ......+|++++..+.--.|..-+-+.-+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46789999999999663 334666654332222222 23445689999988865455444444456677789999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 245677777888889999999999999999996555 99999999964
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.2e-11 Score=111.27 Aligned_cols=210 Identities=19% Similarity=0.245 Sum_probs=151.0
Q ss_pred CceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE----eCCeEEEEEeecCC-CC
Q psy10194 55 SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE----TTHRVYIIMEYAEK-GS 129 (357)
Q Consensus 55 ~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~----~~~~~~lv~e~~~~-gs 129 (357)
--.+.|++....+|..|++|.++..+..... + ...-+++++++.|+|+|++.++|. .+.-+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--k-~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN--K-DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc--c-chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3468899999999999999999544333221 1 124577889999999999999885 45678999999886 57
Q ss_pred HHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 130 LLDIIRK---------------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 130 L~~~l~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
|.++.-. +...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|+..|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776521 2346789999999999999999999999999999999999988888887666554321
Q ss_pred ccccccccccccccCCCCCCccch-hhhcCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCcHHHH-HHHHhcccCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASP-EILKGIPYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQL-LKQVQSKVVFPKD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~~DiwSlG~il~~ll~G~~p-f~~~~~~~~-~~~~~~~~~~~~~ 271 (357)
. .| |-+.. -.+-|.=.||.++..|.||..- +........ +..+.
T Consensus 445 ~---------------------d~~~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------- 491 (655)
T KOG3741|consen 445 E---------------------DPTEPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------- 491 (655)
T ss_pred C---------------------CCCcchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------
Confidence 1 11 11222 1236999999999999999644 222222222 33332
Q ss_pred CCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 272 PNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 272 ~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
+.++.+++++|.-+.. .+++ -++.+++.+
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 3577888888887774 4554 677777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=106.47 Aligned_cols=140 Identities=19% Similarity=0.198 Sum_probs=105.3
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC--CCccceEEEEEeC---CeEEEEEe
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH--PNLIKFLQAIETT---HRVYIIME 123 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~l~~~~~~~---~~~~lv~e 123 (357)
+.|+.|.++.||++...+ |..+++|+....... .....+.+|+.+++.+.+ ..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998754 578999987543321 123456789999999875 3457777776553 26689999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE------------------------------------------ 161 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------------ 161 (357)
|++|.++.+.+.. ..+++.+...++.+++++|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346777777778888888888873
Q ss_pred --------------cCCeecCCCCCceEecC--CCCeEEeecccccc
Q psy10194 162 --------------RGVVHRDIKCENLLIDA--DYNIKLSDFGFARN 192 (357)
Q Consensus 162 --------------~givH~dlkp~NIll~~--~~~~kl~Dfg~~~~ 192 (357)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 56789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-11 Score=98.61 Aligned_cols=144 Identities=18% Similarity=0.164 Sum_probs=105.6
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCC-----CCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ-----APSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
....|-+|+-+.|+++.. .|+.++||.--... ....-.++...+|+++|.++.--.|.--.-++-+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 467889999999999985 46677777532222 22223345667899999988655555444455566677899
Q ss_pred EeecCC-CCHHHHHHHcC-CCCHHH-HHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEeecccccc
Q psy10194 122 MEYAEK-GSLLDIIRKEG-YIDETR-ARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLSDFGFARN 192 (357)
Q Consensus 122 ~e~~~~-gsL~~~l~~~~-~l~~~~-~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~Dfg~~~~ 192 (357)
|||++| .++.+++.+.. .-.++. ...++++|-+.+.-||.++|+|+||..+||++..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47888886532 223333 378999999999999999999999999999996554 358999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.1e-10 Score=98.51 Aligned_cols=127 Identities=24% Similarity=0.331 Sum_probs=83.9
Q ss_pred EEEEEEECCCCcEEEEEEeecCC-----------------------CCchHHHhhHHHHHHHHHcCCCC--CccceEEEE
Q psy10194 58 TVKLATSSRHSCEVAIKIISKMQ-----------------------APSDYLKKFLPREVEVVKGLKHP--NLIKFLQAI 112 (357)
Q Consensus 58 ~Vy~~~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~h~--~Iv~l~~~~ 112 (357)
.||.|... ++..+|+|+..... ...........+|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888864 56699999984311 12223345567899999999755 466666542
Q ss_pred EeCCeEEEEEeecC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 113 ETTHRVYIIMEYAE--KGSLLDIIRKEGYIDETRARKWFAQLVDAINY-CHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 113 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~-LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||++.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2379999998 65665544322 2245567788888885555 689999999999999999877 999999998
Q ss_pred ccc
Q psy10194 190 ARN 192 (357)
Q Consensus 190 ~~~ 192 (357)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-10 Score=100.30 Aligned_cols=137 Identities=24% Similarity=0.303 Sum_probs=103.5
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCC-------------------CCchHHHhhHHHHHHHHHcCCCC--
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ-------------------APSDYLKKFLPREVEVVKGLKHP-- 103 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~-------------------~~~~~~~~~~~~E~~~l~~l~h~-- 103 (357)
+.++..||.|.-|.||.|.+. .|..+|+|.-+.-. .+-..-+...++|..+|+.|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457899999999999999965 67799999863210 01111234456899999998644
Q ss_pred CccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 104 ~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
.+.+.+++ +.-.+|||+++|..|...- ++......++..|+.-+..+-..|+||+|+++-||+++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 66666644 5568999999996666442 24455666777777777777799999999999999999999999
Q ss_pred Eeeccccc
Q psy10194 184 LSDFGFAR 191 (357)
Q Consensus 184 l~Dfg~~~ 191 (357)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99996654
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-11 Score=118.11 Aligned_cols=159 Identities=21% Similarity=0.324 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccccccc--cccc-ccccccCCCCCCccchhhhcCCC
Q psy10194 150 AQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS--RQGY-ESLSETFCGSYAYASPEILKGIP 225 (357)
Q Consensus 150 ~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 225 (357)
.+.+.|+.|+|.. ++||++|.|++|.++.+|..||+.|+++........ +..+ ..+.....-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444899999965 899999999999999999999999998875443111 0111 11122223467899999998844
Q ss_pred CCCCcccHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHHh---cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 226 YCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQ---SKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 226 ~~~~~~DiwSlG~il~~ll-~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
. +.++|++|+||++|.+. .|+.-+............. +.-.+.....+++++++=+.++| .++.-||++.+++.
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4 56699999999999999 6776665543222222211 11122233579999999999999 58999999999999
Q ss_pred CCccccCCC
Q psy10194 301 DPWFRNGPS 309 (357)
Q Consensus 301 hp~f~~~~~ 309 (357)
.|||++..-
T Consensus 265 ~~ff~D~~~ 273 (700)
T KOG2137|consen 265 IPFFSDPGL 273 (700)
T ss_pred ccccCCchh
Confidence 999987643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-09 Score=96.67 Aligned_cols=102 Identities=22% Similarity=0.239 Sum_probs=78.9
Q ss_pred HHHHHHHHHcCCCCCc--cceEEEEEe-----CCeEEEEEeecCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHH
Q psy10194 90 LPREVEVVKGLKHPNL--IKFLQAIET-----THRVYIIMEYAEKG-SLLDIIRK--EGYIDETRARKWFAQLVDAINYC 159 (357)
Q Consensus 90 ~~~E~~~l~~l~h~~I--v~l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~L 159 (357)
+.+|...+..|..-+| +.++.+.+. ....++|+|++++. +|.+++.. ....+......++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 5578888877743333 334444433 23578999999885 79998864 34456778889999999999999
Q ss_pred HhcCCeecCCCCCceEecC-------CCCeEEeeccccc
Q psy10194 160 HERGVVHRDIKCENLLIDA-------DYNIKLSDFGFAR 191 (357)
Q Consensus 160 H~~givH~dlkp~NIll~~-------~~~~kl~Dfg~~~ 191 (357)
|..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999975 4679999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.6e-09 Score=95.74 Aligned_cols=233 Identities=18% Similarity=0.200 Sum_probs=150.7
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc-CCCCCccceEEE------E-EeCCeE
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG-LKHPNLIKFLQA------I-ETTHRV 118 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~l~~~------~-~~~~~~ 118 (357)
.+..||+|+-+.+|..-...+ .+.|+.+....... . +-...|.. -.||-+-.-+.| . ..+...
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 367899999999997754333 35577765432211 1 11222222 245543321111 1 122336
Q ss_pred EEEEeecCCC-CHHHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 119 YIIMEYAEKG-SLLDIIR------KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 119 ~lv~e~~~~g-sL~~~l~------~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.++|..+.|. .+..++. +-....+..+...++.|+.+.+.||..|.+-+|+.++|+|+++++.+.|.|-....
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7889988774 3333332 22457788999999999999999999999999999999999999999999865443
Q ss_pred cccccccccccccccccCCCCCCccchhhhc-----CCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcH-----HHHHH
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILK-----GIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKY-----SQLLK 260 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~-----~~~~~ 260 (357)
... .....-..+|.+.|.+||.-. +..- +...|.|.||+++++++.| ++||.+... .-...
T Consensus 166 i~~-------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 INA-------NGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ecc-------CCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 221 123344567999999999864 2233 2338999999999999876 999976321 00000
Q ss_pred HHh-----------cccCC----CCCCCCCHHHHHHHHHcccC---CCCCCCHH
Q psy10194 261 QVQ-----------SKVVF----PKDPNVSPECKALISKILAP---VKTRLRIK 296 (357)
Q Consensus 261 ~~~-----------~~~~~----~~~~~~~~~~~~li~~~L~~---p~~R~s~~ 296 (357)
.|. .++.. +....++++++.|..++..+ +.-|||++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111 11111 11135789999999999953 55799965
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.2e-09 Score=88.76 Aligned_cols=103 Identities=24% Similarity=0.314 Sum_probs=81.7
Q ss_pred HHHHHHHHHcCCCC--CccceEEEEEeC----CeEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Q psy10194 90 LPREVEVVKGLKHP--NLIKFLQAIETT----HRVYIIMEYAEK-GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162 (357)
Q Consensus 90 ~~~E~~~l~~l~h~--~Iv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 162 (357)
..+|...+..|..- ..++.+.+.+.. ...++|+|++++ .+|.+++.....++......++.+++..+.-||..
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~ 137 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA 137 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC
Confidence 45777777766432 234455555442 245899999988 47999998755577888899999999999999999
Q ss_pred CCeecCCCCCceEecCCC---CeEEeecccccc
Q psy10194 163 GVVHRDIKCENLLIDADY---NIKLSDFGFARN 192 (357)
Q Consensus 163 givH~dlkp~NIll~~~~---~~kl~Dfg~~~~ 192 (357)
||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 138 gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 138 GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999998877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.3e-08 Score=82.03 Aligned_cols=138 Identities=14% Similarity=0.147 Sum_probs=97.5
Q ss_pred eecCceEEEEEEECCCCcEEEEEEeecCCCCc---hHHHhhHHHHHHHHHcCCCCC--ccceEEEEE-e----CCeEEEE
Q psy10194 52 GMGSYATVKLATSSRHSCEVAIKIISKMQAPS---DYLKKFLPREVEVVKGLKHPN--LIKFLQAIE-T----THRVYII 121 (357)
Q Consensus 52 g~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~--Iv~l~~~~~-~----~~~~~lv 121 (357)
|+||-|.|+....... .+-+|.-..--... ......+.+|...++.|..-+ +.+.. ++. . .-.-+||
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4688888888765433 57777654110000 112445668888888875322 44444 222 1 2236799
Q ss_pred EeecCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC--eEEeecccccc
Q psy10194 122 MEYAEK-GSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN--IKLSDFGFARN 192 (357)
Q Consensus 122 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~--~kl~Dfg~~~~ 192 (357)
+|-+.| .+|.+++.+. .+.+......++.+++..+.-||+.|+.|+|+-+.|||++.+|. +.++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 5899888653 34577788899999999999999999999999999999987777 99999987754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.4e-08 Score=82.70 Aligned_cols=141 Identities=22% Similarity=0.261 Sum_probs=91.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-HHhh-----HHHHHHHHHcCC---CCCccceEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-LKKF-----LPREVEVVKGLK---HPNLIKFLQ 110 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-~~~~-----~~~E~~~l~~l~---h~~Iv~l~~ 110 (357)
+...+|.+.+++-......|.+... ++..+++|.........+. .... ..+++..+..+. -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457788889998888777777664 4568999987543211111 1111 123333333332 222233222
Q ss_pred E-----EEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 111 A-----IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 111 ~-----~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
+ +......++||||++|..|.+... +++ .+...|.+++.-||+.|++|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 2 233455679999999988876542 233 2456778889999999999999999999998555 9999
Q ss_pred eccccc
Q psy10194 186 DFGFAR 191 (357)
Q Consensus 186 Dfg~~~ 191 (357)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 997764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.8e-08 Score=83.10 Aligned_cols=138 Identities=19% Similarity=0.202 Sum_probs=94.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC---------------------chHHHhhHHHHHHHHHcCC--CCC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP---------------------SDYLKKFLPREVEVVKGLK--HPN 104 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~---------------------~~~~~~~~~~E~~~l~~l~--h~~ 104 (357)
...|+.|.-+.||+|.. .++..+|+|+....... ...+......|...|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 44777888899999985 56779999998542211 1112233446777777664 333
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCH-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCe
Q psy10194 105 LIKFLQAIETTHRVYIIMEYAEKGSL-LDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNI 182 (357)
Q Consensus 105 Iv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~ 182 (357)
+.+-+.+. .-.|||||+....+ .-.|+. -.+...++..+..++++.+.-|-. .|+||+||+.-|||+. ++.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 44444443 23699999955311 111222 223444788899999999988877 9999999999999998 8999
Q ss_pred EEeecccccc
Q psy10194 183 KLSDFGFARN 192 (357)
Q Consensus 183 kl~Dfg~~~~ 192 (357)
.++|||.+..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=82.14 Aligned_cols=134 Identities=15% Similarity=0.102 Sum_probs=83.4
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC--ccceEEEEEeCCeEEEEEeecC
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN--LIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
..||+|..+.||+.. +..+++|...... . ...+.+|.++++.+..-+ +.+.+.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-D----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-C----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 578999999999842 4467889875422 1 233568999998886433 4777888888888899999999
Q ss_pred CCC-HHHHH--------------HH-----c----CCCCHHHH-HHHHHHH----------HHH-HHHHH----hcCCee
Q psy10194 127 KGS-LLDII--------------RK-----E----GYIDETRA-RKWFAQL----------VDA-INYCH----ERGVVH 166 (357)
Q Consensus 127 ~gs-L~~~l--------------~~-----~----~~l~~~~~-~~i~~qi----------~~~-l~~LH----~~givH 166 (357)
|.+ +...+ .+ + ...+.... ..+..++ ... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 00 0 01111110 0110011 111 12222 124789
Q ss_pred cCCCCCceEecCCCCeEEeecccccc
Q psy10194 167 RDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 167 ~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.8e-07 Score=93.28 Aligned_cols=203 Identities=18% Similarity=0.209 Sum_probs=140.5
Q ss_pred HHHHHHHcCCCCCccceEEEEEeCCeE----EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeec
Q psy10194 92 REVEVVKGLKHPNLIKFLQAIETTHRV----YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167 (357)
Q Consensus 92 ~E~~~l~~l~h~~Iv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~ 167 (357)
-|+..+..+.|+|++.++.+-...... .+..++|...++...+..-+..+....+.+..+++.||.++|+....|.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v 310 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHV 310 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcccee
Confidence 456667777899999999886444332 2456789999999999999999999999999999999999999976666
Q ss_pred CCCCC---ceEecCCCCeEEe--eccccccccccccccccccccccCCCCCCccchhhhcCCCCC-CCcccHHHHHHHHH
Q psy10194 168 DIKCE---NLLIDADYNIKLS--DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC-PQLSDVWSMGVVLF 241 (357)
Q Consensus 168 dlkp~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DiwSlG~il~ 241 (357)
-+... +-..+.++....+ ||+....+...... ....-+..+.+||........ ....|+|.+|....
T Consensus 311 ~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 311 VLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred EEecccccccccCccceeecchhhhcccccCCCcccc-------hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 55555 4444556666666 88887755432211 111224567788876554432 22369999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCC-HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 242 AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS-PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 242 ~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
.+..|..+-.... ....+. +..+ ....+++.+|+ .++++|+++.+++.|+|.+.......
T Consensus 384 ~~~~~~~i~~~~~---~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA---VPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred hhhhcCccccccc---chhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 9998765532111 000000 1111 16778888898 58999999999999999987655443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-07 Score=91.75 Aligned_cols=141 Identities=26% Similarity=0.249 Sum_probs=90.5
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCC---------------------------CCc----hHHHhh------HH
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQ---------------------------APS----DYLKKF------LP 91 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~---------------------------~~~----~~~~~~------~~ 91 (357)
.-|+.++-|+||.|+... |+.||||+.+..- ..- ++..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999765 8999999985421 000 111111 22
Q ss_pred HHHHHHHcCC----CCCccceEEEE-EeCCeEEEEEeecCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q psy10194 92 REVEVVKGLK----HPNLIKFLQAI-ETTHRVYIIMEYAEKGSLLDI--IRKEGYIDETRARKWFAQLVDA-INYCHERG 163 (357)
Q Consensus 92 ~E~~~l~~l~----h~~Iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~--l~~~~~l~~~~~~~i~~qi~~~-l~~LH~~g 163 (357)
+|+..+..+. ...-+++=.+| +....-.++|||++|..+.+. +++. .++.+.+ +..++.+ +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-GIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-CCCHHHH---HHHHHHHHHHHHHhcC
Confidence 3444444442 22222233333 334556899999999888887 4443 3453332 2333222 22333489
Q ss_pred CeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 164 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
++|.|.+|.||+++.+|.+.+.|||......
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999986543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.7e-07 Score=78.21 Aligned_cols=137 Identities=21% Similarity=0.221 Sum_probs=81.5
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC--CccceEEEE---EeCCeEEEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP--NLIKFLQAI---ETTHRVYIIM 122 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~--~Iv~l~~~~---~~~~~~~lv~ 122 (357)
.+.|+.|..+.||++...+ + .+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999999766 3 8999986442 2345566888888887533 355666543 3344579999
Q ss_pred eecCCCCHHH----------------HHH---Hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q psy10194 123 EYAEKGSLLD----------------IIR---KE----GYIDETR------ARKW---------------FAQLVD-AIN 157 (357)
Q Consensus 123 e~~~~gsL~~----------------~l~---~~----~~l~~~~------~~~i---------------~~qi~~-~l~ 157 (357)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0111000 0000 011222 233
Q ss_pred HHH-------hcCCeecCCCCCceEec-CCCCeEEeeccccc
Q psy10194 158 YCH-------ERGVVHRDIKCENLLID-ADYNIKLSDFGFAR 191 (357)
Q Consensus 158 ~LH-------~~givH~dlkp~NIll~-~~~~~kl~Dfg~~~ 191 (357)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24599999999999999 56666899998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=76.60 Aligned_cols=133 Identities=17% Similarity=0.098 Sum_probs=81.4
Q ss_pred eeecCc-eEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEEeecCCC
Q psy10194 51 IGMGSY-ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 51 Lg~G~~-g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~e~~~~g 128 (357)
|..|.. +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444444 889999753 3578888875432 123457888888874 344667787777767789999999997
Q ss_pred CHHHHH----------------H---HcC----CCCHH--HHHHH----HH----------------HHHHHHHHHH---
Q psy10194 129 SLLDII----------------R---KEG----YIDET--RARKW----FA----------------QLVDAINYCH--- 160 (357)
Q Consensus 129 sL~~~l----------------~---~~~----~l~~~--~~~~i----~~----------------qi~~~l~~LH--- 160 (357)
+|.... . ... ++... ..... +. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 766431 0 000 11100 00000 00 0111122221
Q ss_pred ----hcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 161 ----ERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 161 ----~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999987778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.6e-08 Score=94.79 Aligned_cols=242 Identities=17% Similarity=0.144 Sum_probs=165.0
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC-ccceEEEEEeCCeEEEEEe
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN-LIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~l~~~~~~~~~~~lv~e 123 (357)
|...+.+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+++.+++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 556778899999999999977766555 6766432 12235788999999999 7777777788889999999
Q ss_pred ecCCC-CHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 124 YAEKG-SLLDII-RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 124 ~~~~g-sL~~~l-~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
++.++ +..... ...-.+.+-+...+.+.-++++++||+.--+|+| ||+.. ++..+..||+....+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc----
Confidence 99887 222111 1111244455566677788899999999889998 77664 4778999999987665332
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-CC--CCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP-KD--PNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 278 (357)
...+..+++.++|||+.....+... .|.|++|.-..++.-|.+|-..- ......+......+ .. ...++..
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~ 459 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVF 459 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCccc
Confidence 2335678999999999988877555 79999998877887777765330 00000010010000 00 0111222
Q ss_pred H-HHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 279 K-ALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 279 ~-~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
. ++...|+. -|..|+...+++-|.+|..++-+
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 2 36667784 68999999999999999988755
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-06 Score=84.61 Aligned_cols=140 Identities=26% Similarity=0.298 Sum_probs=87.8
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCC----------------------------CchHHHhhHHH------H
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA----------------------------PSDYLKKFLPR------E 93 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~----------------------------~~~~~~~~~~~------E 93 (357)
.+.||.-+.|+|++|+.+. |+.||||+-++.-. --++..+.+.. |
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3679999999999999776 99999999854210 01111222222 2
Q ss_pred HHHHH----cCCCCC------ccceEEEEEeCCeEEEEEeecCCCCHHHH--HHHcCCCCHHHHHHHHHHHHHHHH-HHH
Q psy10194 94 VEVVK----GLKHPN------LIKFLQAIETTHRVYIIMEYAEKGSLLDI--IRKEGYIDETRARKWFAQLVDAIN-YCH 160 (357)
Q Consensus 94 ~~~l~----~l~h~~------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~l~~~~~~~i~~qi~~~l~-~LH 160 (357)
++... .+.|-+ |.+++.-+ ...-.|+||||+|..+.++ +.+.+ ++... ++..+.++.. -+=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHH
Confidence 22222 223444 33333322 3455899999999877654 44544 44443 3333433322 233
Q ss_pred hcCCeecCCCCCceEecC----CCCeEEeecccccccc
Q psy10194 161 ERGVVHRDIKCENLLIDA----DYNIKLSDFGFARNHM 194 (357)
Q Consensus 161 ~~givH~dlkp~NIll~~----~~~~kl~Dfg~~~~~~ 194 (357)
..|++|+|-+|.||+++. ++.+.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 568999999999999984 5679999999987553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.36 E-value=7e-06 Score=85.25 Aligned_cols=80 Identities=18% Similarity=0.191 Sum_probs=56.3
Q ss_pred EeEeeecCceEEEEEEECCCC--cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCc--cceEEEEEeC---CeEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHS--CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNL--IKFLQAIETT---HRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~I--v~l~~~~~~~---~~~~ 119 (357)
...|+.|.+..+|+......+ ..+++|+......... ...+.+|+++++.+. |.++ .+++.++.+. ...|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 677899999999998765432 3677777543221111 235679999999985 6654 7778877664 4678
Q ss_pred EEEeecCCCC
Q psy10194 120 IIMEYAEKGS 129 (357)
Q Consensus 120 lv~e~~~~gs 129 (357)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-05 Score=68.22 Aligned_cols=132 Identities=17% Similarity=0.221 Sum_probs=91.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-------------chHHHhhHHHHHHHHHcCC------CCCccce
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-------------SDYLKKFLPREVEVVKGLK------HPNLIKF 108 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-------------~~~~~~~~~~E~~~l~~l~------h~~Iv~l 108 (357)
...||+|+.-.||.--+. ...+||+....... .....+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999876533 34689998765500 0001233446666555554 7889999
Q ss_pred EEEEEeCCeEEEEEeecCC------CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC--C
Q psy10194 109 LQAIETTHRVYIIMEYAEK------GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD--Y 180 (357)
Q Consensus 109 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~--~ 180 (357)
+++.+++....+|+|.+.+ .+|.+++.+. .+++ . +...+-+-..+|-+.+|+.+|++|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998643 3688888554 3555 3 34444555677889999999999999999532 2
Q ss_pred --CeEEeec
Q psy10194 181 --NIKLSDF 187 (357)
Q Consensus 181 --~~kl~Df 187 (357)
.+.|+|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 4777763
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=65.60 Aligned_cols=128 Identities=20% Similarity=0.241 Sum_probs=90.6
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccc-eEEEEEeCCeEEEEEee
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK-FLQAIETTHRVYIIMEY 124 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~-l~~~~~~~~~~~lv~e~ 124 (357)
+..+.||+|.+|.||++.+.. ..+|+|+-.... -+..+..|+++|..+.--++.. ++.+-++ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeeccC--ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 346789999999999999753 488999865432 2566778999999887655543 3333222 455999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCC-CCceEecCCCCeEEeeccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIK-CENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlk-p~NIll~~~~~~kl~Dfg~~~ 191 (357)
..|..|.++-... + +.-+..+++.-.-|-..||-|+.|+ |...++..++.+.|+||..|.
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9998888765321 2 2334556666666788999999997 444444455599999999886
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.5e-05 Score=70.14 Aligned_cols=73 Identities=10% Similarity=0.035 Sum_probs=44.7
Q ss_pred eEeeecCce-EEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC---CccceEEEEEeC---CeEEEE
Q psy10194 49 TIIGMGSYA-TVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP---NLIKFLQAIETT---HRVYII 121 (357)
Q Consensus 49 ~~Lg~G~~g-~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~l~~~~~~~---~~~~lv 121 (357)
..|+.|+.. .||++. ..+++|+.+... ....+.+|..+++.+... .+.+++...... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456767766 488762 247778754311 133567899999887532 344445443332 245889
Q ss_pred EeecCCCCHH
Q psy10194 122 MEYAEKGSLL 131 (357)
Q Consensus 122 ~e~~~~gsL~ 131 (357)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=70.74 Aligned_cols=142 Identities=22% Similarity=0.274 Sum_probs=98.7
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEeecC-----------------------CCCchHHHhhHHHHHHHHHcCCC
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKM-----------------------QAPSDYLKKFLPREVEVVKGLKH 102 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~-----------------------~~~~~~~~~~~~~E~~~l~~l~h 102 (357)
.+-..|..|.-+.||.|.. .+|..+|||+.+-. ..+...++-....|++.|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3567788999999999984 56777999998531 11222333445578888888765
Q ss_pred CCccceEEEEEeCCeEEEEEeecCCCCHHHH-HHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCCeecCCCCCceEecCCC
Q psy10194 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDI-IRKEGYIDETRARKWFAQLVDAINYC-HERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 103 ~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~givH~dlkp~NIll~~~~ 180 (357)
..|.----+... .-.|||+|+.. +-+.. ..++-.++...+..+-.+++.-+.-| |.+++||.||+--|+|+ .+|
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 544322212111 23799999953 32221 12344578888999999998888776 46799999999999999 788
Q ss_pred CeEEeecccccc
Q psy10194 181 NIKLSDFGFARN 192 (357)
Q Consensus 181 ~~kl~Dfg~~~~ 192 (357)
.+.++|-+.+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 999999987754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=9e-05 Score=67.65 Aligned_cols=76 Identities=11% Similarity=0.005 Sum_probs=54.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC---CCccceEEEEEe---CCeEEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH---PNLIKFLQAIET---THRVYII 121 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h---~~Iv~l~~~~~~---~~~~~lv 121 (357)
.+.||.|..+.||.....+. .+.+|..+. ... ...+..|...|+.|.. -.+.++++++.. .+..++|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~-~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG--NPMPLMARS-FST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcCCC--CEEEEEecc-ccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 56799999999999975433 467777532 111 2356689999988853 367888887754 3668999
Q ss_pred EeecCCCCH
Q psy10194 122 MEYAEKGSL 130 (357)
Q Consensus 122 ~e~~~~gsL 130 (357)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00017 Score=68.14 Aligned_cols=80 Identities=15% Similarity=0.017 Sum_probs=53.3
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--Cc--hHHHhhHHHHHHHHHcCC---CCCccceEEEEEeCCeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PS--DYLKKFLPREVEVVKGLK---HPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~--~~~~~~~~~E~~~l~~l~---h~~Iv~l~~~~~~~~~~~l 120 (357)
.+.||.|.+..||++...+.+..++||.-..... .. ....+....|...|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999865546899997532110 00 111234456888888763 3456677766 4466789
Q ss_pred EEeecCCCC
Q psy10194 121 IMEYAEKGS 129 (357)
Q Consensus 121 v~e~~~~gs 129 (357)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00012 Score=64.27 Aligned_cols=75 Identities=13% Similarity=0.095 Sum_probs=47.7
Q ss_pred EeEeeecCceEEEEEEECC-CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC-ccceEEEEEeCCeEEEEEeec
Q psy10194 48 GTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN-LIKFLQAIETTHRVYIIMEYA 125 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~l~~~~~~~~~~~lv~e~~ 125 (357)
.+.|..|-...+|++.... .+..|++|+....... .-...+|+.+++.+...+ .++++..+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567888888999997543 3567889976532211 112347888888885433 344444332 2 4799999
Q ss_pred CCCCH
Q psy10194 126 EKGSL 130 (357)
Q Consensus 126 ~~gsL 130 (357)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.98 E-value=9.1e-06 Score=73.01 Aligned_cols=136 Identities=17% Similarity=0.224 Sum_probs=95.4
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCC-------------------CCchHHHhhHHHHHHHHHcCCC--C
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ-------------------APSDYLKKFLPREVEVVKGLKH--P 103 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~-------------------~~~~~~~~~~~~E~~~l~~l~h--~ 103 (357)
|.+++.||-|.-+.+|.+.+. .|.+.++|+-.... .+-..-+-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567899999999999999854 56788888753210 0000011223467778887742 2
Q ss_pred CccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 104 ~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
-+.+.+++ +..++|||++.|..|.+.-.- ..+..+...+..-+--|-..|+||+|..--||+++.++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 34444443 456899999999887755421 12345566667777778899999999999999999999999
Q ss_pred Eeeccccc
Q psy10194 184 LSDFGFAR 191 (357)
Q Consensus 184 l~Dfg~~~ 191 (357)
++||-...
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99996543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.3e-05 Score=64.74 Aligned_cols=98 Identities=19% Similarity=0.174 Sum_probs=78.9
Q ss_pred HHHHHHHcCCC-CCccceEEEEEeCCeEEEEEeecCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh---cCC
Q psy10194 92 REVEVVKGLKH-PNLIKFLQAIETTHRVYIIMEYAEKGSLLDI---IRKEGYIDETRARKWFAQLVDAINYCHE---RGV 164 (357)
Q Consensus 92 ~E~~~l~~l~h-~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~qi~~~l~~LH~---~gi 164 (357)
+|.-+++.+.+ +++++++|.|-+ ++|.||...+++... +...-..++..+..++.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 68889999975 699999999933 678999987655421 1111235899999999999999999997 347
Q ss_pred eecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 165 VHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 165 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.-.|++++|+-++.+|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 77999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.1e-05 Score=67.22 Aligned_cols=133 Identities=16% Similarity=0.203 Sum_probs=76.0
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEEEEeecCCC
Q psy10194 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~lv~e~~~~g 128 (357)
.+..|-...+|++. .++..+++|........ ..-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35567788899887 34557888875432111 10123578888888864333 34444332 26899999986
Q ss_pred CHHH--------------HHHH---c----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------cCCeecCC
Q psy10194 129 SLLD--------------IIRK---E----GYIDE-TRARKWFAQL---------VDAINYCHE--------RGVVHRDI 169 (357)
Q Consensus 129 sL~~--------------~l~~---~----~~l~~-~~~~~i~~qi---------~~~l~~LH~--------~givH~dl 169 (357)
.+.. .+.+ . .+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1111 1 11121 1122222122 111222221 24899999
Q ss_pred CCCceEecCCCCeEEeecccccc
Q psy10194 170 KCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.|.||+++.++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999998877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00035 Score=59.29 Aligned_cols=128 Identities=20% Similarity=0.189 Sum_probs=87.7
Q ss_pred cCEEEEeEeeecCc-eEEEEEEECCCCcEEEEEEeec---CC--------CCch-------HHHhhHHHHHHHHHcC---
Q psy10194 43 HGYTLGTIIGMGSY-ATVKLATSSRHSCEVAIKIISK---MQ--------APSD-------YLKKFLPREVEVVKGL--- 100 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~-g~Vy~~~~~~~~~~vaiK~i~~---~~--------~~~~-------~~~~~~~~E~~~l~~l--- 100 (357)
.+++..+.||.|+- |.||++... |..||+|+... .. ...+ ....-+..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 999999975 55999999421 00 0000 1123345666665555
Q ss_pred CCCCc--cceEEEEEeC------------------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q psy10194 101 KHPNL--IKFLQAIETT------------------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160 (357)
Q Consensus 101 ~h~~I--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH 160 (357)
.+.++ ++.+++..-. ....||.||.+... .+... -+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 45566 8888887211 12467888877633 22333 3566777788899
Q ss_pred hcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 161 ~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999987 2 378999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00011 Score=66.95 Aligned_cols=136 Identities=21% Similarity=0.211 Sum_probs=80.4
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC--ccceEE------EEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN--LIKFLQ------AIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~l~~------~~~~~~~~~ 119 (357)
.+.|..|....+|++... +..+++|+... .. ...+..|+.+++.+.+.+ +.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 556778888899998743 23688898754 11 223456777777774322 444433 123445678
Q ss_pred EEEeecCCCCHHH-----------HH---HH-cCCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q psy10194 120 IIMEYAEKGSLLD-----------II---RK-EGYIDE--------TRAR------------KWFAQLVDAINYCHE--- 161 (357)
Q Consensus 120 lv~e~~~~gsL~~-----------~l---~~-~~~l~~--------~~~~------------~i~~qi~~~l~~LH~--- 161 (357)
+|+++++|..+.. .+ .. ...+.. .-.. .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 11 00 000000 0000 011112333444443
Q ss_pred ----cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 ----RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 ----~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.76 E-value=4.8e-06 Score=87.51 Aligned_cols=212 Identities=19% Similarity=0.090 Sum_probs=140.1
Q ss_pred hhHHHHHHHHHcCCCCCccceEEEEE--eCCeEEEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh
Q psy10194 88 KFLPREVEVVKGLKHPNLIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHE 161 (357)
Q Consensus 88 ~~~~~E~~~l~~l~h~~Iv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~ 161 (357)
+....|..-++...|+++.....-.. .....+.+++++.+|.+++.|-++ .++...-+....++.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33344555556667888877665543 334568899999999999998543 345555555555665777777775
Q ss_pred cC-----CeecCCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHH
Q psy10194 162 RG-----VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSM 236 (357)
Q Consensus 162 ~g-----ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 236 (357)
.. .+|+++|+-|.++..+..+++.++|+.+..... ........+++.|++|++...-.+. .++|+|..
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~------~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~ 1426 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV------LSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRR 1426 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch------HhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHH
Confidence 42 789999999999999999999999999832211 1223345678889999987766663 34999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 237 G~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
|+.+|...-|..+|.......+...+.++..+......|.++....-.+| -.-..||.-...+.-+.|..
T Consensus 1427 s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99999999998888543333322233333222222222333333333333 46678888888888777754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00069 Score=62.46 Aligned_cols=30 Identities=40% Similarity=0.598 Sum_probs=26.0
Q ss_pred cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.|++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866556899999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00054 Score=62.87 Aligned_cols=138 Identities=21% Similarity=0.213 Sum_probs=79.3
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC--CccceEEE------EEeCCeE
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP--NLIKFLQA------IETTHRV 118 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~--~Iv~l~~~------~~~~~~~ 118 (357)
..+.++.|....+|++... ++ .+++|+...... . +.+..|+.++..|... .+.+++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~-~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK-A----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEeC-CC-cEEEEEecCCCC-H----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3566778888899998743 33 678897654221 1 2233566666666322 23444332 1234567
Q ss_pred EEEEeecCCCCHH-----------HHH---HH-cCCCCH-------HHHH----------------HHHHHHHHHHHHHH
Q psy10194 119 YIIMEYAEKGSLL-----------DII---RK-EGYIDE-------TRAR----------------KWFAQLVDAINYCH 160 (357)
Q Consensus 119 ~lv~e~~~~gsL~-----------~~l---~~-~~~l~~-------~~~~----------------~i~~qi~~~l~~LH 160 (357)
+++++|++|..+. ..+ .. ...++. ...+ .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 111 10 000100 0000 00112233455554
Q ss_pred h-------cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 161 E-------RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 161 ~-------~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
. .+++|+|+.+.||+++.++...|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 589999999999999988877899998874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00078 Score=61.60 Aligned_cols=76 Identities=18% Similarity=0.106 Sum_probs=47.4
Q ss_pred EeEeeecCceEEEEEEECC------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSR------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~l 120 (357)
.+.|..|-...+|++.... .+..+++|+....... .....+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899887543 2578999986543211 1234578888888753333 445555432 36
Q ss_pred EEeecCCCCHH
Q psy10194 121 IMEYAEKGSLL 131 (357)
Q Consensus 121 v~e~~~~gsL~ 131 (357)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00082 Score=61.36 Aligned_cols=138 Identities=17% Similarity=0.136 Sum_probs=82.6
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC--CCccceEEEEEeCC--eEEEEEe
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH--PNLIKFLQAIETTH--RVYIIME 123 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~l~~~~~~~~--~~~lv~e 123 (357)
.+.+..|..-.+|..... ++.+++. ... ............+|+.+++.+.- --+...++.|.++. ..|.||+
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 444434444445555433 6677887 332 11112223445688888888753 23445566665555 6799999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWF-AQLVDAINYCHE----------------------------------------- 161 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~-~qi~~~l~~LH~----------------------------------------- 161 (357)
|++|..+.+.... ......++ ..+...|..||+
T Consensus 106 ~veGe~~~~~~~~-----~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 106 WVEGEVVWSALPP-----ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EecceeccCcCCc-----ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9998533322211 11111222 255555555553
Q ss_pred -----------------cCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 162 -----------------RGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 162 -----------------~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
..++|+|+.+.|++++.++.+=|.||+.+....
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 248999999999999998889999999987543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=60.66 Aligned_cols=76 Identities=12% Similarity=0.010 Sum_probs=47.1
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEeecC----CCCchHHHhhHHHHHHHHHcCC--CC-CccceEEEEEeCCeEEEEE
Q psy10194 50 IIGMGSYATVKLATSSRHSCEVAIKIISKM----QAPSDYLKKFLPREVEVVKGLK--HP-NLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 50 ~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~----~~~~~~~~~~~~~E~~~l~~l~--h~-~Iv~l~~~~~~~~~~~lv~ 122 (357)
.||.|....||++.....+..++||--..- ...-..-.....-|...|+... .| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997644467899864311 1000111233446778887664 34 34444433 566677999
Q ss_pred eecCC
Q psy10194 123 EYAEK 127 (357)
Q Consensus 123 e~~~~ 127 (357)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0029 Score=59.76 Aligned_cols=76 Identities=18% Similarity=0.078 Sum_probs=49.4
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCC-Cch---HHHhhHHHHHHHHHcCC---CCCccceEEEEEeCCeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA-PSD---YLKKFLPREVEVVKGLK---HPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~E~~~l~~l~---h~~Iv~l~~~~~~~~~~~l 120 (357)
.+.||.|....||++.+. +..++||.-..... ..+ .-......|+..|+.+. ...+++++.+++ +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 678899999999999863 34688987642111 010 01222235677776654 347788888876 44578
Q ss_pred EEeecCC
Q psy10194 121 IMEYAEK 127 (357)
Q Consensus 121 v~e~~~~ 127 (357)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0015 Score=62.50 Aligned_cols=159 Identities=21% Similarity=0.279 Sum_probs=101.5
Q ss_pred HHHHHHHHHcCCCCCccceEEEEEeC-CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Q psy10194 90 LPREVEVVKGLKHPNLIKFLQAIETT-HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168 (357)
Q Consensus 90 ~~~E~~~l~~l~h~~Iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~d 168 (357)
+.-...+++.+.|+|....+++-... ....+|||++.- +|.+.+..+. +-..... +|+-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~~------------------~~~~ 88 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESLL------------------AHGV 88 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhhc------------------cccc
Confidence 33557788889999999999887543 457899999954 9999987654 2221111 2221
Q ss_pred CCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy10194 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRL 248 (357)
Q Consensus 169 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~ 248 (357)
+. -|+ ++.+| .++... ....| +|+||||+|.++.++..|..
T Consensus 89 ~~-~~~-------~~~td-~~~t~~-------------~~~~~-----------------pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 89 LH-LNI-------IYITD-HFLTKY-------------PSPIG-----------------PKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ce-ehh-------hhccc-cccccC-------------CCCCC-----------------cchhhhhHHHHHHHHHHhhH
Confidence 11 112 22233 111000 01111 26999999999999999998
Q ss_pred CCCCCcHHHHHHHHhcccCCCCC-----------CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 249 PFDDTKYSQLLKQVQSKVVFPKD-----------PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 249 pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
.|......+....+..-+..+.. -..+....++...|+ ..|..||...++.+++-|...
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 88776666655555433322211 134566777888888 579999999999999988654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0072 Score=56.38 Aligned_cols=141 Identities=17% Similarity=0.224 Sum_probs=80.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECC----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCe
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSR----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHR 117 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~ 117 (357)
....+. .|-.|-.-.+|++.... .+..|++|+..... +..... .+|..+++.+..-++ .++++.+...
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 344444 45558888999987532 24678899875432 111222 478888888864444 3455555332
Q ss_pred EEEEEeecCCCCHHHH-------H-------H---HcC------CCCHHHHHHHHHHH-----------------HHHHH
Q psy10194 118 VYIIMEYAEKGSLLDI-------I-------R---KEG------YIDETRARKWFAQL-----------------VDAIN 157 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~-------l-------~---~~~------~l~~~~~~~i~~qi-----------------~~~l~ 157 (357)
.|.+|+++.+|... + . ... ......+..++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987665321 1 1 001 01122333333222 11121
Q ss_pred HH----H----hcCCeecCCCCCceEecC-CCCeEEeecccccc
Q psy10194 158 YC----H----ERGVVHRDIKCENLLIDA-DYNIKLSDFGFARN 192 (357)
Q Consensus 158 ~L----H----~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~ 192 (357)
.| . ...++|+|+++.|||++. ++.+.++||..+..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22 1 225899999999999976 46899999988753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0054 Score=57.62 Aligned_cols=78 Identities=15% Similarity=0.067 Sum_probs=49.6
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecC-CC--CchHHHhhHHHHHHHHHcCC--CC-CccceEEEEEeCCeEEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKM-QA--PSDYLKKFLPREVEVVKGLK--HP-NLIKFLQAIETTHRVYII 121 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~-~~--~~~~~~~~~~~E~~~l~~l~--h~-~Iv~l~~~~~~~~~~~lv 121 (357)
.+.||.|.-.-||++.+...+..++||--..- .. .-.--.+...-|...|+.+. .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67889999999999998544557888854211 10 00111334456888888764 34 44445443 66667899
Q ss_pred EeecCC
Q psy10194 122 MEYAEK 127 (357)
Q Consensus 122 ~e~~~~ 127 (357)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0095 Score=55.27 Aligned_cols=141 Identities=16% Similarity=0.252 Sum_probs=78.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~ 118 (357)
...++.. |..|=.-.+|++..... +..|++|+...... .... -.+|..+++.+..-++ .++++++. . .
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~-G- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-N-G- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-C-c-
Confidence 3444444 44477778888865432 33788998754321 1111 2378888888865444 34555553 2 2
Q ss_pred EEEEeecCCCCHHH-------HH-------H---HcC-C----C-CHHHHHHHHHHH----------------------H
Q psy10194 119 YIIMEYAEKGSLLD-------II-------R---KEG-Y----I-DETRARKWFAQL----------------------V 153 (357)
Q Consensus 119 ~lv~e~~~~gsL~~-------~l-------~---~~~-~----l-~~~~~~~i~~qi----------------------~ 153 (357)
+|.+|++|..|.. .+ . ... + + ....+..++.++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998765421 11 1 111 0 1 122233333222 1
Q ss_pred HHHHHHH----hcC----CeecCCCCCceEecC-CCCeEEeecccccc
Q psy10194 154 DAINYCH----ERG----VVHRDIKCENLLIDA-DYNIKLSDFGFARN 192 (357)
Q Consensus 154 ~~l~~LH----~~g----ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~ 192 (357)
.-+..+. ..+ ++|+|+.+.|||++. ++.++++||..|..
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1122221 112 799999999999975 57899999998853
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0091 Score=53.87 Aligned_cols=30 Identities=33% Similarity=0.416 Sum_probs=25.2
Q ss_pred CCeecCCCCCceEecCCCC-eEEeecccccc
Q psy10194 163 GVVHRDIKCENLLIDADYN-IKLSDFGFARN 192 (357)
Q Consensus 163 givH~dlkp~NIll~~~~~-~kl~Dfg~~~~ 192 (357)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987565 56999998854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0065 Score=55.01 Aligned_cols=73 Identities=16% Similarity=0.185 Sum_probs=47.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC---CCCccceEEEEEeCCeEEEEEee
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
.+.++-|....+|+.. .++..+.+|+-.... ...+..|..-|+.|. .-.+++++.+....+..++||||
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 5678889999999988 566789999875221 345667888877773 45678889988887788999999
Q ss_pred cCCC
Q psy10194 125 AEKG 128 (357)
Q Consensus 125 ~~~g 128 (357)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.045 Score=50.24 Aligned_cols=30 Identities=20% Similarity=0.186 Sum_probs=27.3
Q ss_pred CCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 163 GVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 163 givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0071 Score=55.67 Aligned_cols=113 Identities=18% Similarity=0.363 Sum_probs=73.6
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
....+.|++|++- |++|. .++. -...++..++.+.+..+.-+... ..-|||+...|||++ +|++.|+||-+++
T Consensus 296 de~~y~yl~~kdh-gt~is-~ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 296 DETLYLYLHFKDH-GTPIS-IIKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred CCceEEEEEEecC-Cceee-eeec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 3445677888875 44444 2222 35677888999888888777754 799999999999999 9999999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~ 247 (357)
.-.. . ..+-....--|-.+.|.. +..-+||-+ |-.|+.|.
T Consensus 370 l~~~--q---------~~isy~rldhp~lF~G~d--d~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 370 LSYS--Q---------GIISYNRLDHPDLFNGVD--DYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred cccC--C---------ceeeccccCchhhhcCcc--ceeeeHHHH---HHHHhcCc
Confidence 3211 1 011112334566666543 333677765 44455554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.012 Score=50.47 Aligned_cols=117 Identities=13% Similarity=0.151 Sum_probs=72.7
Q ss_pred cCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHH
Q psy10194 54 GSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDI 133 (357)
Q Consensus 54 G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 133 (357)
++-++.-.+...- | +..+|.+......-. ...+.++.+++.+++ .|+++..- ..-.+.++.|+|.....-
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-- 142 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-- 142 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc--
Confidence 3444444443322 3 455666654443311 234457888888764 47777633 445677999999541110
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 134 IRKEGYIDETRARKWFAQLVDAINYCHE--RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 134 l~~~~~l~~~~~~~i~~qi~~~l~~LH~--~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
-..++..=+.+|.-.|+ .+.+|+|-.|+|||-|+.|.+||.|-+...
T Consensus 143 -----------~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll 191 (308)
T PF07387_consen 143 -----------FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL 191 (308)
T ss_pred -----------hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh
Confidence 11122222556777884 469999999999999999999999987653
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.022 Score=53.85 Aligned_cols=80 Identities=19% Similarity=0.129 Sum_probs=45.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCC-CcE-----EEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRH-SCE-----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETT 115 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~ 115 (357)
....+ +.|..|=...+|++..... +.. |.++.... ..+.... -.+|+.+++.+...++ .++++.+..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEec-cHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 34454 4555588889999975433 122 33333211 1111111 1368999998875444 455555542
Q ss_pred CeEEEEEeecCCCCHH
Q psy10194 116 HRVYIIMEYAEKGSLL 131 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~ 131 (357)
++|.||++|.+|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999986653
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.013 Score=54.88 Aligned_cols=59 Identities=22% Similarity=0.234 Sum_probs=44.1
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCCeecCCCCCceEec
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC-HERGVVHRDIKCENLLID 177 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~givH~dlkp~NIll~ 177 (357)
..++-+|..|.++..+++..+ .++..++.++.-.+.|+..+ ---+++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 456777888889998886543 56666777777666665543 456899999999999984
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.012 Score=50.65 Aligned_cols=30 Identities=37% Similarity=0.556 Sum_probs=21.5
Q ss_pred CCeecCCCCCceEe-cCCCCeEEeecccccc
Q psy10194 163 GVVHRDIKCENLLI-DADYNIKLSDFGFARN 192 (357)
Q Consensus 163 givH~dlkp~NIll-~~~~~~kl~Dfg~~~~ 192 (357)
.++|+|+.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999988854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.045 Score=49.73 Aligned_cols=28 Identities=36% Similarity=0.544 Sum_probs=23.5
Q ss_pred CeecCCCCCceEecCC--C---CeEEeeccccc
Q psy10194 164 VVHRDIKCENLLIDAD--Y---NIKLSDFGFAR 191 (357)
Q Consensus 164 ivH~dlkp~NIll~~~--~---~~kl~Dfg~~~ 191 (357)
++|+|++.+|||+..+ | .+++.||-.++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999544 3 58999997764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.19 Score=53.82 Aligned_cols=31 Identities=45% Similarity=0.589 Sum_probs=26.3
Q ss_pred cCCeecCCCCCceEecCCC--CeE-Eeecccccc
Q psy10194 162 RGVVHRDIKCENLLIDADY--NIK-LSDFGFARN 192 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~--~~k-l~Dfg~~~~ 192 (357)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998775 555 999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.11 E-value=1 Score=41.67 Aligned_cols=28 Identities=29% Similarity=0.246 Sum_probs=23.8
Q ss_pred cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899998874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.077 Score=48.56 Aligned_cols=29 Identities=28% Similarity=0.618 Sum_probs=25.4
Q ss_pred cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.17 Score=44.92 Aligned_cols=79 Identities=14% Similarity=0.095 Sum_probs=52.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEeec-C
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA-E 126 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~-~ 126 (357)
...+..|..+.|+.++ ..+|..+++|+......... .. .....|+..+-...|++++.= ...-.|++|++ +
T Consensus 7 ~~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~~~~----E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~ 78 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAEAEH----EA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDP 78 (253)
T ss_pred CCCCCCCcceEEEEEE-cCCCCeEEEEecCCcccchh----hh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccC
Confidence 3456678999999998 45688999998754332111 00 122568877878888888763 34557889998 4
Q ss_pred CCCHHHHH
Q psy10194 127 KGSLLDII 134 (357)
Q Consensus 127 ~gsL~~~l 134 (357)
+.+|.+..
T Consensus 79 g~~L~~~~ 86 (253)
T PF04655_consen 79 GRSLASLP 86 (253)
T ss_pred CCchhhcc
Confidence 44665443
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 357 | ||||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-51 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-51 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-51 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-50 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-50 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-50 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-50 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-49 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-48 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-48 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-45 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-44 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-44 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-44 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-40 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-37 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-37 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-37 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-36 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-36 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-36 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-36 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-36 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-36 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-36 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-36 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-36 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-35 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-35 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-35 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-35 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-35 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-35 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-35 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-35 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-35 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-35 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-35 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-35 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-35 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-35 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-34 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-33 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-33 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-33 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-33 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-33 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-33 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-33 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-33 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-33 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-33 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-32 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-32 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-32 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-32 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-32 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-32 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-32 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-32 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-32 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-32 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-32 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-32 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-32 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-32 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-31 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-31 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-31 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-31 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-31 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-31 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-29 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-29 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-29 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-29 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-29 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-29 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-29 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-28 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-28 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-28 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-28 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-27 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-26 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-26 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-26 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-26 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-25 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-25 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-25 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-25 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-24 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-24 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-24 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-24 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-24 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-23 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-23 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-23 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-22 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-22 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-20 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-20 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-20 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 9e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 |
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-102
Identities = 108/271 (39%), Positives = 153/271 (56%), Gaps = 10/271 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L IG G++A VKLA EVAIKII K Q L+K L REV ++K L HPN
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPN 75
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K + IET +Y+IMEYA G + D + G + E AR F Q+V A+ YCH++ +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRD+K ENLL+DAD NIK++DFGF+ N G + FCG+ YA+PE+ +G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS-NEF----TVG--GKLDAFCGAPPYAAPELFQGK 188
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
Y DVWS+GV+L+ +V G LPFD +L ++V + + +S +C+ L+ +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRGKYRIPFYMSTDCENLLKR 247
Query: 285 ILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
L R ++ I +D W G E
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-100
Identities = 92/314 (29%), Positives = 146/314 (46%), Gaps = 12/314 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L +G G+Y V+LA + VA+KI+ +A + +E+ + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHEN 66
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++KF + Y+ +EY G L D I + + E A+++F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
HRDIK ENLL+D N+K+SDFG A RY +R+ L CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRER---LLNKMCGTLPYVAPELLKRR 182
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ--LLKQVQSKVVFPKDPNVSPECKALI 282
+ + DVWS G+VL AM+ G LP+D S + K + AL+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 283 SKILAP-VKTRLRIKNIKEDPWFRNG---PSRPEYPIMSGDSLEVETCCASEETSFSTAQ 338
KIL R+ I +IK+D W+ ++ G S +++ +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302
Query: 339 SVESASTSEMQYYK 352
++ T + K
Sbjct: 303 VNSASRTPGSGWSK 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = e-100
Identities = 88/266 (33%), Positives = 133/266 (50%), Gaps = 9/266 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L +G G+Y V+LA + VA+KI+ +A + +E+ + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHEN 66
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++KF + Y+ +EY G L D I + + E A+++F QL+ + Y H G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
HRDIK ENLL+D N+K+SDFG A RY +R+ L CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRER---LLNKMCGTLPYVAPELLKRR 182
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ--LLKQVQSKVVFPKDPNVSPECKALI 282
+ + DVWS G+VL AM+ G LP+D S + K + AL+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 283 SKILAP-VKTRLRIKNIKEDPWFRNG 307
KIL R+ I +IK+D W+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKP 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = e-100
Identities = 95/272 (34%), Positives = 149/272 (54%), Gaps = 11/272 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y LG +G+G++ VK+ +VA+KI+++ + S + + RE++ +K +HP+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+IK Q I T +++MEY G L D I K G ++E AR+ F Q++ A++YCH V
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRD+K EN+L+DA N K++DFG + N M G T CGS YA+PE++ G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLS-NMM----SDG--EFLRTSCGSPNYAAPEVISGR 185
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALIS 283
Y D+WS GV+L+A++ G LPFDD L K+++ P ++ L+
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVATLLM 243
Query: 284 KILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
+L R IK+I+E WF+ +P
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-96
Identities = 99/272 (36%), Positives = 152/272 (55%), Gaps = 10/272 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G GS+ VKLAT + +VA+K IS+ + + RE+ +K L+HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+IK I T + +++EYA G L D I ++ + E R++F Q++ AI YCH +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRD+K ENLL+D + N+K++DFG + N M G + +T CGS YA+PE++ G
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIM----TDG--NFLKTSCGSPNYAAPEVINGK 182
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
Y DVWS G+VL+ M+ GRLPFDD L K+V V+ +SP ++LI +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-SCVYVMPDFLSPGAQSLIRR 241
Query: 285 ILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPI 315
++ R+ I+ I+ DPWF P+
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPM 273
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 2e-96
Identities = 92/331 (27%), Positives = 145/331 (43%), Gaps = 22/331 (6%)
Query: 31 PDADGKMTVLESHG-YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF 89
M ++ Y IG G++ +L VA+K I + A + ++
Sbjct: 7 TTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-- 64
Query: 90 LPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWF 149
RE+ + L+HPN+++F + I T + IIMEYA G L + I G E AR +F
Sbjct: 65 --REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF 122
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADY--NIKLSDFGFARNHMRYRSRQGYESLSE 207
QL+ ++YCH + HRD+K EN L+D +K+ DFG++ S +
Sbjct: 123 QQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSV------LHSQPK 175
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267
+ G+ AY +PE+L Y +++DVWS GV L+ M+ G PF+D + + ++ +++
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235
Query: 268 -----FPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNG--PSRPEYPIMSGD 319
P D +SPEC LIS+I TR+ I IK WF
Sbjct: 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295
Query: 320 SLEVETCCASEETSFSTAQSVESASTSEMQY 350
E E S +T +
Sbjct: 296 FQEPEQPMQSLDTIMQIISEATIPAVRNRCL 326
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-95
Identities = 67/272 (24%), Positives = 128/272 (47%), Gaps = 9/272 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y G +G G +A + + A KI+ K + ++ + E+ + + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ F E V++++E + SLL++ ++ + E AR + Q+V Y H V
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K NL ++ D +K+ DFG A R+ + CG+ Y +PE+L
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK------KVLCGTPNYIAPEVLSKK 190
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
+ + DVWS+G +++ ++ G+ PF+ + + ++ K + +++P +LI K
Sbjct: 191 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAASLIQK 248
Query: 285 ILAPV-KTRLRIKNIKEDPWFRNGPSRPEYPI 315
+L R I + D +F +G PI
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-95
Identities = 67/272 (24%), Positives = 128/272 (47%), Gaps = 9/272 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y G +G G +A + + A KI+ K + ++ + E+ + + L H +
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ F E V++++E + SLL++ ++ + E AR + Q+V Y H V
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K NL ++ D +K+ DFG A R+ + CG+ Y +PE+L
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK------KVLCGTPNYIAPEVLSKK 216
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
+ + DVWS+G +++ ++ G+ PF+ + + ++ K + +++P +LI K
Sbjct: 217 GHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAASLIQK 274
Query: 285 ILAPV-KTRLRIKNIKEDPWFRNGPSRPEYPI 315
+L R I + D +F +G PI
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 306
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 5e-95
Identities = 96/279 (34%), Positives = 153/279 (54%), Gaps = 9/279 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y LG +G+G++ VK+ +VA+KI+++ + S + + RE++ +K +HP+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+IK Q I T ++++MEY G L D I K G +DE +R+ F Q++ ++YCH V
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
VHRD+K EN+L+DA N K++DFG + N M G T CGS YA+PE++ G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLS-NMM----SDG--EFLRTSCGSPNYAAPEVISGR 190
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
Y D+WS GV+L+A++ G LPFDD L K++ +F ++P +L+
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-IFYTPQYLNPSVISLLKH 249
Query: 285 ILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
+L R IK+I+E WF+ + +P S
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSST 288
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 6e-95
Identities = 83/290 (28%), Positives = 146/290 (50%), Gaps = 36/290 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP------------- 91
YTL IG GSY VKLA + + A+K++SK + P
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 92 ----------REVEVVKGLKHPNLIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGY 139
+E+ ++K L HPN++K ++ ++ +Y++ E +G ++++
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KP 133
Query: 140 IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199
+ E +AR +F L+ I Y H + ++HRDIK NLL+ D +IK++DFG +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF------ 187
Query: 200 QGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ 257
+G ++L G+ A+ +PE L + + DVW+MGV L+ VFG+ PF D +
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 258 LLKQVQS-KVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFR 305
L +++S + FP P+++ + K LI+++L ++R+ + IK PW
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-94
Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 17/280 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKH 102
Y +G ++G GSY VK S C A+KI+ K ++ + + +E+++++ L+H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRH 65
Query: 103 PNLIKFLQAI--ETTHRVYIIMEYAEKGS--LLDIIRKEGYIDETRARKWFAQLVDAINY 158
N+I+ + + E ++Y++MEY G +LD + E +A +F QL+D + Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H +G+VH+DIK NLL+ +K+S G A + + + T GS A+ P
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA----DDTCRTSQGSPAFQPP 180
Query: 219 EILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSP 276
EI G+ + D+WS GV L+ + G PF+ +L + + P + P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGP 238
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPI 315
L+ +L R I+ I++ WFR E P+
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-94
Identities = 87/325 (26%), Positives = 150/325 (46%), Gaps = 26/325 (8%)
Query: 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF-----LPREVEV 96
S Y+ + +G G++ V A + EV +K I K + D + + E+ +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGS-LLDIIRKEGYIDETRARKWFAQLVDA 155
+ ++H N+IK L E ++ME G L I + +DE A F QLV A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
+ Y + ++HRDIK EN++I D+ IKL DFG A ++ L TFCG+ Y
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERG------KLFYTFCGTIEY 195
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275
+PE+L G PY ++WS+GV L+ +VF PF + + + V++ + P VS
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE-----ETVEAAIHPP--YLVS 248
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPI-----MSGDSLEVETCCAS 329
E +L+S +L P + R ++ + DPW + +Y ++ V + +
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASL 308
Query: 330 EETSFSTAQSVESASTSEMQYYKPN 354
E + S + ++ + + +
Sbjct: 309 EMGNRSLSDVAQAQELCGGEGHHHH 333
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 6e-94
Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 12/270 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G ++G GS+A V A S EVAIK+I K + + + EV++ LKHP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
+++ E ++ VY+++E G + ++ + E AR + Q++ + Y H G
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRD+ NLL+ + NIK++DFG A ++ T CG+ Y SPEI
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPH-----EKHYTLCGTPNYISPEIATR 186
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALI 282
+ + SDVWS+G + + ++ GR PFD L +V P +S E K LI
Sbjct: 187 SAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLI 243
Query: 283 SKILAPV-KTRLRIKNIKEDPWFRNGPSRP 311
++L RL + ++ + P+ S
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 6e-93
Identities = 82/289 (28%), Positives = 139/289 (48%), Gaps = 25/289 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQ----APSDYLKKFLPREVEVVKGL 100
Y +G ++G G + +V + VAIK + K + + +P EV ++K +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKV 103
Query: 101 KH--PNLIKFLQAIETTHRVYIIMEYAE-KGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
+I+ L E +I+E E L D I + G + E AR +F Q+++A+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 158 YCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+CH GV+HRDIK EN+LID + +KL DFG ++ +++ F G+ Y+
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLK-------DTVYTDFDGTRVYS 215
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276
PE ++ Y + + VWS+G++L+ MV G +PF+ + + ++ +V F VS
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--QRVSS 268
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVE 324
EC+ LI LA R + I+ PW ++ E + SL
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-92
Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 25/280 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK---MQAPSDYLKKFLPREVEVVK--- 98
Y LG ++G G + TV +VAIK+I + + P EV ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 99 -GLKHPNLIKFLQAIETTHRVYIIMEYAEKGS-LLDIIRKEGYIDETRARKWFAQLVDAI 156
G HP +I+ L ET +++E L D I ++G + E +R +F Q+V AI
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 157 NYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
+CH RGVVHRDIK EN+LID KL DFG + + F G+ Y
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLH-------DEPYTDFDGTRVY 204
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275
+ PE + Y + VWS+G++L+ MV G +PF+ + + +++++ FP +VS
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEAELHFP--AHVS 257
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
P+C ALI + LAP +R ++ I DPW +
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 3e-91
Identities = 81/270 (30%), Positives = 142/270 (52%), Gaps = 13/270 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G +G G + V LA + +A+K++ K Q ++ L REVE+ L+HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ RVY+I+EYA G++ ++K DE R + +L +A++YCH + V
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK ENLL+ + +K++DFG++ H R CG+ Y PE+++G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT-------DLCGTLDYLPPEMIEGR 182
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALIS 283
+ + D+WS+GV+ + + G+ PF+ Y + K++ + FP V+ + LIS
Sbjct: 183 MHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLIS 239
Query: 284 KILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
++L R ++ + E PW S+P
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPS 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 5e-90
Identities = 86/273 (31%), Positives = 150/273 (54%), Gaps = 13/273 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G +G G + V LA ++ +A+K++ K Q + ++ L RE+E+ L+HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ R+Y+++E+A +G L ++K G DE R+ + +L DA++YCHER V
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK ENLL+ +K++DFG++ H R+ T CG+ Y PE+++G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR-------TMCGTLDYLPPEMIEGK 187
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALIS 283
+ + D+W GV+ + + G PFD +++ +++ + + FP P +S K LIS
Sbjct: 188 THDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLIS 244
Query: 284 KILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPI 315
K+L RL +K + E PW + R P+
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 1e-85
Identities = 58/315 (18%), Positives = 111/315 (35%), Gaps = 54/315 (17%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP------------- 91
Y + + G + + L A+K K
Sbjct: 33 YRIIRTLNQGKFNKIILCEKDNK--FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 92 -REVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETR------ 144
E++++ +K+ + I VYII EY E S+L +D+
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 145 --ARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201
+ ++++ +Y H E+ + HRD+K N+L+D + +KLSDFG + +M
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMV------ 203
Query: 202 YESLSETFCGSYAYASPEILKG-IPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLL 259
+ + G+Y + PE Y D+WS+G+ L+ M + +PF +L
Sbjct: 204 -DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 260 KQVQS-KVVFPKDPN-----------------VSPECKALISKILAP-VKTRLRIKNIKE 300
+++ + +P D N +S E + L R+ ++ +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 301 DPWFRNGPSRPEYPI 315
W +
Sbjct: 323 HEWLADTNIEDLREF 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 8e-83
Identities = 68/326 (20%), Positives = 134/326 (41%), Gaps = 25/326 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y++ IG G + V + AIK ++ +A + L + E+ + L+ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 68
Query: 105 L--IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
I+ T +Y++ME L ++K+ ID + ++ +++A++ H+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+VH D+K N LI D +KL DFG A N M+ + + ++ G+ Y PE +K
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIA-NQMQPDTTSVVK---DSQVGTVNYMPPEAIK 182
Query: 223 GIPYCPQL----------SDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPK 270
+ + SDVWS+G +L+ M +G+ PF S+L +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 271 DPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVETCCAS 329
+ + ++ L K R+ I + P+ + M+ + E
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYVLG 300
Query: 330 EETSFSTAQSVESASTSEMQYYKPNR 355
+ ++ S+ A+ + ++Y
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGE 326
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-82
Identities = 63/281 (22%), Positives = 120/281 (42%), Gaps = 25/281 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y++ IG G + V + AIK ++ +A + L + E+ + L+ +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 87
Query: 105 L--IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
I+ T +Y++ME L ++K+ ID + ++ +++A++ H+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+VH D+K N LI D +KL DFG A N M+ + + ++ G+ Y PE +K
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIA-NQMQPDTTSVVK---DSQVGTVNYMPPEAIK 201
Query: 223 GIPYCPQL----------SDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPK 270
+ + SDVWS+G +L+ M +G+ PF S+L +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 271 DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWFRNGPS 309
+ + ++ L P + R+ I + P+ +
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTH 301
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 6e-82
Identities = 68/327 (20%), Positives = 135/327 (41%), Gaps = 27/327 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y++ IG G + V + AIK ++ +A + L + E+ + L+ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 115
Query: 105 L--IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
I+ T +Y++ME L ++K+ ID + ++ +++A++ H+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+VH D+K N LI D +KL DFG A N M+ + + ++ G+ Y PE +K
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIA-NQMQPDTTSVVK---DSQVGAVNYMPPEAIK 229
Query: 223 GIPYCPQL----------SDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPK 270
+ + SDVWS+G +L+ M +G+ PF S+L +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 271 DPNVSPECKALISKILA--PVKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVETCCA 328
+ + ++ L P + R+ I + P+ + M+ + E
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYVL 346
Query: 329 SEETSFSTAQSVESASTSEMQYYKPNR 355
+ ++ S+ A+ + ++Y
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-80
Identities = 60/304 (19%), Positives = 126/304 (41%), Gaps = 19/304 (6%)
Query: 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL 86
G++ G M ++++ Y +G G ++ V L A+K I +
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--- 69
Query: 87 KKFLPREVEVVKGLKHPNLIKFLQAI----ETTHRVYIIMEYAEKGSLLDII----RKEG 138
++ RE ++ + HPN+++ + H ++++ + ++G+L + I K
Sbjct: 70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 139 YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN-HMRYR 197
++ E + + + H +G HRD+K N+L+ + L D G +
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 198 SRQGYESLSE--TFCGSYAYASPEILKGIPYCP--QLSDVWSMGVVLFAMVFGRLPFDDT 253
+ +L + + +Y +PE+ +C + +DVWS+G VL+AM+FG P+D
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 254 KYSQLLKQ--VQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSR 310
VQ+++ P+ P S L++ ++ R I + P+
Sbjct: 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309
Query: 311 PEYP 314
++
Sbjct: 310 GQHT 313
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 1e-79
Identities = 67/289 (23%), Positives = 129/289 (44%), Gaps = 32/289 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ ++G G++ V A ++ S AIK I + + EV ++ L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQY 63
Query: 105 LIKF-------------LQAIETTHRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFA 150
++++ + A++ ++I MEY E G+L D+I E + F
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE--- 207
Q+++A++Y H +G++HRD+K N+ ID N+K+ DFG A+N R +S +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 208 -----TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262
+ G+ Y + E+L G + + D++S+G++ F M++ + +LK++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 263 QS-KVVFPKD--PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNG 307
+S + FP D N K +I ++ R + + W
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 8e-77
Identities = 68/309 (22%), Positives = 115/309 (37%), Gaps = 56/309 (18%)
Query: 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+H + L I+G G+ A V + AIK+ + + RE EV+K L
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLN 65
Query: 102 HPNLIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGY---IDETRARKWFAQLVDAI 156
H N++K E TT +IME+ GSL ++ + + E+ +V +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 157 NYCHERGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
N+ E G+VHR+IK N++ D KL+DFG AR + + G+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-------ELEDDEQFVSLYGT 178
Query: 213 YAYASPEILKGIPYCPQLS-------DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK 265
Y P++ + D+WS+GV + G LPF + + K+V K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238
Query: 266 VV------------------------FPKDPNVSPECKALISKILA------PVKTRLRI 295
++ P ++S + L++ +LA K
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK-CWGF 297
Query: 296 KNIKEDPWF 304
+
Sbjct: 298 DQFFAETSD 306
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-76
Identities = 83/279 (29%), Positives = 134/279 (48%), Gaps = 19/279 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YTL IG GS+ VK+A A K I K +E+E++K L HPN
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPN 67
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+I+ + E +Y++ME G L + + + E+ A + ++ A+ YCH+ V
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
HRD+K EN L D +KL DFG A R++ + T G+ Y SP++L
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMM----RTKVGTPYYVSPQVL 180
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+G Y P+ D WS GV+++ ++ G PF S+++ +++ FP+ NVSP+
Sbjct: 181 EG-LYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIM 316
++LI ++L K R+ E WF S ++
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-74
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 21/273 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G G++ V L E IK I+K ++ + + E+EV+K L HPN
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPN 81
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINYCH 160
+IK + E H +YI+ME E G LL+ I + + E + Q+++A+ Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 161 ERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ VVH+D+K EN+L IK+ DFG A ++S + G+ Y +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHS----TNAAGTALYMA 194
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP-NVS 275
PE+ K + D+WS GVV++ ++ G LPF T ++ ++ + + + ++
Sbjct: 195 PEVFKR-DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFRNG 307
P+ L+ ++L + R + WF+
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 6e-74
Identities = 86/286 (30%), Positives = 140/286 (48%), Gaps = 25/286 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF-----LPREVEVVKG 99
Y + +G G+ VKLA + +VAIKIISK + ++ + E+E++K
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
L HP +IK + YI++E E G L D + + E + +F Q++ A+ Y
Sbjct: 72 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 160 HERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
HE G++HRD+K EN+L+ + D IK++DFG ++ G SL T CG+ Y
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-------ILGETSLMRTLCGTPTYL 183
Query: 217 SPEILKGI---PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQS-KVVFPKD 271
+PE+L + Y + D WS+GV+LF + G PF + + L Q+ S K F +
Sbjct: 184 APEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242
Query: 272 P--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
VS + L+ K+L K R + PW ++ + ++
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-73
Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 11/265 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG GS+ L S+ + IK I+ + S ++ REV V+ +KHPN
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHPN 84
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCHER 162
++++ ++ E +YI+M+Y E G L I +K E + WF Q+ A+ + H+R
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
++HRDIK +N+ + D ++L DFG A R L+ G+ Y SPEI +
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIA------RVLNSTVELARACIGTPYYLSPEICE 198
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282
PY + SD+W++G VL+ + + F+ L+ ++ S P + S + ++L+
Sbjct: 199 NKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257
Query: 283 SKILAPV-KTRLRIKNIKEDPWFRN 306
S++ + R + +I E +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-73
Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 56/305 (18%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L I+G G+ A V + AIK+ + + RE EV+K L H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68
Query: 105 LIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGY---IDETRARKWFAQLVDAINYC 159
++K E TT +IME+ GSL ++ + + E+ +V +N+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 160 HERGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
E G+VHR+IK N++ D KL+DFG AR + + G+ Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-------ELEDDEQFVSLYGTEEY 181
Query: 216 ASPEILKGIPYCPQLS-------DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV- 267
P++ + D+WS+GV + G LPF + + K+V K++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 268 -----------------------FPKDPNVSPECKALISKILA------PVKTRLRIKNI 298
P ++S + L++ +LA K
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK-CWGFDQF 300
Query: 299 KEDPW 303
+
Sbjct: 301 FAETS 305
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 5e-73
Identities = 77/305 (25%), Positives = 134/305 (43%), Gaps = 25/305 (8%)
Query: 26 KGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
+ LP + E+ Y I+G G + V+ E A+KII S
Sbjct: 2 RDAALPGSHSTHGFYEN--YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 86 ------LKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG 138
L++ +EV++++ + HPN+I+ ET +++ + +KG L D + ++
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 119
Query: 139 YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198
+ E RK L++ I H+ +VHRD+K EN+L+D D NIKL+DFGF+
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------- 172
Query: 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLS-----DVWSMGVVLFAMVFGRLPFDDT 253
+ CG+ +Y +PEI++ D+WS GV+++ ++ G PF
Sbjct: 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232
Query: 254 KYSQLLKQVQS-KVVFPKDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPS 309
K +L+ + S F + S K L+S+ L + R + P+F+
Sbjct: 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292
Query: 310 RPEYP 314
Sbjct: 293 EEVRH 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 6e-73
Identities = 80/312 (25%), Positives = 125/312 (40%), Gaps = 53/312 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF--LPREVEVVKGLKH 102
Y L IG GSY V++A ++ AIKI++K + K + EV ++K L H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYID--------------------- 141
PN+ + + E + ++ME G LLD +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 142 -------------------ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADY 180
E Q+ A++Y H +G+ HRDIK EN L + +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGV 238
IKL DFG ++ Y+ G T G+ + +PE+L Y P+ D WS GV
Sbjct: 208 EIKLVDFGLSK--EFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWSAGV 264
Query: 239 VLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPECKALISKILAP-VKTRLR 294
+L ++ G +PF + + QV + K+ F +SP + L+S +L V R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 295 IKNIKEDPWFRN 306
+ PW
Sbjct: 325 AMRALQHPWISQ 336
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 7e-73
Identities = 86/289 (29%), Positives = 140/289 (48%), Gaps = 24/289 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF-----LPREVEVVKG 99
Y + +G G+ VKLA + +VAI+IISK + ++ + E+E++K
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
L HP +IK + YI++E E G L D + + E + +F Q++ A+ Y
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 160 HERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
HE G++HRD+K EN+L+ + D IK++DFG ++ G SL T CG+ Y
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-------ILGETSLMRTLCGTPTYL 308
Query: 217 SPEILKGIPYCP--QLSDVWSMGVVLFAMVFGRLPFDDTKYSQ-LLKQVQS-KVVFPKDP 272
+PE+L + + D WS+GV+LF + G PF + + L Q+ S K F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 273 --NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRN-GPSRPEYPIMS 317
VS + L+ K+L K R + PW ++ R ++S
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 417
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-72
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 17/285 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G+++ V+ E A KII+ + + +K RE + + L+HPN
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPN 66
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ +I+ Y++ + G L + I + E A Q++++I YCH G+
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHR++K ENLL+ +KL+DFG A + + F G+ Y SPE+L
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAW----HGFAGTPGYLSPEVL 179
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
K PY D+W+ GV+L+ ++ G PF D +L Q+++ +P V+PE
Sbjct: 180 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
K+LI +L K R+ + PW N R I D+++
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNR-ERVASAIHRQDTVD 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 2e-72
Identities = 84/273 (30%), Positives = 132/273 (48%), Gaps = 17/273 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + ++G GS+ V E A+K+I+K A + L REVE++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K + +E + YI+ E G L D I K E A + Q+ I Y H+ +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K EN+L+ + D +IK+ DFG + ++ + G+ Y +PE+L
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKM----KDRIGTAYYIAPEVL 195
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+G Y + DVWS GV+L+ ++ G PF +LK+V++ K F +S +
Sbjct: 196 RG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSR 310
K LI K+L R+ E PW + S
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-71
Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 19/270 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ ++G G+++ V L A+K I K A L E+ V+K +KH N
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHEN 67
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ E+T Y++M+ G L D I + G E A Q++ A+ Y HE G+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K ENLL + + I ++DFG S+ + T CG+ Y +PE+L
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGL--------SKMEQNGIMSTACGTPGYVAPEVL 179
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
PY D WS+GV+ + ++ G PF + S+L ++++ F ++S
Sbjct: 180 AQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNG 307
K I +L R + PW
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-71
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 16/280 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G+++ V+ E A KII+ + + +K RE + + L+HPN
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPN 89
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ +I+ Y++ + G L + I + E A Q++++I YCH G+
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHR++K ENLL+ +KL+DFG A + + F G+ Y SPE+L
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAW----HGFAGTPGYLSPEVL 202
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
K PY D+W+ GV+L+ ++ G PF D +L Q+++ +P V+PE
Sbjct: 203 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMS 317
K+LI +L K R+ + PW N
Sbjct: 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 301
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-71
Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 20/274 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + IG GSY + + K + ++ K+ L EV +++ LKHPN
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 66
Query: 105 LIKFLQAI--ETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINY 158
++++ I T +YI+MEY E G L +I ++ Y+DE + QL A+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 159 CHERG-----VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
CH R V+HRD+K N+ +D N+KL DFG AR S ++TF G+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR------ILNHDTSFAKTFVGTP 180
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
Y SPE + + Y + SD+WS+G +L+ + PF +L +++
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 274 VSPECKALISKILAP-VKTRLRIKNIKEDPWFRN 306
S E +I+++L R ++ I E+P
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 5e-71
Identities = 69/275 (25%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK-----MQAPSDYLKKFLPREVEVVKG 99
Y +IG G + V+ E A+KI+ + +++ RE +++
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 100 LK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+ HP++I + + E++ ++++ + KG L D + ++ + E R L++A+++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H +VHRD+K EN+L+D + I+LSDFGF+ CG+ Y +P
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSC-------HLEPGEKLRELCGTPGYLAP 268
Query: 219 EILKGIPYCPQLS-----DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP 272
EILK D+W+ GV+LF ++ G PF + +L+ + + F
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328
Query: 273 --NVSPECKALISKILAP-VKTRLRIKNIKEDPWF 304
+ S K LIS++L + RL + + P+F
Sbjct: 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-70
Identities = 66/340 (19%), Positives = 125/340 (36%), Gaps = 48/340 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G G + V +VAIK + +P + ++ E++++K L HPN
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPN 73
Query: 105 LIKFLQAIET------THRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDA 155
++ + + + MEY E G L + + + E R + + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 156 INYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+ Y HE ++HRD+K EN+++ K+ D G+A+ + L F G+
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------GELCTEFVGT 186
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFP-- 269
Y +PE+L+ Y + D WS G + F + G PF + + Q +V+ K
Sbjct: 187 LQYLAPELLEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 270 ---------------KDPN-VSPECKALISKILA------PVKTRLRIKNIKEDPWFRNG 307
PN +S + + L + R F+
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ-RGTDPQNPNVGCFQAL 304
Query: 308 PSRPEYPIMSGDSLEVETCCASEETSFSTAQSVESASTSE 347
S ++S ++ T Q+++S +
Sbjct: 305 DSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-70
Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 16/277 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y ++G GS+ V L E A+K+ISK Q K+ L REV+++K L HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K + E Y++ E G L D I E A + Q++ I Y H+ +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K ENLL+ D NI++ DFG + + + + + G+ Y +PE+L
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHF------EASKKMK-DKIGTAYYIAPEVL 200
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
G Y + DVWS GV+L+ ++ G PF+ +LK+V+ K F VS
Sbjct: 201 HG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
K LI K+L R+ ++ + W +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-70
Identities = 80/280 (28%), Positives = 132/280 (47%), Gaps = 15/280 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L +G G+++ V+ E A II+ + + +K RE + + LKHPN
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPN 71
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ +I Y+I + G L + I Y E A Q+++A+ +CH+ GV
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHR++K ENLL+ +KL+DFG A +G + F G+ Y SPE+L
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEV------EGEQQAWFGFAGTPGYLSPEVL 185
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+ PY D+W+ GV+L+ ++ G PF D +L +Q+++ FP V+PE
Sbjct: 186 RKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMS 317
K LI+K+L R+ + PW + +
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQ 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-70
Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 17/275 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + ++G GS+ V E A+K+I+K A + L REVE++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K + +E + YI+ E G L D I K E A + Q+ I Y H+ +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K EN+L+ + D +IK+ DFG + Q + G+ Y +PE+L
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCF------QQNTKMK-DRIGTAYYIAPEVL 195
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+G Y + DVWS GV+L+ ++ G PF +LK+V++ K F +S +
Sbjct: 196 RG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
K LI K+L R+ E PW + S
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-69
Identities = 86/275 (31%), Positives = 132/275 (48%), Gaps = 17/275 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y +G G+Y V L E AIKII K + K L EV V+K L HPN
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPN 97
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K E Y++ME + G L D I +E A Q++ + Y H+ +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K ENLL+ + D IK+ DFG + + +++ + G+ Y +PE+L
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKM----KERLGTAYYIAPEVL 210
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+ Y + DVWS+GV+LF ++ G PF ++L++V+ K F NVS
Sbjct: 211 RK-KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
K LI ++L + R+ + E PW + S+ E
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-68
Identities = 76/316 (24%), Positives = 127/316 (40%), Gaps = 32/316 (10%)
Query: 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL 86
G+D D G+ L + ++ G +A V A E A+K + +
Sbjct: 12 GRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK--- 68
Query: 87 KKFLPREVEVVKGLK-HPNLIKFLQA-------IETTHRVYIIMEYAEKGSLLDII---R 135
+ + +EV +K L HPN+++F A +T ++++ KG L++ +
Sbjct: 69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 136 KEGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYNIKLSDFGFAR-- 191
G + K F Q A+ + H + ++HRD+K ENLL+ IKL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
Query: 192 --NHMRYRSRQGYESLSE--TFCGSYAYASPEIL---KGIPYCPQLSDVWSMGVVLFAMV 244
S Q + E T + Y +PEI+ P + D+W++G +L+ +
Sbjct: 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLC 247
Query: 245 FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPW 303
F + PF+D L+ V K P +LI +L + RL I +
Sbjct: 248 FRQHPFED---GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
Query: 304 FRNG--PSRPEYPIMS 317
P+ PI
Sbjct: 305 EIAAARNVNPKSPITE 320
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-68
Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 21/286 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKH 102
Y L +IG G ++ V+ + + A+KI+ + + L RE + LKH
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLD-IIRKEGYID---ETRARKWFAQLVDAINY 158
P++++ L+ + +Y++ E+ + L I+++ E A + Q+++A+ Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 159 CHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215
CH+ ++HRD+K +L+ + +KL FG A ++ G+ +
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL------GESGLVAGGRVGTPHF 199
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP-- 272
+PE++K PY DVW GV+LF ++ G LPF TK +L + + K
Sbjct: 200 MAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS 257
Query: 273 NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMS 317
++S K L+ ++L R+ + PW + +
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLP 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-68
Identities = 80/287 (27%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKF----------LPREV 94
Y +G G+Y V L E AIK+I K Q + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 95 EVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVD 154
++K L HPN+IK E Y++ E+ E G L + I DE A Q++
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157
Query: 155 AINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG 211
I Y H+ +VHRDIK EN+L+ ++ NIK+ DFG + L G
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF------SKDYKLR-DRLG 210
Query: 212 SYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPK 270
+ Y +PE+LK Y + DVWS GV+++ ++ G PF ++K+V+ K F
Sbjct: 211 TAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 271 DP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
+ N+S E K LI +L R + W + +
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-67
Identities = 41/310 (13%), Positives = 84/310 (27%), Gaps = 59/310 (19%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---- 100
GT++G AT + + + P K + EV ++ L
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 101 ------------------KHPNLIKFLQAIETTHR-----VYIIMEYAEK------GSLL 131
K P K ++ + + + LL
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 132 DIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191
+ + Q++ + H G+VH ++ ++++D + L+ F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL----------SDVWSMGVVLF 241
S + PE+ D W++G+V++
Sbjct: 255 RDGARV----------VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 242 AMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKE 300
+ LP + +F N+ +AL+ L + RL E
Sbjct: 305 WIWCADLPITKDAALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 301 DPWFRNGPSR 310
P + +
Sbjct: 360 TPEYEQLRTE 369
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-67
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 26/288 (9%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHP 103
Y + IG+GSY+ K + E A+KII K K+ E+E++ + +HP
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEILLRYGQHP 76
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
N+I + VY++ E + G LLD I ++ + E A + + Y H +G
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 164 VVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
VVHRD+K N+L +I++ DFGFA + + L T C + + +PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFA------KQLRAENGLLMTPCYTANFVAPE 190
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---SQLLKQVQS-KVVFPKDP--N 273
+L+ Y D+WS+GV+L+ M+ G PF + ++L ++ S K +
Sbjct: 191 VLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249
Query: 274 VSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDS 320
VS K L+SK+L RL + PW + P+Y + D+
Sbjct: 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDA 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 1e-66
Identities = 72/285 (25%), Positives = 129/285 (45%), Gaps = 19/285 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL---KKFLPREVEVVKGLK 101
Y +G +G G +A V+ E A K I K + S ++ + REV +++ ++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HPN+I E V +I+E G L D + ++ + E A ++ Q++D ++Y H
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 162 RGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ + H D+K EN+++ + IKL DFG A + + + + G+ + +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEF----KNIFGTPEFVA 179
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDP--NV 274
PEI+ P + +D+WS+GV+ + ++ G PF + L + F ++ N
Sbjct: 180 PEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSG 318
S K I ++L K R+ I E W + R SG
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-66
Identities = 85/293 (29%), Positives = 144/293 (49%), Gaps = 28/293 (9%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP 103
+G GS++ + + + A+KIISK + +E+ +K + HP
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHP 66
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
N++K + +++ME G L + I+K+ + ET A +LV A+++ H+ G
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 164 VVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
VVHRD+K ENLL + + IK+ DFGFAR + L T C + YA+PE+
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFAR-----LKPPDNQPLK-TPCFTLHYAAPEL 180
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-------TKYSQLLKQVQS-KVVFPKDP 272
L Y D+WS+GV+L+ M+ G++PF T +++K+++ F +
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 273 --NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
NVS E K LI +L RL++ ++ + W ++G P+M+ D L
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-66
Identities = 76/270 (28%), Positives = 132/270 (48%), Gaps = 21/270 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + + +G G+ + V A+K++ K + E+ V+ L HPN
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPN 109
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+IK + ET + +++E G L D I ++GY E A Q+++A+ Y HE G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K ENLL D +K++DFG ++ ++ L +T CG+ Y +PEIL
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSK-------IVEHQVLMKTVCGTPGYCAPEIL 222
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQS-KVVFPKDP--NVSPE 277
+G Y P+ D+WS+G++ + ++ G PF D+ + +++ + + F VS
Sbjct: 223 RGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 278 CKALISKILAP-VKTRLRIKNIKEDPWFRN 306
K L+ K++ K RL + PW
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-65
Identities = 54/281 (19%), Positives = 108/281 (38%), Gaps = 39/281 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +IG G + V A IK + Y + REV+ + L H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVN 65
Query: 105 LIKFLQAIE----------------TTHRVYIIMEYAEKGSLLDII--RKEGYIDETRAR 146
++ + + T ++I ME+ +KG+L I R+ +D+ A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
+ F Q+ ++Y H + +++RD+K N+ + +K+ DFG + R
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT------ 179
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
G+ Y SPE + Y + D++++G++L ++ +T + ++
Sbjct: 180 -RSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS--KFFTDLR-DG 234
Query: 267 VFPKDPNVSPECKALISKILAPV-KTRLRIKNIKEDPWFRN 306
+ + K L+ K+L+ + R I
Sbjct: 235 IIS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-64
Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 16/250 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + IG G ++ V A VA+K + + +E++++K L HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINYCH 160
+IK+ + + + I++E A+ G L +I +++ I E K+F QL A+ + H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
R V+HRDIK N+ I A +KL D G R + + + G+ Y SPE
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FF-----SSKTTAAHSLVGTPYYMSPER 207
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLKQVQSKVVFPKDP--NVSP 276
+ Y + SD+WS+G +L+ M + PF D L K+++ +P P + S
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLPSDHYSE 265
Query: 277 ECKALISKIL 286
E + L++ +
Sbjct: 266 ELRQLVNMCI 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 63/295 (21%), Positives = 119/295 (40%), Gaps = 31/295 (10%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G G + V A + C AIK I ++ + REV+ + L+HP
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPG 64
Query: 105 LIKFLQAIETTHR------------VYIIMEYAEKGSLLDIIRKEG---YIDETRARKWF 149
++++ A + +YI M+ K +L D + + + F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR------NHMRYRSRQGYE 203
Q+ +A+ + H +G++HRD+K N+ D +K+ DFG +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQV 262
+ G+ Y SPE + G Y + D++S+G++LF +++ PF + L V
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 263 QSKVVFPKDPN-VSPECKALISKILAPV-KTRLRIKNIKEDPWFRNGPSRPEYPI 315
+ + FP P ++ +L+P R NI E+ F + + +
Sbjct: 241 R-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL---KKFLPREVEVVKGLK 101
Y +G +G G +A VK E A K I K Q+ + ++ + REV +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
H N+I E V +I+E G L D + ++ + E A + Q++D +NY H
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 162 RGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ + H D+K EN+++ +IKL DFG A + + G+ + +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEF----KNIFGTPEFVA 186
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDP--NV 274
PEI+ P + +D+WS+GV+ + ++ G PF + L + F ++ +
Sbjct: 187 PEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
S K I K+L + RL I+ PW ++
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-64
Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 19/278 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYL---KKFLPREVEVVKGLK 101
Y G +G G +A VK + A K I K + S ++ + REV ++K ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HPN+I + E V +I+E G L D + ++ + E A ++ Q+++ + Y H
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 162 RGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ H D+K EN+++ IK+ DFG A + + + G+ + +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF----KNIFGTPEFVA 185
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDP--NV 274
PEI+ P + +D+WS+GV+ + ++ G PF + L V F + N
Sbjct: 186 PEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRP 311
S K I ++L K R+ I++ + PW + ++
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-64
Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 17/303 (5%)
Query: 6 NVVRQDRPRSNVWKGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSS 65
+ Q +PR ++G D + + + + +G GSY V S
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-FQRLSRLGHGSYGEVFKVRSK 79
Query: 66 RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEY 124
A+K + L EV + + +HP ++ QA E +Y+ E
Sbjct: 80 EDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 125 AEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183
SL G + E + + + A+ + H +G+VH D+K N+ + K
Sbjct: 139 CG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197
Query: 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAM 243
L DFG G E G Y +PE+L+G Y +DV+S+G+ + +
Sbjct: 198 LGDFGLLV-------ELGTAGAGEVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEV 248
Query: 244 VFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDP 302
+ Q L+Q F +S E ++++ +L P K R + + P
Sbjct: 249 ACNMELPHGGEGWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRATAEALLALP 306
Query: 303 WFR 305
R
Sbjct: 307 VLR 309
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-63
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 19/279 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLK 101
Y +G +G G +A VK E A K I K Q+ + ++ + REV +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HPN+I E V +I+E G L D + ++ + E A + Q++D +NY H
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 162 RGVVHRDIKCENLLI----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ + H D+K EN+++ +IKL DFG A + + G+ + +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEF----KNIFGTPEFVA 186
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDP--NV 274
PEI+ P + +D+WS+GV+ + ++ G PF + L + F ++
Sbjct: 187 PEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
S K I K+L + RL I+ PW ++
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 206 bits (524), Expect = 1e-63
Identities = 48/317 (15%), Positives = 83/317 (26%), Gaps = 53/317 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L + +G + V L + A+K+ + S + L L +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 105 LIKFLQAI--------------------------ETTHRVYIIMEYAE------KGSLLD 132
+ ++M A +L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 133 IIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192
+ G AQL+ +G+VH +NL I D + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 193 HMRYRSRQGYESLSETFCGSYAYASPEIL--KGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
+ G + YA E L + + W +G+ ++ + LPF
Sbjct: 243 ------KVG--TRGPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPF 293
Query: 251 DDT--------KYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKED 301
K L + F + K LI + L + RL E
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 302 PWFRNGPSRPEYPIMSG 318
P F + + +G
Sbjct: 354 PEFLQLQNEISSSLSTG 370
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-63
Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 36/308 (11%)
Query: 45 YTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-H 102
Y L ++G G++A V+ + S E A+KII K + + REVE++ + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGH 70
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
N+++ ++ E R Y++ E GS+L I K + +E A + A+++ H +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 163 GVVHRDIKCENLLI---DADYNIKLSDFGFARN-HMRYRSRQGYESLSETFCGSYAYASP 218
G+ HRD+K EN+L + +K+ DF + T CGS Y +P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 219 EILKGI-----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---------------QL 258
E+++ Y + D+WS+GV+L+ ++ G PF S L
Sbjct: 191 EVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 259 LKQVQS-KVVFPKDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
+ +Q K FP ++S K LISK+L K RL + + PW + PE
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA--PENT 307
Query: 315 IMSGDSLE 322
+ + L+
Sbjct: 308 LPTPMVLQ 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-62
Identities = 66/330 (20%), Positives = 132/330 (40%), Gaps = 47/330 (14%)
Query: 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK 87
++P+ + + L I+G GS TV S VA+K +
Sbjct: 4 ANIPNFEQSLKNL----VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDFC------ 52
Query: 88 KFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYID----- 141
E++++ HPN+I++ + T +YI +E +L D++ + D
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111
Query: 142 --ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-------------ADYNIKLSD 186
E Q+ + + H ++HRD+K +N+L+ + I +SD
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLS------DVWSMGVVL 240
FG + + + + G+ + +PE+L+ D++SMG V
Sbjct: 172 FGLCK--KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 241 FAMV-FGRLPFDD--TKYSQLLKQVQS--KVVFPKDPNVSPECKALISKILAP-VKTRLR 294
+ ++ G+ PF D ++ S +++ + S ++ D ++ E LIS+++ R
Sbjct: 230 YYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
Query: 295 IKNIKEDPWFRNGPSRPEYPIMSGDSLEVE 324
+ P F + E+ + D LE+E
Sbjct: 290 AMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 319
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-61
Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 36/297 (12%)
Query: 45 YTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KH 102
Y L ++G+G V R + A+K++ +EV+
Sbjct: 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASGG 81
Query: 103 PNLIKFLQAIETTHR----VYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAI 156
P+++ L E H + IIME E G L I R + E A + + AI
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 157 NYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
+ H + HRD+K ENLL + D +KL+DFGF +++ ++ +T C +
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF--------AKETTQNALQTPCYTP 193
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF----DDTKYSQLLKQVQS-KVVF 268
Y +PE+L Y D+WS+GV+++ ++ G PF + ++++ + F
Sbjct: 194 YYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 269 PKDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
P VS + K LI +L RL I PW P+ P+ + L+
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 61/310 (19%), Positives = 124/310 (40%), Gaps = 24/310 (7%)
Query: 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK 87
+D D + + ++ + ++G G+ T+ + +VA+K I
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRILPECF------ 61
Query: 88 KFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRA 145
F REV++++ +HPN+I++ + YI +E +L + + +K+
Sbjct: 62 SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP 120
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLI-----DADYNIKLSDFGFARNHMRYRSRQ 200
Q + + H +VHRD+K N+LI +SDFG + + +
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK---KLAVGR 177
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCP--QLSDVWSMGVVLFAM-VFGRLPFDDTKYSQ 257
S G+ + +PE+L D++S G V + + G PF + Q
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 258 LLKQVQSKVVFPKDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYP 314
+ + + P + + LI K++A + R K++ + P+F + + ++
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFF 297
Query: 315 IMSGDSLEVE 324
D +E E
Sbjct: 298 QDVSDRIEKE 307
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 48/280 (17%), Positives = 115/280 (41%), Gaps = 19/280 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G + V + K + +K +E+ ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHERG 163
++ ++ E+ + +I E+ + + I ++E + Q+ +A+ + H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 164 VVHRDIKCENLLI--DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+ H DI+ EN++ IK+ +FG AR + + + + Y +PE+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNF----RLLFTAPEYYAPEVH 175
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDP--NVSPEC 278
+ +D+WS+G +++ ++ G PF Q+++ + + + F ++ +S E
Sbjct: 176 QHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMS 317
+ ++L K+R+ + PW + R ++
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 76/315 (24%), Positives = 135/315 (42%), Gaps = 20/315 (6%)
Query: 9 RQDRPRSNVWKGNMEYDKGKDLP-DADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRH 67
+ D P+ N + E K +P + K + + Y + +G G++ V
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY-YDILEELGSGAFGVVHRCVEKAT 75
Query: 68 SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEK 127
K I+ P D K + E+ ++ L HP LI A E + + +I+E+
Sbjct: 76 GRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 128 GSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADYNIKL 184
G L D I ++ + E + Q + + + HE +VH DIK EN++ ++K+
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192
Query: 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
DFG A + + + + +A+PEI+ P +D+W++GV+ + ++
Sbjct: 193 IDFGLAT---KLNPDEIV----KVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLL 244
Query: 245 FGRLPFDDTKYSQLLKQVQS-KVVFPKD--PNVSPECKALISKILAP-VKTRLRIKNIKE 300
G PF + L+ V+ F +D +VSPE K I +L + RL + + E
Sbjct: 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304
Query: 301 DPWFRNGPSRPEYPI 315
PW + S I
Sbjct: 305 HPWLKGDHSNLTSRI 319
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-60
Identities = 85/270 (31%), Positives = 142/270 (52%), Gaps = 15/270 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ G I+G GS++TV LA S E AIKI+ K + ++ RE +V+ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+K + ++Y + YA+ G LL IRK G DET R + A++V A+ Y H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K EN+L++ D +I+++DFG A+ + ++ + +F G+ Y SPE+L
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLS----PESKQARANSFVGTAQYVSPELLTEK 207
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDPNVSPECKALIS 283
C SD+W++G +++ +V G PF +Y K ++ + FP P+ + L+
Sbjct: 208 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLVE 264
Query: 284 KILAP-VKTRL------RIKNIKEDPWFRN 306
K+L RL +K P+F +
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-60
Identities = 73/314 (23%), Positives = 123/314 (39%), Gaps = 34/314 (10%)
Query: 26 KGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
+ K + ++G+G V + R + A+K++
Sbjct: 45 QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-- 102
Query: 86 LKKFLPREVEVVKGL-KHPNLIKFLQAIETT----HRVYIIMEYAEKGSLLDII--RKEG 138
REVE+ + P++++ + E + I+ME + G L I R +
Sbjct: 103 ------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 156
Query: 139 YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMR 195
E A + + +AI Y H + HRD+K ENLL + +KL+DFGFA+
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---E 213
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255
S T C + Y +PE+L Y D+WS+GV+++ ++ G PF
Sbjct: 214 TTSHNSL----TTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHG 268
Query: 256 ----SQLLKQVQS-KVVFPKDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNG 307
+ +++ + FP VS E K LI +L R+ I PW
Sbjct: 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
Query: 308 PSRPEYPIMSGDSL 321
P+ P+ + L
Sbjct: 329 TKVPQTPLHTSRVL 342
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-59
Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 20/278 (7%)
Query: 45 YTL-GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH- 102
Y L +G G +A V+ S E A K + K + D + L E+ V++ K
Sbjct: 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKSC 88
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCH 160
P +I + E T + +I+EYA G + + + E + Q+++ + Y H
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 161 ERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ +VH D+K +N+L+ +IK+ DFG +R + G+ Y +
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACEL----REIMGTPEYLA 201
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDP--NV 274
PEIL P +D+W++G++ + ++ PF + + Q V + ++ +V
Sbjct: 202 PEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRP 311
S I +L + R + W +
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-59
Identities = 44/316 (13%), Positives = 89/316 (28%), Gaps = 50/316 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---- 100
GT++G AT + + + P K + EV ++ L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 101 ------------------KHPNLIKFLQAIETTHR-----VYIIMEYAEK------GSLL 131
K P K ++ + + + LL
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 132 DIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191
+ + Q++ + H G+VH ++ ++++D + L+ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL----SDVWSMGVVLFAMVFGR 247
S + +L + P L D W++G+ ++ +
Sbjct: 260 RDGASAV-----SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 248 LPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRN 306
LP D + +F N+ +AL+ L + RL E P +
Sbjct: 315 LPNTDDAALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
Query: 307 GPS--RPEYPIMSGDS 320
+ P+ D
Sbjct: 370 LRTELSAALPLYQTDG 385
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 19/316 (6%)
Query: 4 GTNVVRQDRPRSNVWKGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLAT 63
G V + SN + K + K + H Y + +G G++ V T
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRVT 177
Query: 64 SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123
A K + SD K+ + +E++ + L+HP L+ A E + + +I E
Sbjct: 178 ERATGNNFAAKFVMT-PHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 124 YAEKGSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADY 180
+ G L + + + + E A ++ Q+ + + HE VH D+K EN++
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN 294
Query: 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVL 240
+KL DFG +Q + G+ +A+PE+ +G P +D+WS+GV+
Sbjct: 295 ELKLIDFGLTA---HLDPKQSV----KVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLS 346
Query: 241 FAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKD--PNVSPECKALISKILAP-VKTRLRIK 296
+ ++ G PF + L+ V+S +S + K I K+L TR+ I
Sbjct: 347 YILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 406
Query: 297 NIKEDPWFRNGPSRPE 312
E PW G +
Sbjct: 407 QALEHPWLTPGNAPGR 422
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 20/277 (7%)
Query: 45 YTLGT--IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
YT+ I+G G + V + ++A KII + D K+ + E+ V+ L H
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKD--KEEVKNEISVMNQLDH 145
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLD-IIRKEGYIDETRARKWFAQLVDAINYCHE 161
NLI+ A E+ + + ++MEY + G L D II + + E + Q+ + I + H+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 162 RGVVHRDIKCENLLI--DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
++H D+K EN+L IK+ DFG AR RY+ R+ + G+ + +PE
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKL----KVNFGTPEFLAPE 258
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKD--PNVSP 276
++ +D+WS+GV+ + ++ G PF ++ L + + + + ++S
Sbjct: 259 VVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317
Query: 277 ECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
E K ISK+L R+ + PW +
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-54
Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 55/296 (18%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHP 103
++G+G V + R + A+K++ REVE+ + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCP 71
Query: 104 NLIKFLQAIETTHR----VYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAIN 157
++++ + E + + I+ME + G L I R + E A + + +AI
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 158 YCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
Y H + HRD+K ENLL + +KL+DFGFA
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------------ 167
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQS-KVVFP 269
E Y D+WS+GV+++ ++ G PF + +++ + FP
Sbjct: 168 ---KETTGE-KYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 270 KDP--NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
VS E K LI +L R+ I PW P+ P+ + L+
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-54
Identities = 62/245 (25%), Positives = 117/245 (47%), Gaps = 13/245 (5%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T+G IG GS+ TV H +VA+K+++ L+ F EV V++ +H N+
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHG-DVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNI 82
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
+ F+ T ++ I+ ++ E SL + E + + Q ++Y H + +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K N+ + D +K+ DFG A +SR E GS + +PE+++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLA----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 225 PYCP--QLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
P SDV++ G+VL+ ++ G+LP+ + Q+++ V + P V C
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 282 ISKIL 286
+ +++
Sbjct: 258 MKRLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-53
Identities = 75/245 (30%), Positives = 131/245 (53%), Gaps = 16/245 (6%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+ IG GS+ TV A H +VA+KI+ + ++ + +FL REV ++K L+HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNI 96
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHER 162
+ F+ A+ + I+ EY +GSL ++ K G +DE R + +NY H R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 163 G--VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+VHR++K NLL+D Y +K+ DFG + R + S++ G+ + +PE+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS------RLKASTFLSSKSAAGTPEWMAPEV 210
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSPECK 279
L+ P + SDV+S GV+L+ + + P+ + +Q++ V K + P N++P+
Sbjct: 211 LRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 280 ALISK 284
A+I
Sbjct: 270 AIIEG 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 7e-52
Identities = 44/300 (14%), Positives = 103/300 (34%), Gaps = 38/300 (12%)
Query: 36 KMTVLESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFL 90
L S + ++G G++A V AT +++ + +K+ Y+
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT-- 115
Query: 91 PREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-----EGYIDETRA 145
+ +E +K +KF A + ++ E G+LL+ I E + +
Sbjct: 116 -QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 146 RKWFAQLVDAINYCHERGVVHRDIKCENLLI-----------DADYNIKLSDFGFARNHM 194
+ +++ I H+ ++H DIK +N ++ D + L D G + +
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK 254
+ + C + + E+L P+ Q D + + ++ M+FG +
Sbjct: 235 LFPKGT----IFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNE 289
Query: 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKIL--APVKTRLRIKNIKE--DPWFRNGPSR 310
+ + + + D +L + +++ F+ +
Sbjct: 290 GGECKPEGLFRRLPHLD-----MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 73/267 (27%), Positives = 132/267 (49%), Gaps = 17/267 (6%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+IG G++ V+L + + +V A+K++SK + F E +++ P +++
Sbjct: 76 VIGRGAFGEVQLV-RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
A + +Y++MEY G L++++ + E AR + A++V A++ H G +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+K +N+L+D ++KL+DFG + + +T G+ Y SPE+LK
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCM-----KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 229 QLS---DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV---QSKVVFPKDPNVSPECKALI 282
D WS+GV L+ M+ G PF ++ ++ + FP D ++S E K LI
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308
Query: 283 SKILAPVKTRLR---IKNIKEDPWFRN 306
L + RL ++ IK +F+N
Sbjct: 309 CAFLTDREVRLGRNGVEEIKRHLFFKN 335
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 14/249 (5%)
Query: 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKII-SKMQAPSDYLKKFLPREVEVVKGLKH 102
Y L ++G G V A + VA+K++ + + + + RE L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-REARTAGRLQE 93
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P+++ E ++Y+ M L ++R++G + RA Q+ A++ H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET--FCGSYAYASPEI 220
G HRD+K EN+L+ AD L DFG A E L++ G+ Y +PE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-------ATTDEKLTQLGNTVGTLYYMAPER 206
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--PNVSPEC 278
+ +D++++ VL+ + G P+ + S + + + P P +
Sbjct: 207 FSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 279 KALISKILA 287
A+I++ +A
Sbjct: 266 DAVIARGMA 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-50
Identities = 61/270 (22%), Positives = 119/270 (44%), Gaps = 21/270 (7%)
Query: 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
IG GS+ TV + + EVA + + ++F E E++KGL+HPN++
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIV 88
Query: 107 KFL----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
+F ++ + ++ E G+L +++ + R W Q++ + + H R
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 163 G--VVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
++HRD+KC+N+ I ++K+ D G A S ++ G+ + +PE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--------TLKRASFAKAVIGTPEFMAPE 200
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKDPNV-SPE 277
+ + Y DV++ G+ + M P+ + +Q+ ++V S V V PE
Sbjct: 201 MYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 278 CKALISKILAP-VKTRLRIKNIKEDPWFRN 306
K +I + R IK++ +F+
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-50
Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 13/249 (5%)
Query: 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
E H T +G GS+ V + + A+K + L+ F E+ GL
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGL 107
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
P ++ A+ V I ME E GSL +I++ G + E RA + Q ++ + Y H
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 161 ERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
R ++H D+K +N+L+ +D L DFG A ++ + G+ + +PE
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDP-NVSPE 277
++ G P + D+WS ++ M+ G P+ + LK + P + +P
Sbjct: 227 VVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285
Query: 278 CKALISKIL 286
I + L
Sbjct: 286 TAQAIQEGL 294
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-50
Identities = 75/250 (30%), Positives = 123/250 (49%), Gaps = 16/250 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII-SKMQAPSDYLKKFLPREVEVVKGLKHP 103
Y + +G G +TV LA + + +VAIK I + + LK+F REV L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-REVHNSSQLSHQ 71
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
N++ + E Y++MEY E +L + I G + A + Q++D I + H+
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET--FCGSYAYASPEIL 221
+VHRDIK +N+LID++ +K+ DFG A+ SL++T G+ Y SPE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK-------ALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKVVFP---KDPNVSPE 277
KG +D++S+G+VL+ M+ G PF+ +T S +K +Q V ++
Sbjct: 185 KGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 278 CKALISKILA 287
+I +
Sbjct: 244 LSNVILRATE 253
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-49
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 33/276 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-------VV 97
+ +G GS+ V L A+KI+ K +K +++E ++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK----QKVVKL---KQIEHTLNEKRIL 95
Query: 98 KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
+ + P L+K + + +Y++MEY G + +R+ G E AR + AQ+V
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y H +++RD+K ENLLID I+++DFGFA+ + + T CG+ +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR---------VKGRTWTLCGTPEALA 206
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSP 276
PEI+ Y + D W++GV+++ M G PF + Q+ ++ V KV FP + S
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSS 263
Query: 277 ECKALISKILAP-VKTRL-RIKN----IKEDPWFRN 306
+ K L+ +L + R +KN IK WF
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-49
Identities = 75/271 (27%), Positives = 135/271 (49%), Gaps = 21/271 (7%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+IG G++ V + +++ +V A+KI++K + E +V+ +
Sbjct: 81 VIGRGAFGEVAVV-KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHR 167
A + + +Y++M+Y G LL ++ K E + E AR + A++V AI+ H+ VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
DIK +N+L+D + +I+L+DFG M + Q S G+ Y SPEIL+ +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-----SSVAVGTPDYISPEILQAMEGG 254
Query: 228 PQL----SDVWSMGVVLFAMVFGRLPF--DDTK--YSQLLKQVQSKVVFPKD-PNVSPEC 278
D WS+GV ++ M++G PF + Y +++ + + FP +VS
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-KERFQFPTQVTDVSENA 313
Query: 279 KALISKILAPVKTRLR---IKNIKEDPWFRN 306
K LI +++ + RL I++ K+ P+F
Sbjct: 314 KDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-49
Identities = 52/250 (20%), Positives = 112/250 (44%), Gaps = 18/250 (7%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+G +IG G + V EVAI++I + D LK F REV + +H N+
Sbjct: 36 EIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENV 91
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
+ F+ A + + II + +L ++R + +D + R+ ++V + Y H +G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+H+D+K +N+ D + + ++DFG ++ + + L G + +PEI++ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR-IQNGWLCHLAPEIIRQL 209
Query: 225 PYCPQL--------SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNV 274
+ SDV+++G + + + PF ++ Q+ + + + +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI-GM 268
Query: 275 SPECKALISK 284
E ++
Sbjct: 269 GKEISDILLF 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-49
Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+IG G+++ V + + + +V A+KI++K E +V+ + +
Sbjct: 68 VIGRGAFSEVAVV-KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERGVVHR 167
A + + +Y++MEY G LL ++ K G I AR + A++V AI+ H G VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
DIK +N+L+D +I+L+DFG + + S G+ Y SPEIL+ +
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-----SLVAVGTPDYLSPEILQAVGGG 241
Query: 228 PQLS------DVWSMGVVLFAMVFGRLPF--DDTK--YSQLLKQVQSKVVFPKDP-NVSP 276
P D W++GV + M +G+ PF D T Y +++ + + P V
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY-KEHLSLPLVDEGVPE 300
Query: 277 ECKALISKILAPVKTRL---RIKNIKEDPWFRN 306
E + I ++L P +TRL + + P+F
Sbjct: 301 EARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 17/253 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII-SKMQAPSDYLKKFLPREVEVVKGLKHP 103
Y LG I+G G + V LA R +VA+K++ + + + +F RE + L HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHP 72
Query: 104 NLIKFL----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
++ YI+MEY + +L DI+ EG + RA + A A+N+
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET--FCGSYAYAS 217
H+ G++HRD+K N++I A +K+ DFG AR S+++T G+ Y S
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-----AIADSGNSVTQTAAVIGTAQYLS 187
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKVVFPKD--PNV 274
PE +G + SDV+S+G VL+ ++ G PF D+ S + V+ + P +
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 275 SPECKALISKILA 287
S + A++ K LA
Sbjct: 247 SADLDAVVLKALA 259
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-49
Identities = 73/277 (26%), Positives = 146/277 (52%), Gaps = 35/277 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVE-------V 96
+ + +G GS+ V L S RH+ A+K++ K ++ ++VE +
Sbjct: 8 FQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKK----EIVVRL---KQVEHTNDERLM 59
Query: 97 VKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+ + HP +I+ + ++++IM+Y E G L ++RK A+ + A++ A+
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
Y H + +++RD+K EN+L+D + +IK++DFGFA+ ++ T CG+ Y
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---------PDVTYTLCGTPDYI 170
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVS 275
+PE++ PY + D WS G++++ M+ G PF D+ + ++ + +++ FP P +
Sbjct: 171 APEVVSTKPYNKSI-DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFN 227
Query: 276 PECKALISKILAP-VKTRL-RIKN----IKEDPWFRN 306
+ K L+S+++ + RL ++N +K PWF+
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 26/245 (10%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKII--SKMQAPSDYLKKFLPREVEVVKGLKHP 103
TL IIG+G + V A EVA+K + S ++ +E ++ LKHP
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHP 66
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
N+I + ++ME+A G L ++ + I W Q+ +NY H+
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 164 ---VVHRDIKCENLLID--------ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
++HRD+K N+LI ++ +K++DFG AR + + + G+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--------HRTTKMSAAGA 177
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
YA+ +PE+++ + SDVWS GV+L+ ++ G +PF + V + P
Sbjct: 178 YAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 273 NVSPE 277
+ PE
Sbjct: 237 STCPE 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 43/248 (17%), Positives = 98/248 (39%), Gaps = 23/248 (9%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T + + ++ +K++ + + F E ++ HPN+
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNV 69
Query: 106 IKFLQAIET--THRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCH- 160
+ L A ++ +I + GSL +++ + +D+++A K+ + + + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 161 -ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
E + + +++ID D ++S + S + A+ +PE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----------SPGRMYAPAWVAPE 178
Query: 220 ILKGIPY--CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSP 276
L+ P + +D+WS V+L+ +V +PF D ++ +V + + P P +SP
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 277 ECKALISK 284
L+
Sbjct: 239 HVSKLMKI 246
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-48
Identities = 53/288 (18%), Positives = 97/288 (33%), Gaps = 41/288 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHP 103
+ IG G + +V C AIK K A S + L REV L +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQHS 71
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDII----RKEGYIDETRARKWFAQLVDAINYC 159
+++++ A + I EY GSL D I R Y E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 160 HERGVVHRDIKCENLLIDAD-------------------YNIKLSDFGFARNHMRYRSRQ 200
H +VH DIK N+ I K+ D G
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI------- 184
Query: 201 GYESLSETFCGSYAYASPEILKG-IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259
S + G + + E+L+ + P+ +D++++ + + +
Sbjct: 185 ---SSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRN---GDQW 237
Query: 260 KQVQSKVVFPKDPNVSPECKALISKILAPV-KTRLRIKNIKEDPWFRN 306
+++ + +S E L+ ++ P + R + + +
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-48
Identities = 65/273 (23%), Positives = 140/273 (51%), Gaps = 32/273 (11%)
Query: 51 IGMGSYATVKLA--TSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVE-------VVKGL 100
+G G Y V + ++ ++ A+K++ K + ++ ++ +++ +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKK----AMIVRN--AKDTAHTKAERNILEEV 78
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
KHP ++ + A +T ++Y+I+EY G L + +EG E A + A++ A+ + H
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
++G+++RD+K EN++++ ++KL+DFG + + + + TFCG+ Y +PEI
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV------THTFCGTIEYMAPEI 192
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECK 279
L + + D WS+G +++ M+ G PF + + + ++ K+ P P ++ E +
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEAR 249
Query: 280 ALISKILAP-VKTRL-----RIKNIKEDPWFRN 306
L+ K+L +RL ++ P+FR+
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-48
Identities = 86/270 (31%), Positives = 138/270 (51%), Gaps = 30/270 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-------VVKGLKHP 103
+G G++ V L A+KI+ K + K EV V++ +HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRK----EVIIAK---DEVAHTVTESRVLQNTRHP 65
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
L A +T R+ +MEYA G L + +E E RAR + A++V A+ Y H R
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
VV+RDIK ENL++D D +IK++DFG + + + +TFCG+ Y +PE+L+
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGI------SDGATMKTFCGTPEYLAPEVLED 179
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKALI 282
Y + D W +GVV++ M+ GRLPF + + +L + + ++ FP +SPE K+L+
Sbjct: 180 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLL 236
Query: 283 SKILAP-VKTRL-----RIKNIKEDPWFRN 306
+ +L K RL K + E +F +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 32/271 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE--------VVKGLKH 102
IG GS+ V LA A+K++ K LKK +E + ++K +KH
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQK----KAILKK---KEEKHIMSERNVLLKNVKH 98
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L+ + +T ++Y +++Y G L +++E E RAR + A++ A+ Y H
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+V+RD+K EN+L+D+ +I L+DFG + ++ + S + TFCG+ Y +PE+L
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST------TSTFCGTPEYLAPEVLH 212
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKAL 281
PY + D W +G VL+ M++G PF +++ + + PN++ + L
Sbjct: 213 KQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHL 269
Query: 282 ISKILA--PVKTRLRIKN----IKEDPWFRN 306
+ +L K RL K+ IK +F
Sbjct: 270 LEGLLQKDRTK-RLGAKDDFMEIKSHVFFSL 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 28/248 (11%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
+ ++G G++ V A + +VAIK I K F+ E+ + + HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIE----SESERKAFI-VELRQLSRVNHPNI 63
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHER 162
+K A + V ++MEYAE GSL +++ Y A W Q + Y H
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 163 ---GVVHRDIKCENLLIDADYN-IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
++HRD+K NLL+ A +K+ DFG A + ++ GS A+ +P
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---------QTHMTNNKGSAAWMAP 172
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
E+ +G Y + DV+S G++L+ ++ R PFD+ ++ V P +
Sbjct: 173 EVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 279 KALISKIL 286
I ++
Sbjct: 230 PKPIESLM 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 49/252 (19%), Positives = 97/252 (38%), Gaps = 15/252 (5%)
Query: 66 RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYA 125
+ S ++ + N + LQ +YI M+
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 126 EKGSLLDIIRKEGYI---DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNI 182
K +L D + + + + F Q+ +A+ + H +G++HRD+K N+ D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 183 KLSDFGFARNHMRYRSRQGYESLSE------TFCGSYAYASPEILKGIPYCPQLSDVWSM 236
K+ DFG + Q + G+ Y SPE + G Y D++S+
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSL 262
Query: 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-NVSPECKALISKILAPV-KTRLR 294
G++LF +++ + +++ V+ + FP P+ ++ +L+P R
Sbjct: 263 GLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319
Query: 295 IKNIKEDPWFRN 306
+I E+ F N
Sbjct: 320 ATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 2/80 (2%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G G + V A + C AIK I ++ + REV+ + L+HP
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPG 65
Query: 105 LIKFLQAIETTHRVYIIMEY 124
++++ A T E
Sbjct: 66 IVRYFNAWLETPPEKWQEEM 85
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 31/269 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVE--------VVKGLK 101
+G GS+ V LA + + + AIK + K L +VE + +
Sbjct: 25 LGKGSFGKVFLAEF-KKTNQFFAIKALKK----DVVLMD---DDVECTMVEKRVLSLAWE 76
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HP L +T ++ +MEY G L+ I+ D +RA + A+++ + + H
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+G+V+RD+K +N+L+D D +IK++DFG + +M ++ + TFCG+ Y +PEIL
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------LGDAKTNTFCGTPDYIAPEIL 190
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKA 280
G Y + D WS GV+L+ M+ G+ PF +L +P + E K
Sbjct: 191 LGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKD 247
Query: 281 LISKILA--PVKTRLRIKN-IKEDPWFRN 306
L+ K+ P K RL ++ I++ P FR
Sbjct: 248 LLVKLFVREPEK-RLGVRGDIRQHPLFRE 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 3e-47
Identities = 72/273 (26%), Positives = 138/273 (50%), Gaps = 34/273 (12%)
Query: 51 IGMGSYATVKLA--TSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVE------VVKGLK 101
+G GS+ V L S + ++ A+K++ K LK V ++ +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKV--RDRVRTKMERDILVEVN 84
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HP ++K A +T ++Y+I+++ G L + KE E + + A+L A+++ H
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
G+++RD+K EN+L+D + +IKL+DFG ++ + + + + +FCG+ Y +PE++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK------AYSFCGTVEYMAPEVV 198
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKA 280
+ Q +D WS GV++F M+ G LPF + + +++K+ P +SPE ++
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQS 255
Query: 281 LISKILA--PVKTRL-----RIKNIKEDPWFRN 306
L+ + P RL ++ IK +F
Sbjct: 256 LLRMLFKRNPAN-RLGAGPDGVEEIKRHSFFST 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 56/265 (21%), Positives = 126/265 (47%), Gaps = 19/265 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109
IG GS+ V + + ++ A+K ++K + + + +E+++++GL+HP L+
Sbjct: 23 IGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDI 169
+ + ++++++ G L +++ + E + + +LV A++Y + ++HRD+
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ 229
K +N+L+D ++ ++DF A E+ T G+ Y +PE+
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLP-------RETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 230 LSDV--WSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS----KVVFPKDPNVSPECKALIS 283
V WS+GV + ++ GR P+ + + V + V +P S E +L+
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVSLLK 252
Query: 284 KILAP-VKTRL-RIKNIKEDPWFRN 306
K+L P R ++ +++ P+ +
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-46
Identities = 50/216 (23%), Positives = 99/216 (45%), Gaps = 13/216 (6%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
G ++G G + T + +K + ++ + + FL +EV+V++ L+HPN+
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFL-KEVKVMRCLEHPNV 69
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
+KF+ + R+ I EY + G+L II+ + ++ + + + Y H +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR--------NHMRYRSRQGYESLSETFCGSYAYA 216
+HRD+ N L+ + N+ ++DFG AR ++ T G+ +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
+PE++ G Y + DV+S G+VL ++ D
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 79/283 (27%), Positives = 142/283 (50%), Gaps = 43/283 (15%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE--------VVKGLK 101
+IG GSYA V L + A+K++ K D +++ +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-------EDIDWVQTEKHVFEQASN 68
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HP L+ +T R++ ++EY G L+ ++++ + E AR + A++ A+NY HE
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
RG+++RD+K +N+L+D++ +IKL+D+G + +R + TFCG+ Y +PEIL
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------TSTFCGTPNYIAPEIL 182
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ----------VQSKVVFPKD 271
+G Y + D W++GV++F M+ GR PFD S Q ++ ++ P
Sbjct: 183 RGEDYGFSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239
Query: 272 PNVSPECKALISKILA--PVKTRL------RIKNIKEDPWFRN 306
++S + +++ L P + RL +I+ P+FRN
Sbjct: 240 RSLSVKAASVLKSFLNKDPKE-RLGCHPQTGFADIQGHPFFRN 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 74/273 (27%), Positives = 132/273 (48%), Gaps = 34/273 (12%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE--------VVKGLKH 102
+G GS+ V LA A+K++ K L+ +VE + H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKK----DVILQD---DDVECTMTEKRILSLARNH 83
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L + +T R++ +ME+ G L+ I+K DE RAR + A+++ A+ + H++
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+++RD+K +N+L+D + + KL+DFG + + + TFCG+ Y +PEIL+
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------CNGVTTATFCGTPDYIAPEILQ 197
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKAL 281
+ Y P + D W+MGV+L+ M+ G PF+ L + + +VV+P + + +
Sbjct: 198 EMLYGPAV-DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHEDATGI 254
Query: 282 ISKILA--PVKTRL------RIKNIKEDPWFRN 306
+ + P RL I P+F+
Sbjct: 255 LKSFMTKNP-TMRLGSLTQGGEHAILRHPFFKE 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-46
Identities = 50/259 (19%), Positives = 103/259 (39%), Gaps = 35/259 (13%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-----YLKKFLPREVEVVKGL 100
IG G + V + VAIK + + + ++F REV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMSNL 80
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYC 159
HPN++K + ++ME+ G L + + + I + + + I Y
Sbjct: 81 NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 160 HERG--VVHRDIKCENLLID-----ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+ +VHRD++ N+ + A K++DFG ++ G+
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---------VHSVSGLLGN 189
Query: 213 YAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF-- 268
+ + +PE + Y + +D +S ++L+ ++ G PFD+ Y ++ + + +
Sbjct: 190 FQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEG 246
Query: 269 --PKDP-NVSPECKALISK 284
P P + P + +I
Sbjct: 247 LRPTIPEDCPPRLRNVIEL 265
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 19/265 (7%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
+G G++ V L A+KI+ K + E V++ +HP L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH-ERGVVHRDI 169
+ +T R+ +MEYA G L + +E E RAR + A++V A++Y H E+ VV+RD+
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ 229
K ENL++D D +IK++DFG + ++ + +TFCG+ Y +PE+L+ Y
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGAT------MKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 230 LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKALISKILA- 287
+ D W +GVV++ M+ GRLPF + + +L + + ++ FP + PE K+L+S +L
Sbjct: 330 V-DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLLSGLLKK 386
Query: 288 -PVKTRL-----RIKNIKEDPWFRN 306
P + RL K I + +F
Sbjct: 387 DPKQ-RLGGGSEDAKEIMQHRFFAG 410
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 64/283 (22%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 51 IGMGSYATVKLA--TSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVV---------- 97
+G G+Y V L S + ++ A+K++ K + ++ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK---------ATIVQKAKTTEHTRTERQVL 112
Query: 98 -KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
+ P L+ A +T ++++I++Y G L + + E + + ++V A+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
+ H+ G+++RDIK EN+L+D++ ++ L+DFG ++ + + FCG+ Y
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-----ADETERAYDFCGTIEYM 227
Query: 217 SPEILKGIPYCPQLS-DVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-----VQSKVVFPK 270
+P+I++G + D WS+GV+++ ++ G PF + ++S+ +P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP- 286
Query: 271 DPNVSPECKALISKILA--PVKTRL-----RIKNIKEDPWFRN 306
+S K LI ++L P K RL IKE +F+
Sbjct: 287 -QEMSALAKDLIQRLLMKDPKK-RLGCGPRDADEIKEHLFFQK 327
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 70/271 (25%), Positives = 133/271 (49%), Gaps = 31/271 (11%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE--------VVKGLKH 102
+G GS+ V L+ A+KI+ K ++ +VE + K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQD---DDVECTMVEKRVLALPGKP 80
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER 162
P L + +T R+Y +MEY G L+ I++ G E A + A++ + + +
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
G+++RD+K +N+++D++ +IK++DFG + ++ ++TFCG+ Y +PEI+
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT------TKTFCGTPDYIAPEIIA 194
Query: 223 GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKAL 281
PY + D W+ GV+L+ M+ G+ PF+ +L + ++ V +P ++S E A+
Sbjct: 195 YQPYGKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAI 251
Query: 282 ISKILAP-VKTRL-----RIKNIKEDPWFRN 306
++ RL ++IKE +FR
Sbjct: 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-45
Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 43/283 (15%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE--------VVKGLK 101
+IG GSYA V L + A++++ K D +++ +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-------EDIDWVQTEKHVFEQASN 111
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HP L+ +T R++ ++EY G L+ ++++ + E AR + A++ A+NY HE
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
RG+++RD+K +N+L+D++ +IKL+D+G + +R + TFCG+ Y +PEIL
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------TSTFCGTPNYIAPEIL 225
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ----------VQSKVVFPKD 271
+G Y + D W++GV++F M+ GR PFD S Q ++ ++ P
Sbjct: 226 RGEDYGFSV-DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 282
Query: 272 PNVSPECKALISKILA--PVKTRL------RIKNIKEDPWFRN 306
++S + +++ L P + RL +I+ P+FRN
Sbjct: 283 RSLSVKAASVLKSFLNKDPKE-RLGCHPQTGFADIQGHPFFRN 324
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 73/273 (26%), Positives = 134/273 (49%), Gaps = 33/273 (12%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK--------GLK 101
++G GS+ V L+ A+KI+ K D +VE K
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVLALPGK 400
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
P L + +T R+Y +MEY G L+ I++ G E A + A++ + +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+G+++RD+K +N+++D++ +IK++DFG + ++ ++TFCG+ Y +PEI+
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI------WDGVTTKTFCGTPDYIAPEII 514
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ-VQSKVVFPKDPNVSPECKA 280
PY + D W+ GV+L+ M+ G+ PF+ +L + ++ V +P ++S E A
Sbjct: 515 AYQPYGKSV-DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVA 571
Query: 281 LISKILA--PVKTRL-----RIKNIKEDPWFRN 306
+ ++ P K RL ++IKE +FR
Sbjct: 572 ICKGLMTKHPGK-RLGCGPEGERDIKEHAFFRY 603
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 31 PDADGKMTVLESHGYTL-----GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
+ D + +LE Y ++G G+Y V + +AIK I + +
Sbjct: 6 EEGDCESDLLEYD-YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-- 62
Query: 86 LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG---YIDE 142
+ L E+ + K LKH N++++L + + I ME GSL ++R + +E
Sbjct: 63 -SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE 121
Query: 143 TRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQG 201
+ Q+++ + Y H+ +VHRDIK +N+LI+ +K+SDFG ++ G
Sbjct: 122 QTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR------LAG 175
Query: 202 YESLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259
+ETF G+ Y +PEI+ P Y +D+WS+G + M G+ P + +L
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPP-----FYELG 229
Query: 260 KQVQS--KVVFPKDP-----NVSPECKALISKIL 286
+ + KV K ++S E KA I K
Sbjct: 230 EPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-43
Identities = 61/280 (21%), Positives = 123/280 (43%), Gaps = 40/280 (14%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVE-------VVKGLK 101
++G G + V + + ++ A K ++K LKK + + ++ +
Sbjct: 192 VLGRGGFGEVFAC-QMKATGKLYACKKLNK-----KRLKK--RKGYQGAMVEKKILAKVH 243
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSL----LDIIRKEGYIDETRARKWFAQLVDAIN 157
++ A ET + ++M G + ++ E RA + AQ+V +
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ H+R +++RD+K EN+L+D D N+++SD G A ++ ++ + G+ + +
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------AGQTKTKGYAGTPGFMA 357
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-----QSKVVFPKDP 272
PE+L G Y + D +++GV L+ M+ R PF K++ + V +P
Sbjct: 358 PELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--D 414
Query: 273 NVSPECKALISKILAP-VKTRLRIKN-----IKEDPWFRN 306
SP K +L + RL ++ ++ P FR+
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 47/277 (16%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV--VKGLKHP 103
TL +G G Y V + VA+KI S K + RE E+ L+H
Sbjct: 11 TLLECVGKGRYGEVWRGS--WQGENVAVKIF-----SSRDEKSWF-RETELYNTVMLRHE 62
Query: 104 NLIKFLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
N++ F+ + T+ ++++I Y E GSL D ++ +D + + + +
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHL 121
Query: 160 HER--------GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG 211
H + HRD+K +N+L+ + ++D G A H + ++ + G
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR--VG 179
Query: 212 SYAYASPEILKGIPYCPQL-----SDVWSMGVVLFAMVFG----------RLPFDDTKYS 256
+ Y +PE+L D+W+ G+VL+ + + PF D +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 257 QL-LKQVQSKVVF----PKDPN--VSPECKALISKIL 286
+ ++ V P PN S ++K++
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKK-------FLPREV-EVVKGL 100
IIG G + V + ++ A+K + K +K R + +V
Sbjct: 196 IIGRGGFGEVYGCRK-ADTGKMYAMKCLDK-----KRIKMKQGETLALNERIMLSLVSTG 249
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
P ++ A T ++ I++ G L + + G E R + A+++ + + H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
R VV+RD+K N+L+D ++++SD G A + + + G++ Y +PE+
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--------ASVGTHGYMAPEV 361
Query: 221 L-KGIPYCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLKQ--VQSKVVFPKDPNVS 275
L KG+ Y +D +S+G +LF ++ G PF TK + + + V P + S
Sbjct: 362 LQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFS 418
Query: 276 PECKALISKILAP-VKTRLRIKN-----IKEDPWFRN 306
PE ++L+ +L V RL +KE P+FR+
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-42
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 12/251 (4%)
Query: 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK 87
+ K+ L+ + + +G G+ V + +A K+I P+ +
Sbjct: 18 EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--R 75
Query: 88 KFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK 147
+ RE++V+ P ++ F A + + I ME+ + GSL +++K G I E K
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 148 WFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS 206
++ + Y + ++HRD+K N+L+++ IKL DFG S Q +S++
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------SGQLIDSMA 187
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266
+F G+ +Y SPE L+G Y Q SD+WSMG+ L M GR P +L +V
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 267 VFPKDPNVSPE 277
Sbjct: 247 EGDAAETPPRP 257
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 60/271 (22%), Positives = 116/271 (42%), Gaps = 25/271 (9%)
Query: 50 IIGMGSYATVKLATSSRHSCEV-AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
++G G + V R + ++ A K + K + + E ++++ + ++
Sbjct: 191 VLGKGGFGEVCAC-QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVH 166
A ET + +++ G L I G E RA + A++ + H +V+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 167 RDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY 226
RD+K EN+L+D +I++SD G A + + G+ Y +PE++K Y
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVP-------EGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 227 CPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-----QSKVVFPKDPNVSPECKAL 281
D W++G +L+ M+ G+ PF K ++V + + SP+ ++L
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSL 419
Query: 282 ISKILAP-VKTRL-----RIKNIKEDPWFRN 306
S++L RL + +KE P F+
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 62/300 (20%), Positives = 113/300 (37%), Gaps = 56/300 (18%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV--VKGLKHP 103
L IG G + V EVA+KI S + + RE E+ L+H
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIF-----SSREERSWF-REAEIYQTVMLRHE 96
Query: 104 NLIKFLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
N++ F+ A + +++++ +Y E GSL D + + + K + +
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHL 155
Query: 160 HER--------GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG 211
H + HRD+K +N+L+ + ++D G A H G
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR--VG 213
Query: 212 SYAYASPEILKGIPYCPQL-----SDVWSMGVVLFAMVFG----------RLPFDDTKYS 256
+ Y +PE+L +D+++MG+V + + +LP+ D S
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 257 QL-LKQVQSKVVF----PKDPNVSPECKALISKILAPVKTRLRIKNIKEDPWFRNGPSRP 311
+++++ V P PN C+AL + I + W+ NG +R
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV-----------MAKIMRECWYANGAARL 322
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 48/232 (20%), Positives = 92/232 (39%), Gaps = 30/232 (12%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV--VKGLKHP 103
+ IG G Y V + +VA+K+ + S + RE E+ ++H
Sbjct: 40 QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWF------RETEIYQTVLMRHE 91
Query: 104 NLIKFLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
N++ F+ A ++Y+I +Y E GSL D ++ +D K V + +
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHL 150
Query: 160 HER--------GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG 211
H + HRD+K +N+L+ + ++D G A + + + G
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VG 208
Query: 212 SYAYASPEILKGIPYCPQL-----SDVWSMGVVLFAMVFGRLPFDDTKYSQL 258
+ Y PE+L +D++S G++L+ + + + QL
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 46/255 (18%), Positives = 97/255 (38%), Gaps = 40/255 (15%)
Query: 45 YTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
Y + I G + LA + R V +K + + + E + + +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRP---VVLKGLVHSGDA-EAQAMAM-AERQFLAEV 136
Query: 101 KHPNLIKFLQAIETTHR-----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDA 155
HP++++ +E T R YI+MEY SL + A + +++ A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPA 194
Query: 156 INYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET--FCGSY 213
++Y H G+V+ D+K EN+++ + +KL D G ++ G+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------------RINSFGYLYGTP 241
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
+ +PEI++ P +D++++G L A+ + + + +
Sbjct: 242 GFQAPEIVRTGP-TVA-TDIYTVGRTLAALTLDLPTRN----GRYVDGLPED---DPVLK 292
Query: 274 VSPECKALISKILAP 288
L+ + + P
Sbjct: 293 TYDSYGRLLRRAIDP 307
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 62/208 (29%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAI+ ++ Q P K+ + E+ V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ +L + ++++MEY GSL D++ E +DE + + + A+ + H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR------STMVGTPYWMAPEVVTRK 191
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
Y P+ D+WS+G++ M+ G P+ +
Sbjct: 192 AYGPK-VDIWSLGIMAIEMIEGEPPYLN 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 36/251 (14%), Positives = 80/251 (31%), Gaps = 44/251 (17%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII-SKMQAPSDYLKKFLPREVEVVKGLKHP 103
Y L G A + +VA+ + + P D L++ L + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKP 91
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
+ + L + T ++ E+ GSL ++ + A + L A + H G
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
V + + D ++ L+ A+P+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM-----------------------PDANPQ---- 182
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFD----DTKYSQLLKQVQSKVVFPKD--PNVSPE 277
D+ +G L+A++ R P + + + + + P D ++ +
Sbjct: 183 -------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 278 CKALISKILAP 288
A+ ++ +
Sbjct: 236 ISAVAARSVQG 246
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 53/208 (25%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
IG GS V LA +VA+K++ + ++ L EV +++ +H N
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFN 103
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ ++ ++++ME+ + G+L DI+ + ++E + ++ A+ Y H +GV
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +++L+ D +KLSDFGF + ++ ++ G+ + +PE++
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRS 216
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
Y + D+WS+G+++ MV G P+
Sbjct: 217 LYATE-VDIWSLGIMVIEMVDGEPPYFS 243
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 49/286 (17%), Positives = 100/286 (34%), Gaps = 54/286 (18%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK--GLKHP 103
L +IG G Y V + VA+K+ + F+ E + + ++H
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVF-----SFANRQNFI-NEKNIYRVPLMEHD 67
Query: 104 NLIKFLQAIETTHRV-----YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
N+ +F+ E ++MEY GSL + D + + + + Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126
Query: 159 CHE---------RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF 209
H + HRD+ N+L+ D +SDFG + R + E +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 210 --CGSYAYASPEILKG------IPYCPQLSDVWSMGVVLFAMVFG-------------RL 248
G+ Y +PE+L+G + D++++G++ + + ++
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 249 PFDDTKYSQL-LKQVQSKVV-------FPKDPNVSPECKALISKIL 286
F + + +Q V FP+ + + + +
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 21/292 (7%)
Query: 26 KGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY 85
K G+ E + +G G+ V + +A+K + + +
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE- 66
Query: 86 LKKFLPREVEVV-KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETR 144
K + +++VV K P +++ T V+I ME + R +G I E
Sbjct: 67 -NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI 125
Query: 145 ARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203
K +V A+ Y + GV+HRD+K N+L+D IKL DFG S + +
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI--------SGRLVD 177
Query: 204 SLSE-TFCGSYAYASPEILKGIPYCPQ----LSDVWSMGVVLFAMVFGRLPFDD--TKYS 256
++ G AY +PE + +DVWS+G+ L + G+ P+ + T +
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
Query: 257 QLLKQVQSKV-VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306
L K +Q + + P S + ++ + L + R + + E + +
Sbjct: 238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 50/304 (16%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
+S L + G + V A + VA+KI D EV +
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFP----IQDKQSWQNEYEVYSLP 73
Query: 99 GLKHPNLIKFLQAIETTHRV----YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVD 154
G+KH N+++F+ A + V ++I + EKGSL D ++ + +
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMAR 132
Query: 155 AINYCHER----------GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204
+ Y HE + HRDIK +N+L+ + ++DFG A +S
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS----AG 188
Query: 205 LSETFCGSYAYASPEILKGIPYCPQL----SDVWSMGVVLFAMVFGRLPFDDTKYSQLL- 259
+ G+ Y +PE+L+G + D+++MG+VL+ + D +L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 260 -----------KQVQSKVVFPK-DPNVSPECKALISKILAPVKTRLRIKNIKEDPWFRNG 307
+ +Q VV K P + + + E+ W +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--------KHAGMAMLCETIEECWDHDA 300
Query: 308 PSRP 311
+R
Sbjct: 301 EARL 304
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
++G G++ TV + VAIK + + K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
+P++ + L I T V +I + G LLD +R+ + I W Q+ +NY
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGY---------ESLSET 208
+R +VHRD+ N+L+ ++K++DFG A+ + +G ES+
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--- 191
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
Y + SDVWS GV ++ M FG P+D S++ ++
Sbjct: 192 LHRIYTHQ--------------SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG GSY V + VAIK +KK RE+ ++K LKHPN
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
L+ L+ R++++ EY + L ++ R + + E + Q + A+N+CH+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---YASPEIL 221
+HRD+K EN+LI IKL DFGFAR S+ + A Y SPE+L
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARL---------LTGPSDYYDDEVATRWYRSPELL 174
Query: 222 KGIP-YCPQLSDVWSMGVVLFAMVFGR 247
G Y P + DVW++G V ++ G
Sbjct: 175 VGDTQYGPPV-DVWAIGCVFAELLSGV 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G GSY +V A VAIK + + +K E+ +++ P+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPH 85
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
++K+ + ++I+MEY GS+ DIIR + + E + + Y H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
+HRDIK N+L++ + + KL+DFG A +++ T G+ + +PE+++
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR------NTVIGTPFWMAPEVIQE 199
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
I Y +D+WS+G+ M G+ P+ D
Sbjct: 200 IGYNCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 77/307 (25%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y ++G GSY V + VAIK +KK RE++++K L+H N
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCHERG 163
L+ L+ + R Y++ E+ + ++LD + +D +K+ Q+++ I +CH
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR-QGYESLSETFCGSYAYASPEILK 222
++HRDIK EN+L+ +KL DFGFAR + + Y+ T Y +PE+L
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFART---LAAPGEVYDDEVATR----WYRAPELLV 197
Query: 223 G-IPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK-------------------Q 261
G + Y + DVW++G ++ M G F D+ QL
Sbjct: 198 GDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 262 VQSKVVFPKD----------PNVSPECKALISKILA--PVKTRLRIKNIKEDPWFRNGPS 309
V + V P+ P +S L K L P K R + +F+
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RPFCAELLHHDFFQMDGF 315
Query: 310 RPEYPIM 316
+
Sbjct: 316 AERFSQE 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 9/216 (4%)
Query: 45 YTLGTIIGMG--SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
Y L T+IG G TV LA V ++ I+ ++ + FL E+ V K H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR--KEGYIDETRARKWFAQLVDAINYCH 160
PN++ + + ++++ + GS D+I ++E ++ A++Y H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG-YESLSETFCGSYAYASPE 219
G VHR +K ++LI D + LS + + + RQ + + SPE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 220 ILK--GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT 253
+L+ Y + SD++S+G+ + G +PF D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDM 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 38/237 (16%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISK-MQAPSDYLKKFLPREVEVVKGLK 101
L +G GS+ V + S + VA+K + + + + + F+ REV + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLD 79
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
H NLI+ L + T + ++ E A GSLLD +RK +G+ ++ Q+ + + Y
Sbjct: 80 HRNLIR-LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSE 207
+ +HRD+ NLL+ +K+ DFG R N Y ++ ESL
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQ 263
++++A SD W GV L+ M +G+ P+ SQ+L ++
Sbjct: 198 --TRTFSHA--------------SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 13/243 (5%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
LG IG G++ V + VA+K + P D KFL +E ++K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCHERGV 164
++ + +YI+ME + G L +R EG + + Y +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGYESLSETFCGSYAYASPEILK 222
+HRD+ N L+ +K+SDFG +R Y + G + + +PE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV------PVKWTAPEALN 288
Query: 223 GIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
Y + SDVWS G++L+ G P+ + Q + V+ P L
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347
Query: 282 ISK 284
+ +
Sbjct: 348 MEQ 350
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+T IG GS+ V +R VAIKII +A + + + +E+ V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPY 81
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+ K+ + +++IIMEY GS LD++ + G +DET+ +++ ++Y H
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK N+L+ +KL+DFG A + ++ TF G+ + +PE++K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR------NTFVGTPFWMAPEVIKQS 194
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
Y + +D+WS+G+ + G P +
Sbjct: 195 AYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 67/326 (20%), Positives = 117/326 (35%), Gaps = 89/326 (27%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQA----PSDYLKKFLPREVEVVKGLKHPNLI 106
+G G+YATV + VA+K + K+ + PS + RE+ ++K LKH N++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAI-----REISLMKELKHENIV 66
Query: 107 KFLQAIETTHRVYIIMEYAEK--GSLLD---IIRKEGYIDETRARKWFAQLVDAINYCHE 161
+ I T +++ ++ E+ + +D + ++ + + QL+ + +CHE
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYESLSET 208
++HRD+K +NLLI+ +KL DFG AR + YR
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR----------- 175
Query: 209 FCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK------ 260
+P++L G Y + D+WS G +L M+ G+ F QL
Sbjct: 176 --------APDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
Query: 261 --------QVQS----KVVFPK--------------DPNVSPECKALISKILA--PVKTR 292
V + + + +L P
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM-- 284
Query: 293 LRI--KNIKEDPWFRNGPSRPEYPIM 316
R+ K PWF
Sbjct: 285 -RLSAKQALHHPWFAEYYHHASMGGS 309
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 38/237 (16%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
++G G + TV V IK+I + ++ + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIGSLD 73
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
H ++++ L + + ++ +Y GSLLD +R+ G + W Q+ + Y
Sbjct: 74 HAHIVR-LLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGY---------ESLSET 208
E G+VHR++ N+L+ + ++++DFG A + ES+
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--- 189
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
G Y + SDVWS GV ++ ++ FG P+ + +++ ++
Sbjct: 190 HFGKYTHQ--------------SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 24/269 (8%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFL 109
+G G+Y V+ +A+K I + +K L ++++ + + P + F
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVTFY 72
Query: 110 QAIETTHRVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCH-ERGV 164
A+ V+I ME + SL + K I E K +V A+ + H + V
Sbjct: 73 GALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLS-ETFCGSYAYASPEILKG 223
+HRD+K N+LI+A +K+ DFG S + ++ + G Y +PE +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGI--------SGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 224 IPYCPQ---LSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVFPKDPNVSPEC 278
SD+WS+G+ + + R P+D + QL + V+ S E
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 279 KALISKILA-PVKTRLRIKNIKEDPWFRN 306
S+ L K R + + P+F
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
++G G++ TV + VAIK + + K+ L E V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVD 75
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
+P++ + L I T V +I + G LLD +R+ + I W Q+ +NY
Sbjct: 76 NPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGY---------ESLSET 208
+R +VHRD+ N+L+ ++K++DFG A+ + +G ES+
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--- 191
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
Y + SDVWS GV ++ M FG P+D S++ ++
Sbjct: 192 LHRIYTHQ--------------SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 56/223 (25%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y L +IG G+ A V+ A + +VAIK I+ + + L +E++ + HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPN 74
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR--------KEGYIDETRARKWFAQLVDAI 156
++ + + ++++M+ GS+LDII+ K G +DE+ ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA------RNHMRYRSRQGYESLSETFC 210
Y H+ G +HRD+K N+L+ D +++++DFG + + R + R+ TF
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK-------TFV 187
Query: 211 GSYAYASPE-ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
G+ + +PE + + Y + +D+WS G+ + G P+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 54/304 (17%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGLK---HP 103
IG+G+Y TV A VA+K + ++ P REV +++ L+ HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGL-PISTVREVALLRRLEAFEHP 74
Query: 104 NLIKFLQAIETTH-----RVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAI 156
N+++ + T+ +V ++ E+ ++ + LD G + + Q + +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGL 133
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
++ H +VHRD+K EN+L+ + +KL+DFG AR Y + + T Y
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPVVVTLW----YR 186
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQ------------ 263
+PE+L Y + D+WS+G + M + F +++ QL K
Sbjct: 187 APEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245
Query: 264 ----SKVVFPKD---------PNVSPECKALISKILA--PVKTRLRIKNIKEDPWFRNGP 308
+ FP P + L+ ++L P K R+ + +
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK-RISAFRALQHSYLHKDE 304
Query: 309 SRPE 312
PE
Sbjct: 305 GNPE 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 58/237 (24%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T+ +G G Y V ++S VA+K + K +++FL +E V+K +KHPNL
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME--VEEFL-KEAAVMKEIKHPNL 278
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
++ L YII E+ G+LLD +R+ + + Q+ A+ Y ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGYESLSETFCGSYAYASPEIL 221
+HR++ N L+ ++ +K++DFG +R Y + G + +PE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-------KFPIKWTAPESL 391
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + SDVW+ GV+L+ + +G P+ SQ+ + ++ + +
Sbjct: 392 AYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 79/319 (24%), Positives = 126/319 (39%), Gaps = 80/319 (25%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA----PSDYLKKFLPREVEVVKGL 100
Y +G G+YATV S VA+K I +++ P + REV ++K L
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAI-----REVSLLKDL 57
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
KH N++ I T + ++ EY +K LD I+ + + QL+ + Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRGLAY 115
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYESL 205
CH + V+HRD+K +NLLI+ +KL+DFG AR + YR
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR-------- 167
Query: 206 SETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK--- 260
P+IL G Y Q+ D+W +G + + M GR F T QL
Sbjct: 168 -----------PPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215
Query: 261 -----------QVQS-----KVVFPKD---------PNVSPECKALISKILA--PVKTRL 293
+ S +PK P + + L++K+L R+
Sbjct: 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN-RI 274
Query: 294 RIKNIKEDPWFRNGPSRPE 312
++ + P+F + R
Sbjct: 275 SAEDAMKHPFFLSLGERIH 293
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 67/310 (21%), Positives = 125/310 (40%), Gaps = 81/310 (26%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQA-----PSDYLKKFLPREVEVVKGLKHPNL 105
IG G+Y TV A + VA+K + ++ PS L RE+ ++K LKH N+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSAL-----REICLLKELKHKNI 63
Query: 106 IKFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
++ + + ++ ++ E+ ++ D G +D + + QL+ + +CH R
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYESLSETFC 210
V+HRD+K +NLLI+ + +KL++FG AR +R YR
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR------------- 168
Query: 211 GSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLK------- 260
P++L G Y + D+WS G + + P + QL +
Sbjct: 169 ------PPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
Query: 261 ----------QVQSKVVFPKD----------PNVSPECKALISKILA--PVKTRLRIKNI 298
++ +P P ++ + L+ +L PV+ R+ +
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ-RISAEEA 280
Query: 299 KEDPWFRNGP 308
+ P+F +
Sbjct: 281 LQHPYFSDFC 290
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 36/248 (14%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
LG IG G + V + + VAIK K +KFL +E ++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 75
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
P+++K L + T + V+IIME G L ++ + +D + QL A+ Y
Sbjct: 76 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGY--------ESLSETFC 210
+ VHRDI N+L+ ++ +KL DFG +R Y++ +G ES+
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI---NF 191
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFP 269
+ A SDVW GV ++ ++ G PF K + ++ ++++ P
Sbjct: 192 RRFTSA--------------SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237
Query: 270 KDPNVSPE 277
PN P
Sbjct: 238 MPPNCPPT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 84/316 (26%), Positives = 130/316 (41%), Gaps = 83/316 (26%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQA-----PSDYLKKFLPREVEVVKGLKHPNL 105
+G G+Y V A + + VAIK I +++ P + REV ++K L+H N+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-----REVSLLKELQHRNI 95
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVV 165
I+ I HR+++I EYAE L + K + + + QL++ +N+CH R +
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 166 HRDIKCENLLIDADY-----NIKLSDFGFAR---NHMR----------YRSRQGYESLSE 207
HRD+K +NLL+ +K+ DFG AR +R YR
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR---------- 204
Query: 208 TFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK----- 260
PEIL G Y + D+WS+ + M+ F D++ QL K
Sbjct: 205 ---------PPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 261 ---------QVQS----KVVFPKDP----------NVSPECKALISKILA--PVKTRLRI 295
V + K FPK + E L++ +L PVK R+
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK-RISA 313
Query: 296 KNIKEDPWFRNGPSRP 311
KN E P+F + P
Sbjct: 314 KNALEHPYFSHNDFDP 329
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 49/234 (20%), Positives = 99/234 (42%), Gaps = 35/234 (14%)
Query: 47 LGTIIGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+G G++ TVK + VA+KI+ + L E V++ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPY 79
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ + I ++ME AE G L +++ ++ + + Q+ + Y E
Sbjct: 80 IVR-MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSETFCG 211
VHRD+ N+L+ + K+SDFG ++ + Y+++ E ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---YY 195
Query: 212 SYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
++ SDVWS GV+++ A +G+ P+ K S++ ++
Sbjct: 196 KFSSK--------------SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 80/313 (25%), Positives = 133/313 (42%), Gaps = 81/313 (25%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA-----PSDYLKKFLPREVEVVKG 99
Y IG G+Y V A ++ A+K I +++ PS + RE+ ++K
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGET-FALKKI-RLEKEDEGIPSTTI-----REISILKE 56
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
LKH N++K I T R+ ++ E+ ++ LLD EG ++ A+ + QL++ I
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA 114
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYES 204
YCH+R V+HRD+K +NLLI+ + +K++DFG AR +R YR
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------- 167
Query: 205 LSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK-- 260
+P++L G Y + D+WS+G + MV G F ++ QL++
Sbjct: 168 ------------APDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
Query: 261 ------------QVQS----KVVFPKD---------PNVSPECKALISKILA--PVKTRL 293
V F + L+SK+L P + R+
Sbjct: 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ-RI 273
Query: 294 RIKNIKEDPWFRN 306
K E +F+
Sbjct: 274 TAKQALEHAYFKE 286
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 36/235 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
L I+G G + V VA+K K D +KF+ E ++K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
P+++K L I +IIME G L + + + + + Q+ A+ Y
Sbjct: 73 PHIVK-LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGY--------ESLSETFC 210
VHRDI N+L+ + +KL DFG +R + Y++ ES++
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN---F 188
Query: 211 GSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
+ A SDVW V ++ ++ FG+ PF + ++ ++
Sbjct: 189 RRFTTA--------------SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 72/313 (23%), Positives = 131/313 (41%), Gaps = 65/313 (20%)
Query: 51 IGMGSYATVKLATSSRHSCE-VAIKIISKMQA-----PSDYLKKFLPREVEVVKGLK--- 101
IG G+Y V A ++ VA+K + ++Q P + REV V++ L+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTI-----REVAVLRHLETFE 72
Query: 102 HPNLIKFL-----QAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVD 154
HPN+++ + ++ ++ E+ ++ + LD + + G + + QL+
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLR 131
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+++ H VVHRD+K +N+L+ + IKL+DFG AR Y + S+ T
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW---- 184
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLK------------- 260
Y +PE+L Y + D+WS+G + M + F + QL K
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 261 -QVQS--KVVFPKD---------PNVSPECKALISKILA--PVKTRLRI--KNIKEDPWF 304
+ + + F ++ K L+ K L P K RI + P+F
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK---RISAYSALSHPYF 300
Query: 305 RNGPSRPEYPIMS 317
++ R + + S
Sbjct: 301 QDLE-RCKENLDS 312
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 74/312 (23%), Positives = 131/312 (41%), Gaps = 82/312 (26%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQA-----PSDYLKKFLPREVEVVKGLKHPNL 105
+G G+Y V A VA+K I ++ A PS + RE+ ++K L HPN+
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRI-RLDAEDEGIPSTAI-----REISLLKELHHPNI 81
Query: 106 IKFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
+ + I + + ++ E+ EK +LD + + +++ + + QL+ + +CH+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEKDLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYESLSETFC 210
++HRD+K +NLLI++D +KL+DFG AR +R YR
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------------- 186
Query: 211 GSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQ----- 263
+P++L G Y + D+WS+G + M+ G+ F T QL K
Sbjct: 187 ------APDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239
Query: 264 --------------SKVVFPKD---------PNVSPECKALISKILA--PVKTRLRIKNI 298
+ F P E L+S +L P K R+ ++
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK-RISARDA 298
Query: 299 KEDPWFRNGPSR 310
P+F++ +
Sbjct: 299 MNHPYFKDLDPQ 310
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 47/231 (20%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 51 IGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G++ +V+ + +VAIK++ K ++ + RE +++ L +P +++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR- 74
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHR 167
L + + ++ME A G L + + I + + Q+ + Y E+ VHR
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 168 DIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSETFCGSYA 214
D+ N+L+ + K+SDFG ++ + Y +R E ++ ++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFS 191
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
SDVWS GV ++ A+ +G+ P+ K +++ ++
Sbjct: 192 SR--------------SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 48/214 (22%), Positives = 109/214 (50%), Gaps = 16/214 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G G++ V A + A K+I + E+E++ HP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPY 77
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERG 163
++K L A +++I++E+ G++ I+ + + + E + + Q+++A+N+ H +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI--- 220
++HRD+K N+L+ + +I+L+DFG + +++ ++ ++F G+ + +PE+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR------DSFIGTPYWMAPEVVMC 191
Query: 221 --LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
+K PY + +D+WS+G+ L M P +
Sbjct: 192 ETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 71/312 (22%), Positives = 122/312 (39%), Gaps = 40/312 (12%)
Query: 19 KGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISK 78
G ++ + + L IG G+Y +V +A+K I
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLG--------EIGRGAYGSVNKMVHKPSGQIMAVKRIRS 57
Query: 79 MQAPSDYLKKFLPREVEVV-KGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK- 136
+ +K L +++VV + P +++F A+ +I ME S +
Sbjct: 58 TVDEKE--QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYV 114
Query: 137 ----EGYIDETRARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191
+ I E K V A+N+ ++HRDIK N+L+D NIKL DFG
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-- 172
Query: 192 NHMRYRSRQGYESLSET-FCGSYAYASPEILKGIPYCPQ---LSDVWSMGVVLFAMVFGR 247
S Q +S+++T G Y +PE + SDVWS+G+ L+ + GR
Sbjct: 173 ------SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
Query: 248 LPFDDTK--YSQLLKQVQS---KVVFPKDPNVSPECKALISKILAPVK---TRLRIKNIK 299
P+ + QL + V+ ++ ++ SP ++ L K R + K +
Sbjct: 227 FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL--TKDESKRPKYKELL 284
Query: 300 EDPWFRNGPSRP 311
+ P+ R
Sbjct: 285 KHPFILMYEERA 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
++ IG GS+ V A R+S VAIK +S S+ + + +EV ++ L+HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
I++ H +++MEY GS D++ + + E + + Y H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFA-----RNHMRYRSRQGYESLSETFCGSYAYASP 218
++HRD+K N+L+ +KL DFG A N +F G+ + +P
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------------SFVGTPYWMAP 219
Query: 219 EI---LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252
E+ + Y DVWS+G+ + + P +
Sbjct: 220 EVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFN 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 20/240 (8%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
LG IG G + V + + VAIK K +KFL +E ++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 450
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
P+++K L + T + V+IIME G L ++ + +D + QL A+ Y
Sbjct: 451 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRSRQGYESLSETFCGSYAYASP 218
+ VHRDI N+L+ ++ +KL DFG +R + Y++ +G + +P
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--------AP 561
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
E + + SDVW GV ++ ++ G PF K + ++ ++++ P PN P
Sbjct: 562 ESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 35/246 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T+ +G G Y V ++S VA+K + K ++FL +E V+K +KHPNL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV--EEFL-KEAAVMKEIKHPNL 71
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
++ L YII E+ G+LLD +R+ + + Q+ A+ Y ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHM--RYRSRQGY---------ESLSETFCGS 212
+HRD+ N L+ ++ +K++DFG +R Y + G ESL
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL---AYNK 188
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKD 271
++ SDVW+ GV+L+ + +G P+ SQ+ + ++ +
Sbjct: 189 FSIK--------------SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 234
Query: 272 PNVSPE 277
+
Sbjct: 235 EGCPEK 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 56/255 (21%), Positives = 109/255 (42%), Gaps = 56/255 (21%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+G G++ +V++ VA+K + + L+ F RE+E++K L+
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH-LRDFE-REIEILKSLQ 69
Query: 102 HPNLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINY 158
H N++K+ + R + +IMEY GSL D ++K + ID + ++ +Q+ + Y
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESL 205
+ +HRD+ N+L++ + +K+ DFG + + ++ ++ ESL
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVL----------------FAMVFGRLP 249
+E ++ A SDVWS GVVL F + G
Sbjct: 190 TE---SKFSVA--------------SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 250 FDDTKYSQLLKQVQS 264
L++ +++
Sbjct: 233 QGQMIVFHLIELLKN 247
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 41/226 (18%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+ +G G++ +V+L VA+K + + P D + F RE++++K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGP-DQQRDFQ-REIQILKALH 82
Query: 102 HPNLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINY 158
++K+ R + ++MEY G L D +++ +D +R + +Q+ + Y
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESL 205
R VHRD+ N+L++++ ++K++DFG A+ + Y R+ ESL
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPF 250
S+ ++ SDVWS GVVL+ + +
Sbjct: 203 SD---NIFSRQ--------------SDVWSFGVVLYELFTYCDKSC 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+ IIG G V +L + VAIK + K + FL E ++ H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDH 109
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
PN+I+ + I+ EY E GSL +R +G + + + Y +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSET 208
G VHRD+ N+L+D++ K+SDFG +R + + G E+++
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-- 227
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
+++ A SDVWS GVV++ + +G P+ + ++ V+
Sbjct: 228 -FRTFSSA--------------SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 76/308 (24%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP----REVEVVKGLKHPNLI 106
+G G +ATV A + VAIK I K+ S+ K + RE+++++ L HPN+I
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEA-KDGINRTALREIKLLQELSHPNII 75
Query: 107 KFLQAIETTHRVYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
L A + ++ ++ E ++ + + + + + + Y H+ +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 133
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFAR---NHMR----------YRSRQGYESLSETFCG 211
+HRD+K NLL+D + +KL+DFG A+ + R YR
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR-------------- 179
Query: 212 SYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF--DDTKYSQLLK-------- 260
+PE+L G Y + D+W++G +L ++ PF D+ QL +
Sbjct: 180 -----APELLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTP 232
Query: 261 ---------QVQSKVVFPKD---------PNVSPECKALISKILA--PVKTRLRIKNIKE 300
+ V F + LI + P R+ +
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA-RITATQALK 291
Query: 301 DPWFRNGP 308
+F N P
Sbjct: 292 MKYFSNRP 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 48/237 (20%), Positives = 97/237 (40%), Gaps = 40/237 (16%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+G G + V+L +VA+K + K ++ +++ +E+E+++ L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLK-KEIEILRNLY 81
Query: 102 HPNLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINY 158
H N++K+ + +IME+ GSL + + K + I+ + K+ Q+ ++Y
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESL 205
R VHRD+ N+L+++++ +K+ DFG + + Y + E L
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQ 261
+ + A SDVWS GV L ++ + +
Sbjct: 202 MQ---SKFYIA--------------SDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 56/280 (20%)
Query: 21 NMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKII 76
N+ + D T E +G G++ +V++ VA+K +
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78
Query: 77 SKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR--VYIIMEYAEKGSLLDII 134
+ L+ F RE+E++K L+H N++K+ + R + +IMEY GSL D +
Sbjct: 79 -QHSTEEH-LRDFE-REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 135 RK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR-- 191
+K + ID + ++ +Q+ + Y + +HRD+ N+L++ + +K+ DFG +
Sbjct: 136 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195
Query: 192 --NHMRYRSRQGY---------ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVL 240
+ Y+ ++ ESL+E ++ A SDVWS GVVL
Sbjct: 196 PQDKEYYKVKEPGESPIFWYAPESLTE---SKFSVA--------------SDVWSFGVVL 238
Query: 241 ----------------FAMVFGRLPFDDTKYSQLLKQVQS 264
F + G L++ +++
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L +G G + V + T + VAIK + K S + FL +E +V+K L+H L
Sbjct: 187 RLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMS--PEAFL-QEAQVMKKLRHEKL 241
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
++ + + +YI+ EY KGSLLD ++ E + AQ+ + Y
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD++ N+L+ + K++DFG AR Y +RQG + + +PE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-------PIKWTAPEAA 353
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + SDVWS G++L + GR+P+ ++L QV+ P P
Sbjct: 354 LYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 27/239 (11%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L IG G + V L +VA+K I +L E V+ L+H NL
Sbjct: 24 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNL 76
Query: 106 IKFLQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHE 161
++ L + + +YI+ EY KGSL+D +R G K+ + +A+ Y
Sbjct: 77 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY--ASPE 219
VHRD+ N+L+ D K+SDFG + ++ G +PE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDT---------GKLPVKWTAPE 184
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
L+ + + SDVWS G++L+ + FGR+P+ ++ +V+ P
Sbjct: 185 ALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 40/240 (16%)
Query: 30 LPDADGKMTVLESHGYTLGTIIGMGSYATVKLA----TSSRHSCEVAIKIISKMQAPSDY 85
L G TV +G G + V L T+ VA+K + K A +
Sbjct: 18 LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQH 76
Query: 86 LKKFLPREVEVVKGLKHPNLIKFLQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDET 143
+ +E+++++ L H ++IK+ E + ++MEY GSL D + + I
Sbjct: 77 RSGWK-QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLA 134
Query: 144 RARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSR 199
+ + Q+ + + Y H + +HRD+ N+L+D D +K+ DFG A+ H YR R
Sbjct: 135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 200 QGY---------ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLP 249
+ E L E + YA SDVWS GV L+ ++
Sbjct: 195 EDGDSPVFWYAPECLKE---YKFYYA--------------SDVWSFGVTLYELLTHCDSS 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 15/235 (6%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L +G G + V + T + VAIK + K S + FL +E +V+K L+H L
Sbjct: 270 RLEVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMS--PEAFL-QEAQVMKKLRHEKL 324
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
++ + + +YI+ EY KGSLLD ++ E + AQ+ + Y
Sbjct: 325 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
VHRD++ N+L+ + K++DFG A R Y + + +PE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLA----RLIEDNEYTARQGAKF-PIKWTAPEAALY 438
Query: 224 IPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + SDVWS G++L + GR+P+ ++L QV+ P P
Sbjct: 439 GRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 23/239 (9%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L +G G + V + +VA+K + K + S FL E ++K L+H L
Sbjct: 16 KLVERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSP--DAFL-AEANLMKQLQHQRL 70
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
++ L A+ T +YII EY E GSL+D ++ I T + AQ+ + + + ER
Sbjct: 71 VR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAY--ASPE 219
+HRD++ N+L+ + K++DFG AR Y +R+G + +PE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG---------AKFPIKWTAPE 180
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + + SDVWS G++L +V GR+P+ ++++ ++ + N E
Sbjct: 181 AINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 68/239 (28%), Positives = 124/239 (51%), Gaps = 23/239 (9%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L +G G + V +AT ++H+ +VA+K + K + S ++ FL E V+K L+H L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTM-KPGSMS--VEAFL-AEANVMKTLQHDKL 245
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHERG 163
+K L A+ T +YII E+ KGSLLD ++ + + + + AQ+ + + + +R
Sbjct: 246 VK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFAR--NHMRYRSRQGYESLSETFCGSYAY--ASPE 219
+HRD++ N+L+ A K++DFG AR Y +R+G + +PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG---------AKFPIKWTAPE 355
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + + SDVWS G++L +V +GR+P+ ++++ ++ P+ N E
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 413
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 38/238 (15%)
Query: 46 TLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
T +IG G + V S + VAIK + K FL E ++
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQFS 104
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCH 160
H N+I+ I + II EY E G+L +R+ +G + + + Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSE 207
VHRD+ N+L++++ K+SDFG +R + + G E++S
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS- 223
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
+ A SDVWS G+V++ M +G P+ + +++K +
Sbjct: 224 --YRKFTSA--------------SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 68/344 (19%), Positives = 125/344 (36%), Gaps = 90/344 (26%)
Query: 47 LGTIIGMGSYATVKLATS--SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
G +G G+Y V A + + A+K I RE+ +++ LKHPN
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPN 79
Query: 105 LIKFLQAIETTH---RVYIIMEYAEK--GSLLDIIRKEGY------IDETRARKWFAQLV 153
+I LQ + +H +V+++ +YAE ++ R + + Q++
Sbjct: 80 VIS-LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYN----IKLSDFGFARNHMRYRSRQGYESLSETF 209
D I+Y H V+HRD+K N+L+ + +K++D GFAR + S +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL---------FNSPLKPL 189
Query: 210 CGSYA------YASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGR--------------- 247
Y +PE+L G Y + D+W++G + ++
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 248 --------------------------LP-----FDDTKYSQLLKQVQSKVVFPKDPNVSP 276
+P D + + K +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 277 ECKALISKILA--PVKTRLRIKNIKEDPWFRNGPSRPEYPIMSG 318
+ L+ K+L P+K R+ + +DP+F P P + +G
Sbjct: 309 KAFHLLQKLLTMDPIK-RITSEQAMQDPYFLEDP-LPTSDVFAG 350
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 48/249 (19%), Positives = 105/249 (42%), Gaps = 37/249 (14%)
Query: 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFL 90
D K+ + + +G G++ +V+ + +VAIK++ K ++ +
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM 384
Query: 91 PREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWF 149
RE +++ L +P +++ L + + ++ME A G L + I + +
Sbjct: 385 -REAQIMHQLDNPYIVR-LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY--- 202
Q+ + Y E+ VHR++ N+L+ + K+SDFG ++ + Y +R
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 203 ------ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKY 255
E ++ ++ SDVWS GV ++ A+ +G+ P+ K
Sbjct: 503 LKWYAPECIN---FRKFSSR--------------SDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 256 SQLLKQVQS 264
+++ ++
Sbjct: 546 PEVMAFIEQ 554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 35/245 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
TL +G G + VKL + +VA+K+I K + S+ +F +E + + L HP L
Sbjct: 11 TLLKELGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMSE--DEFF-QEAQTMMKLSHPKL 65
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGV 164
+KF + +YI+ EY G LL+ +R G ++ ++ + + + + +
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGY---------ESLSETFCGSY 213
+HRD+ N L+D D +K+SDFG R + Y S G E Y
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH---YFKY 182
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+ SDVW+ G++++ + G++P+D S+++ +V +
Sbjct: 183 SSK--------------SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 273 NVSPE 277
S
Sbjct: 229 LASDT 233
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T IG G + V L + +VAIK I + A S+ + F+ E EV+ L HP L
Sbjct: 11 TFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSE--EDFI-EEAEVMMKLSHPKL 65
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
++ + ++ E+ E G L D +R G + + + Y E V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGY---------ESLSETFCGSY 213
+HRD+ N L+ + IK+SDFG R + Y S G E S Y
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF---SRY 182
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
+ SDVWS GV+++ + G++P+++ S++++ + +
Sbjct: 183 SSK--------------SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 37/237 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
++ ++G G + V +L S+ VAIK + K+ + FL E ++ H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE 161
PN+I+ + + V I+ EY E GSL +RK + + + + Y +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFAR----NHMRYRSRQGY---------ESLSET 208
G VHRD+ N+LI+++ K+SDFG R + + +G E+++
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY- 224
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF-AMVFGRLPFDDTKYSQLLKQVQS 264
+ A SDVWS G+VL+ M +G P+ + ++K V
Sbjct: 225 --RKFTSA--------------SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 51/260 (19%), Positives = 99/260 (38%), Gaps = 46/260 (17%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
TLG ++G G + +V +L +VA+K++ S +++FL RE +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDH 84
Query: 103 PNLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK-----WFA- 150
P++ K + +A +I+ + + G L + + F
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQG------ 201
+ + Y R +HRD+ N ++ D + ++DFG +R YR
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 202 ---YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQ 257
ESL++ Y SDVW+ GV ++ ++ G+ P+ + ++
Sbjct: 205 WLALESLAD---NLYTVH--------------SDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 258 LLKQVQSKVVFPKDPNVSPE 277
+ + + P E
Sbjct: 248 IYNYLIGGNRLKQPPECMEE 267
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 58/301 (19%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT +IG GS+ V A S EVAIK K+ K+F RE+++++ +KHPN
Sbjct: 42 YTNCKVIGNGSFGVVFQAKL-VESDEVAIK---KVLQD----KRFKNRELQIMRIVKHPN 93
Query: 105 LIKFLQAIETT------HRVYIIMEYAE---KGSLLDIIRKEGYIDETRARKWFAQLVDA 155
++ + + +++EY + + + + + + QL+ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 156 INYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+ Y H G+ HRDIK +NLL+D +KL DFG A+ + Y C Y
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY------ICSRY- 206
Query: 215 YASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQ--------- 263
Y +PE++ G Y + D+WS G V+ ++ G+ F ++ QL++ ++
Sbjct: 207 YRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 264 --------SKVVFPK----------DPNVSPECKALISKILA--PVKTRLRIKNIKEDPW 303
+ FP+ P P+ LIS++L P RL P+
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA-RLTAIEALCHPF 324
Query: 304 F 304
F
Sbjct: 325 F 325
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 61/285 (21%), Positives = 97/285 (34%), Gaps = 49/285 (17%)
Query: 21 NMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSY-----ATVKLATSSRHSCEVAIKI 75
N EY D+ D + T+ +G GS+ K VAIK
Sbjct: 5 NPEYFSAADVYVPDEW--EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 76 ISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR 135
+ A +FL E V+K ++++ L + +IME +G L +R
Sbjct: 63 V-NEAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 136 KEGYIDETRAR----------KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185
+ ++ D + Y + VHRD+ N ++ D+ +K+
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180
Query: 186 DFGFARNHMR---YRSRQGY---------ESLSETFCGSYAYASPEILKGIPYCPQLSDV 233
DFG R+ YR ESL + G + SDV
Sbjct: 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD---GVFTTY--------------SDV 223
Query: 234 WSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
WS GVVL+ + P+ Q+L+ V + K N
Sbjct: 224 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 53/225 (23%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHP 103
+ L ++G G+Y V + AIK++ + +K+ E+ ++K H
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 81
Query: 104 NLIKFL------QAIETTHRVYIIMEYAEKGSLLDIIR--KEGYIDETRARKWFA----Q 151
N+ + +++++ME+ GS+ D+I+ K + E +W A +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE----EWIAYICRE 137
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCG 211
++ +++ H+ V+HRDIK +N+L+ + +KL DFG + R R+ TF G
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN------TFIG 191
Query: 212 SYAYASPEILKGIPYCP----QLSDVWSMGVVLFAMVFGRLPFDD 252
+ + +PE++ SD+WS+G+ M G P D
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 54/245 (22%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
T +G G + VK R +VAIK+I K + S+ +F+ E +V+ L H L
Sbjct: 27 TFLKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSE--DEFI-EEAKVMMNLSHEKL 81
Query: 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGV 164
++ ++II EY G LL+ +R+ + + + +A+ Y +
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMR--YRSRQGY---------ESLSETFCGSY 213
+HRD+ N L++ +K+SDFG +R + Y S G E L +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY---SKF 198
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+ SD+W+ GV+++ + G++P++ S+ + + + +
Sbjct: 199 SSK--------------SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244
Query: 273 NVSPE 277
S +
Sbjct: 245 LASEK 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL 105
L IG G + V L +VA+K I + FL E V+ L+H NL
Sbjct: 196 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFL-AEASVMTQLRHSNL 248
Query: 106 IKFLQAIETTHR--VYIIMEYAEKGSLLDIIRKEGYIDETRAR--KWFAQLVDAINYCHE 161
++ L + + +YI+ EY KGSL+D +R G K+ + +A+ Y
Sbjct: 249 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY--ASPE 219
VHRD+ N+L+ D K+SDFG + ++ G +PE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDT---------GKLPVKWTAPE 356
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQS 264
L+ + + SDVWS G++L+ + FGR+P+ ++ +V+
Sbjct: 357 ALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 49/259 (18%), Positives = 96/259 (37%), Gaps = 45/259 (17%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
LG I+G G + +V L S +VA+K + + +++FL E +K H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSH 95
Query: 103 PNLIKFL-----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK-----WFA-Q 151
PN+I+ L + + + +I+ + + G L + + F
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQG------- 201
+ + Y R +HRD+ N ++ D + ++DFG ++ YR +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 202 --YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQL 258
ESL++ Y SDVW+ GV ++ + G P+ + ++
Sbjct: 216 IAIESLAD---RVYTSK--------------SDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 259 LKQVQSKVVFPKDPNVSPE 277
+ + + E
Sbjct: 259 YDYLLHGHRLKQPEDCLDE 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 48/261 (18%)
Query: 46 TLGTIIGMGSYATVKLATSSRHSCE--VAIKIISKMQAPSDYLKKFLPREVEVVKGL-KH 102
+IG G++ V A + AIK + K A D + F E+EV+ L H
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLGHH 85
Query: 103 PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN----- 157
PN+I L A E +Y+ +EYA G+LLD +RK ++ A ++
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 158 -----------YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG----- 201
Y ++ +HRD+ N+L+ +Y K++DFG +R Y +
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 202 ----YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYS 256
ESL+ + + SDVWS GV+L+ +V G P+ +
Sbjct: 206 RWMAIESLNYSVYTTN-----------------SDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 257 QLLKQVQSKVVFPKDPNVSPE 277
+L +++ K N E
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDE 269
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP 103
Y L +G G Y+ V A + ++ +V +KI+ ++ KK RE+++++ L+ P
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIK-REIKILENLRGGP 91
Query: 104 NLIKFLQAI--ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
N+I + + ++ E+ + + + + R + +++ A++YCH
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 148
Query: 162 RGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
G++HRD+K N++ID ++ ++L D+G A + + S + PE+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-------VASRYFKGPEL 201
Query: 221 LKGIP-YCPQLSDVWSMGVVLFAMVFGRLPF---DDTKYSQLLK 260
L Y L D+WS+G +L +M+F + PF D Y QL++
Sbjct: 202 LVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDN-YDQLVR 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 40/209 (19%)
Query: 70 EVAIKIISKMQAPSDY--LKKFLPREVEVVKGLKHPNLIKFL-QAIETTHR--VYIIMEY 124
VA+K ++ M + ++F +E++V+ +H NL++ L + + VY Y
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFD-QEIKVMAKCQHENLVELLGFSSDGDDLCLVY---VY 111
Query: 125 AEKGSLLDIIRKEGYID----ETR-------ARKWFAQLVDAINYCHERGVVHRDIKCEN 173
GSLLD + R A IN+ HE +HRDIK N
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GINFLHENHHIHRDIKSAN 163
Query: 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQL--- 230
+L+D + K+SDFG AR + ++ G+ AY +PE L+G ++
Sbjct: 164 ILLDEAFTAKISDFGLARAS----EKFAQTVMTSRIVGTTAYMAPEALRG-----EITPK 214
Query: 231 SDVWSMGVVLFAMVFGRLPFDDTKYSQLL 259
SD++S GVVL ++ G D+ + QLL
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+ V A + VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 85
Query: 105 LIKFLQAI------ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+I L E VYI+ME + +L +I+ E +D R Q++ I +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKH 142
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---- 214
H G++HRD+K N+++ +D +K+ DFG AR + Y
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-----------TSFMMTPYVVTRY 191
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262
Y +PE++ G+ Y + D+WS+G ++ M+ G + F T + +V
Sbjct: 192 YRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 49/252 (19%), Positives = 90/252 (35%), Gaps = 39/252 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+IG G + V L + A+K + + +FL E ++K H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149
Query: 103 PNLIKFLQAI-ETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCH 160
PN++ L + +++ Y + G L + IR E + + Q+ + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFAR-----NHMRYRSRQGY---------ESLS 206
+ VHRD+ N ++D + +K++DFG AR ++ G ESL
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSK 265
+ SDVWS GV+L+ ++ G P+ D + +
Sbjct: 270 T---QKFTTK--------------SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 266 VVFPKDPNVSPE 277
+
Sbjct: 313 RRLLQPEYCPDP 324
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQ 110
IG G++ V A + +VA+K + M+ + RE+++++ LKH N++ L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVN-LI 82
Query: 111 AIETTHR---------VYIIMEYAEK--GSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
I T +Y++ ++ E LL + ++ L++ + Y
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----- 214
H ++HRD+K N+LI D +KL+DFG AR + + Y
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLAR---------AFSLAKNSQPNRYTNRVVT 191
Query: 215 --YASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGR 247
Y PE+L G Y P + D+W G ++ M
Sbjct: 192 LWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 42/245 (17%), Positives = 85/245 (34%), Gaps = 48/245 (19%)
Query: 46 TLGTIIGMGSYATVKLAT-------SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
+G G++ + H EV +K++ K A +Y + F ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFF-EAASMMS 67
Query: 99 GLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAIN 157
L H +L+ ++ E+ + GSL ++K I+ + QL A++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 158 YCHERGVVHRDIKCENLLIDADYN--------IKLSDFGFARNHMRYRSRQGY------- 202
+ E ++H ++ +N+L+ + + IKLSD G + +
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT---VLPKDILQERIPWV 184
Query: 203 --ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLL 259
E + + A +D WS G L+ + G P + L
Sbjct: 185 PPECIE--NPKNLNLA--------------TDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 260 KQVQS 264
+ +
Sbjct: 229 QFYED 233
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 39/252 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+IG G + V + +++ + AIK + ++ FL RE +++GL H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRGLNH 81
Query: 103 PNLIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCH 160
PN++ + + ++++ Y G LL IR + Q+ + Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGY-----------ESLS 206
E+ VHRD+ N ++D + +K++DFG AR+ + Y +Q ESL
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSK 265
+ SDVWS GV+L+ ++ G P+ L +
Sbjct: 202 T---YRFTTK--------------SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
Query: 266 VVFPKDPNVSPE 277
P+
Sbjct: 245 RRLPQPEYCPDS 256
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 50/252 (19%), Positives = 89/252 (35%), Gaps = 39/252 (15%)
Query: 46 TLGTIIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102
+IG G + V L + A+K + + +FL E ++K H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85
Query: 103 PNLIKFLQAI-ETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCH 160
PN++ L + +++ Y + G L + IR E + + Q+ + Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGY-----------ESLS 206
+ VHRD+ N ++D + +K++DFG AR+ Y ESL
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 207 ETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSK 265
+ SDVWS GV+L+ ++ G P+ D + +
Sbjct: 206 T---QKFTTK--------------SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 266 VVFPKDPNVSPE 277
+
Sbjct: 249 RRLLQPEYCPDP 260
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 29/254 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+ V A + VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 122
Query: 105 LIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+I L + +E VY++ME + +L +I+ E +D R Q++ I +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKH 179
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---- 214
H G++HRD+K N+++ +D +K+ DFG AR + Y
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-----------TSFMMTPYVVTRY 228
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP-- 272
Y +PE++ G+ Y + D+WS+G ++ MV ++ F Y +V ++ P
Sbjct: 229 YRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 273 -NVSPECKALISKI 285
+ P + +
Sbjct: 288 KKLQPTVRNYVENR 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 68/274 (24%), Positives = 109/274 (39%), Gaps = 61/274 (22%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
LG +G G + V AT VA+K++ K A L+ L E V+K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL-SEFNVLKQV 83
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-----EGYIDETRARKWFAQ---- 151
HP++IK A + +I+EYA+ GSL +R+ GY+ +R +
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 152 -----LVDAINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR- 195
+ D I++ E +VHRD+ N+L+ +K+SDFG +R+
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 196 --YRSRQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
Y R ESL + + SDVWS GV+L+ +V
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-----------------SDVWSFGVLLWEIV 246
Query: 245 -FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
G P+ +L +++ + N S E
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEE 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y T +G G+Y +V A R +VAIK +S+ + K+ RE+ ++K ++H N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 84
Query: 105 LIKFLQAIETTHR------VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+I L Y++M + + L I+ + E + + Q++ + Y
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHM------RYRSRQGYESLSETF 209
H GVVHRD+K NL ++ D +K+ DFG AR M R+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW------------- 188
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y +PE++ + Q D+WS+G ++ M+ G+ F
Sbjct: 189 -----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT + IG G+Y V A + + VAIK IS + + + RE++++ +H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 105 LIKFL-----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
+I IE VYI+ + E L +++ + ++ + Q++ + Y
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----Y 215
H V+HRD+K NLL++ ++K+ DFG AR G+ L+E Y Y
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF--LTE-----YVATRWY 197
Query: 216 ASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
+PEI+ + D+WS+G +L M+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 76/305 (24%), Positives = 124/305 (40%), Gaps = 65/305 (21%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT +IG GS+ V A VAIK K+ K+F RE+++++ L H N
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQD----KRFKNRELQIMRKLDHCN 108
Query: 105 LIKFLQAIETTHR------VYIIMEYAEKGSLLDIIRKEG----YIDETRARKWFAQLVD 154
+++ ++ + ++++Y + ++ + R + + + QL
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 155 AINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
++ Y H G+ HRDIK +NLL+D D +KL DFG A+ +R Y C Y
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY------ICSRY 221
Query: 214 AYASPEILKG-IPYCPQLSDVWSMGVVLFAMVFGRLPF---------------------- 250
Y +PE++ G Y + DVWS G VL ++ G+ F
Sbjct: 222 -YRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 251 ---------DDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA--PVKTRLRIKNIK 299
+ K+ Q+ +KV P PE AL S++L P RL
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFR---PRTPPEAIALCSRLLEYTPTA-RLTPLEAC 335
Query: 300 EDPWF 304
+F
Sbjct: 336 AHSFF 340
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L +++G G+Y V AT VAIK I P L+ RE++++K KH N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 105 LIKFLQAIETTHR-----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINY 158
+I VYII E + L +I + D+ ++F Q + A+
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHI--QYFIYQTLRAVKV 127
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA---- 214
H V+HRD+K NLLI+++ ++K+ DFG AR + + ++ +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
Y +PE++ + DVWS G +L + R
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 50/266 (18%), Positives = 95/266 (35%), Gaps = 53/266 (19%)
Query: 46 TLGTIIGMGSY-----ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
+G + + + VAIK + K +A ++F E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFR-HEAMLRARL 69
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQLVD 154
+HPN++ L + + +I Y G L + + G D+ R K + D
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 155 AINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQG 201
++ VVH+D+ N+L+ N+K+SD G R Y+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 202 ---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFD 251
E++ G ++ SD+WS GVVL+ + +G P+
Sbjct: 190 SLLPIRWMAPEAI---MYGKFSID--------------SDIWSYGVVLWEVFSYGLQPYC 232
Query: 252 DTKYSQLLKQVQSKVVFPKDPNVSPE 277
+++ ++++ V P +
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAW 258
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 64/269 (23%), Positives = 113/269 (42%), Gaps = 56/269 (20%)
Query: 46 TLGTIIGMGSYATVKLAT-------SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
TLG +G G++ V +A + + VA+K++ K A L + E+E++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQ 151
+ KH N+I L A +Y+I+EYA KG+L + +R E D R +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 152 LVDAINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRS 198
D ++ + + +HRD+ N+L+ + +K++DFG AR+ Y+
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 199 RQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRL 248
E+L + Y + + SDVWS GV+++ + G
Sbjct: 216 TTNGRLPVKWMAPEALFD---RVY---THQ-----------SDVWSFGVLMWEIFTLGGS 258
Query: 249 PFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
P+ +L K ++ K N + E
Sbjct: 259 PYPGIPVEELFKLLKEGHRMDKPANCTNE 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 56/269 (20%)
Query: 46 TLGTIIGMGSYATVKLAT-------SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
TLG +G G + V +A + + VA+K++ K A L + E+E++K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQ 151
+ KH N+I L A +Y+I+EYA KG+L + +R E D R +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 152 LVDAINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRS 198
D ++ + + +HRD+ N+L+ + +K++DFG AR+ Y+
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 199 RQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRL 248
E+L F Y + + SDVWS GV+++ + G
Sbjct: 262 TTNGRLPVKWMAPEAL---FDRVY---THQ-----------SDVWSFGVLMWEIFTLGGS 304
Query: 249 PFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
P+ +L K ++ K N + E
Sbjct: 305 PYPGIPVEELFKLLKEGHRMDKPANCTNE 333
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 58/234 (24%), Positives = 110/234 (47%), Gaps = 38/234 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G+Y +V A ++ VA+K +S+ + K+ RE+ ++K +KH N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 89
Query: 105 LIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAIN 157
+I L +++E + VY++ L +I++ + D+ ++ Q++ +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHV--QFLIYQILRGLK 146
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHM------RYRSRQGYESLSET 208
Y H ++HRD+K NL ++ D +K+ DFG AR + M R+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW------------ 194
Query: 209 FCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262
Y +PEI+ + Q D+WS+G ++ ++ GR F T + LK +
Sbjct: 195 ------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +IG GSY V A VAIK I ++ K+ L RE+ ++ L H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDH 113
Query: 105 LIKFL-----QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
++K L + +E +Y+++E A+ + R Y+ E + L+ + Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----- 214
H G++HRD+K N L++ D ++K+ DFG AR + +S
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 215 ----------------YASPEILKGIPYCPQLSDVWSMG 237
Y +PE++ + DVWS+G
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 57/270 (21%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
+ G +G G++ V AT S + VA+K++ K A + + E++V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM-SELKVLSYL 83
Query: 101 -KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-----------EGYIDETRARKW 148
H N++ L A +I EY G LL+ +R+ +++
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 149 FAQLVD-AI------NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHMRYRS 198
L+ + + + +HRD+ N+L+ K+ DFG AR N Y
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 199 RQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRL 248
+ ES+ SDVWS G+ L+ + G
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFE-----------------SDVWSYGIFLWELFSLGSS 246
Query: 249 PFDD-TKYSQLLKQVQSKVVFPKDPNVSPE 277
P+ S+ K ++ + E
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/267 (24%), Positives = 110/267 (41%), Gaps = 52/267 (19%)
Query: 46 TLGTIIGMGSYATVKLAT-------SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
LG +G G++ V LA +VA+K++ K A L + E+E++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129
Query: 99 GL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQ 151
+ KH N+I L A +Y+I+EYA KG+L + ++ E + + +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 152 LVDAINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRS 198
D ++ + + +HRD+ N+L+ D +K++DFG AR+ Y+
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 199 RQGYESLSETFCGSYAYA-------SPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPF 250
+PE L Y Q SDVWS GV+L+ + G P+
Sbjct: 250 TTN--------------GRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 294
Query: 251 DDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+L K ++ K N + E
Sbjct: 295 PGVPVEELFKLLKEGHRMDKPSNCTNE 321
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 54/269 (20%), Positives = 100/269 (37%), Gaps = 56/269 (20%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
LG +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 87
Query: 101 -KHPNLIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQL 152
H N++ L A + + +I+E+ + G+L +R + K F L
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 153 VDAINYCH----------ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSR 199
I Y R +HRD+ N+L+ +K+ DFG AR+ + Y +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 200 QG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLP 249
E++ F Y SDVWS GV+L+ + G P
Sbjct: 208 GDARLPLKWMAPETI---FDRVYTIQ--------------SDVWSFGVLLWEIFSLGASP 250
Query: 250 F-DDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+ + ++++ +PE
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE 279
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 30/246 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +IG GSY V LA VAIK +++M K+ L RE+ ++ LK
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDY 86
Query: 105 LIKFLQAIETTHR-----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
+I+ I +YI++E A+ L + + ++ E + L+ N+
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA----- 214
HE G++HRD+K N L++ D ++K+ DFG AR + L E
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 215 -----------YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ 263
Y +PE++ + D+WS G + ++ + ++
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR------ 259
Query: 264 SKVVFP 269
+FP
Sbjct: 260 -FPLFP 264
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y +G G+Y V A R +VAIK + + + K+ RE+ ++K ++H N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 85
Query: 105 LIKFL------QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+I L + ++ Y++M + L +++ E + E R + Q++ + Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NHM------RYRSRQGYESLSETF 209
H G++HRD+K NL ++ D +K+ DFG AR + M R+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW------------- 190
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
Y +PE++ Q D+WS+G ++ M+ G+ F
Sbjct: 191 -----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/260 (20%), Positives = 87/260 (33%), Gaps = 47/260 (18%)
Query: 46 TLGTIIGMGSY-----ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
TL +G G++ V + +VA+K + FL E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 90
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV------- 153
H N+++ + + +I+ME G L +R+ + L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 154 DAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARNHMR--YRSRQGY------ 202
Y E +HRDI N L+ K+ DFG AR+ R Y + G
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 203 ----ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQ 257
E+ E S +D WS GV+L+ + G +P+ +
Sbjct: 211 WMPPEAFMEGIFTSK-----------------TDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 258 LLKQVQSKVVFPKDPNVSPE 277
+L+ V S N
Sbjct: 254 VLEFVTSGGRMDPPKNCPGP 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 55/267 (20%), Positives = 102/267 (38%), Gaps = 56/267 (20%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVK 98
L +G G++ V LA ++ VA+K + + A D+ RE E++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-----REAELLT 72
Query: 99 GLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWF--------- 149
L+H +++KF + ++ EY + G L +R G
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 150 -------AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSR 199
+Q+ + Y + VHRD+ N L+ A+ +K+ DFG +R+ YR
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 200 QGYESLSETFCGSYAYA-------SPE-ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPF 250
PE I+ + + SDVWS GV+L+ + +G+ P+
Sbjct: 193 GH--------------TMLPIRWMPPESIMYRK-FTTE-SDVWSFGVILWEIFTYGKQPW 236
Query: 251 DDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+++++ + V + E
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCPKE 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 53/266 (19%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
G +G G++ V AT +VA+K++ K A +D + + E++++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHL 106
Query: 101 -KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRAR------------- 146
+H N++ L A V +I EY G LL+ +R++ + ET
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 147 -KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQG- 201
+ +Q+ + + + +HRD+ N+L+ + K+ DFG AR+ M Y +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 202 --------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDD 252
ES+ F Y SDVWS G++L+ + G P+
Sbjct: 227 RLPVKWMAPESI---FDCVYTVQ--------------SDVWSYGILLWEIFSLGLNPYPG 269
Query: 253 TK-YSQLLKQVQSKVVFPKDPNVSPE 277
S+ K V+ +
Sbjct: 270 ILVNSKFYKLVKDGYQMAQPAFAPKN 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 53/265 (20%), Positives = 92/265 (34%), Gaps = 53/265 (20%)
Query: 46 TLGTIIGMGSY-----ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
L +G G++ A + VA+K + + A + F RE E++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQ-REAELLTML 100
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKW--------FAQL 152
+H ++++F + ++ EY G L +R G + A QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 153 VDAI-------NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQGY 202
+ Y VHRD+ N L+ +K+ DFG +R+ YR
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 203 ---------ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDD 252
ES+ + SDVWS GVVL+ + +G+ P+
Sbjct: 221 MLPIRWMPPESILY---RKFTTE--------------SDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 253 TKYSQLLKQVQSKVVFPKDPNVSPE 277
++ + + + PE
Sbjct: 264 LSNTEAIDCITQGRELERPRACPPE 288
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-24
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y +G G V A + VAIK I + P RE+++++ L H N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQSVKHAL--REIKIIRRLDHDN 69
Query: 105 LIKFLQAIETTHR--------------VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA 150
++K + + + VYI+ EY E L +++ + G + E AR +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMY 127
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGYESLSETF 209
QL+ + Y H V+HRD+K NL I+ D +K+ DFG AR + S +G+ LSE
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH--LSE-- 183
Query: 210 CGSYA----YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
Y SP +L + D+W+ G + M+ G+
Sbjct: 184 ---GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 31/221 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP--------REVEV 96
YT+ I GSY V S VAIK + + + RE+ +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 97 VKGLKHPNLIKFLQAIETTHR-----VYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFA 150
+ HPN++ +Y++ E L +I + I + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFC 210
++ ++ HE GVVHRD+ N+L+ + +I + DF AR E ++
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADANK 190
Query: 211 GSYA----YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
Y Y +PE++ +L D+WS G V+ M +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 72/280 (25%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
G ++G G++ V AT + S +VA+K++ K +A S + + E++++ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM-SELKMMTQL 105
Query: 101 -KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-------EGYIDETRARKWFAQL 152
H N++ L A + +Y+I EY G LL+ +R + E + R +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 153 VDAIN----------------YCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR---NH 193
++ + + + VHRD+ N+L+ +K+ DFG AR +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 194 MRYRSRQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
Y R ESL E SDVWS G++L+ +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIK-----------------SDVWSYGILLWEIF 268
Query: 245 -FGRLPFDDTKY------SQLLKQVQSKVVFPKDPNVSPE 277
G P Y + K +Q+ + + E
Sbjct: 269 SLGVNP-----YPGIPVDANFYKLIQNGFKMDQPFYATEE 303
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 51/260 (19%), Positives = 87/260 (33%), Gaps = 47/260 (18%)
Query: 46 TLGTIIGMGSY-----ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
TL +G G++ V + +VA+K + FL E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 131
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV------- 153
H N+++ + + +I++E G L +R+ + L+
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 154 DAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARNHMR--YRSRQGY------ 202
Y E +HRDI N L+ K+ DFG AR+ R Y + G
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 203 ----ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQ 257
E+ E S +D WS GV+L+ + G +P+ +
Sbjct: 252 WMPPEAFMEGIFTSK-----------------TDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 258 LLKQVQSKVVFPKDPNVSPE 277
+L+ V S N
Sbjct: 295 VLEFVTSGGRMDPPKNCPGP 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 55/274 (20%), Positives = 95/274 (34%), Gaps = 61/274 (22%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
IG G++ V A VA+K++ K +A +D F RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEF 107
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN--- 157
+PN++K L + ++ EY G L + +R ++
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 158 ---------------------YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR- 195
Y ER VHRD+ N L+ + +K++DFG +RN
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 196 --YRSRQG---------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV 244
Y++ ES+ Y SDVW+ GVVL+ +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFY---NRYTTE--------------SDVWAYGVVLWEIF 270
Query: 245 -FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
+G P+ + +++ V+ + N E
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLE 304
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 71/311 (22%), Positives = 119/311 (38%), Gaps = 68/311 (21%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--- 101
+ + + G G++ TV+L VAIK + +Q P + RE+++++ L
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRF--RN---RELQIMQDLAVLH 77
Query: 102 HPNLIKFLQAIETTHR-------VYIIMEYAEKGSLLDIIRKEGYIDETRAR---KWFA- 150
HPN+++ T + ++MEY +L R K F
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 151 QLVDAINYCHER--GVVHRDIKCENLLID-ADYNIKLSDFGFARNHMRYRSRQGYESLSE 207
QL+ +I H V HRDIK N+L++ AD +KL DFG A+ E
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP------SEPNVA 190
Query: 208 TFCGSYAYASPEILKG-IPYCPQLSDVWSMGVVLFAMVFGR------------------- 247
C Y Y +PE++ G Y + D+WS+G + M+ G
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248
Query: 248 -------LPFDDTKYSQL----LKQVQSKVVFPK-DPNVSPECKALISKILA--PVKTRL 293
L + ++ + K + VF + E L+S +L P + R+
Sbjct: 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE-RM 307
Query: 294 RIKNIKEDPWF 304
+ P+F
Sbjct: 308 KPYEALCHPYF 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 49 TIIGMGSYATV---KLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHP 103
+IG G + V L + +VA+K + Q +++F E+E + +HP
Sbjct: 45 FLIGHGVFGKVYKGVLRDGA----KVALKRRTPESSQG----IEEFE-TEIETLSFCRHP 95
Query: 104 NLIKFL-QAIETTHR--VYIIMEYAEKGS----LLDIIRKEGYID-ETR-------ARKW 148
+L+ + E +Y +Y E G+ L + E R AR
Sbjct: 96 HLVSLIGFCDERNEMILIY---KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-- 150
Query: 149 FAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSET 208
++Y H R ++HRD+K N+L+D ++ K++DFG + + + LS
Sbjct: 151 ------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS----KKGTELDQTHLSTV 200
Query: 209 FCGSYAYASPE-ILKGIPYCPQL---SDVWSMGVVLFAMVFGRLPFDDTK 254
G+ Y PE +KG +L SDV+S GVVLF ++ R +
Sbjct: 201 VKGTLGYIDPEYFIKG-----RLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP 103
Y L +G G+Y V + R VA+K I S ++ RE+ ++ L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 104 NLIKFLQAI--ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINYCH 160
N++ L + + VY++ +Y E L +IR + ++ QL+ I Y H
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHK--QYVVYQLIKVIKYLH 126
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA------ 214
G++HRD+K N+L++A+ ++K++DFG +R+ + R LS
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 215 ---------YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
Y +PEIL G + D+WS+G +L ++ G+
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 60/247 (24%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y+LG +G GS+ V A+K + + ++ RE++++K L H N
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMKVLDHVN 61
Query: 105 LIKFLQAIETTHR--------------------------------------VYIIMEYAE 126
+IK + TT + +IMEY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 127 KGSLLDIIRKEGYIDETRAR---KWFA-QLVDAINYCHERGVVHRDIKCENLLIDA-DYN 181
+L +++ + + QL A+ + H G+ HRDIK +NLL+++ D
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 182 IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVL 240
+KL DFG A+ + E C + Y +PE++ G Y P + D+WS+G V
Sbjct: 181 LKLCDFGSAKKLIP------SEPSVAYICSRF-YRAPELMLGATEYTPSI-DLWSIGCVF 232
Query: 241 FAMVFGR 247
++ G+
Sbjct: 233 GELILGK 239
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 54/231 (23%)
Query: 50 IIGMGSYATV---KLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLI 106
I+G G + V +LA + VA+K + + + +F EVE++ H NL+
Sbjct: 37 ILGRGGFGKVYKGRLADGT----LVAVKRLKEERTQGGE-LQFQ-TEVEMISMAVHRNLL 90
Query: 107 KFLQA--IETTHR--VYIIMEYAEKGS----LLDIIRKEGYID-ETR-------ARKWFA 150
+ L+ + T R VY Y GS L + + +D R AR
Sbjct: 91 R-LRGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---- 142
Query: 151 QLVDAINYCHERG---VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207
+ Y H+ ++HRD+K N+L+D ++ + DFG A+ + ++
Sbjct: 143 ----GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-----VTT 193
Query: 208 TFCGSYAYASPE-ILKGIPYCPQL---SDVWSMGVVLFAMVFGRLPFDDTK 254
G+ + +PE + G + +DV+ GV+L ++ G+ FD +
Sbjct: 194 AVRGTIGHIAPEYLSTG-----KSSEKTDVFGYGVMLLELITGQRAFDLAR 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 50/243 (20%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--- 101
Y + +IG GS+ V A + VA+K++ + + ++ E+ +++ L+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAA-EEIRILEHLRKQD 154
Query: 102 HPNLIKFLQAIET-THR--VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAI 156
N + + +E T R + + E +L ++I+K + RK+ ++ +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 157 NYCHERGVVHRDIKCENLLI--DADYNIKLSDFGFA----RNHMRY-RSRQGYESLSETF 209
+ H+ ++H D+K EN+L+ IK+ DFG + + Y +SR
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------- 264
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKVVF 268
Y +PE++ G Y + D+WS+G +L ++ G + + QL ++ +
Sbjct: 265 -----YRAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318
Query: 269 PKD 271
+
Sbjct: 319 SQK 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 58/253 (22%), Positives = 109/253 (43%), Gaps = 41/253 (16%)
Query: 23 EYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP 82
+Y G P G+ + Y L +G G ++TV LA ++ VA+KI+ +
Sbjct: 1 DYRPGGYHPAFKGE--PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGD 55
Query: 83 SDYLKKFLPREVEVVKGLK--------HPNLIKFLQAIET-THR------VYIIMEYAEK 127
Y + E+++++ + L+ ++ H+ V ++ E
Sbjct: 56 KVYTEAAE-DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLG 113
Query: 128 GSLLDIIRKEGY--IDETRARKWFAQLVDAINYCH-ERGVVHRDIKCENLLID------A 178
+LL +I+K + I ++ QL+ ++Y H G++H DIK EN+L++
Sbjct: 114 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173
Query: 179 DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGV 238
IK++D G A + S+ + Y SPE+L G P+ D+WS
Sbjct: 174 LIQIKIADLGNAC----WYDEHYTNSIQ-----TREYRSPEVLLGAPWGCGA-DIWSTAC 223
Query: 239 VLFAMVFGRLPFD 251
++F ++ G F+
Sbjct: 224 LIFELITGDFLFE 236
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 59/225 (26%), Positives = 89/225 (39%), Gaps = 41/225 (18%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKI-ISKMQAPSDYLKKFLPREVEVVKGLKH- 102
Y LG IG GS+ + L T EVAIK+ K + P L E ++ K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQGG 64
Query: 103 ---PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA-QLVDAINY 158
P + E + ++ME SL D+ + A Q++ I Y
Sbjct: 65 VGIPTIRWCGA--EGDYN-VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 159 CHERGVVHRDIKCENLLIDADYN---IKLSDFGFARN--------HMRYRSRQGYESLSE 207
H + +HRD+K +N L+ + + DFG A+ H+ YR +
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN------ 174
Query: 208 TFCGSYAYASPEILKGIPYCPQLS---DVWSMGVVLFAMVFGRLP 249
G+ YAS GI + S D+ S+G VL G LP
Sbjct: 175 -LTGTARYASINTHLGI----EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIIS-KMQAPSDYLKKFLPREVEVVKGLKH- 102
+ LG IG GS+ + L T+ + + EVAIK+ + K + P L E ++ + L+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ------LLYESKIYRILQGG 62
Query: 103 ---PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFA--------- 150
PN+ F E + ++M+ SL D+ RK +
Sbjct: 63 TGIPNVRWFGV--EGDYN-VLVMDLLGP-SLEDLFNFCS-------RK-LSLKTVLMLAD 110
Query: 151 QLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGFAR--------NHMRYRSR 199
Q+++ + + H + +HRDIK +N L+ + + DFG A+ H+ YR
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
+ G+ YAS GI + D+ S+G VL + G LP
Sbjct: 171 KN-------LTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLP 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 38/245 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-- 102
Y + ++IG GS+ V A VAIKII +A +L + EV +++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA---FLNQAQ-IEVRLLELMNKHD 111
Query: 103 -PNLIKFLQAIET-THR--VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAI 156
+ R + ++ E +L D++R + + RK+ Q+ A+
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 157 NYCHER--GVVHRDIKCENLLI--DADYNIKLSDFGFA----RNHMRY-RSRQGYESLSE 207
+ ++H D+K EN+L+ IK+ DFG + + +Y +SR
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------- 223
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD-DTKYSQLLKQVQSKV 266
Y SPE+L G+PY + D+WS+G +L M G F + Q+ K V+
Sbjct: 224 -------YRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 267 VFPKD 271
+ P
Sbjct: 276 IPPAH 280
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 57/234 (24%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKI-ISKMQAPSDYLKKFLPREVEVVKGLKH- 102
+ +G IG G++ ++L + + VAIK+ K +AP L E K L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ------LHLEYRFYKQLGSG 64
Query: 103 ---PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKW-------FA-Q 151
P + F + +++E SL D+ R + A Q
Sbjct: 65 DGIPQVYYFGP--CGKYN-AMVLELLGP-SLEDLFDLCD-------RTFSLKTVLMIAIQ 113
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYN-----IKLSDFGFAR--------NHMRYRS 198
L+ + Y H + +++RD+K EN LI N I + DF A+ H+ YR
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLS---DVWSMGVVLFAMVFGRLP 249
+ G+ Y S G + S D+ ++G + + G LP
Sbjct: 174 HKS-------LTGTARYMSINTHLGK----EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 44/262 (16%), Positives = 95/262 (36%), Gaps = 50/262 (19%)
Query: 45 YTLGTIIGMGSYATVKLAT--------SSRHSCEVAIKIISK----MQAPSDYLKKFLPR 92
+ L + + + A S + ++K+ +K + + + P
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 93 EVEVVKGLKHPNLIKFLQAI-----ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK 147
+V K L L+ + + +R ++++ + SL + +
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGR-SLQSALDVSP-------KH 154
Query: 148 WFA---------QLVDAINYCHERGVVHRDIKCENLLIDADY--NIKLSDFGFAR----- 191
+ +L+DA+ + HE VH ++ EN+ +D + + L+ +GFA
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 192 -NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
H+ Y E G + S ++ KG + SD+ S+G + ++G LP+
Sbjct: 215 GKHVAYV-----EGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPW 268
Query: 251 DDTKYSQLLKQVQSKVVFPKDP 272
+ ++ K F P
Sbjct: 269 TNCL-PNTEDIMKQKQKFVDKP 289
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 49/270 (18%), Positives = 90/270 (33%), Gaps = 59/270 (21%)
Query: 37 MTVLESHGYTLGTIIGMGSY-----ATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLP 91
+T + + + +G IG G + A + + S +K+ P KF
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQ 88
Query: 92 R--------EVEVVKGLKH---PNLIKF--LQAIETTHRVYIIMEYAEKGSLLDIIRKEG 138
R + + LK+ P ++R +IM+ L I
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF-MIMDRFGS-DLQKIYEANA 146
Query: 139 YIDETRARKWFA---------QLVDAINYCHERGVVHRDIKCENLLIDADYN--IKLSDF 187
++ F+ +++D + Y HE VH DIK NLL++ + L D+
Sbjct: 147 -------KR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 188 GFAR--------NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVV 239
G A ++ G+ + S + G+ + D+ +G
Sbjct: 199 GLAYRYCPEGVHKAYAADPKRC-------HDGTIEFTSIDAHNGVAPSRR-GDLEILGYC 250
Query: 240 LFAMVFGRLP----FDDTKYSQLLKQVQSK 265
+ + G LP D KY + K +
Sbjct: 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRE 280
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 51/231 (22%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKI-ISKMQAPSDYLKKFLPREVEVVKGLKH- 102
Y +G IG GS+ + T+ ++ +VAIK + AP L E K L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLAGC 65
Query: 103 ---PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKW-------FA-Q 151
PN+ F Q E H ++++ SL D++ G RK+ A Q
Sbjct: 66 TGIPNVYYFGQ--EGLHN-VLVIDLLGP-SLEDLLDLCG-------RKFSVKTVAMAAKQ 114
Query: 152 LVDAINYCHERGVVHRDIKCENLLIDADYN-----IKLSDFGFAR--------NHMRYRS 198
++ + HE+ +V+RDIK +N LI + I + DFG + H+ YR
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
++ G+ Y S G + D+ ++G V + G LP
Sbjct: 175 KKN-------LSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLP 217
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 57/243 (23%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-- 102
+ + +G G++ V L + A+K++ ++ Y + E +++K +++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAK-IEADILKKIQNDD 92
Query: 103 PNLIKFLQAIET-THR--VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAIN 157
N ++ + + +I E SL +II + Y + + +++ A+N
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 158 YCHERGVVHRDIKCEN-LLIDADY------------------------NIKLSDFGFA-- 190
Y + + H D+K EN LL D + IKL DFG A
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 191 --RNHMRY-RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR 247
H +RQ Y +PE++ + + SD+WS G VL + G
Sbjct: 212 KSDYHGSIINTRQ--------------YRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256
Query: 248 LPF 250
L F
Sbjct: 257 LLF 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 50/239 (20%), Positives = 92/239 (38%), Gaps = 53/239 (22%)
Query: 45 YTLGTIIGMGSYATVKLAT-SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH- 102
Y + +G G++ V +R +VA+KII + Y + E+ V+K +K
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAAR-LEINVLKKIKEK 76
Query: 103 --PNLIKFLQAIET-THR--VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDA 155
N + + + I E K + + +++ + R QL A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 156 INYCHERGVVHRDIKCEN-LLIDADY------------------NIKLSDFGFA----RN 192
+ + HE + H D+K EN L +++++ +I+++DFG A +
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 193 HMRY-RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250
H +R Y PE++ + + DVWS+G +LF G F
Sbjct: 196 HTTIVATRH--------------YRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 47/268 (17%)
Query: 10 QDRPRSNVWKGNMEYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSC 69
D N++ +M + +GK L D +G + LG IG G + + LA +
Sbjct: 11 VDLGTENLYFQSMPFPEGKVLDDMEGNQ-------WVLGKKIGSGGFGLIYLAFPTNKPE 63
Query: 70 EVAIKIIS----------------KMQAPSDYLKKFLPREVEVVKGLKHPNLIKF--LQA 111
+ A ++ + A D +KK++ R+ G+ P +
Sbjct: 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI--PLFYGSGLTEF 121
Query: 112 IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKC 171
++R ++ME L I + G ++ + +++D + Y HE VH DIK
Sbjct: 122 KGRSYRF-MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA 179
Query: 172 ENLLIDADYN--IKLSDFGFARN--------HMRYRSRQGYESLSETFCGSYAYASPEIL 221
NLL+ + L+D+G + + R+G G+ + S +
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG-------HNGTIEFTSLDAH 232
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLP 249
KG+ + SDV +G + + G+LP
Sbjct: 233 KGVALSRR-SDVEILGYCMLRWLCGKLP 259
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 60/305 (19%), Positives = 109/305 (35%), Gaps = 80/305 (26%)
Query: 45 YTLGTIIGMGSYATVKLAT-SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH- 102
Y + +G G++ V VA+KI+ + Y + E++V++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAAR-SEIQVLEHLNTT 71
Query: 103 --PNLIKFLQAIET-THR--VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDA 155
+ + +Q +E H + I+ E S D I++ G+ RK Q+ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 156 INYCHERGVVHRDIKCEN-LLIDADY------------------NIKLSDFGFA----RN 192
+N+ H + H D+K EN L + +DY +IK+ DFG A +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 193 HMRY-RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLF---------- 241
H +R Y +PE++ + + DVWS+G +L
Sbjct: 191 HSTLVSTRH--------------YRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFP 235
Query: 242 --------AM---VFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILAPVK 290
AM + G LP ++++ + + F D E + + K
Sbjct: 236 THDSKEHLAMMERILGPLP------KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 291 TRLRI 295
Sbjct: 290 PLKEF 294
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 53/294 (18%), Positives = 102/294 (34%), Gaps = 84/294 (28%)
Query: 23 EYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP 82
+Y KG G + Y + +G G ++TV L+ + VA+K++ +
Sbjct: 20 DYCKGGYHLVKIG--DLFNGR-YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 83 SDYLKKFLPREVEVVKGLK-----HPNLIKFLQAIET--------THRVYIIMEYAEKGS 129
++ E+ ++K ++ PN +Q ++ TH ++ E
Sbjct: 77 TETAL----DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-MVFEVLGH-H 130
Query: 130 LLDIIRKEGY--IDETRARKWFAQLVDAINYCH-ERGVVHRDIKCENLLIDAD------- 179
LL I K Y + +K Q++ ++Y H + ++H DIK EN+L+ +
Sbjct: 131 LLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190
Query: 180 ------------------------------------------YNIKLSDFGFARNHMRYR 197
+K++D G A ++
Sbjct: 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF 250
Query: 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD 251
+ + Y S E+L G Y +D+WS + F + G F+
Sbjct: 251 T---------EDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFE 294
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 26/132 (19%), Positives = 51/132 (38%), Gaps = 31/132 (23%)
Query: 147 KWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR---YRSRQG-- 201
+ Q+ + + R +HRD+ N+L+ +K+ DFG AR+ + Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 202 -------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDT 253
E++ + SDVWS GV+L+ + G P+
Sbjct: 257 LPLKWMAPETIFDRVYTIQ-----------------SDVWSFGVLLWEIFSLGASPYPGV 299
Query: 254 KY-SQLLKQVQS 264
K + ++++
Sbjct: 300 KIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 21/99 (21%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 46 TLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
LG +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 82
Query: 101 -KHPNLIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRKE 137
H N++ L A + + +I+E+ + G+L +R +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-10
Identities = 33/187 (17%), Positives = 58/187 (31%), Gaps = 48/187 (25%)
Query: 51 IGMGSYATVKLATSSRHSCEVAIKII----------SKMQAPSDYLKKFLP--------- 91
IG G + V + VAIKII S + + L + +
Sbjct: 28 IGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 92 ------------REVEVVKGLKHPNLIKFLQ-------------AIETTHRVYIIMEYAE 126
V V+G P L+K +++I++E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 127 KGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLS 185
G L+ +R + A+ QL ++ HRD+ N+L+ KL
Sbjct: 146 GGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 186 DFGFARN 192
++
Sbjct: 205 YTLNGKS 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 6e-06
Identities = 37/310 (11%), Positives = 88/310 (28%), Gaps = 81/310 (26%)
Query: 14 RSNVWKGNMEYDKGKDLPDADGKMTVLESHGYTL----GTII-GMG----SYATVKLATS 64
R ++ N + K ++ L L +I G+ ++ + + S
Sbjct: 116 RDRLYNDNQVFAKY-NVSRLQ-PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 65 SRHSCEVAIKI----ISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120
+ C++ KI + +P L E+++ L + + + + + +
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVL--------EMLQKLLYQIDPNWTSRSDHSSNIKL 225
Query: 121 IMEYAEKGSLLDIIRKEGY------IDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174
+ + + L +++ + Y + A+ +A ++ C+ L
Sbjct: 226 RIH-SIQAELRRLLKSKPYENCLLVLLNV----QNAKAWNAF-----------NLSCKIL 269
Query: 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESL----SETFCGSYAYAS-----PEILKGIP 225
L + +DF A +L ++ Y E+L P
Sbjct: 270 LTTRFKQV--TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 226 YC-----------PQLSDVWSMGVV-----LFAMVFGRLPFDDTK--YSQLLKQVQSKVV 267
D W + L + + + +L V
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL-------SV 380
Query: 268 FPKDPNVSPE 277
FP ++
Sbjct: 381 FPPSAHIPTI 390
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.83 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.48 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.6 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.13 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 83.34 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.15 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-67 Score=476.57 Aligned_cols=261 Identities=31% Similarity=0.577 Sum_probs=230.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|+++|+.++|||||+++++|++.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999997643222223456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~---- 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---- 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT----
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC----
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECKAL 281 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 281 (357)
.....+.|||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..++..++... +.+| ..+|+++++|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dl 264 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP--EKFFPKARDL 264 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--cccCHHHHHH
Confidence 234457899999999999998877 55699999999999999999999999888888777643 3333 5799999999
Q ss_pred HHHcc-cCCCCCCCHHh------HhcCCccccCCCC
Q psy10194 282 ISKIL-APVKTRLRIKN------IKEDPWFRNGPSR 310 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e------~l~hp~f~~~~~~ 310 (357)
|.+|| .||.+|||++| +++||||++..|.
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 99999 59999999988 5899999986553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-66 Score=463.46 Aligned_cols=255 Identities=35% Similarity=0.657 Sum_probs=215.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++++.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998766555555567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~------- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD------- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-------
Confidence 999 679999999999999999999999999999999999999999999999999999999999999976432
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+...+.+.+..... +.+..+|+++++||
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 243 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLI 243 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Confidence 12234678999999999999998888889999999999999999999999988888887765432 23357999999999
Q ss_pred HHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 283 SKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.+|| .||.+|||++|+++||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999 59999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-65 Score=469.40 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=227.0
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
..|++.++||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654332 355779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 223 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence 99999999999976 56999999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 280 (357)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+..... .+....+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 123456799999999999998888 5669999999999999999999999998888888776543 2333578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
||.+|| .||.+|||++|+|+||||+...
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999 5999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-65 Score=471.83 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=224.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..+++.||||++.+..... ...+.+.+|+.+|+.|+|||||++++++++++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998765544 34567789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||+||+|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--- 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---
Confidence 999999999999754 357999999999999999999999999999999999999999999999999998654211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+++.++......+.+..+|+++++
T Consensus 180 ---~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 180 ---ELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp ---HHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ---ccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 12345689999999999998887 45699999999999999999999999998888888766655666789999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
||.+|| .||.+|||++|+|+||||+...
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999 5999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=469.40 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=227.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
..|++.++||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654332 456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~------ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 300 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC------
Confidence 99999999999965 46999999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 280 (357)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+.+..+..... .+....+|+++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 123456789999999999998888 5569999999999999999999999998888888776543 3344579999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
||.+|| .||.+|||++|+|+||||+...
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999 5999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-63 Score=446.98 Aligned_cols=253 Identities=24% Similarity=0.491 Sum_probs=217.0
Q ss_pred cCE-EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe----CCe
Q psy10194 43 HGY-TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET----THR 117 (357)
Q Consensus 43 ~~y-~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~----~~~ 117 (357)
.+| ++.++||+|+||+||+|.+..++..||+|++........ ..+.+.+|+.+++.++|||||+++++|++ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 788999999999999999999999999999976554433 35667899999999999999999999965 356
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecC-CCCeEEeecccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDA-DYNIKLSDFGFARNHM 194 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~ 194 (357)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999999899999999999999999999999998 999999999999974 7999999999997432
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcccCCC-CCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQSKVVFP-KDP 272 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~~~~~~-~~~ 272 (357)
.....+.+||+.|+|||++.+ .| +.++|||||||++|+|+||+.||.+. +...+...+......+ .+.
T Consensus 184 --------~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 253 (290)
T 3fpq_A 184 --------ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp --------TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred --------CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCc
Confidence 123446789999999999875 45 66799999999999999999999764 4555666666554322 234
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.+++++++||.+|| .||.+|||++|+|+||||++
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 68899999999999 59999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-64 Score=457.26 Aligned_cols=258 Identities=26% Similarity=0.488 Sum_probs=219.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|++.+.||+|+||+||+|++. .+++.||+|++++....... ...+.+|+.+++.++|||||++++++++.+.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 367999999999999999999874 46789999999764332211 23466899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999754321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..++...+.... .+.+..+|+++
T Consensus 180 ----~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 253 (304)
T 3ubd_A 180 ----EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEA 253 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred ----CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHH
Confidence 2234567899999999999988875 56999999999999999999999999888887776543 23345799999
Q ss_pred HHHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 279 KALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
++||.+|| .||.+||| ++|+++||||++..
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 99999999 59999998 57999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=451.32 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=217.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+.|++.++||+|+||+||+|++..+|..||||+++.... ..+|+.+++.++|||||++++++.+.+.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3569999999999999999999999999999999976432 23799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||+||+|.+++++.+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999999989999999999999999999999999999999999999999988 69999999998654322111
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCCCCHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPEC 278 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 278 (357)
. .......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+...+...+..... ...++.+++++
T Consensus 209 ~-~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 209 S-LLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred c-eecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 0 112335689999999999998887 4569999999999999999999988776666666554332 12346799999
Q ss_pred HHHHHHcc-cCCCCCCCHHhH-------------hcCCccccC
Q psy10194 279 KALISKIL-APVKTRLRIKNI-------------KEDPWFRNG 307 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~-------------l~hp~f~~~ 307 (357)
.+||.+|| .||.+|||+.|+ ++|||+...
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999 599999999997 679999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-61 Score=454.55 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=224.3
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe------C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------T 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------~ 115 (357)
.++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 357999999999999999999999999999999997654433 334556799999999999999999999754 3
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+.+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67899999996 58999998888999999999999999999999999999999999999999999999999999986543
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-----
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK----- 270 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~----- 270 (357)
... .......+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+..+.+..+......+.
T Consensus 211 ~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 211 SPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred Ccc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 211 1123445689999999999999887778889999999999999999999999888777776643221111
Q ss_pred -------------------------CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 271 -------------------------DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 271 -------------------------~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+.+++++.+||.+|| .||.+|||++|+|+||||+....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1357899999999999 59999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=431.49 Aligned_cols=261 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC------
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH------ 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~------ 116 (357)
.+|++.+.||+|+||+||+|++..++..||||++.... .+...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999997643 3344566789999999999999999999986544
Q ss_pred ------eEEEEEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 117 ------RVYIIMEYAEKGSLLDIIRKEGY---IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 117 ------~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
++|+|||||+||+|.+++...+. .++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999987654 345678999999999999999999999999999999999999999999
Q ss_pred cccccccccccccc------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHH
Q psy10194 188 GFARNHMRYRSRQG------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLK 260 (357)
Q Consensus 188 g~~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~ 260 (357)
|+|+.......... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++ ||..... ...+.
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 99986543221110 0112345689999999999998877 566999999999999996 8865432 22333
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 261 QVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+......+.....++.+.+||.+|| .||.+|||+.|+++||||++..+
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 33322221222346778899999999 59999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=433.80 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=207.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCe
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHR 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~ 117 (357)
.++|++.++||+|+||+||+|+++ .+++.||+|.+.+... ...+.+|+++|+.+ +||||++++++|.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 367999999999999999999874 4678899999865432 23456899999988 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 196 (357)
+|+|||||+||+|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 49999999999999999999999999999999999999876 79999999999754321
Q ss_pred ccc----------------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-
Q psy10194 197 RSR----------------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT- 253 (357)
Q Consensus 197 ~~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~- 253 (357)
... ........+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 110 001122345689999999999988776678899999999999999999999543
Q ss_pred cHHHHHHHHhcc-----------------------------------------------------cCCCCCCCCCHHHHH
Q psy10194 254 KYSQLLKQVQSK-----------------------------------------------------VVFPKDPNVSPECKA 280 (357)
Q Consensus 254 ~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~~ 280 (357)
+..+.+..+... ........+|+++.|
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 333332222110 001123468999999
Q ss_pred HHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 281 LISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 281 li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
||++||. ||.+|+|++|+|+||||++.
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999995 99999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=426.74 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=221.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466788999999999999999999864 35778999998653 3344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE-------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~ 180 (357)
+.+.++||||||++|+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q psy10194 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLL 259 (357)
Q Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~ 259 (357)
.+||+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++.
T Consensus 166 ~~Ki~DFGla~~~~~~~~----~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp CEEECCCSCHHHHTGGGC----EEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cEEECCcccceecCCCCc----eeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999975432211 122234568999999999988877 566999999999999998 99999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 260 KQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
..+..+...+.+..+++++.+||.+|| .||++|||++++++ |+++
T Consensus 241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~ 286 (299)
T 4asz_A 241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQN 286 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence 888877776777789999999999999 59999999999954 7764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=461.89 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=218.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC---CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA---PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+.-++|++.++||+|+||.||+|++..+|..||+|++.+... ..........+++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 445789999999999999999999999999999999975321 11111222234567777889999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+|||||||+||+|.++|.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~- 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK- 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999976532
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHh-cccCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---YSQLLKQVQ-SKVVFPKDP 272 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---~~~~~~~~~-~~~~~~~~~ 272 (357)
....+.|||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ...+...+. ....+ +.
T Consensus 345 -------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~--p~ 415 (689)
T 3v5w_A 345 -------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--PD 415 (689)
T ss_dssp -------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC--CT
T ss_pred -------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC--Cc
Confidence 223467999999999999765444677999999999999999999997643 333333333 23333 35
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCCC
Q psy10194 273 NVSPECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGPS 309 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~~ 309 (357)
.+|+++++||.+|| .||.+|++ ++|+++||||++..|
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 79999999999999 59999998 799999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-59 Score=427.00 Aligned_cols=257 Identities=21% Similarity=0.372 Sum_probs=216.8
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
...+...+|.+.++||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34566789999999999999999999864 36788999998643 34445678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE---------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll 176 (357)
|.+.+.++||||||++|+|.+++... +++++.+++.|+.||+.||.|||+++|+||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY 255 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~ 255 (357)
+.++.+||+|||+++...... ........+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+.
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~----~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTD----YYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp ETTTEEEECCCC--------------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCCCcEEEcccccceeccCCC----cceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999998653221 1223345679999999999998887 566999999999999998 9999999998
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 256 SQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+.+..+..+...+.+..+++++.+|+.+|| .||.+|||+.|++++
T Consensus 267 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8888888877777777789999999999999 599999999999873
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=422.89 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=222.5
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
..+...++++.++||+|+||+||+|... .++..||||+++..... ...+.+.+|+.+++.++|||||+++++|
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3456678999999999999999999863 46778999999654322 2346678999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll 176 (357)
.+.+.++||||||++|+|.++|... ..+++.++..++.||+.||.|||+++|+||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999642 358999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY 255 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~ 255 (357)
+.++.+||+|||+++...... ........+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~----~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAAD----YYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGG----CBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred CCCCCEEECCcccceeccCCC----ceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999998653221 1223445689999999999988777 566999999999999998 8999999999
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 256 SQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.++...+..+...+.++.+++++.+|+.+|| .||.+|||+.||+++
T Consensus 254 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 254 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999888777777889999999999999 599999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=413.71 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=205.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..+++.+.++||+|+||+||+|++.. .||||+++..... ....+.+.+|+.+++.++|||||++++++.. +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3566789999999999999999998653 5999998755433 3445678899999999999999999998754 568
Q ss_pred EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999999754 579999999999999999999999999999999999999999999999999998654222
Q ss_pred cccccccccccCCCCCCccchhhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccCCC----C
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVVFP----K 270 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~~~----~ 270 (357)
. .......+||+.|+|||++.+.. .++.++|||||||++|||+||+.||.+.+.. .+...+......| .
T Consensus 187 ~----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 187 G----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred c----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 1 22334678999999999996532 3466799999999999999999999876544 4444455544433 2
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+.+++++.+||.+|| .||.+|||+.|+++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3468999999999999 59999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=445.20 Aligned_cols=257 Identities=25% Similarity=0.460 Sum_probs=226.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.++.+|..||+|++.+.. ....+.+.+|+.+|+.++||||++++++|++...+||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999997643 233566789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC--CCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD--YNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--- 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC---
Confidence 99999999999854 4679999999999999999999999999999999999999754 89999999999865422
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCC--CCCCCCH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFP--KDPNVSP 276 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 276 (357)
......+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+.... .++ ....+|+
T Consensus 311 ----~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 311 ----QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ----SEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ----CceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 22345689999999999999887 556999999999999999999999999888888876543 222 2357999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
++++||.+|| .||.+|||+.|+|+||||+...+.
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999 599999999999999999876554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=415.39 Aligned_cols=256 Identities=20% Similarity=0.342 Sum_probs=216.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCC-----CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRH-----SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~ 112 (357)
.+..++|++++.||+|+||+||+|.+... ++.||||.+..... ....+.+.+|+.+|+.+.| ||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 35568999999999999999999987653 35799999865432 2335567799999999965 9999999999
Q ss_pred Ee-CCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 113 ET-THRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 113 ~~-~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
.. ...++||||||++|+|.++|++. ..+++.++..++.||+.||.|||+++|+||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 46789999999999999999752 34899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.+||+|||+|+....... .......+||+.|+|||++.+..| +.++|||||||++|||+| |+.||.+.+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~----~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eCCCCCEEECcchhhhhcccCCC----ceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986532211 122345678999999999988877 566999999999999998 999998865
Q ss_pred -HHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 255 -YSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 255 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
...+...+..+...+.++.+++++.++|.+|| .||.+|||+.|+++|
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 45566667777777777789999999999999 599999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=399.59 Aligned_cols=260 Identities=40% Similarity=0.673 Sum_probs=230.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|.+..++..||+|++.+...... ..+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45689999999999999999999999999999999977554433 34556799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS----
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC----
Confidence 9999999999999988889999999999999999999999999999999999999999999999999999754321
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+..+....+..... ..+..+++++.+
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 243 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCEN 243 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHH
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHH
Confidence 1234568999999999999888877789999999999999999999999998888777665432 223468999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
||++|| .||.+|||++|+++||||+....
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 999999 59999999999999999987544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=395.01 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=224.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||+||+|++..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 34689999999999999999999999999999999975321111123456689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---- 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999753211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 279 (357)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...+...+... ..++ ..+++++.
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~ 233 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAK 233 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred --CCcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHH
Confidence 122345689999999999988777 45599999999999999999999998887777766543 3333 46999999
Q ss_pred HHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 280 ALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 280 ~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
+||.+|| .||.+|| +++|+++||||++..
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 9999999 5999999 899999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=400.97 Aligned_cols=261 Identities=27% Similarity=0.516 Sum_probs=221.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~ 117 (357)
.+..++|++.++||+|+||.||+|++..++..||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 46678999999999999999999999999999999999764322222234566899999988 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999753211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 276 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+.... .++ ..+++
T Consensus 178 -----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~ 249 (353)
T 3txo_A 178 -----GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHE 249 (353)
T ss_dssp -------------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCH
T ss_pred -----CccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCH
Confidence 123346789999999999987776 456999999999999999999999998888887776543 333 46999
Q ss_pred HHHHHHHHcc-cCCCCCCCH------HhHhcCCccccCC
Q psy10194 277 ECKALISKIL-APVKTRLRI------KNIKEDPWFRNGP 308 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~------~e~l~hp~f~~~~ 308 (357)
++.+||++|| .||.+||++ +++++||||++..
T Consensus 250 ~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 9999999999 599999998 8999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=402.30 Aligned_cols=262 Identities=31% Similarity=0.566 Sum_probs=221.6
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCC
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTH 116 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~ 116 (357)
..+..++|++.++||+|+||.||+|++..++..||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 446678999999999999999999999999999999999876555544556677899998876 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999753211
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHHh-ccc
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---------KYSQLLKQVQ-SKV 266 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---------~~~~~~~~~~-~~~ 266 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ....+.+.+. ...
T Consensus 207 ------~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 ------GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp ------TCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred ------CCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 123456789999999999998877 55699999999999999999999632 2223333333 233
Q ss_pred CCCCCCCCCHHHHHHHHHcc-cCCCCCCCH------HhHhcCCccccCC
Q psy10194 267 VFPKDPNVSPECKALISKIL-APVKTRLRI------KNIKEDPWFRNGP 308 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L-~~p~~R~s~------~e~l~hp~f~~~~ 308 (357)
.+| ..+++++.+||++|| .||.+||++ +|+++||||++..
T Consensus 280 ~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 280 RIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp CCC--TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred CCC--CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 333 469999999999999 599999995 7999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=391.48 Aligned_cols=256 Identities=27% Similarity=0.548 Sum_probs=224.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|++..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 45789999999999999999999999999999999975322111123456689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999975421
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 279 (357)
.....+||+.|+|||++.+..+. .++|+|||||++|+|++|..||.+.+.......+... ..++ +.+++++.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~ 231 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVK 231 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred ----ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHH
Confidence 22356899999999999888774 5599999999999999999999988877777666543 3333 46899999
Q ss_pred HHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 280 ALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 280 ~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
++|++|| .||.+|+ +++++++||||++..
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999 5999999 899999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=403.70 Aligned_cols=265 Identities=28% Similarity=0.478 Sum_probs=227.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||+||+|++..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997532111111345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-- 222 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-- 222 (410)
T ss_dssp EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC--
Confidence 999999999999999754 69999999999999999999999999999999999999999999999999997643221
Q ss_pred cccccccccCCCCCCccchhhhcCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIP---YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFPKDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 273 (357)
.......+||+.|+|||++.+.. +++.++|||||||++|+|++|..||.+.+.......+... ..++....
T Consensus 223 ---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 223 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp ---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred ---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 11234678999999999997654 2356799999999999999999999999888887777543 45666668
Q ss_pred CCHHHHHHHHHccc-CCCC--CCCHHhHhcCCccccCCCC
Q psy10194 274 VSPECKALISKILA-PVKT--RLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~--R~s~~e~l~hp~f~~~~~~ 310 (357)
+++++++||.+||. +|.+ |++++|+++||||++..+.
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 99999999999995 6877 9999999999999987553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=391.58 Aligned_cols=262 Identities=31% Similarity=0.554 Sum_probs=225.1
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCC
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTH 116 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~ 116 (357)
..+..++|++.+.||+|+||.||+|++..++..||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 345567899999999999999999999999999999999876655555566778999999887 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999753211
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---------CcHHHHHHHHhc-cc
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD---------TKYSQLLKQVQS-KV 266 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~---------~~~~~~~~~~~~-~~ 266 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.. .....+.+.+.. ..
T Consensus 164 ------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 164 ------GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp ------TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred ------CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 122346789999999999998777 5569999999999999999999965 223333444433 23
Q ss_pred CCCCCCCCCHHHHHHHHHcc-cCCCCCCCH------HhHhcCCccccCC
Q psy10194 267 VFPKDPNVSPECKALISKIL-APVKTRLRI------KNIKEDPWFRNGP 308 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L-~~p~~R~s~------~e~l~hp~f~~~~ 308 (357)
.+ +..+++++.+||.+|| .||.+||++ +++++||||++..
T Consensus 237 ~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 237 RI--PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CC--CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CC--CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 33 3469999999999999 599999995 8999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=393.39 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=224.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|.+++.||+|+||.||+|.+..++..||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999986543221 1235577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
++||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888899999999999999999999999999999999999998776 79999999997653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CC--CC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FP--KD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~--~~ 271 (357)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... ++ ..
T Consensus 171 ~~-------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 171 DG-------VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp TT-------CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CC-------CccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 21 12345679999999999988777 5569999999999999999999999888888777765432 22 12
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+++++++||.+|| .||.+|||+.|+++||||+..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 478999999999999 599999999999999999854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=394.47 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=224.3
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~ 117 (357)
.+..++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999763211111134456788888876 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999999753211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+..++...+..... ..+..++++
T Consensus 172 -----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~ 244 (345)
T 1xjd_A 172 -----DAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKE 244 (345)
T ss_dssp -----TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHH
T ss_pred -----CCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHH
Confidence 122346789999999999988777 5569999999999999999999999888888777754432 223468999
Q ss_pred HHHHHHHcc-cCCCCCCCHH-hHhcCCccccCC
Q psy10194 278 CKALISKIL-APVKTRLRIK-NIKEDPWFRNGP 308 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~-e~l~hp~f~~~~ 308 (357)
+.+||.+|| .||.+||++. ++++||||++..
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 999999999 5999999998 999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=398.19 Aligned_cols=259 Identities=37% Similarity=0.676 Sum_probs=221.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|.+.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+...+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999865322112223457799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||+ +|+|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~----- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD----- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-----
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-----
Confidence 99999 679999998888999999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+... ....+..+++++.+
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQS 237 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHH
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHH
Confidence 122345689999999999998887677799999999999999999999876544433333222 12233568999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
||++|| .||.+|||++|+++||||+...
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 999999 5999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=388.66 Aligned_cols=262 Identities=33% Similarity=0.536 Sum_probs=221.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||+||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999996543322 235677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+++|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 99999999999998887899999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHHhcccCCCCCCCCCHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--QLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...... ............+....+++.+.
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 161 -ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp -ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred -ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 122345689999999999988877677799999999999999999999765442 22222333333344457899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+||.+|| .||.+|||++|+++||||+....
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999 59999999999999999987544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=393.22 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=225.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
...++|++.+.||+|+||.||+|++..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997532211122345668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999975431
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.... ...+..+++++.
T Consensus 194 -----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~ 266 (350)
T 1rdq_E 194 -----RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLK 266 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHH
T ss_pred -----CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHH
Confidence 1235679999999999988777 456999999999999999999999988888777766542 222347999999
Q ss_pred HHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 280 ALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
+||.+|| .||.+||+ ++++++||||+...
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 9999999 59999998 99999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=393.62 Aligned_cols=265 Identities=27% Similarity=0.495 Sum_probs=224.4
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+....+..++|++.+.||+|+||.||+|++..++..||+|++.+.........+.+.+|..++..+ +||+|+++++++.
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 334456778999999999999999999999999999999999764221111234566899999887 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999753
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~ 272 (357)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+... ..++ .
T Consensus 172 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~ 242 (353)
T 2i0e_A 172 IWD------GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--K 242 (353)
T ss_dssp CCT------TCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--T
T ss_pred ccC------CcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--C
Confidence 211 123346789999999999988877 55699999999999999999999998888887776543 3333 4
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 273 NVSPECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
.+++++.+||.+|| .||.+||+ ++++++||||+...
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 79999999999999 59999995 69999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=377.58 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=215.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 58999999999999999999999999999999997655433 33455679999999999999999999999999999999
Q ss_pred eecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++ +|.+.+. ..+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----- 154 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-----
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-----
Confidence 99987 5655554 4678999999999999999999999999999999999999999999999999999764321
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHHhcccCCC-----------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLKQVQSKVVFP----------- 269 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~p-f~~~~~~~~~~~~~~~~~~~----------- 269 (357)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+.+..+......+
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 12233557899999999998877667789999999999999988777 56666666555553321111
Q ss_pred -----------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 270 -----------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 270 -----------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+.+++++++||.+||+ ||.+|||++|+++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 113578999999999995 99999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=393.88 Aligned_cols=262 Identities=29% Similarity=0.529 Sum_probs=219.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHH-HHcCCCCCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV-VKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.+..++|++.+.||+|+||.||+|++..++..||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456789999999999999999999999999999999987654433334445567666 577899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999999753221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+..+..+.+..... ...+.++++
T Consensus 193 -----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~ 265 (373)
T 2r5t_A 193 -----NSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNS 265 (373)
T ss_dssp -----CCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHH
T ss_pred -----CCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHH
Confidence 123446789999999999988777 5569999999999999999999999888888777765422 223579999
Q ss_pred HHHHHHHcc-cCCCCCCCH----HhHhcCCccccCC
Q psy10194 278 CKALISKIL-APVKTRLRI----KNIKEDPWFRNGP 308 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~----~e~l~hp~f~~~~ 308 (357)
+.+||.+|| .||.+|+++ .++++||||+...
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 999999999 599999996 6999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=403.62 Aligned_cols=266 Identities=27% Similarity=0.453 Sum_probs=225.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||+||+|++..++..||+|++.+...........+.+|+.++..++||||++++++|.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 44578999999999999999999999999999999997532211222344778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~- 229 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 229 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-
Confidence 99999999999999987 5789999999999999999999999999999999999999999999999999997543221
Q ss_pred ccccccccccCCCCCCccchhhhc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc---ccCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS---KVVFPKD 271 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~---~~~~~~~ 271 (357)
.......+||+.|+|||++. +...++.++|||||||++|+|++|+.||.+.+..+....+.. .+.+|..
T Consensus 230 ----~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 230 ----TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp ----CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred ----CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 11233568999999999986 233346679999999999999999999999888887777653 2344433
Q ss_pred -CCCCHHHHHHHHHccc-CCCC--CCCHHhHhcCCccccCCCC
Q psy10194 272 -PNVSPECKALISKILA-PVKT--RLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 272 -~~~~~~~~~li~~~L~-~p~~--R~s~~e~l~hp~f~~~~~~ 310 (357)
..+++++++||++||. +|++ |++++|+++||||++..|.
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 4689999999999994 6776 9999999999999887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=384.77 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=191.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC----e
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH----R 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~----~ 117 (357)
.++|.+.++||+|+||+||+|++ +|..||||+++... ........|+..+..++|||||++++++.+.+ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 35799999999999999999987 47899999986432 11222335666677889999999999997654 6
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER--------GVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
++||||||++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 89999999999999999764 589999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCC-----CCCcccHHHHHHHHHHHHhCCCCCCCC-----------
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY-----CPQLSDVWSMGVVLFAMVFGRLPFDDT----------- 253 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~ll~G~~pf~~~----------- 253 (357)
++......... .......+||+.|+|||++.+... ++.++|||||||++|||+||..||...
T Consensus 155 a~~~~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 155 AVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp CEEEETTTTEE--SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccCCCCce--eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 98654322111 122335689999999999976532 245699999999999999997765321
Q ss_pred ----cHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 254 ----KYSQLLKQVQSKVVFPKDP------NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 254 ----~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
....+.+.+......|..+ ..++.+.+|+.+|| .||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2234444443332222211 12356889999999 599999999999873
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=377.91 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=220.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.+.||+|+||+||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 358999999999999999999999999999999987654333 34567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||++||+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 170 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 170 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----
Confidence 9999999999999765 58999999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc--cCCCCCCCCCHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--VVFPKDPNVSPECK 279 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 279 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ........+++.+.
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred --cccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 12335679999999999988877 55699999999999999999999988776655544322 22333457899999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 280 ALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+||.+||. ||.+|||+.|+++||||+..
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 99999995 99999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=404.89 Aligned_cols=262 Identities=34% Similarity=0.657 Sum_probs=230.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|.+++.||+|+||.||+|.+..++..||||++.+...........+.+|+.+++.++||||+++++++.+.+.++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997532212122356779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~---- 168 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---- 168 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT----
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+..... ..+..+++++.
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 244 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVI 244 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHH
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHH
Confidence 12234568999999999999888777789999999999999999999999888888777765543 23346899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+||.+|| .||.+|||+.++++||||+....
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 9999999 59999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=398.96 Aligned_cols=266 Identities=26% Similarity=0.407 Sum_probs=224.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||+||+|++..+++.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999997533222223455778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999999999775 4799999999999999999999999999999999999999999999999999976532111
Q ss_pred ccccccccccCCCCCCccchhhhcC------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---cCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKG------IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---VVFP 269 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---~~~~ 269 (357)
......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+....+... ..++
T Consensus 218 -----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 218 -----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp -----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred -----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 12235689999999999872 223366799999999999999999999998888777766532 3333
Q ss_pred C-CCCCCHHHHHHHHHcccCCCCC---CCHHhHhcCCccccCCCC
Q psy10194 270 K-DPNVSPECKALISKILAPVKTR---LRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 270 ~-~~~~~~~~~~li~~~L~~p~~R---~s~~e~l~hp~f~~~~~~ 310 (357)
. ...+++++++||++||.+|.+| ++++|+++||||++..|.
T Consensus 293 ~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred ccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 2 3479999999999999988887 599999999999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=396.02 Aligned_cols=257 Identities=31% Similarity=0.537 Sum_probs=223.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999765443 33355678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec---CCCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||.||+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-- 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-- 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT--
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC--
Confidence 99999999999999988999999999999999999999999999999999999998 4678999999999765321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-C--CCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-F--PKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~--~~~~~~~ 275 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..... + +..+.++
T Consensus 167 ----~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 167 ----QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp ----CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ----CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 122335679999999999988777 4569999999999999999999999888888877765432 2 3335789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
+++.+||.+|| .||.+|||+.|+|+||||+.
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999999 59999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=383.49 Aligned_cols=265 Identities=27% Similarity=0.390 Sum_probs=214.4
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.....++|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 345567899999999999999999999999999999999755433 2234455689999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-----CCCCeEEeecccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-----ADYNIKLSDFGFARN 192 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-----~~~~~kl~Dfg~~~~ 192 (357)
+++||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988899999999999999999999999999999999999994 445599999999975
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC-
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD- 271 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~- 271 (357)
.... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+.+..+......+..
T Consensus 187 ~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 187 FGIP------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cCCc------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 4321 112234568999999999988665577899999999999999999999988877766665433222211
Q ss_pred ----------------------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 272 ----------------------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 272 ----------------------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
..+++++.+||.+||. ||.+|||++|+++||||++..+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 1168999999999995 99999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=387.47 Aligned_cols=256 Identities=35% Similarity=0.629 Sum_probs=212.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||+||+|++..++..||+|++....... +.+.+|+.+++.++||||+++++++.+...+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4568999999999999999999999999999999997654433 346689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC--eEEeecccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN--IKLSDFGFARNHMRYRS 198 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~ 198 (357)
||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999999999999988888999999999999999999999999999999999999987765 999999998743211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHHh-cccCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY----SQLLKQVQ-SKVVFPKDPN 273 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~----~~~~~~~~-~~~~~~~~~~ 273 (357)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+... ......+. .....+....
T Consensus 172 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 172 -----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred -----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 1223457999999999998888876668999999999999999999986432 33334333 3445555567
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++++.+||.+|| .||.+|||+.|+++||||...
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 8999999999999 599999999999999999654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=386.14 Aligned_cols=256 Identities=30% Similarity=0.569 Sum_probs=223.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997655443 3345677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC---CCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD---YNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||+.||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-- 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence 9999999999999888889999999999999999999999999999999999999764 45999999999765321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCCC--CCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPK--DPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~~--~~~~~ 275 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... .++. ...++
T Consensus 185 -----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 185 -----EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp -----CSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred -----cccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 12235679999999999988776 556999999999999999999999988888777766543 2222 24689
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
+++.+||.+|| .||.+|||+.++++||||..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999 59999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=379.92 Aligned_cols=258 Identities=27% Similarity=0.464 Sum_probs=222.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|.+.+.||+|+||.||+|.+..++..||+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999976543221 1235577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999998877 79999999997653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCCC--C
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFPK--D 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~~--~ 271 (357)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+.... .++. .
T Consensus 170 ~~-------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 170 FG-------NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TT-------SCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CC-------CccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 21 12234679999999999987776 556999999999999999999999888777766665432 2221 2
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+++.+.+||.+|| .||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 468999999999999 599999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=391.07 Aligned_cols=262 Identities=21% Similarity=0.405 Sum_probs=221.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44578999999999999999999999999999999997533212222345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---- 167 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---- 167 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT----
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC----
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhcccCCCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDT---KYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~---~~~~~~~~~~~~~~~~~~~~~ 274 (357)
.......+||+.|+|||++... ..++.++|||||||++|+|++|..||... ........+.... ...+..+
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~p~~~ 243 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAW 243 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-CCCCTTS
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-cCCCCcC
Confidence 1233467899999999999743 22355699999999999999999999743 3344444443322 2333579
Q ss_pred CHHHHHHHHHcc-cCCCCCCC-HHhHhcCCccccCCC
Q psy10194 275 SPECKALISKIL-APVKTRLR-IKNIKEDPWFRNGPS 309 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s-~~e~l~hp~f~~~~~ 309 (357)
++++.+||.+|| .||.+||+ ++++++||||.+..+
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 999999999999 59999998 999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=379.00 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=213.5
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.....++|++.+.||+|+||+||+|.+. ++..||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3445578999999999999999999985 4889999999654332 2334566799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
+++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999986 888887654 45999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK------ 270 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~------ 270 (357)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....+....+......+.
T Consensus 173 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 173 ------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp ------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred ------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 11223457899999999998766557779999999999999999999987665554444432111110
Q ss_pred -----------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 271 -----------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 271 -----------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+.+++++.+||.+||. ||.+|||++|+++||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 13578899999999995 999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=388.57 Aligned_cols=276 Identities=22% Similarity=0.348 Sum_probs=221.1
Q ss_pred CCcceEEeecCEEEEeEeeec--CceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMG--SYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G--~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
..+......++|++.++||+| +||+||+|++..++..||+|++...... ....+.+.+|+.+++.++||||++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 344445677889999999999 9999999999999999999999765443 3456677899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
+.+.+.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999999875 6799999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc-ccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-
Q psy10194 190 ARNHMRYRSRQ-GYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV- 266 (357)
Q Consensus 190 ~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~- 266 (357)
+.......... .........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 87543222111 111223345789999999999873 233567999999999999999999998754433322211100
Q ss_pred --------------------------------------------CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 267 --------------------------------------------VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 267 --------------------------------------------~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+....+++++.+||.+||. ||.+|||+.|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 011224578999999999995 99999999999999
Q ss_pred CccccCCCC
Q psy10194 302 PWFRNGPSR 310 (357)
Q Consensus 302 p~f~~~~~~ 310 (357)
|||+.....
T Consensus 335 p~f~~~~~~ 343 (389)
T 3gni_B 335 SFFKQIKRR 343 (389)
T ss_dssp GGGGGC---
T ss_pred HHHHHHhhc
Confidence 999876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=381.23 Aligned_cols=256 Identities=18% Similarity=0.341 Sum_probs=222.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 368999999999999999999999999999999986432 2345577999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC--CCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA--DYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999987 7899999999997653211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC---CCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK---DPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~ 275 (357)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+........ .+.++
T Consensus 159 ------~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 159 ------NFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ------EEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ------ccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCC
Confidence 1234568999999999988766 5569999999999999999999999888887777765433221 24789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+++.+||.+|| .||.+|||+.|+++||||+....
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 99999999999 59999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=389.85 Aligned_cols=263 Identities=25% Similarity=0.449 Sum_probs=208.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCC--eE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTH--RV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~--~~ 118 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.+..... .....+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 468999999999999999999999999999999986544333 33455668999999997 999999999997654 78
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 999999975 99999876 4699999999999999999999999999999999999999999999999999976432110
Q ss_pred c---------------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q psy10194 199 R---------------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ 263 (357)
Q Consensus 199 ~---------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~ 263 (357)
. ..........+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0 0112233456899999999999876555778999999999999999999999988777666654
Q ss_pred cccCCCC----------------------------------------------CCCCCHHHHHHHHHccc-CCCCCCCHH
Q psy10194 264 SKVVFPK----------------------------------------------DPNVSPECKALISKILA-PVKTRLRIK 296 (357)
Q Consensus 264 ~~~~~~~----------------------------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~ 296 (357)
.....|. ...+++++.+||.+||. ||.+|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 3332221 12678999999999995 999999999
Q ss_pred hHhcCCccccC
Q psy10194 297 NIKEDPWFRNG 307 (357)
Q Consensus 297 e~l~hp~f~~~ 307 (357)
|+|+||||+..
T Consensus 325 e~l~Hp~~~~~ 335 (388)
T 3oz6_A 325 DALKHPFVSIF 335 (388)
T ss_dssp HHTTSTTTTTT
T ss_pred HHhCCHHHHHh
Confidence 99999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=378.52 Aligned_cols=261 Identities=25% Similarity=0.498 Sum_probs=215.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+..++|++.+.||+|+||.||+|++. .++..||+|++.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45678999999999999999999985 68899999999765322 122244566899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999875322
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ...++.++
T Consensus 174 ~------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~ 245 (327)
T 3a62_A 174 D------GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLT 245 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSC
T ss_pred C------CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Confidence 1 112345679999999999988776 556999999999999999999999988877776665432 22335789
Q ss_pred HHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 276 PECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
+++.+||.+|| .||.+|| ++.++++||||+...
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 99999999999 5999999 889999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=397.72 Aligned_cols=260 Identities=31% Similarity=0.546 Sum_probs=217.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999997543222223345568999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++......
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-- 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--
Confidence 999999999999999888899999999999999999999998 99999999999999999999999999999753221
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 277 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+... ..++ ..++++
T Consensus 303 ----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~ 375 (446)
T 4ejn_A 303 ----GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPE 375 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred ----CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHH
Confidence 122345789999999999988777 56699999999999999999999998888777776543 3333 469999
Q ss_pred HHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 278 CKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
+.+||.+|| .||.+|| +++|+++||||++..
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 999999999 5999999 999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=377.06 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=203.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||+||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997544222 134566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 999998653 3589999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------ 269 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~------ 269 (357)
. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 161 ~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 161 P------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp C------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred C------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 1 1122345789999999999876555777999999999999999999999888777666553211100
Q ss_pred ---------------------------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 270 ---------------------------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 ---------------------------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
....+++++.+||.+|| .||.+|||++|+++||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 11257899999999999 4999999999999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=373.46 Aligned_cols=260 Identities=29% Similarity=0.430 Sum_probs=216.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 589999999999999999999999999999999866543 3444566779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----- 156 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc----------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---------------- 266 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---------------- 266 (357)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 122345789999999999875555777999999999999999999999887666554433211
Q ss_pred ----CCCC----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 267 ----VFPK----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 267 ----~~~~----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
..+. .+.+++++.+||.+||. ||.+|||++|+++||||++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 1111 14688999999999995 9999999999999999997544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=374.44 Aligned_cols=259 Identities=31% Similarity=0.586 Sum_probs=216.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc-----------------------hHHHhhHHHHHHH
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS-----------------------DYLKKFLPREVEV 96 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~~ 96 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45679999999999999999999999999999999997643211 1123557799999
Q ss_pred HHcCCCCCccceEEEEEe--CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 97 VKGLKHPNLIKFLQAIET--THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 97 l~~l~h~~Iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
++.++||||+++++++.+ ...+++||||+++++|.+++ ..+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 67899999999999998865 345799999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCC--CCCcccHHHHHHHHHHHHhCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY--CPQLSDVWSMGVVLFAMVFGRLPFDD 252 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~ll~G~~pf~~ 252 (357)
|++.++.+||+|||++....... ......+||+.|+|||++.+... .+.++|||||||++|+|++|+.||..
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCCCCEEEecCCCcccccccc------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999997653211 12234578999999999976543 35668999999999999999999998
Q ss_pred CcHHHHHHHHhc-ccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 253 TKYSQLLKQVQS-KVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 253 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
.........+.. ...++..+.+++++.+||.+|| .||.+|||+.|+++||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 887776666544 3445555689999999999999 5999999999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=371.76 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=211.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+ .++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5799999999999999999998 67889999998654322 222345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+.+ +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc----
Confidence 99986 999998763 679999999999999999999999999999999999999999999999999997543211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC------------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------------ 269 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~------------ 269 (357)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 112345689999999999876655777999999999999999999999877666555543211100
Q ss_pred ----------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 270 ----------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 270 ----------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
....+++++.+||.+||. ||.+|||++|+++||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 013578999999999995 99999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=371.76 Aligned_cols=260 Identities=30% Similarity=0.596 Sum_probs=223.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
...++|++.+.||+|+||+||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34578999999999999999999999999999999986543222223456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---- 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999998864321
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.... ...+..+++.+.
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (279)
T 3fdn_A 162 ----SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGAR 235 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHH
T ss_pred ----ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHH
Confidence 12234578999999999988766 455999999999999999999999988887777665432 233356899999
Q ss_pred HHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 280 ALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 280 ~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+||.+||. ||.+|||++|+++||||+....
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999995 9999999999999999987544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=377.56 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=212.1
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 5799999999999999999999999999999998654321 11223447999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~----- 153 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP----- 153 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-----
Confidence 99975 999888764 46999999999999999999999999999999999999999999999999999754321
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-----------
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK----------- 270 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~----------- 270 (357)
.......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 11223456899999999998765557779999999999999999999999887776666543222111
Q ss_pred ------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 271 ------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 271 ------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+.+++++.+||.+||. ||.+|||++|+++||||.+...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 13578999999999995 99999999999999999876544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=373.03 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=210.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc--hHHHhhHHHHHHHHHcC---CCCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS--DYLKKFLPREVEVVKGL---KHPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~~ 114 (357)
+..++|++.+.||+|+||+||+|.+..++..||+|++....... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45679999999999999999999999999999999987533211 11122345677777666 49999999999987
Q ss_pred CC-----eEEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 115 TH-----RVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 115 ~~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
.. .+++|||++.+ +|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 58999999975 99999987654 999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
|++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 165 g~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 165 GLARIYSY-------QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCTTTSTT-------CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccCC-------CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99975432 122345678999999999988777 4559999999999999999999999888777666643222
Q ss_pred CCC--------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 268 FPK--------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 268 ~~~--------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+. .+.+++++.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 111 13578999999999995 9999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=383.21 Aligned_cols=259 Identities=26% Similarity=0.489 Sum_probs=215.3
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
..++|++.+.||+|+||+||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35689999999999999999999999999999999864211 0011134577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC---eEEeeccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGFAR 191 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~---~kl~Dfg~~~ 191 (357)
++|||||+|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999887542 35899999999999999999999999999999999999976654 9999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVFPK 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~~~ 270 (357)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ....+. .....+.
T Consensus 182 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 182 QLGES------GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNP 253 (351)
T ss_dssp ECCTT------SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCH
T ss_pred EecCC------CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCc
Confidence 65321 112345679999999999988777 56699999999999999999999886543 333333 3332221
Q ss_pred --CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 271 --DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 271 --~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
...+++++.+||.+|| .||.+|||+.++++||||+..
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 2468999999999999 599999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=381.11 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=221.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999986543 22245677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC--CCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA--DYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||+.||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9999999999998754 37999999999999999999999999999999999999974 578999999999765321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CC--CCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VF--PKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~--~~~~~~~ 275 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.... .+ .....++
T Consensus 205 -----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 205 -----EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp -----SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred -----cceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 12234578999999999988776 456999999999999999999999988777776665432 22 2234789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
+++.+||.+|| .||.+|||+.|+++||||+.....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 99999999999 599999999999999999876443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=367.53 Aligned_cols=262 Identities=35% Similarity=0.639 Sum_probs=219.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|.+.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34668999999999999999999999999999999998653221112234567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
.......|++.|+|||++.+..+.+.++||||||+++|+|++|..||.........+.+..... ..+..+++.+
T Consensus 165 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 238 (276)
T 2h6d_A 165 -----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSV 238 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHH
T ss_pred -----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cCchhcCHHH
Confidence 1123456899999999998877666779999999999999999999999888877777765433 2334689999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 279 KALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.++|.+||. ||.+|||+.++++||||++..
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 999999995 999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=363.83 Aligned_cols=254 Identities=31% Similarity=0.559 Sum_probs=221.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..+|+|++....... .+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999997654332 34567999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-- 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence 9999999999999888889999999999999999999999999999999999999 78899999999999764321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC---CCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---PNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 275 (357)
.......||+.|+|||++.+. + +.++||||||+++|+|++|..||......+....+......... ..++
T Consensus 163 -----~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 163 -----KMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp -----SCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred -----cchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 122345789999999998764 4 56699999999999999999999998887777776654332221 3689
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+.+.++|.+||. ||.+|||+.++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999995 99999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=364.18 Aligned_cols=259 Identities=24% Similarity=0.472 Sum_probs=227.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|.+.+.||+|+||.||+|.+..++..+|+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 57999999999999999999999999999999998766555556677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----- 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----- 169 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-----
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+.... ......+++.+.++|
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 246 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLI 246 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHH
T ss_pred -cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHH
Confidence 12234578999999999987766 556999999999999999999999888777666655432 233357899999999
Q ss_pred HHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 283 SKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+||. ||.+|||++++++||||.....
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHcccChhhCcCHHHHhhChheecCCc
Confidence 99994 9999999999999999987544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=362.07 Aligned_cols=258 Identities=30% Similarity=0.561 Sum_probs=224.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999976554433 345677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC---eEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~ 198 (357)
|||+++++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 999999999999988888999999999999999999999999999999999999976655 999999999754321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---CCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 275 (357)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..... .+....++
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 162 -----EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp -----CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred -----ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 12234578999999999988777 5569999999999999999999999888877777654432 22335789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.+||.+||. ||.+|||+.|+++||||++..
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999995 999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=371.70 Aligned_cols=261 Identities=24% Similarity=0.468 Sum_probs=228.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|.+.+.||+|+||.||++.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35799999999999999999999999999999999876655556667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+....+.... ......+++.+.+|
T Consensus 196 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 271 (335)
T 2owb_A 196 --ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASL 271 (335)
T ss_dssp --CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHH
T ss_pred --ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHH
Confidence 12234578999999999988776 556999999999999999999999887776665554432 22334789999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
|.+|| .||.+|||++|+++||||......
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999 499999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=409.27 Aligned_cols=264 Identities=27% Similarity=0.468 Sum_probs=226.1
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETT 115 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~ 115 (357)
...+..++|++.++||+|+||.||+|.+..++..||||++.+.........+.+.+|..++..+ +||+|+++++++.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3345678999999999999999999999999999999999753221112234456899999887 699999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975321
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++.+.+..... ..+..++
T Consensus 495 ~------~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s 566 (674)
T 3pfq_A 495 D------GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMS 566 (674)
T ss_dssp T------TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSC
T ss_pred C------CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCC
Confidence 1 123446789999999999988887 5569999999999999999999999998888888765432 2234799
Q ss_pred HHHHHHHHHcc-cCCCCCCCH-----HhHhcCCccccCC
Q psy10194 276 PECKALISKIL-APVKTRLRI-----KNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~-----~e~l~hp~f~~~~ 308 (357)
+++.+||++|| .||.+|+++ +|+++||||+...
T Consensus 567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999 599999997 9999999998765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=391.39 Aligned_cols=266 Identities=23% Similarity=0.392 Sum_probs=199.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-----CC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-----TH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-----~~ 116 (357)
.++|++.+.||+|+||.||+|.+..++..||||++.+... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4789999999999999999999999999999999965433 33344567799999999999999999999843 35
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 599999988888999999999999999999999999999999999999999999999999999865422
Q ss_pred cccc---------------------ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh----------
Q psy10194 197 RSRQ---------------------GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF---------- 245 (357)
Q Consensus 197 ~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~---------- 245 (357)
.... .........+||++|+|||++.....++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1100 001123456889999999987655555777999999999999998
Q ss_pred -CCCCCCCCcH--------------------HHHHHHHhcccC---------------------C---------CCCCCC
Q psy10194 246 -GRLPFDDTKY--------------------SQLLKQVQSKVV---------------------F---------PKDPNV 274 (357)
Q Consensus 246 -G~~pf~~~~~--------------------~~~~~~~~~~~~---------------------~---------~~~~~~ 274 (357)
|+++|.+... .+.+..+...+. + ...+.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777765431 111111111000 0 012457
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
++++.+||.+||. ||.+|||++|+|+||||+...+
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 9999999999995 9999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=366.29 Aligned_cols=260 Identities=31% Similarity=0.611 Sum_probs=224.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999986532222222355779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999999999999988888999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
.....+|++.|+|||++.+..+. .++||||||+++|+|++|..||......+....+.... ...+..+++++.
T Consensus 168 -----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (284)
T 2vgo_A 168 -----RRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSK 240 (284)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHH
T ss_pred -----ccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHH
Confidence 12345789999999999887774 55999999999999999999999887777666655432 233357899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
++|.+|| .||.+||+++++++||||+....
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999 49999999999999999986544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=363.76 Aligned_cols=262 Identities=33% Similarity=0.539 Sum_probs=221.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 357999999999999999999999999999999997544322 245677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--- 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc---
Confidence 99999999999998777899999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHh-cccCCCCCCCCCHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQ-SKVVFPKDPNVSPECK 279 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~ 279 (357)
.......+|++.|+|||++.+..+.+.++||||||+++|+|++|..||...... .....+. .....+....+++.+.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred -hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 122345678999999999988777667799999999999999999999865432 2222222 2222333457899999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+||.+|| .||.+|||++|+++||||++...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999 59999999999999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=385.24 Aligned_cols=268 Identities=24% Similarity=0.397 Sum_probs=210.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
..++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35789999999999999999999999999999999976543 333455677999999999999999999999766
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
..+|+||||+.+ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 579999999975 9999998888899999999999999999999999999999999999999999999999999986543
Q ss_pred ccccc----------------ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCC-----------C
Q psy10194 196 YRSRQ----------------GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR-----------L 248 (357)
Q Consensus 196 ~~~~~----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~-----------~ 248 (357)
..... .........+||++|+|||++.....++.++|||||||++|+|++|. +
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 21110 00012356789999999999866555577899999999999999844 4
Q ss_pred CCCCCc-----------------HHHHHHHHhcccCC-------------------------C-----CCCCCCHHHHHH
Q psy10194 249 PFDDTK-----------------YSQLLKQVQSKVVF-------------------------P-----KDPNVSPECKAL 281 (357)
Q Consensus 249 pf~~~~-----------------~~~~~~~~~~~~~~-------------------------~-----~~~~~~~~~~~l 281 (357)
+|.+.+ ....+..+...... + ..+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 443322 11111111110000 0 014689999999
Q ss_pred HHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 282 ISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 282 i~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
|.+||. ||.+|||++|+|+||||++..+.
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 999995 99999999999999999886543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=370.15 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=223.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4679999999999999999999999999999999976543221 1235577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888899999999999999999999999999999999999998887 79999999997643
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC---C
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK---D 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~---~ 271 (357)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+........ .
T Consensus 171 ~~-------~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 171 DG-------VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TT-------CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cc-------ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 21 12234568999999999988776 5569999999999999999999999888777777665432211 1
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+++.+.+||.+|| .||.+|||+.|+++||||...
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 468999999999999 599999999999999999854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=396.95 Aligned_cols=260 Identities=32% Similarity=0.516 Sum_probs=226.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|.+..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999977654433335667799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeeccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 99999999999999988899999999999999999999999999999999999999 56789999999999754321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---CCCCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNV 274 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~ 274 (357)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+..... .+....+
T Consensus 183 ------~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 183 ------KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp ------CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred ------cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 12234578999999999976 34 5679999999999999999999999988888877765432 2333578
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999995 9999999999999999986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=392.91 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=221.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch----------HHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD----------YLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
..+|++.++||+|+||+||+|.+..++..||+|++.+...... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4789999999999999999999999999999999976543211 224567799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEeecc
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLSDFG 188 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~Dfg 188 (357)
+.+...+++|||||+||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999998888899999999999999999999999999999999999998776 69999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
++...... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 195 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 195 LSSFFSKD-------YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp TCEECCTT-------SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCEEcCCC-------CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99765321 12335679999999999875 34 56799999999999999999999999988888887655432
Q ss_pred C---CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 269 P---KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 ~---~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
. ....+++++++||++||. ||.+|||++|+|+||||+....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 2 225789999999999995 9999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=377.65 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=214.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~l 120 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.+.... ..+|+.++..+ +||||+++++++.+...+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 46799999999999999999999999999999999765432 23688888777 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC----CCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD----YNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~----~~~kl~Dfg~~~~~~~~ 196 (357)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||+..+ +.+||+|||++......
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999988899999999999999999999999999999999999998433 35999999999764321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHHhcccC-CC--C
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD---TKYSQLLKQVQSKVV-FP--K 270 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~---~~~~~~~~~~~~~~~-~~--~ 270 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ....++...+..... ++ .
T Consensus 174 ------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 174 ------NGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp ------TCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred ------CCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 123345689999999999987666 4569999999999999999999975 455666666654322 22 2
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+..+++++.+||.+|| .||.+|||+.++++||||.+.
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 3578999999999999 599999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=373.97 Aligned_cols=257 Identities=31% Similarity=0.555 Sum_probs=198.6
Q ss_pred cCEEEE---eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeE
Q psy10194 43 HGYTLG---TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRV 118 (357)
Q Consensus 43 ~~y~~~---~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~ 118 (357)
.+|.+. +.||+|+||.||+|.+..++..||+|++.+. ....+.+|+.+++.+. ||||+++++++.+....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 457775 7899999999999999999999999999653 1345668999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEeeccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLSDFGFARNHMR 195 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~Dfg~~~~~~~ 195 (357)
++||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999988999999999999999999999999999999999999997665 799999999975432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHHhcccCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-------YSQLLKQVQSKVVF 268 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-------~~~~~~~~~~~~~~ 268 (357)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+ ..+....+......
T Consensus 162 ~------~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 162 D------NQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp ----------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred C------CCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 1 122345678999999999988777 456999999999999999999997643 24455555443322
Q ss_pred CCC---CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 269 PKD---PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 269 ~~~---~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
... ..+++++.+||.+|| .||.+|||+.++++||||++....+.
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~ 282 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence 111 358999999999999 59999999999999999997655443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=375.01 Aligned_cols=256 Identities=31% Similarity=0.547 Sum_probs=206.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 35679999999999999999999999999999999975431 3456689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeeccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~ 197 (357)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++......
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999999999999988888999999999999999999999999999999999999975 889999999999754321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHHhcccC-C--CCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ-LLKQVQSKVV-F--PKDPN 273 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~-~~~~~~~~~~-~--~~~~~ 273 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....+..... + +..+.
T Consensus 205 ------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 205 ------VLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp --------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT
T ss_pred ------cccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh
Confidence 12235678999999999988776 556999999999999999999997765443 4444443322 2 22357
Q ss_pred CCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 274 VSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
++.++.+||.+||. ||.+|||+.|+++||||.....
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 89999999999995 9999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=362.26 Aligned_cols=254 Identities=29% Similarity=0.508 Sum_probs=212.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|.+.+.||+|+||.||+|.+..++..+|+|++........ .+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3689999999999999999999999999999999976543322 35577999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeecccccccc
Q psy10194 122 MEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHM 194 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~ 194 (357)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998854 3679999999999999999999999999999999999999 456789999999997543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-C-CCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-F-PKDP 272 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~-~~~~ 272 (357)
.. ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+....+....+..... . ....
T Consensus 179 ~~-------~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 179 SD-------EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp ---------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred Cc-------ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 21 12234578999999999864 34 5679999999999999999999999887777666543322 1 2223
Q ss_pred CCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 273 NVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 273 ~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.+++++.+||.+||. ||.+|||+.|+++||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 589999999999995 9999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=378.31 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=211.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC----
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT---- 115 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~---- 115 (357)
-...+|++.+.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 345789999999999999999999999999999999865433 344456677999999999999999999999765
Q ss_pred --CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 116 --HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 116 --~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 7799999976 56999999999999999999999999999999999999999999999999999754
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC----
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP---- 269 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~---- 269 (357)
.. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 179 ~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 179 DS---------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CS---------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cc---------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 21 12345789999999999875445677999999999999999999999887766555443211110
Q ss_pred --------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 270 --------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 270 --------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
..+..++.+.+||.+||. ||.+|||++|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 124679999999999995 9999999999999999987544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=375.47 Aligned_cols=265 Identities=22% Similarity=0.339 Sum_probs=217.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------- 114 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-chHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999865543322 23345689999999999999999999977
Q ss_pred -CCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 115 -THRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 115 -~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.+.+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4568999999986 77777754 35799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC--
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK-- 270 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~-- 270 (357)
........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+........
T Consensus 174 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 174 FSLAKNSQ--PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp CCCCSSSS--CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccc--ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 54222111 12234567899999999998766557789999999999999999999999887776665543221111
Q ss_pred -CCC----------------------------CCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 271 -DPN----------------------------VSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 271 -~~~----------------------------~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.+. .++.+.+||.+||. ||.+|||++|+++||||...+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 111 27889999999995 99999999999999999875443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=391.87 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=209.8
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.......++|++.+.||+|+||+||+|.+..++..||||++.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 55 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 55 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp -CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 33445578999999999999999999999999999999999765333 33345667999999999999999999999654
Q ss_pred ------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 116 ------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 116 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
..+++||||+++ +|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 467999999976 57766643 489999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
++.... .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 211 a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGT-------SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp C------------CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eeecCC-------CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 975432 1223456899999999999988774 56999999999999999999999988776666554322211
Q ss_pred CC--------------------CC---------------------CCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 270 KD--------------------PN---------------------VSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 270 ~~--------------------~~---------------------~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.. .. .++++.+||.+||. ||.+|||++|+|+||||+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 00 15679999999995 9999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=399.32 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=219.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.++||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 56678999999999999999999999999999999997532211112345668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 9999999999999997654 4999999999999999999999999999999999999999999999999999764321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHHhcccCCCCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK----YSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 273 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ...+...+... .......
T Consensus 340 ------~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~ 411 (576)
T 2acx_A 340 ------QTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSER 411 (576)
T ss_dssp ------CCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTT
T ss_pred ------ccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCcc
Confidence 12234589999999999988777 456999999999999999999998753 33444444322 2222357
Q ss_pred CCHHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
+++++.+||.+|| .||.+|| +++|+++||||++..
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 9999999999999 5999999 799999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=372.60 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=218.3
Q ss_pred CCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-----CC
Q psy10194 29 DLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-----HP 103 (357)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ 103 (357)
.+.+-..+...+..++|++.++||+|+||+||+|.+..++..||+|++... ....+...+|+.+++.+. ||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 334444555567789999999999999999999999999999999998642 233455668999999986 99
Q ss_pred CccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---
Q psy10194 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA--- 178 (357)
Q Consensus 104 ~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~--- 178 (357)
||+++++++...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 889999997754 5999999999999999999999999999999999999975
Q ss_pred ----------------------CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHH
Q psy10194 179 ----------------------DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSM 236 (357)
Q Consensus 179 ----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 236 (357)
++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~-~~~Diwsl 245 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---------YHGSIINTRQYRAPEVILNLGWD-VSSDMWSF 245 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---------CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC---------CCcCccCcccccCcHHHcCCCCC-CccchHHH
Confidence 78999999999975321 22356789999999999988774 55999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---------------------------CCC------------------
Q psy10194 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF---------------------------PKD------------------ 271 (357)
Q Consensus 237 G~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~---------------------------~~~------------------ 271 (357)
||++|+|++|+.||...+..+....+...... +..
T Consensus 246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 99999999999999987776665554332111 000
Q ss_pred CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 272 PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 272 ~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
...++.+.+||.+||. ||.+|||+.|+|+||||+
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0124778899999995 999999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=390.67 Aligned_cols=256 Identities=32% Similarity=0.522 Sum_probs=217.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
..+|++.+.||+|+||+||+|.+..++..||+|++.+....... ...+.+|+.+++.++||||+++++++.+...+++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999765432222 34567999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||++|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 999999999999988888999999999999999999999999999999999999975 455999999999765321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---CCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF---PKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 275 (357)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+....++...+...... +....++
T Consensus 193 -----~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 193 -----KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp -----BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred -----ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 12335679999999999874 34 56799999999999999999999999888888777654332 2335789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++.+||.+||. ||.+|||+.++|+||||+..
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999995 99999999999999999763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=374.73 Aligned_cols=253 Identities=32% Similarity=0.516 Sum_probs=217.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch-----HHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-----YLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ .....+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3689999999999999999999999999999999986543221 12344568999999999999999999999999
Q ss_pred eEEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKG-SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999998766 9999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... .... ....+..++
T Consensus 183 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~--~~~~~~~~~ 248 (335)
T 3dls_A 183 G-------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVEA--AIHPPYLVS 248 (335)
T ss_dssp T-------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTTT--CCCCSSCCC
T ss_pred C-------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHhh--ccCCCcccC
Confidence 1 1223467899999999999888867779999999999999999999976321 1111 122334689
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.+||.+|| .||.+|||++++++||||+...
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 99999999999 4999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=393.70 Aligned_cols=258 Identities=32% Similarity=0.552 Sum_probs=221.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||+||+|.+..++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999865322111 134567999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec---CCCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||.+|+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence 99999999999998888899999999999999999999999999999999999995 4567999999999754321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---CCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 275 (357)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+..... .+....++
T Consensus 178 -----~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 178 -----TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp ---------CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred -----CccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 122356799999999999763 4 5679999999999999999999999988888777765432 23335789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+++++||.+||. ||.+|||+.++|+||||+....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999995 9999999999999999987544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=368.46 Aligned_cols=264 Identities=29% Similarity=0.472 Sum_probs=208.3
Q ss_pred ecCEEEE-eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEE
Q psy10194 42 SHGYTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 42 ~~~y~~~-~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~ 119 (357)
.++|++. +.||+|+||+||+|.+..++..||||++....... .+.+.+|+.+++.+ +||||+++++++.+.+.++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679985 78999999999999999999999999997653322 34566899999885 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC---eEEeecccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGFARNHMRY 196 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~ 196 (357)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988888999999999999999999999999999999999999987765 999999998754322
Q ss_pred cccc-ccccccccCCCCCCccchhhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---------------H
Q psy10194 197 RSRQ-GYESLSETFCGSYAYASPEILKG-----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---------------Y 255 (357)
Q Consensus 197 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---------------~ 255 (357)
.... .........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.. .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 1110 00112234569999999999864 234 556999999999999999999997653 2
Q ss_pred HHHHHHHhcc-cCCCC--CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 256 SQLLKQVQSK-VVFPK--DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 256 ~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
..+...+... ..++. ...+++++.+||.+|| .||.+|||+.|+++||||++...
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2334444333 22221 1468999999999999 59999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=365.54 Aligned_cols=253 Identities=24% Similarity=0.449 Sum_probs=218.7
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|...+.||+|+||+||+|.+..+|..||||++....... .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999997654332 3456699999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
|+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------ 195 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------ 195 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence 9999999998864 469999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC--CCCCCCCHHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--PKDPNVSPECKAL 281 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 281 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+...... .....+++.+.++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 12235679999999999988776 45699999999999999999999988877777666544322 2234689999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
|.+|| .||.+|||+.++++||||...
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccC
Confidence 99999 599999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=358.02 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=211.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~l 120 (357)
.++|++.+.||+|+||+||+|.+..++..||+|++......... ...+.+|+..+..+ +||||+++++++.+.+.+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 46799999999999999999999999999999999765444433 34556889998888 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-----------------
Q psy10194 121 IMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD----------------- 179 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~----------------- 179 (357)
||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999764 679999999999999999999999999999999999999844
Q ss_pred --CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH
Q psy10194 180 --YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ 257 (357)
Q Consensus 180 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~ 257 (357)
..++|+|||.+..... .....||+.|+|||++.+....+.++|||||||++|+|++|.+++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS----------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTC----------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred CceEEEEcccccccccCC----------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 4799999999876432 12345899999999998765555679999999999999999988765533
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 258 LLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
...+...........+++++.++|.+||. ||.+|||+.++++||||.+.
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 -WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 23333333333445799999999999995 99999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=372.67 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=214.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc--hHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS--DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
...+|++.+.||+|+||.||+|.+..++..||+|++....... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999999999999999987533221 22334567999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 999999986 898888654 46899999999999999999999999999999999999999999999999999765321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-------
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK------- 270 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~------- 270 (357)
.......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 166 -----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 166 -----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp -----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred -----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 12233567899999999998766556779999999999999999999998887766666543221110
Q ss_pred --------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 271 --------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 271 --------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
...+++++.+||.+||. ||.+|||+.|+++||||.+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 03567999999999995 99999999999999999876544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=374.90 Aligned_cols=266 Identities=28% Similarity=0.471 Sum_probs=215.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC--CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA--PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.+... ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 4679999999999999999999999999999999865321 11223456779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHH----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q psy10194 120 IIMEYAEKGSLLDIIRK----------------------------------------EGYIDETRARKWFAQLVDAINYC 159 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~~l~~L 159 (357)
+||||++||+|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998841 11246788999999999999999
Q ss_pred HhcCCeecCCCCCceEecCCC--CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHH
Q psy10194 160 HERGVVHRDIKCENLLIDADY--NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSM 236 (357)
Q Consensus 160 H~~givH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSl 236 (357)
|+.||+||||||+|||++.++ .+||+|||++.......... ........||+.|+|||++.+. ...+.++|||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE--YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc--cccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999999999999999998776 89999999998653322111 1123356789999999999752 344667999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CC--CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FP--KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 237 G~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
||++|+|++|+.||.+....+....+..... ++ ....+++++.+||.+|| .+|.+||++.++++||||++..+
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999998887777766654433 22 22348999999999999 59999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=364.10 Aligned_cols=255 Identities=29% Similarity=0.523 Sum_probs=220.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|.+.+.||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 46799999999999999999999999999999999754322 234567999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 9999999999999888889999999999999999999999999999999999999 7788999999999865321
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---CCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF---PKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 275 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+...... +....++
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 162 -----GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp -----BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred -----CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 11223468999999999987766 45699999999999999999999998888777777654322 2335789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+++.++|.+|| .||.+|||+.++++||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999 5999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=372.49 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=219.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-----chHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-----SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTH 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~ 116 (357)
.+|.+.+.||+|+||+||+|.+..+|..||||++...... .....+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999998764321 122345677899999998 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC--
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGI-----PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP-- 269 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~-- 269 (357)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...........+.......
T Consensus 254 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 254 -------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp -------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred -------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 122356799999999998632 223566999999999999999999999888777776665443221
Q ss_pred -CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 270 -KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 270 -~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
....+++.+.+||.+|| .||.+|||+.++++||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 22468999999999999 5999999999999999997
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=371.22 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=219.2
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
..+.....++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 34445566789999999999999999999999999999999876543 34445667799999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
.+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999999999999888777889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc---------
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--------- 265 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~--------- 265 (357)
... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||......+....+...
T Consensus 176 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 176 APG------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CCc------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 211 12234578999999999987755577799999999999999999999887765544433211
Q ss_pred -----------cCCCC----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 266 -----------VVFPK----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 266 -----------~~~~~----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
...+. .+.+++.+.+||.+||. ||.+|||+.|+++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 11111 13579999999999995 9999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=376.80 Aligned_cols=265 Identities=22% Similarity=0.366 Sum_probs=214.8
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC--CCCccceEEEEE
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--HPNLIKFLQAIE 113 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~l~~~~~ 113 (357)
....+...+|++.+.||+|+||.||+|.+.. +..||||++...... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp CCEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 3445556679999999999999999999765 889999999765543 344566789999999996 599999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..+.+++||| +.+++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++...
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999999999 56789999999888999999999999999999999999999999999999995 689999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHH
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGI----------PYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLLKQV 262 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~~~~ 262 (357)
..... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... ....+..+
T Consensus 205 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 205 QPDTT----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cCCCc----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 32211 1123456799999999998652 234667999999999999999999998643 22333333
Q ss_pred h-cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 263 Q-SKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 263 ~-~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
. .....+.+...+.++.+||.+|| .||.+|||+.|+++||||+...
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3 33333444567899999999999 5999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=392.08 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=220.2
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|.+.++||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999997543221112345668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999763 4699999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcccCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT----KYSQLLKQVQSKVVFPKD 271 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~----~~~~~~~~~~~~~~~~~~ 271 (357)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. ....+.+.+.... ...+
T Consensus 342 ~~------~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p 413 (543)
T 3c4z_A 342 GQ------TKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYP 413 (543)
T ss_dssp TC------CCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCC
T ss_pred CC------cccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCC
Confidence 11 12335689999999999998777 45699999999999999999999865 3345555544332 2223
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
..+++++.+||.+|| .||.+||+ ++++++||||++..
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 579999999999999 59999996 58999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=378.43 Aligned_cols=255 Identities=27% Similarity=0.505 Sum_probs=204.4
Q ss_pred ecCEEEE-eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHH-HcCCCCCccceEEEEEe----C
Q psy10194 42 SHGYTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFLQAIET----T 115 (357)
Q Consensus 42 ~~~y~~~-~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~l~~~~~~----~ 115 (357)
.++|.+. ++||+|+||+||+|.+..++..||||++... ..+.+|+.++ +..+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3568776 7899999999999999999999999998632 2345788876 55689999999999876 6
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeecccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFA 190 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~ 190 (357)
..+++|||||+||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67899999999999999997643 5999999999999999999999999999999999999987 789999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHh-cc
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ----LLKQVQ-SK 265 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~----~~~~~~-~~ 265 (357)
+..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+... ....+. ..
T Consensus 212 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 212 KETTSH-------NSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp EECC------------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred cccCCC-------CccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 754321 12345688999999999987777 456999999999999999999997654221 222222 22
Q ss_pred cCCC--CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 266 VVFP--KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 266 ~~~~--~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
+.++ ....+++++.+||.+|| .||.+|||+.++++||||......+.
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~ 333 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCC
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCC
Confidence 3332 33579999999999999 59999999999999999987654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=362.85 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=195.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999999999999999996532211222355779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH---- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC----
Confidence 999999999999765 679999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+... ....+..++.++.++
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 167 --EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDL 242 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHH
T ss_pred --CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHH
Confidence 11224568999999999987766 45599999999999999999999876654444433221 122334689999999
Q ss_pred HHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 282 ISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
|.+|| .||.+|||++++++||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999 5999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=359.94 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=217.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 45689999999999999999999999999999999997766666666677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-- 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC----CCCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF----PKDPNVS 275 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~ 275 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.............. ...+.++
T Consensus 166 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 166 ---LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp ------------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred ---ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence 112234578999999999988777 45599999999999999999999988766554443332211 1235789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
+.+.++|.+|| .||.+||+..+.+.+.|..
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999 5999999666655555543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=375.27 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=208.9
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe------
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------ 114 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------ 114 (357)
...+|++.+.||+|+||+||+|.+..++..||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45789999999999999999999999999999999865432 22379999999999999999999843
Q ss_pred --------------------------------CCeEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHH
Q psy10194 115 --------------------------------THRVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINY 158 (357)
Q Consensus 115 --------------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~ 158 (357)
..++++||||+++ +|.+.+. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3458999999985 8777664 35789999999999999999999
Q ss_pred HHhcCCeecCCCCCceEec-CCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHH
Q psy10194 159 CHERGVVHRDIKCENLLID-ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMG 237 (357)
Q Consensus 159 LH~~givH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 237 (357)
||+.||+||||||+|||++ .++.+||+|||++...... ......+||+.|+|||++.+....+.++||||||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999999999999999997 6889999999999765322 1223457899999999998876557789999999
Q ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHhcccC------------------CC----------CCCCCCHHHHHHHHHccc-C
Q psy10194 238 VVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------------------FP----------KDPNVSPECKALISKILA-P 288 (357)
Q Consensus 238 ~il~~ll~G~~pf~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~li~~~L~-~ 288 (357)
|++|+|++|+.||.+.+..+.+..+..... ++ ....+++++.+||.+||. |
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999999998877666555432111 11 123578999999999995 9
Q ss_pred CCCCCCHHhHhcCCcccc
Q psy10194 289 VKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 289 p~~R~s~~e~l~hp~f~~ 306 (357)
|.+|||+.|+++||||+.
T Consensus 310 P~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp GGGSCCHHHHHTSGGGHH
T ss_pred hhhCCCHHHHhcCHHHHH
Confidence 999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=365.45 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=204.6
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.++||+|+||+||+|.+..++..||||++...........+.+.++..+.+..+||||+++++++.+.+.+++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999866554444444444333344455589999999999999999999
Q ss_pred EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 99999 56999888654 46999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-CCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF-PKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 278 (357)
.......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||...... ..+...... .....+++++
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 211 ----GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHHH
T ss_pred ----CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHHH
Confidence 12234568999999999886 44 56799999999999999997776554322 222222211 1224689999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 279 KALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.+||.+||. ||.+|||++|+++||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999995 9999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=370.10 Aligned_cols=266 Identities=28% Similarity=0.433 Sum_probs=219.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC--
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-- 116 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-- 116 (357)
....++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 345678999999999999999999999999999999998766556666677889999999999999999999986654
Q ss_pred --eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 117 --RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 117 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
.+++||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999988899999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC---CC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP---KD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~---~~ 271 (357)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+................+ ..
T Consensus 168 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 168 DSGNS---VTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccc---cccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 22111 112234578999999999988776 456999999999999999999999888776655544333222 12
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..+++++.++|.+|| .||.+||++.+++.|+|++...
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 468999999999999 5999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=368.09 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=218.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||+|+||+||+|.+..++..||||++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998765555555567789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||+.| +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 99974 8888875 456799999999999999999999999999999999999999999999999999975431
Q ss_pred cccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPEC 278 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (357)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...+.......+... ........+++.+
T Consensus 207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 124578999999999852 223356799999999999999999999887766655554433 2233345789999
Q ss_pred HHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 279 KALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 279 ~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+||.+|| .||.+|||++++++||||....
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999999 5999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=374.78 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=202.7
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+......++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp TEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 3444556899999999999999999999999999999999865433 333445667999999999999999999999654
Q ss_pred ------CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 116 ------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 116 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
..+++|+|++ +++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 6799999865 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
++.... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 179 a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTAD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cccccc---------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 975431 12345789999999999875555677999999999999999999999887766555543221111
Q ss_pred ------------------------C------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 270 ------------------------K------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 270 ------------------------~------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
. .+..++++.+||.+||. ||.+|||+.|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 13568999999999995 9999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=371.22 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=216.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-----H 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-----~ 116 (357)
..+|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999986533 333446677999999999999999999999655 4
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+++||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 78999999975 99999865 45999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------- 269 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~------- 269 (357)
.. ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 182 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HD---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GC---BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CC---ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21 11223456899999999998766555777999999999999999999998877655554443211111
Q ss_pred -----------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 270 -----------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 -----------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..+.+++++.+||.+||. ||.+|||+.|+++||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 014578999999999995 999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=369.56 Aligned_cols=258 Identities=24% Similarity=0.433 Sum_probs=211.7
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIE 113 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~ 113 (357)
.-......++|++.+.||+|+||+||+|.+..++..||+|++.... .+.+.+|+.+++.+. ||||+++++++.
T Consensus 28 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp CCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred hhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 3444566789999999999999999999999999999999986432 345679999999997 999999999998
Q ss_pred e--CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccc
Q psy10194 114 T--THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFA 190 (357)
Q Consensus 114 ~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~ 190 (357)
+ ....++||||+.+++|.+++.. +++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 8 6789999999999999998854 89999999999999999999999999999999999999777 8999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhc-----
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQS----- 264 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~----- 264 (357)
...... ......+|++.|+|||++.+....+.++|||||||++|+|++|..||... ...+.+..+..
T Consensus 179 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 179 EFYHPG-------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp EECCTT-------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred eEcCCC-------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 754321 12234578999999999987555577799999999999999999999542 22222211110
Q ss_pred ---------ccC----------------------CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 265 ---------KVV----------------------FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 265 ---------~~~----------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
... ......+++++.+||.+||. ||.+|||++|+|+||||++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 000 00112379999999999995 999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=370.12 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=212.4
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC--CCccceEEEEEe
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH--PNLIKFLQAIET 114 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~l~~~~~~ 114 (357)
...+..++|++.+.||+|+||.||++.+. ++..||+|++...... ....+.+.+|+.+++.++| |||+++++++.+
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 34566778999999999999999999974 5889999999765443 3344667799999999976 999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
...+++|||+ .+++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++....
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999999995 5779999999988999999999999999999999999999999999999996 6789999999997654
Q ss_pred ccccccccccccccCCCCCCccchhhhcC----------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHH
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKG----------IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY--SQLLKQV 262 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~--~~~~~~~ 262 (357)
.... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||..... ......+
T Consensus 159 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 159 PDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccc----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 2211 112335679999999999864 13346679999999999999999999986432 2222333
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
........+...++++.+||.+|| .||.+|||+.|+++||||+....
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 333333444567889999999999 59999999999999999986443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=356.58 Aligned_cols=253 Identities=24% Similarity=0.464 Sum_probs=214.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe----CCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET----THRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~----~~~~ 118 (357)
..|++.+.||+|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34899999999999999999999999999999997655443 335667799999999999999999999865 4668
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEec-CCCCeEEeeccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLID-ADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~ 195 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999964321
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcccCC-CCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQSKVVF-PKDPN 273 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~~~~~-~~~~~ 273 (357)
.......||+.|+|||++.+. .+.++|||||||++|+|++|+.||... ........+...... .....
T Consensus 185 --------~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 185 --------SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred --------cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 122345789999999988753 466799999999999999999999874 444455555443322 22346
Q ss_pred CCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 274 VSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.++++.++|.+||. ||.+|||+.++++||||++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 78999999999995 9999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=372.11 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=219.6
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
...+..++|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 34566789999999999999999999999999999999997643 3444567789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+++||||+++++|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999999999888899999999999999999999996 999999999999999999999999999865421
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH-------------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV------------- 262 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~------------- 262 (357)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+
T Consensus 185 --------~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 185 --------SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp --------HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred --------ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 12234578999999999988776 45699999999999999999999876654432221
Q ss_pred -----------------------------hccc-CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 263 -----------------------------QSKV-VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 263 -----------------------------~~~~-~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.... .......+++++.+||.+||. ||.+|||++|+++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111 111123578999999999995 99999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.78 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=211.9
Q ss_pred cCEEE--EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 43 HGYTL--GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 43 ~~y~~--~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..|.+ .+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 678999999999999999999999999997643 2234567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe--cCCCCeEEeeccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI--DADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999988654 469999999999999999999999999999999999999 56778999999999765321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CC--CCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FP--KDPNV 274 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~ 274 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+..... ++ ....+
T Consensus 243 ------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 243 ------EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp ------CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred ------cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence 12234579999999999987666 5569999999999999999999999888777766654322 22 22478
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
++++.+||.+|| .||.+|||+.|+++||||++.
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999 599999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=358.02 Aligned_cols=261 Identities=29% Similarity=0.487 Sum_probs=222.5
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC------chHHHhhHHHHHHHHHcCC-CCCccceEEEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP------SDYLKKFLPREVEVVKGLK-HPNLIKFLQAIE 113 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~ 113 (357)
..++|++.+.||+|+||.||+|.+..++..||+|++...... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999999999999999999765321 1233456778999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+....++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999764
Q ss_pred cccccccccccccccCCCCCCccchhhhc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILK-----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV- 267 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~- 267 (357)
... .......|++.|+|||++. .....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 175 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 175 DPG-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CTT-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCC-------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 321 1223457899999999985 223335679999999999999999999998887777666654332
Q ss_pred C--CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 F--PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 ~--~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+ +....+++.+.++|.+||. ||.+|||+.++++||||++..
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 2 2224689999999999994 999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=368.41 Aligned_cols=259 Identities=23% Similarity=0.389 Sum_probs=205.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC------
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH------ 116 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~------ 116 (357)
++|++.+.||+|+||.||+|.+..++..||||++..... +...+.+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 579999999999999999999999999999999975442 233566789999999999999999999985543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCCHHHHHHHcC---CCCH
Q psy10194 117 ---------------------------------------------------RVYIIMEYAEKGSLLDIIRKEG---YIDE 142 (357)
Q Consensus 117 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~---~l~~ 142 (357)
.+++|||||++++|.+++.... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999998754 3566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc------cccccccCCCCCCcc
Q psy10194 143 TRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG------YESLSETFCGSYAYA 216 (357)
Q Consensus 143 ~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~gt~~y~ 216 (357)
..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........... ........+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999986543221110 012234567999999
Q ss_pred chhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCH
Q psy10194 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRI 295 (357)
Q Consensus 217 aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~ 295 (357)
|||++.+..+ +.++|||||||++|+|++|..|+.. .......+............++++.+||.+||. ||.+|||+
T Consensus 244 aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 244 SPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp CHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred ChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 9999988776 5569999999999999998776532 122222232222111123467889999999995 99999999
Q ss_pred HhHhcCCcccc
Q psy10194 296 KNIKEDPWFRN 306 (357)
Q Consensus 296 ~e~l~hp~f~~ 306 (357)
+|+++||||++
T Consensus 321 ~~~l~~~~f~~ 331 (332)
T 3qd2_B 321 TDIIENAIFEN 331 (332)
T ss_dssp HHHHHSTTCCC
T ss_pred HHHhhchhhhc
Confidence 99999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=366.45 Aligned_cols=263 Identities=22% Similarity=0.366 Sum_probs=219.2
Q ss_pred EeecCEEEE-eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCe
Q psy10194 40 LESHGYTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHR 117 (357)
Q Consensus 40 ~~~~~y~~~-~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~ 117 (357)
...++|.+. +.||+|+||.||+|.+..++..||+|++......... ...+.+|+.+++.+. ||||+++++++.+...
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345678887 8999999999999999999999999999765433322 345668999999985 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeecccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFARN 192 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~~ 192 (357)
+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 9999999999999999854 367999999999999999999999999999999999999987 78999999999976
Q ss_pred ccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc---CCC
Q psy10194 193 HMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV---VFP 269 (357)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~---~~~ 269 (357)
.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.... ..+
T Consensus 184 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 184 IGHA-------CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp C----------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCc-------cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 5321 12234578999999999988776 456999999999999999999999888777665554322 223
Q ss_pred CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCCC
Q psy10194 270 KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~~ 311 (357)
....+++.+.+||.+||. ||.+|||++++++||||++..+..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 335789999999999995 999999999999999998765543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=373.70 Aligned_cols=260 Identities=26% Similarity=0.401 Sum_probs=208.5
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
+.......++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 95 (371)
T 2xrw_A 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 95 (371)
T ss_dssp TTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecc
Confidence 344445678999999999999999999999999999999999764433 3344566799999999999999999999976
Q ss_pred CC------eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecc
Q psy10194 115 TH------RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFG 188 (357)
Q Consensus 115 ~~------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg 188 (357)
.. .+++||||+.+ +|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 96 QKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 55 78999999975 8888885 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF 268 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~ 268 (357)
++...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 173 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 173 LARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp C-----------------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred cccccccc-------cccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99754321 122346789999999999987774 5699999999999999999999988877666665443221
Q ss_pred CCC--------------------C---------------------CCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 269 PKD--------------------P---------------------NVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 269 ~~~--------------------~---------------------~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
+.. . ..++++.+||.+||. ||.+|||++|+++||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 100 0 015689999999995 9999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=375.41 Aligned_cols=255 Identities=21% Similarity=0.352 Sum_probs=212.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC------CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL------KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~l~~~~~ 113 (357)
....+|++.+.||+|+||+||+|.+..++..||||++... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4567899999999999999999999999999999998642 23345566788888776 5789999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC--eEEeeccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN--IKLSDFGF 189 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~--~kl~Dfg~ 189 (357)
....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999987654 4999999999999999999999999999999999999999887 99999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+.... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 249 a~~~~---------~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 249 SCYEH---------QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp CEETT---------CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceecC---------CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 96432 12235678999999999988777 566999999999999999999999888766655543221111
Q ss_pred C----------------------------------------------------------CCCCCHHHHHHHHHccc-CCC
Q psy10194 270 K----------------------------------------------------------DPNVSPECKALISKILA-PVK 290 (357)
Q Consensus 270 ~----------------------------------------------------------~~~~~~~~~~li~~~L~-~p~ 290 (357)
. ....++++.+||.+||. ||.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0 01247889999999995 999
Q ss_pred CCCCHHhHhcCCccccCCC
Q psy10194 291 TRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 291 ~R~s~~e~l~hp~f~~~~~ 309 (357)
+|||++|+|+||||+....
T Consensus 399 ~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TSCCHHHHHTSTTTC----
T ss_pred hCCCHHHHhCChhhccCCC
Confidence 9999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=356.02 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=219.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 4679999999999999999999999999999999976543221 1245577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998777 89999999997543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC---CC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP---KD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~---~~ 271 (357)
... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+....... ..
T Consensus 164 ~~~-------~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T 3bhy_A 164 AGN-------EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 235 (283)
T ss_dssp ---------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CCC-------cccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence 211 1234568999999999987776 556999999999999999999999988777776665432211 11
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+++.+.++|.+|| .||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 468999999999999 599999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=381.13 Aligned_cols=257 Identities=31% Similarity=0.527 Sum_probs=204.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-----chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-----SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
.++|.+.+.||+|+||+||+|.+..++..||+|++.+.... .......+.+|+.+++.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46899999999999999999999999999999999754211 12223457799999999999999999999854 5
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeEEeeccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIKLSDFGFARNH 193 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~kl~Dfg~~~~~ 193 (357)
.+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998888899999999999999999999999999999999999997544 5999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccCCC-
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVVFP- 269 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~~~- 269 (357)
.. .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...... .....+.......
T Consensus 293 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 293 GE-------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp C------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred CC-------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 32 122345679999999999864 233355799999999999999999999764332 2333333322211
Q ss_pred --CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 270 --KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 270 --~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
....+++.+.+||.+||. ||.+|||++|+++||||++
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 124689999999999995 9999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=357.63 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=203.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.++...++.++||||+++++++.+.+..+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456789999999999999999999999999999999965433 3333444556666688899999999999999999999
Q ss_pred EEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999975 88777643 56799999999999999999999998 99999999999999999999999999997643
Q ss_pred ccccccccccccccCCCCCCccchhhhc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCC-Cc-HHHHHHHHhcccCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TK-YSQLLKQVQSKVVFP 269 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~ll~G~~pf~~-~~-~~~~~~~~~~~~~~~ 269 (357)
.. .......||+.|+|||++. .....+.++|||||||++|+|++|..||.. .. .......+.......
T Consensus 162 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 162 DD-------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred cc-------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 21 1122346899999999973 333346679999999999999999999985 23 333333444443333
Q ss_pred CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 270 KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
....+++++.++|.+||. ||.+|||+.|+++||||+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 445789999999999995 9999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=357.82 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=224.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..+.|++.+.||+|+||.||+|.+..++..||+|++........ .+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 44679999999999999999999999999999999976543322 4557799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||+++++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---
Confidence 9999999999999864 569999999999999999999999999999999999999999999999999997653221
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......|++.|+|||++.+..+. .++||||||+++|+|++|..||...........+...........++..+.+
T Consensus 174 ---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 174 ---IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 249 (303)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHH
T ss_pred ---cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHH
Confidence 112345789999999999887764 5699999999999999999999988877776666555444445678999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
||.+|| .+|.+|||+.++++||||.....
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 999999 59999999999999999976543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=373.67 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=206.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
...+|++.+.||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3457999999999999999999999999999999986532 1233799999999999999999998432
Q ss_pred -CeEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-CCeEEeeccc
Q psy10194 116 -HRVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGF 189 (357)
Q Consensus 116 -~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-~~~kl~Dfg~ 189 (357)
.++++||||+++ +|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 6766654 35679999999999999999999999999999999999999965 5689999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc----
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK---- 265 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~---- 265 (357)
++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 204 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 204 AKQLVRG-------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CEECCTT-------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hhhcccC-------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9864321 11234578999999999987655577799999999999999999999987765544443321
Q ss_pred --------------cCCCC----------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 266 --------------VVFPK----------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 266 --------------~~~~~----------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+.++. .+.+++++.+||.+||. ||.+|||+.|+++||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 11111 13578999999999995 999999999999999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=383.16 Aligned_cols=248 Identities=15% Similarity=0.201 Sum_probs=201.6
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHH---HHHcCCCCCccceE-------EE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE---VVKGLKHPNLIKFL-------QA 111 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~---~l~~l~h~~Iv~l~-------~~ 111 (357)
.++|++.+.||+|+||+||+|.+..++..||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999999999999999998655444445667889995 45555799999998 77
Q ss_pred EEeCCe-----------------EEEEEeecCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHhcCCeec
Q psy10194 112 IETTHR-----------------VYIIMEYAEKGSLLDIIRKEGYIDE-------TRARKWFAQLVDAINYCHERGVVHR 167 (357)
Q Consensus 112 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qi~~~l~~LH~~givH~ 167 (357)
+++.+. .++||||+ +|+|.+++...+.+++ ..++.++.||+.||.|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766542 89999999 5799999987555555 7888899999999999999999999
Q ss_pred CCCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCC-----------CCCCCcccHHHH
Q psy10194 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-----------PYCPQLSDVWSM 236 (357)
Q Consensus 168 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwSl 236 (357)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .+ +.++|||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSl 299 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWAL 299 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHH
Confidence 9999999999999999999999975321 2235577 999999999876 45 567999999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 237 GVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 237 G~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
||++|+|++|+.||.+.........+. .....+++++.+||.+||. ||.+|||+.++++||||+.
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999999997755433222222 2235789999999999995 9999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=370.49 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=209.3
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
+++.......+|++.++||+|+||.||+|.+..++. +|+|.+..... ...+|+.+++.++||||+++++++.
T Consensus 31 ~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~ 102 (394)
T 4e7w_A 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFY 102 (394)
T ss_dssp ESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEE
Confidence 333344556789999999999999999999987765 88887754322 1237999999999999999999995
Q ss_pred eCC------eEEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-CCCCe
Q psy10194 114 TTH------RVYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNI 182 (357)
Q Consensus 114 ~~~------~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-~~~~~ 182 (357)
... .+++||||+++ ++.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp EESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred ecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcE
Confidence 543 38899999987 4444332 356799999999999999999999999999999999999998 79999
Q ss_pred EEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~ 262 (357)
||+|||+++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 182 kL~DFG~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 182 KLIDFGSAKILIAGE-------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp EECCCTTCEECCTTC-------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEeeCCCcccccCCC-------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999997653211 2234578999999999987765677899999999999999999999988766555444
Q ss_pred hccc------------------CCC----------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 263 QSKV------------------VFP----------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 263 ~~~~------------------~~~----------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.... .++ ..+.+++++.+||.+||. ||.+|||+.|+++||||+...+
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 3211 111 113488999999999995 9999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=363.03 Aligned_cols=269 Identities=22% Similarity=0.400 Sum_probs=196.0
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..+..++|++.+.||+|+||.||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 456678999999999999999999999889999999998654322 224456789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRK--------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
.++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF- 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~- 268 (357)
+......... ..........||+.|+|||++.+....+.++|||||||++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 168 SAFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred hheeccCCCc-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 8754322110 01122334578999999999875333466799999999999999999999876654444333222111
Q ss_pred --------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 269 --------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 --------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.....+++++.++|.+||. ||.+|||+.++++||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 1124678999999999995 9999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=366.38 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=215.0
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+...-..++|.+.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3334456899999999999999999999999999999999976443 344456677999999999999999999999876
Q ss_pred CeE------EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 116 HRV------YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 116 ~~~------~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
+.. ++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 654 99999997 48888773 3499999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+..... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 191 a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 191 ARHADA---------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp C-----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccc---------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 975431 12345789999999999885555677999999999999999999999887766655543211111
Q ss_pred ------------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 270 ------------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 ------------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..+.+++++.+||.+||. ||.+|||+.|+++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 013579999999999995 999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.28 Aligned_cols=259 Identities=20% Similarity=0.368 Sum_probs=213.4
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4578999999999999999999999999999999986543222 3456689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999999999865 5679999999999999999999999999999999999999999999999999875432111
Q ss_pred cccccccccCCCCCCccchhhhc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC--CCCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 273 (357)
.......||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+..... ......
T Consensus 172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 172 ----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp ----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred ----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 1122456899999999984 233335679999999999999999999998877766655543322 222346
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
++..+.++|.+|| .||.+|||+.++++||||+...
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 8999999999999 5999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=368.61 Aligned_cols=263 Identities=24% Similarity=0.458 Sum_probs=215.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcC-CCCCccceEEEEEe
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~ 114 (357)
+...+|++.+.||+|+||.||+|.+. .++..||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34578999999999999999999984 58899999998653211 111133455799999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
...+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHHhcccCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDT----KYSQLLKQVQSKVVFP 269 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~----~~~~~~~~~~~~~~~~ 269 (357)
.... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||... ....+...+... ..+
T Consensus 211 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 284 (355)
T 1vzo_A 211 ADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPP 284 (355)
T ss_dssp GGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCC
T ss_pred cCCC-----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCC
Confidence 2211 122346799999999999863 33466799999999999999999999643 233343333322 223
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
....+++.+.+||.+|| .||.+|| +++++++||||+...
T Consensus 285 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 34578999999999999 5999999 999999999998643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=360.26 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=214.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT----- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~----- 115 (357)
..++|++.+.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 3578999999999999999999999999999999986432 333455667999999999999999999988654
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
...++||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 679999999974 99999876 4699999999999999999999999999999999999999999999999999986542
Q ss_pred cccccc----cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---
Q psy10194 196 YRSRQG----YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--- 268 (357)
Q Consensus 196 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--- 268 (357)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 211100 0111234578999999999876555567799999999999999999999988766554443221110
Q ss_pred ----------------------CC------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 269 ----------------------PK------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 ----------------------~~------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+. .+.+++++.+||.+||. ||.+|||+.|+++||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 13689999999999995 9999999999999999987544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=361.62 Aligned_cols=266 Identities=19% Similarity=0.331 Sum_probs=202.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+..++|++.+.||+|+||.||+|.+..++. .||+|++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH-HHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH-HHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 4566789999999999999999999877665 7999999765433333 45677999999999999999999999877
Q ss_pred CeE------EEEEeecCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 116 HRV------YIIMEYAEKGSLLDIIRKEG------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 116 ~~~------~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
... ++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 665 99999999999999986532 589999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~ 262 (357)
|+|||++........ ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+
T Consensus 178 l~Dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDY----YRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp ECCCCC---------------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred Eeecccccccccccc----ccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 999999976532211 111223446788999999987766 556999999999999999 99999998888888877
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCC-------HHhHhcCCccccCCCC
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLR-------IKNIKEDPWFRNGPSR 310 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s-------~~e~l~hp~f~~~~~~ 310 (357)
......+..+.+++++.+||.+|| .||.+||| +++++.|+|+......
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 777666667789999999999999 59999999 8889999999875443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=366.96 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=218.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSS-------RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~ 111 (357)
+..++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 45678999999999999999999864 345679999986542 334455677999999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
+.+.+.+++||||+++|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999997653 4789999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.+||+|||+++....... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCT----TCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEEccccCCcccCcccc----eecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999975432211 112234457889999999988776 556999999999999998 999999988
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
..++...+......+.+..+++++.++|.+|| .+|.+||++.|++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888888777666666789999999999999 599999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=354.83 Aligned_cols=262 Identities=29% Similarity=0.477 Sum_probs=211.6
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
+....+...+|++.+.||+|+||+||+|.+ ++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 333446678999999999999999999987 46789999997655433 334557799999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecCCCCeEEeeccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEGY---IDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
...+++||||+++|+|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999976543 999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVF 268 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~ 268 (357)
+...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....+. .....
T Consensus 186 a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 186 SRLKAST------FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred Ccccccc------ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9753221 112234578999999999988777 456999999999999999999999988877776664 33334
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc--CCcccc
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKE--DPWFRN 306 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~--hp~f~~ 306 (357)
.....+++++.+||.+|| .+|.+|||+.++++ .++++.
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 445679999999999999 59999999999987 455543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=360.81 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=219.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...+|++.+.||+|+||+||+|.+..++. .||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567899999999999999999999976554 49999986543 333456678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+.+++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999654 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
..... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+......+....
T Consensus 203 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 203 DDPDA---AYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp ----C---CEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred cCccc---eeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 32111 112223446788999999987766 456999999999999998 9999999999998888888877777778
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++.+.+||.+|| .||.+|||+.++++
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999 59999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=353.47 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=213.9
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
.....++|++.+.||+|+||.||+|.+..++..||+|.+..... .+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 34556789999999999999999999999999999999976432 2346689999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
+++||||+++++|.+++. ....+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999999996 4567999999999999999999999999999999999999999999999999999764322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNV 274 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 274 (357)
. .......|++.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... .+.....+
T Consensus 179 ~------~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T 3com_A 179 M------AKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251 (314)
T ss_dssp B------SCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred c------cccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence 1 112345689999999999887764 55999999999999999999999877665554443332 22223457
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
++.+.+||.+|| .||.+|||+.++++||||+...
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999 5999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=352.93 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=220.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~ 119 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999999765543 3345667899999999999999999998854 67899
Q ss_pred EEEeecCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----CeecCCCCCceEecCCCCeEEeecccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE----GYIDETRARKWFAQLVDAINYCHERG-----VVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~g-----ivH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999653 34999999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK 270 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~ 270 (357)
....... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+........
T Consensus 164 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 164 RILNHDT------SFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp HHC---C------HHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeecccc------ccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 7543211 11123468999999999988766 4569999999999999999999999888887777766655455
Q ss_pred CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 271 DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
...+++++.++|.+||. +|.+|||+.|+++|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 56789999999999995 99999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=361.16 Aligned_cols=258 Identities=32% Similarity=0.550 Sum_probs=207.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-----chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-----SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
.++|++.+.||+|+||.||+|.+..++..||||++...... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999999999999999998654321 1222345779999999999999999999997765
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC---eEEeeccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGFARNH 193 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~---~kl~Dfg~~~~~ 193 (357)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987654 999999999764
Q ss_pred cccccccccccccccCCCCCCccchhhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccC-CC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILK--GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVV-FP 269 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~-~~ 269 (357)
... ......+||+.|+|||++. +....+.++|||||||++|+|++|..||...... .+...+..... +.
T Consensus 168 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 168 GET-------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CCC-------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ccc-------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 321 1122346899999999974 2333466799999999999999999999764332 22233322211 11
Q ss_pred --CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 270 --KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 270 --~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
....+++.+.+||.+||. ||.+||++.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 124689999999999995 99999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=371.74 Aligned_cols=259 Identities=24% Similarity=0.424 Sum_probs=194.7
Q ss_pred cCEEE-EeEeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCe
Q psy10194 43 HGYTL-GTIIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THR 117 (357)
Q Consensus 43 ~~y~~-~~~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~ 117 (357)
+.|.+ +++||+|+||+||+|.+. .++..||+|++...... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45777 568999999999999965 56889999999754332 345689999999999999999999954 778
Q ss_pred EEEEEeecCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe----cCCCCeEE
Q psy10194 118 VYIIMEYAEKGSLLDIIRKE---------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI----DADYNIKL 184 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll----~~~~~~kl 184 (357)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999999975 888887532 249999999999999999999999999999999999999 67789999
Q ss_pred eeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH--------
Q psy10194 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-------- 256 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-------- 256 (357)
+|||++........ ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 174 ADMGFARLFNSPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CCTTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EECCCceecCCCCc---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999986532111 1122345678999999999988665677899999999999999999999765431
Q ss_pred -HHHHHHhcccCCCCC-------------------------------------CCCCHHHHHHHHHccc-CCCCCCCHHh
Q psy10194 257 -QLLKQVQSKVVFPKD-------------------------------------PNVSPECKALISKILA-PVKTRLRIKN 297 (357)
Q Consensus 257 -~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~li~~~L~-~p~~R~s~~e 297 (357)
+.+..+...+..+.. ...++.+.+||.+||. ||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 233333222222111 1237889999999995 9999999999
Q ss_pred HhcCCccccCCCC
Q psy10194 298 IKEDPWFRNGPSR 310 (357)
Q Consensus 298 ~l~hp~f~~~~~~ 310 (357)
+|+||||...+..
T Consensus 331 ~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQDPYFLEDPLP 343 (405)
T ss_dssp HHTSGGGTSSSCC
T ss_pred HhcChhhccCCCC
Confidence 9999999876544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=357.75 Aligned_cols=262 Identities=28% Similarity=0.561 Sum_probs=216.3
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc-hHHHhhHHHHHHHHHcCCCCCccceEEEE--EeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS-DYLKKFLPREVEVVKGLKHPNLIKFLQAI--ETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~--~~~~~~ 118 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++....... ....+.+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999999999999999986532110 12245677999999999999999999998 445689
Q ss_pred EEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+.++ |.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999875 7777765 457999999999999999999999999999999999999999999999999999765322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. ........||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+.......+.... ......++
T Consensus 163 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~ 237 (305)
T 2wtk_C 163 AA----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCG 237 (305)
T ss_dssp CS----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSC
T ss_pred cc----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccC
Confidence 11 11223456899999999997643 33557999999999999999999999988887777765543 23345789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+.+.+||.+|| .||.+|||+.++++||||+....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999 49999999999999999987544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=351.92 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=219.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++........ ..+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3689999999999999999999999999999999976433222 234567999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC---CCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD---YNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 198 (357)
|||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.+ +.+||+|||++.......
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 9999999999999888889999999999999999999999999999999999999654 469999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---CCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 275 (357)
......|++.|+|||++.+. + +.++||||||+++|+|++|..||.+.+..+....+..... .+....++
T Consensus 179 ------~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 179 ------KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp ------SCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred ------ccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 11234578999999998764 3 5679999999999999999999999888877777654432 22235789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++.++|.+||. ||.+|||+.++++||||+..
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999995 99999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=355.13 Aligned_cols=259 Identities=22% Similarity=0.380 Sum_probs=212.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEe----
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIET---- 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~---- 114 (357)
...++|++.+.||+|+||.||+|.+..++..||+|++...... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3467899999999999999999999999999999999754432 24566899999998 79999999999977
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 115 --THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 115 --~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 56899999999999999999764 57999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
....... .......||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+....
T Consensus 177 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 177 AQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp C-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eecCcCc------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 7643211 11234568999999999872 2233566999999999999999999998877666555544332
Q ss_pred -CCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 267 -VFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 267 -~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.......+++.+.+||.+|| .||.+||++.++++||||++.+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 22234578999999999999 5999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=356.59 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=209.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE------
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE------ 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~------ 113 (357)
...++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4467899999999999999999999999999999998643 2334556779999999999999999999873
Q ss_pred --------eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-CCCCeEE
Q psy10194 114 --------TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKL 184 (357)
Q Consensus 114 --------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-~~~~~kl 184 (357)
+...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4478899999998 599999854 5699999999999999999999999999999999999997 5679999
Q ss_pred eeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy10194 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~ 264 (357)
+|||++......... ........|++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 163 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp CCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCccccccCCCccc---ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999865322111 11223456799999999987655556779999999999999999999998877665555433
Q ss_pred ccCC-----------------------C------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 265 KVVF-----------------------P------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 265 ~~~~-----------------------~------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.... + ..+.+++++.+||.+||. ||.+|||+.++++||||+....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 2211 1 113589999999999995 99999999999999999875543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=369.23 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=220.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|++.+.||+|+||.||+|. +..++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556889999999999999999999 44567789999986433 2333445678999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC---CeE
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG-------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY---NIK 183 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~---~~k 183 (357)
+....++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997643 589999999999999999999999999999999999998555 599
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~ 262 (357)
|+|||+++....... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||......+....+
T Consensus 225 L~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 225 IGDFGMARDIYRAGY----YRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp ECCCHHHHHHHHHSS----CTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ECCCccccccccccc----cccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999975432211 122234567999999999987766 556999999999999998 99999999999888888
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
...........+++.+.+||.+|| .+|.+|||+.+++++.|+.
T Consensus 300 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 877766666789999999999999 5999999999999998774
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=371.76 Aligned_cols=253 Identities=18% Similarity=0.154 Sum_probs=193.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC--CCCCccceE-------EEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL--KHPNLIKFL-------QAIE 113 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~l~-------~~~~ 113 (357)
..|.+.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999887665556667777885444444 699987755 5554
Q ss_pred eC-----------------CeEEEEEeecCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHhcCCeecCC
Q psy10194 114 TT-----------------HRVYIIMEYAEKGSLLDIIRKE-GYIDETRA------RKWFAQLVDAINYCHERGVVHRDI 169 (357)
Q Consensus 114 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qi~~~l~~LH~~givH~dl 169 (357)
.. ..+++||||++ |+|.+++... ..+++..+ ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 7999999763 34555555 677799999999999999999999
Q ss_pred CCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCC
Q psy10194 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGR 247 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~ 247 (357)
||+|||++.++.+||+|||++....... ....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG---------PASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE---------EGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc---------cCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999997643211 13345799999999976 445 66799999999999999999
Q ss_pred CCCCCCcHHHHH--------HHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 248 LPFDDTKYSQLL--------KQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 248 ~pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.||......... ........++..+.+++.+.+||.+|| .||.+|||+.++++||||++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 999865322100 000112233444578999999999999 59999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=363.26 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=202.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe-
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR- 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~- 117 (357)
....++|++.+.||+|+||.||+|.+..++..||||++....... ....+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344578999999999999999999999999999999986543322 234467888888899999999999965433
Q ss_pred ------EEEEEeecCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCCceEecC-CCCeEE
Q psy10194 118 ------VYIIMEYAEKGSLLDIIR----KEGYIDETRARKWFAQLVDAINYCH--ERGVVHRDIKCENLLIDA-DYNIKL 184 (357)
Q Consensus 118 ------~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH--~~givH~dlkp~NIll~~-~~~~kl 184 (357)
+++||||+++ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999987 5554443 4567899999999999999999999 999999999999999996 899999
Q ss_pred eeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhc
Q psy10194 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~ 264 (357)
+|||++...... .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 174 ~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 174 CDFGSAKKLSPS-------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCCTTCBCCCTT-------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCceecCCC-------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 999999765422 1223457899999999998776567789999999999999999999998887766655543
Q ss_pred ccCCC-------------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCCC
Q psy10194 265 KVVFP-------------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 265 ~~~~~-------------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
....+ .....++++.+||.+||. ||.+|||+.|+++||||+.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 21111 112357899999999995 99999999999999999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=365.51 Aligned_cols=258 Identities=22% Similarity=0.405 Sum_probs=217.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH--------------HHhhHHHHHHHHHcCCCCCc
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY--------------LKKFLPREVEVVKGLKHPNL 105 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~I 105 (357)
...++|++.+.||+|+||.||+|.+ ++..||+|++......... ..+.+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4468999999999999999999998 8889999998653221110 11567799999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEe
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDI------IRK--EGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLI 176 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll 176 (357)
+++++++.+.+.+++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999998 655 5679999999999999999999999 999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcH
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY 255 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~ 255 (357)
+.++.++|+|||++...... ......|++.|+|||++.+. .+...++|||||||++|+|++|..||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999764321 22345689999999999877 4444379999999999999999999987765
Q ss_pred -HHHHHHHhcc-cCCCCC-----------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 256 -SQLLKQVQSK-VVFPKD-----------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 256 -~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
.+....+... ..++.. ..+++++.+||.+||. ||.+|||+.|+++||||++.
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 6666666543 222311 5689999999999995 99999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=359.43 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=212.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..-...+|.+.+.||+|+||.||+|.+..++..||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 33456889999999999999999999999999999999976443 34445667799999999999999999999977653
Q ss_pred ------EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 118 ------VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 118 ------~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+++||||+.+ +|.+++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp GGGCCCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred cccceeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 5999999974 8888774 349999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC----
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---- 267 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---- 267 (357)
.... ......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 175 ~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 175 HADA---------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp C-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred CCCC---------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5421 122457899999999998755556779999999999999999999998876655544432110
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 268 --------------------------FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 268 --------------------------~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
....+.+++++.+||.+||. ||.+|||+.++++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 01124679999999999995 999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=348.39 Aligned_cols=252 Identities=20% Similarity=0.373 Sum_probs=216.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||++.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+...+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 466789999999999999999999876 56689999997654332 4467999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999976 5679999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...+.......+............++
T Consensus 175 ~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T 3gen_A 175 Y-----TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 248 (283)
T ss_dssp H-----HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred c-----ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence 1 11223446788999999987766 556999999999999998 9999999998888888887776666678899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+.++|.+|| .+|.+|||+.++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999 599999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=362.50 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=206.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC--------chHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--------SDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4689999999999999999999765 889999998654322 2223466779999999999999999999984
Q ss_pred e-----CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 114 T-----THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 114 ~-----~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
. ...+++||||+.| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 4 3478999999985 888887654 47999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
|++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 179 g~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 179 NLAREDTAD-------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp TC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Ccccccccc-------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999743321 1223457899999999998755557779999999999999999999998877666555532111
Q ss_pred CC-------------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 268 FP-------------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 268 ~~-------------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+ ..+..++.+.+||.+||. ||.+|||+.|+++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 11 113578999999999995 9999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=352.84 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=211.7
Q ss_pred ecCEEEEeEeeecCceEEEEEEEC-CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEE----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSS-RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIE---- 113 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~---- 113 (357)
.++|++.+.||+|+||.||+|.+. .++..||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 6788999999875432211 123445777777665 8999999999987
Q ss_pred -eCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 114 -TTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 114 -~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5677899999998 59999997743 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP- 269 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~- 269 (357)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+......+
T Consensus 168 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 168 RIYSFQ-------MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCCCGG-------GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccCC-------CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 764321 12234578999999999988776 556999999999999999999999887776665554221110
Q ss_pred -------------------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 270 -------------------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 270 -------------------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
....+++.+.+||.+||. ||.+|||+.++++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 124688999999999995 999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=345.22 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=219.0
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 356688999999999999999999987 46689999997654332 4467999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999999999965 4568999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+........+..+++
T Consensus 161 ~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 161 Y-----TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp H-----HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred c-----ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence 1 12223456788999999987766 456999999999999999 9999999998888888887766666677899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+.+++.+|| .+|.+|||+.++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999 599999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=343.62 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=217.5
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 356789999999999999999999876 46679999997654332 3467899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999999999765 459999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...........+........+..+++
T Consensus 159 ~-----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T 3sxs_A 159 Y-----VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD 232 (268)
T ss_dssp E-----EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred h-----hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChH
Confidence 1 112234467789999999877764 45999999999999998 9999999888888888777766666667899
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.+.++|.+||. +|.+|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999994 99999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=364.81 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=219.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 456688999999999999999999999999999999986432 233455677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999999999764 469999999999999999999999999999999999999999999999999997532211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+......+.+..+++
T Consensus 268 ~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 268 Y----AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342 (377)
T ss_dssp E----ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred e----eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 0 011112234678999999987666 556999999999999998 9999999988888888877777777778999
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+||.+||. ||.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999994 9999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=354.64 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=210.1
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC------CccceEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP------NLIKFLQAI 112 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~------~Iv~l~~~~ 112 (357)
...++|++.+.||+|+||+||+|.+ ..++..||+|++... ....+.+.+|+.+++.++|+ +++++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 4567999999999999999999998 567889999998642 23355677899999888654 599999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC------------
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA------------ 178 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~------------ 178 (357)
.+.+.+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 789999998765 6899999999999999999999999999999999999987
Q ss_pred -------CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy10194 179 -------DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD 251 (357)
Q Consensus 179 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~ 251 (357)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE---------HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS---------CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCceEeeCcccccCcc---------ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Confidence 67899999999975321 2234578999999999988776 556999999999999999999998
Q ss_pred CCcHHHHHHHHhcccCC-------------------------------------------CCCCCCCHHHHHHHHHccc-
Q psy10194 252 DTKYSQLLKQVQSKVVF-------------------------------------------PKDPNVSPECKALISKILA- 287 (357)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~L~- 287 (357)
..+..+....+...... ......++++.+||.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 87766554443221110 0111235778999999995
Q ss_pred CCCCCCCHHhHhcCCccccC
Q psy10194 288 PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 288 ~p~~R~s~~e~l~hp~f~~~ 307 (357)
||.+|||+.|+++||||+..
T Consensus 316 dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHH
Confidence 99999999999999999853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=351.61 Aligned_cols=261 Identities=21% Similarity=0.379 Sum_probs=211.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|.+++.||+|+||+||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 46778999999999999999999999999999999988542 344456778999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++.. .+.+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999997654322
Q ss_pred cccc--------cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHHhcccC
Q psy10194 198 SRQG--------YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL--LKQVQSKVV 267 (357)
Q Consensus 198 ~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~--~~~~~~~~~ 267 (357)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 1110 0111225679999999999988776 5569999999999999999999865321100 000000001
Q ss_pred CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 268 FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 ~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
....+.+++.+.++|.+||. ||.+|||+.++++ |++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 11235688999999999995 9999999999998 664
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=359.62 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=221.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFL 109 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~ 109 (357)
..+..++|.+.+.||+|+||.||+|.+.. .+..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 35667899999999999999999999753 33579999986543 233345677999999999 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCc
Q psy10194 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCEN 173 (357)
Q Consensus 110 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~N 173 (357)
+++.+.+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 48999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDD 252 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~ 252 (357)
||++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT----TCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EEEcCCCcEEEcccCcccccccccc----cccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999976532211 112234457889999999988766 556999999999999999 9999999
Q ss_pred CcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 253 TKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
....++.+.+...........+++++.+||.+||. ||.+|||+.+++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998888888877776677899999999999995 99999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=354.22 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=218.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 345678999999999999999999873 455789999986543 2334566779999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCCeecCC
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEGY------------------------IDETRARKWFAQLVDAINYCHERGVVHRDI 169 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~l~~LH~~givH~dl 169 (357)
+.+.+++||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999976543 899999999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy10194 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRL 248 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~ 248 (357)
||+|||++.++.+||+|||++........ ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC----EECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred chheEEEcCCCCEEEcccccccccccccc----ceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999975532211 111223457889999999987666 456999999999999999 999
Q ss_pred CCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 249 PFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 249 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
||.+.........+...........+++++.++|.+|| .||.+||++.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99998888877777776666666789999999999999 599999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=348.33 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=209.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
....++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++...+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 34457899999999999999999999999999999999766555555567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK- 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC--CCCCCCCH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--PKDPNVSP 276 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 276 (357)
........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||.......+...+...... ...+.+++
T Consensus 189 ----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 189 ----LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred ----cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence 112234568999999999987766 45599999999999999999999988776655555544332 23357899
Q ss_pred HHHHHHHHcc-cCCCCCC-CHHhHhc
Q psy10194 277 ECKALISKIL-APVKTRL-RIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~-s~~e~l~ 300 (357)
++.++|.+|| .||.+|| +++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999 5999999 7888776
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=360.15 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=208.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CC-----CccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP-----NLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~Iv~l~~~~~ 113 (357)
...++|++.+.||+|+||+||+|.+..++..||||++... ......+.+|+.+++.+. |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3458999999999999999999999999999999998642 233455667888888775 44 4999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCCceEec--CCCCeEEeec
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCH--ERGVVHRDIKCENLLID--ADYNIKLSDF 187 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH--~~givH~dlkp~NIll~--~~~~~kl~Df 187 (357)
..+.+++||||+.+ +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999965 999999765 46999999999999999999999 57999999999999994 4778999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
|++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 206 G~a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 206 GSSCQLGQ---------RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp TTCEETTC---------CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cCceeccc---------ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99976421 1235678999999999998876 5669999999999999999999998887766655543221
Q ss_pred CCCC-----------------------------------CC----------------------------CCHHHHHHHHH
Q psy10194 268 FPKD-----------------------------------PN----------------------------VSPECKALISK 284 (357)
Q Consensus 268 ~~~~-----------------------------------~~----------------------------~~~~~~~li~~ 284 (357)
.+.. +. .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 1100 00 01478999999
Q ss_pred ccc-CCCCCCCHHhHhcCCccccC
Q psy10194 285 ILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 285 ~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
||. ||.+|||++|+|+||||+..
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hcCCChhhCCCHHHHhcCcccccC
Confidence 995 99999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=356.47 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=219.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999986 345789999987543 3344567789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCC
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE------------------------GYIDETRARKWFAQLVDAINYCHERGVVHRDI 169 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dl 169 (357)
+.+.+++||||+++|+|.+++... ..+++.+++.++.||+.||.|||+.||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 56999999999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy10194 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRL 248 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~ 248 (357)
||+|||++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc----ccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999975432111 112234567899999999987766 556999999999999998 999
Q ss_pred CCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 249 PFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 249 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
||.+....+....+......+....+++++.++|.+|| .||.+|||+.++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999888888887776655556689999999999999 59999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=355.49 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=205.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC--e
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH--R 117 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~--~ 117 (357)
...++|++.+.||+|+||+||+|.+..++..||+|++........ .+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345789999999999999999999999999999999975432222 344568999999999999999999998765 7
Q ss_pred EEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe----cCCCCeEEeecccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI----DADYNIKLSDFGFA 190 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll----~~~~~~kl~Dfg~~ 190 (357)
+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77788999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhc--------CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc----HHHH
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILK--------GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK----YSQL 258 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~----~~~~ 258 (357)
...... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|+.||.... ..+.
T Consensus 164 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 164 RELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCTT-------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred eecCCC-------CceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 765321 1223457899999999986 3444 566999999999999999999996422 2333
Q ss_pred HHHHhcccC--------------------CCCC----CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 259 LKQVQSKVV--------------------FPKD----PNVSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 259 ~~~~~~~~~--------------------~~~~----~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
+..+..... ++.. ..+++.+.++|++||+ ||.+|||++|+++||-
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 333332211 1111 1345688899999995 9999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=363.92 Aligned_cols=253 Identities=19% Similarity=0.310 Sum_probs=203.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC--------CCCccceEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--------HPNLIKFLQ 110 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~Iv~l~~ 110 (357)
.+..++|++.++||+|+||+||+|.+..++..||+|++... ....+.+.+|+.+++.+. |+||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34568999999999999999999999999999999998642 334556778999999885 788999999
Q ss_pred EEE----eCCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCC---
Q psy10194 111 AIE----TTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADY--- 180 (357)
Q Consensus 111 ~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~--- 180 (357)
++. ....+++||||+ +++|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 997 566899999999 55777766543 5699999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------------CeEEeeccccccccccccccccccccccCCCCCC
Q psy10194 181 ----------------------------------------------NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214 (357)
Q Consensus 181 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~ 214 (357)
.+||+|||++..... .....+||+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---------~~~~~~gt~~ 258 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---------HFTEDIQTRQ 258 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---------CSCSCCSCGG
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---------cCccCCCCCc
Confidence 799999999976432 1234578999
Q ss_pred ccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHHhcccCC--------------------
Q psy10194 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK------YSQLLKQVQSKVVF-------------------- 268 (357)
Q Consensus 215 y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~------~~~~~~~~~~~~~~-------------------- 268 (357)
|+|||++.+..+ +.++|||||||++|+|++|+.||...+ ....+..+......
T Consensus 259 y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 259 YRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred ccCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999988776 456999999999999999999997543 12222221110000
Q ss_pred ---------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 269 ---------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 269 ---------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
......++.+.+||.+||. ||.+|||++|+|+||||++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0011235678899999995 9999999999999999973
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=354.33 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=211.6
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEE----EEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEV----AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
....+..++|++.+.||+|+||+||+|.+..++..+ |+|.+..... ....+.+.+|+.+++.++||||++++++
T Consensus 8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp SSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred HHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355677889999999999999999999988777654 6776643321 2224567799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
+.+.. .++|+|++.+|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 98765 7789999999999999976 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+....... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+......+
T Consensus 165 ~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3poz_A 165 KLLGAEEK----EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp HHHTTTCC-----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred eEccCCcc----cccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC
Confidence 76532211 112223456889999999988776 556999999999999999 999999988888877777777777
Q ss_pred CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 270 KDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
....++.++.+++.+|| .+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 77789999999999999 599999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=356.85 Aligned_cols=254 Identities=30% Similarity=0.516 Sum_probs=214.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCC--CCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLK--HPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~l~~~~~ 113 (357)
.....+|++.+.||+|+||.||+|.+..++..||+|++........ ...+.+.+|+.+++.+. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999999999999999999976533221 11234558999999996 599999999999
Q ss_pred eCCeEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-CCCCeEEeeccccc
Q psy10194 114 TTHRVYIIMEYAEK-GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKLSDFGFAR 191 (357)
Q Consensus 114 ~~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-~~~~~kl~Dfg~~~ 191 (357)
..+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999999888999999999999999999999999999999999999998 78899999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD 271 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (357)
.... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... ....... ..
T Consensus 199 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~--~~ 263 (320)
T 3a99_A 199 LLKD--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIRGQVF--FR 263 (320)
T ss_dssp ECCS--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHCCCC--CS
T ss_pred cccc--------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhccccc--cc
Confidence 6432 1223456899999999998777766778999999999999999999976431 1222222 33
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+++++.+||.+|| .||.+|||++++++||||++.
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 578999999999999 599999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=361.18 Aligned_cols=256 Identities=20% Similarity=0.345 Sum_probs=212.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~ 112 (357)
.+..++|++.+.||+|+||.||+|. +..++..||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4566889999999999999999998 55677899999996543 233345677999999999 789999999999
Q ss_pred EeCC-eEEEEEeecCCCCHHHHHHHcCC----------------------------------------------------
Q psy10194 113 ETTH-RVYIIMEYAEKGSLLDIIRKEGY---------------------------------------------------- 139 (357)
Q Consensus 113 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------- 139 (357)
.+.+ .+++||||+++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 7754 48999999999999999976432
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 140 --------------IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 140 --------------l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ...
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----~~~ 251 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVR 251 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT----CEE
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc----chh
Confidence 89999999999999999999999999999999999999999999999999975432211 112
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcH-HHHHHHHhcccCCCCCCCCCHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKY-SQLLKQVQSKVVFPKDPNVSPECKALIS 283 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~ 283 (357)
.....||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+... ......+...........+++++.++|.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 334567899999999987766 456999999999999998 9999987653 3444555555555556679999999999
Q ss_pred Hccc-CCCCCCCHHhHhcC
Q psy10194 284 KILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 284 ~~L~-~p~~R~s~~e~l~h 301 (357)
+||. ||.+|||+.++++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9995 99999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=344.09 Aligned_cols=258 Identities=27% Similarity=0.478 Sum_probs=203.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------- 114 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 35799999999999999999999999999999998642 3335667799999999999999999998855
Q ss_pred ------CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 115 ------THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 115 ------~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
...+++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 467899999999999999997543 5788999999999999999999999999999999999999999999999
Q ss_pred cccccccccccc--------cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHH
Q psy10194 188 GFARNHMRYRSR--------QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQL 258 (357)
Q Consensus 188 g~~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~ 258 (357)
|++......... ...........||+.|+|||++.+....+.++|||||||++|+|++ ||... +....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999765321100 0001223355789999999999876555777999999999999998 66532 33344
Q ss_pred HHHHhcc-cCCC--CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 259 LKQVQSK-VVFP--KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 259 ~~~~~~~-~~~~--~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
...+... ..++ .....++.+.++|.+|| .||.+|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 4444432 1222 23457788999999999 59999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=352.19 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=208.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCC-cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC------ccceEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHS-CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN------LIKFLQAI 112 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~l~~~~ 112 (357)
...++|++.+.||+|+||+||+|.+..++ ..||+|++... ....+.+.+|+.+++.+.|++ ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 35789999999999999999999998776 68999998642 234556778999999887654 89999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe--------------
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI-------------- 176 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll-------------- 176 (357)
.....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 55777777654 369999999999999999999999999999999999999
Q ss_pred -----cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy10194 177 -----DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD 251 (357)
Q Consensus 177 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~ 251 (357)
+.++.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE---------HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS---------CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCcEEEeecCccccccc---------cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCC
Confidence 5678999999999975321 1234578999999999988777 556999999999999999999999
Q ss_pred CCcHHHHHHHHhcccCC-------------------------------------------CCCCCCCHHHHHHHHHccc-
Q psy10194 252 DTKYSQLLKQVQSKVVF-------------------------------------------PKDPNVSPECKALISKILA- 287 (357)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~L~- 287 (357)
..+..+....+...... ......++++.+||.+||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 87766544433221110 0111224588999999995
Q ss_pred CCCCCCCHHhHhcCCccccC
Q psy10194 288 PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 288 ~p~~R~s~~e~l~hp~f~~~ 307 (357)
||.+|||+.|+++||||+..
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGC
T ss_pred ChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=354.92 Aligned_cols=255 Identities=19% Similarity=0.334 Sum_probs=212.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcE----EEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCE----VAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+..++|++.+.||+|+||+||+|.+..++.. ||+|.+....... ....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35668999999999999999999999888776 6777664332211 1234558999999999999999999986
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
....++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45688999999999999999764 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
..... ........|++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..........
T Consensus 166 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 166 PPDDK----QLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240 (325)
T ss_dssp CCCTT----CCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred Ccccc----cccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence 42221 122334567889999999987776 556999999999999999 999999988878777777766666666
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+++++.++|.+|| .||.+|||+.+++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999 599999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=352.25 Aligned_cols=256 Identities=33% Similarity=0.526 Sum_probs=205.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcC----CCCCccceEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGL----KHPNLIKFLQA 111 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~Iv~l~~~ 111 (357)
....++|++.+.||+|+||.||+|.+..++..||+|++........ .....+.+|+.+++.+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999976443221 1223445789999888 89999999999
Q ss_pred EEeCCeEEEEEee-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec-CCCCeEEeeccc
Q psy10194 112 IETTHRVYIIMEY-AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID-ADYNIKLSDFGF 189 (357)
Q Consensus 112 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~-~~~~~kl~Dfg~ 189 (357)
+.+.+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78899999999888899999999999999999999999999999999999999 889999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP 269 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~ 269 (357)
+...... ......|++.|+|||++.+..+.+.++|||||||++|+|++|+.||..... .......
T Consensus 187 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~-- 251 (312)
T 2iwi_A 187 GALLHDE--------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILEAELH-- 251 (312)
T ss_dssp CEECCSS--------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHTCCC--
T ss_pred hhhcccC--------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----HhhhccC--
Confidence 8765321 123456899999999998777766679999999999999999999976421 1222222
Q ss_pred CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 270 KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 270 ~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
....+++.+.++|.+||. +|.+|||++|+++||||+....
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 235689999999999994 9999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=343.99 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=209.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|....+||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+.++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 333444445599999999999999999999999999876432 22456779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeeccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE---GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHMR 195 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 195 (357)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999999764 24679999999999999999999999999999999999987 89999999999976532
Q ss_pred cccccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHHhcccCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--QLLKQVQSKVVFPKDP 272 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~--~~~~~~~~~~~~~~~~ 272 (357)
.. .......|++.|+|||++.+.. ..+.++||||||+++|+|++|+.||...... ................
T Consensus 176 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 176 IN------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp -----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred CC------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 21 1223457899999999987543 2356799999999999999999999754322 2222222222333345
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.+++++.++|.+|| .||.+||++.++++||||+...
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 78999999999999 5999999999999999998643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=345.48 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=206.7
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
..+..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 346678999999999999999999998654 4569999886432 344556778999999999999999999998 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567889999999999999997654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
..... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+......+..+
T Consensus 167 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (281)
T 1mp8_A 167 EDSTY-----YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred Ccccc-----cccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC
Confidence 32211 11223456788999999987666 456999999999999996 999999888777777777766666667
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+++++.++|.+|| .||.+|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999 499999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=347.67 Aligned_cols=268 Identities=22% Similarity=0.352 Sum_probs=212.0
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC--CCCccceEE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK--HPNLIKFLQ 110 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~l~~ 110 (357)
-..+...+..++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+.+|+.+++.+. |+||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344455667788999999999999999999975 4889999999765443 334566779999999997 599999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 111 AIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 111 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
++.+...+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence 9999999999999 55779999999888999999999999999999999999999999999999996 489999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHHHH
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGI----------PYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQLL 259 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~~~ 259 (357)
........ .......+|++.|+|||++.+. ...+.++|||||||++|+|++|+.||.... .....
T Consensus 174 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 174 NQMQPDTT----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccCccc----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 76532211 1122345789999999998752 234567999999999999999999997643 22222
Q ss_pred HH-HhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 260 KQ-VQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 260 ~~-~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.. +............++++.++|.+||. ||.+||++.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 33 33333333445678999999999995 999999999999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=345.95 Aligned_cols=255 Identities=22% Similarity=0.393 Sum_probs=208.0
Q ss_pred EEeecCEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+..++|++.+.||+|+||+||+|. +..++..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 5678899999998643 23345667799999999999999999999854
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 115 --THRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 115 --~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999997654 59999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---------------
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--------------- 256 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~--------------- 256 (357)
....... .........|++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 163 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 163 VLPQDKE---FFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccCCcc---eeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 6542211 1112233456788999999987776 55699999999999999999998653321
Q ss_pred -HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 257 -QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 257 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.....+......+....+++++.++|.+||. ||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2334444555566667899999999999995 9999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=350.08 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=217.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-------CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-------RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQ 110 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~ 110 (357)
.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 566789999999999999999999975 456789999986543 233355677999999999 8999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 111 AIETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 111 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
++.+.+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.++.+||+|||++........ ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY----YKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS----EECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc----ccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999976532211 111223456889999999987666 556999999999999999 99999999
Q ss_pred cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
...+....+......+....+++++.++|.+|| .+|.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888888887776666666789999999999999 499999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=354.06 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=184.5
Q ss_pred EeecCEEEEe-EeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe----
Q psy10194 40 LESHGYTLGT-IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET---- 114 (357)
Q Consensus 40 ~~~~~y~~~~-~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~---- 114 (357)
...++|.+.+ +||+|+||+||+|.+..++..||+|++... .. ...+....++.+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PK---ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3457899955 699999999999999999999999998652 11 12233344677799999999999976
Q ss_pred CCeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeeccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGF 189 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~ 189 (357)
...+++||||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 556899999999999999998653 6999999999999999999999999999999999999976 45599999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----Hh--
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQ----VQ-- 263 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~----~~-- 263 (357)
+..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........... +.
T Consensus 178 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 178 AKETTQ--------NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp CEEC------------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred ceeccc--------cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 975431 12234578999999999977666 4569999999999999999999977654433211 11
Q ss_pred -cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 264 -SKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 264 -~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
.....+....+++++.+||.+|| .||.+|||+.|+++||||+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 297 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence 11222333578999999999999 599999999999999999875433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=350.73 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=219.1
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEE--EEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceE
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEV--AIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFL 109 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~ 109 (357)
....++.+..++|++.+.||+|+||.||+|.+..++..+ |+|.+..... ....+.+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp -CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 344556677889999999999999999999998888765 9998865332 22345677999999999 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCc
Q psy10194 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEG----------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCEN 173 (357)
Q Consensus 110 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~N 173 (357)
+++.+.+.+++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999997654 69999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDD 252 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~ 252 (357)
||++.++.+||+|||++...... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVY-------VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEE-------CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEEcCCCeEEEcccCcCcccccc-------ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999998743211 11223456889999999987666 456999999999999998 9999999
Q ss_pred CcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 253 TKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.+..+....+...........+++++.+||.+||. +|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 245 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99888888887776666667899999999999995 99999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=337.88 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=217.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 45678999999999999999999986 5678999999765433 245679999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+++++|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999999765 5689999999999999999999999999999999999999999999999999976532111
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......|++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+........+..+++.
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 160 -----TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp -----HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred -----cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence 11223456888999999987666 456999999999999999 99999998888888888777666666678999
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+.+++.+|| .+|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999 599999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=358.56 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=208.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC---CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS---RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...+|.+.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 356678999999999999999999876 467789999986543 334456678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999997654 69999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
..... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||......+....+......+....
T Consensus 199 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 274 (373)
T 2qol_A 199 DDPEA---AYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTT
T ss_pred cCCcc---ceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 22110 111122345778999999987766 456999999999999997 9999999988888888887777777778
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
++..+.++|.+|| .+|.+||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999 59999999999876
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=349.38 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=211.1
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEE----EEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEV----AIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
...+..++|++.+.||+|+||+||+|.+..++..+ |+|.+...... ...+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 44567789999999999999999999998887765 55655433222 2245577999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.... .++|++++.+|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8765 7889999999999999976 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPK 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~ 270 (357)
....... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 166 ~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T 3lzb_A 166 LLGAEEK----EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred EccCccc----cccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 6532211 112223456889999999987776 456999999999999999 9999999888888888877777777
Q ss_pred CCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 271 DPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
...+++++.++|.+||. ||.+||++.++++
T Consensus 241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 241 PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77899999999999995 9999999999997
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.96 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=214.7
Q ss_pred EEeecCEEEEe-EeeecCceEEEEEE--ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGT-IIGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~-~Lg~G~~g~Vy~~~--~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...+|.+.+ .||+|+||+||+|. ...++..||+|++...... ....+.+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 45567899998 99999999999995 4567789999999765432 33456678999999999999999999999 56
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 77899999999999999999888899999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
.... ........|++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+...........+
T Consensus 170 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 170 DENY---YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245 (291)
T ss_dssp TCSE---EEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCc---ccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 2211 111223346788999999987666 456999999999999999 99999998888888877776655566689
Q ss_pred CHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 275 SPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 275 ~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+.++|.+||. ||.+||++.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999995 9999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=355.58 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=205.0
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-----------CCCccc
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-----------HPNLIK 107 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~ 107 (357)
.+...+|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.+++.+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 34668999999999999999999999999999999998642 233456678999988876 899999
Q ss_pred eEEEEEeCC----eEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEec---
Q psy10194 108 FLQAIETTH----RVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLID--- 177 (357)
Q Consensus 108 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~--- 177 (357)
+++++.... .+++|||++ +++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999997654 789999999 78999999763 4599999999999999999999998 999999999999994
Q ss_pred ---CCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Q psy10194 178 ---ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK 254 (357)
Q Consensus 178 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~ 254 (357)
..+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCcceEEEcccccccccCC---------CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 344799999999975432 1234578999999999988776 566999999999999999999998643
Q ss_pred H------HHHHHHHhcccC-----------------------------------------CCCCCCCCHHHHHHHHHccc
Q psy10194 255 Y------SQLLKQVQSKVV-----------------------------------------FPKDPNVSPECKALISKILA 287 (357)
Q Consensus 255 ~------~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~li~~~L~ 287 (357)
. ...+..+..... ......+++++.+||.+||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 1 111212111000 01112346789999999995
Q ss_pred -CCCCCCCHHhHhcCCccccCCCC
Q psy10194 288 -PVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 288 -~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
||.+|||+.|+++||||++....
T Consensus 320 ~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 320 LDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp SSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred cCccccCCHHHHhhChhhhcccCc
Confidence 99999999999999999875443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=343.17 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=213.5
Q ss_pred CCCcceEEeecCEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccce
Q psy10194 33 ADGKMTVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108 (357)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l 108 (357)
..-....+..++|++.+.||+|+||.||+|. +..++..||+|++....... ..+.+.+|+.+++.++||||+++
T Consensus 11 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCE
T ss_pred eecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeee
Confidence 3344445667889999999999999999999 56788999999997544222 23557799999999999999999
Q ss_pred EEEEEeC--CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEe
Q psy10194 109 LQAIETT--HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 109 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
++++.+. ..+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEEC
Confidence 9999776 778999999999999999954 4679999999999999999999999999999999999999999999999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC------------
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT------------ 253 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~------------ 253 (357)
|||++........ .........||+.|+|||++.+..+. .++|||||||++|+|++|..|+...
T Consensus 169 Dfg~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 169 DFGLTKAIETDKE---YYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp CCTTCEECCTTCC---EEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred cccccccccCCCc---ceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence 9999976542211 11223345688899999999877664 5699999999999999999886422
Q ss_pred ---cHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 254 ---KYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 254 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
........+......+....+++++.+||.+||. ||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2333445555556666667899999999999995 9999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=338.35 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=200.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc-hHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS-DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
+...+|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45678999999999999999999975 6789999987543322 22235677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCCceEecC--------CCCeEEeec
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG---VVHRDIKCENLLIDA--------DYNIKLSDF 187 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g---ivH~dlkp~NIll~~--------~~~~kl~Df 187 (357)
++||||+++++|.+++. .+.+++..++.++.|++.||.|||+.| |+||||||+|||++. ++.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999885 457999999999999999999999999 899999999999985 778999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-ccc
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKV 266 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~ 266 (357)
|++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+. ...
T Consensus 161 g~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 161 GLAREWHRT--------TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred Ccccccccc--------cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 999754321 1124468999999999987766 556999999999999999999999887766655544 344
Q ss_pred CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 267 VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
..+....+++.+.++|.+||. +|.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 445556799999999999995 99999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=348.18 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=205.9
Q ss_pred CCCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccc
Q psy10194 28 KDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK 107 (357)
Q Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 107 (357)
.+..|..+.-..+...+|++.++||+|+||+||+|++. +..||||++.... .......+|+.+++.++||||++
T Consensus 9 ~~~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~ 82 (322)
T 3soc_A 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQ 82 (322)
T ss_dssp -----CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred ccccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchh
Confidence 45566777777899999999999999999999999876 6799999986432 22334457899999999999999
Q ss_pred eEEEEEeCC----eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc----------CCeecCCCCCc
Q psy10194 108 FLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER----------GVVHRDIKCEN 173 (357)
Q Consensus 108 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------givH~dlkp~N 173 (357)
+++++.... .+++||||+++|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~N 161 (322)
T 3soc_A 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGG
T ss_pred hcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHh
Confidence 999997744 479999999999999999764 599999999999999999999999 99999999999
Q ss_pred eEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCC----CCCcccHHHHHHHHHHHHhCCCC
Q psy10194 174 LLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY----CPQLSDVWSMGVVLFAMVFGRLP 249 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwSlG~il~~ll~G~~p 249 (357)
||++.++.+||+|||++........ .......+||+.|+|||++.+... .+.++|||||||++|+|++|+.|
T Consensus 162 ill~~~~~~kL~DFg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p 237 (322)
T 3soc_A 162 VLLKNNLTACIADFGLALKFEAGKS----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237 (322)
T ss_dssp EEECTTCCEEECCCTTCEEECTTSC----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred EEECCCCeEEEccCCcccccccccC----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence 9999999999999999976542221 112334679999999999986422 23457999999999999999999
Q ss_pred CCCC----------------cHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 250 FDDT----------------KYSQLLKQVQSKVVFPKDP------NVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 250 f~~~----------------~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
|.+. ........+......+... ..++++.+||.+||. ||.+|||+.++++
T Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9653 2223333333222222211 123559999999995 9999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=342.32 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=201.9
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.++......++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.++..+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 344455667899999999999999999999999999999999976543 2333444556666788889999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+.+.+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 999999999999 5566666544 56799999999999999999999995 99999999999999999999999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhccc
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQSKV 266 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~~~ 266 (357)
...... ......||+.|+|||++.. ....+.++|||||||++|+|++|+.||... ...+....+....
T Consensus 174 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (318)
T 2dyl_A 174 RLVDDK-------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246 (318)
T ss_dssp --------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC
T ss_pred hccCCc-------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC
Confidence 543211 1224568999999999952 233456799999999999999999999863 3444444443332
Q ss_pred --CCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 267 --VFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 267 --~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+....+++++.++|.+|| .||.+||+++++++||||+..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 23333468999999999999 599999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=336.71 Aligned_cols=249 Identities=17% Similarity=0.276 Sum_probs=213.1
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC--
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-- 115 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-- 115 (357)
..+..++|++.+.||+|+||.||+|.+. +..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3456678999999999999999999985 7789999997654433 3345677999999999999999999999877
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765 4899999999999999999999999 9999999999999999999999999875
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCC--cccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh-cccCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ--LSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ-SKVVF 268 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~-~~~~~ 268 (357)
... .....||+.|+|||++.+..+... ++|||||||++|+|++|+.||.+.+.......+. .....
T Consensus 162 ~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 162 SFQ-----------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp TTS-----------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred eec-----------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 421 123467999999999987655443 6999999999999999999999887776655544 44444
Q ss_pred CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 269 PKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
..+..+++++.++|.+||. ||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5556799999999999995 9999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=344.51 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=220.1
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3567889999999999999999999999999999999865332 245567999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999999864 45899999999999999999999999999999999999999999999999999765322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+...........++
T Consensus 165 ~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 3kfa_A 165 TY-----TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238 (288)
T ss_dssp SS-----EEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred cc-----ccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence 11 11223346788999999987766 556999999999999999 999999988888888887777777777899
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.+.+||.+||. ||.+|||+.++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999995 9999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=347.78 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=218.3
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 355688999999999999999999876 356789999986543 2233455779999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE----------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999998652 4579999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQV 262 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~ 262 (357)
|+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 179 l~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ECcCccccccccccc----cccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999975432211 112223456889999999987666 556999999999999999 89999998888888887
Q ss_pred hcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 263 QSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
......+....+++.+.++|.+||. +|.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7666555667899999999999995 99999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=346.65 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=214.5
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~ 112 (357)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45667899999999999999999984 45778899999975432 23356678999999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEG------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999997654 489999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
|++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEcCCCCEEEcccccccccccccc----ceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999976543211 112234456889999999987666 566999999999999998 99999876
Q ss_pred cHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 254 KYS-QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
... .....+...........+++++.++|.+||. ||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 543 3444445555555556799999999999995 99999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=336.93 Aligned_cols=255 Identities=19% Similarity=0.209 Sum_probs=209.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHR 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~ 117 (357)
.+..++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.+ +|+|++++++++.....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4567889999999999999999999999999999999865432 23466899999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC-----eEEeeccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN-----IKLSDFGFAR 191 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~-----~kl~Dfg~~~ 191 (357)
.++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 889999998654 6999999999999999999999999999999999999987765 9999999998
Q ss_pred cccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHHhccc-
Q psy10194 192 NHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT---KYSQLLKQVQSKV- 266 (357)
Q Consensus 192 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~---~~~~~~~~~~~~~- 266 (357)
.......... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. ........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 6543222111 0122345679999999999988776 55699999999999999999999873 3333333332211
Q ss_pred CCC---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 267 VFP---KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 267 ~~~---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+ ....+++++.++|.+|| .+|.+||+++++++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 111 12468999999999999 59999999999887
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=343.74 Aligned_cols=248 Identities=18% Similarity=0.300 Sum_probs=208.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCC-------cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHS-------CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
.+..++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999988776 469999986533 2234567799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC--------e
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN--------I 182 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~--------~ 182 (357)
+.+.+..++||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999988887 9
Q ss_pred EEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQ 261 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~ 261 (357)
||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...........
T Consensus 161 kl~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EECCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999998654321 123468899999999875555677999999999999999 5566666666655555
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 262 VQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.......+ ...++++.++|.+||. ||.+|||+.++++|
T Consensus 231 ~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YEDRHQLP--APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55444433 3578899999999995 99999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=351.99 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=212.5
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~ 112 (357)
.+..++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45668999999999999999999997 34566899999975432 22345677999999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCC
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRKEG-----------------------YIDETRARKWFAQLVDAINYCHERGVVHRDI 169 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dl 169 (357)
...+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997643 3799999999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCC
Q psy10194 170 KCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRL 248 (357)
Q Consensus 170 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~ 248 (357)
||+|||++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc----ceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999976532211 112234457889999999987766 556999999999999998 999
Q ss_pred CCCCCcHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCC
Q psy10194 249 PFDDTKYS-QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDP 302 (357)
Q Consensus 249 pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp 302 (357)
||.+.... .....+......+....+++++.+||.+||. ||.+|||+.++++|-
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99876543 3444455555555566789999999999995 999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=349.47 Aligned_cols=276 Identities=20% Similarity=0.347 Sum_probs=216.1
Q ss_pred cccCCCCCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC
Q psy10194 23 EYDKGKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102 (357)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (357)
+.+..++.....+++..+..++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++|
T Consensus 9 ~~~~~~~~~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h 85 (317)
T 2buj_A 9 HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNH 85 (317)
T ss_dssp -------CCSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCC
T ss_pred cccccccceeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCC
Confidence 334445566677888889999999999999999999999999999999999998653 23345667799999999999
Q ss_pred CCccceEEEEE----eCCeEEEEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCce
Q psy10194 103 PNLIKFLQAIE----TTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENL 174 (357)
Q Consensus 103 ~~Iv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NI 174 (357)
|||+++++++. .....++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 86 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NI 165 (317)
T 2buj_A 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNI 165 (317)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 99999999986 34578999999999999999875 46799999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeccccccccccccccc---cccccccCCCCCCccchhhhcCCCC--CCCcccHHHHHHHHHHHHhCCCC
Q psy10194 175 LIDADYNIKLSDFGFARNHMRYRSRQG---YESLSETFCGSYAYASPEILKGIPY--CPQLSDVWSMGVVLFAMVFGRLP 249 (357)
Q Consensus 175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~ll~G~~p 249 (357)
|++.++.++|+|||++........... .........||+.|+|||++.+... .+.++|||||||++|+|++|+.|
T Consensus 166 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp EECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999875432111000 0000123457999999999876542 35679999999999999999999
Q ss_pred CCCCcH--HHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 250 FDDTKY--SQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 250 f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
|..... ......+......+....+++++.++|.+||. ||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 246 YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp THHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 954211 12223334455556667899999999999995 99999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.99 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=213.2
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCC----cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHS----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
.+...+|.+.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456789999999999999999999876543 359999986543 33345567799999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.+.+++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999764 67999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (357)
...... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||......+....+......+...
T Consensus 198 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 198 EDDPEA---TYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cccccc---ccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence 422110 111223346788999999987776 456999999999999998 999999988888888888777777677
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+++.+.++|.+|| .+|.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999 599999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=360.19 Aligned_cols=245 Identities=26% Similarity=0.453 Sum_probs=212.5
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-e
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-R 117 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-~ 117 (357)
.+...+|++.+.||+|+||.||+|.+. +..||||+++.... .+.+.+|+.+++.++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 356678999999999999999999975 56999999975431 345679999999999999999999987665 7
Q ss_pred EEEEEeecCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+++||||+++|+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987543 79999999999999999999999999999999999999999999999999974321
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||......+....+..+...+.+..+
T Consensus 342 ~---------~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~ 411 (450)
T 1k9a_A 342 T---------QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 411 (450)
T ss_dssp --------------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred c---------ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 1 112356889999999988776 556999999999999998 99999988888888888877777777789
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
++++.+||.+|| .||.+|||+.++++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999 59999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=337.79 Aligned_cols=254 Identities=19% Similarity=0.378 Sum_probs=208.9
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHH----hhHHHHHHHHHcCCCCCccceEEE
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLK----KFLPREVEVVKGLKHPNLIKFLQA 111 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~----~~~~~E~~~l~~l~h~~Iv~l~~~ 111 (357)
..+.+..++|++.+.||+|+||.||+|.+..++..||+|++........... +.+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 4556777899999999999999999999999999999999865443322211 567799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEecCCCC-----eE
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLIDADYN-----IK 183 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~~~~~-----~k 183 (357)
+.+.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.++. +|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 97666 6999999999999888654 47999999999999999999999999 999999999999987776 99
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH--HHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI-PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ--LLK 260 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~--~~~ 260 (357)
|+|||++..... ......||+.|+|||++... ...+.++|||||||++|+|++|+.||....... ...
T Consensus 170 l~Dfg~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVH---------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp ECCCTTCBCCSS---------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred eCCCCccccccc---------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 999999974321 22345789999999998432 233566999999999999999999998654332 233
Q ss_pred HH-hcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 261 QV-QSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 261 ~~-~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.+ ...........+++++.++|.+||. ||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33 3334444556799999999999995 9999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=349.72 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=218.0
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEE-----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFL 109 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~ 109 (357)
..+..+...+|++.+.||+|+||.||+|. +..++..||+|++.... .......+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 34455777899999999999999999999 55678899999986433 233345677899999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---C
Q psy10194 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEG-------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---D 179 (357)
Q Consensus 110 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~ 179 (357)
+++.+....++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 99999999999999999999999998753 4899999999999999999999999999999999999984 4
Q ss_pred CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQL 258 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~ 258 (357)
..++|+|||++........ ........|++.|+|||++.+..+ +.++|||||||++|+|++ |..||......+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 254 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASY----YRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254 (327)
T ss_dssp CCEEECCCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ceEEECccccccccccccc----cccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH
Confidence 4699999999875432111 112234457889999999987666 456999999999999998 9999999888888
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
...+...........+++.+.++|.+||. ||.+||++.++++|.|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 88887766666667899999999999995 999999999999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.54 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=203.0
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...+|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34579999999999999999999999999999999976555555566778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999864 456999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHHhcccCCC-CCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT--KYSQLLKQVQSKVVFP-KDPN 273 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~--~~~~~~~~~~~~~~~~-~~~~ 273 (357)
. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+. +.......+......+ ....
T Consensus 190 ~------~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (310)
T 2wqm_A 190 T------TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTT
T ss_pred C------ccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccc
Confidence 1 12234568999999999988766 45699999999999999999999754 3334444444332222 2356
Q ss_pred CCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+++++.++|.+||. ||.+|||+.++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 89999999999994 9999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=346.05 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=215.0
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
..++.++|++.+.||+|+||.||+|. +..++..||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 35778899999999999999999999 5678889999998653 2334566789999999999999999999986
Q ss_pred --eCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccc
Q psy10194 114 --TTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 114 --~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
+...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 56679999999999999999976 456999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH---------------
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY--------------- 255 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~--------------- 255 (357)
........ .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 175 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 175 KLLPLDKD---YYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp EECCTTCS---EEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred eecccCCc---cceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 86532211 1112334567889999999987766 5569999999999999999999965432
Q ss_pred HHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 256 SQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
......+......+....+++++.+||.+||. ||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 23444455555566667899999999999995 99999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=338.98 Aligned_cols=258 Identities=20% Similarity=0.343 Sum_probs=216.2
Q ss_pred EEeecCEEEEe-EeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGT-IIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~-~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...+|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 35567788877 9999999999999853 467789999997643 334456678999999999999999999999 55
Q ss_pred CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 668999999999999999964 3569999999999999999999999999999999999999999999999999997653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
..... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||......+....+......+.+..
T Consensus 162 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 237 (287)
T 1u59_A 162 ADDSY---YTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 237 (287)
T ss_dssp TCSCE---ECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred cCcce---eeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCC
Confidence 22111 112233456889999999987666 456999999999999998 9999998888888777777665556678
Q ss_pred CCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 274 VSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
+++++.++|.+||. +|.+||++.+++++.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999995 9999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=367.14 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=220.2
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+...+|.+.+.||+|+||.||+|.+..++..||||++...... .+.+.+|+.+++.++||||+++++++.+...+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 45678899999999999999999999988999999999754332 34567999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999999763 45899999999999999999999999999999999999999999999999999765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..++.+.+......+.+..++
T Consensus 372 ~-----~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 372 T-----YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp C-----EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred c-----eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 1 111223446788999999987766 556999999999999998 999999988888888888777777777899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++.+||.+|| .||.+|||+.++++
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999999 59999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.22 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=192.3
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHH-HHHcCCCCCccceEEEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVE-VVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~l~~~~~ 113 (357)
.....+..++|++.+.||+|+||.||+|.+..++..||+|++..... ... ...+.+|+. +++.++||||+++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKE-QKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chH-HHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 33445667899999999999999999999999999999999976432 222 233335555 778889999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCCceEecCCCCeEEeec
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRK-----EGYIDETRARKWFAQLVDAINYCHER-GVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~-givH~dlkp~NIll~~~~~~kl~Df 187 (357)
+.+..++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999999986 88888763 56799999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHH
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILK----GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQV 262 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~ 262 (357)
|++....... ......||+.|+|||++. +..+ +.++|||||||++|+|++|+.||...... +....+
T Consensus 171 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 171 GISGQLVDSI-------AKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp SSSCC-------------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred CCceeccccc-------ccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence 9997653211 122346899999999984 3334 56799999999999999999999864321 222111
Q ss_pred hcccC--C--CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 263 QSKVV--F--PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 263 ~~~~~--~--~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
..... . .....+++.+.+||.+|| .||.+|||+.++++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 11111 1 112358999999999999 599999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=343.52 Aligned_cols=253 Identities=18% Similarity=0.249 Sum_probs=206.6
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~ 118 (357)
+...+|++.+.||+|+||+||+|.+..++..||||++..... .+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 455789999999999999999999999999999999875432 23467899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC-----eEEeecccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN-----IKLSDFGFARN 192 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~-----~kl~Dfg~~~~ 192 (357)
++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8899999976 467999999999999999999999999999999999999998887 99999999986
Q ss_pred ccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcc-cC
Q psy10194 193 HMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---YSQLLKQVQSK-VV 267 (357)
Q Consensus 193 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---~~~~~~~~~~~-~~ 267 (357)
......... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ..+....+... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 543221110 0112346689999999999998777 556999999999999999999998743 33333333221 11
Q ss_pred CCC---CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 268 FPK---DPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 268 ~~~---~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+. ...++ ++.++|..|| .||.+||+++++++
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111 12244 9999999999 59999999988776
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.24 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=215.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+...+|.+.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+++.++||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 5667889999999999999999999864 568999999754322 345679999999999999999999986 6678
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999999743 36899999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. .......+++.|+|||++....+ +.++|||||||++|+|++ |+.||.+.+..+....+......+.+..++
T Consensus 338 ~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 338 EY-----TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp HH-----HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred ce-----eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 11 11123346788999999987666 556999999999999999 999999999888888888887777777899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++.+||.+|| .||.+|||+++++.
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999 59999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=345.61 Aligned_cols=256 Identities=20% Similarity=0.346 Sum_probs=212.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAI 112 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~ 112 (357)
.+..++|++.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45678999999999999999999984 4567889999996543 233345677999999999 689999999998
Q ss_pred EeCC-eEEEEEeecCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 113 ETTH-RVYIIMEYAEKGSLLDIIRKEGY----------------IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 113 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
...+ .+++||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 58999999999999999987543 899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+..
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT----SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECCCCCEEECCCccccccccCcc----ceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999999975432111 112223457889999999987766 456999999999999998 999998755
Q ss_pred H-HHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 255 Y-SQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
. ......+...........+++++.++|.+||. +|.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 34445555555555556789999999999995 99999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=335.06 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=211.0
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE-E
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV-Y 119 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~-~ 119 (357)
.|.+.++||+|+||+||+|.+..++. .+|+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57788999999999999999755544 79999986533 333456677999999999999999999999776655 9
Q ss_pred EEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45789999999999999999999999999999999999999999999999999975432211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
. .........+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+......+....+++.
T Consensus 180 ~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 180 Y--SVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp G--CSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred c--ccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHH
Confidence 1 1122334567899999999988776 456999999999999999 55667777777777777777666667789999
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.++|.+|| .+|.+|||+.++++
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999 49999999999887
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=342.04 Aligned_cols=257 Identities=18% Similarity=0.296 Sum_probs=206.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECC---CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+..++|.+.+.||+|+||.||+|.+.. ++..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 4567889999999999999999998765 45589999987654433 3345677999999999999999999999765
Q ss_pred C-----eEEEEEeecCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEE
Q psy10194 116 H-----RVYIIMEYAEKGSLLDIIRK------EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKL 184 (357)
Q Consensus 116 ~-----~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl 184 (357)
. ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 45999999999999999843 356999999999999999999999999999999999999999999999
Q ss_pred eeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHh
Q psy10194 185 SDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQ 263 (357)
Q Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~ 263 (357)
+|||++........ ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+.
T Consensus 189 ~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDY----YRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp CSCSCC--------------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred eecCcceecccccc----cCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 99999976532211 111223456889999999987766 456999999999999999 999999888777777777
Q ss_pred cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 264 SKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 264 ~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
..........+++++.++|.+|| .+|.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66666666789999999999999 599999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=337.26 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=210.8
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECC---CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+..++|.+.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4456789999999999999999998653 34469999987543 233356677999999999999999999998654
Q ss_pred CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 568999999999999999764 469999999999999999999999999999999999999999999999999997653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
.... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........+......+....
T Consensus 165 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (281)
T 3cc6_A 165 DEDY-----YKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred cccc-----cccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCC
Confidence 2211 11223456889999999987666 456999999999999998 9999987777666666666666666678
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+++.+.++|.+|| .+|.+|||+.+++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999 599999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=333.16 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=212.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 34578999999999999999999975 4568999998754432 3456799999999999999999999864 5689
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 999999999999998643 269999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+...........+++
T Consensus 164 ~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 Y-----TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp E-----ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred c-----ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 1 11223456889999999987666 456999999999999999 9999999888888888877766666678999
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+++.+||. +|.+|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999995 9999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=343.87 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=213.4
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCc-----EEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEE
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSC-----EVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQA 111 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~ 111 (357)
..+..++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45667899999999999999999999876654 79999986543 233356677999999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE--------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID 177 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~ 177 (357)
+.+.+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998642 4589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHH
Q psy10194 178 ADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYS 256 (357)
Q Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~ 256 (357)
.++.+||+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN----YIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT----SEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred CCCeEEECccccccccccccc----eeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 999999999999975432211 112233456889999999987766 456999999999999998 99999876543
Q ss_pred H-HHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 257 Q-LLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 257 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
. ....+......+.....++.+.++|.+||. +|.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3 334444455555556789999999999994 9999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=341.22 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=211.8
Q ss_pred CCCCCCCCCcceEEeecCEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC
Q psy10194 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH 102 (357)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (357)
++.....++....+..+.|++.+.||+|+||+||++. +..++..||+|++.... .....+.+.+|+.+++.++|
T Consensus 15 ~~~~~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h 92 (318)
T 3lxp_A 15 LEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYH 92 (318)
T ss_dssp ---------CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCC
T ss_pred eeeeecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCC
Confidence 3445556666667777778999999999999998875 34578899999997543 33445667899999999999
Q ss_pred CCccceEEEEEe--CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC
Q psy10194 103 PNLIKFLQAIET--THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 103 ~~Iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~ 180 (357)
|||+++++++.+ ...+++||||+++++|.+++...+ +++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 93 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~ 171 (318)
T 3lxp_A 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR 171 (318)
T ss_dssp TTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred cchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC
Confidence 999999999987 468999999999999999997654 99999999999999999999999999999999999999999
Q ss_pred CeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH----
Q psy10194 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---- 256 (357)
Q Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---- 256 (357)
.+||+|||++........ .........||+.|+|||++.+..+. .++|||||||++|+|++|..||......
T Consensus 172 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 247 (318)
T 3lxp_A 172 LVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247 (318)
T ss_dssp CEEECCGGGCEECCTTCS---EEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred CEEECCcccccccccccc---ccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhh
Confidence 999999999986543211 11123345678899999999877664 5699999999999999999999754321
Q ss_pred -----------HHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 257 -----------QLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 257 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
.....+......+....+++++.+||.+||. ||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 248 IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2333444455556667899999999999995 9999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.03 Aligned_cols=252 Identities=25% Similarity=0.463 Sum_probs=195.6
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||+||+|.+.. .+|+|++..... .....+.+.+|+.+++.++||||+++++++ .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 5667889999999999999999998643 599999875543 334456678999999999999999999965 56678
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999999954 4569999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccCCCCCCccchhhhc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHHhcccCCCC---
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILK---GIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKVVFPK--- 270 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-~~~~~~~~~~~~~~~--- 270 (357)
. ........||+.|+|||++. +..+ +.++|||||||++|+|++|+.||..... ......+......+.
T Consensus 175 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 175 G----SHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred c----cccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 1 12223457899999999986 3333 5569999999999999999999987544 344444433322221
Q ss_pred -CCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 271 -DPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 271 -~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
...+++++.+||.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 24688999999999994 9999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=348.04 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=201.2
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC---CCcEEEEEEeecCCCCchH--------HHhhHHHHHHHHHcCCCCCccce
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR---HSCEVAIKIISKMQAPSDY--------LKKFLPREVEVVKGLKHPNLIKF 108 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~---~~~~vaiK~i~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~Iv~l 108 (357)
+..++|++.+.||+|+||.||+|.+.. ++..+|+|++......... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345789999999999999999999987 7889999998764321110 11234578889999999999999
Q ss_pred EEEEEe----CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC--Ce
Q psy10194 109 LQAIET----THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY--NI 182 (357)
Q Consensus 109 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~--~~ 182 (357)
++++.. ...+++||||+ +++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 78899999999 899999998777899999999999999999999999999999999999998877 99
Q ss_pred EEeeccccccccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC--CcHHHHH
Q psy10194 183 KLSDFGFARNHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD--TKYSQLL 259 (357)
Q Consensus 183 kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~--~~~~~~~ 259 (357)
||+|||+++.......... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.. .+.....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999976543221111 1112245679999999999988766 5569999999999999999999964 2222221
Q ss_pred HHH---hcccC-----CCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 260 KQV---QSKVV-----FPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 260 ~~~---~~~~~-----~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
... ..... ......+++++.++|.+||. ||.+||+++++++ .++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~ 325 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNP 325 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCT
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhc
Confidence 111 11111 01112689999999999995 9999999999988 4543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=356.33 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=211.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+..+ ..||||++...... .+.+.+|+.+++.++||||+++++++.+ +.+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 45678899999999999999999998754 57999999764432 2456799999999999999999999866 678
Q ss_pred EEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999999964 356999999999999999999999999999999999999999999999999999765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
. ........+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+....+....+......+.+..++
T Consensus 334 ~-----~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 407 (452)
T 1fmk_A 334 E-----YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred c-----eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 1 111123346788999999987766 556999999999999999 999999999888888888887777777899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+.+||.+|| .+|.+|||++++++
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999 59999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=334.52 Aligned_cols=254 Identities=19% Similarity=0.289 Sum_probs=207.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE-EeCCe
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-ETTHR 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-~~~~~ 117 (357)
..+|++.+.||+|+||+||+|.+..+ ...+|+|.+.... .....+.+.+|+.+++.++||||+++++++ .....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34699999999999999999996543 3358899886533 333456677999999999999999999986 45668
Q ss_pred EEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999975 456899999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.... ........||+.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+...........++
T Consensus 182 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 182 EYYS--VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp GGCB--C-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred chhc--cccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 2111 112234567889999999987766 456999999999999999 677888777666666666666555566789
Q ss_pred HHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 276 PECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+.+.++|.+||. +|.+|||+.++++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999995 9999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=333.59 Aligned_cols=244 Identities=26% Similarity=0.446 Sum_probs=204.2
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-CCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-THRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-~~~~ 118 (357)
+..++|++.+.||+|+||+||++.+. +..||+|++.... ..+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 45678999999999999999999874 7799999986533 23456789999999999999999999754 4578
Q ss_pred EEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999999997654 3899999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+...........++
T Consensus 171 ---------~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (278)
T 1byg_A 171 ---------QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred ---------ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCC
Confidence 123356889999999987666 456999999999999998 999999888777777777766666667899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+.++|.+|| .||.+|||+.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999 59999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=336.75 Aligned_cols=261 Identities=23% Similarity=0.383 Sum_probs=206.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECC-CCc--EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSR-HSC--EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
..+..++|++.+.||+|+||+||+|.+.. ++. .||+|++...........+.+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 45667899999999999999999998643 333 689999876544444456677899999999999999999999977
Q ss_pred CCeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.. .++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 78999999999999998763 57999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcc-cCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSK-VVFPKD 271 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~-~~~~~~ 271 (357)
...... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+... ...+..
T Consensus 172 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 172 PQNDDH---YVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CC-CCE---EEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccc---hhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 422111 112234457889999999987666 456999999999999999 99999998888777776543 344555
Q ss_pred CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 272 PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 272 ~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
..+++++.++|.+||. +|.+|||+.++++ +++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~ 280 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLL 280 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHH
Confidence 6899999999999994 9999999999998 454
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=340.45 Aligned_cols=270 Identities=25% Similarity=0.398 Sum_probs=196.4
Q ss_pred CCCCCCCCCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCc
Q psy10194 27 GKDLPDADGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNL 105 (357)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~I 105 (357)
.....+..++...+...+|++.++||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.+. ||||
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i 88 (337)
T 3ll6_A 12 GRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNI 88 (337)
T ss_dssp ---CCSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTB
T ss_pred cchHHHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCCh
Confidence 344455667777888889999999999999999999999999999999985532 333456779999999996 9999
Q ss_pred cceEEEEE--------eCCeEEEEEeecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCC
Q psy10194 106 IKFLQAIE--------TTHRVYIIMEYAEKGSLLDIIRK---EGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCE 172 (357)
Q Consensus 106 v~l~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~ 172 (357)
+++++++. ....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+
T Consensus 89 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~ 167 (337)
T 3ll6_A 89 VQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167 (337)
T ss_dssp CCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGG
T ss_pred hhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcc
Confidence 99999984 3456899999996 599998864 567999999999999999999999999 999999999
Q ss_pred ceEecCCCCeEEeecccccccccccccc------ccccccccCCCCCCccchhhhc--CCCCCCCcccHHHHHHHHHHHH
Q psy10194 173 NLLIDADYNIKLSDFGFARNHMRYRSRQ------GYESLSETFCGSYAYASPEILK--GIPYCPQLSDVWSMGVVLFAMV 244 (357)
Q Consensus 173 NIll~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~ll 244 (357)
|||++.++.+||+|||++.......... .........+||+.|+|||++. .....+.++|||||||++|+|+
T Consensus 168 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp GCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred cEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 9999999999999999998654322110 0001122456899999999984 2223356799999999999999
Q ss_pred hCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCc
Q psy10194 245 FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPW 303 (357)
Q Consensus 245 ~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~ 303 (357)
+|+.||......... ......+.....++.+.+||.+||+ ||.+|||+.|+++|-+
T Consensus 248 ~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 248 FRQHPFEDGAKLRIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCcchhHHHhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999875544332 3334445556788999999999995 9999999999999743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=363.78 Aligned_cols=255 Identities=20% Similarity=0.350 Sum_probs=210.0
Q ss_pred EEeecCEEEEe-EeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGT-IIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~-~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...++.+.+ .||+|+||.||+|.+. .++..||||+++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556677776 8999999999999865 45667999999764322 224567799999999999999999999976
Q ss_pred CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+.+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 568999999999999999965 3469999999999999999999999999999999999999999999999999998653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
..... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+..++...+......+.+..
T Consensus 488 ~~~~~---~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 563 (613)
T 2ozo_A 488 ADDSY---YTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTT
T ss_pred CCCce---eeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 22110 111122345789999999987766 556999999999999998 9999999888888888887777777778
Q ss_pred CCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
+++++.+||.+||. +|.+||++.++++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999994 9999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.50 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=198.7
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
.....+...+|.+.++||+|+||+|+.. ...++..||||++..... ..+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 4455667778999999999999997643 345788999999865322 2345899999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---C--CCeEEeec
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---D--YNIKLSDF 187 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~--~~~kl~Df 187 (357)
+...+++|||||.| +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. + ..+||+||
T Consensus 89 ~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 99999999999975 9999997653 4566678899999999999999999999999999999943 2 35889999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS 264 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~ 264 (357)
|++......... .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+ .
T Consensus 168 G~a~~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~-~ 243 (432)
T 3p23_A 168 GLCKKLAVGRHS---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-G 243 (432)
T ss_dssp TEEECC---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT-T
T ss_pred cceeeccCCCcc---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh-c
Confidence 999765422111 1123356799999999999752 333557999999999999999 99999765544433222 2
Q ss_pred ccCCC---CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 265 KVVFP---KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 265 ~~~~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
..... .....+..+.+||.+||. ||.+|||+.++++||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 21111 112345678999999995 99999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.81 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=206.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------- 114 (357)
..+|++.+.||+|+||.||+|.+..++..||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 457999999999999999999999999999999997542 235589999999999999999999864
Q ss_pred ---------CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 115 ---------THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 115 ---------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ 263 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~ 263 (357)
|+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||... ......+.
T Consensus 163 l~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-------KRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp ECCCTTCEESSCCS-------CCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred ECcchhheeccccc-------cccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 99999987653211 1234568999999999988776 55699999999999999999988532 22333333
Q ss_pred cccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 264 SKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 264 ~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
... ....+++.+.++|.+|| .||.+|||+.++++|.|.-.
T Consensus 233 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 322 23468999999999999 59999999999999987653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=330.37 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=199.6
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE-EeC
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-ETT 115 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-~~~ 115 (357)
+.....++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++|++++..+..+ ...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 444556889999999999999999999999999999998765432 23466899999999987776666555 778
Q ss_pred CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeeccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFAR 191 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~ 191 (357)
+..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 8899999974 5579999999999999999999999999999999999999 788999999999998
Q ss_pred cccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHH-hccc
Q psy10194 192 NHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS---QLLKQV-QSKV 266 (357)
Q Consensus 192 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~---~~~~~~-~~~~ 266 (357)
.......... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... .....+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 6543222111 0112345678999999999988776 55699999999999999999999763321 111121 1111
Q ss_pred CCC---CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 267 VFP---KDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 267 ~~~---~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
..+ ....+++++.++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 121 124689999999999995 9999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=333.81 Aligned_cols=233 Identities=27% Similarity=0.523 Sum_probs=189.5
Q ss_pred cCEEEE-eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHH-HcCCCCCccceEEEEEe----CC
Q psy10194 43 HGYTLG-TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFLQAIET----TH 116 (357)
Q Consensus 43 ~~y~~~-~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~l~~~~~~----~~ 116 (357)
++|.+. +.||+|+||.||+|.+..++..||+|++... ....+|+.++ +.++||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 568777 7899999999999999999999999998642 2345788887 66789999999999987 77
Q ss_pred eEEEEEeecCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeeccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFAR 191 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~ 191 (357)
.+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999999998754 6999999999999999999999999999999999999987 7889999999986
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC-
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK- 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~- 270 (357)
... +..+ +.++|||||||++|+|++|..||....................
T Consensus 169 ~~~----------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 169 ETT----------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp ECT----------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccc----------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 431 0112 4469999999999999999999987654443322222211111
Q ss_pred --C----CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 271 --D----PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 271 --~----~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
. ..+++++.+||.+|| .||.+|||+.|+++||||.+....+.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 1 468999999999999 59999999999999999987654443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.22 Aligned_cols=258 Identities=23% Similarity=0.286 Sum_probs=204.3
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE-Ee
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI-ET 114 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~-~~ 114 (357)
.+.....++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+|+.+++.++|++++..+..+ ..
T Consensus 2 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 2 SMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 34455678999999999999999999999999999999998754432 3466899999999988766666554 67
Q ss_pred CCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeecccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFA 190 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~ 190 (357)
....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 78899999999 8899999974 4579999999999999999999999999999999999999 48889999999999
Q ss_pred ccccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhc-c
Q psy10194 191 RNHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---SQLLKQVQS-K 265 (357)
Q Consensus 191 ~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~---~~~~~~~~~-~ 265 (357)
........... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 86543222110 0112345679999999999988776 5569999999999999999999976321 112222211 1
Q ss_pred cCCC---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 266 VVFP---KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 266 ~~~~---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
...+ ....+++++.++|.+|| .||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111 12468999999999999 49999999999887
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=345.69 Aligned_cols=259 Identities=17% Similarity=0.270 Sum_probs=199.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCC-----CcEEEEEEeecCCCCchHH--------HhhHHHHHHHHHcCCCCCcc
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRH-----SCEVAIKIISKMQAPSDYL--------KKFLPREVEVVKGLKHPNLI 106 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-----~~~vaiK~i~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~Iv 106 (357)
+..++|++.+.||+|+||.||+|.+..+ +..||+|++.......... .....+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999998764 5789999986543110000 01123456667788899999
Q ss_pred ceEEEEEeC----CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec--CC
Q psy10194 107 KFLQAIETT----HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID--AD 179 (357)
Q Consensus 107 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~--~~ 179 (357)
++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998664 5689999999 89999999775 6799999999999999999999999999999999999998 88
Q ss_pred CCeEEeecccccccccccccccc-ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-HHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGY-ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-YSQ 257 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-~~~ 257 (357)
+.+||+|||+++........... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. ...
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999999765433221111 112244569999999999988776 566999999999999999999998532 122
Q ss_pred HHHHHhc----ccC-----CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 258 LLKQVQS----KVV-----FPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 258 ~~~~~~~----~~~-----~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
....... ... ......+++++.+++..|| .+|.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111111 000 0112468999999999999 59999999999886
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=364.88 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=211.0
Q ss_pred eecCEEEE-eEeeecCceEEEEEEE--CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 41 ESHGYTLG-TIIGMGSYATVKLATS--SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 41 ~~~~y~~~-~~Lg~G~~g~Vy~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
....+.+. +.||+|+||.||+|.+ ..++..||||+++..... ....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 33445553 4899999999999954 556788999999764332 2334567799999999999999999999965 45
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 78999999999999999988889999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .........||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+..+....+......+.+..+++
T Consensus 524 ~---~~~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 524 N---YYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 599 (635)
T ss_dssp --------------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred c---ccccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 1 1112223456788999999987776 556999999999999998 9999999999888888888777777778999
Q ss_pred HHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 277 ECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 277 ~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
++.+||.+||. ||.+||++.++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999995 9999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=350.57 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=192.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~l 120 (357)
.+.|.+.++||+|+||+||.+. ..+|..||||++.... .+.+.+|+.+++.+ +||||+++++++.+...+++
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 4568889999999999998754 4578899999986522 23456899999875 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC-------------C
Q psy10194 121 IMEYAEKGSLLDIIRKEGYI-------DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD-------------Y 180 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l-------~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~-------------~ 180 (357)
|||||. |+|.+++...... ++..++.++.||+.||.|||+.||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999996 5999999765432 233457899999999999999999999999999999754 4
Q ss_pred CeEEeeccccccccccccccccccccccCCCCCCccchhhhcC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy10194 181 NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG------IPYCPQLSDVWSMGVVLFAMVF-GRLPFDDT 253 (357)
Q Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~ 253 (357)
.+||+|||++......... ........+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSS--FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EEEECCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEEEcccccceecCCCCcc--ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 7999999999865432211 0112234679999999999975 2344677999999999999998 99999765
Q ss_pred cHHHHHHHHhcccCCCCC-----CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 254 KYSQLLKQVQSKVVFPKD-----PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.... ...+......+.. ..+++++.+||.+|| .||.+|||+.++++||||..
T Consensus 244 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 244 YSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 4333 2222322222221 134588999999999 59999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=347.21 Aligned_cols=254 Identities=19% Similarity=0.284 Sum_probs=199.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE-eCCeE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE-TTHRV 118 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~-~~~~~ 118 (357)
..|.+.+.||+|+||+||+|.+..+ +..||+|.+..... ....+.+.+|+.+++.++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4588999999999999999987543 24689998865332 233556779999999999999999999874 45688
Q ss_pred EEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999999999999999997543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+..+....+........+..+++
T Consensus 247 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~ 323 (373)
T 3c1x_A 247 FDS--VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCH
T ss_pred ccc--ccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 100 111223456889999999987766 456999999999999999 7888987766666666666555555567999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.+.++|.+|| .+|.+|||+.+++++
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999 599999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.21 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=195.0
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc--CCCCCccceEEEEEe---
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG--LKHPNLIKFLQAIET--- 114 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~l~~~~~~--- 114 (357)
...++|++.+.||+|+||+||+|.+ ++..||+|++.... .....+|..++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 57799999986431 2233456666665 789999999998644
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCeecCCCCCceEecCCCCeEEe
Q psy10194 115 -THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH--------ERGVVHRDIKCENLLIDADYNIKLS 185 (357)
Q Consensus 115 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~givH~dlkp~NIll~~~~~~kl~ 185 (357)
...+++||||+++|+|.++++. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3568999999999999999954 56999999999999999999999 9999999999999999999999999
Q ss_pred eccccccccccccccccccccccCCCCCCccchhhhcCCCCC-----CCcccHHHHHHHHHHHHhC----------CCCC
Q psy10194 186 DFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC-----PQLSDVWSMGVVLFAMVFG----------RLPF 250 (357)
Q Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~~ll~G----------~~pf 250 (357)
|||++.......... .......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||
T Consensus 156 Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL--DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CCTTCEEEETTTTEE--ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eCCCeeecccccccc--cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 999997544322111 1122345799999999999876332 2469999999999999999 8888
Q ss_pred CCC-----cHHHHHHHHhcccCCCCC------CCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 251 DDT-----KYSQLLKQVQSKVVFPKD------PNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 251 ~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
... ........+......+.. ...++++.+||.+|| .||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 542 223333333222222211 124578999999999 59999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=333.54 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=198.8
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR 117 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~ 117 (357)
..+..++|++.+.||+|+||+||++.+. +..||+|.+... ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--P 73 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C
Confidence 3456788999999999999999999975 578999998532 224567799999999999999999998864 4
Q ss_pred EEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---cCCeecCCCCCceEecCCCC-eEEeecccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHE---RGVVHRDIKCENLLIDADYN-IKLSDFGFA 190 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~---~givH~dlkp~NIll~~~~~-~kl~Dfg~~ 190 (357)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 789999999999999997654 47899999999999999999999 89999999999999998887 799999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHHhcccCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK--YSQLLKQVQSKVVF 268 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~--~~~~~~~~~~~~~~ 268 (357)
...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .......+......
T Consensus 154 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (307)
T 2eva_A 154 CDIQTH---------MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223 (307)
T ss_dssp --------------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred cccccc---------cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence 754311 123468999999999988766 556999999999999999999997532 33344444444444
Q ss_pred CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 269 PKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 269 ~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+....+++.+.++|.+|| .||.+|||++++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 555679999999999999 59999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=352.75 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=200.8
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC--eE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH--RV 118 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~--~~ 118 (357)
..++|++.++||+|+||+||+|.+..++..||+|++........ .+.+.+|+.+++.++||||+++++++.... ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 45789999999999999999999999999999999975432221 344568999999999999999999998765 78
Q ss_pred EEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe----cCCCCeEEeeccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI----DADYNIKLSDFGFAR 191 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll----~~~~~~kl~Dfg~~~ 191 (357)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999996543 39999999999999999999999999999999999999 777789999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCC-------CCCCCcccHHHHHHHHHHHHhCCCCCCCC----cHHHHHH
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGI-------PYCPQLSDVWSMGVVLFAMVFGRLPFDDT----KYSQLLK 260 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~ll~G~~pf~~~----~~~~~~~ 260 (357)
..... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||... ...+.+.
T Consensus 165 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 165 ELEDD-------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp ECCCG-------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred EccCC-------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 65322 122346789999999998641 22245699999999999999999999642 2233333
Q ss_pred HHhcccC--------------------CCCC----CCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 261 QVQSKVV--------------------FPKD----PNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 261 ~~~~~~~--------------------~~~~----~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.+..... .+.. ..+++.+.++|.+|| .||.+||+++++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 3332211 1111 124567889999999 59999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=359.33 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=215.7
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+..+ ..||||++...... .+.+.+|+.+|+.++||||+++++++.+ ..+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 45678899999999999999999998754 57999999764432 2456799999999999999999999866 678
Q ss_pred EEEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+.+|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999964 356999999999999999999999999999999999999999999999999999765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
.. .......++..|+|||++.+..+ +.++|||||||++|+|++ |+.||.+....++...+......+....++
T Consensus 417 ~~-----~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 490 (535)
T 2h8h_A 417 EY-----TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490 (535)
T ss_dssp HH-----HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ce-----ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 11 11123346788999999987666 556999999999999999 999999999888888888887777777899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++.+||.+|| .||.+|||++++++
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999 59999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.79 Aligned_cols=253 Identities=20% Similarity=0.318 Sum_probs=203.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 3468999999999999999999964 688999998865432 224567799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEG----YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986543 5899999999999999999999999999999999999999999999999999754322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHH------HH-HHhcc-cC-
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL------LK-QVQSK-VV- 267 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~------~~-~~~~~-~~- 267 (357)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+. .. ..... +.
T Consensus 193 ~~----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 193 DQ----THLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp SC----CCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred cc----cccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 11 112234568999999999987766 5669999999999999999999975432211 11 11110 10
Q ss_pred -------CCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCC
Q psy10194 268 -------FPKDPNVSPECKALISKIL-APVKTRLRIKNIKEDP 302 (357)
Q Consensus 268 -------~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp 302 (357)
....+..+..+.+++.+|| .||.+|||+.+++++-
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0111234577899999999 4999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=340.41 Aligned_cols=249 Identities=17% Similarity=0.246 Sum_probs=201.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECC--------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccc------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSR--------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIK------ 107 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~------ 107 (357)
.++|++.+.||+|+||.||+|.+.. .+..||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999987 4789999998753 34668999999999999887
Q ss_pred ---------eEEEEEe-CCeEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 108 ---------FLQAIET-THRVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 108 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
+++++.. ...+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777766 78899999999 89999999875 78999999999999999999999999999999999999
Q ss_pred ecCCC--CeEEeeccccccccccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy10194 176 IDADY--NIKLSDFGFARNHMRYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD 252 (357)
Q Consensus 176 l~~~~--~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~ 252 (357)
++.++ .+||+|||++........... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 899999999986543222111 1112234579999999999988766 5569999999999999999999986
Q ss_pred Cc--HHHHHHHHh---cccC-CC----CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 253 TK--YSQLLKQVQ---SKVV-FP----KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 253 ~~--~~~~~~~~~---~~~~-~~----~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.. ...+..... .... +. ....+++++.+||.+|| .||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 333332222 1111 11 11257999999999999 59999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=341.78 Aligned_cols=249 Identities=16% Similarity=0.242 Sum_probs=197.3
Q ss_pred CcceEEeecCEEEEeEeeecCceEEEEE-----EECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC---CCCcc
Q psy10194 35 GKMTVLESHGYTLGTIIGMGSYATVKLA-----TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLI 106 (357)
Q Consensus 35 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv 106 (357)
.....+..++|.+.+.||+|+||+||+| .+..++..||+|++.... ...+.+|+.+++.++ |+||+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhh
Confidence 3445567788999999999999999999 467788999999986532 234557888888886 89999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---
Q psy10194 107 KFLQAIETTHRVYIIMEYAEKGSLLDIIRK-----EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA--- 178 (357)
Q Consensus 107 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~--- 178 (357)
++++++...+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 999999999999999999999999999974 457999999999999999999999999999999999999988
Q ss_pred --------CCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy10194 179 --------DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF 250 (357)
Q Consensus 179 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf 250 (357)
++.+||+|||++........ .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPK----GTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCT----TEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCC
T ss_pred CccccccccCCEEEeeCchhhhhhccCC----CceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCcc
Confidence 89999999999975432211 123345689999999999998876 56699999999999999999999
Q ss_pred CCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHh
Q psy10194 251 DDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIK 299 (357)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l 299 (357)
........ .....+. ....++.+.+++..||. +|.+|++..+.+
T Consensus 286 ~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 286 VKNEGGEC----KPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp EEEETTEE----EECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ccCCCCce----eechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 65432110 0001111 11357789999999995 888886544333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=334.98 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=208.8
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEE----ECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLAT----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
...+..++|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 345677889999999999999999998 46688999999986532 23355677999999999999999999998
Q ss_pred EeC--CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 113 ETT--HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 113 ~~~--~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
... ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 654 3789999999999999999775 4699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH--------------
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-------------- 255 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~-------------- 255 (357)
+......... ........++..|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 192 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEY---YKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSE---EECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred hhhccccccc---cccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 9765422111 111233456788999999987766 4569999999999999999999864311
Q ss_pred --HHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 256 --SQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 256 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+.+.+......+....+++++.++|.+|| .+|.+|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223334444445556689999999999999 59999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=330.87 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=194.6
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC--CCCCccceEEEEEeC---
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL--KHPNLIKFLQAIETT--- 115 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~l~~~~~~~--- 115 (357)
..++|++.+.||+|+||.||+|.+. +..||+|++.... .....+|..++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3468999999999999999999975 7799999986432 12223455555544 899999999999887
Q ss_pred -CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCeecCCCCCceEecCCCCeEEee
Q psy10194 116 -HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER--------GVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 116 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------givH~dlkp~NIll~~~~~~kl~D 186 (357)
..+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7899999999999999999664 699999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCCC-----cccHHHHHHHHHHHHhC----------CCCCC
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQ-----LSDVWSMGVVLFAMVFG----------RLPFD 251 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlG~il~~ll~G----------~~pf~ 251 (357)
||++.......... .......+||+.|+|||++.+...... ++|||||||++|+|++| ..||.
T Consensus 186 fg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 186 LGLAVKFISDTNEV--DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeeccccccc--cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99997554222111 112235679999999999987665443 38999999999999999 77775
Q ss_pred CC-----cHHHHHHHHhcccCCCCC------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 252 DT-----KYSQLLKQVQSKVVFPKD------PNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 252 ~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.. ........+......+.. ..+++++.+||.+||. ||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 42 222333333222211111 2456779999999995 99999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=336.96 Aligned_cols=257 Identities=19% Similarity=0.294 Sum_probs=202.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++........ ...+.+|+.+++.++||||+++++++.+....
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 445678999999999999999999854 688999999875432221 23467999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEG----YIDETRARKWFAQLVDAINYCHER---GVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~---givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997543 499999999999999999999999 99999999999999999999999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHHhccc
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK-----YSQLLKQVQSKV 266 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~-----~~~~~~~~~~~~ 266 (357)
...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+....
T Consensus 183 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 183 LMDYKD-----THVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp ECCSSS-----SCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccCccc-----ccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 653211 122334568999999999987766 556999999999999999999995211 111111111111
Q ss_pred C---CC----------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcc
Q psy10194 267 V---FP----------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 267 ~---~~----------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f 304 (357)
. .. .....++.+.+++.+||. ||.+|||+.++++|-+-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0 00 011234789999999994 99999999999997543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=334.68 Aligned_cols=263 Identities=19% Similarity=0.327 Sum_probs=210.5
Q ss_pred cceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 36 KMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 36 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+...+..++|++.+.||+|+||.||+|.+.. .+|+|++........ ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3344567889999999999999999999764 499999875433222 234456899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999997654 699999999999999999999999999999999999998 7899999999987543
Q ss_pred ccccccccccccccCCCCCCccchhhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGI--------PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV 266 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~ 266 (357)
...... .........|++.|+|||++.+. ...+.++|||||||++|+|++|..||...........+....
T Consensus 181 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 181 VLQAGR-REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred cccccc-cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 221111 11223345689999999999752 233567999999999999999999999988887777766554
Q ss_pred CCCC-CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 267 VFPK-DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 267 ~~~~-~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.... ...+++++.++|.+|| .+|.+|||+.++++ .++.
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~ 299 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEK 299 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTT
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHH
Confidence 4332 2368899999999999 49999999999998 5544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=332.08 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=199.7
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCC-CchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA-PSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
|..++.||+|+||.||+|.+ ++..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999986 567999999865432 233445677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 124 YAEKGSLLDIIRK---EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 124 ~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--
Confidence 9999999999963 35699999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHHhcc----------c
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQ----LLKQVQSK----------V 266 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~----~~~~~~~~----------~ 266 (357)
........||+.|+|||++.+. + +.++|||||||++|+|++|..||....... +...+... .
T Consensus 189 --~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 189 --TVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp --CEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred --cccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 1123345789999999998763 3 567999999999999999999997654322 22222111 0
Q ss_pred CCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 267 VFPKDPNVSPECKALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 267 ~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
........+..+.+++.+||. +|.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011112345778999999994 99999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=356.25 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=212.9
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCC---CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRH---SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+...+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998643 4568999876432 3444567789999999999999999999984 4
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 56899999999999999997654 68999999999999999999999999999999999999999999999999998653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
.... .......|++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+......+.++.
T Consensus 543 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 616 (656)
T 2j0j_A 543 DSTY-----YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616 (656)
T ss_dssp C---------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCcc-----eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 2211 11223456789999999987766 556999999999999997 9999999988888888877766666678
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++.+.++|.+|| .||.+|||+.++++
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 59999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=330.76 Aligned_cols=265 Identities=20% Similarity=0.302 Sum_probs=191.7
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe---
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--- 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--- 114 (357)
..+..++|++.+.||+|+||.||+|.. ++..||+|++..... .......|+..+..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 445678999999999999999999976 577999999864321 11111234444455899999999986542
Q ss_pred --CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---------CCeecCCCCCceEecCCCCeE
Q psy10194 115 --THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER---------GVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 115 --~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------givH~dlkp~NIll~~~~~~k 183 (357)
...+++||||+++|+|.+++.... +++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 336789999999999999997654 58999999999999999999999 999999999999999999999
Q ss_pred Eeecccccccccccccc--ccccccccCCCCCCccchhhhcCCC------CCCCcccHHHHHHHHHHHHhCCCCCCCCc-
Q psy10194 184 LSDFGFARNHMRYRSRQ--GYESLSETFCGSYAYASPEILKGIP------YCPQLSDVWSMGVVLFAMVFGRLPFDDTK- 254 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~ll~G~~pf~~~~- 254 (357)
|+|||++.......... .........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654221110 1112233557999999999998631 22346899999999999999977763211
Q ss_pred -----------------HHHHHHHHhcccCCCCC-------CCCCHHHHHHHHHccc-CCCCCCCHHhH------hcCCc
Q psy10194 255 -----------------YSQLLKQVQSKVVFPKD-------PNVSPECKALISKILA-PVKTRLRIKNI------KEDPW 303 (357)
Q Consensus 255 -----------------~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~-~p~~R~s~~e~------l~hp~ 303 (357)
.......+......+.. ..+++++.+||.+||. ||.+|||+.|+ +.++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11111222221111111 1244579999999995 99999999999 55677
Q ss_pred cccCCC
Q psy10194 304 FRNGPS 309 (357)
Q Consensus 304 f~~~~~ 309 (357)
-++...
T Consensus 321 ~~~~~~ 326 (336)
T 3g2f_A 321 ERNKSV 326 (336)
T ss_dssp CC----
T ss_pred HhcccC
Confidence 766443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.74 Aligned_cols=254 Identities=21% Similarity=0.263 Sum_probs=203.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~~~ 118 (357)
...++|++.++||+|+||.||+|.+..++..||||++...... ..+.+|+.+++.+.| ++|..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4567899999999999999999999999999999998654432 346689999999986 5666666677888999
Q ss_pred EEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe---cCCCCeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI---DADYNIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~ 194 (357)
++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 5679999999999999999999999999999999999999 688999999999998654
Q ss_pred cccccccc-ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHHhccc-CC-
Q psy10194 195 RYRSRQGY-ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY---SQLLKQVQSKV-VF- 268 (357)
Q Consensus 195 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~---~~~~~~~~~~~-~~- 268 (357)
........ .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ...+..+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 32221110 112235679999999999988776 5569999999999999999999986432 22232222111 11
Q ss_pred --CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 269 --PKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 269 --~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
.....+++++.+||..|| .+|.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111468999999999999 59999999887654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=327.24 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=200.2
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHc--CCCCCccceEEEEEeCC--
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG--LKHPNLIKFLQAIETTH-- 116 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~l~~~~~~~~-- 116 (357)
..++|.+.+.||+|+||.||+|.+ ++..||+|++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 347899999999999999999997 47899999986421 2345578888887 78999999999998876
Q ss_pred --eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCeecCCCCCceEecCCCCeEEee
Q psy10194 117 --RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH--------ERGVVHRDIKCENLLIDADYNIKLSD 186 (357)
Q Consensus 117 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~givH~dlkp~NIll~~~~~~kl~D 186 (357)
.+++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 899999999999999999764 5899999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccccccccccccCCCCCCccchhhhcCCCCCC-----CcccHHHHHHHHHHHHhC----------CCCCC
Q psy10194 187 FGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP-----QLSDVWSMGVVLFAMVFG----------RLPFD 251 (357)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlG~il~~ll~G----------~~pf~ 251 (357)
||++.......... ........||+.|+|||++.+..... .++|||||||++|+|++| ..||.
T Consensus 191 fg~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 191 LGLAVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CTTCEEEETTTTEE--EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceecccccccc--ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99997654322110 11234557899999999997653322 468999999999999999 78987
Q ss_pred CC-----cHHHHHHHHhcccCCCCC------CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 252 DT-----KYSQLLKQVQSKVVFPKD------PNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 252 ~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
.. ....+...+......+.. ...++.+.+||.+|| .||.+|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 54 234444444333222211 123467899999999 599999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.59 Aligned_cols=247 Identities=17% Similarity=0.202 Sum_probs=191.8
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCc---------cc-----
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNL---------IK----- 107 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~I---------v~----- 107 (357)
..|.++++||+|+||.||+|.+..++..||||++...........+.+.+|+.+++.+.| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999875444443335667899999999976 221 11
Q ss_pred -------eEEEEEe-----CCeEEEEEeecCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Q psy10194 108 -------FLQAIET-----THRVYIIMEYAEKGSLLDIIRK-------EGYIDETRARKWFAQLVDAINYCHERGVVHRD 168 (357)
Q Consensus 108 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~givH~d 168 (357)
+..++.. ...++++|+++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 23467888877 4699998841 23477889999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhc----------CCCCCCCcccHHHHHH
Q psy10194 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK----------GIPYCPQLSDVWSMGV 238 (357)
Q Consensus 169 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DiwSlG~ 238 (357)
|||+|||++.++.+||+|||+++..... ....+| +.|+|||++. +..+ +.++|||||||
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGv 305 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGL 305 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHH
Confidence 9999999999999999999998754321 335678 9999999993 3333 55799999999
Q ss_pred HHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 239 VLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 239 il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
++|+|++|+.||...+.......+ +.....+++++.+||.+||. ||.+||++.++++||||+.
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999999999876544332222 22334789999999999995 9999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=359.63 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=203.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe------C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------T 115 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------~ 115 (357)
.++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 378999999999999999999999999999999986542 33445667799999999999999999998755 6
Q ss_pred CeEEEEEeecCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCC---eEEeeccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEG---YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYN---IKLSDFGF 189 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~---~kl~Dfg~ 189 (357)
+..++||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999997644 6899999999999999999999999999999999999987765 99999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHH------
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL-KQV------ 262 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~-~~~------ 262 (357)
+...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ..+
T Consensus 171 a~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQG-------ELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSC-------CCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccc-------cccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9765321 12235678999999999988777 45599999999999999999999764322110 000
Q ss_pred --------hcccCC----CC----CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 263 --------QSKVVF----PK----DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 263 --------~~~~~~----~~----~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.....+ +. ...+++.+.++|.+||. ||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000111 11 12357889999999995 9999999999999999965
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.69 Aligned_cols=244 Identities=15% Similarity=0.198 Sum_probs=191.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-----chHHHhhHHHHHHHHHcCC---------CCCcc
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-----SDYLKKFLPREVEVVKGLK---------HPNLI 106 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~Iv 106 (357)
..++|++.+.||+|+||+||+|++ ++..||||++...... .....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 356799999999999999999998 5789999999865422 1112245668999988875 77777
Q ss_pred ceEEEEE------------------------------eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH
Q psy10194 107 KFLQAIE------------------------------TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156 (357)
Q Consensus 107 ~l~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l 156 (357)
++.+++. +...+++|||||++|++.+.+.+ +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 7777642 27889999999999977666643 5689999999999999999
Q ss_pred HHHH-hcCCeecCCCCCceEecCCC--------------------CeEEeeccccccccccccccccccccccCCCCCCc
Q psy10194 157 NYCH-ERGVVHRDIKCENLLIDADY--------------------NIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY 215 (357)
Q Consensus 157 ~~LH-~~givH~dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y 215 (357)
.||| ++||+||||||+|||++.++ .+||+|||+++.... ...+||+.|
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----------~~~~gt~~y 243 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------TEEECCCCT
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------CcEEEeecc
Confidence 9999 99999999999999999887 899999999986431 134789999
Q ss_pred cchhhhcCCCCCCCcccHHHHHHH-HHHHHhCCCCCCCCcH-HHHHHHHhcccCCCC------CCCCCHHHHHHHHHccc
Q psy10194 216 ASPEILKGIPYCPQLSDVWSMGVV-LFAMVFGRLPFDDTKY-SQLLKQVQSKVVFPK------DPNVSPECKALISKILA 287 (357)
Q Consensus 216 ~aPE~~~~~~~~~~~~DiwSlG~i-l~~ll~G~~pf~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~ 287 (357)
+|||++.+.. +.++||||||++ .++++.|..||....+ ......+........ .+.+++++.+||++||.
T Consensus 244 ~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 244 MDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp TCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred cChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 9999998765 567999998777 7778899999965332 222333332222211 12478999999999996
Q ss_pred -CCCCCCCHHhHh-cCCccc
Q psy10194 288 -PVKTRLRIKNIK-EDPWFR 305 (357)
Q Consensus 288 -~p~~R~s~~e~l-~hp~f~ 305 (357)
| |++|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 4 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.10 Aligned_cols=224 Identities=14% Similarity=0.174 Sum_probs=186.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999999999999999998766655555667789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
+||||++|++|.+++.++ ....++..++.||+.||.|||+.||+||||||+|||++.+|.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999999543 4666789999999999999999999999999999999999999998543
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHHhcccCC--CCCCC
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL----KQVQSKVVF--PKDPN 273 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~----~~~~~~~~~--~~~~~ 273 (357)
|++| .+.++|||||||++|+|++|+.||.+.+....+ ..+...... ...+.
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 2232 256699999999999999999999875432211 001111110 11246
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++++.++|.+|| .||.+| |+.++++
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 8999999999999 599999 9999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=351.34 Aligned_cols=241 Identities=19% Similarity=0.296 Sum_probs=197.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC-CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCe-
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR-HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHR- 117 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~- 117 (357)
+..++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 445899999999999999999999976 78899999986532 33445567799999999999999999999987665
Q ss_pred ----EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 118 ----VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 118 ----~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||++...
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988755 69999999999999999999999999999999999999875 8999999999764
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-CCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF-PKDP 272 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~-~~~~ 272 (357)
... ...+||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.... .... ....
T Consensus 232 ~~~----------~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~ 291 (681)
T 2pzi_A 232 NSF----------GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVL 291 (681)
T ss_dssp TCC----------SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHH
T ss_pred ccC----------CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc--------ccccccccc
Confidence 321 3457899999999987653 56799999999999999999998753211 0000 0001
Q ss_pred CCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 273 NVSPECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 273 ~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
..++.+.++|.+|| .||.+||+..+.+.|+|+.
T Consensus 292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 24678999999999 5999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=295.50 Aligned_cols=189 Identities=17% Similarity=0.096 Sum_probs=136.6
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCC-------chHHHhhHHHHHHHHHcC-CCCCccceEEEEEeCCeEEE
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP-------SDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++.|++|.+..++....|+.|++|++.+.... .+...+.+.+|+.+|+++ +|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3456788888888787778999999999764322 122345688999999999 69999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++|++|.++|.+.+++++. .|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~---- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD---- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC----
Confidence 99999999999999999888875 47899999999999999999999999999999999999999999765322
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRL 248 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~ 248 (357)
.....+.+||+.|+|||++.+.. ..++|+||+|++++.+.++..
T Consensus 393 --~~~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 --CSWPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred --CccccCceechhhccHHHhCCCC--CCcccccccccchhhhccccc
Confidence 12334578999999999998753 345899999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=250.51 Aligned_cols=193 Identities=18% Similarity=0.192 Sum_probs=143.8
Q ss_pred EEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchH-----HHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDY-----LKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
...++||+|+||+||++. ..+..+++|........... ..+.+.+|+.+++.++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446799999999999995 34668899886543332222 23456899999999999999965555557777899
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999865 6789999999999999999999999999999988 99999999998764322110
Q ss_pred -ccccccccCCCCCCccchhhhcC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy10194 201 -GYESLSETFCGSYAYASPEILKG--IPYCPQLSDVWSMGVVLFAMVFGRLPFD 251 (357)
Q Consensus 201 -~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~ll~G~~pf~ 251 (357)
.........+||+.|+|||++.. ..| ...+|+||..+-..+.+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 00012235679999999999976 445 344899999998888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=210.98 Aligned_cols=147 Identities=18% Similarity=0.218 Sum_probs=118.2
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---------------HHHhhHHHHHHHHHcCCCCCccce
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---------------YLKKFLPREVEVVKGLKHPNLIKF 108 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~Iv~l 108 (357)
.|.+++.||+|+||.||+|.+ .++..||+|+++....... .....+.+|+.+++.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 355669999999999999999 8899999999864321110 12455779999999998 5 666
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecc
Q psy10194 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFG 188 (357)
Q Consensus 109 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg 188 (357)
.+++.. +..++||||++|++|.+ +. ......++.|++.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 666644 45599999999999998 42 123567999999999999999999999999999999 9999999999
Q ss_pred ccccccccccccccccccccCCCCCCccchhhhc
Q psy10194 189 FARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222 (357)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 222 (357)
++.. +..+.|||++.
T Consensus 238 ~a~~-------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE-------------------VGEEGWREILE 252 (282)
T ss_dssp TCEE-------------------TTSTTHHHHHH
T ss_pred CCeE-------------------CCCCCHHHHHH
Confidence 9963 44678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=180.63 Aligned_cols=139 Identities=19% Similarity=0.263 Sum_probs=108.2
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcE--EEEEEeecCCCC---------------------chHHHhhHHHHHHHHHcCC
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCE--VAIKIISKMQAP---------------------SDYLKKFLPREVEVVKGLK 101 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~--vaiK~i~~~~~~---------------------~~~~~~~~~~E~~~l~~l~ 101 (357)
|.+.+.||+|+||.||+|.+..+|.. ||||+++..... .......+.+|+.+++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998777888 999997543211 0111235678999999998
Q ss_pred CCCc--cceEEEEEeCCeEEEEEeecCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hcCCeecCCCCCc
Q psy10194 102 HPNL--IKFLQAIETTHRVYIIMEYAEK-G----SLLDIIRKEGYIDETRARKWFAQLVDAINYCH-ERGVVHRDIKCEN 173 (357)
Q Consensus 102 h~~I--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH-~~givH~dlkp~N 173 (357)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.||+.+|.||| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 344432 345899999942 3 67666432 235578899999999999999 9999999999999
Q ss_pred eEecCCCCeEEeecccccc
Q psy10194 174 LLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 174 Ill~~~~~~kl~Dfg~~~~ 192 (357)
||++. .++|+|||++..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=168.38 Aligned_cols=139 Identities=17% Similarity=0.240 Sum_probs=99.7
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC---------------chH----HHhhHHHHHHHHHcCCCCCc
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP---------------SDY----LKKFLPREVEVVKGLKHPNL 105 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~---------------~~~----~~~~~~~E~~~l~~l~h~~I 105 (357)
|++++.||+|+||.||+|.+. +|..||||+++..... ... .+-...+|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999974 6889999997532100 000 01112356677777654443
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-----
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----- 180 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----- 180 (357)
.- ...+.... .+|||||++|++|.++. ....+..++.||+.+|.+||+.|||||||||.|||++.+|
T Consensus 176 ~v-p~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PV-PEPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SC-CCEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CC-CeeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 22 22222222 27999999998886543 2234567899999999999999999999999999998776
Q ss_pred -----CeEEeecccccc
Q psy10194 181 -----NIKLSDFGFARN 192 (357)
Q Consensus 181 -----~~kl~Dfg~~~~ 192 (357)
.+.|+||+.+..
T Consensus 248 ~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TSEEEEEEECCCTTCEE
T ss_pred cccccceEEEEeCCccc
Confidence 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.6e-13 Score=121.56 Aligned_cols=139 Identities=16% Similarity=0.082 Sum_probs=111.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+|++...++.|+.+.||++... +..+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 46889999999999999999854 5689999986422111 234778999999885 67788999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE---------------------------------------- 161 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------- 161 (357)
||+++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999988653 1223345788999999999998
Q ss_pred -------------------cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 -------------------RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 -------------------~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=6.4e-12 Score=110.72 Aligned_cols=133 Identities=17% Similarity=0.116 Sum_probs=99.1
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC--ccceEEEEEeCCeEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN--LIKFLQAIETTHRVYII 121 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~l~~~~~~~~~~~lv 121 (357)
+|.+..+.+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 456555555667799999974 456789999875431 234668999998885434 56788888888889999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG-------------------------------------- 163 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g-------------------------------------- 163 (357)
|||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998884 21 122 2356777778888888643
Q ss_pred --------------------CeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 164 --------------------VVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 164 --------------------ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-11 Score=112.98 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=105.4
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEee--cCCCCchHHHhhHHHHHHHHHcCC--CCCccceEEEEEeC---CeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIIS--KMQAPSDYLKKFLPREVEVVKGLK--HPNLIKFLQAIETT---HRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~l~~~~~~~---~~~~l 120 (357)
.+.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. ...|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 677899999999999864 3578888765 32211 11346778999999887 45578888888766 44899
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE--------------------------------------- 161 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--------------------------------------- 161 (357)
||||++|..+.+.. ...++..+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998775321 2346788889999999999999997
Q ss_pred -------------------cCCeecCCCCCceEecCCCC--eEEeeccccccc
Q psy10194 162 -------------------RGVVHRDIKCENLLIDADYN--IKLSDFGFARNH 193 (357)
Q Consensus 162 -------------------~givH~dlkp~NIll~~~~~--~kl~Dfg~~~~~ 193 (357)
.+++|+|+++.|||++.++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999987753 689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.4e-11 Score=111.63 Aligned_cols=182 Identities=13% Similarity=0.135 Sum_probs=121.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCC--ccceEEEEEeCC---eEEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPN--LIKFLQAIETTH---RVYII 121 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--Iv~l~~~~~~~~---~~~lv 121 (357)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999874 36888985421 23456778999998873 332 344544433333 34789
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE---------------------------------------- 161 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~---------------------------------------- 161 (357)
|++++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875433 237888888899999999999986
Q ss_pred ------------------cCCeecCCCCCceEecC--CCCeEEeeccccccccccccccccccccccCCCCCCc---cch
Q psy10194 162 ------------------RGVVHRDIKCENLLIDA--DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAY---ASP 218 (357)
Q Consensus 162 ------------------~givH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y---~aP 218 (357)
..++|+|++|.||+++. ++.+.|+||+.+........... ...+ ..|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~----------~~~~~~~~~~ 242 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS----------LMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT----------TCCTTTSCCH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH----------HHhhccccCH
Confidence 13699999999999987 45688999998865432111100 0011 222
Q ss_pred hhhcC--CCCCCC-----------cccHHHHHHHHHHHHhCCCCCC
Q psy10194 219 EILKG--IPYCPQ-----------LSDVWSMGVVLFAMVFGRLPFD 251 (357)
Q Consensus 219 E~~~~--~~~~~~-----------~~DiwSlG~il~~ll~G~~pf~ 251 (357)
+.... ..|... ..+.|++|.++|.+.+|..+|.
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 22110 001011 1589999999999999988773
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=4.5e-08 Score=86.65 Aligned_cols=133 Identities=15% Similarity=0.114 Sum_probs=99.8
Q ss_pred EeeecCce-EEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEEeecCC
Q psy10194 50 IIGMGSYA-TVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIMEYAEK 127 (357)
Q Consensus 50 ~Lg~G~~g-~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~e~~~~ 127 (357)
.+..|..+ .||+......+..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 7999887777778999986432 2345678999998875 33377889999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q psy10194 128 GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER--------------------------------------------- 162 (357)
Q Consensus 128 gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------- 162 (357)
.++.+..... ......+..++...|..||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8888776442 223445677777777778741
Q ss_pred -------------CCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 163 -------------GVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 163 -------------givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999998877777999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.7e-07 Score=84.68 Aligned_cols=134 Identities=13% Similarity=0.115 Sum_probs=94.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC---CccceEEEEE-eCCeEEEEEe
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP---NLIKFLQAIE-TTHRVYIIME 123 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~l~~~~~-~~~~~~lv~e 123 (357)
.+.++.|....||++ +..+++|+-.. ......+.+|..+|+.+.+. .+.+++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788999999998 45688887421 23345677999999998642 3566666664 4456789999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER----------------------------------------- 162 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------------------- 162 (357)
+++|.+|.+..- ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 2245555666666666666666642
Q ss_pred -------------------CCeecCCCCCceEecC---CCC-eEEeeccccccc
Q psy10194 163 -------------------GVVHRDIKCENLLIDA---DYN-IKLSDFGFARNH 193 (357)
Q Consensus 163 -------------------givH~dlkp~NIll~~---~~~-~kl~Dfg~~~~~ 193 (357)
.++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 455 489999988653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=5.4e-07 Score=84.37 Aligned_cols=79 Identities=15% Similarity=0.058 Sum_probs=48.6
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCC-Cch---HHHhhHHHHHHHHHcCCC--C-CccceEEEEEeCCeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQA-PSD---YLKKFLPREVEVVKGLKH--P-NLIKFLQAIETTHRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~Iv~l~~~~~~~~~~~l 120 (357)
.+.||.|.++.||++....++..+++|....... ..+ .....+..|..+++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5689999999999998666677899998643211 000 012334578888887632 3 34455543 4445689
Q ss_pred EEeecCCC
Q psy10194 121 IMEYAEKG 128 (357)
Q Consensus 121 v~e~~~~g 128 (357)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=6.2e-07 Score=82.60 Aligned_cols=81 Identities=11% Similarity=0.111 Sum_probs=54.1
Q ss_pred EEeEe-eecCceEEEEEEEC--C----CCcEEEEEEeecCC---CCchHHHhhHHHHHHHHHcCC-C--CCccceEEEEE
Q psy10194 47 LGTII-GMGSYATVKLATSS--R----HSCEVAIKIISKMQ---APSDYLKKFLPREVEVVKGLK-H--PNLIKFLQAIE 113 (357)
Q Consensus 47 ~~~~L-g~G~~g~Vy~~~~~--~----~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~l~~~~~ 113 (357)
..+.| +.|....+|++... . ++..+++|+..... ... ...+.+|+.+++.+. + -.+.+++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 35677 88889999988753 1 15578889764322 100 134668888888774 2 34677887776
Q ss_pred eC---CeEEEEEeecCCCCH
Q psy10194 114 TT---HRVYIIMEYAEKGSL 130 (357)
Q Consensus 114 ~~---~~~~lv~e~~~~gsL 130 (357)
+. ...++|||+++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 55 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.9e-05 Score=71.78 Aligned_cols=135 Identities=12% Similarity=0.072 Sum_probs=76.7
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-----CCCccceE-E--EEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-----HPNLIKFL-Q--AIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~l~-~--~~~~~~~~~ 119 (357)
.+.|+.|..+.||++... ++ .+++|+.... . ..+..|..+++.|. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~---~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP---E----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET-TE-EEEEEEECSC---H----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC-CC-CEEEEecCCC---H----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 345667788999999864 33 5899988641 1 12234455554442 34443311 0 224567889
Q ss_pred EEEeecCCCCHH-----------HHH---HH-cCCC-------------CHHH---------------------------
Q psy10194 120 IIMEYAEKGSLL-----------DII---RK-EGYI-------------DETR--------------------------- 144 (357)
Q Consensus 120 lv~e~~~~gsL~-----------~~l---~~-~~~l-------------~~~~--------------------------- 144 (357)
+||+|++|..+. ..+ .. ...+ .+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986432 111 11 1101 1100
Q ss_pred ----HHHHHHHHHHHHHHHHh-------------cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 145 ----ARKWFAQLVDAINYCHE-------------RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 145 ----~~~i~~qi~~~l~~LH~-------------~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+..+..++..++.+|+. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112233445666652 579999999999999888899999999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.00 E-value=7.2e-05 Score=63.00 Aligned_cols=121 Identities=18% Similarity=0.216 Sum_probs=79.8
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeeccccccccccccccccccc
Q psy10194 128 GSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESL 205 (357)
Q Consensus 128 gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 205 (357)
.+|.++|+. +.+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 479999865 5689999999999999999877622 2222444567899999999988764 1111
Q ss_pred cccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Q psy10194 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284 (357)
Q Consensus 206 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 284 (357)
.....+.|||... ...+.+.=|||||+++|.-+- |-.+ .....+|+.+..||..
T Consensus 98 ----~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-------------------~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-------------------NEERELSPPLEQLIDH 152 (229)
T ss_dssp -------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-------------------TEEECCCHHHHHHHHH
T ss_pred ----ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-------------------ccchhhCHHHHHHHHH
Confidence 0123467888763 122345689999999999983 3221 1224699999999999
Q ss_pred cccC
Q psy10194 285 ILAP 288 (357)
Q Consensus 285 ~L~~ 288 (357)
|..+
T Consensus 153 Mt~~ 156 (229)
T 2yle_A 153 MANT 156 (229)
T ss_dssp HTTC
T ss_pred HHhc
Confidence 9843
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.4e-05 Score=67.83 Aligned_cols=75 Identities=13% Similarity=0.125 Sum_probs=58.8
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC---CCCccceEEEEEeCCeEEEEEee
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK---HPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
.+.|+.|....+|++.. ++..+++|+..... ...+..|...|+.|. ...+++++.+....+..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 56789999999999985 35688899875421 345678888888774 35688888888888899999999
Q ss_pred cCCCCH
Q psy10194 125 AEKGSL 130 (357)
Q Consensus 125 ~~~gsL 130 (357)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.6e-05 Score=71.75 Aligned_cols=33 Identities=15% Similarity=0.341 Sum_probs=28.4
Q ss_pred HhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 160 H~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
+...++|+|++|.|||++.++ +.|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999998776 999999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00022 Score=63.35 Aligned_cols=80 Identities=8% Similarity=-0.008 Sum_probs=54.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC---CCccceEEEEEeCCeEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH---PNLIKFLQAIETTHRVY 119 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h---~~Iv~l~~~~~~~~~~~ 119 (357)
....-...+|.|..+.||++... +|..|++|+........ ...+..|+..|+.|.. --+++++.+ +. -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 34556788999999999999854 67789999865432221 2456789999888742 124445543 22 27
Q ss_pred EEEeecCCCCH
Q psy10194 120 IIMEYAEKGSL 130 (357)
Q Consensus 120 lv~e~~~~gsL 130 (357)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00012 Score=65.66 Aligned_cols=133 Identities=14% Similarity=0.122 Sum_probs=74.1
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEEEEeec-
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYIIMEYA- 125 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~lv~e~~- 125 (357)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ .+++.. +.+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 567889999999999 46888987542111 1122467777777642222 455544 333347899999
Q ss_pred CCCCHHHH---------------H---HHcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH----h--
Q psy10194 126 EKGSLLDI---------------I---RKEG-YID-----ETRARKWFAQ--------------LVDAINYCH----E-- 161 (357)
Q Consensus 126 ~~gsL~~~---------------l---~~~~-~l~-----~~~~~~i~~q--------------i~~~l~~LH----~-- 161 (357)
+|.+|... + ...+ .++ ...+..+... +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444311 0 0111 010 1111111111 111111111 1
Q ss_pred --cCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 162 --RGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 162 --~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 23899999999999 56777899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00011 Score=66.26 Aligned_cols=138 Identities=20% Similarity=0.151 Sum_probs=76.9
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC--ccceEE------EEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN--LIKFLQ------AIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~l~~------~~~~~~~~~ 119 (357)
.+.|+.|....+|++...+ + .+++|+...... ...+..|..+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeCC-c-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 5667888889999998643 3 688998865211 223446777776653111 233331 123356789
Q ss_pred EEEeecCCCCHH-----------HH---HHHc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q psy10194 120 IIMEYAEKGSLL-----------DI---IRKE-GYI--------DETRARKW---------------FAQLVDAINYCHE 161 (357)
Q Consensus 120 lv~e~~~~gsL~-----------~~---l~~~-~~l--------~~~~~~~i---------------~~qi~~~l~~LH~ 161 (357)
++++|++|..+. .. +... ..+ ....-... -..+...+..+..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999985431 01 1110 001 11100000 0113344555552
Q ss_pred -------cCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 162 -------RGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 162 -------~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998776668999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00022 Score=67.26 Aligned_cols=73 Identities=16% Similarity=0.104 Sum_probs=48.1
Q ss_pred EeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~ 119 (357)
.+.|+.|-...||++.... .+..+++|+.... .. ...+.+|..+++.|...++ .++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 5678889899999998653 2568899987432 11 0233478888887753333 56666553 2 3
Q ss_pred EEEeecCCCC
Q psy10194 120 IIMEYAEKGS 129 (357)
Q Consensus 120 lv~e~~~~gs 129 (357)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998733
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00041 Score=62.91 Aligned_cols=32 Identities=31% Similarity=0.352 Sum_probs=27.4
Q ss_pred cCCeecCCCCCceEecCC----CCeEEeeccccccc
Q psy10194 162 RGVVHRDIKCENLLIDAD----YNIKLSDFGFARNH 193 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~----~~~kl~Dfg~~~~~ 193 (357)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67899999988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00024 Score=65.79 Aligned_cols=137 Identities=13% Similarity=0.098 Sum_probs=80.8
Q ss_pred EeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~~~~ 119 (357)
.+.|..|-...+|++.... ++..+++|+..... .. ...+.+|..+++.|.. .-..++++.+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4567778888899998642 35689999863321 11 2334589988887752 223566666543 2
Q ss_pred EEEeecCCCCHH--------------HHHH---Hc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q psy10194 120 IIMEYAEKGSLL--------------DIIR---KE-----GYID--ETRARKWFAQLVD-------------------AI 156 (357)
Q Consensus 120 lv~e~~~~gsL~--------------~~l~---~~-----~~l~--~~~~~~i~~qi~~-------------------~l 156 (357)
+||||++|.+|. +.+. .. +... ..++..++.++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 999999985442 1111 11 1112 3556666655422 23
Q ss_pred HHHH----h----cCCeecCCCCCceEecCC----CCeEEeecccccc
Q psy10194 157 NYCH----E----RGVVHRDIKCENLLIDAD----YNIKLSDFGFARN 192 (357)
Q Consensus 157 ~~LH----~----~givH~dlkp~NIll~~~----~~~kl~Dfg~~~~ 192 (357)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 259999999999999876 7899999998853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.001 Score=59.98 Aligned_cols=136 Identities=14% Similarity=0.093 Sum_probs=76.2
Q ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCC--CccceEEE-----EEeCCeEEEE
Q psy10194 49 TIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP--NLIKFLQA-----IETTHRVYII 121 (357)
Q Consensus 49 ~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~--~Iv~l~~~-----~~~~~~~~lv 121 (357)
..|+ |....||++.. .+|..+++|+....... ...+..|..+++.+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3456 88889998864 34567999998643222 23345677777766311 13333332 2345677899
Q ss_pred EeecCCCCHH-----H------HH---HH---cC------CCCHHHH----H------------------HHHHHHHHHH
Q psy10194 122 MEYAEKGSLL-----D------II---RK---EG------YIDETRA----R------------------KWFAQLVDAI 156 (357)
Q Consensus 122 ~e~~~~gsL~-----~------~l---~~---~~------~l~~~~~----~------------------~i~~qi~~~l 156 (357)
|++++|..+. . .+ .. .. ..+.... . ..+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874321 1 11 11 00 1111110 1 1111222222
Q ss_pred HHH----HhcCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 157 NYC----HERGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 157 ~~L----H~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 124589999999999998 4 899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0026 Score=60.39 Aligned_cols=75 Identities=16% Similarity=0.111 Sum_probs=48.1
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEEEEeecC
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~lv~e~~~ 126 (357)
.+.|+.|-...+|++.....+..+++|+...... . .. ...+|..+++.|...++ .++++++. +. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~-~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--E-II-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--S-CS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--h-hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 5678889899999998765457888998743211 1 01 12478888888865444 56776662 32 5999998
Q ss_pred CCCH
Q psy10194 127 KGSL 130 (357)
Q Consensus 127 ~gsL 130 (357)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00063 Score=62.68 Aligned_cols=74 Identities=18% Similarity=0.020 Sum_probs=43.5
Q ss_pred EeEeeecCceEEEEEEECC--------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC-ccceEEEEEeCCeE
Q psy10194 48 GTIIGMGSYATVKLATSSR--------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN-LIKFLQAIETTHRV 118 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~l~~~~~~~~~~ 118 (357)
...|+.|....+|++.... .+..+++|+.... .+. ......|..+++.+...+ ..+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888889999998653 1357888886432 111 112357888888775333 34666544 22
Q ss_pred EEEEeecCCCC
Q psy10194 119 YIIMEYAEKGS 129 (357)
Q Consensus 119 ~lv~e~~~~gs 129 (357)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0067 Score=55.14 Aligned_cols=32 Identities=22% Similarity=0.284 Sum_probs=28.0
Q ss_pred cCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.015 Score=54.50 Aligned_cols=74 Identities=14% Similarity=0.038 Sum_probs=46.9
Q ss_pred EeEeeecCceEEEEEEECCC-------CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCC-ccceEEEEEeCCeEE
Q psy10194 48 GTIIGMGSYATVKLATSSRH-------SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN-LIKFLQAIETTHRVY 119 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~l~~~~~~~~~~~ 119 (357)
.+.|..|-...+|++..... +..+++++..... +. .-...+|..+++.+...+ ..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 55677788889999987531 5678999864321 11 112347888888775222 34555533 22 6
Q ss_pred EEEeecCCCC
Q psy10194 120 IIMEYAEKGS 129 (357)
Q Consensus 120 lv~e~~~~gs 129 (357)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.88 E-value=0.058 Score=50.10 Aligned_cols=29 Identities=24% Similarity=0.464 Sum_probs=24.9
Q ss_pred CeecCCCCCceEe------cCCCCeEEeecccccc
Q psy10194 164 VVHRDIKCENLLI------DADYNIKLSDFGFARN 192 (357)
Q Consensus 164 ivH~dlkp~NIll------~~~~~~kl~Dfg~~~~ 192 (357)
++|+|+.+.|||+ +.+..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.48 E-value=2.1 Score=35.79 Aligned_cols=84 Identities=14% Similarity=0.100 Sum_probs=61.9
Q ss_pred CCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC
Q psy10194 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY 180 (357)
Q Consensus 101 ~h~~Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~ 180 (357)
.||++ -..+-.+++.+.+.++.-+++.=+..++. ++....+.++.+|+.... -|...-+|--|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence 57888 45555788888888877655433444433 688888888888877554 1335678889999999999999
Q ss_pred CeEEeecccc
Q psy10194 181 NIKLSDFGFA 190 (357)
Q Consensus 181 ~~kl~Dfg~~ 190 (357)
.+++.-.|+-
T Consensus 122 ~p~i~hRGi~ 131 (219)
T 4ano_A 122 EPFFLHVGVK 131 (219)
T ss_dssp CEEESCCEET
T ss_pred cEEEEEcCCc
Confidence 9999877764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.60 E-value=1.4 Score=36.79 Aligned_cols=121 Identities=10% Similarity=0.140 Sum_probs=81.6
Q ss_pred HHHHHHcCCCCCccceEEEEEeCCeEEEEEeecCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Q psy10194 93 EVEVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKG-SLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKC 171 (357)
Q Consensus 93 E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp 171 (357)
|+.+|.. .||+++.. .+-++.+.+.+.++.-..+ ++.. ++ .++....+.++.+|+.... |...-+|--|+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~--~~~~r~tf~L~P 107 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEE--VNRTRYTFVLAP 107 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGG--GGGSSEECCCSG
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHH--HhcCceEEEEec
Confidence 4444443 58888876 6777778777777665432 3332 32 3688888999999888773 445567888999
Q ss_pred CceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCccc-HHHHHHHHHHHHhCCCCC
Q psy10194 172 ENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSD-VWSMGVVLFAMVFGRLPF 250 (357)
Q Consensus 172 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D-iwSlG~il~~ll~G~~pf 250 (357)
+||+++.++.+++.-.|+-.. ++|.-+ +. .| +-..=|++..++.++..|
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~-----------------------l~P~~~------~e-e~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV-----------------------VDPLPV------SE-AEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT-----------------------BSCCCC------CH-HHHHHHHHHHHHHHHCTTCCH
T ss_pred ceEEEcCCCCEEEEEccCccC-----------------------CCCCCC------CH-HHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999987766432 122200 11 23 334668888999998888
Q ss_pred C
Q psy10194 251 D 251 (357)
Q Consensus 251 ~ 251 (357)
.
T Consensus 158 e 158 (215)
T 4ann_A 158 D 158 (215)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.13 E-value=0.067 Score=50.71 Aligned_cols=61 Identities=13% Similarity=0.091 Sum_probs=16.2
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEE------EEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAI------KIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
.+.|| ||.||++.......+||+ |.........+. ...+.+|..+++.++|||+++.+.+.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~-~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR-LTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccc-cccccccccccccccccccCCCcceE
Confidence 45565 999999998765567888 655432222222 23455788889999999999988765
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=83.34 E-value=28 Score=33.81 Aligned_cols=81 Identities=16% Similarity=0.292 Sum_probs=50.3
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCC-----------------CCHHHHHHHHHHHHH--HHHHHHhcCCee
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-----------------IDETRARKWFAQLVD--AINYCHERGVVH 166 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------l~~~~~~~i~~qi~~--~l~~LH~~givH 166 (357)
++.|.+........+| |++++.++.+.+...+. ........++..++- .+.|+=..
T Consensus 402 i~~Y~Vipls~~~GlI-E~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGi---- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGFM-QFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGV---- 476 (614)
T ss_dssp CCCCCEEESSSSEEEE-ECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred eeccEEEEecCCCceE-EEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeec----
Confidence 5566677666665554 67776555555433211 112334445544433 24444333
Q ss_pred cCCCCCceEecCCCCeEEeeccccc
Q psy10194 167 RDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 167 ~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+|=+++|||++.+|++.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 4889999999999999999999984
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.15 E-value=26 Score=34.65 Aligned_cols=81 Identities=16% Similarity=0.330 Sum_probs=48.6
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHHcCC---------------C--CHHHHHHHHHHHHH--HHHHHHhcCCee
Q psy10194 106 IKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY---------------I--DETRARKWFAQLVD--AINYCHERGVVH 166 (357)
Q Consensus 106 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------l--~~~~~~~i~~qi~~--~l~~LH~~givH 166 (357)
++.|.+........+| |++++.+|.+++.+.+. + .......++..++- .+.|+=..
T Consensus 476 i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILGl---- 550 (696)
T 2x6h_A 476 LTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLGV---- 550 (696)
T ss_dssp CCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred EeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHccC----
Confidence 4455666555554444 66666566666544321 1 11233344444432 23333333
Q ss_pred cCCCCCceEecCCCCeEEeeccccc
Q psy10194 167 RDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 167 ~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
+|-+++|||++.+|.+.=+|||.+-
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhh
Confidence 5889999999999999999999974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 357 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-73 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-72 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-72 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-66 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-65 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-61 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-60 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-58 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-55 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-50 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-39 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-20 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 4e-75
Identities = 80/262 (30%), Positives = 141/262 (53%), Gaps = 11/262 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G +G G + V LA + +A+K++ K Q ++ L REVE+ L+HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ RVY+I+EYA G++ ++K DE R + +L +A++YCH + V
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK ENLL+ + +K++DFG++ + S T CG+ Y PE+++G
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAP--------SSRRTTLCGTLDYLPPEMIEGR 179
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
+ + D+WS+GV+ + + G+ PF+ Y + K++ S+V F V+ + LIS+
Sbjct: 180 MHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTEGARDLISR 237
Query: 285 ILAP-VKTRLRIKNIKEDPWFR 305
+L R ++ + E PW
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-73
Identities = 86/264 (32%), Positives = 131/264 (49%), Gaps = 9/264 (3%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ L +G G+Y V+LA + VA+KI+ +A + + +E+ + K L H N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHEN 64
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++KF + Y+ +EY G L D I + + E A+++F QL+ + Y H G+
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
HRDIK ENLL+D N+K+SDFG A E L CG+ Y +PE+LK
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS--QLLKQVQSKVVFPKDPNVSPECKALI 282
+ + DVWS G+VL AM+ G LP+D S + + K + AL+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 283 SKILAP-VKTRLRIKNIKEDPWFR 305
KIL R+ I +IK+D W+
Sbjct: 241 HKILVENPSARITIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 5e-72
Identities = 63/275 (22%), Positives = 128/275 (46%), Gaps = 17/275 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G G++ V A + S A K+I + L+ ++ E++++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYM-VEIDILASCDHPN 70
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCHERG 163
++K L A + ++I++E+ G++ ++ E + E++ + Q +DA+NY H+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRD+K N+L D +IKL+DFG + + R R+ +F G+ + +PE++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD------SFIGTPYWMAPEVVMC 184
Query: 224 IPYCPQL----SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--VVFPKDPNVSPE 277
+ +DVWS+G+ L M P + ++L ++ + S
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 278 CKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRP 311
K + K L V R + + P+ ++P
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 8e-72
Identities = 81/269 (30%), Positives = 141/269 (52%), Gaps = 13/269 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ G I+G GS++TV LA S E AIKI+ K + ++ RE +V+ L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+K + ++Y + YA+ G LL IRK G DET R + A++V A+ Y H +G+
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K EN+L++ D +I+++DFG A + S + ++ + +F G+ Y SPE+L
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTA----KVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
C SD+W++G +++ +V G PF + +++ K+ + P+ + L+ K
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFPEKFFPKARDLVEK 243
Query: 285 ILAP-------VKTRLRIKNIKEDPWFRN 306
+L + +K P+F +
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (557), Expect = 8e-70
Identities = 56/266 (21%), Positives = 109/266 (40%), Gaps = 14/266 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
++ IG GS+ V A R+S VAIK +S S+ + + +EV ++ L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
I++ H +++MEY + + + + E + + Y H +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K N+L+ +KL DFG A + +F G+ + +PE++ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP----------ANSFVGTPYWMAPEVILAM 186
Query: 225 PYCP--QLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
DVWS+G+ + + P + S L Q++ + + S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 282 ISKILAP-VKTRLRIKNIKEDPWFRN 306
+ L + R + + + +
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-69
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 20/271 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + IG GSY + + K + + + EV +++ LKHPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPN 64
Query: 105 LIKFLQAI--ETTHRVYIIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINY 158
++++ I T +YI+MEY E G L +I K Y+DE + QL A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 159 CHERG-----VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
CH R V+HRD+K N+ +D N+KL DFG AR S ++ F G+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR------ILNHDTSFAKAFVGTP 178
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPN 273
Y SPE + + Y + SD+WS+G +L+ + PF +L +++
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 274 VSPECKALISKILAP-VKTRLRIKNIKEDPW 303
S E +I+++L R ++ I E+P
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-68
Identities = 67/271 (24%), Positives = 129/271 (47%), Gaps = 14/271 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT IG G+ TV A EVAI+ ++ Q P K+ + E+ V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ +L + ++++MEY GSL D++ + DE + + + A+ + H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQV 137
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRDIK +N+L+ D ++KL+DFGF +S++ T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS------TMVGTPYWMAPEVVTRK 191
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV--FPKDPNVSPECKALI 282
Y P+ D+WS+G++ M+ G P+ + + L + + +S + +
Sbjct: 192 AYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 283 SKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
++ L V+ R K + + + +
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 216 bits (551), Expect = 3e-68
Identities = 74/319 (23%), Positives = 134/319 (42%), Gaps = 20/319 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G++ V K I+ K + E+ ++ L HP
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPK 87
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERG 163
LI A E + + +I+E+ G L D I E Y + E + Q + + + HE
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 164 VVHRDIKCENLLIDADYN--IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+VH DIK EN++ + +K+ DFG A + + + + + +A+PEI+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLAT-------KLNPDEIVKVTTATAEFAAPEIV 200
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKD--PNVSPEC 278
P +D+W++GV+ + ++ G PF + L+ V + F +D +VSPE
Sbjct: 201 DREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLEVETCCASEETSFSTA 337
K I +L + RL + + E PW + S I S ++ + +
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAP 319
Query: 338 QSVES--ASTSEMQYYKPN 354
Q A+ S ++ ++P
Sbjct: 320 QPAIGRIANFSSLRKHRPQ 338
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 7e-68
Identities = 63/271 (23%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
IG GS+ TV + + EVA + + ++F E E++KGL+HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPN 69
Query: 105 LIKFLQAIETT----HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
+++F + E+T + ++ E G+L +++ + R W Q++ + + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 161 ERG--VVHRDIKCENLLIDA-DYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
R ++HRD+KC+N+ I ++K+ D G A S ++ G+ + +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--------TLKRASFAKAVIGTPEFMA 181
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKY-SQLLKQVQSKVVFPK-DPNVS 275
PE+ + Y DV++ G+ + M P+ + + +Q+ ++V S V D
Sbjct: 182 PEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 276 PECKALISKILAP-VKTRLRIKNIKEDPWFR 305
PE K +I + R IK++ +F+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 215 bits (548), Expect = 8e-68
Identities = 71/323 (21%), Positives = 135/323 (41%), Gaps = 21/323 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G++ V T A K + P + K+ + +E++ + L+HP
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPT 84
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCHERG 163
L+ A E + + +I E+ G L + + + + E A ++ Q+ + + HE
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 164 VVHRDIKCENLLIDADYN--IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VH D+K EN++ + +KL DFG + +S + G+ +A+PE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-------VTTGTAEFAAPEVA 197
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---PNVSPEC 278
+G P +D+WS+GV+ + ++ G PF + L+ V+S D +S +
Sbjct: 198 EGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPS---RPEYPIMSGDSLEVETCCASEETSF 334
K I K+L TR+ I E PW G + + P + +
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316
Query: 335 STAQSVESASTSEMQYYKPNRIS 357
++ S ++ ++P S
Sbjct: 317 PLPPLGRISNYSSLRKHRPQEYS 339
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 6e-67
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 17/275 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y ++G G+++ V LA R VAIK I+K + + E+ V+ +KHPN
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPN 68
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++ E+ +Y+IM+ G L D I ++G+ E A + Q++DA+ Y H+ G+
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 165 VHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+K ENLL D D I +SDFG ++ + S+ T CG+ Y +PE+L
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSK-------MEDPGSVLSTACGTPGYVAPEVL 181
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVSPEC 278
PY D WS+GV+ + ++ G PF D ++L +Q+ P ++S
Sbjct: 182 AQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
K I ++ + R + + PW + +
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 209 bits (534), Expect = 1e-66
Identities = 74/277 (26%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS------DYLKKFLPREVEVVK 98
Y I+G G + V+ E A+KII S L++ +EV++++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 99 GLK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAIN 157
+ HPN+I+ ET +++ + +KG L D + ++ + E RK L++ I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
H+ +VHRD+K EN+L+D D NIKL+DFGF+ + CG+ +Y +
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-------QLDPGEKLREVCGTPSYLA 177
Query: 218 PEILKGIPYCPQL-----SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FP 269
PEI++ D+WS GV+++ ++ G PF K +L+ + S P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 270 KDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFR 305
+ + S K L+S+ L + R + P+F+
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-66
Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 17/252 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
T+G IG GS+ TV + +VA+K+++ L+ F EV V++ +H N
Sbjct: 10 ITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVN 65
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERG 163
++ F+ T ++ I+ ++ E SL + E + + Q ++Y H +
Sbjct: 66 ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRD+K N+ + D +K+ DFG A +SR E GS + +PE+++
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLA----TVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 224 IPYCP--QLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPK----DPNVSP 276
P SDV++ G+VL+ ++ G+LP+ + Q++ V + P N
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 277 ECKALISKILAP 288
K L+++ L
Sbjct: 241 AMKRLMAECLKK 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-66
Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 11/265 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHP 103
+ L ++G GS+ V LA + + AIK + K D + E V+ +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 104 NLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
L +T ++ +MEY G L+ I+ D +RA + A+++ + + H +G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
+V+RD+K +N+L+D D +IK++DFG + +M ++ TFCG+ Y +PEIL G
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------TFCGTPDYIAPEILLG 177
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALIS 283
Y D WS GV+L+ M+ G+ PF +L ++ F + E K L+
Sbjct: 178 QKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY-PRWLEKEAKDLLV 235
Query: 284 KILAP-VKTRLRIKN-IKEDPWFRN 306
K+ + RL ++ I++ P FR
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-65
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 56/307 (18%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G G+ V + +A K+I P+ + + RE++V+ P
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-RNQII-RELQVLHECNSPY 65
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHER-G 163
++ F A + + I ME+ + GSL +++K G I E K ++ + Y E+
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
++HRD+K N+L+++ IKL DFG + Q +S++ +F G+ +Y SPE L+G
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV----------------- 266
Y Q SD+WSMG+ L M GR P +L +V
Sbjct: 178 THYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 267 ------------------------VFPKDPN--VSPECKALISKILAP-VKTRLRIKNIK 299
PK P+ S E + ++K L R +K +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 300 EDPWFRN 306
+ +
Sbjct: 297 VHAFIKR 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-65
Identities = 48/280 (17%), Positives = 113/280 (40%), Gaps = 19/280 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G + V + K + +K +E+ ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHERG 163
++ ++ E+ + +I E+ + + I + ++E + Q+ +A+ + H
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 164 VVHRDIKCENLLIDAD--YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+ H DI+ EN++ IK+ +FG AR + Y +PE+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------KPGDNFRLLFTAPEYYAPEVH 175
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKD--PNVSPEC 278
+ +D+WS+G +++ ++ G PF Q+++ + + + F ++ +S E
Sbjct: 176 QHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMS 317
+ ++L K+R+ + PW + R ++
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 83/281 (29%), Positives = 136/281 (48%), Gaps = 24/281 (8%)
Query: 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEV 96
LES Y +G ++G G + +V + VAIK + K + +P EV +
Sbjct: 2 LESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 97 VKGLK--HPNLIKFLQAIETTHRVYIIMEYAEKGSLL-DIIRKEGYIDETRARKWFAQLV 153
+K + +I+ L E +I+E E L D I + G + E AR +F Q++
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 154 DAINYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+A+ +CH GV+HRDIK EN+LID + +KL DFG +++ F G+
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGT 172
Query: 213 YAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
Y+ PE ++ Y + + VWS+G++L+ MV G +PF+ + + ++ +V F
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--Q 225
Query: 273 NVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPE 312
VS EC+ LI LA R + I+ PW ++ E
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 195 bits (496), Expect = 1e-60
Identities = 67/269 (24%), Positives = 136/269 (50%), Gaps = 19/269 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ + +G GS+ V L S + A+K++ K + E ++ + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+I+ + ++++IM+Y E G L ++RK A+ + A++ A+ Y H + +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
++RD+K EN+L+D + +IK++DFGFA+ ++ T CG+ Y +PE++
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKY---------VPDVTYTLCGTPDYIAPEVVSTK 176
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPECKALIS 283
PY D WS G++++ M+ G PF D+ + +++ +++ FP P + + K L+S
Sbjct: 177 PYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLS 233
Query: 284 KILA------PVKTRLRIKNIKEDPWFRN 306
+++ + +++K PWF+
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 2e-60
Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 11/251 (4%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y LG I+G G + V LA R +VA+K++ A RE + L HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 105 LIKFLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
++ E YI+MEY + +L DI+ EG + RA + A A+N+ H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ G++HRD+K N++I A +K+ DFG AR + + + G+ Y SPE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV---TQTAAVIGTAQYLSPEQ 185
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFP--KDPNVSPE 277
+G + SDV+S+G VL+ ++ G PF D+ S + V+ + P + +S +
Sbjct: 186 ARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 278 CKALISKILAP 288
A++ K LA
Sbjct: 245 LDAVVLKALAK 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-60
Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 19/278 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLK 101
Y G +G G +A VK + A K I K + S ++ + REV ++K ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
HPN+I + E V +I+E G L D + ++ + E A ++ Q+++ + Y H
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 162 RGVVHRDIKCENLLIDAD----YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
+ H D+K EN+++ IK+ DFG A + + + + G+ + +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-------KIDFGNEFKNIFGTPEFVA 184
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---PNV 274
PEI+ P + +D+WS+GV+ + ++ G PF + L V + +D N
Sbjct: 185 PEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 275 SPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRP 311
S K I ++L K R+ I++ + PW + ++
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-60
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 34/296 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV-VKGLKHP 103
++G+G V + R + A+K++ REVE+ + + P
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 65
Query: 104 NLIKFLQAIETTHR----VYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAIN 157
++++ + E + + I+ME + G L I+ G E A + + +AI
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 158 YCHERGVVHRDIKCENLLIDADYN---IKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
Y H + HRD+K ENLL + +KL+DFGFA+ + S T C +
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-------TPCYTPY 178
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV------- 267
Y +PE+L Y D+WS+GV+++ ++ G PF + +++++
Sbjct: 179 YVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 268 FPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPIMSGDSLE 322
P+ VS E K LI +L R+ I PW P+ P+ + L+
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 195 bits (496), Expect = 5e-60
Identities = 61/273 (22%), Positives = 119/273 (43%), Gaps = 19/273 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV---VKGLK 101
+++ IIG G + V + A+K + K + + E + V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
P ++ A T ++ I++ G L + + G E R + A+++ + + H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
R VV+RD+K N+L+D ++++SD G A + + + G++ Y +PE+L
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--------SVGTHGYMAPEVL 177
Query: 222 KGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQL--LKQVQSKVVFPKDPNVSPECK 279
+ +D +S+G +LF ++ G PF K + ++ + + SPE +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 280 ALISKILAP-VKTRLRIKN-----IKEDPWFRN 306
+L+ +L V RL +KE P+FR+
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-58
Identities = 83/269 (30%), Positives = 136/269 (50%), Gaps = 16/269 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ ++G G++ V L A+KI+ K + E V++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
L A +T R+ +MEYA G L + +E E RAR + A++V A+ Y H R V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
V+RDIK ENL++D D +IK++DFG + + + FCG+ Y +PE+L+
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT------FCGTPEYLAPEVLEDN 180
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS-KVVFPKDPNVSPECKALIS 283
Y D W +GVV++ M+ GRLPF + + +L + + ++ FP+ +SPE K+L++
Sbjct: 181 DYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLA 237
Query: 284 KILAP-VKTRLR-----IKNIKEDPWFRN 306
+L K RL K + E +F +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-58
Identities = 53/262 (20%), Positives = 116/262 (44%), Gaps = 15/262 (5%)
Query: 51 IGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G++ +V+ + +VAIK++ + +D ++ + RE +++ L +P +++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMM-REAQIMHQLDNPYIVRL 74
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
+ + + ++ME A G L + K I + + Q+ + Y E+ VHR
Sbjct: 75 IGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+ N+L+ + K+SDFG ++ + Y + + +PE + +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSK---ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 228 PQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL 286
+ SDVWS GV ++ + +G+ P+ K +++ ++ P PE AL+S
Sbjct: 191 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 287 AP-VKTRLRIKNIK---EDPWF 304
+ R ++ ++
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYY 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-58
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 22/261 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L IG G + V L +VA+K I + FL E V+ L+H N
Sbjct: 9 LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN----DATAQAFL-AEASVMTQLRHSN 61
Query: 105 LIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHE 161
L++ L +E +YI+ EY KGSL+D +R G + K+ + +A+ Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
VHRD+ N+L+ D K+SDFG + S +T + +PE L
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---------ASSTQDTGKLPVKWTAPEAL 172
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280
+ + + SDVWS G++L+ + FGR+P+ ++ +V+ P
Sbjct: 173 REKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 281 LISKILAP-VKTRLRIKNIKE 300
++ R ++E
Sbjct: 232 VMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-58
Identities = 54/261 (20%), Positives = 111/261 (42%), Gaps = 13/261 (4%)
Query: 51 IGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKF 108
+G G++ TVK + VA+KI+ + L E V++ L +P +++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIVRM 73
Query: 109 LQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRD 168
+ E ++ME AE G L +++ ++ + + Q+ + Y E VHRD
Sbjct: 74 IGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 169 IKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCP 228
+ N+L+ + K+SDFG ++ R+ + Y + +PE + +
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSK---ALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 229 QLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISKILA 287
+ SDVWS GV+++ +G+ P+ K S++ ++ E L++
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 288 P-VKTRLRIKNIK---EDPWF 304
V+ R ++ + ++
Sbjct: 249 YDVENRPGFAAVELRLRNYYY 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 1e-55
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ +G GS+ V L A+KI+ K + + E +++ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
L+K + + +Y++MEY G + +R+ G E AR + AQ+V Y H +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
++RD+K ENLLID I+++DFGFA+ T CG+ +PEI+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---------TLCGTPEALAPEIILSK 213
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALISK 284
Y D W++GV+++ M G PF + Q+ +++ S + S + K L+
Sbjct: 214 GYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLRN 271
Query: 285 ILA------PVKTRLRIKNIKEDPWFRN 306
+L + + +IK WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 36/289 (12%)
Query: 50 IIGMGSYATVKLATSSRHSCEVAIKIISK--MQAPSDYLKKFLPREVEVVKGLKHPNLIK 107
+G G +ATV A + VAIK I D + + RE+++++ L HPN+I
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 108 FLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHR 167
L A + ++ ++ E + I + + + + + + Y H+ ++HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 168 DIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYC 227
D+K NLL+D + +KL+DFG A++ + + Y +PE+L G
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH------QVVTRWYRAPELLFGARMY 178
Query: 228 PQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD---------------- 271
D+W++G +L ++ L ++ + P +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 272 -----------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGP 308
+ LI + R+ + +F N P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 2e-55
Identities = 52/249 (20%), Positives = 100/249 (40%), Gaps = 9/249 (3%)
Query: 45 YTLGTIIGMGSYATVKLAT---SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
+ +IG G + V + VAIK + + FL E ++
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-RRDFL-SEASIMGQFD 85
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCH 160
HPN+I + + V II E+ E GSL +R+ G + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ VHRD+ N+L++++ K+SDFG +R + + + + + +PE
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
++ + SDVWS G+V++ ++ +G P+ D ++ ++ P +
Sbjct: 205 IQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 280 ALISKILAP 288
L+
Sbjct: 264 QLMLDCWQK 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-55
Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 20/275 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L +G G + V + T + VAIK + + +E +V+K L+H
Sbjct: 19 LRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLRHEK 73
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEG--YIDETRARKWFAQLVDAINYCHER 162
L++ A+ + +YI+ EY KGSLLD ++ E Y+ + AQ+ + Y
Sbjct: 74 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
VHRD++ N+L+ + K++DFG AR + + + +PE
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 223 GIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
+ + SDVWS G++L + GR+P+ ++L QV+ P P L
Sbjct: 188 YGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
Query: 282 ISKILAP-VKTRLRIKNIKE--DPWFRNGPSRPEY 313
+ + + R + ++ + +F + + P+Y
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTS--TEPQY 279
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-55
Identities = 51/246 (20%), Positives = 101/246 (41%), Gaps = 13/246 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
T +G G + VK R +VAIK+I + D E +V+ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 60
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERG 163
L++ ++II EY G LL+ +R + + + +A+ Y +
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
+HRD+ N L++ +K+SDFG +R + S ++ PE+L
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-----SVGSKFPVRWSPPEVLMY 175
Query: 224 IPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282
+ + SD+W+ GV+++ + G++P++ S+ + + + + S + ++
Sbjct: 176 SKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 283 SKILAP 288
Sbjct: 235 YSCWHE 240
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-54
Identities = 64/308 (20%), Positives = 117/308 (37%), Gaps = 41/308 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT + IG G+Y V A + + VAIK IS + Y ++ L RE++++ +H N
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTL-REIKILLRFRHEN 67
Query: 105 LIKFLQAIET----THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
+I I + ++ + L +++ ++ + Q++ + Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 126
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
V+HRD+K NLL++ ++K+ DFG AR + + + Y +PEI
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLAR---VADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--------- 271
+ + D+WS+G +L M+ R F Y L + + P
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 272 ---------------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPS 309
PN + L+ K+L R+ ++ P+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 310 RPEYPIMS 317
+ PI
Sbjct: 304 PSDEPIAE 311
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-54
Identities = 60/263 (22%), Positives = 111/263 (42%), Gaps = 12/263 (4%)
Query: 45 YTLGTIIGMGSYATVKLAT---SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
L +G GS+ V+ S + VA+K + REV + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCH 160
H NLI+ + T + ++ E A GSLLD + + +G+ ++ Q+ + + Y
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ +HRD+ NLL+ +K+ DFG R + + E +A+ +PE
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMR---ALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQV-QSKVVFPKDPNVSPEC 278
LK + SD W GV L+ M +G+ P+ SQ+L ++ + P+ + +
Sbjct: 186 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 279 KALISKILAP-VKTRLRIKNIKE 300
++ + A + R +++
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-53
Identities = 60/266 (22%), Positives = 117/266 (43%), Gaps = 18/266 (6%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L +G G + V + + H+ +VA+K + + D E ++K L+H
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY--IDETRARKWFAQLVDAINYCHER 162
L++ A+ T +YII EY E GSL+D ++ + + AQ+ + + + ER
Sbjct: 70 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+HRD++ N+L+ + K++DFG AR + E + +PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLAR-----LIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 223 GIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
+ + SDVWS G++L +V GR+P+ ++++ ++ + N E L
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
Query: 282 ISKILAP-VKTRLRIKNIKE--DPWF 304
+ + R ++ + +F
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 8e-53
Identities = 56/247 (22%), Positives = 107/247 (43%), Gaps = 13/247 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
T+ +G G Y V ++S VA+K + + + +++FL +E V+K +KHPN
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFL-KEAAVMKEIKHPN 74
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDII--RKEGYIDETRARKWFAQLVDAINYCHER 162
L++ L YII E+ G+LLD + + Q+ A+ Y ++
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 163 GVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILK 222
+HRD+ N L+ ++ +K++DFG +R + + +PE L
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLA 189
Query: 223 GIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281
+ + SDVW+ GV+L+ + +G P+ SQ+ + ++ + + L
Sbjct: 190 YNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 282 ISKILAP 288
+
Sbjct: 249 MRACWQW 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-53
Identities = 59/256 (23%), Positives = 112/256 (43%), Gaps = 10/256 (3%)
Query: 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKM--QAPSDYLKKFLPREV 94
+ +L+ + ++G G++ TV +V I + K +A S K + E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 95 EVVKGLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLV 153
V+ + +P++ + L T V +I + G LLD + + I W Q+
Sbjct: 63 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSY 213
+NY +R +VHRD+ N+L+ ++K++DFG A + + E +E
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA----KLLGAEEKEYHAEGGKVPI 177
Query: 214 AYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDP 272
+ + E + Y Q SDVWS GV ++ ++ FG P+D S++ ++ P+ P
Sbjct: 178 KWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236
Query: 273 NVSPECKALISKILAP 288
+ + ++ K
Sbjct: 237 ICTIDVYMIMVKCWMI 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-52
Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 39/288 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHS-----CEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
G ++G G++ V AT+ S +VA+K++ + S+ ++ L E++++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQ 96
Query: 100 L-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE--------------------- 137
L H N++ L A + +Y+I EY G LL+ +R +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 138 --GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195
+ + Q+ + + + VHRD+ N+L+ +K+ DFG AR+ M
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM- 215
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDD-T 253
+ + +PE L Y + SDVWS G++L+ + G P+
Sbjct: 216 ---SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 254 KYSQLLKQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKE 300
+ K +Q+ + + E ++ A + R N+
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-52
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 13/252 (5%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK 98
V++ T IG G + V L + +VAIK I + ++ E EV+
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIRE----GAMSEEDFIEEAEVMM 55
Query: 99 GLKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYI-DETRARKWFAQLVDAIN 157
L HP L++ + ++ E+ E G L D +R + + + + +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 158 YCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYAS 217
Y E V+HRD+ N L+ + IK+SDFG R + + S +AS
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-----STGTKFPVKWAS 170
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276
PE+ Y + SDVWS GV+++ + G++P+++ S++++ + + K S
Sbjct: 171 PEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 277 ECKALISKILAP 288
+++
Sbjct: 230 HVYQIMNHCWKE 241
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 172 bits (436), Expect = 4e-52
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 37/290 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+Y V A + + A+K I + + RE+ ++K LKH N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSN 61
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
++K I T R+ ++ E+ ++ + EG ++ A+ + QL++ I YCH+R V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K +NLLI+ + +K++DFG AR + + Y +P++L G
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY------THEIVTLWYRAPDVLMGS 175
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD------------- 271
D+WS+G + MV G F + L ++ + P
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 272 ---------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFR 305
+ L+SK+L R+ K E +F+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-52
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 15/263 (5%)
Query: 45 YTLGTIIGMGSYATVKLAT---SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK 101
LG IG G + V + VAIK SD +++ +E ++
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD 66
Query: 102 HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDII-RKEGYIDETRARKWFAQLVDAINYCH 160
HP+++K + I T + V+IIME G L + ++ +D + QL A+ Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
+ VHRDI N+L+ ++ +KL DFG +R + + +PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASKGKLPIKWMAPES 180
Query: 221 LKGIPYCPQLSDVWSMGVVLFAM-VFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECK 279
+ + SDVW GV ++ + + G PF K + ++ ++++ P PN P
Sbjct: 181 INFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239
Query: 280 ALISKILAP-VKTRLRIKNIKED 301
+L++K A R R +K
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-52
Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 30/270 (11%)
Query: 39 VLESHGYTLGTIIGMGSYATVKLAT--SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEV 96
VL+ + +IG G++ V A + AIK + + + D + F E+EV
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFA-GELEV 63
Query: 97 VKGL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKE----------------GY 139
+ L HPN+I L A E +Y+ +EYA G+LLD +RK
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 140 IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199
+ + + A + ++Y ++ +HRD+ N+L+ +Y K++DFG +R Y +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQL 258
+ + E L Y SDVWS GV+L+ +V G P+ ++L
Sbjct: 184 T-------MGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 259 LKQVQSKVVFPKDPNVSPECKALISKILAP 288
+++ K N E L+ +
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 3e-51
Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 37/274 (13%)
Query: 45 YTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
IG G++ V A + VA+K++ + +A +D F RE ++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQ-REAALMAE 72
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY-------------------- 139
+PN++K L + ++ EY G L + +R
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 140 ----IDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195
+ Q+ + Y ER VHRD+ N L+ + +K++DFG +RN
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY- 191
Query: 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTK 254
Y + PE + Y + SDVW+ GVVL+ + +G P+
Sbjct: 192 ---SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKILAP 288
+ +++ V+ + N E L+ +
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-51
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 37/292 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
+ IG G+Y V A + VA+K I + RE+ ++K L HPN
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPN 62
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSL-LDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
++K L I T +++Y++ E+ + I + + QL+ + +CH
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 164 VVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKG 223
V+HRD+K +NLLI+ + IKL+DFG AR + Y +PEIL G
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLG 176
Query: 224 IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD------------ 271
Y D+WS+G + MV R F L ++ + P +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 272 ----------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRN 306
P + + ++L+S++L R+ K P+F++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-51
Identities = 65/277 (23%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDY-LKKFLPREVEVVKGL 100
+ L ++G G+Y V L A+K++ K + E +V++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 101 KH-PNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYC 159
+ P L+ A +T ++++I++Y G L + + E + + ++V A+ +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
H+ G+++RDIK EN+L+D++ ++ L+DFG ++ + + + Y FCG+ Y +P+
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-----DFCGTIEYMAPD 200
Query: 220 ILKGIPYCP-QLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVS 275
I++G + D WS+GV+++ ++ G PF ++ +++ P +S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 276 PECKALISKILAP-VKTRLR-----IKNIKEDPWFRN 306
K LI ++L K RL IKE +F+
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-50
Identities = 56/304 (18%), Positives = 104/304 (34%), Gaps = 43/304 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G++ V A + +VA+K + + L RE+++++ LKH N
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHEN 70
Query: 105 LIKFLQAIETT--------HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAI 156
++ ++ T +Y++ ++ E + + ++ L++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 157 NYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYA 216
Y H ++HRD+K N+LI D +KL+DFG AR ++ + + Y
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR--AFSLAKNSQPNRYTNRVVTLWYR 188
Query: 217 SPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------- 269
PE+L G D+W G ++ M L +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 270 ------------------------KDPNVSPECKALISKILAP-VKTRLRIKNIKEDPWF 304
K P LI K+L R+ + +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 305 RNGP 308
+ P
Sbjct: 309 WSDP 312
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-50
Identities = 59/287 (20%), Positives = 103/287 (35%), Gaps = 23/287 (8%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y LG IG GS+ + L T EVAIK+ L E ++ K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 105 LIKFLQAIETT-HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
I ++ ++ME Q++ I Y H +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 164 VVHRDIKCENLLI---DADYNIKLSDFGFARNHMRYRSRQG-YESLSETFCGSYAYASPE 219
+HRD+K +N L+ + + DFG A+ + R+ Q ++ G+ YAS
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD----DTKYSQLLKQVQSKVVFPKD---P 272
GI + D+ S+G VL G LP+ TK + + + K+ P +
Sbjct: 184 THLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 273 NVSPECKALISKILA--PVK--TRLRIKNIKEDPWFRNGPSRPEYPI 315
E ++ + ++ + + + R G S +Y
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS-YDYVF 288
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-49
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 53/301 (17%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
YT +IG GS+ V A VAIK + + K+F RE+++++ L H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCN 74
Query: 105 LIKFLQAIETTHR------VYIIMEYAEKG---SLLDIIRKEGYIDETRARKWFAQLVDA 155
+++ ++ + ++++Y + R + + + + QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 156 INYCHERGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+ Y H G+ HRDIK +NLL+D D +KL DFG A+ +R + ++ S
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-------GEPNVSYICSRY 187
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--- 271
Y +PE++ G DVWS G VL ++ G+ F L ++ + P
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 272 -------------------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFR 305
P PE AL S++L RL +F
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 306 N 306
Sbjct: 308 E 308
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 59/299 (19%), Positives = 114/299 (38%), Gaps = 46/299 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCE-VAIKIISKMQAPSDYLKKFLPREVEVVKGLK-- 101
Y IG G+Y V A ++ VA+K + + REV V++ L+
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 67
Query: 102 -HPNLIKFLQAIETTH-----RVYIIMEYAEKGSL-LDIIRKEGYIDETRARKWFAQLVD 154
HPN+++ + ++ ++ E+ ++ E + + QL+
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 155 AINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYA 214
+++ H VVHRD+K +N+L+ + IKL+DFG AR + + + +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-------SVVVTLW 180
Query: 215 YASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--- 271
Y +PE+L Y D+WS+G + M + F + L ++ + P +
Sbjct: 181 YRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 272 -----------------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRN 306
++ K L+ K L R+ + P+F++
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-48
Identities = 54/250 (21%), Positives = 97/250 (38%), Gaps = 12/250 (4%)
Query: 45 YTLGTIIGMGSYATVKLA----TSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL 100
T +IG G + V +S + VAIK + K FL E ++
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQF 66
Query: 101 KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDI-IRKEGYIDETRARKWFAQLVDAINYC 159
H N+I+ I + II EY E G+L K+G + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 160 HERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPE 219
VHRD+ N+L++++ K+SDFG +R + + +PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR---VLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 220 ILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278
+ + SDVWS G+V++ ++ +G P+ + +++K + P +
Sbjct: 184 AISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242
Query: 279 KALISKILAP 288
L+ +
Sbjct: 243 YQLMMQCWQQ 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (409), Expect = 5e-48
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y IG G+Y TV A + VA+K + L RE+ ++K LKH N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKN 62
Query: 105 LIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGV 164
+++ + + ++ ++ E+ ++ G +D + + QL+ + +CH R V
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 165 VHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGI 224
+HRD+K +NLLI+ + +KL++FG AR + Y P++L G
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA------EVVTLWYRPPDVLFGA 176
Query: 225 PYCPQLSDVWSMGVVLFAMVFGRLP-FDDTKYSQLLKQVQSKVVFPKD------------ 271
D+WS G + + P F LK++ + P +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 272 ----------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRN 306
P ++ + L+ +L R+ + + P+F +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-48
Identities = 68/310 (21%), Positives = 122/310 (39%), Gaps = 49/310 (15%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y +G G+Y V A R +VAIK + + + K+ RE+ ++K ++H N
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 78
Query: 105 LIKFLQAIETTHR------VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINY 158
+I L Y++M + G+ L + K + E R + Q++ + Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 159 CHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASP 218
H G++HRD+K NL ++ D +K+ DFG AR +S + + Y +P
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---------ADSEMTGYVVTRWYRAP 187
Query: 219 EILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVFPKD------ 271
E++ Q D+WS+G ++ M+ G+ F QL + ++ P +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 272 -----------------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNG 307
N SP L+ K+L + R+ P+F +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 308 PSRPEYPIMS 317
+ P +
Sbjct: 308 HDTEDEPQVQ 317
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-48
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 33/283 (11%)
Query: 45 YTLGTIIGMGSYATVKLAT-------SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV 97
LG +G G++ V LA +VA+K++ D L + E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLI-SEMEMM 72
Query: 98 KGL-KHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIR----------------KEGYI 140
K + KH N+I L A +Y+I+EYA KG+L + ++ E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 141 DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200
Q+ + Y + +HRD+ N+L+ D +K++DFG AR+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHI 188
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLL 259
Y + + +PE L Y Q SDVWS GV+L+ + G P+ +L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 260 KQVQSKVVFPKDPNVSPECKALISKILAPV-KTRLRIKNIKED 301
K ++ K N + E ++ V R K + ED
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-47
Identities = 50/248 (20%), Positives = 100/248 (40%), Gaps = 11/248 (4%)
Query: 47 LGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHP 103
+IG G + V T + A+K ++++ + + +FL E ++K HP
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFL-TEGIIMKDFSHP 88
Query: 104 NLIKFLQA-IETTHRVYIIMEYAEKGSLLDIIRKEGY-IDETRARKWFAQLVDAINYCHE 161
N++ L + + +++ Y + G L + IR E + + Q+ + +
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEIL 221
+ VHRD+ N ++D + +K++DFG AR Y + + E L
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 222 KGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280
+ + + SDVWS GV+L+ ++ G P+ D + + +
Sbjct: 207 QTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 281 LISKILAP 288
++ K P
Sbjct: 266 VMLKCWHP 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-46
Identities = 52/270 (19%), Positives = 100/270 (37%), Gaps = 33/270 (12%)
Query: 45 YTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
+ G +G G++ V AT+ S + VA+K++ ++ ++ L E++V+
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSY 82
Query: 100 LK-HPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRK------------------EGYI 140
L H N++ L A +I EY G LL+ +R+ E +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 141 DETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200
D + Q+ + + + +HRD+ N+L+ K+ DFG AR+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK----ND 198
Query: 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD--TKYSQL 258
+ + +PE + Y + SDVWS G+ L+ + S+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 259 LKQVQSKVVFPKDPNVSPECKALISKILAP 288
K ++ + E ++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-45
Identities = 60/284 (21%), Positives = 101/284 (35%), Gaps = 30/284 (10%)
Query: 45 YTLGTIIGMGSYATVKLAT-----SSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
T+ +G GS+ V VAIK +++ + + + E V+K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMKE 79
Query: 100 LKHPNLIKFLQAIETTHRVYIIMEYAEKGSLLDIIRKEGY----------IDETRARKWF 149
++++ L + +IME +G L +R ++ +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 150 AQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETF 209
++ D + Y + VHRD+ N ++ D+ +K+ DFG R Y
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYYRKGGKG 195
Query: 210 CGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMV-FGRLPFDDTKYSQLLKQVQSKVVF 268
+ SPE LK + SDVWS GVVL+ + P+ Q+L+ V +
Sbjct: 196 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 269 PKDPNVSPECKALISKILAP-VKTRLRIKNIKE------DPWFR 305
K N L+ K R I +P FR
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 154 bits (390), Expect = 7e-45
Identities = 64/304 (21%), Positives = 128/304 (42%), Gaps = 58/304 (19%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HP 103
Y L +G G Y+ V A + ++ +V +KI+ ++ KK + RE+++++ L+ P
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGP 90
Query: 104 NLIKFLQAIE--TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE 161
N+I ++ + ++ E+ + + + + R + +++ A++YCH
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 147
Query: 162 RGVVHRDIKCENLLIDAD-YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
G++HRD+K N++ID + ++L D+G A + + S + PE+
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-------VASRYFKGPEL 200
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFD----------------------------- 251
L D+WS+G +L +M+F + PF
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 252 ---DTKYSQLLKQVQSK-----VVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKEDP 302
D +++ +L + K V VSPE + K+L ++RL + E P
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 303 WFRN 306
+F
Sbjct: 321 YFYT 324
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 1e-44
Identities = 48/268 (17%), Positives = 91/268 (33%), Gaps = 14/268 (5%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y +G IG GS+ + T+ ++ +VAIK + L E K L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCT 61
Query: 105 LIKFLQAI-ETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG 163
I + + ++++ + Q++ + HE+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 164 VVHRDIKCENLLIDADY-----NIKLSDFGFARNHMRYRSRQG-YESLSETFCGSYAYAS 217
+V+RDIK +N LI I + DFG + + ++Q + G+ Y S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 218 PEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277
G + D+ ++G V + G LP+ K + ++ + ++ K E
Sbjct: 182 INTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKKQSTPLRE 239
Query: 278 CKALISKILAPVKTRLRIKNIKEDPWFR 305
A + R P +
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYD 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-44
Identities = 55/261 (21%), Positives = 100/261 (38%), Gaps = 30/261 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
L IG G + V EVA+KI S + S F E+ L+H N
Sbjct: 5 IVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS----WFREAEIYQTVMLRHEN 58
Query: 105 LIKFLQAIE----TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
++ F+ A T +++++ +Y E GSL D + + + K + + H
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 117
Query: 161 E--------RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGS 212
+ HRD+K +N+L+ + ++D G A H + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD--SATDTIDIAPNHRVGT 175
Query: 213 YAYASPEILKGIPYCPQL-----SDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267
Y +PE+L +D+++MG+V + + + Q+ +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE----DYQLPYYDL 231
Query: 268 FPKDPNVSPECKALISKILAP 288
P DP+V K + + L P
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRP 252
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-44
Identities = 64/315 (20%), Positives = 120/315 (38%), Gaps = 45/315 (14%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPN 104
Y + +G G+Y +V A ++ VA+K +S+ + K+ RE+ ++K +KH N
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 105 LIKFLQAIETTHRV----YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH 160
+I L + + + G+ L+ I K + + + Q++ + Y H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 161 ERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEI 220
++HRD+K NL ++ D +K+ DFG AR+ + + + Y +PEI
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---------GYVATRWYRAPEI 189
Query: 221 LKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD--------- 271
+ + Q D+WS+G ++ ++ GR F T + LK + V P
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 272 ---------------------PNVSPECKALISKILAP-VKTRLRIKNIKEDPWFRNGPS 309
+P L+ K+L R+ +F
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 310 RPEYPIMSGDSLEVE 324
+ P+ E
Sbjct: 310 PDDEPVADPYDQSFE 324
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-40
Identities = 50/282 (17%), Positives = 103/282 (36%), Gaps = 33/282 (11%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSC-----EVAIKIISKMQAPSDYLKKFLPREVEVVKG 99
LG +G G++ V A + VA+K++ + S+ + L E++++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIH 72
Query: 100 LKHPNLIKFLQAI--ETTHRVYIIMEYAEKGSLLDIIRKEG----------------YID 141
+ H + L + + +I+E+ + G+L +R + ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 142 ETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201
+ Q+ + + R +HRD+ N+L+ +K+ DFG A R +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA----RDIYKDP 188
Query: 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQ-LL 259
+ +PE + Y Q SDVWS GV+L+ + P+ K +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 260 KQVQSKVVFPKDPNVSPECKALISKILAP-VKTRLRIKNIKE 300
++++ +PE + R + E
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-39
Identities = 72/341 (21%), Positives = 131/341 (38%), Gaps = 64/341 (18%)
Query: 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPRE 93
D TVL+ Y IG G+ V A + VAIK +S+ + K+ RE
Sbjct: 10 DSTFTVLKR--YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RE 66
Query: 94 VEVVKGLKHPNLIKFLQA------IETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARK 147
+ ++K + H N+I L +E VY++ME + I + +D R
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSY 123
Query: 148 WFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSE 207
Q++ I + H G++HRD+K N+++ +D +K+ DFG AR Y
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----- 178
Query: 208 TFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267
+ Y +PE++ G+ Y D+WS+G ++ MV ++ F Y +V ++
Sbjct: 179 --VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 268 FP-----------------------------------------KDPNVSPECKALISKIL 286
P + + + + L+SK+L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 287 AP-VKTRLRIKNIKEDPWFRNG--PSRPEYPIMSGDSLEVE 324
R+ + + + P+ P+ E P +++
Sbjct: 296 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (299), Expect = 2e-31
Identities = 57/338 (16%), Positives = 112/338 (33%), Gaps = 77/338 (22%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD-------YLKKFLPREVEVV 97
Y L +G G ++TV LA ++ VA+KI+ + ++ L++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 98 KGLKHPNLIKFLQAIET-----THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQL 152
+ +++K L H V + E L + I ++ QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 153 VDAINYC-HERGVVHRDIKCENLLIDAD------YNIKLSDFGFARNHMRYRSRQGYESL 205
+ ++Y G++H DIK EN+L++ IK++D G A + + +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN------ 188
Query: 206 SETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQS- 264
+ Y SPE+L G P+ +D+WS ++F ++ G F+ + K
Sbjct: 189 ---SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 265 ----------------------------------------------KVVFPKDPNVSPEC 278
+ + + E
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304
Query: 279 KALISKILAP-VKTRLRIKNIKEDPWFRNGPSRPEYPI 315
+S +L + R + PW ++ E +
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 9e-20
Identities = 27/188 (14%), Positives = 58/188 (30%), Gaps = 24/188 (12%)
Query: 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKII-------SKMQAPSDYLKKFLPREVEVV 97
+G ++G G + V S + E +K K++ DY
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 98 KGLKHPNLIKFLQAIETTH----RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLV 153
+ L K ++ME + + + + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMIL 113
Query: 154 DAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ----GYESLSETF 209
+ + + RG+VH D+ N+L+ + I + DF + R+ ++ F
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 210 CGSYAYAS 217
+Y
Sbjct: 173 SRTYRTEK 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 357 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.46 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-64 Score=450.99 Aligned_cols=259 Identities=34% Similarity=0.549 Sum_probs=221.2
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..+++.||||++......+ ..+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 47999999999999999999999999999999997654322 2456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~---- 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---- 158 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE----
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHH-hcccCCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQV-QSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 280 (357)
.......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...... .....+ ......+....+|+++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 223456789999999999998888777899999999999999999999765432 222222 333333444578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
||.+|| .||.+|||++|+++||||+..
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999 599999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-64 Score=447.02 Aligned_cols=254 Identities=31% Similarity=0.612 Sum_probs=225.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++++.||+|+||+||+|++..++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997543322333456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~------- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-------
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.... ...++.+|+++++||
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 235 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLI 235 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHH
T ss_pred -CcccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 12335679999999999998877 456999999999999999999999998888887775433 233357999999999
Q ss_pred HHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 283 SKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
.+|| .||.+|||++|+|+||||+.
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999 59999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-63 Score=445.79 Aligned_cols=261 Identities=31% Similarity=0.560 Sum_probs=224.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++++.||+|+||+||+|++..+++.||||++.+.....+...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997543222222456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~---- 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---- 163 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc----
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++..++.... ...+..+++++++||
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 223345689999999999998877 556999999999999999999999998888887776442 223357999999999
Q ss_pred HHcc-cCCCCCCCHHh------HhcCCccccCCC
Q psy10194 283 SKIL-APVKTRLRIKN------IKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~s~~e------~l~hp~f~~~~~ 309 (357)
.+|| .||.+|||++| +++||||++..+
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 9999 59999999998 588999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-62 Score=438.44 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=221.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.+|++.+.||+|+||+||+|++..+|..||||++....... .+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 46999999999999999999999999999999997654333 355779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~------ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------ 169 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc------
Confidence 99999999998865 46999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc--cCCCCCCCCCHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK--VVFPKDPNVSPECKA 280 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 280 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+... ...+.++.+++++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 123345689999999999998877 45699999999999999999999988776655554332 223344578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
||.+|| .||.+|||++|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999 599999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-61 Score=439.95 Aligned_cols=256 Identities=31% Similarity=0.564 Sum_probs=210.4
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
.+.|++.+.||+|+||+||+|++..+++.||||++.+...... ...+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999976543322 34567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec---CCCCeEEeecccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999888999999999999999999999999999999999999994 578999999999975432
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC---CCCCCCCC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV---FPKDPNVS 275 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 275 (357)
.....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+....+..... .+..+.+|
T Consensus 163 ----~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 163 ----GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ----CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 122345689999999999998877 5569999999999999999999999888887777765432 23345799
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++.+||.+|| .||.+|||++|+++||||++.
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999 599999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=436.16 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=220.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
+.|++.+.||+|+||+||+|++..++..||+|++.+.... ..+.+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999764322 2456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 123 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
|||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccCCCCCCccchhhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc--CCCCCCCCC
Q psy10194 202 YESLSETFCGSYAYASPEILKG----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV--VFPKDPNVS 275 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~ 275 (357)
......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+..+.... ....+..+|
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 12235689999999999853 2334667999999999999999999999888777766665433 223345789
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
+++.+||.+|| .||.+|||++|+++||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999 599999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-61 Score=431.17 Aligned_cols=255 Identities=30% Similarity=0.499 Sum_probs=213.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe--CCeEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET--THRVY 119 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~--~~~~~ 119 (357)
.++|++.+.||+|+||+||+|++..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 367999999999999999999999999999999997765543 345667899999999999999999999854 56689
Q ss_pred EEEeecCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----CeecCCCCCceEecCCCCeEEeecccc
Q psy10194 120 IIMEYAEKGSLLDIIRK----EGYIDETRARKWFAQLVDAINYCHERG-----VVHRDIKCENLLIDADYNIKLSDFGFA 190 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~g-----ivH~dlkp~NIll~~~~~~kl~Dfg~~ 190 (357)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 467999999999999999999999976 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC
Q psy10194 191 RNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK 270 (357)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~ 270 (357)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..++...+......+.
T Consensus 162 ~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (269)
T d2java1 162 RILNHD------TSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234 (269)
T ss_dssp HHC-----------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred eecccC------CCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 865321 122345789999999999988777 5669999999999999999999999998888888876655555
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcc
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKEDPWF 304 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f 304 (357)
+..+|+++.+||.+|| .||.+|||++|+++|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 5679999999999999 599999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-61 Score=443.32 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=228.1
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
.-++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 34689999999999999999999999999999999976432222224556799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~---- 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999864321
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
.......+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..++.+.+.... ...+..+|+++++
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~d 234 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKS 234 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred --CcccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHH
Confidence 123346789999999999999888 456999999999999999999999999888877766543 2334579999999
Q ss_pred HHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 281 LISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 281 li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
||.+|| .||.+|++ ++|+++||||++..
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 999999 59999995 89999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-61 Score=436.41 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=224.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIME 123 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e 123 (357)
.|++.+.||+|+||+||+|++..++..||||++.+.........+.+.+|+.+++.++|||||++++++.+.+.+++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987766666666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccccc
Q psy10194 124 YAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYE 203 (357)
Q Consensus 124 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 203 (357)
||.+|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888899999999999999999999999999999999999999999999999999975432
Q ss_pred cccccCCCCCCccchhhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-cCCCCCCCCCHHHHH
Q psy10194 204 SLSETFCGSYAYASPEILKGI--PYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-VVFPKDPNVSPECKA 280 (357)
Q Consensus 204 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 280 (357)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+... ........+|+++.+
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2346799999999999653 23466799999999999999999999988777666655443 334445578999999
Q ss_pred HHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 281 LISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
||.+|| .||.+|||++|+|+||||...
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999 599999999999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-61 Score=437.46 Aligned_cols=255 Identities=26% Similarity=0.528 Sum_probs=226.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..+|..||||++++.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999999999999999997543222222456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-------
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999976532
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+...++..... ..++.+++++.++|
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 232 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLL 232 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHH
T ss_pred --ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Confidence 23357899999999999988885 569999999999999999999999998888887765432 33357999999999
Q ss_pred HHcc-cCCCCCC-----CHHhHhcCCccccCC
Q psy10194 283 SKIL-APVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 283 ~~~L-~~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
.+|| .||.+|+ |++++++||||++..
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 9999 5999996 899999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=442.34 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=216.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||+||+|++..++..||+|+++.... ....+.+.+|+.+|+.++|||||+++++|.+...++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456789999999999999999999999999999999976433 233566779999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 999999999999999988899999999999999999999997 5999999999999999999999999999986532
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHH-------------------
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLL------------------- 259 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~------------------- 259 (357)
....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+..+..
T Consensus 158 -----~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 -----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp -----HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred -----CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 223457899999999999988874 5599999999999999999999765422211
Q ss_pred -----------------------HHHhcccCC-CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccC
Q psy10194 260 -----------------------KQVQSKVVF-PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 260 -----------------------~~~~~~~~~-~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~ 307 (357)
..+...... .....+|+++.+||.+||. ||.+|||++|+|+||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001101000 0112468999999999995 99999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=424.11 Aligned_cols=250 Identities=24% Similarity=0.488 Sum_probs=214.7
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe----CCeEEE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET----THRVYI 120 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~----~~~~~l 120 (357)
|++.++||+|+||+||+|.+..++..||+|.+....... ...+.+.+|+++++.++||||+++++++++ ...+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 478889999999999999999999999999997655443 335567899999999999999999999865 456899
Q ss_pred EEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCCceEec-CCCCeEEeeccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERG--VVHRDIKCENLLID-ADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~g--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~ 197 (357)
|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 9999999999999998889999999999999999999999999 99999999999996 578999999999975321
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHHhcccCCC-CCCCCC
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDT-KYSQLLKQVQSKVVFP-KDPNVS 275 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~ 275 (357)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+. +...+.+.+......+ .+..++
T Consensus 168 ------~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 168 ------SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred ------CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 22345689999999999876 34 66799999999999999999999764 4555566665544322 234689
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
+++.+||.+|| .||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999 5999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=429.74 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=224.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc---hHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS---DYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
.++|++++.||+|+||+||+|++..+|..||||++.+..... ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999999999999999997654322 12245677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC----CeEEeecccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY----NIKLSDFGFARNHM 194 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~ 194 (357)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999998776 59999999997653
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-C--CC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF-P--KD 271 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~-~--~~ 271 (357)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+...... + ..
T Consensus 169 ~~-------~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 169 FG-------NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp TS-------CBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CC-------ccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 21 22345678999999999998777 56699999999999999999999999888888777654322 2 12
Q ss_pred CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 272 PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 272 ~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
+.+|+++++||++||. ||.+|||++|+++||||+...
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 5789999999999994 999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.2e-60 Score=437.54 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=223.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||.||+|++..+|..||||++.+.. ....+.+.+|+.+|+.++||||++++++|.+++.+|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997643 223456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec--CCCCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID--ADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+||+|.+++... .++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---- 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---- 181 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT----
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC----
Confidence 999999999887654 4699999999999999999999999999999999999997 578999999999986542
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CCC--CCCCCCH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VFP--KDPNVSP 276 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 276 (357)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+.... .++ ..+.+|+
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 123345678999999999998887 456999999999999999999999988888877775533 222 3357999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
++.+||.+|| .||.+|||++|+|+||||+...
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999 5999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.3e-60 Score=435.86 Aligned_cols=257 Identities=25% Similarity=0.459 Sum_probs=224.3
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..+|..||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999996543 233567789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec--CCCCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID--ADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--- 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---
Confidence 9999999999985 456799999999999999999999999999999999999995 4678999999999765322
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CC--CCCCCCH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FP--KDPNVSP 276 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 276 (357)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+..... ++ ..+.+|+
T Consensus 180 ----~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 180 ----QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ----SCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ----cccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 22335689999999999998887 4569999999999999999999999888888877764432 22 2246899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSR 310 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~ 310 (357)
++++||.+|| .||.+|||++|+|+||||+.....
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 9999999999 599999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-59 Score=420.09 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=224.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCc------hHHHhhHHHHHHHHHcCC-CCCccceEEEEEeC
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPS------DYLKKFLPREVEVVKGLK-HPNLIKFLQAIETT 115 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~ 115 (357)
++|++.+.||+|+||+||+|++..++..||||++.+..... ....+.+.+|+.+++.++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999997654332 223456778999999997 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
+.+|||||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999986542
Q ss_pred cccccccccccccCCCCCCccchhhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhccc-CC-
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKG-----IPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKV-VF- 268 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~-~~- 268 (357)
. ......+||+.|+|||++.+ ....+.++||||+||++|+|++|+.||.+.+..+....+.... .+
T Consensus 163 ~-------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 163 G-------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred C-------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 1 12345679999999999853 2334667999999999999999999999998888777765442 22
Q ss_pred -CCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCcccc
Q psy10194 269 -PKDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 269 -~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~ 306 (357)
+..+.+|+++++||.+|| .||.+|||++|+++||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 233479999999999999 59999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-60 Score=438.71 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=226.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|++..+|..||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999999999999999997533222222345679999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~------- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-------
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHHH
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKALI 282 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 282 (357)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..... ..+..+++++.+||
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLL 269 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHH
T ss_pred --ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHH
Confidence 22356799999999999988874 569999999999999999999999988888887765543 23357999999999
Q ss_pred HHcc-cCCCCCC-----CHHhHhcCCccccCCC
Q psy10194 283 SKIL-APVKTRL-----RIKNIKEDPWFRNGPS 309 (357)
Q Consensus 283 ~~~L-~~p~~R~-----s~~e~l~hp~f~~~~~ 309 (357)
++|| .||.+|+ |++++++||||++..+
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 9999 5999985 9999999999987653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-60 Score=439.62 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=216.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhH---HHHHHHHHcCCCCCccceEEEEEeCCeE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFL---PREVEVVKGLKHPNLIKFLQAIETTHRV 118 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~---~~E~~~l~~l~h~~Iv~l~~~~~~~~~~ 118 (357)
-++|++.++||+|+||.||+|++..+|..||||++.+...........+ .+++.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4689999999999999999999999999999999865322111111222 2457778888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 99999999999999999989999999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH--hcccCCCCCCCCCH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV--QSKVVFPKDPNVSP 276 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~ 276 (357)
......+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+..... ........+..+|+
T Consensus 160 -----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 160 -----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp -----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred -----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 12345689999999999986655567799999999999999999999875433222222 22223334457999
Q ss_pred HHHHHHHHcc-cCCCCCCC-----HHhHhcCCccccCC
Q psy10194 277 ECKALISKIL-APVKTRLR-----IKNIKEDPWFRNGP 308 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s-----~~e~l~hp~f~~~~ 308 (357)
++++||.+|| .||.+||| ++|+++||||++..
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 9999999999 59999999 79999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=427.43 Aligned_cols=257 Identities=30% Similarity=0.513 Sum_probs=221.7
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHH-HcCCCCCccceEEEEEeCCeEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVV-KGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
++|++++.||+|+||+||+|.+..+++.||||++++.........+.+.+|..++ +.++||||+++++++.+.+.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999753211111122334566655 578999999999999999999999
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~----- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-----
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-----
Confidence 999999999999999889999999999999999999999999999999999999999999999999999754322
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKAL 281 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 281 (357)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+..... ..+..+|+++.+|
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dl 233 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDL 233 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred -cccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCccCCHHHHHH
Confidence 1233456899999999999998885 579999999999999999999999998888887764432 3335789999999
Q ss_pred HHHcc-cCCCCCCCHH-hHhcCCccccC
Q psy10194 282 ISKIL-APVKTRLRIK-NIKEDPWFRNG 307 (357)
Q Consensus 282 i~~~L-~~p~~R~s~~-e~l~hp~f~~~ 307 (357)
|++|| .||.+|||+. ++++||||++.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999 5999999996 89999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-59 Score=424.59 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=214.9
Q ss_pred EEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC--chHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEEee
Q psy10194 47 LGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP--SDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIMEY 124 (357)
Q Consensus 47 ~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~e~ 124 (357)
..++||+|+||+||+|++..+++.||||+++..... .+...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999999999999999999754322 223345677999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccccc
Q psy10194 125 AEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGYES 204 (357)
Q Consensus 125 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 204 (357)
+.++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------NR 155 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------CC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------cc
Confidence 999877777766778999999999999999999999999999999999999999999999999999764322 12
Q ss_pred ccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC--------------
Q psy10194 205 LSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK-------------- 270 (357)
Q Consensus 205 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~-------------- 270 (357)
.....+||+.|+|||++.....++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 233567999999999998776667789999999999999999999999887777666543211110
Q ss_pred -------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 271 -------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 271 -------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
.+.+++++.+||.+||. ||++|||++|+|+||||++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 13568999999999995 9999999999999999987553
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-59 Score=424.66 Aligned_cols=254 Identities=18% Similarity=0.370 Sum_probs=221.5
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++++.||+|+||+||+|.+..+++.||+|++++.. .....+.+|+.+|+.++||||+++++++++.+.+|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997643 22345779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC--CCeEEeeccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEG-YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD--YNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 199 (357)
|||+||+|.+++...+ .+++.+++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--- 157 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC---
Confidence 9999999999997655 79999999999999999999999999999999999999754 48999999999764321
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-CCC--CCCCCH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-FPK--DPNVSP 276 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~~~--~~~~~~ 276 (357)
......+||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... ++. .+.+|+
T Consensus 158 ----~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 158 ----DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ----CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ----CcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 12334578999999999988777 4569999999999999999999999998888887765432 222 246899
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCccccCC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~ 308 (357)
++++||++|| .||.+|||++|+++||||+...
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 9999999999 5999999999999999997643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-59 Score=415.54 Aligned_cols=251 Identities=31% Similarity=0.549 Sum_probs=214.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCch---HHHhhHHHHHHHHHcCC--CCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSD---YLKKFLPREVEVVKGLK--HPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~l~~~~~~~~ 116 (357)
.++|+++++||+|+||+||+|++..++..||||++.+...... .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999999999999999999976433221 11233458999999986 899999999999999
Q ss_pred eEEEEEeecCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-CCCeEEeecccccccc
Q psy10194 117 RVYIIMEYAEK-GSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-DYNIKLSDFGFARNHM 194 (357)
Q Consensus 117 ~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~ 194 (357)
.+++||||+.+ +++.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 688889988889999999999999999999999999999999999999985 4799999999997542
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
. ......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+ +.......+ ...+
T Consensus 163 ~--------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~~~~~--~~~~ 227 (273)
T d1xwsa_ 163 D--------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFF--RQRV 227 (273)
T ss_dssp S--------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHCCCCC--SSCC
T ss_pred c--------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhhcccCC--CCCC
Confidence 1 223457899999999999888777777999999999999999999997642 122233333 3479
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKEDPWFRNG 307 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~ 307 (357)
|+++++||.+|| .||.+|||++|+++||||++.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999 599999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=413.24 Aligned_cols=259 Identities=28% Similarity=0.450 Sum_probs=215.6
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.+.||+|+||+||+|.+..+++.||||+++..... +...+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5899999999999999999999999999999999654322 223456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHH-H-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 123 EYAEKGSLLDIIR-K-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 123 e~~~~gsL~~~l~-~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||+.+ .+.+++. . .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---- 155 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 155 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC----
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC----
Confidence 99976 5554443 2 457999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-----------
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP----------- 269 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~----------- 269 (357)
........||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 1233455799999999999888888888999999999999999999999887766555543211000
Q ss_pred --------C---------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 270 --------K---------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 270 --------~---------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
. .+.+++++.+||++||. ||.+|||++|+++||||++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0 13578999999999995 9999999999999999987644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=419.46 Aligned_cols=254 Identities=27% Similarity=0.496 Sum_probs=207.8
Q ss_pred cCEEEEe-EeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHH-cCCCCCccceEEEEEe----CC
Q psy10194 43 HGYTLGT-IIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVK-GLKHPNLIKFLQAIET----TH 116 (357)
Q Consensus 43 ~~y~~~~-~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~l~~~~~~----~~ 116 (357)
++|.+.+ +||+|+||+||+|.+..+++.||||++++. ..+.+|+.++. .++||||++++++|++ ..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 5798865 699999999999999999999999998642 34568998864 5689999999999976 46
Q ss_pred eEEEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC---CCCeEEeeccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA---DYNIKLSDFGFAR 191 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~---~~~~kl~Dfg~~~ 191 (357)
.+|+|||||+||+|.+++.+. ..+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 789999999999999999764 46999999999999999999999999999999999999975 5679999999997
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc-----c
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-----V 266 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-----~ 266 (357)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+.+.......+... .
T Consensus 163 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 163 ETTSH-------NSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp ECCCC-------CCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred eccCC-------CccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 65322 22345689999999999988777 45699999999999999999999876544433333222 2
Q ss_pred CCCCC--CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCCCCC
Q psy10194 267 VFPKD--PNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPSRPE 312 (357)
Q Consensus 267 ~~~~~--~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~~~~ 312 (357)
.++.. ..+|+++.+||.+|| .||.+|||+.|+++||||......+.
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 283 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence 22221 358999999999999 59999999999999999987655443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-57 Score=406.13 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=214.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.++||+|+||+||+|++. +++.||||++...... +...+.+.+|+.+|+.++||||+++++++.+.+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 58999999999999999999986 6789999999665432 223456779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
|++.++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+.......
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----- 154 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----- 154 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-----
Confidence 999887777777778889999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCC-------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFP------------- 269 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~------------- 269 (357)
.......|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.+.+..+.+.++......+
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 122344689999999999887777888999999999999999999999887776665543211100
Q ss_pred ---------------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 270 ---------------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 270 ---------------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
..+.+++++.+||++||. ||++|||++|+|+||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 113578999999999995 9999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-56 Score=400.52 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=213.6
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC----
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH---- 116 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~---- 116 (357)
..++|++.+.||+|+||+||+|.+..+++.||||++++....+....+.+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3578999999999999999999999999999999998776666666777889999999999999999999997654
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+|+|||||+|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++..+|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999999999899999999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC-C--CCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV-F--PKDPN 273 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~-~--~~~~~ 273 (357)
.. ........+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+.+..+...++..... . ...+.
T Consensus 165 ~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 165 GN---SVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp -----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred cc---cccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 21 1223446689999999999988777 4569999999999999999999998887776655543322 2 23457
Q ss_pred CCHHHHHHHHHcc-cCCCCCC-CHHhHhcCCccc
Q psy10194 274 VSPECKALISKIL-APVKTRL-RIKNIKEDPWFR 305 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~-s~~e~l~hp~f~ 305 (357)
+|+++.+||.+|| .||.+|| |++++ .|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 9999999999999 5999999 55554 455653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-56 Score=403.81 Aligned_cols=258 Identities=21% Similarity=0.344 Sum_probs=209.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCc---EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSC---EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+...+|++.++||+|+||+||+|.+..++. .||||.+.... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 445789999999999999999999876654 57888875433 3334566789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+++|||||++|+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998876 45799999999999999999999999999999999999999999999999999986543
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
...... ........||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++...+......+.+..+
T Consensus 181 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 181 DTSDPT-YTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCcce-eeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 222111 111223457899999999988777 456999999999999997 89999999999999888888877777889
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
++++.+||.+|| .||.+|||+.|++++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 599999999998874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-56 Score=404.87 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=213.5
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-------
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------- 114 (357)
.++|++.++||+|+||+||+|++..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 478999999999999999999999999999999987654332 223456699999999999999999999854
Q ss_pred -CCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 -THRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 -~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
...+++|||++.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999988777666666678999999999999999999999999999999999999999999999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCCC--
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPKD-- 271 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~~-- 271 (357)
...... ........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 168 ~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 168 SLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 432211 1223345679999999999987766677899999999999999999999988777666555432211110
Q ss_pred -----------------------------CCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 272 -----------------------------PNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 272 -----------------------------~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
...++++.+||.+||. ||++|||++|+|+||||+..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0137788999999995 999999999999999998643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=400.26 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=212.9
Q ss_pred EEEE-eEeeecCceEEEEEEEC--CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEE
Q psy10194 45 YTLG-TIIGMGSYATVKLATSS--RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYII 121 (357)
Q Consensus 45 y~~~-~~Lg~G~~g~Vy~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv 121 (357)
+.+. ++||+|+||+||+|.+. .++..||||+++.... +....+.+.+|+.+++.++||||++++++++++ .+++|
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 3443 47999999999999864 4557899999965443 334456678999999999999999999999754 56899
Q ss_pred EeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQG 201 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 201 (357)
||||++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-- 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-- 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE--
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc--
Confidence 999999999999999889999999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHHHH
Q psy10194 202 YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPECKA 280 (357)
Q Consensus 202 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (357)
........||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..+|+++.+
T Consensus 164 -~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 241 (277)
T d1xbba_ 164 -YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241 (277)
T ss_dssp -EEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 122334578999999999988776 456999999999999997 89999999988888888877777777789999999
Q ss_pred HHHHcc-cCCCCCCCHHhH---hcCCccc
Q psy10194 281 LISKIL-APVKTRLRIKNI---KEDPWFR 305 (357)
Q Consensus 281 li~~~L-~~p~~R~s~~e~---l~hp~f~ 305 (357)
||.+|| .||.+|||++++ |+|+|++
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999999 599999999998 4666653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=394.78 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=209.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+...+|++.+.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 34578999999999999999999976 4568999999764433 245679999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998654 5689999999999999999999999999999999999999999999999999976542211
Q ss_pred ccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHH
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPE 277 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (357)
.......||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+..++...+......+.+..++++
T Consensus 157 -----~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 230 (263)
T d1sm2a_ 157 -----TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230 (263)
T ss_dssp -------------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred -----eeecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHH
Confidence 12234568999999999998877 556999999999999998 57778888888888888877776666788999
Q ss_pred HHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 278 CKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 278 ~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+.+||.+|| .||.+|||++|+++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999 599999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-56 Score=402.50 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=209.8
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCC-CcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC---CCCCccceEEEEEe---
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRH-SCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL---KHPNLIKFLQAIET--- 114 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~l~~~~~~--- 114 (357)
.++|++.++||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 66799999875433221 123345777777665 79999999999853
Q ss_pred --CCeEEEEEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 115 --THRVYIIMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 115 --~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
...++++||++.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999999876654443 34569999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--- 268 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--- 268 (357)
..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 165 ~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 165 IYSFQ-------MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCCGG-------GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhccc-------ccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 54321 23346789999999999998887 55699999999999999999999998877766665321110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 269 -----------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 269 -----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.....+++.+.+||.+||. ||.+|||++|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0123578999999999995 999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=401.03 Aligned_cols=260 Identities=20% Similarity=0.352 Sum_probs=220.7
Q ss_pred EEeecCEEEEeE-eeecCceEEEEEEECC--CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTI-IGMGSYATVKLATSSR--HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~-Lg~G~~g~Vy~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
.+..++|.+.+. ||+|+||+||+|.+.. ++..||||+++... .....+.+.+|+++|+.++|||||++++++.+
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 355678999985 9999999999998754 45579999997543 23345667799999999999999999999975
Q ss_pred CeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+.+++|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 457899999999999999754 4679999999999999999999999999999999999999999999999999998654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
..... .......+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++...+..+...+.++.
T Consensus 161 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 236 (285)
T d1u59a_ 161 ADDSY---YTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236 (285)
T ss_dssp TCSCE---ECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTT
T ss_pred ccccc---cccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 32221 122335578999999999987776 556999999999999997 9999999888888888888777777778
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhH---hcCCccc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNI---KEDPWFR 305 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~---l~hp~f~ 305 (357)
+++++.+||.+|| .+|++|||+.++ |+|+|+.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999 599999999887 6778774
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-56 Score=401.97 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=219.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||+||+|.+..++..||||+++..... .+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 5567899999999999999999999999999999998765433 345679999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999999764 578999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCC-CCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRL-PFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
. .......|++.|+|||++.+..+ +.++|||||||++|+|++|.. ||.+.+...+.+.+......+.+..+++
T Consensus 170 ~-----~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 170 Y-----TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp S-----EEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred c-----eeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 1 11223457899999999988777 567999999999999999655 4566777777777777777777778999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhcCCccc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~hp~f~ 305 (357)
++.+||.+|| .||.+|||++|+++ +|+
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~--~L~ 271 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ--AFE 271 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH--HHH
Confidence 9999999999 59999999999976 454
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=396.71 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=217.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++.+.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.+++.++|||||++++++.+ +.++
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34578999999999999999999976 5678999999764433 2456799999999999999999998754 5678
Q ss_pred EEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999999997743 3369999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
........||+.|+|||++.+..+ +.++|||||||++|+|+|| .+||...+..+....+......+.+..+++
T Consensus 164 -----~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 164 -----YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp -----EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred -----cccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 112334568999999999987776 5669999999999999985 566777788888888888777777778999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc--CCcccc
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE--DPWFRN 306 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~--hp~f~~ 306 (357)
++.+||.+|| .||.+|||++++++ |+||..
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999 59999999999998 788853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=407.59 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=210.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH----- 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~----- 116 (357)
.++|++.++||+|+||+||+|.+..+|+.||||++++... .+...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5789999999999999999999999999999999976543 3444566779999999999999999999997654
Q ss_pred -eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 -RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+|+||||| +.+|..+++ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 557777765 45799999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC-------
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF------- 268 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~------- 268 (357)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 174 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 174 ---------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ---------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ---------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 2235678999999999988777677899999999999999999999887765554433221100
Q ss_pred -----------------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 269 -----------------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 269 -----------------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
.....+++++.+||++||. ||.+|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0124679999999999995 999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=397.30 Aligned_cols=253 Identities=23% Similarity=0.410 Sum_probs=204.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++++.||+|+||+||+|+... .||||+++....... ..+.+.+|+.+++.++||||+++++++. ...++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 446789999999999999999998543 599999976544333 3556779999999999999999999874 45689
Q ss_pred EEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRS 198 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 198 (357)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999754 5699999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccCCCCCCccchhhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhcccCCC----CC
Q psy10194 199 RQGYESLSETFCGSYAYASPEILKGIP--YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQSKVVFP----KD 271 (357)
Q Consensus 199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~~~~~~----~~ 271 (357)
........||+.|+|||++.+.. .++.++|||||||++|+|+||+.||.+.+.. .+...+......+ ..
T Consensus 160 ----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 160 ----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 12334567999999999997542 2366799999999999999999999886544 3444444443333 23
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
..+++++.+||.+|| .||.+|||++|++++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 568999999999999 599999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=406.62 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=212.4
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCc-----EEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSC-----EVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|+++++||+|+||+||+|++...+. .||+|.+..... ......+.+|+.+++.+ +|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 456789999999999999999999865443 589998865432 22345677899999887 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCC
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE-----------------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIK 170 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlk 170 (357)
+.+.+++|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999999999999653 248999999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q psy10194 171 CENLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLP 249 (357)
Q Consensus 171 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~p 249 (357)
|+|||++.++.+||+|||+|+....... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|+| |..|
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN----YVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhccccccCCeEEEeeccccccccCCCc----eeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999986543221 112334568999999999988777 556999999999999997 8999
Q ss_pred CCCCcHH-HHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 250 FDDTKYS-QLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 250 f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
|.+.+.. .+.+.+......+.+..+|+++.+||.+|| .||.+|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9876544 445556666666677789999999999999 599999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=390.23 Aligned_cols=250 Identities=20% Similarity=0.374 Sum_probs=220.7
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEE
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~l 120 (357)
..++|++.++||+|+||+||+|+++ ++..||||++++..... +.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 3568999999999999999999985 67789999998755443 456799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccccc
Q psy10194 121 IMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSR 199 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 199 (357)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence 9999999999999754 45789999999999999999999999999999999999999999999999999976543211
Q ss_pred cccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCCHHH
Q psy10194 200 QGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVSPEC 278 (357)
Q Consensus 200 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (357)
.......||+.|+|||++.+..+ +.++|||||||++|+|+| |+.||.+.+..++...+......+.+...++++
T Consensus 156 ----~~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 230 (258)
T d1k2pa_ 156 ----TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230 (258)
T ss_dssp ----CCCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ----eeecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHH
Confidence 12234568999999999988777 456999999999999998 899999999999999898887777777899999
Q ss_pred HHHHHHccc-CCCCCCCHHhHhcC
Q psy10194 279 KALISKILA-PVKTRLRIKNIKED 301 (357)
Q Consensus 279 ~~li~~~L~-~p~~R~s~~e~l~h 301 (357)
.+||.+||+ ||.+|||++++++|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999995 89999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=404.17 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=207.8
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe------CCe
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET------THR 117 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~------~~~ 117 (357)
+|+..++||+|+||+||+|++..+++.||||++.+... ...+|+.+|+.++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976432 22379999999999999999999843 345
Q ss_pred EEEEEeecCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeeccccccc
Q psy10194 118 VYIIMEYAEKGSLLDII---RKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNH 193 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~ 193 (357)
+++|||||+++.+..+. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999875433332 3456799999999999999999999999999999999999999775 8999999999765
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcc--------
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSK-------- 265 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~-------- 265 (357)
... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 174 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRG-------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTT-------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCC-------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 321 22345679999999999987766678899999999999999999999887766655444211
Q ss_pred ----------cCCC----------CCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCC
Q psy10194 266 ----------VVFP----------KDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGP 308 (357)
Q Consensus 266 ----------~~~~----------~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~ 308 (357)
..++ ..+.+++++.+||.+||. ||.+|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1111 123579999999999995 999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=391.53 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=219.4
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEEEEE
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
++|++.++||+|+||+||+|++..++..||||+++..... +.....+.+|+.+++.++||||+++++++.+...+++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 4899999999999999999999999999999999765543 334566779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccccc
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQGY 202 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (357)
+++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----- 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-----
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHHhcccCC-------------
Q psy10194 203 ESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPF-DDTKYSQLLKQVQSKVVF------------- 268 (357)
Q Consensus 203 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf-~~~~~~~~~~~~~~~~~~------------- 268 (357)
.......+++.|.|||++.+..+.+.++|||||||++|+|++|+.|| .+.+..+....+......
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 12234457889999999988877788899999999999999999985 455555555544321110
Q ss_pred ---------------CCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCcccc
Q psy10194 269 ---------------PKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRN 306 (357)
Q Consensus 269 ---------------~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~ 306 (357)
.....+++.+.+||++||+ ||++|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0113578999999999995 9999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=401.18 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=210.9
Q ss_pred cCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC-----e
Q psy10194 43 HGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH-----R 117 (357)
Q Consensus 43 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~-----~ 117 (357)
.+|++.++||+|+||+||+|.+..+|..||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997644 2333456779999999999999999999996543 3
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
++++ +++.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4555 456688999999764 69999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCC---------
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVF--------- 268 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~--------- 268 (357)
. ........+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........
T Consensus 164 ~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 164 D---HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp C---BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred c---cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 2 1223456789999999999977666678899999999999999999999887655444333211100
Q ss_pred ------------C---------CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcCCccccCCC
Q psy10194 269 ------------P---------KDPNVSPECKALISKIL-APVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 269 ------------~---------~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
+ ..+.+++++.+||.+|| .||.+|||++|+|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0 11367899999999999 59999999999999999986544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-55 Score=400.59 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=207.6
Q ss_pred eecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEe--CCe
Q psy10194 41 ESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIET--THR 117 (357)
Q Consensus 41 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~--~~~ 117 (357)
..++|+++++||+|+||+||+|++..+++.||||++++.. .+.+.+|+.+|+.++ ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999986532 345678999999985 9999999999975 456
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCC-CeEEeecccccccccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADY-NIKLSDFGFARNHMRY 196 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 196 (357)
+++|||||.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999998764 4599999999999999999999999999999999999998665 6999999999765321
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHHhc-----------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-QLLKQVQS----------- 264 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-~~~~~~~~----------- 264 (357)
......+||+.|+|||.+.+...++.++||||+||++|+|++|+.||...... .....+..
T Consensus 184 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 184 -------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp -------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred -------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 12345678999999999988776677899999999999999999999754321 11111100
Q ss_pred ---c----------------------cCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 265 ---K----------------------VVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 265 ---~----------------------~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
. ........+++++.+||++||. ||.+|||++|+|+||||++..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0 0001113478999999999995 9999999999999999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=388.03 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=214.7
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCCeEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTHRVY 119 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~~~~ 119 (357)
+..++|++++.||+|+||+||+|.+..+ ..||||++...... .+.+.+|+.+++.++|||||++++++.+ +.++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 4567899999999999999999998765 57999999765433 2457799999999999999999999854 5678
Q ss_pred EEEeecCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccccc
Q psy10194 120 IIMEYAEKGSLLDIIRK--EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYR 197 (357)
Q Consensus 120 lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 197 (357)
+|||||++|+|..++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999999988743 4579999999999999999999999999999999999999999999999999997543211
Q ss_pred cccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcccCCCCCCCCCH
Q psy10194 198 SRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQVQSKVVFPKDPNVSP 276 (357)
Q Consensus 198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (357)
........||+.|+|||++.+..+ +.++|||||||++|+|++| .+||......+.+..+......+.++.+++
T Consensus 168 -----~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 168 -----YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred -----ceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence 112234568999999999988777 4569999999999999985 556677777888888888877777889999
Q ss_pred HHHHHHHHcc-cCCCCCCCHHhHhc--CCccccCC
Q psy10194 277 ECKALISKIL-APVKTRLRIKNIKE--DPWFRNGP 308 (357)
Q Consensus 277 ~~~~li~~~L-~~p~~R~s~~e~l~--hp~f~~~~ 308 (357)
++.+||.+|| .||++|||++++++ ++||....
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 9999999999 59999999999988 88987643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-55 Score=397.83 Aligned_cols=262 Identities=25% Similarity=0.450 Sum_probs=216.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEE---CCCCcEEEEEEeecCCCC-chHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATS---SRHSCEVAIKIISKMQAP-SDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~---~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~ 116 (357)
-++|++++.||+|+||+||+|.+ ..+|+.||||++.+.... +....+.+.+|+.+++.++| |||+++++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999987 446889999998654321 11224556689999999976 89999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHh---cccCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIP-YCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQ---SKVVFPKDP 272 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~---~~~~~~~~~ 272 (357)
.. .......|++.|+|||.+.+.. +.+.++|||||||+||+|++|+.||.+.+..+....+. .....+.+.
T Consensus 183 ~~-----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 183 ET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp GG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred cc-----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 21 2234567899999999997654 45667999999999999999999997754333222221 122333345
Q ss_pred CCCHHHHHHHHHccc-CCCCCC-----CHHhHhcCCccccCC
Q psy10194 273 NVSPECKALISKILA-PVKTRL-----RIKNIKEDPWFRNGP 308 (357)
Q Consensus 273 ~~~~~~~~li~~~L~-~p~~R~-----s~~e~l~hp~f~~~~ 308 (357)
.+++++.+||++||. ||.+|| |++|+++||||+...
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 799999999999995 999999 589999999998643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=400.18 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=213.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC-----C
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT-----H 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~-----~ 116 (357)
.++|++.++||+|+||+||+|++..+|+.||||++++...... ..+.+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 5789999999999999999999999999999999976554333 345567999999999999999999998532 3
Q ss_pred eEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
..+++++++.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||++.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34566677789999999854 5699999999999999999999999999999999999999999999999999975431
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccCCCC------
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVVFPK------ 270 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~~~~------ 270 (357)
......|++.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 174 --------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 --------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp --------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred --------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 233567899999999998887778889999999999999999999998877666555532221110
Q ss_pred ------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccccCCC
Q psy10194 271 ------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFRNGPS 309 (357)
Q Consensus 271 ------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~~~~~ 309 (357)
...+++++++||++||. ||.+|||++|+|+||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 13579999999999995 9999999999999999986543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=386.09 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=209.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCC----cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHS----CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETT 115 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~ 115 (357)
+...+|++.++||+|+||+||+|.+..++ ..||||.+..... +.....+.+|+.+++.++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 45578999999999999999999876554 4699999865432 33345577999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccc
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHM 194 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 194 (357)
+..++|||||.++++.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999987654 679999999999999999999999999999999999999999999999999998654
Q ss_pred ccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHhcccCCCCCCC
Q psy10194 195 RYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQVQSKVVFPKDPN 273 (357)
Q Consensus 195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (357)
.... .........||+.|+|||++.+..+ +.++|||||||++|+|++| .+||...+..++.+.+..+...+.+..
T Consensus 162 ~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 237 (283)
T d1mqba_ 162 DDPE---ATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CCCc---cceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchh
Confidence 2211 1112234568999999999988777 4569999999999999985 555667777888888888887777778
Q ss_pred CCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 274 VSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 274 ~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+++++.+||.+|| .+|.+|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999 59999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=385.60 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=207.5
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
+..++|++++.||+|+||+||+|.+..++ ..||||.++... .+...+.+.+|+.+++.++||||+++++++. .+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 34578999999999999999999986543 468888875432 3444567789999999999999999999995 56
Q ss_pred eEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccccc
Q psy10194 117 RVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMR 195 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 195 (357)
.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999998755 45799999999999999999999999999999999999999999999999999986542
Q ss_pred cccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCC
Q psy10194 196 YRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNV 274 (357)
Q Consensus 196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (357)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..++...+......+.++.+
T Consensus 161 ~~-----~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (273)
T d1mp8a_ 161 ST-----YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred Cc-----ceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 21 122334568999999999987777 556999999999999997 89999999888888888888777777899
Q ss_pred CHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 275 SPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 275 ~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
|+++.+||.+|| .||.+|||+.|+++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 599999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=390.17 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=212.4
Q ss_pred ceEEeecCEEEEeEeeecCceEEEEEEECCCCc----EEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEE
Q psy10194 37 MTVLESHGYTLGTIIGMGSYATVKLATSSRHSC----EVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAI 112 (357)
Q Consensus 37 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~ 112 (357)
+..+..++|++.++||+|+||+||+|.+..+++ .||+|.+..... ....+.+.+|+.+++.++|||||++++++
T Consensus 3 ~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp SEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345667789999999999999999999987776 477887754332 22245677999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 113 ETTHRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 113 ~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
.++ ..++++|++.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 81 LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp ESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred ecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 875 45677888889999988765 4679999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCC
Q psy10194 192 NHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPK 270 (357)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~ 270 (357)
....... ........||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||.+.+..++...+..+...+.
T Consensus 160 ~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (317)
T d1xkka_ 160 LLGAEEK----EYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234 (317)
T ss_dssp HTTTTCC------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred ecccccc----cccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 6542211 122234568999999999988776 566999999999999998 8999999888888888888777777
Q ss_pred CCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 271 DPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 271 ~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
++.+++++.+||.+|| .||.+|||+.|+++|
T Consensus 235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 7789999999999999 599999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=381.37 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=206.2
Q ss_pred eEEeecCEEEEeEeeecCceEEEEEEECC-CC--cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe
Q psy10194 38 TVLESHGYTLGTIIGMGSYATVKLATSSR-HS--CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET 114 (357)
Q Consensus 38 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~ 114 (357)
..+..++|++.+.||+|+||+||+|+... ++ ..||||++.+....++...+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34667889999999999999999998643 33 3689999977655555556678899999999999999999999965
Q ss_pred CCeEEEEEeecCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccccccc
Q psy10194 115 THRVYIIMEYAEKGSLLDIIRK-EGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNH 193 (357)
Q Consensus 115 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 193 (357)
..+++|||||++|+|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 467899999999999987754 457999999999999999999999999999999999999999999999999999865
Q ss_pred cccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhc-ccCCCCC
Q psy10194 194 MRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQS-KVVFPKD 271 (357)
Q Consensus 194 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~-~~~~~~~ 271 (357)
...... ........|++.|+|||++.+..+ +.++|||||||++|+|+| |..||.+.+..+....+.. ....+..
T Consensus 162 ~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 162 PQNDDH---YVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237 (273)
T ss_dssp CC-CCE---EEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred ccCCCc---ceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence 432221 123334567889999999988776 556999999999999997 8999999998888877754 4555666
Q ss_pred CCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 272 PNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 272 ~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+++++.+||.+|| .||++|||+++|++
T Consensus 238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 789999999999999 59999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=385.66 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=215.4
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECCCCcE--EEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEEeC
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSRHSCE--VAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIETT 115 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~~~ 115 (357)
.+.-++|++.++||+|+||+||+|.+..++.. ||||.+..... ....+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 45567899999999999999999999888764 66777654332 22355678999999998 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCC
Q psy10194 116 HRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDAD 179 (357)
Q Consensus 116 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~ 179 (357)
+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999643 569999999999999999999999999999999999999999
Q ss_pred CCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCcHHHH
Q psy10194 180 YNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR-LPFDDTKYSQL 258 (357)
Q Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~-~pf~~~~~~~~ 258 (357)
+.+||+|||+++...... ......||+.|+|||.+.+..+ +.++|||||||++|+|++|. +||.+.+..++
T Consensus 164 ~~~kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp GCEEECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CceEEccccccccccccc-------cccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999997543221 1234568999999999988777 55699999999999999964 67999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 259 LKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
...+..+...+.+..+++++.+||.+|| .||++|||+.|+++|
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9888887777777789999999999999 599999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=393.31 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=205.2
Q ss_pred CCcceEEeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 34 DGKMTVLESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 34 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.|........+|++.++||+|+||+||+|++..+|..||||++.+.... ......+.+|+.+++.++||||++++++|.
T Consensus 8 ~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred eCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 3444444557899999999999999999999999999999999876543 333456779999999999999999999995
Q ss_pred ------eCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeec
Q psy10194 114 ------TTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDF 187 (357)
Q Consensus 114 ------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Df 187 (357)
....+|+|||||.+ ++.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred cccccccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeech
Confidence 34789999999976 454444 346899999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHhcccC
Q psy10194 188 GFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQVQSKVV 267 (357)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~~~~~~ 267 (357)
|+++..... ......+||+.|+|||++.+..+.. ++||||+||++|+|++|+.||.+.+......++.....
T Consensus 164 ~~~~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~-~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 164 GLARTAGTS-------FMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp CC----------------------CCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred hhhhccccc-------cccccccccccccChhhhcCCCCCC-CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 998764322 2233557899999999999877754 59999999999999999999988776665544432111
Q ss_pred CCC-----------------------------------------CCCCCHHHHHHHHHccc-CCCCCCCHHhHhcCCccc
Q psy10194 268 FPK-----------------------------------------DPNVSPECKALISKILA-PVKTRLRIKNIKEDPWFR 305 (357)
Q Consensus 268 ~~~-----------------------------------------~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~hp~f~ 305 (357)
.+. ....++++.+||++||. ||++||||+|+|+||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 000 01246789999999995 999999999999999998
Q ss_pred cC
Q psy10194 306 NG 307 (357)
Q Consensus 306 ~~ 307 (357)
..
T Consensus 316 ~~ 317 (355)
T d2b1pa1 316 VW 317 (355)
T ss_dssp GG
T ss_pred CC
Confidence 64
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=377.00 Aligned_cols=245 Identities=25% Similarity=0.441 Sum_probs=206.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE-eCCeE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE-TTHRV 118 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~-~~~~~ 118 (357)
+..++|++++.||+|+||.||+|.+. |..||||++++... .+.+.+|+.+++.++||||+++++++. ..+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 34568999999999999999999984 56899999965332 345779999999999999999999884 45668
Q ss_pred EEEEeecCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccc
Q psy10194 119 YIIMEYAEKGSLLDIIRKE--GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 119 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 196 (357)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 9999999999999999654 3589999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHHhcccCCCCCCCCC
Q psy10194 197 RSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTKYSQLLKQVQSKVVFPKDPNVS 275 (357)
Q Consensus 197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (357)
......+++.|+|||++.+..+ +.++|||||||++|+|+| |++||...+..++...+..+...+.++.++
T Consensus 156 --------~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (262)
T d1byga_ 156 --------TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred --------CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 1223467899999999988776 566999999999999998 799999988888888888877777777899
Q ss_pred HHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 276 PECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 276 ~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+++.+||.+|| .||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999 599999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-52 Score=381.38 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=216.9
Q ss_pred ecCEEEEeEeeecCceEEEEEEEC-----CCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSS-----RHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH 116 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~ 116 (357)
.++|++.+.||+|+||+||+|+.. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 467999999999999999999864 356789999986543 3344567789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCC
Q psy10194 117 RVYIIMEYAEKGSLLDIIRKEG------------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCE 172 (357)
Q Consensus 117 ~~~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~ 172 (357)
..++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996432 3889999999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCC-CCCC
Q psy10194 173 NLLIDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGR-LPFD 251 (357)
Q Consensus 173 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~-~pf~ 251 (357)
|||++.++.+||+|||+++....... .......+|++.|+|||++.+..+ +.++|||||||++|+|++|. +||.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGC----BC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceEECCCCcEEEccchhheeccCCcc----ccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999975432211 223345678999999999988777 45699999999999999885 6899
Q ss_pred CCcHHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 252 DTKYSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
+.+..+....+..+...+.+..+++++.+||.+|| .+|.+|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999998888887776677789999999999999 59999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=380.70 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=213.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECCCC-------cEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSRHS-------CEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~ 111 (357)
+..++|++++.||+|+||.||+|+...++ ..||||++++... ......+.+|...+..+ +||||++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 56679999999999999999999875543 4699999865432 23344566788888777 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 112 IETTHRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
|.++..+++|||||++|+|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999644 35899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.+||+|||+++....... .......+|++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY----YKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT----TCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCCeEeccchhhcccccccc----ccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999986643222 223345678999999999988777 566999999999999997 799999999
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..++...+..+...+.+..+++++.+||.+|| .||++|||+.|+++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 99888888888777777889999999999999 59999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=378.95 Aligned_cols=255 Identities=20% Similarity=0.337 Sum_probs=200.3
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|+++++||+|+||.||+|.+.. +++.||||+++..... .. .+.+.+|..++..+ +|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~-~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SE-HRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HH-HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HH-HHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999644 3467999998654322 22 34455666666655 6899999999886
Q ss_pred e-CCeEEEEEeecCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEe
Q psy10194 114 T-THRVYIIMEYAEKGSLLDIIRKE----------------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLI 176 (357)
Q Consensus 114 ~-~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll 176 (357)
. ...+++|||||++|+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 45689999999999999999653 248999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCc-
Q psy10194 177 DADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTK- 254 (357)
Q Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~- 254 (357)
+.++.+||+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++| .+||.+..
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CGGGCEEECC------CCSCTT----SCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCcEEEccCcchhhcccccc----ccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999976432221 223345679999999999988776 5669999999999999986 56787654
Q ss_pred HHHHHHHHhcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 255 YSQLLKQVQSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~h 301 (357)
...+...+..+...+.++.+++++.+||.+|| .||.+|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 34455566666666666789999999999999 599999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=375.57 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=219.5
Q ss_pred EEeecCEEEEeEeeecCceEEEEEEECC-----CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEE
Q psy10194 39 VLESHGYTLGTIIGMGSYATVKLATSSR-----HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIE 113 (357)
Q Consensus 39 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~ 113 (357)
.+..++|.+++.||+|+||+||+|.+.. ++..||||++++.. .......+.+|+.+++.++||||+++++++.
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 4556899999999999999999998742 35689999987543 2333456779999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeE
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKE----------GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIK 183 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~k 183 (357)
.....++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 999999999999999999998542 2468999999999999999999999999999999999999999999
Q ss_pred EeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHH
Q psy10194 184 LSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFG-RLPFDDTKYSQLLKQV 262 (357)
Q Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G-~~pf~~~~~~~~~~~~ 262 (357)
|+|||+++....... ........||+.|+|||.+.+..+ +.++|||||||++|+|+|| ..||.+.+..+....+
T Consensus 174 l~DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp ECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EeecccceeccCCcc----eeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999986543222 122334568999999999988777 4569999999999999998 5889999999988888
Q ss_pred hcccCCCCCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 263 QSKVVFPKDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
......+.++.+++.+.++|.+|| .+|.+|||+.++++
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 887777777789999999999999 59999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=373.43 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=213.8
Q ss_pred EeecCEEEEeEeeecCceEEEEEEE-----CCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcC-CCCCccceEEEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATS-----SRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGL-KHPNLIKFLQAIE 113 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~l~~~~~ 113 (357)
+..++|+++++||+|+||.||+|++ ..++..||||+++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 5668999999999999999999985 34667899999976543 23345677999999998 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceE
Q psy10194 114 TTHRVYIIMEYAEKGSLLDIIRKEG------------------YIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLL 175 (357)
Q Consensus 114 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIl 175 (357)
+.+.+++|||||++|+|.+++.+.. .+++..++.++.||+.||.|||++|++||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999997543 5899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCc
Q psy10194 176 IDADYNIKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVF-GRLPFDDTK 254 (357)
Q Consensus 176 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~-G~~pf~~~~ 254 (357)
++.++.++|+|||.++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT----SEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCcccccccchheeccCCCc----ceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999986543221 123345678999999999987766 556999999999999998 666676655
Q ss_pred HHH-HHHHHhcccCCCCCCCCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 255 YSQ-LLKQVQSKVVFPKDPNVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 255 ~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
... +.+.+..+.....+..+++++.+||.+||. ||++|||++++++
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 543 444556666666666799999999999995 9999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=365.98 Aligned_cols=251 Identities=18% Similarity=0.266 Sum_probs=204.2
Q ss_pred EEEeEeeecCceEEEEEEECCCC---cEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEe-CCeEEEE
Q psy10194 46 TLGTIIGMGSYATVKLATSSRHS---CEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIET-THRVYII 121 (357)
Q Consensus 46 ~~~~~Lg~G~~g~Vy~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~-~~~~~lv 121 (357)
.+.++||+|+||+||+|.+..++ ..||||.+++.. .....+.+.+|++++++++||||+++++++.. +..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 44789999999999999986543 368999986533 34445667899999999999999999999865 5689999
Q ss_pred EeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeecccccccccccccc
Q psy10194 122 MEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGFARNHMRYRSRQ 200 (357)
Q Consensus 122 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (357)
||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999998754 457888999999999999999999999999999999999999999999999998654322211
Q ss_pred ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHHhcccCCCCCCCCCHHHH
Q psy10194 201 GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDD-TKYSQLLKQVQSKVVFPKDPNVSPECK 279 (357)
Q Consensus 201 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (357)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.. .+..+....+..+...+.++.+++++.
T Consensus 188 --~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 188 --VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp --TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred --ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 122334568999999999987776 5669999999999999997777654 344455566666666666678999999
Q ss_pred HHHHHcc-cCCCCCCCHHhHhcC
Q psy10194 280 ALISKIL-APVKTRLRIKNIKED 301 (357)
Q Consensus 280 ~li~~~L-~~p~~R~s~~e~l~h 301 (357)
+||.+|| .||++||++.|+++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999 599999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-48 Score=353.22 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=201.2
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~~~~~~~~~l 120 (357)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++|+++ +.+..++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 35799999999999999999999999999999998764332 346689999999987664 555566688899999
Q ss_pred EEeecCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEec---CCCCeEEeecccccccccc
Q psy10194 121 IMEYAEKGSLLDIIR-KEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLID---ADYNIKLSDFGFARNHMRY 196 (357)
Q Consensus 121 v~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 196 (357)
||||+.+ +|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..++|+|||+++.....
T Consensus 81 vme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 81 VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999955 6666654 456899999999999999999999999999999999999985 4557999999999876543
Q ss_pred cccc-ccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHHHHHHHH----hcccCCC--
Q psy10194 197 RSRQ-GYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYSQLLKQV----QSKVVFP-- 269 (357)
Q Consensus 197 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~~~~~~~----~~~~~~~-- 269 (357)
.... .........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+ ......+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 2211 11223446689999999999998777 55699999999999999999999875543322221 1111111
Q ss_pred -CCCCCCHHHHHHHHHcc-cCCCCCCCHH---hHhcCCcccc
Q psy10194 270 -KDPNVSPECKALISKIL-APVKTRLRIK---NIKEDPWFRN 306 (357)
Q Consensus 270 -~~~~~~~~~~~li~~~L-~~p~~R~s~~---e~l~hp~f~~ 306 (357)
..+.+|+++.++|..|| .+|.+||++. ++|+|+|.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 12478999999999999 5999999986 5578877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=353.22 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=191.0
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCccceEEEEEeCC----e
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNLIKFLQAIETTH----R 117 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~l~~~~~~~~----~ 117 (357)
.++|.+.+.||+|+||+||+|+. +|..||||+++... ........|+..+..++||||+++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46799999999999999999986 57799999986432 11222234566666789999999999997654 6
Q ss_pred EEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------cCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 118 VYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE--------RGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 118 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
+++|||||++|+|.+++++. .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 89999999999999999775 58999999999999999999996 5999999999999999999999999999
Q ss_pred cccccccccccccccccccCCCCCCccchhhhcCCCC-----CCCcccHHHHHHHHHHHHhCCCCCCCC-----------
Q psy10194 190 ARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPY-----CPQLSDVWSMGVVLFAMVFGRLPFDDT----------- 253 (357)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~ll~G~~pf~~~----------- 253 (357)
++......... .......+||+.|+|||++.+... .+.++|||||||+||+|+||..||...
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 155 AVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp CEEEETTTTEE--CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred cccccCCCcce--eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 98654322211 123345789999999999876532 244689999999999999998877321
Q ss_pred ----cHHHHHHHHhcccCCCCCC------CCCHHHHHHHHHccc-CCCCCCCHHhHhc
Q psy10194 254 ----KYSQLLKQVQSKVVFPKDP------NVSPECKALISKILA-PVKTRLRIKNIKE 300 (357)
Q Consensus 254 ----~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L~-~p~~R~s~~e~l~ 300 (357)
........+......|..+ .....+.+|+.+||. ||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2233333333222222111 123458899999995 8999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-47 Score=345.69 Aligned_cols=252 Identities=19% Similarity=0.207 Sum_probs=204.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC-CCccceEEEEEeCCeEEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH-PNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~l~~~~~~~~~~~l 120 (357)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|++.++.+.| +|++.+++++......++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 56899999999999999999999999999999998654332 345688999999975 899999999999999999
Q ss_pred EEeecCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecC-----CCCeEEeecccccccc
Q psy10194 121 IMEYAEKGSLLDIIRKE-GYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDA-----DYNIKLSDFGFARNHM 194 (357)
Q Consensus 121 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~-----~~~~kl~Dfg~~~~~~ 194 (357)
||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67999998764 47999999999999999999999999999999999999964 5789999999998754
Q ss_pred ccccccc-cccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHHhcc-cCCC
Q psy10194 195 RYRSRQG-YESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTK---YSQLLKQVQSK-VVFP 269 (357)
Q Consensus 195 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~---~~~~~~~~~~~-~~~~ 269 (357)
....... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .......+... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3322111 1123445789999999999998777 556999999999999999999997543 22222222211 1111
Q ss_pred ---CCCCCCHHHHHHHHHcc-cCCCCCCCHHhHhc
Q psy10194 270 ---KDPNVSPECKALISKIL-APVKTRLRIKNIKE 300 (357)
Q Consensus 270 ---~~~~~~~~~~~li~~~L-~~p~~R~s~~e~l~ 300 (357)
..+.+|+++.+++..|+ .+|.+||+.+.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12468999999999999 49999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-47 Score=351.50 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=195.1
Q ss_pred ecCEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-----------CCCccceEE
Q psy10194 42 SHGYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-----------HPNLIKFLQ 110 (357)
Q Consensus 42 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~l~~ 110 (357)
+.+|+++++||+|+||+||+|++..+|+.||||++++. ....+.+.+|+.+++.++ |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 35699999999999999999999999999999999653 223455668998888775 578999998
Q ss_pred EEE--eCCeEEEEEeecCCCCHHHH-H--HHcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCCceEecCCCC---
Q psy10194 111 AIE--TTHRVYIIMEYAEKGSLLDI-I--RKEGYIDETRARKWFAQLVDAINYCHE-RGVVHRDIKCENLLIDADYN--- 181 (357)
Q Consensus 111 ~~~--~~~~~~lv~e~~~~gsL~~~-l--~~~~~l~~~~~~~i~~qi~~~l~~LH~-~givH~dlkp~NIll~~~~~--- 181 (357)
++. .....+++++++..+..... . .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 874 44677777777765443332 2 234578999999999999999999998 89999999999999976653
Q ss_pred ---eEEeeccccccccccccccccccccccCCCCCCccchhhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcHH--
Q psy10194 182 ---IKLSDFGFARNHMRYRSRQGYESLSETFCGSYAYASPEILKGIPYCPQLSDVWSMGVVLFAMVFGRLPFDDTKYS-- 256 (357)
Q Consensus 182 ---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~~ll~G~~pf~~~~~~-- 256 (357)
++++|||.+..... .....+||+.|+|||++.+..++ .++||||+||++++|++|+.||......
T Consensus 168 ~~~~kl~dfg~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE---------HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EEEEEECCCTTCEETTB---------CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceeeEeeccccccccc---------ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 99999999875432 22356799999999999988874 5699999999999999999999754321
Q ss_pred ----HHHHHHhcc---------------------c--------------------CCCCCCCCCHHHHHHHHHccc-CCC
Q psy10194 257 ----QLLKQVQSK---------------------V--------------------VFPKDPNVSPECKALISKILA-PVK 290 (357)
Q Consensus 257 ----~~~~~~~~~---------------------~--------------------~~~~~~~~~~~~~~li~~~L~-~p~ 290 (357)
+.+...... . ........++++.+||.+||+ ||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 111110000 0 000012346889999999995 999
Q ss_pred CCCCHHhHhcCCccccCCCCC
Q psy10194 291 TRLRIKNIKEDPWFRNGPSRP 311 (357)
Q Consensus 291 ~R~s~~e~l~hp~f~~~~~~~ 311 (357)
+|||++|+|+||||++.....
T Consensus 318 ~Rpta~e~L~Hp~f~~~~~~~ 338 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKDTLGME 338 (362)
T ss_dssp TCBCHHHHHTCGGGTTCTTCT
T ss_pred HCcCHHHHhcCcccCCCCCcc
Confidence 999999999999999665443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.6e-26 Score=194.31 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=106.6
Q ss_pred EEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCC---------------chHHHhhHHHHHHHHHcCCCCCccceE
Q psy10194 45 YTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAP---------------SDYLKKFLPREVEVVKGLKHPNLIKFL 109 (357)
Q Consensus 45 y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~Iv~l~ 109 (357)
|.++++||+|+||+||+|.+. +|+.||||+++..... .........+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999975 6789999987532110 011123345688899999999999887
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCCceEecCCCCeEEeeccc
Q psy10194 110 QAIETTHRVYIIMEYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHERGVVHRDIKCENLLIDADYNIKLSDFGF 189 (357)
Q Consensus 110 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~givH~dlkp~NIll~~~~~~kl~Dfg~ 189 (357)
++. . .+++|||+++..+.+ ++...+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||.
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 653 2 279999998865432 45566788999999999999999999999999999998654 89999999
Q ss_pred cccc
Q psy10194 190 ARNH 193 (357)
Q Consensus 190 ~~~~ 193 (357)
|...
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 8654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=2.6e-08 Score=85.62 Aligned_cols=138 Identities=15% Similarity=0.076 Sum_probs=95.2
Q ss_pred CEEEEeEeeecCceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCC-CCCccceEEEEEeCCeEEEEE
Q psy10194 44 GYTLGTIIGMGSYATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLK-HPNLIKFLQAIETTHRVYIIM 122 (357)
Q Consensus 44 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~l~~~~~~~~~~~lv~ 122 (357)
.|+..+..+-++.+.||++. .++..+++|+........ ...+.+|...++.+. +--+.+++.+..+.+..++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 56666665556667999886 344567888875432221 234567888887764 333678888888899999999
Q ss_pred eecCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy10194 123 EYAEKGSLLDIIRKEGYIDETRARKWFAQLVDAINYCHE----------------------------------------- 161 (357)
Q Consensus 123 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~----------------------------------------- 161 (357)
++++|.++.+.... ......++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 99999887654321 11223345555555666663
Q ss_pred ------------------cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 162 ------------------RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 162 ------------------~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999877667799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=6.9e-07 Score=75.97 Aligned_cols=127 Identities=16% Similarity=0.110 Sum_probs=81.9
Q ss_pred EeeecC-ceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCC--CCccceEEEEEeCCeEEEEEeecC
Q psy10194 50 IIGMGS-YATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKH--PNLIKFLQAIETTHRVYIIMEYAE 126 (357)
Q Consensus 50 ~Lg~G~-~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~l~~~~~~~~~~~lv~e~~~ 126 (357)
.+..|. .+.||++.. .++..+++|....... ..+.+|...++.+.. -.+.+++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 334454 468999884 4566788897654332 235578888776642 336778888888889999999998
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q psy10194 127 KGSLLDIIRKEGYIDETRARKWFAQLVDAINYCH---------------------------------------------- 160 (357)
Q Consensus 127 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH---------------------------------------------- 160 (357)
|.++.+. .+... ..+.++...|.-||
T Consensus 90 G~~~~~~-----~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 90 GQDLLSS-----HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp SEETTTS-----CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccccc-----cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 8655321 01111 11122222222333
Q ss_pred -----h-------cCCeecCCCCCceEecCCCCeEEeeccccc
Q psy10194 161 -----E-------RGVVHRDIKCENLLIDADYNIKLSDFGFAR 191 (357)
Q Consensus 161 -----~-------~givH~dlkp~NIll~~~~~~kl~Dfg~~~ 191 (357)
. ..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2 137999999999999887667899998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.23 E-value=1.4e-06 Score=79.28 Aligned_cols=81 Identities=15% Similarity=0.034 Sum_probs=48.4
Q ss_pred EeEeeecCceEEEEEEECCCCcEEEEEEeecC----CCCchHHHhhHHHHHHHHHcCC-C--CCccceEEEEEeCCeEEE
Q psy10194 48 GTIIGMGSYATVKLATSSRHSCEVAIKIISKM----QAPSDYLKKFLPREVEVVKGLK-H--PNLIKFLQAIETTHRVYI 120 (357)
Q Consensus 48 ~~~Lg~G~~g~Vy~~~~~~~~~~vaiK~i~~~----~~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~l~~~~~~~~~~~l 120 (357)
.+.||.|....||++....++..+++|.-... ......-......|...|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998877888999964321 0000001123446888877663 2 335555543 4555689
Q ss_pred EEeecCCCCH
Q psy10194 121 IMEYAEKGSL 130 (357)
Q Consensus 121 v~e~~~~gsL 130 (357)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.44 E-value=0.00026 Score=62.02 Aligned_cols=68 Identities=7% Similarity=0.050 Sum_probs=43.3
Q ss_pred ceEEEEEEECCCCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-----cce--EEEEEeCCeEEEEEeecCCC
Q psy10194 56 YATVKLATSSRHSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-----IKF--LQAIETTHRVYIIMEYAEKG 128 (357)
Q Consensus 56 ~g~Vy~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----v~l--~~~~~~~~~~~lv~e~~~~g 128 (357)
--.||++.. ++|..|++|+........ +.+..|...+..|...++ +.. -..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999985 567789999986544332 335567777776642111 111 12345677889999999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.09 E-value=0.00086 Score=60.22 Aligned_cols=81 Identities=16% Similarity=0.121 Sum_probs=51.9
Q ss_pred EeecCEEEEeEeeecCceEEEEEEECC-------CCcEEEEEEeecCCCCchHHHhhHHHHHHHHHcCCCCCc-cceEEE
Q psy10194 40 LESHGYTLGTIIGMGSYATVKLATSSR-------HSCEVAIKIISKMQAPSDYLKKFLPREVEVVKGLKHPNL-IKFLQA 111 (357)
Q Consensus 40 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~l~~~ 111 (357)
+..+..++ +.|+-|-.=.+|++.... ....|.+++..... .. ....+|..+++.+.-.++ .+++++
T Consensus 40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~--idr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TE--SHLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CH--HHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---hh--hHHHHHHHHHHHHHhCCCCCeEEEE
Confidence 34445554 578888889999998653 23567777764221 11 123478888888853344 567776
Q ss_pred EEeCCeEEEEEeecCCCCH
Q psy10194 112 IETTHRVYIIMEYAEKGSL 130 (357)
Q Consensus 112 ~~~~~~~~lv~e~~~~gsL 130 (357)
+.+ .+|+||++|..|
T Consensus 114 ~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 114 FSG----GRLEEYIPSRPL 128 (395)
T ss_dssp ETT----EEEECCCCEEEC
T ss_pred cCC----ceEEEEeccccC
Confidence 643 689999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.46 E-value=0.009 Score=51.30 Aligned_cols=31 Identities=39% Similarity=0.479 Sum_probs=27.4
Q ss_pred cCCeecCCCCCceEecCCCCeEEeecccccc
Q psy10194 162 RGVVHRDIKCENLLIDADYNIKLSDFGFARN 192 (357)
Q Consensus 162 ~givH~dlkp~NIll~~~~~~kl~Dfg~~~~ 192 (357)
.|++|+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998853
|